id,sessionId,parentSessionId,title,location,date,timeRange,timezone,sessionType,category,chairName,chairCountry,presenterName,presenterCountry
382,EA,NULL,"Excellence Award Lectures","Hall 1 |","16:15 - 17:30CETAwards",,CET,Awards,"12. Professional and educational affairs","Jon S. FRIEDLAND","United Kingdom",NULL,NULL
383,EA,382,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon S. FRIEDLAND","United KingdomChair"
384,EA,382,"Towards pandemic prevention, moonshot or utopia?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion KOOPMANS",Netherlands
385,EA,382,"Can global warming bring new infectious diseases?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arturo CASADEVALL","United States"
386,EF003,NULL,"On the frontiers of vaccine driven prevention","Arena 1 |","08:30 - 09:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)","Maria GANCZAK",Poland,NULL,NULL
387,EF003,386,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria GANCZAK",PolandChair
388,EF003,386,"A Pragmatic Randomized Trial to Evaluate Bivalent RSV Prefusion F Protein–based Vaccine Effectiveness for Preventing RSV Hospitalizations in Older Adults (DAN-RSV): Rationale & Trial Design",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mats LASSEN",Denmark
389,EF003,386,"A phase 1 study with an innovative approach for an HIV-1 prophylactic vaccine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pedro GARBES","United States"
390,EF003,386,"Changes in dose interval can impact T cell responses but not antibody levels in individuals receiving the modified vaccinia Ankara Mpox vaccine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph PARSONS","United Kingdom"
391,EF003,386,"Six-month Immunogenicity of mRNA-1345 RSV Vaccine in Adults Aged ≥60 Years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mihir DESAI","United Kingdom"
392,EF003,386,"Comparative Immune Responses to Homologous and Heterologous SARS-CoV-2 Vaccination Using DNA and Protein Platforms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia PRIETO MARTIN GIL",Spain
393,EF003,386,"Quantitative correlates of protection against SARS-CoV-2 variants using individual-level reconstructed antibody kinetics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tim RUSSELL","United Kingdom"
394,EF003,386,"Effectiveness of the 2023-24 seasonal influenza vaccine in UK healthcare workers: results from the SIREN prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luke MCGEOCH","United Kingdom"
395,EF003,386,"Immunogenicity and safety of second COVID-19 booster and Influenza vaccination coadministration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabell WAGENHÄUSER",Germany
396,EF003,386,"The degree of immunization against the Measles virus of the infant population in Sibiu county, Romania",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan-Vasile CRISTEA",Romania
397,EF004,NULL,"Pharmacology from bench to the bedside","Arena 3 |","08:30 - 09:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Alina Karoline NUSSBAUMER-PRÖLL",Austria,NULL,NULL
398,EF004,397,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alina Karoline NUSSBAUMER-PRÖLL",AustriaChair
399,EF004,397,"Enterococcus faecalis impairs Escherichia coli response to antibiotics in a dual-species intracellular infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francoise VAN BAMBEKE",Belgium
400,EF004,397,"In vitro investigations of ceftazidime-avibactam and fosfomycin against carbapenemase-producing Enterobacterales clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miklas MARTENS",Germany
401,EF004,397,"In vivo activity and PK of the novel siderophore-cephalosporin AR-2126 in a lethal lung infection model in mice infected with a carbapenem-resistant Pseudomonas aeruginosa following subcutaneous administration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wolfgang WICHA",Austria
402,EF004,397,"Synergistic Potency Unveiled: β-Lactam and β-Lactamase Inhibitor Combination against Mycobacterium abscessus with Dual Action of β-Lactamase Inhibition and Multi-Target Receptor Inactivation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eunjeong SHIN","United States"
403,EF004,397,"Pharmacokinetic/pharmacodynamic evaluation of benzoxaborole MRX-5 in mouse pneumonia model with Mycobacterium abscessus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wen WANG","United States"
404,EF004,397,"Pharmacokinetic/pharmacodynamic modelling of immune response and meropenem activity in immunocompetent and neutropenic mouse lung infection models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raphaël SAPORTA",Sweden
405,EF004,397,"Implementation of a model-based nomogram for amoxicillin precision dosing in patients suspected of infective endocarditis: preliminary results of the NOMOBA-AMX multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul LE TURNIER","French Guiana"
406,EF004,397,"No time to waste: hospital-wide assessment of IV- vial and line residuals and impact on target attainment.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorian VANNESTE",Belgium
407,EF004,397,"Population pharmacokinetic modelling of colistin in critically-ill patients on sustained low-efficiency dialysis: implications for dose selection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dominika FUHS",Australia
408,EF005,NULL,"It's all in the blood","Arena 2 |","09:30 - 10:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Colin R. MACKENZIE",Germany,NULL,NULL
409,EF005,408,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Colin R. MACKENZIE",GermanyChair
410,EF005,408,"Limited delayed incubation of blood culture bottles has limited effect on yield and time-to-positivity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liselotte HARDY",Belgium
411,EF005,408,"Unnecessary clinical interventions due to blood culture contamination in a large Canadian hospital network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clayton Wallace HALL",Canada
412,EF005,408,"Utility of sigmoidal growth curve when no organisms are seen on Gram stain in positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Declan CRILLY","United Kingdom"
413,EF005,408,"Clinical microbiology laboratory consultancy to optimize blood culture workflow: Analysis of results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlotta MAGRI",Italy
414,EF005,408,"Comparison of Syndromic Sepsis Panel and Standard Blood Culture Results: Contribution to Patient Management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sevim Gayenur BUYUKBERBER",Türkiye
415,EF005,408,"Predicting blood culture positivity using machine learning with complete blood and differential counts in a tertiary care hospital of Turkiye",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özlem TÜRKMEN RECEN",Türkiye
416,EF005,408,"Performance of direct pathogen and β-lactamase detection workflow using MALDI-TOF MS from positive blood culture specimens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kosuke KOSAI",Japan
417,EF005,408,"Waiting for follow-up blood cultures is not always necessary for diagnosis of central line-associated bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lieke VAN BALEN",Netherlands
418,EF005,408,"Economic and health gains associated with the adoption of the 2-hour phenotypic antimicrobial susceptibility testing in patients with bloodstream infection in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cidália PINA-VAZ",Portugal
419,EF006,NULL,"Emerging developments in antifungal pharmacology","Arena 4 |","09:30 - 10:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","06. Fungal infection & disease","Roger BRÜGGEMANN",Netherlands,NULL,NULL
420,EF006,419,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roger BRÜGGEMANN",NetherlandsChair
421,EF006,419,"NATURE-US: the natural history of antifungal failure in invasive candidiasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis OSTROSKY-ZEICHNER","United States"
422,EF006,419,"The antidepressant vortioxetine enhances resistance toward multiple azoles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia RIZZO",Italy
423,EF006,419,"Enhancing Isavuconazole Pharmacokinetics: A Comprehensive Population (PPK) Model from Three Phase 3 Trials and Covariate Exploration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amit DESAI","United States"
424,EF006,419,"Identification of efflux inhibitors for Candida albicans through a drug repurposing strategy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Débora MARQUES",Portugal
425,EF006,419,"Clinical outcomes of micafungin 100 mg vs. 150 mg daily for the treatment of Candida auris fungemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jysheng HOU","United States"
426,EF006,419,"Resolution of clinical signs in adults with invasive candidiasis and/or candidaemia treated with rezafungin or caspofungin: ReSTORE and STRIVE trial pooled analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"George R THOMPSON","United States"
427,EF006,419,"Ibrexafungerp is effective in treatment of patients with candidiasis, including candidaemia, caused by Candida auris: a multicentre, open-label study (CARES)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marisa H. MICELI","United States"
428,EF006,419,"High-dose isavuconazole therapy is well-tolerated and significantly improves survival in a fruit fly model of invasive mucormycosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastian WURSTER","United States"
429,EF006,419,"Pharmacokinetics, pharmacodynamics, safety, and efficacy of innovative dosing schedules of liposomal amphotericin B for treatment of experimental invasive pulmonary aspergillosis in persistently neutropenic rabbits",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruta PETRAITIENE","United States"
430,EF014,NULL,"Infection control and prevention around the World","Arena 2 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","08. Healthcare-associated infections, infection prevention & control","Divyashree SHANTHAMURTHY",India,NULL,NULL
431,EF014,430,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Divyashree SHANTHAMURTHY",IndiaChair
432,EF014,430,"WHO Global Survey on Infection Prevention and Control Minimum Requirements: Laying the Foundation for 2030 Global Targets",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter BISCHOFF",Switzerland
433,EF014,430,"Healthcare-associated infections in african intensive care units: A muliticentre prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bamba GAYE",Senegal
434,EF014,430,"Epidemiology of community-acquired versus hospital-acquired sepsis in acute hospitals in Ireland - 2016-2022.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emer LIDDY",Ireland
435,EF014,430,"Epidemiology of Central Line-Associated Bloodstream Infections (CLABSIs) in a Network of Ten Hospitals across Greece: A 30-Month Surveillance Study – GRIPP-SNF Network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ioannis KOPSIDAS",Greece
436,EF014,430,"Characterisation of plasmids disseminating antibiotic resistance in Klebsiella pneumoniae isolates from Pretoria, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theevasha GOVENDER","South Africa"
437,EF014,430,"Transmission dynamics of carbapenemase-producing bacteria between hospital and household settings in Benin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kevin Mael Patrick Zinsou SINTONDJI",Benin
438,EF014,430,"Evaluating the impact of a rapid screening test for carbapenem-resistant organisms in Brazilian intensive care units.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matias SALOMÃO",Brazil
439,EF014,430,"Genomic Insights into the Rapid Rise of Pseudomonas aeruginosa ST463: A High-Risk Clone's Adaptive Strategy in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xu DONG",China
440,EF014,430,"Nanopore long-read only genome assembly for public health surveillance of Enterobacterales bloodstream infections and plasmid epidemiology in England: A pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorottya NAGY","United Kingdom"
441,EF015,NULL,"Advances in the diagnosis and treatment of skin, bone, and joint infections","Arena 3 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","02. Bacterial infection & disease","Norma JUNG",Germany,NULL,NULL
442,EF015,441,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Norma JUNG",GermanyChair
443,EF015,441,"Potential benefits of PET-CT in the management of bone and joint infections in infective endocarditis: a retrospective analysis from the Mayo Clinic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco PETRI",Italy
444,EF015,441,"Synovial fluid microRNA biomarkers enable accurate diagnosis of periprosthetic joint infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernhard J.h. FRANK",Austria
445,EF015,441,"Diagnostic accuracy of 16S rDNA PCR, multiplex PCR and metagenomic Next-Generation Sequencing in periprosthetic joint infections: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Flaminia OLEARO",Germany
446,EF015,441,"Comparison of microbiology, management and outcome between patients with native and with post-surgical vertebral osteomyelitis: a 7-year retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giacomo FRANCESCHI",Italy
447,EF015,441,"Cefiderocol real-life use in bone and joint infection: a retrospective French multicenter study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ava DIARRA",France
448,EF015,441,"Real-Life Experience with Dalbavancin as Suppressive Antibiotic Treatment in orthopaedic implant-related infections.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rosa ESCUDERO-SÁNCHEZ",Spain
449,EF015,441,"Short or Long Antibiotic Regimes in Orthopaedics: the SOLARIO multicentre randomised controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria DUDAREVA","United Kingdom"
450,EF015,441,"Clinical and Antibacterial Diversity of Staphylococcal Phenotypes in Skin and Soft Tissue Infections: A Resource-Limited Country Perspective.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Faiza ZEESHAN",Pakistan
451,EF015,441,"Discrepancy between clinical-radiological diagnosis and surgical confirmation in 62 patients undergoing fasciotomy for suspected necrotizing fasciitis: a 11-year retrospective study.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico ROMANI",Italy
452,EF016,NULL,"Rising threats: antimicrobial resistance in STIs","Arena 4 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Marcos RUST",Austria,NULL,NULL
453,EF016,452,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcos RUST",AustriaChair
454,EF016,452,"Important rise of antibiotic resistance of Mycoplasma genitalium, a sexually transmitted pathogen, in a French University hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Florence DOUCET POPULAIRE",France
455,EF016,452,"Molecular characterization of antimicrobial resistance and genotyping of Mycoplasma genitalium positive samples of the Lisbon area, Portugal",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Margarida BARROS",Portugal
456,EF016,452,"Antimicrobial Resistance in Mycoplasma genitalium: Surveillance and Management in São Paulo, Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor PASSARELLI",Brazil
457,EF016,452,"Impact of genotypic substitutions on treatment failure for Mycoplasma genitalium infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicholas Brian BANA",Italy
458,EF016,452,"Macrolide-resistant Mycoplasma genitalium: an emerging threat to public health?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge CISCAR SORIANO",Spain
459,EF016,452,"Comparison of carbapenem MIC in wild-type, MDR and XDR Neisseria gonorrhoeae isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie BROUSSEAU",France
460,EF016,452,"Unsettling surge in antimicrobial resistance patterns of Neisseria gonorrhoeae - A study from national reference centre in India.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Devanshi SHARMA",India
461,EF016,452,"Surveillance of Neisseria gonorrhoeae antimicrobial resistance rate and treatment regimes in Singapore from 2014 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcella GIOVANNI",Singapore
462,EF016,452,"Molecular surveillance results of N. gonorrhoeae in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyoung Ho ROH","Republic Of"
463,EF021,NULL,"Infections in hemato-oncological hosts: from bacterial to viral","Arena 1 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","10. Immune compromise & transplant ID","Genovefa PAPANICOLAOU","United States",NULL,NULL
464,EF021,463,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Genovefa PAPANICOLAOU","United StatesChair"
465,EF021,463,"Vancomycin-resistant Enterococcus faecium bloodstream infection in patients with hematological malignancy and stem cell transplant: a case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jollee FUNG",Canada
466,EF021,463,"Bacteremia secondary to urinary tract infection in oncology patients: risk factors and impact of multidrug-resistant Gram-negative bacilli.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ignacio GRAFIA",Spain
467,EF021,463,"Rectal carriage of multidrug-resistant organisms and subsequent bloodstream infections in hematologic patients undergoing hematopoietic stem cell transplantation or chimeric antigen receptor T-cell therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charalampos CHARALAMPIDIS",Greece
468,EF021,463,"The RUSTIC Study: Respiratory Virus Infection in a Contemporary Longitudinal Cohort of Patients with Haematological Malignancy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin TEH",Australia
469,EF021,463,"Viral respiratory infections in patients with hematological diseases over 10 years: epidemiology and impact on disease severity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patrizia BONO",Italy
470,EF021,463,"Safety and tolerability of SYN-004 in allogeneic hematopoietic cell transplant (HCT) recipients receiving meropenem (MER) or piperacillin/tazobactam (P/T)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erik DUBBERKE","United States"
471,EF021,463,"Standardized gastrointestinal cytomegalovirus (CMV) tissue quantitative-nucleic-acid testing (QNAT) compared to immunohistochemistry in allogeneic hematopoietic cell transplant (HCT) recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara DE ARAGÓN DE LA CRUZ",Switzerland
472,EF021,463,"Real-life experience with maribavir for the treatment of cytomegalovirus infection in hematological patients.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge BOAN PEREZ",Spain
473,EF022,NULL,"Syndromic testing is still coming of age","Arena 2 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Tommaso GIANI",Italy,NULL,NULL
474,EF022,473,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso GIANI",ItalyChair
475,EF022,473,"Bacterial infections of the central nervous system: addressing the diagnostic gap in non- community-acquired meningitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia MENCHINELLI",Italy
476,EF022,473,"Epidemiological surveillance of central nervous system infections through a rapid syndromic testing platform",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melisa REY",Spain
477,EF022,473,"Impact of Syndromic Panel Implementation on Meningitis/Encephalitis Diagnosis, Antimicrobial Use, Costs, and Hospital Stay in a Regional Australian Hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shradha SUBEDI",Australia
478,EF022,473,"Performance evaluation of the NxTAG® GPP Panel for the detection of gastrointestinal pathogens by comparison with current routine methods in Nantes University Hospital.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie GIBAUD",France
479,EF022,473,"Correct discrimination of Monkeypox virus clades by fast syndromic testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sven REISTER",Germany
480,EF022,473,"Managing a Mycoplasma pneumoniae Outbreak: Impact of Syndromic Panels on Antimicrobial Prescriptions in Pediatric Emergencies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis BRUSCA",Spain
481,EF022,473,"Performance of BIOFIRE® FILMARRAY® Pneumonia plus in general population, solid organ transplant recipients and patients with hematologic malignancies – Interim analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Riccardo RICCARDI",Italy
482,EF022,473,"Impact of the molecular rapid diagnostic panel testing in adjustment of antimicrobial therapy in febrile neutropenic patients with bacteremia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sorawit CHANTHARASUT",Thailand
483,EF022,473,"BacteREVEAL: Analytical performance and contribution of BioFire® BCID2 and Vitek® REVEALTM in intensive care patients with Gram-negative bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claire ROGER",France
484,EF023,NULL,"Effective microbiology for the management of sepsis","Arena 3 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","02. Bacterial infection & disease","Maurizio SANGUINETTI",Italy,NULL,NULL
485,EF023,484,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maurizio SANGUINETTI",ItalyChair
486,EF023,484,"Molecular epidemiology of Klebsiella bloodstream infection-causing isolates across England using Nanopore longread-only sequencing: An interim analysis of the NEKSUS study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorottya NAGY","United Kingdom"
487,EF023,484,"Investigating seasonality of antibiotic resistance associated with E. coli and Klebsiella pneumoniae bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sam LIPWORTH","United Kingdom"
488,EF023,484,"Sensitivity of a host-protein test for microbiologically confirmed bacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roy NAVON",Israel
489,EF023,484,"Comparative genomics of Klebsiella pneumoniae from gut colonisation and bloodstream infections reveal novel genetic associations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marit HETLAND",Norway
490,EF023,484,"Conventional microbiology vs. conventional microbiology + nucleic acid-based multiplex real-time polymerase chain reaction (MPCR) test kit in septic shock: results of a matched cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gamze SANLIDAG ISBILEN",Türkiye
491,EF023,484,"Contribution of Escherichia coli microbiological factors to the presentation as sepsis/septic shock in patients with bacteraemia: a matched case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia MALDONADO",Spain
492,EF023,484,"Simplified and rapid bacterial identification with antimicrobial resistance detection in bacteremia by on-chip multiplexed LAMP.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Capucine TREILLE",France
493,EF023,484,"Community-onset bloodstream infection among people with opioid use disorders: A twenty-year population-based cohort study in Queensland, Australia.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kevin LAUPLAND",Australia
494,EF023,484,"Microbiological diagnosis tools for primary and secondary abdominal aortic infections requiring surgery",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah SOUEGES",France
495,EF024,NULL,"A never-ending evolution of antimicrobial resistance","Arena 4 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Antonio OLIVER",Spain,NULL,NULL
496,EF024,495,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio OLIVER",SpainChair
497,EF024,495,"Gfa, a novel integron-born fosfomycin resistance mechanism",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas KIEFFER",Spain
498,EF024,495,"Regulons of RamA, RarA and SoxS mediated tigecycline resistance and oxidative stress among in vitro tigecycline resistant evolution trajectory of Klebsiella pneumoniae.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaojuan WANG",China
499,EF024,495,"Assessing the impact of altered penicillin binding proteins on susceptibility to novel antimicrobials among clinical isolates of carbapenemase-producing Escherichia col",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaitanya TELLAPRAGADA",Sweden
500,EF024,495,"Enterococcus faecalis penicillin-binding protein-4 sequence differences based on penicillin minimum inhibitory concentration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivia FUNK","United States"
501,EF024,495,"Uncommon genomic rearrangements drive vancomycin resistance in vanB-positive Enterococcus faecium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyriaki XANTHOPOULOU",Germany
502,EF024,495,"Heteroresistance in Enterococcus faecalis: prevalence and mechanistic insights across clinically relevant antibiotics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sheida HEIDARIAN",Sweden
503,EF024,495,"Side effects of rifampicin resistance: transcriptome modulation by rpoB mutations in Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mélanie ROCH",Switzerland
504,EF024,495,"Novel continuous experimental evolution methodology revealing rapid resistance development and cross-resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thaddäus ECHELMEYER",Germany
505,EF029,NULL,"Vaccination uptake-challenges and opportunities","Arena 2 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","11. Public health & vaccines","Joanne M. LANGLEY",Canada,NULL,NULL
506,EF029,505,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanne M. LANGLEY",CanadaChair
507,EF029,505,"Electronic nudges to increase influenza vaccination uptake among patients with heart failure: insights from 3 nationwide randomized trials enrolling >2 million patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niklas Dyrby JOHANSEN",Denmark
508,EF029,505,"Psychological Predictors of Influenza Vaccination Intent Among Healthcare Workers in Bulgaria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Petar VELIKOV",Bulgaria
509,EF029,505,"Determinants of COVID-19 vaccine uptake in patients with hematologic malignancies: a nationwide cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Quincy HOFSINK",Netherlands
510,EF029,505,"Inequality in vaccine uptake among children in Denmark in the national childhood vaccination programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Christine Mariager BRESCHEL",Denmark
511,EF029,505,"Prevalence and associated factors of parental refusal rates for routine immunisation: A cross-sectional study in Peshawar, Khyber Pakhtunkhwa, Pakistan-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammad HAKIM",Pakistan
512,EF029,505,"Shingles Prevalence, Vaccine Awareness, and Acceptance in People Living with HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dilara YAMAN",Türkiye
513,EF029,505,"Tick-borne encephalitis vaccine uptake, effectiveness, and impact in Sweden, 2018−2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas PALMBORG",Sweden
514,EF029,505,"Monkeypox (mpox) vaccination willingness and determinants among people living with HIV (PLWH) in turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cemre BOSNAK",Türkiye
515,EF030,NULL,"Viruses crossing the blood-brain barrier","Arena 3 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
516,EF030,515,"Clinical characteristics and outcome of Herpes simplex virus type 1 and varicella zoster virus encephalitis: A prospective population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laerke DUERLUND",Denmark
517,EF030,515,"Arbovirus associated neurological disease in adults and children in Brazil: a multicentre case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suzannah LANT","United Kingdom"
518,EF030,515,"Challenges in managing Central nervous system infections: Battling the Unknown Enemy, West Nile virus vs unknown etiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cosmin-Alexandru MARIN",Romania
519,EF030,515,"Spatial and temporal profiling of the immune responses induced by Japanese encephalitis virus in a mouse model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhihua OU",China
520,EF030,515,"Intrathecal immunoglobulin synthesis in tick-borne encephalitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sambor S. GRYGORCZUK",Poland
521,EF030,515,"B and T cell responses to Tick-borne Encephalitis Virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nuria MAYOLA DANES",Sweden
522,EF030,515,"Enterovirus infections in pediatric central nervous system (CNS) diseases: molecular epidemiology and neuroimaging insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepanjli SHARMA",India
523,EF030,515,"Neuroimaging findings and their correlation with autopsy findings: Prospective study on Rabies encephalitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Madhav MOHATA",India
524,EF030,515,"Toxoplasma gondii IgG Screening and Central Nervous System Complications among People with HIV in the Combination Antiretroviral Therapy Era",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taohung OU",China
525,EF031,NULL,"AMS around the world: know your data!","Arena 4 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Eoghan DE BARRA",Ireland,NULL,NULL
526,EF031,525,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eoghan DE BARRA",IrelandChair
527,EF031,525,"Duration of antibiotic treatment for respiratory tract infections in primary care.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carl LLOR",Spain
528,EF031,525,"Antibiotic prescribing for common acute infections in Pakistan - an analysis using IQVIA prescriber healthcare surveys",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nam NGUYEN","United Kingdom"
529,EF031,525,"Antibiotic prescribing for common acute infections in Egypt - an analysis using IQVIA prescriber healthcare surveys",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nam NGUYEN","United Kingdom"
530,EF031,525,"Population based analysis of the impact of Japan's AMR national action plan and the COVID-19 pandemic on antimicrobial prescription",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ryuji KOIZUMI",Japan
531,EF031,525,"Quality of antibiotic prescribing in Portuguese hospitals: a snapshot of the first National Antimicrobial Prescribing Survey.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos PALOS",Portugal
532,EF031,525,"Evaluating the impact on 28-day mortality of different empiric AWaRe antibiotic treatment strategies for hospital-acquired infections across different hospital settings.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cherry LIM","United Kingdom"
533,EF031,525,"Update on WHO's Global antibiotic use surveillance system (GLASS-AMU)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benedikt HUTTNER",Switzerland
534,EF031,525,"Harmonisation trajectory of Global-Point Prevalence Survey (Global-PPS) and WHO-PPS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ann VERSPORTEN",Belgium
535,EF031,525,"Implementation of prospective audit and feedback strategy in intensive care units: Analysis of antimicrobial prescription patterns in a Guatemalan tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nancy SANDOVAL",Guatemala
536,EF033,NULL,"Current treatment options for invasive fungal infections","Arena 2 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","06. Fungal infection & disease","Andreas H. GROLL",Germany,NULL,NULL
537,EF033,536,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas H. GROLL",GermanyChair
538,EF033,536,"The paediatric European Confederation of Clinical Mycology (ECMM) Quality (paed-EQUAL) Score for the management of candidaemia in children and neonates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zoi Dorothea PANA",Cyprus
539,EF033,536,"Prevalence rate, species distribution and antifungal susceptibility of bloodstream infections caused by rare yeasts of the Saccharomycetales order documented in 28 Brazilian medical centers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina PALAMIN BUONAFINE",Brazil
540,EF033,536,"Rezafungin showed high in vitro activity and very low resistance rate against a collection of yeasts causing fungaemia in patients admitted to a tertiary hospital in Madrid from 2014 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesus GUINEA",Spain
541,EF033,536,"Posaconazole Drug-Drug Interaction Potential is Similar Across Bodyweight",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca E. WRISHKO","United States"
542,EF033,536,"Phase 2, open-label, non-comparative clinical trial evaluating the safety and efficacy of posaconazole in paediatric patients 2 to <18 years old with invasive aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyoung Jin KANG","Republic Of"
543,EF033,536,"Activity of manogepix against a worldwide collection of mould isolates from 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marisa WINKLER","United States"
544,EF033,536,"Candida auris displays an inoculum effect with multiple antifungal drug classes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ronen BEN-AMI",Israel
545,EF033,536,"In vitro olorofim activity against Aspergillus spp clinical isolates collected as part as two national surveys on azole resistance conducted in Spain (ASPEIN II and III)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesus GUINEA",Spain
546,EF034,NULL,"Surgical site infections: epidemiology, risk factors, and prevention strategies","Arena 4 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","08. Healthcare-associated infections, infection prevention & control","Trisha PEEL",Australia,NULL,NULL
547,EF034,546,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Trisha PEEL",AustraliaChair
548,EF034,546,"Incidence of Surgical Site Infections (SSIs) from the automated patient-based surveillance system, SPICMI, France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pascal ASTAGNEAU",France
549,EF034,546,"Beta-lactam versus non-beta-lactam antimicrobial prophylaxis and its association with the surgical site infection rate, a nationwide cohort study with 348 793 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selina LARGIADÈR",Switzerland
550,EF034,546,"Cutibacterium species in Neurosurgical Infections: Not Such a "Cute" Pathogen After All",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James DONNELLY",Ireland
551,EF034,546,"The polymicrobial nature of wound infections in an emergency orthopaedic ward in Northern Nigeria - implications for treatment and patient outcome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kate COOK","United Kingdom"
552,EF034,546,"Efficacy of Octenidine Dihydrochloride Versus Chlorhexidine Gluconate Solutions in Reducing Surgical-Site Infections in Total Hip and Knee Arthroplasty: A Comparative Analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Artsiom ABIALEVICH",Israel
553,EF034,546,"Impact on rates of surgical site infection of requiring pre-authorization of surgical antibiotic prophylaxis choice and post-operative antibiotic doses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carmenchu Marie VILLAVICENCIO",Philippines
554,EF035,NULL,"Genomics in pathogen surveillance","Arena 1 |","17:15 - 18:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Vítor BORGES",Portugal,NULL,NULL
555,EF035,554,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vítor BORGES",PortugalChair
556,EF035,554,"Genomic Surveillance of Invasive Group A Streptococcus in Argentina's 2023 Epidemic: Unveiling Hypervirulent emm1 Lineages and Pediatric emm12 Burden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia CIPOLLA",Argentina
557,EF035,554,"Understanding the population structure of Moraxella catarrhalis using core-genome multilocus sequence typing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iman YASSINE","United Kingdom"
558,EF035,554,"Impact of the COVID-19 pandemic on the Streptococcus pyogenes clones causing adult invasive infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario RAMIREZ",Portugal
559,EF035,554,"Unveiling the Hidden Complexity of Providencia: Genomic Insights into Species Reclassification and Antibiotic Resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xu DONG",China
560,EF035,554,"Genomic description of outbreak of VIM-1 carrying Enterobacter in Switzerland suggests plasmid transmission between sequence types",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helena SETH-SMITH",Switzerland
561,EF035,554,"Genomic epidemiology of Klebsiella pneumoniae bloodstream infections in a german tertiary centre: increased virulence in carbapenem-resistant strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leonard KNEGENDORF",Germany
562,EF035,554,"Phylogenetic mixing and undetected circulation of multiple Candida auris lineages following recognition of imported cases in Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincenzo DI PILATO",Italy
563,EF035,554,"Using Long-Read Sequencing for Core Plasmid Multilocus Sequence Typing to Investigate Plasmid Relationships Among Bacterial Species in German Hospital Wastewater",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anurag Kumar BARI",Netherlands
564,EF035,554,"Screening for rectal colonization with multidrug-resistant pathogens: usage of rapid metagenomic long-read technology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Srinithi PURUSHOTHAMAN",Switzerland
565,EF036,NULL,"Heads up! CNS infections","Arena 3 |","17:15 - 18:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","13. Case reports and case series (n less than 10)","Jacob BODILSEN",Denmark,NULL,NULL
566,EF036,565,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob BODILSEN",DenmarkChair
567,EF036,565,"Central Nervous System Involvement by Mycobacterium avium Complex in Advanced HIV: A Rare and Underdiagnosed Challenge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Estefania SIENRA IRACHETA",Mexico
568,EF036,565,"Acute disseminated encephalomyelitis following bacterial meningoencephalitis – Two Case reports & Review of Literature",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Megha PRIYADARSHI",India
569,EF036,565,"Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Patient: A Case Report and Literature review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Davide CHEMELLO",Italy
570,EF036,565,"Breaking barriers: meropenem-vaborbactam as a game-changer for KPC central nervous system infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca PRATAVIERA",Italy
571,EF036,565,"Multidrug-Resistant Klebsiella pneumoniae Meningitis in the Absence of Intracranial Devices: A Case Report",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana CHUMBITA",Spain
572,EF036,565,"Triple Threat: Sequential Meningitis Infections in an Immunosuppressed Patient with Morganella morganii, Acinetobacter baumannii, and Vancomycin-resistant Enterococcus faecium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yasemin ÇAKIR KIYMAZ",Türkiye
573,EF036,565,"Invasive pulmonary Arthrographis kalrae infection with cerebral abscesses in an immunocompromised child",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice WINKEL",Netherlands
574,EF036,565,"Treatment of herpes simplex encephalitis with the helicase-primase inhibitor pritelivir in an immunocompromised patient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander BIRKMANN",Germany
575,EF036,565,"A case of influenza A (H1N1) encephalitis: Rare neurological implication in a healthy adult",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Naresh Kumar MIDHA",India
576,EF039,NULL,"Novel approaches to antiviral therapy","Arena 1 |","08:30 - 09:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)","Pinyo RATTANAUMPAWAN",Thailand,NULL,NULL
577,EF039,576,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pinyo RATTANAUMPAWAN",ThailandChair
578,EF039,576,"Obeldesivir exhibits broad anti-RSV activity and a high barrier to resistance in vitro and is efficacious in a non-human primate challenge model of RSV infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jared PITTS","United States"
579,EF039,576,"EDP-323, a first-in-class, oral, RSV L-protein inhibitor reduces disease severity (respiratory mucus production) and accelerates viral clearance in a human viral challenge study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John DEVINCENZO","United States"
580,EF039,576,"A Combined In Silico and In Vitro Pipeline for Optimizing Nanobodies Targeting Surface Proteins of Pathogens: Applications to SARS-CoV-2, WNV, and Influenza A Virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ciro Leonardo PIERRI",Italy
581,EF039,576,"Bemnifosbuvir and Remdesivir exhibit potent antiviral activity against tick-borne encephalitis virus in vitro",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Denis GRANDGIRARD",Switzerland
582,EF039,576,"Combinations of antiviral drugs demonstrating synergistic inhibition of multiple respiratory RNA viruses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel ELLIS","United Kingdom"
583,EF039,576,"The safety and pharmacokinetics of ABI-5366, a novel, oral, long-acting HSV helicase-primase inhibitor: Interim results from a Phase 1a/1b study in healthy participants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anuj GAGGAR","United States"
584,EF039,576,"Efficacy of ganciclovir against CMV infection is dependent on treatment initiation time",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lalitya SUDARSONO",Netherlands
585,EF039,576,"Efficacy of molnupiravir and baloxavir against influenza A H1N1 infection in vitro and in vivo",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Danlei LIU",China
586,EF039,576,"Human defensin derived peptide showing broad antiviral activity against human adenoviruses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiankun WANG",China
587,EF040,NULL,"New frontiers in parasitic disease and migrant health research","Arena 3 |","08:30 - 09:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
588,EF040,587,"Targeting metabolic bioenergetics: the ‘Achilles' heel' of Leishmania",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deblina SARKAR",India
589,EF040,587,"Leishmaniasis in Southern Alicante (Spain): what is the new patient profile?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mª Dolores HERNÁNDEZ RABADÁN",Spain
590,EF040,587,"Schistosoma haematobium infection is associated with oncogenic gene expression in cervical mucosa, with enhanced effects following treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna MERTELSMANN",Switzerland
591,EF040,587,"Associations between water and sanitation service, risk of intestinal schistosomiasis, infection intensity, and liver fibrosis in selected households living near Lake Albert: a descriptive cross-sectional study?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Germain LAM","United Kingdom"
592,EF040,587,"Schistosomiasis detected by Screening of sub-Saharan African Unaccompanied Minor Refugees in Berlin between 2023 and 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriela EQUIHUA MARTINEZ",Germany
593,EF040,587,"NADPH oxidase of the mosquitoes and the antioxidant genes repertoire of the bacteria coordinate mosquito-bacteria interaction in midgut",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Baolin SONG",China
594,EF040,587,"Molecular detection and sequencing of the genes encoding the predicted enzymes; Amidase, NADH ubiquinone oxidoreductase, and sodium neurotransmitter symporter in Onchocerca volvulus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anabel ACHEAMPONG",Ghana
595,EF040,587,"Tuberculosis outcomes among international migrants living in Europe compared to the non-migrant population: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giacomo GUIDO",Italy
596,EF041,NULL,"Contemporary diagnostic approaches for fungal infections","Arena 2 |","09:30 - 10:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","06. Fungal infection & disease","Ilse D. JACOBSEN",Germany,NULL,NULL
597,EF041,596,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilse D. JACOBSEN",GermanyChair
598,EF041,596,"Evaluation of persistence of C. auris colonization in a cohort of patients discharged from a C. auris endemic area",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina BAVASTRO",Italy
599,EF041,596,"A pilot study of digital retinal photography (DRP) and tele-ophthalmology of patients with candidemia.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelius CLANCY","United States"
600,EF041,596,"Epidemiology and diagnosis of Pneumocystis pneumonia : a 11 years-surveillance in France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandre ALANIO",France
601,EF041,596,"Chronic pulmonary aspergillosis coexisting with pulmonary cystic echinococcosis: a global systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aayush ADHIKARI",Nepal
602,EF041,596,"Implementation and performance of a universal Mucorales PCR assay for diagnosis of mucormycosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Allison HAAS","United States"
603,EF041,596,"Blood cultures (BCs) contain populations of genetically diverse Candida strains that may differ in antifungal resistance and tolerance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelius CLANCY","United States"
604,EF041,596,"Clinical validation of a urinary antigen test as an aid to diagnose invasive aspergillosis in hematology patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yuri VANBIERVLIET",Belgium
605,EF041,596,"Genomic epidemiology of Greek Candida auris clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria SIOPI",Greece
606,EF042,NULL,"Prosthetic and device-associated infections","Arena 4 |","09:30 - 10:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","13. Case reports and case series (n less than 10)","Marjan WOUTHUYZEN-BAKKER",Netherlands,NULL,NULL
607,EF042,606,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marjan WOUTHUYZEN-BAKKER",NetherlandsChair
608,EF042,606,"Case series of gluteal Apophysomycosis post intramuscular injection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ramakrishnan SIVASANKARAN",India
609,EF042,606,"MIGRATING mesh - an unusual cause of pyogenic liver abscess",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martine CARIS",Netherlands
610,EF042,606,"Ceftaroline salvage monotherapy: successful treatment of a cerebrospinal fluid drain infection caused by a multidrug-resistant Staphylococcus epidermidis strain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Daria DI TRAPANI",Italy
611,EF042,606,"Timeline of early infections post porcine xenothymokidney transplant",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henry NEUMANN","United States"
612,EF042,606,"Invasive Non-tuberculous mycobacteria Infection in children undergoing Cardiac Surgery at the specialized Cardiology Hospital of Peshawar",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria KHAN",Pakistan
613,EF042,606,"Use of multiplex PCR assay analysis in patients with suspected implant-based breast reconstruction infection: a single center experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto PAGOTTO",Italy
614,EF042,606,"PET CT controls and Dalbavancin therapeutic drug monitoring can help guiding Dalbavancin treatment duration of complicated cardiovascular infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christina KUJAT",Germany
615,EF042,606,"A complex case of pelvic bone infection caused by carbapenem-resistant Acinetobacter baumanii successfully treated with eravacycline",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuel ZAGARRIGO",Italy
616,EF042,606,"Oritavancin in a patient with recurrent endocarditis by Enterococcus faecalis: a new therapeutic option?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco BONGIOVANNI",Switzerland
617,EF049,NULL,"Sometimes it's hard to be a woman","Arena 2 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)","Debora KONOPNICKI",Belgium,NULL,NULL
618,EF049,617,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debora KONOPNICKI",BelgiumChair
619,EF049,617,"Interleukins 17 and 18: Key players in Cervical Cancer Progression in Indian Population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priyal GUPTA",India
620,EF049,617,"Risk evaluation of iatrogenic transmission of Human Papillomavirus (HPV) during gynaecological procedures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice CASINI",Italy
621,EF049,617,"Rubella screening in pregnancy – Slovakian one-center retrospective analysis around COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zuzana PARALICOVÁ",Slovakia
622,EF049,617,"The impact of maternal influenza infection and vaccination during pregnancy on birth outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balasubramani GOUNDAPPA","United States"
623,EF049,617,"Use of valaciclovir therapy during pregnancy for the prevention of congenital cytomegalovirus infection: a monocentric experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia LORENZETTI",Italy
624,EF049,617,"Multi-systemic long-term sequelae following SARS-CoV-2 Omicron infection in pregnancy: a population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yong Yi TAN",Singapore
625,EF049,617,"The Impact of OAS1 rs4766664 and OAS3 rs10735079 Polymorphisms on the Clinical Course of COVID-19 in Pregnant Women",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sema KIRIK YILMAZ",Türkiye
626,EF049,617,"Sex-stratified analysis of T cell activation, exhaustion, proliferation and HIV reservoir among PLWH",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Letizia SANTINELLI",Italy
627,EF050,NULL,"Expanding MALDI-TOF applications","Arena 3 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Belen RODRIGUEZ-SANCHEZ",Spain,NULL,NULL
628,EF050,627,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Belen RODRIGUEZ-SANCHEZ",SpainChair
629,EF050,627,"Application of MALDI-TOF Mass Spectrometry and Machine Learning for the Detection of Vancomycin-Resistant Enterococcus faecium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria SÁNCHEZ CUETO",Spain
630,EF050,627,"Early detection of ampicillin susceptibility in Enterococcus faecium with MALDI-TOF MS and machine learning",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas PICHL",Germany
631,EF050,627,"Rapid antifungal resistance prediction based on MALDI TOF mass spectrometry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diane DUROUX",Switzerland
632,EF050,627,"Rapid prediction of fluconazole resistance by machine-learning analysis of Candida parapsilosis MALDI-TOF mass profiles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlotta MAGRI",Italy
633,EF050,627,"Optimizing pretreatment for MALDI-TOF MS: Evaluating the dispersion method for filamentous fungal identification",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Run HUANG",China
634,EF050,627,"Rapid detection of colistin resistance in Acinetobacter baumannii by a MALDI-TOF MS-based assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ekin KIRBAS",Türkiye
635,EF050,627,"Discrimination of clinical Pseudomonas strains at the species level using a large-scale genomically predicted protein mass database with MALDI-MS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kanae TERAMOTO",Japan
636,EF050,627,"Automatic differentiation of Clostridioides difficile ribotypes using MALDI-TOF MS and web-based classification models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario BLAZQUEZ SANCHEZ",Spain
637,EF050,627,"Identification of sepsis-causing bacteria using shotgun proteomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa MEEKES",Netherlands
638,EF051,NULL,"The enemy of my enemy: From jumbo phages to cocktails for difficult to treat infections","Arena 4 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Paul G. HIGGINS",Germany,NULL,NULL
639,EF051,638,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul G. HIGGINS",GermanyChair
640,EF051,638,"Anti-K2 recombinant phage depolymerases as anti-virulence agents against hypervirulent Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mélanie ROCH",Switzerland
641,EF051,638,"Jumbo Klebsiella bacteriophage demonstrates efficient multidrug-resistant Klebsiella pneumoniae killing and significant clinical potential",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang LIU",Singapore
642,EF051,638,"A new phage cocktail targeting at Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xin YIN",China
643,EF051,638,"Bacteriophages against pulmonary infection and colonization of the gut by multidrug-resistant Klebsiella pneumoniae in murine models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anni-Maria ÖRMÄLÄ-TIZNADO",Sweden
644,EF051,638,"A novel broad-spectrum phage cocktail effictive for carbapenem resistant Acinetobacter baumannii of capsular type 104/2/7 in vitro",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Li WEI",China
645,EF051,638,"Proteomic and Genomic Characterization of a Novel Bacteriophage of a New Genus Infecting Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sezin UNLU",Türkiye
646,EF051,638,"Phages as innovative adjuvants of antibiotics therapy against S. aureus and P. aeruginosa in the context of Cystic Fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antoine GLORIEUX",Belgium
647,EF051,638,"Evaluation of bacteriophages against Staphylococcus aureus strains isolated from orthopaedic infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sheetal PATPATIA",Finland
648,EF051,638,"Anti-Staphylococcus aureus phages: assessing the risk of bacterial resistance emergence through selective pressure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthieu DEGREZE",France
649,EF054,NULL,"Beware the sink! Pathogen reservoirs in drains and waste water","Arena 3 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","08. Healthcare-associated infections, infection prevention & control","Stephan Juergen HARBARTH",Switzerland,NULL,NULL
650,EF054,649,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephan Juergen HARBARTH",SwitzerlandChair
651,EF054,649,"Genomic Epidemiology to Investigate Healthcare Environment as Reservoir for Carbapenem-Resistant Organisms in an Academic Hospital in Miami, Florida.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adriana JIMENEZ","United States"
652,EF054,649,"Two clusters of carbapenemase-producing Enterobacterales linked to hospital wastewater drainage in utility rooms – an outbreak investigation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabelle VOCK",Switzerland
653,EF054,649,"Assessing the burden of carbapenemase and colistin antimicrobial resistance genes in hospital wastewater",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily AU",Canada
654,EF054,649,"Hospital wastewater as a reservoir for carbapenemase-producing organisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ahalieyah ANANTHARAJAH",Belgium
655,EF054,649,"Reversing and controlling microbial proliferation in the water system of a high-risk hospital ward after extended closure and reconstruction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dominique L. CHAPUT","United Kingdom"
656,EF054,649,"Whole-genome sequencing as part of the tracking and managing Carbapenemase producing Enterobacterales transmission in an acute hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Darragh COFFEY",Ireland
657,EF054,649,"Is there a solution for hospital acquired infections due to the aquatic reservoir in the near patient environment?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiba ZAYYAD",Israel
658,EF054,649,"Reducing Antimicrobial Resistance (AMR) across the One Health Landscape: Diverse Perspectives on AMR risks and their mitigation in sinks, drains, and wastewater",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hillary A. CRADDOCK",Ireland
659,EF055,NULL,"The cutting edge in tuberculosis","Arena 4 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","02. Bacterial infection & disease","Graeme Ayton MEINTJES","South Africa",NULL,NULL
660,EF055,659,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Graeme Ayton MEINTJES","South AfricaChair"
661,EF055,659,"Personalised risk predictions for incident TB and preventive treatment uptake.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rubin ROSE-KEY","United Kingdom"
662,EF055,659,"Programmatic migrant screening for tuberculosis identifies a spectrum of clinical phenotypes and outcomes: cohort data from a national migrant screening programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marjan GOHAR","United Kingdom"
663,EF055,659,"An investigation into the relationship between human and animal Mycobacterium bovis isolates using whole genome analysis.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary MANSFIELD",Ireland
664,EF055,659,"Distinguishing relapse from reinfection in tuberculosis patients from Lithuania",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laima VASILIAUSKAITE",Lithuania
665,EF055,659,"Rapid Resistance Profiling of Mycobacterium tuberculosis from Clinical Specimens using Targeted Next-Generation Sequencing: A Pilot Validation Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pratiksha CHHEDA",India
666,EF055,659,"Inflammation precedes early respiratory worsening in HIV-negative tuberculosis patients during antituberculosis treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arjan VAN LAARHOVEN",Netherlands
667,EF055,659,"Impact of fluoroquinolone resistance on the cost-effectiveness of empiric treatment for multidrug- or rifampicin-resistant tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaelin KIM","United Kingdom"
668,EF055,659,"A longitudinal study on the evolution of drug resistance during tuberculosis treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emelia DANSO",Ghana
669,EF055,659,"Phase 1, randomized, double-blind, parallel-group, dose-escalation safety and tolerability of PLGA encapsulated first line antitubercular drugs nanoparticles in healthy volunteers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Avaneesh Kumar PANDEY",India
670,EF059,NULL,"Bacterial infections in the post pandemic era","Arena 2 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","02. Bacterial infection & disease","Özlem Kurt AZAP",Türkiye,NULL,NULL
671,EF059,670,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özlem Kurt AZAP",TürkiyeChair
672,EF059,670,"Genomic epidemiology of invasive meningococcal disease in Scotland: The impact of the COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niall AHMAD","United Kingdom"
673,EF059,670,"Targeted probe-capture culture-independent sequencing identifies emergence of Macrolide-Resistant Bordetella pertussis in Australia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Winkie FONG",Australia
674,EF059,670,"Invasive pneumococcal disease in Spanish adults. Multicenter analysis of serotypes and lineages in the post-pandemic period.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rocío ESPAÑA BONILLA",Spain
675,EF059,670,"Group A streptococcal infections in Germany from 2017 to 2024: a post-pandemic rebound above expected numbers?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anja VON LAER",Germany
676,EF059,670,"Invasive group A streptococcus infections is often preceeded by seasonal influenza.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johan WESTIN",Sweden
677,EF059,670,"Impact of the COVID-19 Pandemic on Tuberculosis Transmission Rates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angela CANNAS",Italy
678,EF059,670,"Treatment outcomes of bedaquiline-based longer oral regimens in Indian children above 5-years of age",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dhruv GANDHI",India
679,EF059,670,"Incidence of Invasive Escherichia coli Disease in the Northwestern United States (2002–2022): Insights from Electronic Health Records",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maxim BLUM",Belgium
680,EF059,670,"A prospective controlled cross-sectional study demonstrates significantly higher IgG seroprevalence of leptospirosis among Munich's Eisbach river surfers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Florian VOIT",Germany
681,EF060,NULL,"AMR in the community","Arena 3 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Camilla WIUFF COIA",Denmark,NULL,NULL
682,EF060,681,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camilla WIUFF COIA",DenmarkChair
683,EF060,681,"Socio-demographic factors associated with community-acquired extended spectrum β-lactamase producing E. coli urinary tract infections at intermunicipal level in France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie PRIME",France
684,EF060,681,"Prolonged community outbreak of OXA-48-producing Escherichia coli linked to a food premises: Lower Hutt, New Zealand, 2018-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Craig THORNLEY","New Zealand"
685,EF060,681,"Low rates of macrolide resistance found in Mycoplasma pneumoniae cases in Australia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca ROCKETT",Australia
686,EF060,681,"Epidemiology of antibiotic resistance associated with E. coli/Klebsiella pneumoniae bloodstream infections in England 2012-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sam LIPWORTH","United Kingdom"
687,EF060,681,"The effect of long-term fluoroquinolone prophylaxis on carriage of antimicrobial resistant organisms in children.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chante BRAND","South Africa"
688,EF060,681,"Risk factors and prevalence of AntiMicrobial Resistant microbes In the English Community (AMRIC)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Donna LECKY","United Kingdom"
689,EF060,681,"Risk factors for antimicrobial resistance in community commensal Staphylococcus aureus isolates, a sub-analysis of the AMRIC project.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mollie JOYCE","United Kingdom"
690,EF060,681,"Prevalence and risk factors for antimicrobial resistance in invasive pneumococcal disease in southern Ontario in the late post PCV13 era (2014-2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Allison MCGEER",Canada
691,EF060,681,"Antimicrobial resistance in Streptococcus pneumoniae in the Netherlands: an 11-year trend analysis of surveillance data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilse NAUTA",Netherlands
692,EF061,NULL,"Infections in the immunocompromised: a multifaceted overview","Arena 4 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","10. Immune compromise & transplant ID","Effrossyni GKRANIA-KLOTSAS","United Kingdom",NULL,NULL
693,EF061,692,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Effrossyni GKRANIA-KLOTSAS","United KingdomChair"
694,EF061,692,"Impact of Donor Colonization or Infection, or preservation fluid  contamination with Multiresistant Bacteria and Fungi in Solid Organ Transplantation. Multicenter registry of Argentina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura Alicia BARCAN",Argentina
695,EF061,692,"Analysis of viral load kinetics and risk factors for Epstein-Barr virus  DNAemia and Post-transplant lymphoproliferative disorders in pediatric liver transplant recipients - a single centre experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beata KASZTELEWICZ",Poland
696,EF061,692,"Impact of pre-transplant infection on post-transplant morbidity and graft survival in liver transplant recipients: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura MANI-PERREN",Switzerland
697,EF061,692,"Risks of live-attenuated vaccines in children with primary immunodeficiency",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siwar FRIGUI EP OUESLATI",Tunisia
698,EF061,692,"Chagas reactivation/ transmission in kidney transplantation.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcelo Victor RADISIC",Argentina
699,EF061,692,"Clinical presentation and treatment of tuberculosis in solid organ transplant recipients: a multicentric retrospective analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia MOLTÓ",Spain
700,EF061,692,"Clinical presentation, risk factors and outcome of non-tuberculous mycobacteria infection in hematopoietic stem-cell transplant recipients: a multinational case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario FERNANDEZ RUIZ",Spain
701,EF061,692,"Impact of bronchoalveolar lavage results on clinical decision-making among immunocompromised, critically ill patients.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara FANELLI",Italy
702,EF061,692,"Campylobacter spp. bloodstream infections: preliminary results from a multicenter differential clinical analysis in immunocompromised and immunocompetent patients.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María PANIAGUA-GARCÍA",Spain
703,EF065,NULL,"The Antibiotic bakery: Novel compounds in the pipeline","Arena 1 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Susanne HAEUSSLER",Germany,NULL,NULL
704,EF065,703,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne HAEUSSLER",GermanyChair
705,EF065,703,"In vitro activity and in vivo proof-of-efficacy of epimutilin derivatives AR-7732, AR-7731, AR-9842 and AR-10058 against AMR bacterial pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne PAUKNER",Austria
706,EF065,703,"SC5005 and DHA: A Novel, Rapid-Acting Combination Therapy for Biofilm Eradication in Catheter-Associated Infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yeo HUI HUI",China
707,EF065,703,"In vitro potency of ceftibuten with xeruborbactam against β-lactamase-producing isolates of Enterobacterales (ENT) from the SENTRY global surveillance programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olga LOMOVSKAYA","United States"
708,EF065,703,"Effect of novel antimicrobial peptides SET-M33L and SET-M33L-PEG on Pseudomonas aeruginosa biofilm formation.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessio FONTANOT",Austria
709,EF065,703,"Broad spectrum coverage of serine β-lactamase and high in vitro potency against KPC- and OXA-48-like-producing Enterobacterales of meropenem in combination with the novel diazabyciccloctane β-lactamase inhibitor ANT3310",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucía SÁNCHEZ-PEÑA",Spain
710,EF065,703,"Antibacterial potential of D-limonene and diallyl disulfide and their interaction with gentamicin against multidrug-resistant Pseudomonas aeruginosa in rat pneumonia model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yasir ALMUHANNA","Saudi Arabia"
711,EF065,703,"In vivo pharmacokinetic/pharmacodynamic targets of a novel macrolide antibiotic nafithromycin, determined in neutropenic murine lung infection model of Streptococcus pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk Edwina MULLER",Netherlands
712,EF065,703,"NiPharmins: novel low resistance-inducing antimicrobials with antibiofilm activity against Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra Isabel NUNES",Portugal
713,EF066,NULL,"Modelling infectious disease burden and impact of vaccination","Arena 2 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","11. Public health & vaccines","David FISMAN",Canada,NULL,NULL
714,EF066,713,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",CanadaChair
715,EF066,713,"Evaluating the Impact of Re-vaccination on Pneumococcal Disease in Individuals Previously Vaccinated with PPSV23 in Germany: Comparative Approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwaseun SHAROMI","United States"
716,EF066,713,"Modeling the public health impact of a 21-valent PCV in the Canadian adult population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwaseun SHAROMI","United States"
717,EF066,713,"Estimating the health and economic burden of pneumococcal diseases attributable to PCV21 (V116) vs. PCV20 or PPSV23 serotypes among adults in Norway",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zinan YI","United States"
718,EF066,713,"Shifting from risk-based to age-based approach for pneumococcal vaccination in adults in France: a comprehensive evaluation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwaseun SHAROMI","United States"
719,EF066,713,"The socio-economic value of adult respiratory immunisation programmes in the United Kingdom – Are we measuring what matters to society?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cale HARRISON","United Kingdom"
720,EF066,713,"Improving Danish all-cause mortality monitoring by nowcasting weekly deaths",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert KALNÆS",Denmark
721,EF066,713,"Modelling to identify an optimal ring vaccination strategy to mitigate a smallpox outbreak",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina COSTANTINO",Australia
722,EF066,713,"The impact of introducing meningococcal C/ACWY booster vaccination among adolescents in Germany: a dynamic transmission modelling study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Felix GÜNTHER",Germany
723,EF066,713,"Potential public health impacts of gonorrhoea vaccination programmes under declining incidences: a modelling analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lin GENG",Singapore
724,EF067,NULL,"Blood parasitology at its best","Arena 3 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","13. Case reports and case series (n less than 10)","Miriam José ÁLVAREZ-MARTÍNEZ",Spain,NULL,NULL
725,EF067,724,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam José ÁLVAREZ-MARTÍNEZ",SpainChair
726,EF067,724,"Unexepected P.malariae diagnosis in Italian woman with no history of travel to endemic areas",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea BUSNI",Italy
727,EF067,724,"A blue-hued mystery: Primaquine-induced methemoglobinemia in mixed infection with Plasmodium vivax and Plasmodium falciparum",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ummu Afeera ZAINULABID",Malaysia
728,EF067,724,"Trick or Treat? An unrelenting malaria case",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Catherine UHOMOIBHI",Ireland
729,EF067,724,""64% Parasitaemia in Falciparum Malaria: Challenges in Managing Severe Infection and Delayed Haemolysis"",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fiona MURPHY",Ireland
730,EF067,724,"Benznidazole treatment in Chagas Disease: a case series in Luigi Sacco Hospital, Milan (Italy)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico SABAINI",Italy
731,EF067,724,"The Challenge of Managing Visceral Leishmaniasis in Immunocompromised Patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Serena VITA",Italy
732,EF067,724,"Diagnosis and management of visceral leishmaniasis in children in France : a national retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justine DE LARMINAT",France
733,EF067,724,"Chronic cutaneous leishmaniasis following visceral leishmaniasis in a pediatric patient: a rare report of extensive facial involvement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alpana MOHTA",India
734,EF067,724,"Therapeutic challenges in the management of Disseminated leishmaniasis in a patient with HIV co-infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neetha T R",India
735,EF068,NULL,"A global perspective on antimicrobial resistance surveillance","Arena 4 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Mirfin MPUNDU",Zambia,NULL,NULL
736,EF068,735,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mirfin MPUNDU",ZambiaChair
737,EF068,735,"Global, regional and country-level prevalence of antimicrobial resistance in human bacterial infections under surveillance in WHO's Global Antimicrobial Resistance and Use Surveillance System (GLASS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther VAN KLEEF",Netherlands
738,EF068,735,"Comparative analysis of antimicrobial resistance (AMR) burden across european countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Achim DÖRRE",Germany
739,EF068,735,"Setting up a regional AMR surveillance network in the Netherlands: challenges and opportunities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carsten VAN ROSSUM",Netherlands
740,EF068,735,"Bridging gaps in antimicrobial resistance surveillance: the CAESAR network's first decade",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robin JANSSEN",Netherlands
741,EF068,735,"Global, regional, and national temporal trends in mortality for carbapenem-resistant bacteria from 1990 to 2021: An age-period-cohort analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chen ZHIHUI",China
742,EF068,735,"Global Trends and Impact of Antimicrobial Resistance in Paediatric Populations: An Analysis Using WHO AWaRe Classification and Priority Pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph HARWELL",Australia
743,EF068,735,"Antibiotic resistance profile and comparative evaluation of WHO AWaRe Guidelines at the Emergency's Children's Surgical Hospital in Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia BARCELLINI",Italy
744,EF068,735,"Initiatives in antimicrobial resistance surveillance: Using automated bacteraemia surveillance for hospital-wide multidrug resistance monitoring",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ferenc Darius RUETHER",Germany
745,EF068,735,"Global and regional prevalence of antimicrobial resistance in GLASS target bacterial pathogens for bloodstream, urinary tract and gastrointestinal infections: a systematic review of the global literature (2019-2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin CADDEY",Canada
746,EF074,NULL,"New methods for rapid pathogen detection and typing","Arena 1 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Sylvain BRISSE",France,NULL,NULL
747,EF074,746,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvain BRISSE",FranceChair
748,EF074,746,"Rapid detection of Shiga toxin-producing Escherichia coli (stx2a and stx2d) in korean diarrheal stool samples: a performance evaluation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lee HYEONJI","Republic Of"
749,EF074,746,"Global prevalence of O-serotypes and antibiotic resistance among extraintestinal pathogenic Escherichia coli isolated from older adult patients with bacteraemia (2011–2021)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeroen GEURTSEN",Netherlands
750,EF074,746,"Strategy for the rapid typing of Salmonella spp using infrared spectroscopy: a one health perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javiera JIMÉNEZ",Chile
751,EF074,746,"WGS-based surveillance as a paradigm shift in outbreak detection, AMR monitoring and source attribution in Campylobacter",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra Isabel NUNES",Portugal
752,EF074,746,"Prevalence of Staphylococcus aureus clonal complex 97 amongst BORSA isolates in a large UK hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hughes GARETH","United Kingdom"
753,EF074,746,"The effectiveness of clinical laboratory tools in the surveillance of nontuberculous mycobacterium isolations within different counties in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hsueh-Wei CHU",China
754,EF074,746,"Rapid detection of oxazolidinone-resistance-related mutations in Enterococcus spp. by using High Resolution Melting-qPCR-typing analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rosario MUSUMECI",Italy
755,EF074,746,"An automated pipeline to genotype bacteriophages using third generation sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zsolt HALÁSZ",Hungary
756,EF074,746,"Novel approach for fast, automated strain typing and source tracking by Fourier-transform infrared spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Norman MAUDER",Germany
757,EF075,NULL,"Healthcare (workers') safety revisited","Arena 2 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","08. Healthcare-associated infections, infection prevention & control","Daniel DIEKEMA","United States",NULL,NULL
758,EF075,757,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel DIEKEMA","United StatesChair"
759,EF075,757,"Preparedness and cooperation throughout the chain of care during regional-level outbreaks with multidrug resistant organisms: a network analysis and interview study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Berend BEISHUIZEN",Netherlands
760,EF075,757,"Preparing First-Line health care workers for 'Virus X' through targeted training (FiLi-Vi-X)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annelies MONDELAERS",Belgium
761,EF075,757,"Analysis of the current situation of hospital inspection practices by German health authorities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SCHWABE",Germany
762,EF075,757,"A nationwide survey on the status and implementation of infection prevention and control practice on behalf of INSIEME Project (Italian National project for contrast antibiotic resistance a cooperation between Simit (Italian society of infectious diseases) E (&) Ministry of hEalth)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marianna MESCHIARI",Italy
763,EF075,757,"High level of measles immunity among Dutch healthcare workers with self-reported “unknown” measles immunity status.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Corianne MEIJER",Netherlands
764,EF075,757,"Factors associated with positive latent TB screening results in healthcare workers at two tertiary referral hospitals in Ireland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ciara ANDERSON",Ireland
765,EF075,757,"Systematic review of determinants of vaccine hesitancy among healthcare workers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valeria GABELLONE",Italy
766,EF075,757,"Post-pandemic questions on vaccine usage: Two qualitative analyses of open-ended responses comparing hypothetical and novel vaccines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Parichehr SHAMSRIZI",Germany
767,EF075,757,"Do healthcare professionals working in acute healthcare settings identify infection prevention and control related knowledge deficits?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aoife KEARNEY",Ireland
768,EF076,NULL,"Knowing me, knowing you: behaviour influencing AMS","Arena 3 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Elena CARRARA",Italy,NULL,NULL
769,EF076,768,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena CARRARA",ItalyChair
770,EF076,768,"Exploring determinants in deciding the optimal antimicrobial dose in patients recieving CRRT: a mixed method study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tugba YANIK YALÇIN",Türkiye
771,EF076,768,"Behaviour change vs policy change: Key drivers of inappropriate antibiotic use among health care professionals in LMICs – insights from Indian community setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ninu P MATHEW",India
772,EF076,768,"Contextual determinants to antimicrobial stewardship implementation in 16 hospitals: a four-country analysis in Asia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huong VU THI LAN",Vietnam
773,EF076,768,"SpeakAB, a pilot study to encourage nurses to speak up about antibiotic care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria BOS",Netherlands
774,EF076,768,"Understanding what matters to patients in antimicrobial stewardship in hospitals. PERSPEcT study update",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benson JACOB",Ireland
775,EF076,768,"Determinants of antibiotic prescribing in hospitals from low, middle and high-income countries in Asia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Srishti CHHABRA",Singapore
776,EF076,768,"Riding "the antimicrobial rollercoaster": The behavioural and phenomenological science of antimicrobial use in haemato-oncology.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chris EADES","United Kingdom"
777,EF076,768,"Addressing Antimicrobial Resistance: Expert Insights and Policy Recommendations for Effective Interventions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bahar MADRAN",Türkiye
778,EF076,768,"Implementation of hospital antimicrobial stewardship in Europe using a data-driven behaviour change approach: insights from the drive-AMS EU project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines PAUWELS",Belgium
779,EF077,NULL,"Viral aphrodites","Arena 4 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)","Rémi CHARREL",France,NULL,NULL
780,EF077,779,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rémi CHARREL",FranceChair
781,EF077,779,"Potential for international spread of Oropouche virus via commercial air travel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana TORRES PORTILLO",Canada
782,EF077,779,"Estimating mpox Clade Ib outbreak size in the Democratic Republic of the Congo to attenuate surveillance gaps during the early stages of the 2024 outbreak",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana TORRES PORTILLO",Canada
783,EF077,779,"Disparate epitope recognition between MPXV-infected and Smallpox-vaccinated individuals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashley OTTER","United Kingdom"
784,EF077,779,"Diverse residual and late-onset symptoms of severe fever with thrombocytopenia syndrome: insights from a multicenter questionnaire study in Western Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ryuichi Minoda SADA",Japan
785,EF077,779,"Post-Acute Sequelae and Excess Healthcare Utilization Following Dengue Infection: A Population-Based Cohort Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jue Tao LIM",Singapore
786,EF077,779,"Challenges of dengue in haematological malignancy patients: Analysis from the DANGO registry during the 2023-2024 outbreak in Argentina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gustavo Adolfo MÉNDEZ",Argentina
787,EF077,779,"Key predictors of critical illness and mortality in Crimean-Congo haemorrhagic fever",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Defne YIGCI",Türkiye
788,EF077,779,"Kyasanur Forest Disease in 2024: A Retrospective Cohort Study from a tertiary care centre in South India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pothumarthy VENKATA SWATHI KIRAN",India
789,EF077,779,"Unravelling the aetiology of summer flu-like illness in Czechia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michal Frantisek KRÍHA","Czech Republic"
790,EF079,NULL,"AMS around the world: what we can learn from each other","Arena 1 |","08:30 - 09:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Benedikt HUTTNER",Switzerland,NULL,NULL
791,EF079,790,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benedikt HUTTNER",SwitzerlandChair
792,EF079,790,"Battlefield Stewardship: Implementing Antimicrobial Management in the Ukrainian Trauma Pathway",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hailie UREN",Ukraine
793,EF079,790,"Evaluating a Tailored Antimicrobial Stewardship Strategy to Optimise IV to Oral Conversion: A Pre and Post-intervention Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mai A H ALYAZJI","United Arab Emirates"
794,EF079,790,"Antimicrobial stewardship program for antibiotic use in the community: impact of multidisciplinary local guidelines during the 2023-2024 influenza a H1N1 season in northern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romina CORSINI",Italy
795,EF079,790,"Effectiveness of Clinical Algorithms combined with Point-of-Care testing to improve Antibiotic Prescribing practices of physicians in outpatient setting of low middle-income country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia QURESHI",Pakistan
796,EF079,790,"Antibiotic prescribing behaviour in a public Bangladeshi hospital: a snapshot from BALANCE study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Md Shafiul KABIR",Bangladesh
797,EF079,790,"Tailored response to antimicrobial resistance emergence: remote-created stewardship program in a low/middle-income country pediatric hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricio FAVIER",Spain
798,EF079,790,"Weekly interdisciplinary antimicrobial stewardship rounds at two surgical wards show notable potential in optimising antimicrobial treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gerda BRUNHOFER-BOLZER",Austria
799,EF079,790,"Antimicrobial stewardship programmes may improve patients' outcome and hospitalization: a sub-analysis of the CASAS (CArbapenem Sparing Antimicrobial Stewardship) Project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco BONGIOVANNI",Switzerland
800,EF079,790,"“Prescribing antibiotics is a gamble…”: A mixed-methods approach to current practices and implementation challenges of antimicrobial stewardship in a Ugandan tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura JUNG",Germany
801,EF080,NULL,"Acinetobacter baumannii, still a strong knight to be knocked","Arena 3 |","08:30 - 09:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Parikshit PRAYAG",India,NULL,NULL
802,EF080,801,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Parikshit PRAYAG",IndiaChair
803,EF080,801,"Evaluation of the Antibacterial Activity of New Dermaseptin Derivatives against Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Houda HADDAD",Tunisia
804,EF080,801,"Clonal dissemination of highly resistant Acinetobacter baumannii ST2: Insights from the BALANCE study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaima ABDELLAOUI","United Kingdom"
805,EF080,801,"Prevalence and genomic characterization of Sulbactam-Durlobactam-resistant and Carbapenem-resistant Acinetobacter baumannii in ICU Patients in a tertiary hospital in Hanoi, Northern Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dennis NURJADI",Germany
806,EF080,801,"In vitro activity of nitroxoline among Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther WOHLFARTH",Germany
807,EF080,801,"Assessing biocide resistance genes and susceptibility to biocides in carbapenem-resistant Acinetobacter baumannii isolates from Thai hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Made Rai Dwitya WIRADIPUTRA",Thailand
808,EF080,801,"Epidemiological and Genomic Characteristics of Acinetobacter baumannii in a Hospital in Zhejiang, China: A Study from 2015 to 2020",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yisha ZHANG",China
809,EF080,801,"Evaluation of the susceptibility  of Carbapenem-resistant Acinetobacter baumannii to sulbactam-durlobactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana CAIERÃO",Brazil
810,EF080,801,"Clonal dissemination of Acinetobacter baumannii International Clone 2 Carrying ArmA and emergence of OXA-23-NDM1 co-producers in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Geetha NAGARAJ",India
811,EF080,801,"Insight into Acinetobacter baumannii's phenotypic and genotypic traits in oncological patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca SIVORI",Italy
812,EF081,NULL,"Clinical features and outcome of invasive fungal infections","Arena 2 |","09:30 - 10:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","06. Fungal infection & disease","Marcus DE MELO TEIXEIRA",Brazil,NULL,NULL
813,EF081,812,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcus DE MELO TEIXEIRA",BrazilChair
814,EF081,812,"Management, outcomes and predictors of mortality of Cryptococcus infection in patients without HIV: a multicentre study in 46 hospitals from Australia and New Zealand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julien COUSSEMENT",Guadeloupe
815,EF081,812,"Incidence of invasive fungal infections in hospitalised paediatric patients in England",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adilia WARRIS","United Kingdom"
816,EF081,812,"Invasive fungal disease in critically ill patients with cirrhosis: an autopsy study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lenn MAESSEN",Belgium
817,EF081,812,"Non-Aspergillus mould infections in Australia and New Zealand: a multi-centre study on epidemiology and clinical outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chin Fen NEOH",Australia
818,EF081,812,"Leveraging natural language processing (NLP) for early detection of aspergillosis: A retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa NWANKWO","United Kingdom"
819,EF081,812,"How often does Mucormycosis (MCM) contribute to mortality in Hematologic Malignancy (HM) patients? Analysis of 103 patients over 20 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastian WURSTER","United States"
820,EF081,812,"Emergence of Wickerhamomyces anomalus invasive infections in injecting drug users",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maxime LEFRANC",France
821,EF081,812,"Prevalence and risk-factors for secondary localizations during candidemia in intensive care unit patients: the French CandidICU multicenter study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Pierre GANGNEUX",France
822,EF081,812,"Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam STEWART","United States"
823,EF089,NULL,"Emerging Infectious Diseases, Zoonoses and Outbreaks","Arena 2 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
824,EF089,823,"Seasonality of Influenza and Respiratory Syncytial Virus related hospital contacts in Denmark (1999-2021)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omid REZAHOSSEINI",Denmark
825,EF089,823,"Are we serologically prepared against an avian influenza pandemic and could seasonal flu vaccines help us?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ivan SANZ-MUÑOZ",Spain
826,EF089,823,"The UK Imported Fever Service (IFS): National VHF testing 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amy BELFIELD","United Kingdom"
827,EF089,823,"Reemergence of Poliovirus in Pakistan: Challenges and Implications for Global Health Security",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saeed AHMAD",Finland
828,EF089,823,"Preparing an emerging infectious diseases unit for high-consequence infectious diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"André SILVA-PINTO",Portugal
829,EF089,823,"Correlation between clinical and wastewater measles positivity rate in three towns of karachi, pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Farah NAZ QAMAR",Pakistan
830,EF089,823,"Salmonella serovars in wild European hedgehogs (Erinaceus europaeus): an over 12-year monitoring in the Ferrara Province, Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa MASSELLA",Italy
831,EF089,823,"Clinico-epidemiological and Microbiological Investigation of Diphtheria Outbreak in Odisha, India, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ira PRAHARAJ",India
832,EF089,823,"Seroprevalence of nine causes of acute febrile illness in rural Cambodia and Thailand using a multiplex assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meiwen ZHANG",Thailand
833,EF090,NULL,"Addressing the need for speed: advances in point-of-care testing","Arena 3 |","11:00 - 12:00CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Jennifer DIEN BARD","United States",NULL,NULL
834,EF090,833,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer DIEN BARD","United StatesChair"
835,EF090,833,"Rapid respiratory microbiological POCTs and antibiotic use in primary care: the RAPID-TEST RCT",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily BROWN","United Kingdom"
836,EF090,833,"Evaluation of the prototype BIOFIRE® nasal HR panel (nHRP) in children with acute respiratory illness, a nasal swab-based rapid hoSt gene expression test",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gregory STORCH","United States"
837,EF090,833,"Evaluation of the analytical performance of the Biosynex AMPLIQUICK Fecal Bacteriology kit in the diagnossis of bacterial intestinal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philippe LEHOURS",France
838,EF090,833,"Development and Validation of a Novel Rapid Antigen Test for Norovirus Detection: A Comparative Performance Analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadin YOUNES",Qatar
839,EF090,833,"A Rapid Molecular POCT System for Detection of Carbapenem-Resistant Enterobacterales (CRE)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seong Yeol CHOI","Republic Of"
840,EF090,833,"Validation of an ultra-rapid, point-of-care, antibiotic susceptibility testing device",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ardjan VAN DER LINDEN",Netherlands
841,EF090,833,"Development of a frugal multiplexed paper sensor for rapid detection of sepsis-causing pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaitali SINGHAL",India
842,EF090,833,"Multianalyte POCT device for a sample-to-result detection of nucleic acid and protein",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lilas POMMIÈS",France
843,EF090,833,"A smartphone app for point-of-care quantification of lateral flow assays",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ryan ARMIGER","United Kingdom"
844,EF093,NULL,"Real world experience with modern HIV treatment: the art of ART","Arena 2 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
845,EF093,844,"Use of long-acting cabotegravir/rilpivirine in HIV-viraemic individuals: a metanalysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco BONGIOVANNI",Switzerland
846,EF093,844,"Assessment of HIV-DNA, immune activation and senescence biomarkers during injectable cabotegravir/rilpivirine treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria MAZZITELLI",Italy
847,EF093,844,"Impact of Cabotegravir plus Rilpivirine Long-Acting on Body Composition: Results from a Prospective Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea DE VITO",Italy
848,EF093,844,"Real-World Efficacy and Tolerability of Long-Acting Cabotegravir/Rilpivirine in Older Woman with Polypharmacy and Comorbidities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta ROSAS CANCIO-SUÁREZ",Spain
849,EF093,844,"Two-year comparative analysis of lipid profile changes between INSTI-based single tablet regimens in treatment-naïve people living with HIV: real-world evidence from South Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"So Yun LIM","Republic Of"
850,EF093,844,"Long-acting antiretroviral therapy in PLWH with prior HBV exposure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Ignacio MATEO GONZALEZ",Spain
851,EF093,844,"Protease inhibitors in today's antiretroviral landscape: are we tracking resistance?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge CISCAR SORIANO",Spain
852,EF093,844,"Effect after Switching from Efavirenz to Rilpivirine on Liver Steatosis Among People Living with HIV with Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laddarat SRIKHAM",Thailand
853,EF093,844,"Impact of maternal dolutegravir on growth outcomes of HIV-exposed uninfected children: A prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ezekielluoga YORAM","United Republic Of"
854,EF094,NULL,"Speed, convenience and performance of virus diagnostic methods","Arena 3 |","13:30 - 14:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","04. Diagnostic microbiology","Hans H. HIRSCH",Switzerland,NULL,NULL
855,EF094,854,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hans H. HIRSCH",SwitzerlandChair
856,EF094,854,"Prospective evaluation of a rapid diagnostic test in a tertiary hospital and prospects for reinforced dengue surveillance in Catalonia (Northeastern Spain)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura HORVATH",Spain
857,EF094,854,"Sequence-Independent Single-Primer Amplification (SISPA) followed by Next-Generation Sequencing for Diagnosing Viral Respiratory Tract Infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priscila TRINDADE",Brazil
858,EF094,854,"Seasonal trends and co-infection dynamics of respiratory pathogens: insights from a yearlong study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zafeirios TSINARIS",Greece
859,EF094,854,"Speed meets reliability in respiratory infections diagnosis with a new nucleic acid extraction workflow",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura PASTOR-BERNAD",Spain
860,EF094,854,"Pathobiome characterization and role in disease severity in children under 5-years with respiratory infection symptoms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leonardo TERRANOVA",Italy
861,EF094,854,"Viral viability markers of SARS-CoV-2: A Comparison of cell culture genomic RNA RT-PCR and subgenomic RNA RT-PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cuesta-Chasco CUESTA CHASCO",Spain
862,EF094,854,"Diagnostic performance of Hepatitis B virus surface antigens in the Netherlands using type-specific external quality assessment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emiel VANHULLE",Netherlands
863,EF094,854,"Low utility of parallel testing by multiplex and individual real-time PCR assays for the diagnosis of viral meningitis and encephalitis at a large public hospital in the United States.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia CUBER","United States"
864,EF094,854,"Plasma Separation Card as an alternative sampling method for quantitative HCV RNA testing with high comparability to EDTA plasma",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico GARCIA",Spain
865,EF099,NULL,"Infection Prevention in Action: Innovations, Insights, and Global Intervention","Arena 1 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","08. Healthcare-associated infections, infection prevention & control","Allison MCGEER",Canada,NULL,NULL
866,EF099,865,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Allison MCGEER",CanadaChair
867,EF099,865,"A Candida auris cgMLST Scheme for Enhanced Outbreak Surveillance and Global Epidemiological Tracking",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Casey HARLESS","United States"
868,EF099,865,"Machine Learning-Augmented Clinical Scoring System for Predicting KPC Infections in Healthcare Crisis Scenarios",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andres REARTE",Argentina
869,EF099,865,"Incident infections with respiratory syncytial virus in a hospital-based healthcare worker cohort, 2023-2024 winter season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camelia SAVULESCU",France
870,EF099,865,"Evaluation of the efficiency of reusable terminal filters for showers for nosocomial legionellosis prevention in a French university hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nagham Léa KHANAFER",France
871,EF099,865,"Emerging uncommon non-fermenters and their decreasing antibiotic susceptibility in patients with prolonged hospital stay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vikas KHILLAN",India
872,EF099,865,"Air and surface sampling around mpox Clade 1b in hospitals in the UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susan GOULD","United Kingdom"
873,EF099,865,"Utilization of a healthcare facilities rapid assessment tool to define infection prevention and control and Water, Sanitation and Hygiene baseline criterion met during Democratic Republic of Congo mpox outbreak from August to November 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"April BALLER",Switzerland
874,EF099,865,"The REACT study: Exploring the BSI Potential of KPC, NDM, VRE, and CRAB rectal colonization",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta COLANERI",Italy
875,EF100,NULL,"Cefiderocol: an efficient Trojan horse?","Arena 2 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Anna SRAMKOVA","Czech Republic",NULL,NULL
876,EF100,875,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SRAMKOVA","Czech RepublicChair"
877,EF100,875,"Acceleration of Emergence of Cefiderocol Resistance in Microfluidic Evolution System",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bowen LI",China
878,EF100,875,"The hidden link between cefiderocol resistance and increased virulence in Klebsiella pneumoniae: Insights from a TraDIS-based investigation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elias EGER",Germany
879,EF100,875,"Resistance profiles of Carbapenemase-producing Enterobacterales in a large centre in England: are we already losing cefiderocol?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ioannis BALTAS","United Kingdom"
880,EF100,875,"Impact of cefiderocol therapy on patient survival across different multi-drug resistant Gram-negative bacilli infections: insights from the SUSANA cohort.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolò CORTI",Italy
881,EF100,875,"Decoding resistance: investigating cefiderocol's battle against carbapenem-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi-Tzu LEE",China
882,EF100,875,"Long-read sequencing reveals novel genetic factors in cefiderocol resistance in Pseudomonas aeruginosa ATCC 27853: A stepwise adaptive evolution study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Joao CARDOSO",Netherlands
883,EF100,875,"Activity of cefiderocol against carbapenem-resistant and molecularly characterized Enterobacterales clinical isolates causing infection in hospitals in Europe and adjacent regions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo E. MENDES","United States"
884,EF100,875,"Cefiderocol activity against planktonic and biofilm forms of β-lactamase-producing Pseudomonas aeruginosa from people with cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia FABRIZIO",Italy
885,EF100,875,"Activity of cefiderocol against clinical isolates of Pseudomonas aeruginosa collected from five European countries as part of SENTRY antimicrobial surveillance program 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher LONGSHAW","United Kingdom"
886,EF101,NULL,"Immunology of bacterial pathogens","Arena 3 |","14:45 - 15:45CETCMEePoster Flash Session",,CET,"ePoster Flash Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
887,EF101,886,"Serotype 38 Streptococcus pneumoniae emerges as one of the dominant serotypes causing invasive pneumococcal disease in Germany and Poland, but not in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karim HAJJI",Netherlands
888,EF101,886,"Cross reactivity within pneumococcal serogroups 6 and 15 following adult vaccination with pneumococcal conjugate vaccine V116: a secondary analysis of five phase 3 studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Alejandra ESTEVES JARAMILLO","United States"
889,EF101,886,"Baseline serotype-specific IgG responses to pneumococcal vaccines in type 2 diabetes: implications for vaccine strategy in vulnerable populations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shincy METTINGAL RAMAKRISHNAN",India
890,EF101,886,"Protection against invasive meningococcal disease and gonorrhoea, 5 years post introduction of a 4CMenB immunisation program in infants and adolescents in South Australia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helen MARSHALL","United States"
891,EF101,886,"Molecular epidemiology and correlates of protection among group B Streptococcus from carriage and disease: assessing vaccine coverage in Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tatiana PINTO",Brazil
892,EF101,886,"Impact of BCG vaccination on adaptive immune responses to mycobacterial and non-mycobacterial antigens in HIV-exposed, uninfected infants.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rhoda NAMAKULA",Norway
893,EF101,886,"Immune signature against Klebsiella pneumoniae proteins in a mother-baby cohort from Blantyre, Malawi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eva HEINZ","United Kingdom"
894,EF101,886,"A comprehensive computational mapping of B-cell epitopes in the Klebsiella pneumoniae porinome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia PRIETO MARTIN GIL",Spain
895,EF101,886,"Chronic infection induces a broadly neutralizing antibody response to Elastase B of Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra ALBUS",Germany
896,EF104,NULL,"Cutting-edge technologies to improve viral diagnostics","Arena 1 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","01. Viral infection & disease (incl COVID-19)","Patricia ALVAREZ",Brazil,NULL,NULL
897,EF104,896,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia ALVAREZ",BrazilChair
898,EF104,896,"How straightforward is the switch from qPCR to dPCR in a routine lab setting for quantification of Varicella-zoster virus in CSF samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ariane BAUMHÖGGER",Germany
899,EF104,896,"A novel biosensor for the detection of RSV infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carla ZANNELLA",Italy
900,EF104,896,"Insufficient sexual health bloods don't always need throwing away!",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephanie HUTCHINGS","United Kingdom"
901,EF104,896,"A comparison of 4 HAV serology assays: the value of consensus results as a reference standard",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taeyang CHIN",Belgium
902,EF104,896,"Advancing herpesvirus diagnostics: clinical evaluation of a high-performance real-time PCR assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
903,EF104,896,"Evaluation of microbiological techniques for the diagnosis of West Nile Virus in the Virgen del Rocío hospital area (Sevilla, Spain).",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria AZNAR FERNANDEZ",Spain
904,EF104,896,"Development of Non-Cross-Reactive Monoclonal Antibodies Against West Nile Virus and Usutu Virus Non-Structural Protein 1 to Improve Early Diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina CECONI",Belgium
905,EF104,896,"Enhancing Diagnostics and Global Standards through the QCMD Viral Metagenomics EQA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Greg SUTTON","United Kingdom"
906,EF104,896,"Analysis of HIV-1 drug-resistence in newly diagnosed subjects using Next Generation Sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valeria MICHELI",Italy
907,EF105,NULL,"New data in non-tuberculous mycobacterial disease","Arena 2 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","02. Bacterial infection & disease","Lorenzo GUGLIELMETTI",France,NULL,NULL
908,EF105,907,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorenzo GUGLIELMETTI",FranceChair
909,EF105,907,"Deciphering genotypic resistance to amikacin in Mycobacterium abscessus using whole genome sequencing and a specific pipeline (GenoMAB)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille ALLAM",France
910,EF105,907,"Pseudomonas aeruginosa rapidly kills Mycobacterium abscessus in dual-species biofilms in vitro",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melissa MCDANIEL",Netherlands
911,EF105,907,"Distribution of contezolid in different tissues of mice and human patients infected with Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wenjuan NIE",China
912,EF105,907,"Exploration of clofazimine and bedaquiline activity against clinical strains of Mycobacterium abscessus to advance innovative therapeutic strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cano Fernández MARIA",Spain
913,EF105,907,"Leveraging stem cell technology to identify new treatment options for nontuberculous mycobacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sohinee SARKAR",Australia
914,EF105,907,"Recovery of Non-Tuberculous Mycobacteria and Detection of Dominant Circulating Clones in Indoor Water Samples from Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nils WETZSTEIN",Germany
915,EF105,907,"Deciphering the Epidemiology of Mycobacterium chimaera: Genetic Lineages, Environmental Sources, and Infection Prevention Insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanni LORENZIN",Italy
916,EF105,907,"Evaluation of a novel media for susceptibility testing of Mycobacterium avium-intracellulare complex isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tristan GRAMS","United States"
917,EF105,907,"Emerging cases of Mycobacterium chelonae endocarditis associated with BioIntegral bioprostheses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Judith KIKHNEY",Germany
918,EF106,NULL,"The ABC (allergy, bloodstream infections and clinical decision support) in AMS","Arena 3 |","16:15 - 17:15CETCMEePoster Flash Session",,CET,"ePoster Flash Session","05. New antibacterial agents, PK/PD & Stewardship","Céline PULCINI",France,NULL,NULL
919,EF106,918,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Céline PULCINI",FranceChair
920,EF106,918,"Evaluation of the allergy fact checker, a clinical decision support system to promote non-invasive delabeling of incorrect penicillin allergy labels: a mixed-methods study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dries WETS",Belgium
921,EF106,918,"Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record to assess safety, de-labelling and antibiotic prescribing: The ALABAMA randomised controlled trial.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jonathan SANDOE","United Kingdom"
922,EF106,918,"Stewardship interventions reduced blood culture utilization by 40% during BD BACTEC™ Blood Culture media shortage",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xena LI",Canada
923,EF106,918,"Prescriptive Impact of Rapid Microbiological Diagnostics in Bloodstream Infections Caused by Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus (PRIMEKA): A Retrospective Single-Center Cohort Study.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica SALVATI",Italy
924,EF106,918,"The inappropriate use of antibiotics for blood culture contamination and colonisation by multidrug-resistante microorganisms: the role of counselling on antibiotic prescription",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca Rowena PEÑA-ZALBIDEA",Spain
925,EF106,918,"Factors influencing meropenem prescription following the 2020 EUCAST « I » definition update : a multicentric observational study in Belgian hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucy CATTEAU",Belgium
926,EF106,918,"Impact of an Antimicrobial Stewardship Mobile Application on Antimicrobial Prescribing, Length of Hospital Stay, and Cost Savings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zahir Osman Eltahir BABIKER","United Arab Emirates"
927,EF106,918,"Evaluation of a model-based clinical decision support system for empirical antimicrobial therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mads Lause MOGENSEN",Denmark
928,EF106,918,"A rapid systematic review of criteria to facilitate prompt intravenous-to-oral antimicrobial switch in children and young people in England.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca OETTLE","United Kingdom"
929,EF110,NULL,"Advancing diagnostics and treatment of endocarditis","Arena 1 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","02. Bacterial infection & disease","Benoît GUERY",Switzerland,NULL,NULL
930,EF110,929,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoît GUERY",SwitzerlandChair
931,EF110,929,"18F-FDG-PET/CT improves source control of extra-cardiac complications in infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan M. PRINS",Netherlands
932,EF110,929,"Comparing Duke criteria updates: Advancing IE diagnosis in patients with prosthetic intracardiac materials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthaios PAPADIMITRIOU OLIVGERIS",Switzerland
933,EF110,929,"In vivo Dalbavancin efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and high-level aminoglycoside resistant (HLAR) Enterococcus faecalis (EFAE) experimental endocarditis model.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina GARCIA DE LA MARIA",Spain
934,EF110,929,"Identification and validation of clinical phenotypes in Staphylococcus aureus blood stream infection and their association with mortality (FEN-AUREUS study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesús RODRÍGUEZ-BAÑO",Spain
935,EF110,929,"Enterococcal Infective Endocarditis: demographics, comorbidities, diagnostic evaluation and mortality outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mita SINGH","United Kingdom"
936,EF110,929,"Health related quality of life of patients with infective endocarditis – preliminary data of the DERIVE cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte MEYER-SCHWICKERATH",Germany
937,EF110,929,"The optimal management of Enterococcus faecium catheter-related bloodstream infections: a gap to bridge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria RANCAN",Italy
938,EF110,929,"Ceftobiprole alone versus in combination with ampicillin against borderline penicillin-resistant, vancomycin-resistant Enterococcus faecalis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivia FUNK","United States"
939,EF110,929,"Risk factors for in- hospital mortality in 500 cases of infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristiane LAMAS",Brazil
940,EF111,NULL,"Don't blink: STIs are everywhere","Arena 2 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","13. Case reports and case series (n less than 10)","Mathew BEALE","United Kingdom",NULL,NULL
941,EF111,940,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathew BEALE","United KingdomChair"
942,EF111,940,"Neurosyphillis and Mpox co-infection mimic HIV encephalitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lamiss MEJDOUBI",Austria
943,EF111,940,"An unusal cause of transverse myelitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junais KOLERI",Qatar
944,EF111,940,"Ocular Syphilis, an uncommon presentation form of syphilis: two cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romina KARDASHI",Germany
945,EF111,940,"Case report of a severe skin infection in a young man on PrEP and DoxyPEP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milan ZLÁMAL","Czech Republic"
946,EF111,940,"Serowaffling in PrEP Users: The Difficulty of HIV Diagnosis – A Case Report.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pablo PILLADO ALONSO",Spain
947,EF111,940,"Severe disseminated mpox in a patient with advanced HIV: A case report",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Ana QUADROS FLORES",Portugal
948,EF111,940,"Sensorimotor polyneuropathy in a patient affected by HIV-1: an atypical presentation of neurosyphilis associated to anti-SOX-1 antibodies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arianna LIPPI",Italy
949,EF112,NULL,"Clinical considerations in resistant organisms","Arena 3 |","17:30 - 18:30CETCMEePoster Flash Session",,CET,"ePoster Flash Session","03. Bacterial susceptibility & resistance","Divya DEODHAR",Oman,NULL,NULL
950,EF112,949,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Divya DEODHAR",OmanChair
951,EF112,949,"Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicenter clinical experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca SERAPIDE",Italy
952,EF112,949,"Clinical outcomes of MSSA bacteremia exhibiting the cefazolin inoculum effect and development of a novel diagnostic method",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sadako YOSHIZAWA",Japan
953,EF112,949,"Third- and fourth-generation cephalosporins for the treatment of infections due to OXA48 carbapenemase-producing Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandro BLANCO ARÉVALO",Spain
954,EF112,949,"Are meropenem or imipenem-cilastatin effective therapies for patients with invasive ertapenem-resistant infections?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Sophie PETERS",Chile
955,EF112,949,"Oral Fosfomycin after Carbapenems as de-escalating therapy in Complicated Urinary Tract Infection: A randomized controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kirun ANGKANAVISAN",Thailand
956,EF112,949,"Oral switch vs. intravenous antibiotics treatment for serious carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa infections on hospital discharge: the next frontier for oral switch?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christen ARENA","United States"
957,EF112,949,"Metallo-β-lactamase colonization and subsequent risk of infection: a retrospective study.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carol LEE LUNA FERNANDES",Brazil
958,EF112,949,"Polymyxin including therapy versus colistin including therapy in the therapy of carbapenem-resistant Gram-negative infections: A retrospective matched cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merve MERT VAHABI",Türkiye
959,EF112,949,"Prognostic factors and role of clinical management in carbapenem-resistant Acinetobacter baumannii bacteraemia: results from a prospective, international, multicentre cohort (EURECA)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco COGLIATI DEZZA",Italy
960,EW001,NULL,"Surgical site infections: principles and practice in the era of multidrug resistance","Hall 2 |","08:30 - 10:30CETEducational Session",,CET,"Educational Session","08. Healthcare-associated infections, infection prevention & control","Gabriel BIRGAND",France,NULL,NULL
961,EW001,960,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel BIRGAND",FranceChair
962,EW001,960,"Evolving antimicrobial resistance: do we need a change in surgical antimicrobial prophylaxis?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camilla RODRIGUES",India
963,EW001,960,"Role of decolonisation and bowel decontamination in regions of overwhelming multidrug resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Prasannakumar PALANIKUMAR",India
964,EW001,960,"Screening for MDR GNR coloniSation: is there evidence for prophylaxis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisabeth PRESTERL",Austria
965,EW001,960,"Perioperative prophylaxis in special populations in the era of MDR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Divyashree SHANTHAMURTHY",India
966,EW002,NULL,"Demystifying pharmacokinetics and population pharmacokinetics: a toolkit for non-experts","Hall 3 |","08:30 - 10:30CETEducational Session",,CET,"Educational Session","05. New antibacterial agents, PK/PD & Stewardship","Shampa DAS","United Kingdom",NULL,NULL
967,EW002,966,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shampa DAS","United KingdomChair"
968,EW002,966,"Pharmacokinetics 101: navigating the basics for optimal dosing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linda AULIN",Netherlands
969,EW002,966,"The ABCs of population pharmacokinetic models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erwin DREESEN",Belgium
970,EW002,966,"Looking into the crystal ball: exploring the fabulous world of PK-PD simulations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincent ARANZANA-CLIMENT",France
971,EW002,966,"Decoding population pharmacokinetic papers: interpreting, comparing and discussing results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iris K. MINICHMAYR",Austria
972,EW003,NULL,"Challenges in identification and relevance of slow-growing pathogens","Hall 5 |","08:30 - 10:30CETEducational Session",,CET,"Educational Session","04. Diagnostic microbiology","Kerrie DAVIES","United Kingdom",NULL,NULL
973,EW003,972,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kerrie DAVIES","United KingdomChair"
974,EW003,972,"Sampling and culturing anaerobes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hugo CRUZ",Portugal
975,EW003,972,"I have an anaerobe: what is it and does it matter?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathleen BOITEN",Netherlands
976,EW003,972,"Actinomyces in clinical samples: when is it worth the trouble?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eija Inkeri KÖNÖNEN",Finland
977,EW003,972,"Nocardiosis: when to test and how to manage results?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David LEBEAUX",France
978,EW004,NULL,"A hard nut to crack in HIV","Hall 6 |","08:30 - 10:30CETEducational Session",,CET,"Educational Session","01. Viral infection & disease (incl COVID-19)","Yoav KEYNAN",Canada,NULL,NULL
979,EW004,978,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yoav KEYNAN",CanadaChair
980,EW004,978,"Viral reservoir: what a physician should know",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ivailo ALEXIEV",Bulgaria
981,EW004,978,"Non-suppressible viraemia during HIV-1 therapy: a challenge for clinicians",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose ARRIBAS",Spain
982,EW004,978,"Chronic vascular and pulmonary disease and HIV: what can we do about it?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne Dam POULSEN",Denmark
983,EW004,978,"Opportunistic infections: most common and most deadly",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milena STEVANOVIKJ","Republic Of"
984,EW005,NULL,"Diagnostic parasitology in the XXIst century: is microscopy "+" still useful?","Hall 8 |","08:30 - 10:30CETEducational Session",,CET,"Educational Session","07. Parasitic diseases, travel medicine & migrant health","Miriam José ÁLVAREZ-MARTÍNEZ",Spain,NULL,NULL
985,EW005,984,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam José ÁLVAREZ-MARTÍNEZ",SpainChair
986,EW005,984,"Artificial Intelligence for the diagnosis of parasitic infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bobbi PRITT","United States"
987,EW005,984,"Histopathology of parasitic infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Richard BRADBURY",Australia
988,EW005,984,"Molecular diagnosis vs. microscopy in the diagnosis of parasitic infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sitara Sr AJJAMPUR",India
989,EW005,984,"Paleoparasitology: what diagnostic tools?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayman EL-BADRY",Egypt
990,EW006,NULL,"Vaccine hesitancy: from issues to solutions through developing communication skills","Hall 9 |","08:30 - 10:30CETEducational Session",,CET,"Educational Session","11. Public health & vaccines","Monia CHEMAIS",Belgium,NULL,NULL
991,EW006,990,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monia CHEMAIS",BelgiumChair
992,EW006,990,"Vaccine hesitancy and its consequences",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Noni MACDONALD",Canada
993,EW006,990,"Why are patients and parents hesitant about vaccination?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eve DUBE",Canada
994,EW006,990,"Using social media to deal with vaccine hesitancy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muge CEVIK","United Kingdom"
995,EW006,990,"Strengthening vaccine confidence in patients and parents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
996,EW025,NULL,"AMR surveillance: current challenges and new perspectives","Hall 2 |","16:15 - 18:15CETEducational Session",,CET,"Educational Session","03. Bacterial susceptibility & resistance","Tomislav MESTROVIC",Croatia,NULL,NULL
997,EW025,996,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tomislav MESTROVIC",CroatiaChair
998,EW025,996,"The essentials of GRAM project: data sources, methodology and challenges in estimating AMR burden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Authia GRAY","United States"
999,EW025,996,"Networks for surveillance of AMR in animal pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucie COLLINEAU",France
1000,EW025,996,"Transition to genomic-based methodology for surveillance and outbreak detection to effectively combact AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camilla WIUFF COIA",Denmark
1001,EW025,996,"Implementing and running hospital-wide genomic surveillance of pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander MELLMANN",Germany
1002,EW026,NULL,"New insights into antifungal agents and resistance","Hall 3 |","16:15 - 18:15CETEducational Session",,CET,"Educational Session","06. Fungal infection & disease","Anuradha CHOWDHARY",India,NULL,NULL
1003,EW026,1002,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anuradha CHOWDHARY",IndiaChair
1004,EW026,1002,"Emerging resistance in Candida tropicalis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sharon CHEN",Australia
1005,EW026,1002,"Mechanisms of resistance in Candida glabrata",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David PERLIN","United States"
1006,EW026,1002,"Surveillance of resistance in Aspergillus species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maiken Cavling ARENDRUP",Denmark
1007,EW026,1002,"Environmental surveillance for antifungal resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eveline SNELDERS",Netherlands
1008,EW027,NULL,"Going Viral! Phage Therapy Clinical rounds","Hall 5 |","16:15 - 18:15CETEducational Session",,CET,"Educational Session","05. New antibacterial agents, PK/PD & Stewardship","Gregory GERMAN",Canada,NULL,NULL
1009,EW027,1008,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gregory GERMAN",CanadaChair
1010,EW027,1008,"Clinical cases and lessons from the STAMP protocol",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Holly SINCLAIR",Australia
1011,EW027,1008,"Difficult cases treated with phages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ghady HAIDAR","United States"
1012,EW027,1008,"Challenging osteoarticular cases treated with phages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tristan FERRY",France
1013,EW027,1008,"Treating urinary tract infections with phages: dream or reality?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saima ASLAM","United States"
1014,EW028,NULL,"Addressing infection challenges in immunocompromised patients: a case-based exploration","Hall 6 |","16:15 - 18:15CETEducational Session",,CET,"Educational Session","10. Immune compromise & transplant ID","Maddalena GIANNELLA",Italy,NULL,NULL
1015,EW028,1014,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maddalena GIANNELLA",ItalyChair
1016,EW028,1014,"Challenges in managing gastrointestinal infections in patients with primary immunodeficiency",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Effrossyni GKRANIA-KLOTSAS","United Kingdom"
1017,EW028,1014,"Respiratory infections in patients receiving CAR-T cells or bispecific monoclonal antibodies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gemma REYNOLDS",Australia
1018,EW028,1014,"Mycobacterial infections in patients with HIV infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Graeme Ayton MEINTJES","South Africa"
1019,EW028,1014,"Breakthrough fungal infections in haematopoietic cancer and in stem cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dimitrios P. KONTOYIANNIS","United States"
1020,EW029,NULL,"Impact of diabetes on infectious diseases: what should we know?","Hall 8 |","16:15 - 18:15CETEducational Session",,CET,"Educational Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Mark G. J. DE BOER",Netherlands,NULL,NULL
1021,EW029,1020,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark G. J. DE BOER",NetherlandsChair
1022,EW029,1020,"The impact of diabetes and host-pathogen interaction and gut microbiome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reinout VAN CREVEL",Netherlands
1023,EW029,1020,"Diabetes and invasive fungal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jochem BUIL",Netherlands
1024,EW029,1020,"Viral infections and diabetes: is there a connection?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malin FLODSTRÖM-TULLBERG",Sweden
1025,EW029,1020,"Pathogenesis of diabetic wound infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1026,EW030,NULL,"Primer on infection prevention and control: the crucial support by clinical microbiology","Hall 9 |","16:15 - 18:15CETEducational Session",,CET,"Educational Session","08. Healthcare-associated infections, infection prevention & control","Nico Tom MUTTERS",Germany,NULL,NULL
1027,EW030,1026,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nico Tom MUTTERS",GermanyChair
1028,EW030,1026,"Microbial fundamentals: building blocks of infection prevention and control",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurence ARMAND-LEFEVRE",France
1029,EW030,1026,"Optimising environmental sampling in infection control: rational use of the microbiology laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John E. COIA",Denmark
1030,EW030,1026,"The crucial role of molecular typing in infection control",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefanie KAMPMEIER",Germany
1031,EW030,1026,"How can we link diagnostic and antibiotic stewardship?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Constantinos TSIOUTIS",Cyprus
1032,EW038,NULL,"EUCAST Educational Workshop","Hall 4 |","08:30 - 11:30CETCMEEducational Session",,CET,"Educational Session","03. Bacterial susceptibility & resistance","Marlene AMARA",France,NULL,NULL
1033,EW038,1032,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marlene AMARA",FranceChair
1034,EW038,1032,"EUCAST update",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sören G. GATERMANN",Germany
1035,EW038,1032,"Setting clinical breakpoints, assessing evidence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk Edwina MULLER",Netherlands
1036,EW038,1032,"Benzylpenicillin susceptibility testing of S. pneumoniae by disk diffusion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gunnar KAHLMETER",Sweden
1037,EW038,1032,"What to do when there are no breakpoints",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Barbara Juliane HOLZKNECHT",Denmark
1038,EW038,1032,"Detection of resistance mechanisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian GISKE",Sweden
1039,EW039,NULL,"Are urinary tract infections still the same?","Hall 2 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","02. Bacterial infection & disease","Suzanne GEERLINGS",Netherlands,NULL,NULL
1040,EW039,1039,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suzanne GEERLINGS",NetherlandsChair
1041,EW039,1039,"Update on paediatric UTI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael BUETTCHER",Switzerland
1042,EW039,1039,"Diagnosis and treatment of UTI in the era of antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer KRANZ",Germany
1043,EW039,1039,"Can UTI be prevented?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chris HARDING","United Kingdom"
1044,EW039,1039,"Fungal and parasitic infections of the urinary tract",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gladys MBWANJI","United Republic Of"
1045,EW040,NULL,"OPAT: from aged wine to new vintage","Hall 3 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","05. New antibacterial agents, PK/PD & Stewardship","Birgit KOCH",Netherlands,NULL,NULL
1046,EW040,1045,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit KOCH",NetherlandsChair
1047,EW040,1045,"OPAT: principles, practice and checklists",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte QUINTENS",Belgium
1048,EW040,1045,"COPAT: complex outpatient parenteral antimicrobial therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ronald Andrew SEATON","United Kingdom"
1049,EW040,1045,"Antimicrobial stability and other challenges for OPAT practice?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark GILCHRIST","United Kingdom"
1050,EW040,1045,"New OPAT safety and efficacy data to guide practice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthew RAWLINS",Australia
1051,EW041,NULL,"RSV infections: diagnosis, surveillance and treatment in the advent of vaccines","Hall 13 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","01. Viral infection & disease (incl COVID-19)","Monika REDLBERGER-FRITZ",Austria,NULL,NULL
1052,EW041,1051,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monika REDLBERGER-FRITZ",AustriaChair
1053,EW041,1051,"Costs of RSV infection, compared to other respiratory viruses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Barbara RATH",France
1054,EW041,1051,"Virology and host interactions of RSV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter OPENSHAW","United Kingdom"
1055,EW041,1051,"RSV surveillance in the EU/EEA in the vaccine era",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eeva BROBERG",Sweden
1056,EW041,1051,"RSV fusion inhibitors and monoclonals: current status and future developments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Louis BONT",Netherlands
1057,EW042,NULL,"Traumatic wound infections: diagnosis and treatment options","Hall 14 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","02. Bacterial infection & disease","Amparo FERNÁNDEZ-RODRÍGUEZ",Spain,NULL,NULL
1058,EW042,1057,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amparo FERNÁNDEZ-RODRÍGUEZ",SpainChair
1059,EW042,1057,"Multidrug-resistant infections after trauma in warzone",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shehan HETTIARATCHY","United Kingdom"
1060,EW042,1057,"Fungal infections during natural disasters",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anuradha CHOWDHARY",India
1061,EW042,1057,"Bacteriophage therapy for multidrug-resistant wound infections in trauma",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tristan FERRY",France
1062,EW042,1057,"Infection of burn wounds",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nur BENZONANA",Türkiye
1063,EW070,NULL,"Malaria: when the drugs don't work Management of treatment failure in non-endemic countries","Hall 3 |","16:15 - 18:15CETCMEEducational Session",,CET,"Educational Session","07. Parasitic diseases, travel medicine & migrant health","Laura NABARRO","United Kingdom",NULL,NULL
1064,EW070,1063,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura NABARRO","United KingdomChair"
1065,EW070,1063,"Malaria in the non-endemic setting: who to treat as an outpatient and how to detect treatment failure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanuel BOTTIEAU",Belgium
1066,EW070,1063,"Malaria resistance mutations in the non-endemic setting: role of genomic surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna ROSANAS URGELL",Belgium
1067,EW070,1063,"How to manage Plasmodium Knowlesi infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giri Shan RAJAHRAM",Malaysia
1068,EW070,1063,"Epidemiology and control of Plasmodium Knowlesi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kimberly FORNACE",Singapore
1069,EW071,NULL,"The rare art of writing scientific articles: from conception to submission","Hall 15 |","16:15 - 18:15CETCMEEducational Session",,CET,"Educational Session","12. Professional and educational affairs","Marlieke DE KRAKER",Switzerland,NULL,NULL
1070,EW071,1069,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marlieke DE KRAKER",SwitzerlandChair
1071,EW071,1069,"Expressing yourself correctly: writing tips",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angela HUTTNER",Switzerland
1072,EW071,1069,"Constructing your manuscript for an original article",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesús RODRÍGUEZ-BAÑO",Spain
1073,EW071,1069,"The use of artificial intelligence tools for writing articles: what to do and not to do",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erlangga YUSUF",Netherlands
1074,EW071,1069,"Selecting the best journal for my manuscript",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andre KALIL","United States"
1075,EW077,NULL,"New tools in acute bacterial infections and sepsis: from machine learning to precision medicine","Hall 2 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","02. Bacterial infection & disease","Benjamin MCFADDEN",Australia,NULL,NULL
1076,EW077,1075,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin MCFADDEN",AustraliaChair
1077,EW077,1075,"Differentiating acute infection, sepsis and sepsis mimics in the ED?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa MELLHAMMAR",Sweden
1078,EW077,1075,"Machine learning for early recognition of sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karsten BORGWARDT",Germany
1079,EW077,1075,"How to avoid common mistakes in randomised clinical study design",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yin MO",Singapore
1080,EW077,1075,"Improved clinical trials in community-acquired pneumonia using precision medicine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lennie DERDE",Netherlands
1081,EW078,NULL,"Implementing metagenomics in my lab and mistakes to avoid","Hall 4 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","04. Diagnostic microbiology","Hege Vangstein AAMOT",Norway,NULL,NULL
1082,EW078,1081,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hege Vangstein AAMOT",NorwayChair
1083,EW078,1081,"Is metagenomics right for my lab?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula MÖLLING",Sweden
1084,EW078,1081,"Understanding the experimental and certification aspects of metagenomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mads ALBERTSEN",Denmark
1085,EW078,1081,"Navigating tools, techniques, and procurement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Basil Britto XAVIER",Netherlands
1086,EW078,1081,"Setting realistic goals and outcomes for metagenomics integration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claire BERTELLI",Switzerland
1087,EW079,NULL,"New guidelines for management of brain infections","Hall 11 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","02. Bacterial infection & disease","Jacob BODILSEN",Denmark,NULL,NULL
1088,EW079,1087,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob BODILSEN",DenmarkChair
1089,EW079,1087,"Tuberculous meningitis: what can we learn from the first global guidelines?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph DONOVAN",Vietnam
1090,EW079,1087,"WHO guidelines on bacterial meningitis: change of clinical practice?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthijs BROUWER",Netherlands
1091,EW079,1087,"ESCMID encephalitis guidelines 2024: what's new?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tom SOLOMON","United Kingdom"
1092,EW079,1087,"WHO guidelines for cryptococcal meningitis: success stories and barriers to implementation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nelesh GOVENDER","South Africa"
1093,EW096,NULL,"Tools for successful development as a medical educator","Hall 15 |","13:30 - 15:30CETCMEEducational Session",,CET,"Educational Session","12. Professional and educational affairs","Giorgia CARUANA",Switzerland,NULL,NULL
1094,EW096,1093,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia CARUANA",SwitzerlandChair
1095,EW096,1093,"Developing your educator professional identity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Todd CASSESE","United States"
1096,EW096,1093,"What do IPC doctors need to learn to be prepared",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone SCHEITHAUER",Germany
1097,EW096,1093,"Communities of practice: successful experience of a transformative collaboration and roadmap",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erin BONURA","United States"
1098,EW096,1093,"The critical need for ongoing innovations in medical education",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clémentine SCHILTE",France
1099,EW109,NULL,"Infections in cancer patients: tips for daily practice","Hall 2 |","16:15 - 18:15CETCMEEducational Session",,CET,"Educational Session","10. Immune compromise & transplant ID","José MOLINA GIL-BERMEJO",Spain,NULL,NULL
1100,EW109,1099,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"José MOLINA GIL-BERMEJO",SpainChair
1101,EW109,1099,"Tailoring pharmacologic prophylaxis in patients with non-haematologic cancer: from viruses to fungi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janne VEHRESCHILD",Germany
1102,EW109,1099,"Pneumonitis or pneumonia? A practical approach to lung infiltrates in patients with solid tumours",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1103,EW109,1099,"The diagnostic dilemmas and treatment challenges of mycobacteria in cancer patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siran KESKE",Türkiye
1104,EW109,1099,"HTLV-1 and T-cell lymphoma - predict & prevent",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucy COOK","United Kingdom"
1105,EW118,NULL,"How can we infer and track plasmid outbreaks?","Hall 2 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","04. Diagnostic microbiology","Alessandra CARATTOLI",Italy,NULL,NULL
1106,EW118,1105,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra CARATTOLI",ItalyChair
1107,EW118,1105,"Evolutionary modelling of plasmids",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuel ARES ARROYO",France
1108,EW118,1105,"How plasmids shape the emergence of nosocomial pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jukka CORANDER",Norway
1109,EW118,1105,"Understanding the complexity of plasmid outbreaks using bioinformatics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Torsten SEEMANN",Australia
1110,EW118,1105,"Plasmid transmission at the One Health interface",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole STOESSER","United Kingdom"
1111,EW119,NULL,"This bacterium might harbour AmpC, what should I do?!","Hall 11 |","08:30 - 10:30CETCMEEducational Session",,CET,"Educational Session","03. Bacterial susceptibility & resistance","Sören G. GATERMANN",Germany,NULL,NULL
1112,EW119,1111,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sören G. GATERMANN",GermanyChair
1113,EW119,1111,"Laboratory identification of AmpC and its impact on /i>in vitro resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana GALES",Brazil
1114,EW119,1111,"Divergent levels of AmpC expression in Gram-negative pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio OLIVER",Spain
1115,EW119,1111,"Rational choice of antimicrobial therapy against AmpC-producing pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patrick HARRIS",Australia
1116,EW119,1111,"Novel antimicrobials active against AmpC: what RCTs tell us in support of their use?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amy MATHERS","United States"
1117,EW135,NULL,"Transforming your research idea into an appropriate study design","Hall 3 |","13:30 - 15:30CETCMEEducational Session",,CET,"Educational Session","12. Professional and educational affairs","Casandra BULESCU",Romania,NULL,NULL
1118,EW135,1117,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Casandra BULESCU",RomaniaChair
1119,EW135,1117,"Designing high-quality research studies: methodological skills and knowledge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mical PAUL",Israel
1120,EW135,1117,"How to design and run scientific studies using AI agents as research assistants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alyssa BILINSKI","United States"
1121,EW135,1117,"Designing your first study: how to construct a workable project when your work environment may not help",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas TÄNGDÉN",Sweden
1122,EW135,1117,"Bridging early-career professionals with partners and seniors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia CARUANA",Switzerland
1123,EW146,NULL,"How to detect, manage and communicate hospital outbreaks","Hall 13 |","16:15 - 18:15CETCMEEducational Session",,CET,"Educational Session","08. Healthcare-associated infections, infection prevention & control","Margaret IP","Hong-kong Sar China",NULL,NULL
1124,EW146,1123,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Margaret IP",ChinaChair
1125,EW146,1123,"How to detect hospital outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
1126,EW146,1123,"How to confirm hospital outbreaks using genomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John W. A. ROSSEN",Netherlands
1127,EW146,1123,"How to rapidly respond to an ongoing hospital outbreak",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ermira TARTARI",Malta
1128,EW146,1123,"How to communicate hospital outbreaks via scientific publication",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines STEFFENS",Sweden
1129,FIPL1,NULL,"Fireplace: Asia: An AMR Hot Zone","Fireplace area |","12:15 - 13:15CETFireplace Session",,CET,"Fireplace Session","03. Bacterial susceptibility & resistance","Giulia DE ANGELIS",Italy,NULL,NULL
1130,FIPL1,1129,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia DE ANGELIS",ItalyChair
1131,FIPL1,1129,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David L. PATERSON",Singapore
1132,FIPL2,NULL,"Fireplace: Defending against dengue: global epidemiology and strategies for prevention and control","Fireplace area |","16:00 - 17:00CETFireplace Session",,CET,"Fireplace Session","07. Parasitic diseases, travel medicine & migrant health","Anu KANTELE",Finland,NULL,NULL
1133,FIPL2,1132,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anu KANTELE",FinlandChair
1134,FIPL2,1132,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernanda BOULOS",Brazil
1135,FIPL3,NULL,"Fireplace: Infections after Solid organ transplantation: past, present and future","Fireplace area |","10:45 - 11:45CETFireplace Session",,CET,"Fireplace Session","10. Immune compromise & transplant ID","Nina KHANNA",Switzerland,NULL,NULL
1136,FIPL3,1135,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nina KHANNA",SwitzerlandChair
1137,FIPL3,1135,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jay FISHMAN","United States"
1138,FIPL4,NULL,"Fireplace: The new frontiers in antimicrobial stewardship","Fireplace area |","12:15 - 13:15CETFireplace Session",,CET,"Fireplace Session","05. New antibacterial agents, PK/PD & Stewardship","Jose Ramon PANO-PARDO",Spain,NULL,NULL
1139,FIPL4,1138,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Ramon PANO-PARDO",SpainChair
1140,FIPL4,1138,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karin THURSKY",Australia
1141,FIPL5,NULL,"Fireplace: Tuberculosis: where are we now and where should we be","Fireplace area |","17:30 - 18:30CETFireplace Session",,CET,"Fireplace Session","02. Bacterial infection & disease","Jon S. FRIEDLAND","United Kingdom",NULL,NULL
1142,FIPL5,1141,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon S. FRIEDLAND","United KingdomChair"
1143,FIPL5,1141,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guy THWAITES",Vietnam
1144,FIPL6,NULL,"Fireplace: HIV: from needle parks to injectables","Fireplace area |","12:15 - 13:15CETFireplace Session",,CET,"Fireplace Session","01. Viral infection & disease (incl COVID-19)","Mary HORGAN",Ireland,NULL,NULL
1145,FIPL6,1144,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary HORGAN",IrelandChair
1146,FIPL6,1144,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huldrych GÜNTHARD",Switzerland
1147,FIPL7,NULL,"Fireplace: Staphylococcus aureus host-microbe interaction: ecology, disease, and vaccine development","Fireplace area |","16:00 - 17:00CETFireplace Session",,CET,"Fireplace Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Werner RUPPITSCH",Austria,NULL,NULL
1148,FIPL7,1147,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Werner RUPPITSCH",AustriaChair
1149,FIPL7,1147,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliane BUBECK WARDENBURG","United States"
1150,FO050,NULL,"HIV: a global ethical Conundrum","Arena 1 |","11:00 - 12:00CETCMEOpen Forum",,CET,"Open Forum","01. Viral infection & disease (incl COVID-19)","Seif AL-ABRI",Oman,NULL,NULL
1151,FO050,1150,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seif AL-ABRI",OmanChair
1152,FO050,1150,"HIV, from key population to general population: a Pandora's Box",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Syed Faisal MAHMOOD",Pakistan
1153,FO050,1150,"Ethical considerations in preventing mother-to-child HIV transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Glory ALEXANDER",India
1154,FO050,1150,"HIV drug trials in Africa: ethical concerns",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shah REENA",Kenya
1155,FO050,1150,"HIV-related stigma and discrimination in the healthcare setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teymur NOORI",Sweden
1156,FO063,NULL,"Science communication in a noisy world: podcasting and social media in ID/CM","Arena 1 |","14:45 - 15:45CETCMEOpen Forum",,CET,"Open Forum","12. Professional and educational affairs","Emily G. MCDONALD",Canada,NULL,NULL
1157,FO063,1156,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily G. MCDONALD",CanadaChair
1158,FO063,1156,"The ID:IOTS guide to creating a successful CM/ID podcast"",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Callum MUTCH","United Kingdom"
1159,FO063,1156,"Using social media for CM/ID education",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Scott JAKE","United States"
1160,FO063,1156,"Podcasting and social media for antimicrobial stewardship and pharmacy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erin MCCREARY","United States"
1161,FO090,NULL,"European CM/ID exam: going forward","Arena 1 |","11:00 - 12:00CETCMEOpen Forum",,CET,"Open Forum","12. Professional and educational affairs","Siri GOEPEL",Germany,NULL,NULL
1162,FO090,1161,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siri GOEPEL",GermanyChair
1163,FO090,1161,"View from medical microbiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maeve DOYLE",Ireland
1164,FO090,1161,"view from infectious diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eoghan DE BARRA",Ireland
1165,FO090,1161,"view from trainees (TAE)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian KRAEF",Denmark
1166,FO090,1161,"European exam - how to prepare?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annelies VERBON",Netherlands
1167,FO097,NULL,"Essential diagnostics in Low-Resource Settings: why are we still talking?","Arena 1 |","13:30 - 14:30CETCMEOpen Forum",,CET,"Open Forum","04. Diagnostic microbiology","Truls Michael LEEGAARD",Norway,NULL,NULL
1168,FO097,1167,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Truls Michael LEEGAARD",NorwayChair
1169,FO097,1167,"Training skilled personnel in LMIC and brain drain: is the solution the problem?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sipho Kenneth DLAMINI","South Africa"
1170,FO097,1167,"Leveraging surveillance networks to strengthen basic bacteriology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dissou AFFOLABI",Benin
1171,FO097,1167,"Clinical bacteriology laboratories in low-resource settings: considerations for sustainability",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Makeda SEMRET",Canada
1172,FO098,NULL,"Best of ID Week","Arena 2 |","13:30 - 14:30CETCMEOpen Forum",,CET,"Open Forum","12. Professional and educational affairs","Tina TAN","United States",NULL,NULL
1173,FO098,1172,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tina TAN","United StatesChair"
1174,FO098,1172,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seth COHEN","United States"
1175,FO102,NULL,"Navigating the future of pandemics across One Health","Arena 1 |","14:45 - 15:45CETCMEOpen Forum",,CET,"Open Forum","11. Public health & vaccines","Xavier LESCURE",France,NULL,NULL
1176,FO102,1175,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xavier LESCURE",FranceChair
1177,FO102,1175,"Status of the One Health Joint Plan of Action by the Quadripartite",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chadia WANNOUS",France
1178,FO102,1175,"Evidence review on One Health governance and implementation at the European level",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tyra Grove KRAUSE",Denmark
1179,FO102,1175,"Long-term consequences of emerging viral diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso J. RODRIGUEZ-MORALES",Colombia
1180,FO129,NULL,"Predatory journals in CM/ID: from symptoms to cure","Arena 1 |","11:00 - 12:00CETCMEOpen Forum",,CET,"Open Forum","12. Professional and educational affairs","Emily G. MCDONALD",Canada,NULL,NULL
1181,FO129,1180,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily G. MCDONALD",CanadaChair
1182,FO129,1180,"The genesis of predatory journals: symptoms and root problems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leonard LEIBOVICI",Israel
1183,FO129,1180,"The role of editors and publishers of 'reputable journals': what can they do to stop predatory journals?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Till BÄRNIGHAUSEN",Germany
1184,FO129,1180,"The roles of authors and academic institutions: towards governance and regulation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luigia SCUDELLER",Italy
1185,FO129,1180,"Bibliometric literacy in scientific publication",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lauren MAGGIO","United States"
1186,FO136,NULL,"Diversity in CM and ID: gender gaps and policy traps","Arena 1 |","13:30 - 14:30CETCMEOpen Forum",,CET,"Open Forum","12. Professional and educational affairs","Andre FUCHS",Germany,NULL,NULL
1187,FO136,1186,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andre FUCHS",GermanyChair
1188,FO136,1186,"How to avoid parity traps in ID/CM research?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muge CEVIK","United Kingdom"
1189,FO136,1186,"Gender gaps in visibility at scientific conferences",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah DELLIERE",France
1190,FO136,1186,"Psychological determinants of empowerment at individual and societal level",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1191,IPT01,NULL,"Clinical application of the UllCORE BSI Test - deepull's direct-from-blood multiplex PCR","Innovation theatre |","10:30 - 10:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1192,IPT01,1191,"Clinical application of the UllCORE BSI Test - deepull's direct-from-blood multiplex PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kimberle CHAPIN",Spain
1193,IPT02,NULL,"Race against resistance: understanding the impact of AMR on cancer care and advancing solutions","Innovation theatre |","11:00 - 11:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1194,IPT02,1193,"Race against resistance: understanding the impact of AMR on cancer care and advancing solutions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1195,IPT03,NULL,"Developing a potential first-in-class live biotherapeutic product (LBP) to prevent recurrent C. difficile infection (rCDI)","Innovation theatre |","11:30 - 11:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1196,IPT03,1195,"Developing a potential first-in-class live biotherapeutic product (LBP) to prevent recurrent C. difficile infection (rCDI)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver A. CORNELY",Germany
1197,IPT04,NULL,"The DRAIGON project: developing MDR diagnosis with AI-driven whole-genome sequencing for rapid, precise, and comprehensive detection of resistant infections","Innovation theatre |","12:00 - 12:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1198,IPT04,1197,"The DRAIGON Project: developing MDR diagnosis with AI-driven whole-genome sequencing for rapid, precise, and comprehensive detection of resistant infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irina MELN",France
1199,IPT05,NULL,"Evolving impact of long COVID","Innovation theatre |","12:30 - 12:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1200,IPT05,1199,"Evolving impact of long COVID",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roger PAREDES",Spain
1201,IPT06,NULL,"Molecular diagnostic tests: how do you QC? Increase compliance for your IQC programs","Innovation theatre |","13:00 - 13:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1202,IPT06,1201,"Molecular diagnostic tests: how do you QC? Increase compliance for your IQC programs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chris CONNELLY","United States"
1203,IPT08,NULL,"BACTEROMIC: One system ... Many comprehensive solutions","Innovation theatre |","14:00 - 14:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1204,IPT08,1203,"BACTEROMIC: One system . Many comprehensive solutions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lukasz RICHTER",Poland
1205,IPT09,NULL,"T cell directed mRNA vaccines for infectious diseases","Innovation theatre |","15:00 - 15:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1206,IPT09,1205,"T Cell directed mRNA vaccines for infectious diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadine SALISCH",Germany
1207,IPT10,NULL,"Data-driven approaches to managing patients at high risk for severe COVID-19","Innovation theatre |","15:30 - 15:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1208,IPT10,1207,"Data-driven approaches to managing patients at high risk for severe COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina GARCIA VIDAL",Spain
1209,IPT11,NULL,"Innovation in preventing the unseen threat: central line-associated bloodstream infections","Innovation theatre |","16:00 - 16:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1210,IPT11,1209,"Innovation in preventing the unseen threat: central line-associated bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nisha GUPTA","United States"
1211,IPT12,NULL,"Isothermal recombinase polymerase (RPA) reagents for diagnostic assay development and research","Innovation theatre |","10:00 - 10:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1212,IPT12,1211,"Isothermal recombinase polymerase (RPA) reagents for diagnostic assay development and research",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agne ALMINAITE",Lithuania
1213,IPT13,NULL,"Fosmanogepix - a novel clinical phase 3 stage antifungal agent","Innovation theatre |","10:30 - 10:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1214,IPT13,1213,"Fosmanogepix - a novel clinical phase 3 stage antifungal agent",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc  ENGELHARDT",Switzerland
1215,IPT14,NULL,"Drive for discovery: the long road for new uUTI antibiotic approvals","Innovation theatre |","11:00 - 11:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1216,IPT14,1215,"Drive for discovery: the long road for new uUTI antibiotic approvals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Judith ABSALON","United States"
1217,IPT15,NULL,"From dysbiosis to detection: exploring the impact of vaginal microbiome testing on reproductive success","Innovation theatre |","11:30 - 11:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1218,IPT15,1217,"From dysbiosis to detection: exploring the impact of vaginal microbiome testing on reproductive success",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arne MATERNA",Denmark
1219,IPT15,1217,"From dysbiosis to detection: exploring the impact of vaginal microbiome testing on reproductive success",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1220,IPT16,NULL,"The need for rapid diagnostics in sepsis management using innovative OnePCR point of care","Innovation theatre |","12:00 - 12:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1221,IPT16,1220,"The need for rapid diagnostics in sepsis management using innovative OnePCR point of care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priyadarshini PANDE",France
1222,IPT17,NULL,"Physicochemical stability of cefepime/emmetazobactam in medical devices for continuous infusion. Is it possible to use it in OPAT?","Innovation theatre |","12:30 - 12:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1223,IPT17,1222,"Physicochemical stability of cefepime/emmetazobactam in medical devices for continuous infusion. Is it possible to use it in OPAT?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dolores SERRANO",Spain
1224,IPT18,NULL,"Nontuberculous mycobacteria: an overlooked threat with a growing impact on global public health","Innovation theatre |","13:00 - 13:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1225,IPT18,1224,"Nontuberculous mycobacteria: an overlooked threat with a growing impact on global public health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joaquin ORTIZ",Spain
1226,IPT20,NULL,"The magic of randomization for understanding the public health value of influenza vaccination","Innovation theatre |","14:00 - 14:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1227,IPT20,1226,"The magic of randomization for understanding the public health value of influenza vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathieu BANGERT",France
1228,IPT21,NULL,"Revolutionizing vaginitis diagnosis: the Impact of molecular screening tools","Innovation theatre |","14:30 - 14:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1229,IPT21,1228,"Revolutionizing vaginitis diagnosis: the Impact of molecular screening tools",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jonas AMZALAG",France
1230,IPT22,NULL,"Microbiological diagnosis of sepsis: an emerging molecular approach in a clinical microbiology laboratory setting","Innovation theatre |","15:00 - 15:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1231,IPT22,1230,"Microbiological diagnosis of sepsis: an emerging molecular approach in a clinical microbiology laboratory setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicasio MANCINI",Italy
1232,IPT23,NULL,"Molecular testing for intestinal protozoa: how a laboratory developed test compares to one that is FDA-cleared","Innovation theatre |","15:30 - 15:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1233,IPT23,1232,"Molecular testing for intestinal protozoa: how a laboratory developed test compares to one that is FDA-cleared",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susan MADISON-ANTENUCCI","United States"
1234,IPT24,NULL,"Implementation of pan-enteric PCR screening at a UK general district hospital - benefits, pitfalls and lessons learnt","Innovation theatre |","16:00 - 16:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1235,IPT24,1234,"Implementation of pan-enteric PCR screening at a UK general district hospital - benefits, pitfalls and lessons learnt",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisabetta SAVANCO","United Kingdom"
1236,IPT25A,NULL,"Genomic data. Insights. Action (II): Rapid mNGS for emergency response (RANGER) for HERA's next-generation cross-border threat capability","Innovation theatre |","11:30 - 11:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1237,IPT25A,1236,"Rapid mNGS for emergency response (RANGER): building the next-generation cross-border pandemic threat capability for HERA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew ENGELI","United Kingdom"
1238,IPT25,NULL,"Genomic data. Insights. Action (I): (Re)Shaping the future of infectious disease management with EIT Pathogena","Innovation theatre |","11:00 - 11:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1239,IPT25,1238,"Genomic data. Insights. Action: (Re)Shaping the future of infectious diseases management with EIT Pathogena",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma STANTON","United Kingdom"
1240,IPT26,NULL,"AMR: are new antibiotics the only solution?","Innovation theatre |","12:00 - 12:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1241,IPT26,1240,"AMR: are new antibiotics the only solution?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seamus O'BRIEN","United Kingdom"
1242,IPT27,NULL,"Beyfortus® (nirsevimab) and its outcomes against RSV LRTD in real-world analyses from Galicia (Spain)","Innovation theatre |","14:00 - 14:20CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1243,IPT27,1242,"Beyfortus® (nirsevimab) and its outcomes against RSV LRTD in real-world analyses from Galicia (Spain)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia LOPEZ GRANADOS",France
1244,IPT28,NULL,"Lateral flow assays: optimizing fiber pads in test development and manufacture","Innovation theatre |","14:30 - 14:50CETInnovation Theatre",,CET,"Innovation Theatre","32. Industry session",NULL,NULL,NULL,NULL
1245,IPT28,1244,"Optimizing fiber pads in test development and manufacture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Klaus HOCHLEITNER","United Kingdom"
1246,IS01,NULL,"Advancements in paediatric RSV prevention: navigating the evolving clinical landscape and public health strategies","Hall 6 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Monika REDLBERGER-FRITZ",Austria,NULL,NULL
1247,IS01,1246,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monika REDLBERGER-FRITZ","AustriaESCMID-appointed chair"
1248,IS01,1246,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monika REDLBERGER-FRITZ",Austria
1249,IS01,1246,"Burden of RSV disease in infants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanne WILDENBEEST",Netherlands
1250,IS01,1246,"Development of new monoclonal antibody to prevent RSV disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Louis BONT",Netherlands
1251,IS01,1246,"From theory to practice - public health implementation for RSV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico MARTINÓN-TORRES",Spain
1252,IS01,1246,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monika REDLBERGER-FRITZ",Austria
1253,IS02,NULL,"Revisiting treatment strategies for MBL-producing Enterobacterales and S. maltophilia: what's new?","Hall 7 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Matteo BASSETTI",Italy,NULL,NULL
1254,IS02,1253,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",ItalyChair
1255,IS02,1253,"Welcome and Introduction - MBLs on the rise: current insights on epidemiology and disease burden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1256,IS02,1253,"Navigating the challenges: the importance of surveillance and early diagnosis in the management of MBL-producing bacterial infections?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camilla RODRIGUES",India
1257,IS02,1253,"Revisiting the unmet need: what's new in the treatment landscape*",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yehuda CARMELI",
1258,IS02,1253,"Panel Discussion and Q&A - When should the contemporary treatment options be used for MBL infections*?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1259,IS03,NULL,"Options for best-in-class influenza and COVID-19 vaccines: methodologies, challenges and opportunities in assessing vaccine performance","Hall 8 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Meral AKCAY",France,NULL,NULL
1260,IS03,1259,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meral AKCAY",FranceChair
1261,IS03,1259,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meral AKCAY",France
1262,IS03,1259,"A comparative analysis of timing and hospitalisation burden of influenza and COVID-19: US, EU and UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nabila SHAIKH","United Kingdom"
1263,IS03,1259,"Vaccine options for the control of SARS-CoV-2: why having different vaccine platforms matter for public health?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert OSTERHAUS",Germany
1264,IS03,1259,"Vaccine options for control of Influenza: methodologies, challenges and opportunities in assessing vaccine performance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Salah MAHMUD",Canada
1265,IS03,1259,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meral AKCAY",France
1266,IS05,NULL,"mRNA innovation in action: a new era for respiratory care","Hall 10 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Albert VOLLAARD",Netherlands,NULL,NULL
1267,IS05,1266,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert VOLLAARD","NetherlandsESCMID-appointed chair"
1268,IS05,1266,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert VOLLAARD",Netherlands
1269,IS05,1266,"Beyond the sneeze: unmasking hidden risks of respiratory disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1270,IS05,1266,"From lab to life: safety and durability of mRNA vaccines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1271,IS05,1266,"More than meets the eye: the hidden toll of respiratory infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1272,IS05,1266,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert VOLLAARD",Netherlands
1273,IS06,NULL,"Enter a new era of MDx for antimicrobial resistance","Hall 6 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Te-Din Daniel HUANG",Belgium,NULL,NULL
1274,IS06,1273,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Te-Din Daniel HUANG",BelgiumChair
1275,IS06,1273,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Te-Din Daniel HUANG",Belgium
1276,IS06,1273,"More surveillance swabs and more sequencing: the best strategy to reduce and control MDR microorganisms diffusion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefania STEFANI",Italy
1277,IS06,1273,"Advantages of molecular methods over culture methods to optimise screening for carriage of CPE, ESBL and VRE",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theresa CUNNINGHAM",Ireland
1278,IS06,1273,"Routine STI-AMR testing: past and future perspectives",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carsten TIEMANN",Germany
1279,IS06,1273,"Pre-treatment STI-AMR testing for better diagnostics and resistance control of Mycoplasma genitalium infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis PIÑEIRO",Spain
1280,IS06,1273,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Te-Din Daniel HUANG",Belgium
1281,IS07,NULL,"Rewriting the plot: understanding invasive mould disease diagnosis and treatment for vulnerable patients","Hall 7 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Cornelia LASS-FLÖRL",Austria,NULL,NULL
1282,IS07,1281,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",AustriaChair
1283,IS07,1281,"Welcome and Introduction - The pilot episode: welcome and launch of our exploration into IMD",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",Austria
1284,IS07,1281,"Better call microbiology: uniting with microbiologists for effective and timely IMD diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arunaloke CHAKRABARTI",
1285,IS07,1281,"The crown: exploring the realm of IMD management challenges in paediatric haematology-oncology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas H. GROLL",Germany
1286,IS07,1281,"True detective: solving the puzzle of Mucorales and Aspergillus co-infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malgorzata MIKULSKA",Italy
1287,IS07,1281,"Racing against time to diagnose and manage IMD in critical care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joost WAUTERS",Belgium
1288,IS07,1281,"Panel Discussion and Q&A - Season finale: audience questions and final reflections on IMD",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",Austria
1289,IS09,NULL,"COVID-19 5 years later: advancing hospital care in the new normal","Hall 9 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Roy CHEMALY","United States",NULL,NULL
1290,IS09,1289,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roy CHEMALY","United StatesESCMID official"
1291,IS09,1289,"Welcome and Introduction - The new normal in COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew USTIANOWSKI","United Kingdom"
1292,IS09,1289,"The different faces of COVID-19: clear cause vs contributing factor",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert KRAUSE",Austria
1293,IS09,1289,"Advancing hospital care: the interplay between guidelines and clinical judgement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristobal RODRÍGUEZ-LEAL",Spain
1294,IS09,1289,"Bridging clinical gaps in COVID-19 care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1295,IS09,1289,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew USTIANOWSKI","United Kingdom"
1296,IS10,NULL,"Maximising efficiency in microbiology: navigating resource scarcity with lab automation","Hall 10 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Antony CROXATTO",Switzerland,NULL,NULL
1297,IS10,1296,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antony CROXATTO",SwitzerlandChair
1298,IS10,1296,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antony CROXATTO",Switzerland
1299,IS10,1296,"Modernising microbiology: the multidimensional impact of automation assessed by HTA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucrezia FERRARIO",Italy
1300,IS10,1296,"Optimising automation: efficiency gains through continuous LEAN improvement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew BAMBER","United Kingdom"
1301,IS10,1296,"Innovative imaging: completing the automation transformation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christie VERMEIREN",Canada
1302,IS10,1296,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antony CROXATTO",Switzerland
1303,IS11,NULL,"Innovative antibiotics: are we using them in the right patients, at the right time? The example of cefiderocol in CRGNI","Hall 6 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Mathias PLETZ",Germany,NULL,NULL
1304,IS11,1303,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathias PLETZ",GermanyChair
1305,IS11,1303,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathias PLETZ",Germany
1306,IS11,1303,"Are we using innovative antibiotics optimally?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gennaro DE PASCALE",Italy
1307,IS11,1303,"What has real world experience of cefiderocol taught us about its place in therapy?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula RAMÍREZ",Spain
1308,IS11,1303,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathias PLETZ",Germany
1309,IS12,NULL,"The power of prevention: incorporating adult vaccination into health systems","Hall 7 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Maria GANCZAK",Poland,NULL,NULL
1310,IS12,1309,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria GANCZAK","PolandESCMID-appointed chair"
1311,IS12,1309,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria GANCZAK",Poland
1312,IS12,1309,"The preventable burden of co-circulating vaccine-preventable respiratory diseases in adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charles FELDMAN","South Africa"
1313,IS12,1309,"The impact of respiratory infections on non-communicable diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eva POLVERINO",Spain
1314,IS12,1309,"Driving change through global vaccine advocacy to build robust immunisation programmes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael MOORE",Australia
1315,IS12,1309,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria GANCZAK",Poland
1316,IS13,NULL,"Embracing the change: success stories of innovation in clinical microbiology","Hall 8 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Fusun CAN",Türkiye,NULL,NULL
1317,IS13,1316,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fusun CAN","TürkiyeESCMID-appointed chair"
1318,IS13,1316,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gilbert GREUB",Switzerland
1319,IS13,1316,"Embracing change to empower people to self-sample for STI testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Barbara VAN DER POL","United States"
1320,IS13,1316,"Driving the changing needs of diagnostics: how should labs prepare for the next unknown?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giuseppe TOGNI",Switzerland
1321,IS13,1316,"The automation transition journey: ready for the change?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher ALLAN","United Kingdom"
1322,IS13,1316,"The automation transition journey: shifting mindset, embracing innovation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annette SKOVBY",Denmark
1323,IS13,1316,"The automation transition journey: impacts and outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cécile MEEX",Belgium
1324,IS13,1316,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gilbert GREUB",Switzerland
1325,IS14,NULL,"Details make the difference. Do you know everything about the new antibiotics?","Hall 9 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Matteo BASSETTI",Italy,NULL,NULL
1326,IS14,1325,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",ItalyChair
1327,IS14,1325,"Welcome and Introduction - Are All BL/BLI combinations equal?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1328,IS14,1325,"BL/BLIs combinations. An antimicrobial activity review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent DORTET",France
1329,IS14,1325,"BL/BLIs combinations. Lung ELF PK/PD review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus ZEITLINGER",Austria
1330,IS14,1325,"Role of new BL/BLIs combinations for Gram-negative bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina GARCIA VIDAL",Spain
1331,IS14,1325,"F2F debate: BL/BLIs combinations for the treatment of ESBLs and Carbapenem Resistant infections; OXA-48 vs KPC infections - same approach?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luke MOORE","United Kingdom"
1332,IS14,1325,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1333,IS15,NULL,"Changing microbiology: advanced spectroscopy and molecular biology techniques","Hall 10 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Elena DE CAROLIS",Italy,NULL,NULL
1334,IS15,1333,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena DE CAROLIS","ItalyESCMID-appointed chair"
1335,IS15,1333,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus KOSTRZEWA",Germany
1336,IS15,1333,"Application of Fourier transform infrared spectroscopy (FTIR) in infection control: investigation of fungal and bacterial transmission events",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arthur PRANADA",Germany
1337,IS15,1333,"The rising significance of filamentous fungi as pathogens and the crucial role of modern diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit WILLINGER",Austria
1338,IS15,1333,"CMV RNA testing: a game changer in the management of personalized therapies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlo Federico PERNO",Italy
1339,IS15,1333,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus KOSTRZEWA",Germany
1340,IS16,NULL,"New horizon of RSV LRTD in infants: reflection on two seasons of prevention options","Hall 6 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Markus KNUF",Germany,NULL,NULL
1341,IS16,1340,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus KNUF",GermanyChair
1342,IS16,1340,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus KNUF",Germany
1343,IS16,1340,"Landscape of RSV LRTD prevention strategies for infants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CASTELLS VILELLA",Spain
1344,IS16,1340,"Local implementation strategies and real-world evidence for the prevention  of RSV LRTD in infants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CASTELLS VILELLA",Spain
1345,IS16,1340,"Real-world experience and the evolution of the immunoprophylaxis against RSV LRTD in a broad infant population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CASTELLS VILELLA",Spain
1346,IS16,1340,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus KNUF",Germany
1347,IS17,NULL,"Unlocking evidence: opening doors to integrate real-world evidence into the treatment of MDR Gram-negative bacterial infections","Hall 7 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Christian GISKE",Sweden,NULL,NULL
1348,IS17,1347,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian GISKE","SwedenESCMID-appointed chair"
1349,IS17,1347,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice GRABEIN",Germany
1350,IS17,1347,"Rral-world evidence (RWE) and me: what is RWE and why is it important to me in my daily role?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David VAN DUIN","United States"
1351,IS17,1347,"Connecting the dots: leveraging RWE to optimise early appropriate therapy for improved patient outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula RAMÍREZ",Spain
1352,IS17,1347,"A mountain of RWE: robust data that support the value of ceftazimide-avibactam for the treatment of MDR Gram-negative bacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David L. PATERSON",Singapore
1353,IS17,1347,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice GRABEIN",Germany
1354,IS18,NULL,"Addressing diverse clinical needs in respiratory infections: choosing the appropriate test, in the right location, to best serve your patient population","Hall 8 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Truls Michael LEEGAARD",Norway,NULL,NULL
1355,IS18,1354,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Truls Michael LEEGAARD","NorwayESCMID-appointed chair"
1356,IS18,1354,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam THORNBERG",
1357,IS18,1354,"Respiratory infection control and prevention: insights from daycare settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Enni SANMARK",Finland
1358,IS18,1354,"Molecular point of care respiratory virus testing: operational experience from an Integrated Healthcare Network in Texas, United States",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robyn OLNEY",
1359,IS18,1354,"Decision making and clinical implementation for syndromic respiratory testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erin MCELVANIA","United States"
1360,IS18,1354,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam THORNBERG",
1361,IS19,NULL,"Invasive fungal disease: navigating the risks, benefits and challenges of current practice","Hall 9 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Roger BRÜGGEMANN",Netherlands,NULL,NULL
1362,IS19,1361,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roger BRÜGGEMANN","NetherlandsESCMID-appointed chair"
1363,IS19,1361,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia MUNOZ",Spain
1364,IS19,1361,"Antifungal stewardship in a time of rising resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malgorzata MIKULSKA",Italy
1365,IS19,1361,"Time is of the essence: the ICU perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert KRAUSE",Austria
1366,IS19,1361,"Addressing the crisis on our wards",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tobias LAHMER",Germany
1367,IS19,1361,"Interactive case series: recent experience with novel antifungal treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia MUNOZ",Spain
1368,IS19,1361,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia MUNOZ",Spain
1369,IS20,NULL,"Redefining preparedness: monitoring evolving pathogens and the changing epidemiology of STI's and HIV","Hall 10 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Cecile BEBEAR",France,NULL,NULL
1370,IS20,1369,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cecile BEBEAR","FranceESCMID-appointed chair"
1371,IS20,1369,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna Maria GERETTI","United Kingdom"
1372,IS20,1369,"Confidence for today, protection for tomorrow: how a global network of virus hunters is transforming healthcare by staying one step ahead",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gavin CLOHERTY","United States"
1373,IS20,1369,"Speeding up diagnosis: community-based rapid testing for HIV, syphilis and viral hepatitis in Europe and Central Asia - challenges and opportunities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura FERNÀNDEZ LÓPEZ",Spain
1374,IS20,1369,"Introduction of Prep and DoxyPEP: what are the implications for HIV/STI testing?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jürgen ROCKSTROH",Germany
1375,IS20,1369,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna Maria GERETTI","United Kingdom"
1376,IS21,NULL,"Reducing the global burden of RSV in infants via maternal immunisation","Hall 6 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Debby BOGAERT","United Kingdom",NULL,NULL
1377,IS21,1376,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debby BOGAERT","United KingdomESCMID-appointed chair"
1378,IS21,1376,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debby BOGAERT","United Kingdom"
1379,IS21,1376,"The global burden of RSV disease in infants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paolo MANZONI",Italy
1380,IS21,1376,"RSVpreF vaccine clinical overview",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta NUNES",France
1381,IS21,1376,"Key learnings from the real-world implementation of RSV maternal immunisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irene CETIN",Italy
1382,IS21,1376,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debby BOGAERT","United Kingdom"
1383,IS23,NULL,"Does number of serotypes matter? A new adult-specific pneumococcal conjugate vaccine to expand protection across the lifespan","Hall 8 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Zitta Barrella HARBOE",Denmark,NULL,NULL
1384,IS23,1383,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zitta Barrella HARBOE","DenmarkESCMID-appointed chair"
1385,IS23,1383,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert KRAUSE",Austria
1386,IS23,1383,"Overview of PCV21 phase III clinical development programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Alejandra ESTEVES JARAMILLO","United States"
1387,IS23,1383,"Pneumococcal pNeumonia Epidemiology, Urine serotyping, Mental Outcomes (PNEUMO) EU study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina PRAT AYMERICH",Netherlands
1388,IS23,1383,"Adult immunisation as a priority for public health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pier Luigi LOPALCO",Italy
1389,IS23,1383,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert KRAUSE",Austria
1390,IS24,NULL,"Maximising the impact of syndromic molecular diagnostics: enhancing respiratory infection management and antimicrobial stewardship in the ED and ICU","Hall 9 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Maurizio SANGUINETTI",Italy,NULL,NULL
1391,IS24,1390,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maurizio SANGUINETTI","ItalyESCMID-appointed chair"
1392,IS24,1390,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan WINKLER",Austria
1393,IS24,1390,"Improving diagnosis and management of patients with acute respiratory infections in emergency departments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rangaraj SELVARANGAN",
1394,IS24,1390,"Evaluating the impact of pneumonia (PN) panel on ICU therapeutic strategies: insights and future directions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra BANDERA",Italy
1395,IS24,1390,"Syndromic testing: a key tool in the battle against drug-resistant Gram-negative bacilli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ali OMRANI",Qatar
1396,IS24,1390,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan WINKLER",Austria
1397,IS25,NULL,"Preventing bacterial infections: a crucial front in the fight against sepsis and antimicrobial resistance","Hall 10 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Michele BARTOLETTI",Italy,NULL,NULL
1398,IS25,1397,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michele BARTOLETTI","ItalyESCMID-appointed chair"
1399,IS25,1397,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariam JASHI",Germany
1400,IS25,1397,"Sepsis survivor witness",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wilbert KRUIJSEN",Netherlands
1401,IS25,1397,"Sepsis susceptibility and comorbidities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio ARTIGAS",Spain
1402,IS25,1397,"Multidrug-resistant bacteria and sepsis: fact or foe?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evelina TACCONELLI",Italy
1403,IS25,1397,"From trained immunity to vaccination: room for prevention from multidrug-resistant bacteria?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evangelos GIAMARELLOS-BOURBOULIS",Greece
1404,IS25,1397,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariam JASHI",Germany
1405,IS26,NULL,"Expert insights in COVID-19: from vaccination to treatment","Hall 6 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Laurent KAISER",Switzerland,NULL,NULL
1406,IS26,1405,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent KAISER","SwitzerlandESCMID-appointed chair"
1407,IS26,1405,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefania MAGGI",Italy
1408,IS26,1405,"The reality of COVID-19 in 2025: is there still a need for vaccination and treatment?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Colin RUSSELL",
1409,IS26,1405,"Keeping pace with viral evolution: updated vaccines to help protect individuals against COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albertus OSTERHAUS",Netherlands
1410,IS26,1405,"The role of COVID-19 antivirals today: getting the right treatment to the right patient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roger PAREDES",Spain
1411,IS26,1405,"From HCPs to patients and carers: why sharing COVID-19 data remains key to improving outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sven SCHELLBERG",Germany
1412,IS26,1405,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefania MAGGI",Italy
1413,IS28,NULL,"Refining the management of cytomegalovirus and Gram-negative infections: latest updates and therapeutic advances","Hall 8 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Dina AVERBUCH",Israel,NULL,NULL
1414,IS28,1413,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina AVERBUCH",IsraelChair
1415,IS28,1413,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina AVERBUCH",Israel
1416,IS28,1413,"Opening Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina AVERBUCH",Israel
1417,IS28,1413,"Part 1: Advancements in CMV management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina AVERBUCH",Israel
1418,IS28,1413,"CMV management after HSCT: state of the art update",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Per LJUNGMAN",
1419,IS28,1413,"Navigating the shifting landscape in SOT and evolving RWE",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nassim KAMAR",France
1420,IS28,1413,"Panel discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina AVERBUCH",Israel
1421,IS28,1413,"Opening Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Souha S. KANJ",Lebanon
1422,IS28,1413,"Part 2: Recent advances in treating pneumonia caused by resistant Gram-negative infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Souha S. KANJ",Lebanon
1423,IS28,1413,"Novel approaches: clinical evidence and advancements in addressing resistant Gram-negative infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1424,IS28,1413,"Optimising care for critically ill pneumonia patients: current practices and future directions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ignacio MARTIN-LOECHES",Ireland
1425,IS28,1413,"Panel Discussion, Q&A and Closing Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Souha S. KANJ",Lebanon
1426,IS29,NULL,"Serious bacterial infections in high-risk populations: a race against time","Hall 9 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Diane ASHIRU-OREDOPE","United Kingdom",NULL,NULL
1427,IS29,1426,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diane ASHIRU-OREDOPE","United KingdomESCMID-appointed chair"
1428,IS29,1426,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tonya VILLAFANA",
1429,IS29,1426,"The microbial hurdle: firsthand experience(s) of serious bacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1430,IS29,1426,"Pit stops in progress: recent developments in bacterial infection research",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanna ESPOSITO",Italy
1431,IS29,1426,"The bacterial pursuit: a marathon, not a sprint",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WILCOX","United Kingdom"
1432,IS29,1426,"Panel Discussion and Q&A - An ongoing race: perspectives on tackling the bacterial challenge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James CHALMERS","United Kingdom"
1433,IS29,1426,"Thank you and Closing Statement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tonya VILLAFANA",
1434,IS30,NULL,"Transforming STI treatment and management with highly-extended molecular point-of-care testing","Hall 10 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Jean-Pierre ALLAIN","United Kingdom",NULL,NULL
1435,IS30,1434,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Pierre ALLAIN","United KingdomChair"
1436,IS30,1434,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Pierre ALLAIN","United Kingdom"
1437,IS30,1434,"Balancing doing well with doing good",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1438,IS30,1434,"MPox in Africa: myths, facts and the way forward",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isaac SSEWANYANA",Uganda
1439,IS30,1434,"Advancing STI diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonny Michael ASSENNATO","United Kingdom"
1440,IS30,1434,"Breaking barriers: impact of point-of-care STI testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John WHITE","United Kingdom"
1441,IS30,1434,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Pierre ALLAIN","United Kingdom"
1442,IS31,NULL,"The challenges of keeping patients on antifungals. Can new thinking help us?","Hall 6 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Cornelia LASS-FLÖRL",Austria,NULL,NULL
1443,IS31,1442,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",AustriaChair
1444,IS31,1442,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",Austria
1445,IS31,1442,"Challenges and future goals in selecting the right antifungal treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ali OMRANI",Qatar
1446,IS31,1442,"Data-driven insights for antifungal treatment selection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dennis NEOFYTOS",Switzerland
1447,IS31,1442,"Time to rethink? New ways in which current antifungal treatments can be applied",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas HARRISON","United Kingdom"
1448,IS31,1442,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",Austria
1449,IS31,1442,"Meetign Close",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",Austria
1450,IS32,NULL,"Real life challenges in Gram-positive infections: what's the real deal?","Hall 7 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Marlene AMARA",France,NULL,NULL
1451,IS32,1450,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marlene AMARA","FranceESCMID-appointed chair"
1452,IS32,1450,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alex SORIANO",Spain
1453,IS32,1450,"Daily microbiological challenges to optimise treatment for serious G+ (and polymicrobial) infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefania STEFANI",Italy
1454,IS32,1450,"Real life scenarios clinicians face when managing complicated G+ infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco BONGIOVANNI",Switzerland
1455,IS32,1450,"Untangling the universe of complicated G+ and polymicrobial skin and skin structure infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
1456,IS32,1450,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alex SORIANO",Spain
1457,IS32,1450,"Closing Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alex SORIANO",Spain
1458,IS33,NULL,"Improving patient management in respiratory infections with innovative and automated diagnostic solutions","Hall 8 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Daniela CIRILLO",Italy,NULL,NULL
1459,IS33,1458,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela CIRILLO",ItalyChair
1460,IS33,1458,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela CIRILLO",Italy
1461,IS33,1458,"The clinical-virology.net, a surveillance system for respiratory pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rolf KAISER",Germany
1462,IS33,1458,"New advanced automated urinary antigen testing for determining pneumonia aetiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pablo BECKERS",Belgium
1463,IS33,1458,"Sharing of experiences from a maximum care hospital implementing fully automated urinary antigen testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander MENZER",Germany
1464,IS33,1458,"Impact of a routine automated IGRA testing on latent tuberculosis diagnosis: the experience of an Italian TB reference laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paola DAL MONTE",Italy
1465,IS33,1458,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela CIRILLO",Italy
1466,IS34,NULL,"Next-generation molecular diagnostics for multiplex testing of infectious diseases: a performance-driven approach","Hall 10 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Neven PAPIC",Croatia,NULL,NULL
1467,IS34,1466,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neven PAPIC","CroatiaESCMID-appointed chair"
1468,IS34,1466,TBA,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1469,IS34,1466,TBA,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1470,IS34,1466,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neven PAPIC",Croatia
1471,IS34,1466,TBA,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1472,IS34,1466,TBA,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
1473,IS34,1466,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neven PAPIC",Croatia
1474,IS35,NULL,"TBE and Lyme borreliosis: a pan European challenge","Hall 6 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Andreas PILZ",Austria,NULL,NULL
1475,IS35,1474,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas PILZ",AustriaChair
1476,IS35,1474,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas PILZ",Austria
1477,IS35,1474,"Tick-borne diseases: from risk to diagnosis of infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katerina KYBICOVÁ",
1478,IS35,1474,"Lyme borreliosis in Switzerland:  from seroprevalence to burden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reto LIENHARD",Switzerland
1479,IS35,1474,"TBE in Latvia: how research data led to new recommendations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dace ZAVADSKA",Latvia
1480,IS35,1474,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas PILZ",Austria
1481,IS36,NULL,"Individualised antibiotic strategies: from monotherapy to antibiotic combinations with new perspectives through IV fosfomycin","Hall 8 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Shampa DAS","United Kingdom",NULL,NULL
1482,IS36,1481,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shampa DAS","United KingdomESCMID-appointed chair"
1483,IS36,1481,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selma TOBUDIC",Austria
1484,IS36,1481,"Antibiotic combination therapy from a PK/PD perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastian WICHA",Germany
1485,IS36,1481,"Antimicrobial monotherapy vs. combination therapy: weighing microbiological and clinical factors for successful therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco FALCONE",Italy
1486,IS36,1481,"Rationale for antibiotic combination therapy including IV fosfomycin in the treatment of infections caused by Gram-positive and Gram-negative pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra OLIVA",Italy
1487,IS36,1481,"Real-world data on IV fosfomycin: the FORTRESS study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan HAGEL",Germany
1488,IS36,1481,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selma TOBUDIC",Austria
1489,IS37,NULL,"The RSV landscape in adults: disease burden, public health impact, and the latest clinical and real-world data on vaccination with RSVpreF","Hall 9 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Pier Luigi LOPALCO",Italy,NULL,NULL
1490,IS37,1489,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pier Luigi LOPALCO",ItalyChair
1491,IS37,1489,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pier Luigi LOPALCO",Italy
1492,IS37,1489,"The underrecognised burden of severe RSV in vulnerable adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter OPENSHAW","United Kingdom"
1493,IS37,1489,"Bivalent RSV vaccination: RSV protection in adults at increased risk",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iona MIUNJAL",
1494,IS37,1489,"Helping to protect against RSV with RSVpreF in real world practice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph LEWNARD","United States"
1495,IS37,1489,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pier Luigi LOPALCO",Italy
1496,IS38,NULL,"Fast-track immunity: rapid immune protection through advanced vaccination strategies","Hall 10 |","08:30 - 10:00CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Martin P. GROBUSCH",Netherlands,NULL,NULL
1497,IS38,1496,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin P. GROBUSCH","NetherlandsESCMID-appointed chair"
1498,IS38,1496,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther KUENZLI",Switzerland
1499,IS38,1496,"Abridged preventive regimens against rabies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patrick SOENTJENS",Belgium
1500,IS38,1496,"Maximising opportunities to help protect last-minute travellers: immunisation against chikungunya",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"George KASSIANOS","United Kingdom"
1501,IS38,1496,"Rapid protection strategies for tick-borne encephalitis vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyra ZENS",Switzerland
1502,IS38,1496,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther KUENZLI",Switzerland
1503,IS39,NULL,"Fighting foes, old and new: maintaining and expanding direct protection against persistent and emerging serotypes in adults with pneumococcal vaccination","Hall 6 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Carmen ARDANUY",Spain,NULL,NULL
1504,IS39,1503,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carmen ARDANUY",SpainChair
1505,IS39,1503,"Welcome and Introduction - Opening remarks on the importance of pneumococcal vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario RAMIREZ",Portugal
1506,IS39,1503,"Addressing persistent and emerging serotypes in a dynamic epidemiological landscape",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gili REGEV-YOCHAY",Israel
1507,IS39,1503,"Improving vaccine uptake among adults with PCV20",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jana SHAW","United States"
1508,IS39,1503,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario RAMIREZ",Portugal
1509,IS40,NULL,"RSV and hMPV disease burden in adults: a dual dilemma","Hall 7 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Siran KESKE",Türkiye,NULL,NULL
1510,IS40,1509,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siran KESKE","TürkiyeESCMID-appointed chair"
1511,IS40,1509,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siran KESKE",Türkiye
1512,IS40,1509,"RSV and hMPV disease burden in adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harish NAIR",France
1513,IS40,1509,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siran KESKE",Türkiye
1514,IS41,NULL,"Bridging the gap: innovative partnerships to expand global antimicrobial access","Hall 8 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Marc MENDELSON","South Africa",NULL,NULL
1515,IS41,1514,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc MENDELSON","South AfricaESCMID-appointed chair"
1516,IS41,1514,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul SCHAPER","United States"
1517,IS41,1514,"Moderator-led discussion with panellists on access barriers to antibiotics in low- and middle-income countries (LMICs)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul SCHAPER","United States"
1518,IS41,1514,"Moderator-led discussion with panellists on new approaches to support antibiotic access in LMICs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul SCHAPER","United States"
1519,IS41,1514,"Opne Q&A with Audience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul SCHAPER","United States"
1520,IS41,1514,"Closing Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul SCHAPER","United States"
1521,IS42,NULL,"Bloodstream infections: management, clinical algorithms and rapid diagnostic solution","Hall 9 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Elda RIGHI","United Kingdom",NULL,NULL
1522,IS42,1521,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elda RIGHI","United KingdomESCMID-appointed chair"
1523,IS42,1521,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit WILLINGER",Austria
1524,IS42,1521,"Blood culture management, stewardship and best practices to support BSI management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robin PATEL","United States"
1525,IS42,1521,"Sepsis management among BSI, clinical algorithms, decision support systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Timothy RAWSON","United Kingdom"
1526,IS42,1521,"AMS in BSI associated sepsis, full potential of rapid diagnostic solution",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maurizio SANGUINETTI",Italy
1527,IS42,1521,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit WILLINGER",Austria
1528,IS43,NULL,"Decentralised point-of-care molecular diagnostics for accessible STI testing","Hall 10 |","12:15 - 13:15CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Kwame Ohene BUABENG",Ghana,NULL,NULL
1529,IS43,1528,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kwame Ohene BUABENG","GhanaESCMID-appointed chair"
1530,IS43,1528,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kwame Ohene BUABENG",Ghana
1531,IS43,1528,"Evaluation of new cartridge-based test for STI detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vittorio SAMBRI",Italy
1532,IS43,1528,"Usability of the HPV POC PCR platform and an overview of the STI situation in Zimbabwe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stanford MUPANDASEKWA",Zimbabwe
1533,IS43,1528,"Empowering community health: performance of point-of-care molecular diagnostics for HPV in urban Indonesia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Endah INDRIASTUTI",Indonesia
1534,IS43,1528,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kwame Ohene BUABENG",Ghana
1535,IS44,NULL,"Expert insights on diagnostics and antimicrobial resistance","Hall 6 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Laurent DORTET",France,NULL,NULL
1536,IS44,1535,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent DORTET","FranceESCMID-appointed chair"
1537,IS44,1535,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Devasena GNANASHANMUGAM","United States"
1538,IS44,1535,"Protecting patient pathways and healthcare delivery though the intelligent use of diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alison Helen HOLMES","United Kingdom"
1539,IS44,1535,"Rapid respiratory testing: experience of POC and laboratory molecular testing in a large teaching hospital Trust",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicholas MACHIN","United Kingdom"
1540,IS44,1535,"The Kentucky Viral Hepatitis Treatment (KeY Treat) Trial: a model of care in a rural appalachian county, US",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer HAVENS","United States"
1541,IS44,1535,"Antimicrobial resistance, an update from the Middle East",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammad ALZUNITA","Saudi Arabia"
1542,IS44,1535,"Impact of carbapenemase-PCR in outbreak management: cost vs. benefit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas BOLLINGER",Germany
1543,IS44,1535,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Devasena GNANASHANMUGAM","United States"
1544,IS45,NULL,"Influenza connect: challenging conversations in respiratory vaccination","Hall 7 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","David FISMAN",Canada,NULL,NULL
1545,IS45,1544,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN","CanadaESCMID-appointed chair"
1546,IS45,1544,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
1547,IS45,1544,"Roundtable: why are respiratory vaccination rates suboptimal?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
1548,IS45,1544,"Debate: which should we be more concerned about, COVID-19 or influenza?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
1549,IS45,1544,"Interactive discussion: how do we optimise protection against influenza and COVID-19?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
1550,IS45,1544,"Q&A and Closing Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
1551,IS46,NULL,"From guidelines to clinical practice: towards better care for patients with Clostridioides difficile infection","Hall 8 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Simon GOLDENBERG","United Kingdom",NULL,NULL
1552,IS46,1551,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon GOLDENBERG","United KingdomESCMID-appointed chair"
1553,IS46,1551,"Welcome and Introduction - CDI patient journey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoît GUERY",Switzerland
1554,IS46,1551,"Clinical care pathway and associated challenges in CDI treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa STADLBAUER-KÖLLNER",Austria
1555,IS46,1551,"Gut microbiota and CDI: what do we know?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frédéric BARBUT",France
1556,IS46,1551,"Microbiome-related approaches in CDI management of patients at risk for severe and recurrent CDI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoît GUERY",Switzerland
1557,IS46,1551,"Identification of patients at risk of recurrence and current treatment of CDI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea MARINO",Italy
1558,IS46,1551,"CDI patients with chronic kidney disease (CKD)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Uta KUNTER",Germany
1559,IS46,1551,"Microbiota driven new treatment approaches of CDI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena REIGADAS RAMIREZ",
1560,IS46,1551,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoît GUERY",Switzerland
1561,IS46,1551,"Summary and Close",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoît GUERY",Switzerland
1562,IS47,NULL,"The double burden: clinical perspectives on RSV and hMPV","Hall 9 |","13:30 - 15:30CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Simona RUTA",Romania,NULL,NULL
1563,IS47,1562,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simona RUTA","RomaniaESCMID-appointed chair"
1564,IS47,1562,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daiana STOLZ",Switzerland
1565,IS47,1562,"25 years of hMPV research: where are we now and where are we heading?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernadette VAN DEN HOOGEN",Netherlands
1566,IS47,1562,"A comprehensive look at disease burden of RSV and hMPV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thushan DE SILVA","United Kingdom"
1567,IS47,1562,"Clinical insights on hMPV and RSV: learnings from real-life cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul LOUBET",France
1568,IS47,1562,"Q&A and Closing Statement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daiana STOLZ",Switzerland
1569,IS48,NULL,"Unlocking rapid, comprehensive pathogen genomics with real-time nanopore sequencing","Hall 6 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Hege Vangstein AAMOT",Norway,NULL,NULL
1570,IS48,1569,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hege Vangstein AAMOT","NorwayESCMID-appointed chair"
1571,IS48,1569,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justin O'GRADY","United Kingdom"
1572,IS48,1569,"Implementing next generation sequencing for rapid diagnostics and public health investigations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kimberlee MUSSER","United States"
1573,IS48,1569,"Reliable whole-genome genotyping for bacterial surveillance using nanopore sequencing data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel WAGNER-LICHTENEGGER",Austria
1574,IS48,1569,"Implementing portable, real-time 16S rRNA sequencing in the healthcare sector enhances antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SMIELEWSKA","United Kingdom"
1575,IS48,1569,"Utilising nanopore metagenomic sequencing for rapid identification of infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Judith BREUER",
1576,IS48,1569,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justin O'GRADY","United Kingdom"
1577,IS49,NULL,"Antimicrobial resistance and immunocompromised patients in the era of personalised medicine: are we doing our best?","Hall 7 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Rafael CANTON",Spain,NULL,NULL
1578,IS49,1577,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael CANTON","SpainESCMID-appointed chair"
1579,IS49,1577,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian ECKMANN",Germany
1580,IS49,1577,"The toll of AMR on cancer patients: from quality of life to death",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonella CARDONE",Italy
1581,IS49,1577,"Is AMR in haematology-oncology patients compromising innovative cancer care?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver A. CORNELY",Germany
1582,IS49,1577,"AMR in the ICU: a never-ending menace",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ignacio MARTIN-LOECHES",Ireland
1583,IS49,1577,"Access to rapid diagnostic tools to optimise tailored treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Louise SWEENEY","United Kingdom"
1584,IS49,1577,"Impact of AMR on vulnerable patients: a call to action",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco FALCONE",Italy
1585,IS49,1577,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian ECKMANN",Germany
1586,IS49,1577,"Closing Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian ECKMANN",Germany
1587,IS50,NULL,"Conquering the superbug crisis: new hope for treating carbapenem-resistant Acinetobacter baumannii","Hall 8 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Ana GALES",Brazil,NULL,NULL
1588,IS50,1587,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana GALES","BrazilESCMID-appointed chair"
1589,IS50,1587,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sumathi NAMBIAR","United States"
1590,IS50,1587,"The impact of carbapenem-resistant A. baumannii on global healthcare",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David L. PATERSON",Singapore
1591,IS50,1587,"Optimising polymyxin B: clinical strategies, personal insights, and case-based approaches to effective and safe use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helmi SULAIMAN",Malaysia
1592,IS50,1587,"Optimising drug pharmacokinetics and pharmacodynamics for enhanced therapeutic outcomes for CRAB infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus ZEITLINGER",Austria
1593,IS50,1587,"Advancing treatment for CRAB with rifabutin for injection: a comprehensive review of Phase 2 clinical trial data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frantzeska FRANTZESKAKI",Greece
1594,IS50,1587,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sumathi NAMBIAR","United States"
1595,IS51,NULL,"The present and future of cytomegalovirus viral load monitoring in transplant patients: from quantification harmonisation to new therapeutic strategies","Hall 10 |","16:15 - 17:45CETIntegrated Symposium",,CET,"Integrated Symposium","31. Integrated symposium","Scott HAUENSTEIN","United States",NULL,NULL
1596,IS51,1595,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Scott HAUENSTEIN","United StatesChair"
1597,IS51,1595,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Scott HAUENSTEIN","United States"
1598,IS51,1595,"The importance of CMV viral load measurement accuracy in guiding clinical decisions in the era of new therapeutic options",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanna TRAVI",Italy
1599,IS51,1595,"Are CMV viral load reported in international units adequate to compare results across laboratories? A question of commutability",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincent THIBAULT",France
1600,IS51,1595,"Would a redesigned WHO International Standard for human cytomegalovirus resolve the commutability issue among nucleic acid amplification tests?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacqueline FRYER","United Kingdom"
1601,IS51,1595,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Scott HAUENSTEIN","United States"
1602,JS1,NULL,"Late-breaker research from CMI and CMI Communications","Hall 12 |","13:30 - 14:30CETJournal Session",,CET,"Journal Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
1603,JS1,1602,"Measuring the impact of hospitalization for infectious diseases on the quality of life of older patients in four European countries: the AEQUI longitudinal matched cohort study (2020-2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gaetan GAVAZZI",France
1604,JS1,1602,"Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas HOLLAND","United States"
1605,JS1,1602,"The long-term sustainability of a pharmacist-led antimicrobial stewardship penicillin allergy delabelling ward round: A prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elise MITRI",Australia
1606,JS1,1602,"Efficacy and safety of mechanical thrombectomy in acute ischemic stroke secondary to infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillermo CUERVO",Spain
1607,JS1,1602,"A randomised non-inferiority trial investigating antibiotic adjustments based on blood culture in acute cholangitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sang Hyub LEE","Republic Of"
1608,JS2,NULL,"Late-breaker research from the Lancet group: new interventions for familiar and new infectious diseases","Hall 16 |","16:15 - 17:15CETJournal Session",,CET,"Journal Session","12. Professional and educational affairs","Syeda Saleha HASSAN","United Kingdom",NULL,NULL
1609,JS2,1608,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Syeda Saleha HASSAN","United KingdomChair"
1610,JS2,1608,TBA,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1611,JS2,1608,"The spatio-temporal ecology of Oropouche virus: a laboratory-based modelling study across Latin America",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan Felix DREXLER",Germany
1612,JS2,1608,"The WHO Bacterial Priority Pathogens List: guiding research and development, and informing innovative public health strategies to address antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hatim SATI",Switzerland
1613,JS2,1608,"Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) in older adults over three RSV seasons: a randomized trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto PAPI",Italy
1614,KN044,NULL,"Asia: an AMR Hot Zone","Hall 1 |","11:00 - 12:00CETCMEKeynote Lecture",,CET,"Keynote Lecture","03. Bacterial susceptibility & resistance","Giulia DE ANGELIS",Italy,NULL,NULL
1615,KN044,1614,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia DE ANGELIS",ItalyChair
1616,KN044,1614,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David L. PATERSON",Singapore
1617,KN056,NULL,"Defending against dengue: global epidemiology and strategies for prevention and control","Hall 1 |","14:45 - 15:45CETCMEKeynote Lecture",,CET,"Keynote Lecture","07. Parasitic diseases, travel medicine & migrant health","Anu KANTELE",Finland,NULL,NULL
1618,KN056,1617,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anu KANTELE",FinlandChair
1619,KN056,1617,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernanda BOULOS",Brazil
1620,KN080,NULL,"Infections after solid organ transplantation: past, present and future","Hall 1 |","09:30 - 10:30CETCMEKeynote Lecture",,CET,"Keynote Lecture","10. Immune compromise & transplant ID","Nina KHANNA",Switzerland,NULL,NULL
1621,KN080,1620,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nina KHANNA",SwitzerlandChair
1622,KN080,1620,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jay FISHMAN","United States"
1623,KN081,NULL,"The new frontiers in antimicrobial stewardship","Hall 1 |","11:00 - 12:00CETCMEKeynote Lecture",,CET,"Keynote Lecture","05. New antibacterial agents, PK/PD & Stewardship","Jose Ramon PANO-PARDO",Spain,NULL,NULL
1624,KN081,1623,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Ramon PANO-PARDO",SpainChair
1625,KN081,1623,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karin THURSKY",Australia
1626,KN103,NULL,"Tuberculosis: where are we now and where should we be","Hall 1 |","16:15 - 17:15CETCMEKeynote Lecture",,CET,"Keynote Lecture","02. Bacterial infection & disease","Jon S. FRIEDLAND","United Kingdom",NULL,NULL
1627,KN103,1626,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon S. FRIEDLAND","United KingdomChair"
1628,KN103,1626,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guy THWAITES",Vietnam
1629,KN121,NULL,"HIV: from needle parks to injectables","Hall 1 |","11:00 - 12:00CETCMEKeynote Lecture",,CET,"Keynote Lecture","01. Viral infection & disease (incl COVID-19)","Mary HORGAN",Ireland,NULL,NULL
1630,KN121,1629,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary HORGAN",IrelandChair
1631,KN121,1629,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huldrych GÜNTHARD",Switzerland
1632,KN130,NULL,"Infectious disease challenges in an ever-changing environment","Hall 1 |","13:30 - 14:30CETCMEKeynote Lecture",,CET,"Keynote Lecture","11. Public health & vaccines","Jacob MORAN-GILAD",Israel,NULL,NULL
1633,KN130,1632,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob MORAN-GILAD",IsraelChair
1634,KN130,1632,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pamela RENDI WAGNER",Sweden
1635,KN137,NULL,"Staphylococcus aureus host-microbe interaction: ecology, disease, and vaccine development","Hall 1 |","14:45 - 15:45CETCMEKeynote Lecture",,CET,"Keynote Lecture","09. Fundamental microbiology, pathogenesis & immunity to infection","Werner RUPPITSCH",Austria,NULL,NULL
1636,KN137,1635,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Werner RUPPITSCH",AustriaChair
1637,KN137,1635,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliane BUBECK WARDENBURG","United States"
1638,LB001,NULL,"Advances in vaccine effectiveness for viral respiratory infections","Hall 9 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","Late Breakers","Jean Paul STAHL",France,NULL,NULL
1639,LB001,1638,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean Paul STAHL",FranceChair
1640,LB001,1638,"Vaccination in pregnancy with RSVpreF elicits IgG, IgA and total secretory antibody responses in milk of lactating individuals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica ATWELL","United States"
1641,LB001,1638,"Real-world effectiveness of 20-valent pneumococcal conjugate vaccine among adults ≥65 years of age in the United States",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amanda MILES","United States"
1642,LB001,1638,"Safety and immunogenicity of the MERS vaccine, ChAdOx1 MERS, in older adults with and without prior ChAdOx1 exposure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel JENKIN","United Kingdom"
1643,LB001,1638,"Immunogenicity of JN.1- and KP.2-encoding mRNA COVID-19 vaccines against JN.1 SARS-CoV-2 sublineages in adult participants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amparo FIGUEROA","United States"
1644,LB001,1638,"JN.1-adapted vaccine effectiveness against COVID-19 hospitalisation in Europe: a test-negative case-control study using id.DRIVE",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hannah R VOLKMAN","United States"
1645,LB002,NULL,"Investigation of intriguing outbreaks","Hall 4 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","Late Breakers",NULL,NULL,NULL,NULL
1646,LB002,1645,"AI-driven live cough rate tracking for public health surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mikael KÅGEBÄCK",Sweden
1647,LB002,1645,"Evolving cluster of severe infective endocarditis with non-toxigenic C. diphtheriae amongst people experiencing homelessness and substance misuse in the UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca CORDERY","United Kingdom"
1648,LB002,1645,"Molecular surveillance of artemisinin and sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Uganda: results of ERASE study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariangela L'EPISCOPIA",Italy
1649,LB002,1645,"Investigation of an international pseudo-outbreak involving Paraburkholderia fungorum blood culture contamination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob MORAN-GILAD",Israel
1650,LB003,NULL,"New solutions for difficult-to-treat infection","Hall 13 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","Late Breakers",NULL,NULL,NULL,NULL
1651,LB003,1650,"Multivalent OMV-based vaccine against Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatriz CANO CASTAÑO",Spain
1652,LB003,1650,"Epidermicin NI01, a first-in-class peptide antibiotic candidate, has potent efficacy in a robust MRSA wound infection model and low allergic reaction liabilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathew UPTON","United Kingdom"
1653,LB003,1650,"Minimum inhibitory concentrations of quabodepistat in Mycobacterium tuberculosis clinical isolates from patients with drug-susceptible pulmonary tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irina KONTSEVAYA",Germany
1654,LB003,1650,"Antimicrobial CRISPR-Cas9-based treatment against antibiotic resistant extraintestinal pathogenic E. coli (ExPEC) ST131",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia MORROS-BERNAUS","United Kingdom"
1655,LB003,1650,"Ultra-narrow spectrum antibiotic against multi-drug resistant gonococci with novel mode of action",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nhung NGUYEN",Austria
1656,LB004,NULL,"Trials in severe infections","Hall 9 |","16:15 - 18:15CETCME2-hour Oral Session",,CET,"2-hour Oral Session","Late Breakers","Steven TONG",Australia,NULL,NULL
1657,LB004,1656,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steven TONG",AustraliaChair
1658,LB004,1656,"Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): a randomised, pragmatic trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco COGLIATI DEZZA",Italy
1659,LB004,1656,"HRS-8427 versus imipenem-cilastatin for complicated urinary tract infections: a randomised, double-blind phase 2 study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohan JU",China
1660,LB004,1656,"Efficacy and safety in a Phase 2 study of intravenous BV100 combined with polymyxin B versus best available therapy in adult subjects with ventilator-associated bacterial pneumonia suspected or confirmed to be due to carbapenem resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Glenn E. DALE",Switzerland
1661,LB004,1656,"Neutralising plasma versus placebo for hospitalised patients with West Nile fever: a double-blind randomised controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michal CANETTI",Israel
1662,LB004,1656,"Randomised placebo controlled trial of faecal microbiota transplantation to tackle antimicrobial resistance: inducing bacteriophage network remodelling and enteric pathogen reduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lindsey Ann EDWARDS","United Kingdom"
1663,LB004,1656,"Double-dose dolutegravir and lamivudine versus efavirenz-based antiretroviral therapy for patients coinfected with HIV and tuberculosis: a multicentre, open-label, randomised trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yinzhong SHEN",China
1664,LB004,1656,"Initial vancomycin taper for the prevention of recurrent Clostridioides difficile infection: the TAPER-V randomised controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily G. MCDONALD",Canada
1665,LB004,1656,"Beneficial effects of a clinical metagenomics intervention on clinical outcomes, healthcare economics, and quality of life in patients with sepsis/septic shock: results of the DigiSep-trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thorsten BRENNER",Germany
1666,LB004,1656,"Shortened antibiotic treatment for 5 days in patients hospitalised with community-acquired pneumonia (CAP5): a multicentre randomised controlled noninferiority trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone BASTRUP ISRAELSEN",Denmark
1667,LB004,1656,"High-dose rifampicin in the treatment of tuberculous meningitis: results of the HARVEST phase III multi-country randomised clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reinout VAN CREVEL",Netherlands
1668,LB005,NULL,"Emerging pathogens in humans, animals and vectors","Hall 3 |","16:15 - 17:15CETCME1-hour Oral Session",,CET,"1-hour Oral Session","Late Breakers",NULL,NULL,NULL,NULL
1669,LB005,1668,"Genome-wide association study identifies ABCG1 as a susceptibility locus for tick-borne encephalitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Piyush GAMPAWAR",Austria
1670,LB005,1668,"First detection of tick-borne encephalitis virus in Belgian ticks, May 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena PORTELL-BUJ",Belgium
1671,LB005,1668,"H5N1 human infection in the United Kingdom: a One-Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Richard PULESTON","United Kingdom"
1672,LB005,1668,"Spread of a fusidic acid and methicillin-resistant Staphylococcus aureus clone causing impetigo in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anders Rhod LARSEN",Denmark
1673,LB005,1668,"Increase of PVL-positive livestock-associated MRSA in the Netherlands: a growing concern beyond livestock settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karuna VENDRIK",Netherlands
1674,LB006,NULL,"The Trial Run: recent trials on S. aureus bacteraemia management","Hall 13 |","16:15 - 18:15CETCME2-hour Oral Session",,CET,"2-hour Oral Session","Late Breakers","Julia Anna BIELICKI","United Kingdom",NULL,NULL
1675,LB006,1674,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia Anna BIELICKI","United KingdomChair"
1676,LB006,1674,Introduction,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia Anna BIELICKI","United Kingdom"
1677,LB006,1674,"Description of SNAP trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1678,LB006,1674,"Benzylpenicillin versus (flu)cloxacillin for the treatment of penicillin-susceptible Staphylococcus aureus bacteraemia: a randomised controlled trial of the S. aureus network adaptive platform (SNAP)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steven TONG",Australia
1679,LB006,1674,"Cefazolin versus (flu)cloxacillin for the treatment of penicillin-resistant, methicillin-susceptible Staphylococcus aureus bacteraemia: a randomised controlled trial within the S. aureus network adaptive platform (SNAP)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joshua Saul DAVIS",Australia
1680,LB006,1674,"Cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): a randomised, controlled, non-inferiority trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xavier LESCURE",France
1681,LB006,1674,"Trial Discussion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia Anna BIELICKI","United Kingdom"
1682,LB006,1674,"Trial Discussion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vance FOWLER","United States"
1683,LB006,1674,"Open Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
1684,M4,NULL,"Malaria differential diagnosis (beginners)","Mobile lab |","08:30 - 10:30CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1685,M4,1684,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1686,M5,NULL,"Malaria differential diagnosis (advanced)","Mobile lab |","13:30 - 15:30CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1687,M5,1686,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1688,M6,NULL,"Morphological diagnosis of faecal protozoa","Mobile lab |","16:15 - 18:15CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1689,M6,1688,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1690,M7,NULL,"Faecal examination (eggs and cysts -advanced)","Mobile lab |","08:30 - 10:30CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1691,M7,1690,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1692,M8,NULL,"Malaria differential diagnosis (beginners)","Mobile lab |","13:30 - 15:30CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1693,M8,1692,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1694,M9,NULL,"Malaria differential diagnosis (advanced)","Mobile lab |","16:15 - 18:15CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1695,M9,1694,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1696,M10,NULL,"Diagnosis of malaria by thick film","Mobile lab |","08:30 - 10:30CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1697,M10,1696,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1698,M11,NULL,"Morphological diagnosis of faecal protozoa","Mobile lab |","13:30 - 15:30CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1699,M11,1698,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1700,M12,NULL,"Faecal examination (eggs and cysts -advanced)","Mobile lab |","16:15 - 18:15CETHands-on Workshop",,CET,"Hands-on Workshop","04. Diagnostic microbiology","Debbie NOLDER","United Kingdom",NULL,NULL
1701,M12,1700,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debbie NOLDER","United KingdomChair"
1702,ME007,NULL,"How to interpret resistance patterns from antibiograms","Hall 2 |","11:00 - 12:00CETMeet-the-Expert",,CET,Meet-the-Expert,"03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
1703,ME007,1702,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso GIANI",Italy
1704,ME007,1702,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diaz LORENA",Chile
1705,ME008,NULL,"Children are not just small adults: interactive paediatric cases","Hall 3 |","11:00 - 12:00CETMeet-the-Expert",,CET,Meet-the-Expert,"02. Bacterial infection & disease",NULL,NULL,NULL,NULL
1706,ME008,1705,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie TOUBIANA",France
1707,ME008,1705,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sanjay PATEL","United Kingdom"
1708,ME009,NULL,"How to practise WHO Guidelines for the prevention of bloodstream infections and other intravascular catheter infections","Hall 5 |","11:00 - 12:00CETMeet-the-Expert",,CET,Meet-the-Expert,"08. Healthcare-associated infections, infection prevention & control",NULL,NULL,NULL,NULL
1709,ME009,1708,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kushlani JAYATILLEKE","Sri Lanka"
1710,ME009,1708,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Walter ZINGG",Switzerland
1711,ME010,NULL,"Can we stop vertical transmission of syphilis, HIV and hepatitis? Regional experience","Hall 6 |","11:00 - 12:00CETMeet-the-Expert",,CET,Meet-the-Expert,"01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
1712,ME010,1711,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ecaterina NOROC","Republic Of"
1713,ME010,1711,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fakhriddin NIZAMOV",Kazakhstan
1714,ME011,NULL,"Biofilm-related nontuberculous mycobacterial infections: ongoing nightmare","Hall 8 |","11:00 - 12:00CETMeet-the-Expert",,CET,Meet-the-Expert,"02. Bacterial infection & disease",NULL,NULL,NULL,NULL
1715,ME011,1714,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaime ESTEBAN",Spain
1716,ME011,1714,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philippe MORAND",France
1717,ME012,NULL,"How to understand infectious disease risks in changing climates","Hall 9 |","11:00 - 12:00CETMeet-the-Expert",,CET,Meet-the-Expert,"11. Public health & vaccines",NULL,NULL,NULL,NULL
1718,ME012,1717,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kimberly FORNACE",Singapore
1719,ME012,1717,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rachel LOWE",Spain
1720,ME013,NULL,"Orthopaedic implant infections: new approaches for improved outcomes","Hall 2 |","13:30 - 14:30CETMeet-the-Expert",,CET,Meet-the-Expert,"08. Healthcare-associated infections, infection prevention & control",NULL,NULL,NULL,NULL
1721,ME013,1720,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marjan WOUTHUYZEN-BAKKER",Netherlands
1722,ME013,1720,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Trisha PEEL",Australia
1723,ME014,NULL,"Timing of antimicrobials in sepsis and septic shock - the sooner the better?","Hall 3 |","13:30 - 14:30CETMeet-the-Expert",,CET,Meet-the-Expert,"02. Bacterial infection & disease",NULL,NULL,NULL,NULL
1724,ME014,1723,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura EVANS","United States"
1725,ME014,1723,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evangelos GIAMARELLOS-BOURBOULIS",Greece
1726,ME015,NULL,"PrEP in Europe: Current gaps and solutions","Hall 5 |","13:30 - 14:30CETMeet-the-Expert",,CET,Meet-the-Expert,"01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
1727,ME015,1726,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teymur NOORI",Sweden
1728,ME015,1726,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milosz PARCZEWSKI",Poland
1729,ME016,NULL,"Short regimens for treating drug-susceptible and drug-resistant tuberculosis: Insights from guidelines","Hall 6 |","13:30 - 14:30CETMeet-the-Expert",,CET,Meet-the-Expert,"02. Bacterial infection & disease",NULL,NULL,NULL,NULL
1730,ME016,1729,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daria PODLEKAREVA",Denmark
1731,ME016,1729,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raquel DUARTE",Portugal
1732,ME017,NULL,"How to navigate Risk Communication in Public Health","Hall 8 |","13:30 - 14:30CETMeet-the-Expert",,CET,Meet-the-Expert,"11. Public health & vaccines",NULL,NULL,NULL,NULL
1733,ME017,1732,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christina ROLFHEIM-BYE",Norway
1734,ME017,1732,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marius GILBERT",Belgium
1735,ME018,NULL,"Do we need antiviral stewardship in immunocompromised hosts? role of cell-mediated immunity","Hall 9 |","13:30 - 14:30CETMeet-the-Expert",,CET,Meet-the-Expert,"10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
1736,ME018,1735,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michelle YONG",Australia
1737,ME018,1735,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Genovefa PAPANICOLAOU","United States"
1738,ME019,NULL,"Healthcare-associated CNS infections","Hall 2 |","14:45 - 15:45CETMeet-the-Expert",,CET,Meet-the-Expert,"02. Bacterial infection & disease",NULL,NULL,NULL,NULL
1739,ME019,1738,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diederik VAN DE BEEK",Netherlands
1740,ME019,1738,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra MAILLES",France
1741,ME020,NULL,"Translation of gut microbiome data to clinical practice: a guide for clinicians","Hall 3 |","14:45 - 15:45CETMeet-the-Expert",,CET,Meet-the-Expert,"04. Diagnostic microbiology",NULL,NULL,NULL,NULL
1742,ME020,1741,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aycan GUNDOGDU",Türkiye
1743,ME020,1741,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niranjan NAGARAJAN",Singapore
1744,ME021,NULL,"How to make sense out of guidelines and scientific evidence","Hall 5 |","14:45 - 15:45CETMeet-the-Expert",,CET,Meet-the-Expert,"12. Professional and educational affairs",NULL,NULL,NULL,NULL
1745,ME021,1744,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luigia SCUDELLER",Italy
1746,ME021,1744,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Blin NAGAVCI",Kosovo
1747,ME022,NULL,"Multidisciplinary management of bone and joint infections: is there a recipe for success?","Hall 6 |","14:45 - 15:45CETMeet-the-Expert",,CET,Meet-the-Expert,"05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
1748,ME022,1747,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natividad BENITO",Spain
1749,ME022,1747,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tiziana ASCIONE",Italy
1750,ME023,NULL,"How to manage and prevent travellers' diarrhoea","Hall 8 |","14:45 - 15:45CETMeet-the-Expert",,CET,Meet-the-Expert,"07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
1751,ME023,1750,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tinja LAAVERI",Finland
1752,ME023,1750,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David TRIBBLE","United States"
1753,ME024,NULL,"How to diagnose and treat infectious complications in critically ill patients receiving ECMO support","Hall 9 |","14:45 - 15:45CETMeet-the-Expert",,CET,Meet-the-Expert,"08. Healthcare-associated infections, infection prevention & control",NULL,NULL,NULL,NULL
1754,ME024,1753,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordi RIERA",Spain
1755,ME024,1753,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giacomo GRASSELLI",Italy
1756,ME048,NULL,"Cut a long story short: choosing NGS platforms","Hall 12 |","11:00 - 12:00CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"04. Diagnostic microbiology",NULL,NULL,NULL,NULL
1757,ME048,1756,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Etienne RUPPE",France
1758,ME048,1756,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan GREEN","United States"
1759,ME049,NULL,"How to perform clinical trials in mycoses?","Hall 14 |","11:00 - 12:00CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"06. Fungal infection & disease",NULL,NULL,NULL,NULL
1760,ME049,1759,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monica SLAVIN",Australia
1761,ME049,1759,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nkechi AZIE","United States"
1762,ME054,NULL,"How antimicrobial tolerance impacts polymicrobial biofilm-associated infections","Hall 3 |","13:30 - 14:30CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
1763,ME054,1762,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hans STEENACKERS",Belgium
1764,ME054,1762,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brian CONLON","United States"
1765,ME055,NULL,"Long acting injectables to treat and prevent infections: an example from HIV field","Hall 14 |","13:30 - 14:30CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
1766,ME055,1765,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monica GANDHI","United States"
1767,ME055,1765,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pedro CAHN",Argentina
1768,ME061,NULL,"How to use large language models and machine learning for improving One Health","Hall 3 |","14:45 - 15:45CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"11. Public health & vaccines",NULL,NULL,NULL,NULL
1769,ME061,1768,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier FERNÁNDEZ",Spain
1770,ME061,1768,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas RADOMSKI",Italy
1771,ME062,NULL,"Untangling the web: antimicrobial dose adjustments in renal impairment","Hall 16 |","14:45 - 15:45CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
1772,ME062,1771,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claire ROGER",France
1773,ME062,1771,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel SPRIET",Belgium
1774,ME088,NULL,"Global AMR Policy after UNGA: what do we do now!","Hall 2 |","11:00 - 12:00CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
1775,ME088,1774,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gisela ROBLES AGUILAR","United Kingdom"
1776,ME088,1774,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mike SHARLAND","United Kingdom"
1777,ME089,NULL,"How to teach Medical Mycology","Hall 15 |","11:00 - 12:00CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"06. Fungal infection & disease",NULL,NULL,NULL,NULL
1778,ME089,1777,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katrien LAGROU",Belgium
1779,ME089,1777,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mihai MARES",Romania
1780,ME095,NULL,"Local antimicrobials for deep infections","Hall 16 |","13:30 - 14:30CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
1781,ME095,1780,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karolina AKINOSOGLOU",Greece
1782,ME095,1780,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pierre TATTEVIN",France
1783,ME101,NULL,"How to master conflict management and negotiation in healthcare","Hall 14 |","14:45 - 15:45CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"12. Professional and educational affairs",NULL,NULL,NULL,NULL
1784,ME101,1783,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther CALBO",Spain
1785,ME101,1783,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan A.J.W. KLUYTMANS",Netherlands
1786,ME108,NULL,"Navigating travel medicine: expert tips for safe international travel","Hall 12 |","16:15 - 17:15CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
1787,ME108,1786,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie SCHNEITLER",Germany
1788,ME108,1786,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas NEUMAYR",Switzerland
1789,ME127,NULL,"EUCAST: What's new in susceptibility testing","Hall 9 |","11:00 - 12:00CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
1790,ME127,1789,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erika MATUSCHEK",Sweden
1791,ME127,1789,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael CANTON",Spain
1792,ME128,NULL,"How to apply organoid models to study infectious disease","Hall 14 |","11:00 - 12:00CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
1793,ME128,1792,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer ROHN","United Kingdom"
1794,ME128,1792,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathalie SAUVONNET",France
1795,ME134,NULL,"The older solid organ transplant recipient: between frailty, immunosenescence and infection","Hall 16 |","13:30 - 14:30CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
1796,ME134,1795,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maheen ABIDI","United States"
1797,ME134,1795,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alaa ATAMNA",Israel
1798,ME140,NULL,"Bioinformatic tools from start to finish","Hall 11 |","14:45 - 15:45CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"04. Diagnostic microbiology",NULL,NULL,NULL,NULL
1799,ME140,1798,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vítor BORGES",Portugal
1800,ME140,1798,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clare SLOGGETT",Australia
1801,ME141,NULL,"AI use in antimicrobial stewardship","Hall 13 |","14:45 - 15:45CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
1802,ME141,1801,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shruti GOHIL","United States"
1803,ME141,1801,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Ramon PANO-PARDO",Spain
1804,ME145,NULL,"Fungal meningitis: recognition and current status of management","Hall 15 |","16:15 - 17:15CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"06. Fungal infection & disease",NULL,NULL,NULL,NULL
1805,ME145,1804,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier LORTHOLARY",France
1806,ME145,1804,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janis BLAIR","United States"
1807,ME149,NULL,"How to perform molecular surveillance of multidrug resistant bacteria","Hall 2 |","17:30 - 18:30CETCMEMeet-the-Expert",,CET,Meet-the-Expert,"03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
1808,ME149,1807,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina LENGEROVA","Czech Republic"
1809,ME149,1807,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henrik HASMAN",Denmark
1810,MEET8,NULL,"Ecraid Young Investigator Workshop","Schubert 3 (Venue) |","10:00 - 11:00CETESCMID open meeting",,CET,"ESCMID open meeting",,NULL,NULL,NULL,NULL
1811,MEET60,NULL,"Genomic and Molecular Diagnostics Study Group open meeting (ESGMD)","Schubert 1+2 (Venue) |","09:30 - 10:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Hege Vangstein AAMOT",Norway,NULL,NULL
1812,MEET60,1811,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hege Vangstein AAMOT","NorwayESCMID official"
1813,MEET61,NULL,"Anaerobic Infections Study Group open meeting (ESGAI)","Schubert 6 (Venue) |","09:30 - 10:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Michael BUHL",Germany,NULL,NULL
1814,MEET61,1813,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael BUHL","GermanyESCMID official"
1815,MEET62,NULL,"Clostridioides difficile Study Group open meeting (ESGCD)","Schubert 4+5 (Venue) |","11:00 - 12:00CETESCMID open meeting",,CET,"ESCMID open meeting",,"John E. COIA",Denmark,NULL,NULL
1816,MEET62,1815,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John E. COIA","DenmarkESCMID official"
1817,MEET63,NULL,"Viral Hepatitis Study Group open meeting (ESGVH)","Schubert 3 (Venue) |","11:00 - 12:00CETESCMID open meeting",,CET,"ESCMID open meeting",,"Imran HASANOGLU",Türkiye,NULL,NULL
1818,MEET63,1817,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU","TürkiyeESCMID official"
1819,MEET64,NULL,"Antimicrobial Stewardship Study Group open meeting (ESGAP)","Schubert 1+2 (Venue) |","13:30 - 14:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Diane ASHIRU-OREDOPE","United Kingdom",NULL,NULL
1820,MEET64,1819,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diane ASHIRU-OREDOPE","United KingdomESCMID official"
1821,MEET65,NULL,"Food- and Water-borne Infections Study Group open meeting (EFWISG)","Schubert 6 (Venue) |","13:30 - 14:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Merica CAREV",Croatia,NULL,NULL
1822,MEET65,1821,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merica CAREV","CroatiaESCMID official"
1823,MEET66,NULL,"Fungal Infection Study Group open meeting (EFISG)","Schubert 4+5 (Venue) |","14:45 - 15:45CETESCMID open meeting",,CET,"ESCMID open meeting",,"Robina AERTS",Belgium,NULL,NULL
1824,MEET66,1823,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robina AERTS","BelgiumESCMID official"
1825,MEET67,NULL,"Infections in the Elderly Study Group open meeting (ESGIE)","Schubert 3 (Venue) |","14:45 - 15:45CETESCMID open meeting",,CET,"ESCMID open meeting",,"Niccolò BUETTI",Switzerland,NULL,NULL
1826,MEET67,1825,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niccolò BUETTI","SwitzerlandESCMID official"
1827,MEET68,NULL,"Mycobacterial Infections Study Group open meeting (ESGMYC)","Schubert 4+5 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Daniela CIRILLO",Italy,NULL,NULL
1828,MEET68,1827,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela CIRILLO","ItalyESCMID official"
1829,MEET69,NULL,"Forensic and Postmortem Microbiology Study Group open meeting (ESGFOR)","Schubert 6 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Domitille CALLON",France,NULL,NULL
1830,MEET69,1829,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Domitille CALLON","FranceESCMID official"
1831,MEET70,NULL,"Staphylococci Study Group open meeting (ESGS)","Schubert 3 (Venue) |","17:15 - 18:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Anna GOODMAN","United Kingdom",NULL,NULL
1832,MEET70,1831,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna GOODMAN","United KingdomESCMID official"
1833,MEET71,NULL,"ESCMID Study Group for Urinary Tracy Infections (ESGUTI)","Schubert 3 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Angela HUTTNER",Switzerland,NULL,NULL
1834,MEET71,1833,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angela HUTTNER","SwitzerlandESCMID official"
1835,MEET72,NULL,"Respiratory Viruses Study Group open meeting (ESGREV)","Schubert 1+2 (Venue) |","09:30 - 10:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Roy CHEMALY","United States",NULL,NULL
1836,MEET72,1835,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roy CHEMALY","United StatesESCMID official"
1837,MEET73,NULL,"Public Health Microbiology Study Group open meeting (ESGPHM)","Schubert 6 (Venue) |","09:30 - 10:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Aura AGUIRRE-BELTRAN",Denmark,NULL,NULL
1838,MEET73,1837,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aura AGUIRRE-BELTRAN","DenmarkESCMID official"
1839,MEET74,NULL,"PK/PD of Anti-Infectives Study Group open meeting (EPASG)","Schubert 4+5 (Venue) |","10:30 - 11:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Birgit KOCH",Netherlands,NULL,NULL
1840,MEET74,1839,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit KOCH","NetherlandsESCMID official"
1841,MEET75,NULL,"Travel and Migration Infection Study Group open meeting (ESGITM)","Schubert 6 (Venue) |","13:30 - 14:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Peter CHIODINI","United Kingdom",NULL,NULL
1842,MEET75,1841,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter CHIODINI","United KingdomESCMID official"
1843,MEET76,NULL,"Non-traditional Antibacterial Therapy Study Group open meeting (ESGNTA)","Schubert 1+2 (Venue) |","13:30 - 14:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Zuzanna DRULIS-KAWA",Poland,NULL,NULL
1844,MEET76,1843,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zuzanna DRULIS-KAWA","PolandESCMID official"
1845,MEET77,NULL,"Mycoplasma and Chlamydia Study Group open meeting (ESGMAC)","Schubert 6 (Venue) |","13:30 - 14:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Sylvia BRUISTEN",Netherlands,NULL,NULL
1846,MEET77,1845,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvia BRUISTEN","NetherlandsESCMID official"
1847,MEET78,NULL,"Clinical Parasitology Study Group open meeting (ESGCP)","Schubert 4+5 (Venue) |","14:45 - 15:45CETESCMID open meeting",,CET,"ESCMID open meeting",,"Miriam José ÁLVAREZ-MARTÍNEZ",Spain,NULL,NULL
1848,MEET78,1847,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam José ÁLVAREZ-MARTÍNEZ","SpainESCMID official"
1849,MEET79,NULL,"Legionella Infections Study Group open meeting (ESGLI)","Schubert 3 (Venue) |","14:45 - 15:45CETESCMID open meeting",,CET,"ESCMID open meeting",,"Anastasia FLOUNTZI",Greece,NULL,NULL
1850,MEET79,1849,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anastasia FLOUNTZI","GreeceESCMID official"
1851,MEET80,NULL,"Antimicrobial Resistance Surveillance Study Group open meeting (ESGARS)","Schubert 1+2 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Ini ADEBIYI",Nigeria,NULL,NULL
1852,MEET80,1851,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ini ADEBIYI","NigeriaESCMID official"
1853,MEET81,NULL,"Nosocomial Infections Study Group open meeting (ESGNI)","Schubert 6 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Cansu CIMEN",Germany,NULL,NULL
1854,MEET81,1853,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansu CIMEN","GermanyESCMID official"
1855,MEET82,NULL,"Bloodstream Infections Study Group open meeting (ESGBIES)","Schubert 4+5 (Venue) |","17:30 - 18:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Michele BARTOLETTI",Italy,NULL,NULL
1856,MEET82,1855,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michele BARTOLETTI","ItalyESCMID official"
1857,MEET83,NULL,"Lyme Borreliosis Study Group open meeting (ESGBOR)","Schubert 3 (Venue) |","17:30 - 18:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Randi EIKELAND",Norway,NULL,NULL
1858,MEET83,1857,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Randi EIKELAND","NorwayESCMID official"
1859,MEET84,NULL,"Host and Microbiota Interaction Study Group open meeting (ESGHAMI)","Schubert 1+2 (Venue) |","09:30 - 10:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Nicolas BENECH",France,NULL,NULL
1860,MEET84,1859,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas BENECH","FranceESCMID official"
1861,MEET85,NULL,"Biofilms Study Group open meeting (ESGB)","Schubert 6 (Venue) |","09:30 - 10:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Joana AZEREDO",,NULL,NULL
1862,MEET85,1861,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joana AZEREDO",
1863,MEET86,NULL,"Compromised Host Infections Study Group open meeting (ESGICH)","Schubert 1+2 (Venue) |","17:15 - 18:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Elisa CORDERO MATIA",Spain,NULL,NULL
1864,MEET86,1863,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa CORDERO MATIA","SpainESCMID official"
1865,MEET87,NULL,"Vaccine Study Group open meeting (EVASG)","Schubert 3 (Venue) |","11:00 - 12:00CETESCMID open meeting",,CET,"ESCMID open meeting",,"Olivier EPAULARD",France,NULL,NULL
1866,MEET87,1865,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier EPAULARD","FranceESCMID official"
1867,MEET88,NULL,"Critically Ill Patients Study Group open meeting (ESGCIP)","Schubert 3 (Venue) |","08:30 - 09:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Matteo BASSETTI",Italy,NULL,NULL
1868,MEET88,1867,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI","ItalyESCMID official"
1869,MEET89,NULL,"Epidemiological Markers Study Group open meeting (ESGEM)","Schubert 4+5 (Venue) |","14:45 - 15:45CETESCMID open meeting",,CET,"ESCMID open meeting",,"Sylvain BRISSE",France,NULL,NULL
1870,MEET89,1869,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvain BRISSE","FranceESCMID official"
1871,MEET90,NULL,"Veterinary Microbiology Study Group open meeting (ESGVM)","Schubert 4+5 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Els BROENS",Netherlands,NULL,NULL
1872,MEET90,1871,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Els BROENS","NetherlandsESCMID official"
1873,MEET91,NULL,"Brain Infections Study Group open meeting (ESGIB)","Schubert 6 (Venue) |","16:15 - 17:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Jacob BODILSEN",Denmark,NULL,NULL
1874,MEET91,1873,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob BODILSEN","DenmarkESCMID official"
1875,MEET92,NULL,"Implant-associated Infections Study Group open meeting (ESGIAI)","Schubert 1+2 (Venue) |","17:30 - 18:30CETESCMID open meeting",,CET,"ESCMID open meeting",,"Craig ABOLTINS",Australia,NULL,NULL
1876,MEET92,1875,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Craig ABOLTINS","AustraliaESCMID official"
1877,MEET109,NULL,"Sexually Transmitted Infections Study Group open meeting (ESTISG)","Schubert 3 (Venue) |","12:15 - 13:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Arjan HARXHI",,NULL,NULL
1878,MEET109,1877,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arjan HARXHI",
1879,MEET110,NULL,"AI and Digitalisation Study Group open meeting (ESGAID)","Schubert 4+5 (Venue) |","12:15 - 13:15CETESCMID open meeting",,CET,"ESCMID open meeting",,"Bram LESTRADE",Netherlands,NULL,NULL
1880,MEET110,1879,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bram LESTRADE","NetherlandsESCMID official"
1881,"Movie Session",NULL,"Behind the scenes: Contagion","Hall 5 |","15:00 - 18:30CETSpecial Session",,CET,"Special Session",,"William HANAGE","United States",NULL,NULL
1882,"Movie Session",1881,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"William HANAGE","United StatesChair"
1883,OPENING,NULL,"Opening Ceremony","Hall 1 |","18:30 - 20:00CETCongress Event",,CET,"Congress Event",,NULL,NULL,NULL,NULL
1884,OS001,NULL,"One Health means resistance everywhere","Hall 5 |","08:30 - 10:30CETCME2-hour Oral Session",,CET,"2-hour Oral Session","03. Bacterial susceptibility & resistance","Alessandra CARATTOLI",Italy,NULL,NULL
1885,OS001,1884,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra CARATTOLI",ItalyChair
1886,OS001,1884,"Decoding the role of blaCPE-carrying plasmids on wings: A holistic view using the One Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra A. MARTÍNEZ-ÁLVAREZ",Spain
1887,OS001,1884,"A novel isolation room model leveraging culture-independent Hi-C metagenomics for tracking antimicrobial resistance transmission between patients and hospital environmental reservoirs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa KOH",Singapore
1888,OS001,1884,"Deciphering the pathogenic potentials and epidemiological identities of Staphylococcus pseudintermedius colonizing companion dogs in Sao Paulo",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ikechukwu Benjamin MOSES",Nigeria
1889,OS001,1884,"Recent progress towards integrated surveillance of antimicrobial resistance in France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucie COLLINEAU",France
1890,OS001,1884,"Exploring the plasmidome of 3rd generation cephalosporin-resistant Enterobacterales in wild birds: Insights into horizontal gene transfer and AMR dissemination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bálint TIMMER",Hungary
1891,OS001,1884,"Emergence of mobile colistin resistance in Klebsiella at human-animal-environment interface in Bangladesh",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saifur RAHMAN","United Kingdom"
1892,OS001,1884,"Unveiling the invisible: antimicrobial resistance genes and pathogenic microbial diversity in sewage of North India's largest industrial hub, A metagenomic perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inderjit SINGH",India
1893,OS001,1884,"Culturomics as a tool for ONE HEALTH approach: Unveiling the role of unknown microorganisms as antibiotic resistance carriers in wastewater samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleni OURANOU",Greece
1894,OS001,1884,"One Health intervention impacts on antibiotic resistance in Denmark, England and Senegal: A mathematical model comparison",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gwen KNIGHT","United Kingdom"
1895,OS001,1884,"Clinically important sequence types and resistance genes in Enterobacteriaceae from coastal environments and gulls",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa SILVA",Portugal
1896,OS002,NULL,"Translating metagenomics into clinical practice","Hall 11 |","08:30 - 10:30CETCME2-hour Oral Session",,CET,"2-hour Oral Session","04. Diagnostic microbiology","Benjamin Peter HOWDEN",Australia,NULL,NULL
1897,OS002,1896,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin Peter HOWDEN",AustraliaChair
1898,OS002,1896,"Nanopore metagenomic sequencing for rapid bloodstream infection diagnostics evaluated in a prospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hans Linde NIELSEN",Denmark
1899,OS002,1896,"Interpretative Criteria for Adjudicating Clinical Significance to Next-Generation Sequencing Results from Bronchial-alveolar Lavage and Bronchial Wash.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose ALEXANDER","United States"
1900,OS002,1896,"Implementing same-day respiratory metagenomic diagnostics in paediatric intensive care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robbie HAMMOND","United Kingdom"
1901,OS002,1896,"Detection of pathogenic microorganisms using metagenomic next-generation sequencing in ICU patients with ongoing antibiotic therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Torsten SCHROEDER",Germany
1902,OS002,1896,"Analysis of metagenomic pathogen detection compared to conventional diagnostics: clinical usage and relevance for patient outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ekkehard SIEGEL",Germany
1903,OS002,1896,"Same-day pan-microbial metagenomics for personalized therapy and pathogen surveillance on the intensive care unit: a single-centre prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luke Blagdon SNELL","United Kingdom"
1904,OS002,1896,"Evaluation of the diagnostic efficacy of targeted next-generation sequencing in the detection of pathogens in bronchoalveolar lavage fluid from patients with lower respiratory tract infections in ICU",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bowen RAN",China
1905,OS002,1896,"Prognostic and diagnostic value of Next-generation sequencing in female reproductive tract infection and HPV persistence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chunyan PENG",China
1906,OS002,1896,"A promising approach to rapid, non-culture diagnosis of invasive fungal infections (IFIs) by targeted next-generation sequencing (tNGS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"M. Hong NGUYEN","United States"
1907,OS002,1896,"Implementation of Clinical Metagenomics in France: Insights from a Five-Years Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion DUTKIEWICZ",France
1908,OS007,NULL,"New developements in prophylaxis and treatment of COVID-19","Hall 6 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","01. Viral infection & disease (incl COVID-19)","Snjezana ZIDOVEC LEPEJ",Croatia,NULL,NULL
1909,OS007,1908,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Snjezana ZIDOVEC LEPEJ",CroatiaChair
1910,OS007,1908,"Ensitrelvir for the prevention of COVID-19 among household contacts: key subgroup analyses of a randomized, double-blinded, placebo controlled post-exposure prophylaxis study, SCORPIO-PEP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frederick HAYDEN","United States"
1911,OS007,1908,"Efficacy of nirmatrelvir/ritonavir on overall COVID-19 related symptoms in immunocompromised adult participants from the EPIC-IC trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruth MOKGOKONG","United Kingdom"
1912,OS007,1908,"COVID-19 patients benefitting from remdesivir for improved survival: a neural network-based approach.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso Francesco AIELLO",Spain
1913,OS007,1908,"Efficacy and safety of sotrovimab vs oral antivirals in omicron waves: a retrospective analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara CACACE",Italy
1914,OS007,1908,"Pharmacokinetics and immunogenicity of AZD7442 (Tixagevimab/Cilgavimab) in hospitalised COVID-19 patients: results from the DisCoVeRy trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clément MASSONNAUD",France
1915,OS008,NULL,"Advancing Malaria Research: From Molecular Insights to Clinical Challenges","Hall 7 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","07. Parasitic diseases, travel medicine & migrant health","Kamruddin AHMED",Malaysia,NULL,NULL
1916,OS008,1915,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kamruddin AHMED",MalaysiaChair
1917,OS008,1915,"Influence of second blood meals on Plasmodium vivax development and infectivity in mosquitoes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sirasate BANTUCHAI",Thailand
1918,OS008,1915,"Severe imported Plasmodium falciparum malaria with hyperparasitaemia: evaluation of predictors for critical disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tilman LINGSCHEID",Germany
1919,OS008,1915,"The current status of Plasmodium falciparum chloroquine resistance transporter gene (K76T) and Plasmodium falciparum multi-drug resistance gene 1 (N86Y) in Cameroon",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Magdany FRU",Cameroon
1920,OS008,1915,"SOFA score vs WHO severity criteria to guide antimalarial treatment - 10 years of imported malaria cases in a UK tertiary centre reviewed.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmie SAVORY","United Kingdom"
1921,OS009,NULL,"Osteoarticular uninvited guests","Hall 8 |","11:00 - 12:00CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Tiziana ASCIONE",Italy,NULL,NULL
1922,OS009,1921,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tiziana ASCIONE",ItalyChair
1923,OS009,1921,"Antibiotic-refractory oligoarthritis in an adolescent caused by Borrelia bavariensis in Croatia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nina KRAJCAR",Croatia
1924,OS009,1921,"Progression of vertebral echinococcosis despite radiotherapy treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta GONZÁLEZ-SANZ",Spain
1925,OS009,1921,"Two cases of septic osteoarthritis of Cutibacterium acnes detected by 16S rRNA gene sequencing in immunocompetent adolescents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hideo OKUNO",Japan
1926,OS009,1921,"A UK case of Melioidosis with osteomyelitis two years after geographical exposure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher DARLOW","United Kingdom"
1927,OS009,1921,"When Infection Masquerades as Malignancy: A Case of Disseminated Mycobacterium fortuitum complex infection with Mixed Osteoblastic and Osteolytic Lesions and Lymphadenopathy in Anti-IFN-γ Immunodeficiency Syndrome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Napon HIRANBURANA",Thailand
1928,OS010,NULL,"Antimicrobial drugs in action","Hall 10 |","11:00 - 12:00CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Katy JEANNOT",France,NULL,NULL
1929,OS010,1928,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katy JEANNOT",FranceChair
1930,OS010,1928,"In vivo cefiderocol resistance due to cirA modification during treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edoardo CARRETTO",Italy
1931,OS010,1928,"Long-term outcomes in dalbavancin-treated patients with vascular graft infection.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antoine SPECKLIN",France
1932,OS010,1928,"Aztreonam, ceftazidime/avibactam, and tigecycline combination for the management of multi-drug resistant E.coli on peritonitis in a pediatric liver transplant recipient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ronaldo MORALES JUNIOR","United States"
1933,OS010,1928,"Early oral antibiotic treatment in patients with post-neurosurgical brain abscesses caused by Cutibacterium acnes – a case series",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario KAROLYI",Austria
1934,OS010,1928,"Meropenem-vaborbactam as intrathecal-sparing therapy for the treatment of carbapenem-resistant K. pneumoniae shunt-related ventriculitis: two case reports.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriele GIULIANO",Italy
1935,OS011,NULL,"Around the lab in 80 ways: a journey through innovative therapeutics","Hall 13 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","05. New antibacterial agents, PK/PD & Stewardship","Zuzanna DRULIS-KAWA",Poland,NULL,NULL
1936,OS011,1935,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zuzanna DRULIS-KAWA",PolandChair
1937,OS011,1935,"In vivo expression of an mRNA encoded multi-mechanistic mAb combination against Staphylococcus aureus and protection in a disease model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christine TKACZYK","United States"
1938,OS011,1935,"Hijacking intrinsic resistance in Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gregory PHELPS","United States"
1939,OS011,1935,"Tripartite bacteriophage-based strategy to combat human clinical pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Panos KALATZIS",Denmark
1940,OS011,1935,"Eosin Y and Ceragenin combinations for enhanced antimicrobial photodynamic therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yamac TEKINTAS",Türkiye
1941,OS011,1935,"Identification of compounds capable of removing established bacterial biofilms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas INZANA","United States"
1942,OS012,NULL,"Climate Impact and One Health Approaches Against Infectious Diseases","Hall 15 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","11. Public health & vaccines","Chadia WANNOUS",France,NULL,NULL
1943,OS012,1942,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chadia WANNOUS",FranceChair
1944,OS012,1942,"Airborne Threats: Pollution, Climate, and Respiratory Infections in a Pyrenean setting: The Andorran hospital based respiratory perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina ROYO-CEBRECOS",Andorra
1945,OS012,1942,"Effects of climate change on Aedes aegypti abundance and dengue transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lin GENG",Singapore
1946,OS012,1942,"Impact of climate variables on Crimean-Congo hemorrhagic fever in Iran, Iraq, Kazakhstan, and Russia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammad FEREIDOUNI","Islamic Republic Of"
1947,OS012,1942,"Successful public health and one health response to a high pathogenicity avian influenza outbreak in poultry farms in Victoria, Australia: implications for future planning",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eugene ATHAN",Australia
1948,OS012,1942,"Turning disease surveillance into reality: Using metagenomic sequencing with piggery wastewater",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manavi MURALIDHAR",Australia
1949,OS013,NULL,"Viral challenges in organ transplantation","Hall 16 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","10. Immune compromise & transplant ID","Ghady HAIDAR","United States",NULL,NULL
1950,OS013,1949,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ghady HAIDAR","United StatesChair"
1951,OS013,1949,"Evaluation of an individualized CMV prevention strategy guided by post-transplant CMV-specific cell-mediated immunity in intermediate-risk kidney transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel RODRÍGUEZ-GONCER",Spain
1952,OS013,1949,"Real-world Use of Letermovir Prophylaxis for Cytomegalovirus (CMV) Prevention in Non-kidney Transplant Recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdallah MUGHRABI","United States"
1953,OS013,1949,"Real-world administration of maribavir beyond the eight weeks established in the clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David MARTÍNEZ-SIMÓN",Spain
1954,OS013,1949,"Prediction of BK Polyomavirus nephropathy in kidney transplantation by measuring neutralizing responses in a large cohort of donor and recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Morgane SOLIS",France
1955,OS013,1949,"Dengue in solid organ transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Santiago Iván GALIAN",Argentina
1956,OS017,NULL,"Bad bacteria","Hall 5 |","13:30 - 14:30CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Maristela P. FREIRE",Brazil,NULL,NULL
1957,OS017,1956,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maristela P. FREIRE",BrazilChair
1958,OS017,1956,"Vancomycin Dependent Enterococci: An evolutionary dead end or the ultimate evolution of a superbug",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruchika GUPTA (BAGGA)",Canada
1959,OS017,1956,"Whipple's disease: one of medicine's great imitators",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saumiya KESAVAN","United Kingdom"
1960,OS017,1956,"Phage Therapy as a Rescue Treatment for Recurrent Pseudomonas aeruginosa Bentall Infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor EIFERMAN",France
1961,OS017,1956,"A clinical case of Legionella longbeachae pneumonia featuring unique epidemiological features in a major italian hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia GUERRIERO",Italy
1962,OS017,1956,"Francisella tularensis – First autochthonous case in the UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gemma VANSTONE","United Kingdom"
1963,OS018,NULL,"Battling the Spore: C. difficile epidemiology and management","Hall 11 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","08. Healthcare-associated infections, infection prevention & control","Nicolas BENECH",France,NULL,NULL
1964,OS018,1963,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas BENECH",FranceChair
1965,OS018,1963,"Molecular epidemiology and antimicrobial resistome of Clostridioides difficile from private and public healthcare settings in three provinces in South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hlambani SHIRINDA","South Africa"
1966,OS018,1963,"Screening for Clostridioides difficile colonization at admission and during hospitalization",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nagham Léa KHANAFER",France
1967,OS018,1963,"Revolutionizing CDI treatment: Are shorter antibiotic regimens the future",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marek DURICEK","Czech Republic"
1968,OS018,1963,"Extended-pulsed fidaxomicin versus conventional dosing in patients at high risk of recurrence of Clostridioides difficile infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena RUBIO-MARTÍN",Spain
1969,OS018,1963,"Gut phageome profiling in Clostridioides difficile infection and faecal microbiota transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carmen CHEN",Switzerland
1970,OS019,NULL,"Microbiome Dynamics and Health: From Pathogenesis to Therapeutic Potential","Hall 12 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Mauricio FARFAN",Chile,NULL,NULL
1971,OS019,1970,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mauricio FARFAN",ChileChair
1972,OS019,1970,"Multi-omics integrated analysis revealed the key role of Fusobacterium periodonticum in colorectal tumorigenesis by decanoic acid promoting neutrophil chemotaxis.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaobing CHU",China
1973,OS019,1970,"Exploring the respiratory microbiome in COPD patients: The role of Haemophilus spp. in disease pathogenesis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula CAMPS-MASSA",Spain
1974,OS019,1970,"Using the in vitro MiGut system to simulate the ulcerative colitis microbiome and post-antibiotic recovery supported by a pre-defined consortium of microbes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines B. MOURA","United Kingdom"
1975,OS019,1970,"Functional characterization of the Brazilian Yanomami microbiome along an urbanization gradient: Insights into the impacts of Westernization on human health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie THORP",Belgium
1976,OS019,1970,"Colonization resistance of the intestinal microbiota to multidrug-resistant bacteria?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Khanh VILLAGEOIS-TRAN",France
1977,OS020,NULL,"How to evaluate AMS programs","Hall 15 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","05. New antibacterial agents, PK/PD & Stewardship","Esther CALBO",Spain,NULL,NULL
1978,OS020,1977,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther CALBO",SpainChair
1979,OS020,1977,"Preference-based instrumental variables for estimating the causal effects of antibiotic prescribing decisions in common infections: Assessing potential validity using CPRD data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nam NGUYEN","United Kingdom"
1980,OS020,1977,"Novel antibiotic spectrum metrics to quantify the impact of antimicrobial stewardship: a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ben MOSHY","United Kingdom"
1981,OS020,1977,"Utilizing a weighted-incidence syndromic antibiogram to evaluate antimicrobial therapies and resistance trends in community-acquired infections in a community teaching hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanthida HUANG","United States"
1982,OS020,1977,"Capturing days of therapy per days of service as a stewardship tool to identify outliers in prescribing broad-spectrum antimicrobials in the hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arielle HOPKINS","United States"
1983,OS020,1977,"Timing of Novel β-Lactams vs. Alternatives in Hospitalized Patients with Gram-Negative Infections: Line of Therapy (LoT) Analysis Preliminary findings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre YUCEL","United States"
1984,OS025,NULL,"Bacterial battles: a paediatric perspective on infections and interventions","Hall 5 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","02. Bacterial infection & disease","Angelika BERGER",,NULL,NULL
1985,OS025,1984,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angelika BERGER",
1986,OS025,1984,"Strong Alignment Between National Standard Treatment Guidelines and WHO AWaRe Book Recommendations for Primary Care Pediatric Infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniele DONA",Italy
1987,OS025,1984,"Correlation between antibiotic consumption and digestive colonization with multidrug-resistant Enterobacterales in a paediatric haematology department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siwar FRIGUI EP OUESLATI",Tunisia
1988,OS025,1984,"Interleukin-6 as a diagnostic biomarker for sepsis in neonates, children and pregnant women – a real-world cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean Olann WHELAN",Ireland
1989,OS025,1984,"Impact of rapid diagnostic stewardship interventions to reduce blood culture utilization in a pediatric medical center",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther VAUGON",Canada
1990,OS025,1984,"Infective endocarditis: A Decade of Experience at a Tertiary Pediatric Care Centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maia DE LUCA",Italy
1991,OS026,NULL,"Carbapenem resistance Gram-negatives, what's new in treatment?","Hall 11 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","03. Bacterial susceptibility & resistance","Maria Milagro MONTERO",Spain,NULL,NULL
1992,OS026,1991,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Milagro MONTERO",SpainChair
1993,OS026,1991,"Ceftriaxone sulbactam disodium EDTA combination(CSE) as a treatment option for carbapenem resistant gram negative bacilli - to be or not to be?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yogita VERMA",India
1994,OS026,1991,"Sulbactam-durlobactam as an effective alternative option against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates in Swizterland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christophe LE TERRIER",Switzerland
1995,OS026,1991,"Optimising Difficult-to-treat Gram-negative Bacterial Infection Outcomes with Personalised Fosfomycin-Based Combination Therapy Guided by in vitro Antibiotic Combination Testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tze-Peng LIM",Singapore
1996,OS026,1991,"Management of infections caused by ST308 New Dehli metallo-ß-lactamase-producing Pseudomonas aeruginosa with in vitro-guided combination antibiotic therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jocelyn TEO",Singapore
1997,OS026,1991,"In vitro activity of cefepime/enmetazobactam against clinical isolates of Enterobacterales in Portugal: A multicentre retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hugo CRUZ",Portugal
1998,OS027,NULL,"Staphylococcus aureus: colonisation, virulence, and persistence","Hall 12 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Stefano GIULIERI",Australia,NULL,NULL
1999,OS027,1998,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano GIULIERI",AustraliaChair
2000,OS027,1998,"The nasal microbiome redefines and predicts Staphylococcus aureus nasal colonisation status",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dinesh AGGARWAL","United Kingdom"
2001,OS027,1998,"Development of a Staphylococcus aureus human nasal colonisation model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdou HACHANI",Australia
2002,OS027,1998,"Selection-free, virulence gene promoter-controlled CRISPR interference system for in vivo pathogenesis study of Staphylococcus aureus - A proof of concept",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roni MIAH",Norway
2003,OS027,1998,"Placebo-controlled study of competitive exclusion using Lactococcus lactis to reduce transmission of LA-MRSA from pigs to humans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgitta DUIM",Netherlands
2004,OS027,1998,"Rifampicin-induced Staphylococcus aureus persister formation is driven by CodY and oxidative stress level",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicola PORDONE",France
2005,OS028,NULL,"Unlocking the potential of the human microbiome for clinical diagnostics","Hall 15 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","04. Diagnostic microbiology","John W. A. ROSSEN",Netherlands,NULL,NULL
2006,OS028,2005,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John W. A. ROSSEN",NetherlandsChair
2007,OS028,2005,"Deep learning-enhanced wellness scores: Advancing gut microbiome-based health predictions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ozkan Ufuk NALBANTOGLU",Türkiye
2008,OS028,2005,"Comparison of Second-Generation and Third-Generation Sequencing technologies for 16S rRNA amplicon-based gut microbiome analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa RUBIO GARCÍA",Spain
2009,OS028,2005,"Donor for fecal microbiota transplantation: a challenging research.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice Silvia ORENA",Italy
2010,OS028,2005,"Antibiotic resistance genes diversity and antimicrobial effects in the vaginal microbiome during pregnancy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nassim BOUTOUCHENT",France
2011,OS028,2005,"Distinct gut microbiota and metabolic profiles in brain tumor patients: Bridging microbial insights to CNS oncology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aycan GUNDOGDU",Türkiye
2012,OS032,NULL,"Unraveling respiratory viruses, 2025","Hall 14 |","16:15 - 18:15CETCME2-hour Oral Session",,CET,"2-hour Oral Session","01. Viral infection & disease (incl COVID-19)","Eeva BROBERG",Sweden,NULL,NULL
2013,OS032,2012,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eeva BROBERG",SwedenChair
2014,OS032,2012,"Human metapneumovirus infections in hospitalized adults compared to respiratory syncytial virus and influenza infections over ten years in France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul LOUBET",France
2015,OS032,2012,"Unveiling animal susceptibility to influenza viruses (H1N1(pdm09) and H5N1 HPAIV) using animal-derived respiratory organoids",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ferran TARRÉS-FREIXAS",Spain
2016,OS032,2012,"Exploring the impact of acute lung hypoxia on CD8 T cell phenotypes following severe influenza infection.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brydie HUCKESTEIN","United States"
2017,OS032,2012,"Virological characterisation of RSV after Nirsevimab Breakthrough Infections in a Multicentre Observational Real-world Study in France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Slim FOURATI",France
2018,OS032,2012,"Baseline immunity to highly pathogenic avian influenza viruses in a healthcare worker cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Corine GEURTS VAN KESSEL",Netherlands
2019,OS032,2012,"Impact of reinfection on post-acute sequelae of COVID-19 over multi-organ systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janice TAN",Singapore
2020,OS032,2012,"Clinical and economic burden of respiratory syncytial virus in adults with acute respiratory infections – a Danish nationwide cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stanislava BRATKOVIC",Denmark
2021,OS032,2012,"The burden of respiratory syncytial virus in children <3 years old presenting to primary, secondary and tertiary care in England: report from the STOP RSV prospective surveillance study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma CARTER","United Kingdom"
2022,OS032,2012,"Targeted metagenomic sequencing of influenza, RSV, and symptomatic respiratory infections from UK healthcare workers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marissa KNOLL","United Kingdom"
2023,OS037,NULL,"Whole genome sequencing: tracking transmission and reservoirs in outbreaks","Hall 5 |","08:30 - 10:30CETCME2-hour Oral Session",,CET,"2-hour Oral Session","08. Healthcare-associated infections, infection prevention & control","Eric CLAAS",Netherlands,NULL,NULL
2024,OS037,2023,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eric CLAAS",NetherlandsChair
2025,OS037,2023,"From outbreaks to outcomes: Harnessing WGS for IPC in a high-risk paediatric setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathaniel STOREY","United Kingdom"
2026,OS037,2023,"Why do routine genome-oriented surveillance for Pseudomonas aeruginosa?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anca RATH",Germany
2027,OS037,2023,"TreeTime estimation depicts transmission dynamics of clinical and environmental Pseudomonas aeruginosa from common reservoirs in healthcare environment through whole genome sequencing (WGS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özge YETIS","United Kingdom"
2028,OS037,2023,"Understanding Serratia transmission during a neonatal ICU outbreak: A combined genotyping and risk factor analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaisa JAAKKOLA",France
2029,OS037,2023,"Genomic Insights into the Regional Transmission of KPC-Producing Bacteria: Clonal and Non-Clonal Plasmid Sharing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaitra SHANKAR","United States"
2030,OS037,2023,"Genome-oriented analysis of the first outbreaks involving the novel Serratia sarumanii at a neonatal unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anca RATH",Germany
2031,OS037,2023,"Evaluating the Utility of Whole-Genome Sequencing to Optimise Infection Prevention and Control in a Hospital Setting: Findings from the GENOTIPE Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James PRICE","United Kingdom"
2032,OS037,2023,"Outbreak of Carbapenem-Resistant Acinetobacter seifertii in a Neonatal Intensive Care Unit: Genomic Characterization and Surveillance.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dariane PEREIRA",Brazil
2033,OS037,2023,"Unveiling the Clonal Dynamics and transmission mechanism of Carbapenem-Resistant Klebsiella pneumoniae in the ICU environment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xinhong HAN",China
2034,OS037,2023,"Survey of Infection Prevention staff perception of WGS integration into routine IPC practice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorothy LING",Australia
2035,OS038,NULL,"Making fast for making better: AMR rapid diagnostics","Hall 14 |","08:30 - 10:30CETCME2-hour Oral Session",,CET,"2-hour Oral Session","03. Bacterial susceptibility & resistance","Giulia DE ANGELIS",Italy,NULL,NULL
2036,OS038,2035,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia DE ANGELIS",ItalyChair
2037,OS038,2035,"Point of care rapid lateral flow antibiotic resistance test to detect carbapenem resistance in lower respiratory tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia ROGERS","United Kingdom"
2038,OS038,2035,"Evaluation of a new rapid Lateral flow immunoassay for the detection of DHA-producing Gram-negative bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian MOGUET",France
2039,OS038,2035,"The NitroSpeed Taniborbactam NP test; easy detection of β-lactamase sensitivity to taniborbactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Otavio RARO",Switzerland
2040,OS038,2035,"Rapid detection of β-lactamase-mediated resistance to aminopenicillins from urines.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patrice NORDMANN",Switzerland
2041,OS038,2035,"Rapid detection of antibiotic resistance in direct urine samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marit BOT",Netherlands
2042,OS038,2035,"Next-Generation Utilizer Dipsticks for direct-from-sample phenotypic Antibiotic Susceptibility Testing in UTIs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre ISERI",Sweden
2043,OS038,2035,"Screening for ceftriaxone-resistant Neisseria gonorrhoeae with the Urogenital and Resistance kit (AusDiagnostic)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aymeric BRAILLE",France
2044,OS038,2035,"Comparative evaluation of rapid antimicrobial susceptibility testing assays for Gram-negative bacteria from positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Damiano SQUITIERI",Italy
2045,OS038,2035,"Rapid detection of Carbapenemases directly from positive blood culture bottle: A tool for early shifting from empirical to targeted therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kanika CHAUDHARY",India
2046,OS043,NULL,"Navigating disinfection challenges: resistance, outbreaks, and efficacy","Hall 3 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","08. Healthcare-associated infections, infection prevention & control","Hillary A. CRADDOCK",Ireland,NULL,NULL
2047,OS043,2046,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hillary A. CRADDOCK",IrelandChair
2048,OS043,2046,"Prolonged disinfectant exposure impacts the antimicrobial resistance of healthcare-associated microorganisms: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ângela Rita FERNANDES",Portugal
2049,OS043,2046,"Sink-associated outbreak of verona integron-encoded metallo-??-lactamase-producing carbapenem-resistant Pseudomonas aeruginosa in a Dutch intensive care unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marieke VAN DEN BOS  KROMHOUT",Netherlands
2050,OS043,2046,"Carbapenemase-producing Enterobacterales outbreak control by replacement of toilets or long-term disinfection? A real-life experience.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Line ENGSBRO",Denmark
2051,OS043,2046,"Tolerance of Klebsiella pneumoniae biofilms to disinfection with peracetic acid",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mardjan ARVAND",Germany
2052,OS043,2046,"Bringing balance to the formulation: disinfection efficacy and material compatibility",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jake JENNINGS","United Kingdom"
2053,OS044,NULL,"Unusual presentations of unusual parasites","Hall 5 |","11:00 - 12:00CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Emmanuel BOTTIEAU",Belgium,NULL,NULL
2054,OS044,2053,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanuel BOTTIEAU",BelgiumChair
2055,OS044,2053,"Atypical neonatal cutaneous myiasis: a diagnostic challenge mimicking pustular rash in a resource-limited setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Doris EKWEM AMARACHI",Uganda
2056,OS044,2053,"An itchy awakening due to Dermanyssus infestation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacques SEVESTRE",France
2057,OS044,2053,"Uterine Myiasis: A Rare Case of External Genitourinary Myiasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert L. JOHNSON","United States"
2058,OS044,2053,"Neurognathostomiasis Presenting with Cerebral Venous Sinus Thrombosis: A case report of rare clinical manifestation.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chatrawee NORSUNGNERN",Thailand
2059,OS044,2053,"If at first, you don't succeed… Treatment-resistant Fascioliasis: case report",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Winifred GARR","United Kingdom"
2060,OS045,NULL,"Social behavioural dynamics of antibiotic use and AMR","Hall 8 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","03. Bacterial susceptibility & resistance","Sonia LEWYCKA",Vietnam,NULL,NULL
2061,OS045,2060,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia LEWYCKA",VietnamChair
2062,OS045,2060,"Investigating the Knowledge, Attitudes, and Practices around Antimicrobial Resistance and Stewardship Among Syrian Healthcare Professionals: A Cross-Sectional Survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aula ABBARA","United Kingdom"
2063,OS045,2060,"Gamified Intervention to Enhance Antimicrobial Stewardship: Improving Knowledge and Practices on the Rational Use of Antimicrobials Among Medicines and Therapeutics Committee Members ???",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sumana MAHADEVAIAH",India
2064,OS045,2060,"Healthcare providers' perspectives on antibiotic use and resistance in pregnancy, childbirth, and children under five years of age across four levels of hospitals in Lao PDR, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonephet VANTAVA","Lao People's Democratic Republic"
2065,OS045,2060,"High gender gap in female labour force participation and reduced gender inequality linked to high antibiotic consumption: Evidence from a global analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Divija SAMRIA",India
2066,OS045,2060,"Gender gaps in knowledge of antibiotics and antimicrobial resistance: Evidence from India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepshikha BATHEJA",India
2067,OS046,NULL,"Vaccines and prophylaxis against respiratory viral infections","Hall 9 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","11. Public health & vaccines","Ana ATTI","United Kingdom",NULL,NULL
2068,OS046,2067,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana ATTI","United KingdomChair"
2069,OS046,2067,"Public health impact of universal prophylaxis with nirsevimab for prevention of infant hospitalizations due to respiratory syncytial virus. Full 2023-24 season analysis of the NIRSE-GAL study (www.nirsegal.es/en)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico MARTINÓN-TORRES",Spain
2070,OS046,2067,"Relative effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against hospitalizations and mortality according to Charlson Comorbidity Index: A post-hoc analysis of the DANFLU-1 randomized trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katrine FELDBALLE BERNHOLM",Denmark
2071,OS046,2067,"Relative vaccine efficacy of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine versus mRNA-1273: subgroup analyses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Spyros CHALKIAS","United States"
2072,OS046,2067,"Effectiveness of RSV vaccine in lung transplant recipients: neutralizing antibody response against reference and seasonal strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neta SHIRIN",Israel
2073,OS046,2067,"Novavax investigational COVID-19 Influenza Combination nanoparticle vaccine phase 2 study safety evaluation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chijioke BENNETT","United States"
2074,OS047,NULL,"Clinical studies in UTI","Hall 11 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","02. Bacterial infection & disease","Iva BUTIC",Croatia,NULL,NULL
2075,OS047,2074,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iva BUTIC",CroatiaChair
2076,OS047,2074,"Short versus long antibiotic treatment for pyelonephritis and complicated UTIs: an updated systematic review and meta-analysis of RCTs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Itay ZAHAVI",Israel
2077,OS047,2074,"Antibiotic treatment duration of complicated urinary tract infection patients in Europe: results from the Ecraid POS-cUTI study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chantal J.A.R. KATS",Netherlands
2078,OS047,2074,"Prevalence and impact of multidrug resistance in a cohort of patients admitted to emergency department for urinary tract infections: the UTILITY study, a prospective multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorenzo ONORATO",Italy
2079,OS047,2074,"Weekly sequential antibioprophylaxis for UTI in neurogenic bladder",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruxandra CALIN",France
2080,OS047,2074,"Evidence for the duration of antibiotic therapy for chronic bacterial prostatitis: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CORDES",Switzerland
2081,OS048,NULL,"Complexities of infections in solid organ transplantation","Hall 12 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","10. Immune compromise & transplant ID","Silvia CORCIONE",Italy,NULL,NULL
2082,OS048,2081,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia CORCIONE",ItalyChair
2083,OS048,2081,"Solid Organ Transplants from donors with positive blood cultures: watch out for carbapenem-resistant Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea CONA",Italy
2084,OS048,2081,"Risk factors for carbapenem-resistant Enterobacteriaceae infection after orthotopic liver transplant in a large cohort of pre-transplant CRE carriers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo RINALDI",Italy
2085,OS048,2081,"Serologic follow up of solid organ transplant recipients who receive organs from syphilis seropositive donors.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oscar FERNANDEZ GARCIA",Canada
2086,OS048,2081,"Prophylaxis strategies and risk of cytomegalovirus in solid organ transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anja DAHL",Denmark
2087,OS048,2081,"Burden of non-microbiologically confirmed infections in solid organ transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ming ZOU",Switzerland
2088,OS052,NULL,"AI in infectious diseases: the lab and beyond","Hall 2 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","04. Diagnostic microbiology","Miranda LANGENDAM",Netherlands,NULL,NULL
2089,OS052,2088,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miranda LANGENDAM",NetherlandsChair
2090,OS052,2088,"Accurate strain typing of key bacterial pathogens through artificial intelligence analysis of MALDI-TOF mass spectra",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nenad MACESIC",Australia
2091,OS052,2088,"CarbaDetector: An Artificial Intelligence-Driven Prediction Model for Detecting Carbapenemase-Producing Enterobacterales Using Disk-Diffusion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linea Katharina MUHSAL",Germany
2092,OS052,2088,"AI-Driven Early Infectious Disease Detection in Dutch Primary Care: leveraging Bidirectional Encoder Representations from Transformers (BERT) and Early Recognition using Neural Information Encoding (ERNIE)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gijs DANOE",Netherlands
2093,OS052,2088,"Predicting potentially infection-related findings in structured radiology reports",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justin XU","United Kingdom"
2094,OS052,2088,"Application of Artificial Intelligence in Assisting X-ray Diagnosis of Pediatric Pulmonary Infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Haocheng ZHANG",China
2095,OS053,NULL,"Immune evasion and intracellular survival strategies","Hall 3 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Juliane BUBECK WARDENBURG","United States",NULL,NULL
2096,OS053,2095,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliane BUBECK WARDENBURG","United StatesChair"
2097,OS053,2095,"Capsule-Dependent Modulation of Cell Death Pathways and Immune Evasion in Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hui WANG",China
2098,OS053,2095,"Intracellular lifestyle of Acinetobacter baumannii: Role of phospholipase A2 and transcriptional factor EB (TFEB)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Younes SMANI",Spain
2099,OS053,2095,"The role of peg344 of hypervirulent Klebsiella pneumoniae on suppressing autophagy responses of macrophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeynep Ece KULOGLU",Türkiye
2100,OS053,2095,"c-Myc Inhibits Macrophage Antimycobacterial Response in Mycobacterium tuberculosis Infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cédric DOLLÉ",Switzerland
2101,OS053,2095,"Targeting neutrophil extracellular traps (NETs) prevents tuberculosis immunopathology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia KUTSCHENREUTER","United Kingdom"
2102,OS056,NULL,"Emerging trends in viral hepatitis across Europe","Hall 2 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","01. Viral infection & disease (incl COVID-19)","Federico GARCIA",Spain,NULL,NULL
2103,OS056,2102,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico GARCIA",SpainChair
2104,OS056,2102,"One of the largest outbreak of hepatitis A in the 21st century in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ivana HOCKICKOVA",Slovakia
2105,OS056,2102,"Higher prevalence of Cytomegalovirus and Epstein–Barr virus in acute-on-chronic liver failure – cause or consequence?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jannik SONNENBERG",Germany
2106,OS056,2102,"Delta in Denmark: current prevalence of hepatitis delta virus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hugh WATSON",France
2107,OS056,2102,"RatHEV as an aetiological agent of acute hepatitis in Europe: results from the ESGHV-RHEV Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio RIVERO-JUAREZ",Spain
2108,OS056,2102,"Understanding the incidence and risk factors of low-level viremia in chronic hepatitis B: A propensity-matched comparison of tenofovir and entecavir",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU",Türkiye
2109,OS057,NULL,"Precision Medecine: from models to patient care","Hall 3 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","05. New antibacterial agents, PK/PD & Stewardship","Anouk Edwina MULLER",Netherlands,NULL,NULL
2110,OS057,2109,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk Edwina MULLER",NetherlandsChair
2111,OS057,2109,"Pharmacokinetics and pharmacodynamics of BPaLM, BPaLC and BPaL regimens for treatment of RR-TB",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frank KLOPROGGE","United Kingdom"
2112,OS057,2109,"Physiologically Based Pharmacokinetic Modeling for Nemonoxacin in Predicting the Respiratory System Pharmacokinetic Profile: Based on Comprehensive Preclinical and Clinical Data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yinru CHEN",China
2113,OS057,2109,"Context-specific genome-scale metabolic modelling reveals metabolic alterations in multidrug-resistant Klebsiella pneumoniae in response to polymyxin B/zidovudine combination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jinxin ZHAO",Australia
2114,OS057,2109,"Agent-based model predictions of polymyxin B activity on Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiie SOEORG",Estonia
2115,OS057,2109,"Monthly dalbavancin dosing for suppressive therapy: a case series and pharmacokinetic estimation analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cecilia VOLK","United States"
2116,OS058,NULL,"In the field with fungi","Hall 16 |","14:45 - 15:45CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Beatriz L. GOMEZ",Colombia,NULL,NULL
2117,OS058,2116,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatriz L. GOMEZ",ColombiaChair
2118,OS058,2116,"Fosmanogepix expanded access in patients with Fusarium infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sanjeet DADWAL","United States"
2119,OS058,2116,"Voriconazole's hidden toll: unveiling periostitis in a heart transplant recipient and a hematologic patient.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel MOTOA","United States"
2120,OS058,2116,"Unveiling the Uncommon: Managing Geotrichum candidum in Pancreatic Necrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa Marie KRIEGL",Austria
2121,OS058,2116,"Detection of siderophores as a superior non-invasive diagnostic tool in unravelling mixed fungal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vladimir HAVLICEK","Czech Republic"
2122,OS058,2116,"Efficacy of novel antifungal therapies in refractory Candida and Aspergillus infections: insights from compassionate use and clinical trials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah SEDIK",Austria
2123,OS062,NULL,"Heterogeneity and complexity of sepsis","Hall 13 |","16:15 - 18:15CETCME2-hour Oral Session",,CET,"2-hour Oral Session","02. Bacterial infection & disease","Despoina KOULENTI","United Kingdom",NULL,NULL
2124,OS062,2123,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Despoina KOULENTI","United KingdomChair"
2125,OS062,2123,"A consensus immune dysregulation framework for sepsis: results of the SUBSPACE consortium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew MOORE","United States"
2126,OS062,2123,"BLOODICU: Bloodstream infections and their outcomes in ICU patients - Insights from the PROSAFE Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camilla GENOVESE",Italy
2127,OS062,2123,"Deciphering the Dynamics of Klebsiella pneumoniae Colonization and Infection: Genomic Insights and Microbiome Interactions in ICU Patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wei YU",China
2128,OS062,2123,"Antibiotics with anti-anaerobe activity promote enteric pathobionts in ICU patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steven TAYLOR",Australia
2129,OS062,2123,"Association between blood culture time to positivity and 30-day bacteremia mortality differs for bacterial groups",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melissa Hornbæk ØVRE",Denmark
2130,OS062,2123,"Treatment patterns of patients with sepsis/SIRS/septic shock treated with ceftolozane/tazobactam – results from SPECTRA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre YUCEL","United States"
2131,OS062,2123,"Risk of myocardial infarction and stroke following bloodstream infection: a population-based self-controlled case series",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jonathan UNDERWOOD","United Kingdom"
2132,OS062,2123,"Is transthoracic echocardiography required in all patients with Staphylococcus aureus bacteremia? Validating the VIRSTA and VIRSTA+ scores to define the population at low risk of endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel Ángel VERDEJO GÓMEZ",Spain
2133,OS062,2123,"DNA methylation changes in Sepsis: Potential use as biomarkers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ian LÓPEZ-CRUZ",Spain
2134,OS062,2123,"Host response plasma biomarkers and transcriptomic alterations in critically ill patients with suspected aspiration pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne DOELEMAN",Netherlands
2135,OS063,NULL,"Improving blood culture diagnostics: rethinking the basics","Hall 11 |","16:15 - 17:15CETCME1-hour Oral Session",,CET,"1-hour Oral Session","04. Diagnostic microbiology","Direk LIMMATHUROTSAKUL",Thailand,NULL,NULL
2136,OS063,2135,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Direk LIMMATHUROTSAKUL",ThailandChair
2137,OS063,2135,"Blood culture volume, guideline adherence and pathogen yield of 35,433 paediatric blood cultures in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johannes FORSTER",Germany
2138,OS063,2135,"Changing the paradigm: are two sets of blood cultures always needed?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rossana ROSA",Canada
2139,OS063,2135,"Evaluating clinical and economic empact of reducing blood culture incubation timings: Time to shift the paradigm?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruchika GUPTA (BAGGA)",Canada
2140,OS063,2135,"Revolutionizing hospital workflows with blood culture-free ultra-rapid antimicrobial susceptibility testing: A clinical pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sunghoon KWON","Republic Of"
2141,OS063,2135,"Human in vivo footprints from blood plasma for improved diagnostics in sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mirko SONNTAG",Germany
2142,OS064,NULL,"Viral immune response - nature or nurture? Exploring the limits of immune response","Hall 16 |","16:15 - 17:15CETCME1-hour Oral Session",,CET,"1-hour Oral Session","01. Viral infection & disease (incl COVID-19)","Malin FLODSTRÖM-TULLBERG",Sweden,NULL,NULL
2143,OS064,2142,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malin FLODSTRÖM-TULLBERG",SwedenChair
2144,OS064,2142,"Orthopoxvirus-specific antibody dynamics up to two years after monkeypoxvirus infection or vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christophe VAN DIJCK",Belgium
2145,OS064,2142,"DENG-VAC study: preliminary data on immunogenity and reactogenity of Qdenga vaccine versus natural infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra D'ABRAMO",Italy
2146,OS064,2142,"Long-Lasting Immunity Followed by Natural CCHFV Infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanife Nur KARAKOC",Türkiye
2147,OS064,2142,"Why does rabies virus not induce an anti-viral immune response : insights from experimental models and a human cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Corine GEURTS VAN KESSEL",Netherlands
2148,OS064,2142,"Establishing a human challenge model for human metapneumovirus: disease characteristics and immune responses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas NOULIN","United Kingdom"
2149,OS069,NULL,"Determining new and revising old breakpoints","Hall 4 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","03. Bacterial susceptibility & resistance","Jaroslav HRABAK","Czech Republic",NULL,NULL
2150,OS069,2149,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaroslav HRABAK","Czech RepublicChair"
2151,OS069,2149,"EUCAST disk diffusion testing of ten additional species of anaerobic bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jenny AHMAN",Sweden
2152,OS069,2149,"Standardised antimicrobial susceptibility testing protocol for Legionella pneumophila validated across ten European reference laboratories.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Max SEWELL","United Kingdom"
2153,OS069,2149,"Antimicrobial susceptibility testing of the combination of aztreonam and avibactam in carbapenem-resistant Enterobacterales: a practical evaluation using the CLSI and EUCAST methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linda CHAN",China
2154,OS069,2149,"Determination of optimal disk diffusion mass for zosurabalpin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana CASTANHEIRA","United States"
2155,OS069,2149,"The clinical significance of aminoglycoside susceptibility breakpoints modification",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oryan HENIG",Israel
2156,OS070,NULL,"What's new in antifungal guidelines and management","Hall 12 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","06. Fungal infection & disease","Sharon CHEN",Australia,NULL,NULL
2157,OS070,2156,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sharon CHEN",AustraliaChair
2158,OS070,2156,"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rosanne SPRUTE",Germany
2159,OS070,2156,"Impact of achieving early mycological eradication with rezafungin on all-cause mortality and ICU length of stay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo BASSETTI",Italy
2160,OS070,2156,"An open-label study of ibrexafungerp in patients with refractory fungal infections (FURI)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver A. CORNELY",Germany
2161,OS070,2156,"Novel immunotherapy approach using pan-Candida monoclonal antibodies to treat life-threatening invasive candidiasis and tackle global AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yixin ZHAO","United Kingdom"
2162,OS070,2156,"Relative contribution of pharmacokinetics and immune signatures to clinical outcomes in patients with HIV-associated cryptococcal meningitis.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katharine STOTT","United Kingdom"
2163,OS071,NULL,"Intestinal parasitic uncovered: epidemiology and treatment success","Hall 14 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","07. Parasitic diseases, travel medicine & migrant health","Kurt HANEVIK",Norway,NULL,NULL
2164,OS071,2163,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kurt HANEVIK",NorwayChair
2165,OS071,2163,"Giardia- Does the treatment work? The experience from a national tertiary referral centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna BOTÉ CASAMITJANA","United Kingdom"
2166,OS071,2163,"Giardiasis: Who gets it? Experience from a Central London Teaching Hospital.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna BOTÉ CASAMITJANA","United Kingdom"
2167,OS071,2163,"Assessing the Effect of Antimicrobial Treatment on the Accuracy of Serial Serum and Urine Testing for Detecting E. histolytica cfDNA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priya DATTA",India
2168,OS071,2163,"Longitudinal observation of  Blastocystis sp. and Dientamoeba fragilis in children: a very rare occurrence in chronic diseases with gut dysbiosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jakub HURYCH","Czech Republic"
2169,OS071,2163,"High prevalence of the zoonotic Angiostrongylus cantonensis in rats in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier CABALLERO GÓMEZ",Spain
2170,OS072,NULL,"Training models - a new model for training","Hall 15 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","12. Professional and educational affairs","Erin BONURA","United States",NULL,NULL
2171,OS072,2170,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erin BONURA","United StatesChair"
2172,OS072,2170,"Can ChatGPT4o help build Objective Structured Clinical Examination (OSCE) stations in infectious diseases ?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sébastien VILLARD",France
2173,OS072,2170,"Large language model in real-world clinical infectious diseases: are we there yet?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia CARRA",Switzerland
2174,OS072,2170,"Artificial Intelligence-Powered Transformation: Enhancing Public Health Education at Tampere University Towards Sustainable Development Goal 3",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saeed AHMAD",Finland
2175,OS072,2170,"A Survey on Perceived Priorities for the Implementation of Artificial Intelligence in Developing ESCMID Guidelines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"José MOLINA GIL-BERMEJO",Spain
2176,OS072,2170,"Expect the unexpected: Longitudinally extensive transverse myelitis in a healthy young adult -  a rare  manifestation of tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shekhar ANGIREKULA",India
2177,OS073,NULL,"Still going viral","Hall 16 |","17:30 - 18:30CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Ursula HOFER","United Kingdom",NULL,NULL
2178,OS073,2177,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ursula HOFER","United KingdomChair"
2179,OS073,2177,"Clinical outcomes of adoptive cell therapy for EBV reactivation and EBV-PTLD in primary immunodeficiencies: prophylactic and therapeutic applications of post-allo-HSCT memory T cell infusions.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antimo TESSITORE",Italy
2180,OS073,2177,"Histopathological proof of herpes simplex pneumonitis in a patient with severe COVID-19 pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jannes HEYLEN",Belgium
2181,OS073,2177,"Transmission of dengue virus from donors to recipient after solid organ transplantation. Case series in Argentina.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura Alicia BARCAN",Argentina
2182,OS073,2177,"Rash without borders: waning immunity in a travelling physician",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo VILLE BENAVIDES",Mexico
2183,OS073,2177,"A handful of Orf: a case of successful management with cidofovir in a renal transplant recipient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arda KAYA",Türkiye
2184,OS078,NULL,"Trending topics in tuberculosis","Hall 5 |","08:30 - 10:30CETCME2-hour Oral Session",,CET,"2-hour Oral Session","02. Bacterial infection & disease","Delia GOLETTI",Italy,NULL,NULL
2185,OS078,2184,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Delia GOLETTI",ItalyChair
2186,OS078,2184,"Lineage-specific immune responses to Mycobacterium tuberculosis: insights into L4 and L6 pathogenesis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta SILVA",Portugal
2187,OS078,2184,"Deciphering the functional role of distinctive Mycobacterium tuberculosis peptidoglycan modifications in modulating antibiotic resistance and the immune response",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cátia SILVEIRO",Portugal
2188,OS078,2184,"Increased innate immune and neutrophil blood transcriptomic signatures associate with poor outcome in HIV-1 tuberculous meningitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James BARNACLE","United Kingdom"
2189,OS078,2184,"Subpopulations in clinical samples of Mycobacterium tuberculosis can give rise to rifampicin resistance and shed light on how resistance is acquired",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Viktoria BRUNNER","United Kingdom"
2190,OS078,2184,"A systematic comparison of automated Mycobacterium tuberculosis complex whole genome sequencing analysis pipelines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruan SPIES",Vietnam
2191,OS078,2184,"Lung ultrasound for the detection of pulmonary tuberculosis using expert and AI-guided interpretation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronique SUTTELS",Switzerland
2192,OS078,2184,"Nanomotion Technology for Rapid Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis: Evaluating Novel Benzothiazinone Derivatives.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anthony VOCAT",Switzerland
2193,OS078,2184,"Rapid drug susceptibility testing of Mycobacterium tuberculosis directly from clinical samples using targeted next-generation sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ebba ROSENDAL",Portugal
2194,OS078,2184,"Enhancing cerebral tuberculosis therapy with an innovative particulate nose-to-Brain drug delivery system: Insights from pharmacokinetic and pharmacodynamic studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Krishna Sudhakar JADHAV",India
2195,OS078,2184,"Multi-drug resistant tuberculosis among migrants in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sally HAYWARD","United Kingdom"
2196,OS082,NULL,"New insights in bloodstream infections and  endocarditis","Hall 2 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","02. Bacterial infection & disease","Barbara HASSE",Switzerland,NULL,NULL
2197,OS082,2196,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Barbara HASSE",SwitzerlandChair
2198,OS082,2196,"Different from the start – Sex differences in Staphylococcus aureus bacteremia mortality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annette WESTGEEST",Netherlands
2199,OS082,2196,"Tracking evolution in action during invasive Staphylococcus aureus infections: the BARISTA study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano GIULIERI",Australia
2200,OS082,2196,"Identifying heterogeneity of treatment effect for antibiotic duration in bloodstream infection – an exploratory post-hoc analysis of the BALANCE randomized clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean Wei Xiang ONG",Australia
2201,OS082,2196,"Bloodstream infection pathogen diversity and clinical impact revealed through unbiased whole genome sequencing: a prospective genomic epidemiology study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nenad MACESIC",Australia
2202,OS082,2196,"Risk of infection of intracardiac devices in patients with valvular infective endocarditis who carry cardiovascular implanted electronic devices. Analysis on a national cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandro BLANCO ARÉVALO",Spain
2203,OS083,NULL,"Don't 'rash' it","Hall 5 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","01. Viral infection & disease (incl COVID-19)","Heli HARVALA",Finland,NULL,NULL
2204,OS083,2203,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heli HARVALA",FinlandChair
2205,OS083,2203,"Current Prevalence of Parvovirus B 19 Infections: Ankara Bilkent City Hospital Experience 2019-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bedia DINC",Türkiye
2206,OS083,2203,"Managing an outbreak of parvovirus B19 infection in pregnancy: clinical outcomes from a single-centre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monica MELCHIO",Italy
2207,OS083,2203,"The dark side of the „fifth disease” endemic: human parvovirus B19 infections transmitted through blood transfusions in adults with malignant hematological diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balint Gergely SZABO",Hungary
2208,OS083,2203,"Key learnings from a measles outbreak with multiple hospital exposures in Ireland, May-July 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ann Marie MURRAY",Ireland
2209,OS083,2203,"Measles virus in the context of subacute sclerosing panencephalitis (SSPE)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia DINA",France
2210,OS084,NULL,"Weird and unusual infections","Hall 8 |","11:00 - 12:00CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Murat AKOVA",Türkiye,NULL,NULL
2211,OS084,2210,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat AKOVA",TürkiyeChair
2212,OS084,2210,"Vertical Transmission of Clade Ib monkeypoxvirus during Pregnancy: Clinical and Histopathological description of 3 cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanuel HASIVIRWE VAKANIAKI","The Democratic Republic Of The"
2213,OS084,2210,"First case of Oropouche fever in the South of Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel Ascensión PÉREZ HERNÁNDEZ",Spain
2214,OS084,2210,"Wild hippopotamus bite and Aeromonas spp. infection: a treatment challenge. First case report.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jhongert ALZA ARCILA",Colombia
2215,OS084,2210,"From the sea to the land: an emerging species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katherine Pamela RODRÍGUEZ MARTÍNEZ","Dominican Republic"
2216,OS084,2210,"The first findings of Wohlfahrtiimonas chitiniclastica and Ignatzschineria species bacteremia in two cases with maggot infested wounds in Scandinavia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Line ENGSBRO",Denmark
2217,OS085,NULL,"Planes, Pains, and Pathogens: The Perils of Travel Medicine","Hall 10 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","07. Parasitic diseases, travel medicine & migrant health","Anu KANTELE",Finland,NULL,NULL
2218,OS085,2217,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anu KANTELE",FinlandChair
2219,OS085,2217,"Fever in returning travelers from tropical regions: what not to miss in an evolving epidemiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefania CARONNI",Italy
2220,OS085,2217,"Tracing the itch: A spatiotemporal analysis of scabies rates and its risk factors using the Global Burden of Disease data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saptorshi GUPTA","New Zealand"
2221,OS085,2217,"Molecular epidemiological characterization of enterotoxigenic and enteroaggregative Escherichia coli causing traveller's diarrhoea and their relationship with clinical features",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pol OLIVERAS JULIA",Spain
2222,OS085,2217,"Bites and bytes – can digital surveillance of travellers' illness predict outbreaks?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadja HEDRICH",Switzerland
2223,OS085,2217,"Travel-associated infections and diseases: a retrospective cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milan TROJANEK","Czech Republic"
2224,OS086,NULL,"Marker based diagnostics: forget the pathogen","Hall 11 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","04. Diagnostic microbiology","Virginie PRENDKI",Switzerland,NULL,NULL
2225,OS086,2224,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Virginie PRENDKI",SwitzerlandChair
2226,OS086,2224,"A 29-mRNA molecular host response test demonstrates enhanced accuracy compared to a protein-based host response test for the diagnosis of bacterial and viral infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalie WHITFIELD","United States"
2227,OS086,2224,"Diagnostic accuracy of a bacterial versus viral host-protein test for pediatric inpatients with acute infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tanya GOTTLIEB",Israel
2228,OS086,2224,"Diagnostic accuracy of combined urine lipocalin 2 and copper test in acute pyelonephritis or cystitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vladimir HAVLICEK","Czech Republic"
2229,OS086,2224,"Diagnostic Performance of Whole-Blood RNA Signatures for Tuberculosis Diagnosis in a Cohort of Patients with Non-Tuberculous Mycobacterial Lung Disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricio ESCALANTE","United States"
2230,OS086,2224,"Diagnostic utility of MxA and MxA/CRP ratio in differentiating viral and bacterial infections: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ondrej BERÁNEK","Czech Republic"
2231,OS087,NULL,"Antimicrobial resistance around birth","Hall 15 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","03. Bacterial susceptibility & resistance","Julia Anna BIELICKI","United Kingdom",NULL,NULL
2232,OS087,2231,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia Anna BIELICKI","United KingdomChair"
2233,OS087,2231,"Prevalence and risk factors of antibiotic resistance genes in breastmilk and neonatal oral cavity of preterm mother-infant pairs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ambika SHARMA",India
2234,OS087,2231,"Effect of maternal peripartum antibiotic exposure on the microbial diversity, relative abundance of taxa, and resistome in breastmilk",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anwesha CHAKRABORTY",India
2235,OS087,2231,"Dynamics of gastrointestinal colonisation by antibiotic-resistant bacteria in high-risk infants in Swiss and Greek neonatal intensive care units",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk BRASPENNING",Belgium
2236,OS087,2231,"Harnessing functional omics to decipher how probiotics reduce antibiotic resistance gene carriage in infants' gut",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronika PETTERSEN",Norway
2237,OS087,2231,"Dynamics of gut resistome and mobilome in early life: A meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronika PETTERSEN",Norway
2238,OS088,NULL,"Advancing diagnostics and preventive measures in hemato-oncological patients","Hall 16 |","11:00 - 12:00CETCME1-hour Oral Session",,CET,"1-hour Oral Session","10. Immune compromise & transplant ID","Dina AVERBUCH",Israel,NULL,NULL
2239,OS088,2238,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina AVERBUCH",IsraelChair
2240,OS088,2238,"Prediction of bacterial and fungal bloodstream infections using machine learning in patients undergoing chemotherapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maristela P. FREIRE",Brazil
2241,OS088,2238,"Viral metagenomics in patients with persistent unexplained neutropenic fever- some clues to the cause of fever?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abby Patricia DOUGLAS",Australia
2242,OS088,2238,"Results of Optifil study: 18F-FDG-PET/CT guided antifungal stewardship in invasive pulmonary aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fanny LANTERNIER",France
2243,OS088,2238,"Long-term immunogenicity and boostability of the 5-dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sabine HAGGENBURG",Netherlands
2244,OS088,2238,"Humoral and cellular immune response to adjuvanted respiratory syncytial virus vaccine RSVPreF3 in adults after allogeneic hematopoietic cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jonas LÖTSCHER",Switzerland
2245,OS091,NULL,"Genomic and molecular drivers of bacterial virulence and resistance","Hall 5 |","13:30 - 14:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Ecaterina NOROC","Moldova Republic Of",NULL,NULL
2246,OS091,2245,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ecaterina NOROC","Republic OfChair"
2247,OS091,2245,"Characterization of the virulence shaping and adaptability in the methicillin-resistant Staphylococcus aureus ST9 lineage.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yiyi CHEN",China
2248,OS091,2245,"Elucidating molecular mechanisms of bacterial conjugation: towards an improved understanding of plasmid evolution and epidemiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophia DAVID","United Kingdom"
2249,OS091,2245,"Clinical carbapenem-resistant Klebsiella pneumoniae (CRKP) strains carrying a mutH mutation are hypermutators that have heightened virulence and readily develop β-lactam/β-lactamase resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shaoji CHENG","United States"
2250,OS091,2245,"Genomic insights into the new prophages of MDR Pseudomonas aeruginosa: an example of phage-host-phage interaction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aylin USKUDAR GUCLU",Türkiye
2251,OS091,2245,"Genome-wide association study (GWAS) reveals importance of vaginal epithelium associated genes in case of recurrent vaginitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reet MÄNDAR",Estonia
2252,OS092,NULL,"Mycobacterial mayhem","Hall 14 |","13:30 - 14:30CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Seif AL-ABRI",Oman,NULL,NULL
2253,OS092,2252,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seif AL-ABRI",OmanChair
2254,OS092,2252,"Limitations of the Xpert® MTB/RIF assay: A series of four clinical cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Allison HAAS","United States"
2255,OS092,2252,"Pharmacokinetic analysis of blood and cerebrospinal fluid contezolid concentrations in a patient with tuberculous meningoencephalitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wenjuan NIE",China
2256,OS092,2252,"Is this the first case of Mycobacterium stephanolepidis infection in humans?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra PÉREZ-RECIO",Spain
2257,OS092,2252,"Diagnostic Aspects of a Bacillus Calmette-Guërin Infection Following Intravesical Treatment for Bladder Cancer",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Keun Ju KIM","Republic Of"
2258,OS092,2252,"Mycobacterium abscessus: Is Shorter Antibiotic Therapy Combined with Surgery Sufficient?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria João LOPES",Portugal
2259,OS095,NULL,"Community respiratory tract infections: latest trends and approaches","Hall 2 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","02. Bacterial infection & disease","Catia CILLONIZ",Spain,NULL,NULL
2260,OS095,2259,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Catia CILLONIZ",SpainChair
2261,OS095,2259,"Mycoplasma pneumoniae increase in 2023/24 causes disease in adults in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bianca Margaretha Maria STRENG",Netherlands
2262,OS095,2259,"Serotype distribution of pneumococcal community-acquired pneumonia in hospitalized adults in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dian KARSSEN",Netherlands
2263,OS095,2259,"Community-acquired pneumonia identification from electronic health records in the absence of a gold standard: a Bayesian latent class analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jia WEI","United Kingdom"
2264,OS095,2259,"Causes of death and risk factors for 90-day mortality and readmission in community-acquired pneumonia.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fatimah AL-ZERGANI",Denmark
2265,OS095,2259,"Oropharyngeal carriage of gut-derived Enterobacterales increases RTI risk in long-term aged care residents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie MILLER",Australia
2266,OS096,NULL,"Trends in antifungal resistance","Hall 5 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","06. Fungal infection & disease","Alexandre ALANIO",France,NULL,NULL
2267,OS096,2266,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandre ALANIO",FranceChair
2268,OS096,2266,"Turning resistance into vulnerability: leveraging genetic insights to predict collateral sensitivity and synergism for effective multidrug therapies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kara SCHMIDLIN","United States"
2269,OS096,2266,"Role of the C2585G substitution in the MRR1 gene in the development of azole resistance in Candida parapsilosis sensu strictu.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iacopo FRANCONI",Italy
2270,OS096,2266,"Fungaemia in a tertiary Madrid hospital from 2007 to 2024: changes in species epidemiology, increase in echinocandin resistance and low patient-to-patient transmission in recent years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesus GUINEA",Spain
2271,OS096,2266,"A multicentre study for determination of epidemiological cutoff values for rezafungin and four comparators against Candida auris with EUCAST broth microdilution reference methodology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph MELETIADIS",Greece
2272,OS096,2266,"Decoding Candida auris Resistance in Latin America: Candida.app vs. Pathogenwatch",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaime David ACOSTA ESPAÑA",Ecuador
2273,OS097,NULL,"Update on zoonotic and enteric infections","Hall 14 |","14:45 - 15:45CETCME1-hour Oral Session",,CET,"1-hour Oral Session","02. Bacterial infection & disease","Steen ETHELBERG",,NULL,NULL
2274,OS097,2273,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steen ETHELBERG",
2275,OS097,2273,"A large-scale epidemiological study of Campylobacter employing whole genome analysis reveals the evolution of highly virulent and multidrug-resistant clones in the UK.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bruno LOPES","United Kingdom"
2276,OS097,2273,"Population dynamics and evolution of multidrug resistant clones of Shigella sonnei in Metropolitan France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina SILVA NODARI",France
2277,OS097,2273,"Shiga toxin-producing Escherichia coli O26 as an increasingly common cause of haemolytic uraemic syndrome in England: A fifteen-year analysis of national enhanced surveillance data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luke MCGEOCH","United Kingdom"
2278,OS097,2273,"Incidence, clinical presentation, and outcomes of Pasteurella infections: a population-based Danish study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura ØBO LARSEN",Denmark
2279,OS097,2273,"Natural history of latent brucellosis and efficacy evaluation of B-spot in active and latent cases: A 12-month prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hongyu WANG",China
2280,OS098,NULL,"Opportunistic infections in the Immunocompromised","Hall 15 |","14:45 - 15:45CETCME1-hour Case Session",,CET,"1-hour Case Session","13. Case reports and case series (n less than 10)","Aleksandra BARAC",Serbia,NULL,NULL
2281,OS098,2280,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aleksandra BARAC",SerbiaChair
2282,OS098,2280,"Dog scratch disease? A case of Vibrio vulnificus in a liver transplant patient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily KIM","United States"
2283,OS098,2280,"Mpox infection among solid organ transplant recipients: a single center experience at a U.S. Tertiary Care Facility.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia BINI VIOTTI","United States"
2284,OS098,2280,"Histoplasmosis in Hansen's Disease: Thalidomide for TNF-alpha Inhibition in ENL with a Risk of Opportunistic Infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karthick Kumar VAITHEESWARAN",India
2285,OS098,2280,"Nocardiosis in a kidney transplant recipient: pros & cons of tedizolid",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariachiara PELLEGRINO",Italy
2286,OS098,2280,"Mycobacterium genavense-Associated IRIS with Macrophage Activation Syndrome: A Case Report Highlighting Diagnostic Challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco MEROI",Italy
2287,OS102,NULL,"AI tools empowering AMR prediction in WGS and MALDI-TOF","Hall 2 |","16:15 - 17:15CETCME1-hour Oral Session",,CET,"1-hour Oral Session","03. Bacterial susceptibility & resistance","Oliver NOLTE",Switzerland,NULL,NULL
2288,OS102,2287,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver NOLTE",SwitzerlandChair
2289,OS102,2287,"A scalable machine learning approach to predict antimicrobial susceptibility from whole genome sequencing data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yinzheng ZHONG","United Kingdom"
2290,OS102,2287,"Machine Learning-Based Antimicrobial Resistance Prediction of 11 antibiotics for Klebsiella pneumoniae from Clinical NGS Data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jia XINMIAO",China
2291,OS102,2287,"AI-Powered Real-Time Plasmid Prediction Using Nanopore Sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ela Djamila SAUERBORN",Germany
2292,OS102,2287,"MALDI-TOF Prediction model based on machine learning algorithm for the detection of ST23 high-virulence K. pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent DORTET",France
2293,OS102,2287,"Predicting rifampicin resistance in Mycobacterium tuberculosis complex with a machine learning based MALDI-TOF MS approche",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun-Wen SUN",China
2294,OS103,NULL,"Polymicrobial interactions and competition","Hall 5 |","16:15 - 17:15CETCME1-hour Oral Session",,CET,"1-hour Oral Session","09. Fundamental microbiology, pathogenesis & immunity to infection","Alessandra BRAGONZI",Italy,NULL,NULL
2295,OS103,2294,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra BRAGONZI",ItalyChair
2296,OS103,2294,"The Klebsiella pneumoniae type VI secretion system effector Tle4 facilitates adaptation survival by damaging the cell membrane of competing bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wanzhen LI",China
2297,OS103,2294,"Candida albicans promotes TSST-1 production in Staphylococcus aureus by depleting glucose and lifting carbon catabolite repression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathias CARRIOU",France
2298,OS103,2294,"Understanding polymicrobial biofilm dynamics: focus on Pseudomonas aeruginosa and its molecular interactions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shubhangi KANSAL",India
2299,OS103,2294,"Intra- and interspecific antagonism inhibits growth of Staphyloccous aureus in human nasal microbial communities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura BRÜLISAUER",Switzerland
2300,OS103,2294,"Combination therapy against drug resistance biomimetic dual-species biofilm model of Pseudomonas aeruginosa and Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paria MOJARRAD",Finland
2301,OS107,NULL,"Novel vaccines in clinical development","Hall 3 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","11. Public health & vaccines","Mateusz HASSO-AGOPSOWICZ",Switzerland,NULL,NULL
2302,OS107,2301,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mateusz HASSO-AGOPSOWICZ",SwitzerlandChair
2303,OS107,2301,"Safety and immunogenicity of a seasonal booster dose of the 6-valent, OspA-based Lyme borreliosis vaccine candidate VLA15 in a healthy population aged 5-65 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Messier MESSIER",France
2304,OS107,2301,"Safety and immunogenicity of mRNA mpox vaccine candidate mRNA-1769: Interim analysis results from a Phase 1/2 Trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiwot HIRUY","United States"
2305,OS107,2301,"Development of a Rapid-Acting Oral Cholera Vaccine: Phase I Clinical Trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alisse HANNAFORD","United States"
2306,OS107,2301,"Safety and immunogenicity of a Group B Streptococcus vaccine in participants aged 55-75 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lidia OOSTVOGELS",Denmark
2307,OS107,2301,"Aggregated summary of immunogenicity and safety for the chikungunya virus virus-like particle (VLP) vaccine development programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lauren TINDALE",Canada
2308,OS108,NULL,"Novel approaches to preventing device-related infections","Hall 5 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","08. Healthcare-associated infections, infection prevention & control","Natividad BENITO",Spain,NULL,NULL
2309,OS108,2308,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natividad BENITO",SpainChair
2310,OS108,2308,"Clinical and microbiological impact of antibiotic-impregnated catheters in ventriculoperitoneal shunt infections in adults.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuela SANZ DE MENA",Spain
2311,OS108,2308,"Reducing drainage-associated meningitis by using an antiseptic dressing: A randomized controlled trial AntiRedMen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone SCHEITHAUER",Germany
2312,OS108,2308,"Efficacy of antimicrobial envelopes in preventing cardiac implantable electronic device infections – systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akanksha MAHAJAN",Australia
2313,OS108,2308,"A bundled approach to reducing central line associated blood stream infections (CLABSI) in hemodialysis (HD) patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jayvee GUERRERO",Canada
2314,OS108,2308,"Increased long-term mortality in patients with prosthetic joint infection after primary total hip arthroplasty – a cohort study with 89'709 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadine IMHASLY",Switzerland
2315,OS109,NULL,"Training CM/ID - a global view","Hall 16 |","17:30 - 18:30CETCME1-hour Oral Session",,CET,"1-hour Oral Session","12. Professional and educational affairs","Mihai MARES",Romania,NULL,NULL
2316,OS109,2315,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mihai MARES",RomaniaChair
2317,OS109,2315,"Specialist training in infectious diseases in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon SALMANTON-GARCIA",Germany
2318,OS109,2315,"Infectious Diseases Residency Training over the World",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pelin IRKÖREN",Türkiye
2319,OS109,2315,"Five years of experience with the virtual International Postgraduate Diploma in Infection Prevention and Control from the Infection Control Africa Network.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alma TOSTMANN",Netherlands
2320,OS109,2315,"Combatting challenges in laboratory capacity through an innovative, longitudinal Gram stain training programme for blood culture specimens in Zimbabwe.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tinashe Cynthia MWATURURA",Zimbabwe
2321,OS109,2315,"Benefit of the implementation of Entrustable Professional Activities (EPA) as an assessment tool in the Laboratory of clinical bacteriology: a study focused on the improvement of residents' skills and feelings.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hélène PAILHORIÈS",France
2322,PC1,NULL,Diagnostics,"Arena 4 |","11:00 - 12:00CETPipeline Corner",,CET,"Pipeline Corner","04. Diagnostic microbiology","Till T. BACHMAN","United Kingdom",NULL,NULL
2323,PC1,2322,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Till T. BACHMAN","United KingdomChair"
2324,PC1,2322,"Presymptom Health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iain MILLER","United Kingdom"
2325,PC1,2322,Readily,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liza LÖF",Sweden
2326,PC1,2322,SoundCell,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aleksandre JAPARIDZE",Netherlands
2327,PC2,NULL,Bioinformatics,"Arena 4 |","13:30 - 14:30CETPipeline Corner",,CET,"Pipeline Corner","04. Diagnostic microbiology","Tim-Christoph ROLOFF",Switzerland,NULL,NULL
2328,PC2,2327,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tim-Christoph ROLOFF",SwitzerlandChair
2329,PC2,2327,BugSeq,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elizabeth OGUNDARE",Canada
2330,PC2,2327,"Solu Healthcare",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Timo SARATTO",Finland
2331,PC2,2327,"Clover Bioanalytical Software",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis MANCERA PASCUAL",Spain
2332,PC2,2327,SmartGene,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan EMLER",Switzerland
2333,PC2,2327,Abrinca,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas RODER",Switzerland
2334,PC3,NULL,Vaccines,"Arena 4 |","14:45 - 15:45CETPipeline Corner",,CET,"Pipeline Corner","11. Public health & vaccines","Charlotte VERNHES",Belgium,NULL,NULL
2335,PC3,2334,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte VERNHES",BelgiumChair
2336,PC3,2334,Immunethep,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pedro MADUREIRA",Portugal
2337,PC3,2334,Vaxdyn,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"José INFANTE",Spain
2338,PC3,2334,Baxerna,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lyudmila KOVALCHUKE",Belgium
2339,PC3,2334,"LimmaTech Biologics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanna BOBROVSKY",Switzerland
2340,PC4,NULL,Therapeutics,"Arena 4 |","16:15 - 17:15CETPipeline Corner",,CET,"Pipeline Corner","05. New antibacterial agents, PK/PD & Stewardship","Ursula THEURETZBACHER",Austria,NULL,NULL
2341,PC4,2340,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ursula THEURETZBACHER",AustriaChair
2342,PC4,2340,"Fundación MEDINA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olga GENILLOUD",Spain
2343,PC4,2340,Antabio,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc LEMONNIER",France
2344,PC4,2340,"Infex Therapeutics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter JACKSON","United Kingdom"
2345,PC4,2340,MetalloBio,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jim A. THOMAS","United Kingdom"
2346,PC4,2340,"Kinvard Bio",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lloyd PAYNE","United States"
2347,PC4,2340,"Deutsches Zentrum für Infektionsforschung",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silke ALT",Germany
2348,PM1,NULL,"Progress and challenges in drug discovery and development","Hall 12 |","08:30 - 10:30CETPipeline Symposium",,CET,"Pipeline Symposium","05. New antibacterial agents, PK/PD & Stewardship","Douglas HUSEBY",Sweden,NULL,NULL
2349,PM1,2348,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Douglas HUSEBY",SwedenChair
2350,PM1,2348,"Antibacterial therapies in clinical development",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valeria GIGANTE",Switzerland
2351,PM1,2348,"Challenges of finding new anti-infectives against bacterial pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin EMPTING",Germany
2352,PM1,2348,"Antifungal drugs in clinical development",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver A. CORNELY",Germany
2353,PM1,2348,"The pros and cons of pathogen-specific or individualised treatment in acute bacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul A. TAMBYAH",Singapore
2354,PM2,NULL,"AMR and vaccines","Hall 12 |","11:00 - 12:00CETPanel Discussion",,CET,"Panel Discussion","11. Public health & vaccines","Charlotte VERNHES",Belgium,NULL,NULL
2355,PM2,2354,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte VERNHES",BelgiumChair
2356,PM2,2354,"Overview of the current evidence of the impact of vaccines on AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam CUNNINGHAM","United Kingdom"
2357,PM2,2354,"Panel discussion: gaps, needs, and opportunities to leverage vaccines against AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam CUNNINGHAM","United Kingdom"
2358,PM3,NULL,"Future prospects of electronic clinical decision support systems in stewardship programs","Hall 12 |","13:30 - 14:30CETMeet-the-Innovators",,CET,Meet-the-Innovators,"05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
2359,PM3,2358,"Opportunities for clinical decision support systems in infectious disease management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathan PEIFFER-SMADJA",France
2360,PM3,2358,"CDSS and AMS programs: the Lumed example",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valiquette LOUIS",Canada
2361,PM4,NULL,"Do we need new antibiotics?","Hall 12 |","14:45 - 15:45CETPipeline Symposium",,CET,"Pipeline Symposium","05. New antibacterial agents, PK/PD & Stewardship","Ursula THEURETZBACHER",Austria,NULL,NULL
2362,PM4,2361,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ursula THEURETZBACHER",AustriaChair
2363,PM4,2361,"Yes: antibacterial resistance threatens medical outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evelina TACCONELLI",Italy
2364,PM4,2361,"No: the bang for buck lies elsewhere'",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc MENDELSON","South Africa"
2365,PM5,NULL,"Innovation in direct from blood detection of BSIs","Hall 12 |","16:15 - 18:15CETPipeline Symposium",,CET,"Pipeline Symposium","04. Diagnostic microbiology","Till T. BACHMAN","United Kingdom",NULL,NULL
2366,PM5,2365,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Till T. BACHMAN","United KingdomChair"
2367,PM5,2365,"Ultra-rapid pathogen ID and AST directly from whole blood",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tae Hyun KIM","Republic Of"
2368,PM5,2365,"Swedish Foundation for Strategic Research Project Ultrafast bacterial species identification and antibiotic susceptibility testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johan ELF",Sweden
2369,PM5,2365,"Direct from blood pathogen and antibiotic-resistant marker identification in about one hour",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kimberle CHAPIN",Spain
2370,PM5,2365,"Critical review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna Maria PERI",Australia
2371,PM6,NULL,"Fungal Infections","Arena 4 |","09:30 - 10:30CETInnovation Forum",,CET,"Innovation Forum","06. Fungal infection & disease","Alexandra CAMERON",France,NULL,NULL
2372,PM6,2371,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra CAMERON",FranceChair
2373,PM6,2371,"Introduction on WHOs: reference to the landscape & pipeline analysis of fungal diagnostics therapeutics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra CAMERON",France
2374,PM6,2371,"Panel Discussion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc  ENGELHARDT",Switzerland
2375,PM7,NULL,"Health technology assessment of innovations in infectious diseases: hurdles and facilitators","Arena 4 |","17:30 - 18:30CETInnovation Forum",,CET,"Innovation Forum","11. Public health & vaccines","Claudia WILD",Austria,NULL,NULL
2376,PM7,2375,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia WILD",AustriaChair
2377,PM7,2375,"Using health economics to decide which interventions to prioritise to reduce the burden of AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Koen POUWELS","United Kingdom"
2378,PM7,2375,"Innovative approaches and techniques in Vaccination strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelis BOERSMA",Netherlands
2379,PM7,2375,"Using anti-microbial testing to reduce (unnecessary) antibiotic prescriptions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maarten POSTMA",Netherlands
2380,PS001,NULL,"01a. HIV/AIDS (incl diagnostics & epidemiology, anti-retroviral drugs, vaccines, treatment & susceptibility/resistance)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2381,PS001,2380,"Measles seroprevalence in  people living with human immunodeficiency virus in  northern Transylvania, Romania",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adriana Violeta TOPAN",Romania
2382,PS001,2380,"Evaluation of HIV Ag/Ab combo, HBsAg and anti-HCV serological assays on a new-to-market, high throughput analyser for emergency department opt-out testing in a high prevalence population as part of the United Kingdom screening programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana Sofia GIL VIEIRA DA SILVA","United Kingdom"
2383,PS001,2380,"Enhanced clearance of broadly neutralising HIV-1 Antibody VRC07-523-LS under Viremia: influences on trial design and analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brian HO","United States"
2384,PS001,2380,"Clinical impact of integrase inhibitor resistance: a growing challenge for the future?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge CISCAR SORIANO",Spain
2385,PS001,2380,"Evaluation of the new DxI 9000 anti-HIV antibody and antigen combo assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin OBERMEIER",Germany
2386,PS001,2380,"Cytomegalovirus IgG concentration is associated with reduced lung function in well-treated persons with HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeppe Terpager CHRISTIANSEN",Denmark
2387,PS001,2380,"Mental health in PLWH: psychopathological variables and personality traits in patients compared with non-clinical subjects in Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco ROMANO",Italy
2388,PS001,2380,"Significant mortality reduction of severe Pneumocystis jirovecii pneumonia in people living with HIV treated in the intensive care unit, Croatia, 2002-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filip GLAVAC",Croatia
2389,PS001,2380,"Analysis of resistance profiles in relation to subtypes and immune markers in newly diagnosed HIV patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Öznur GÜNES",Türkiye
2390,PS001,2380,"Analysis of the effect of high-sensitive CRP on bone density in people living with HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philipp MATHÉ",Germany
2391,PS001,2380,"Understanding the evolution of HIV-1 in Ghana: subtype distribution and drug resistance challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pious APPIAH",Ghana
2392,PS001,2380,"Safety and efficacy of long-acting HIV treatment in real life at a tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francisco ARNAIZ DE LAS REVILLAS ALMAJANO",Spain
2393,PS001,2380,"Evaluating HIV-1 protease drug binding affinity: structural prediction with AlphaFold2 and AutoDock Vina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francisco MERCA",Belgium
2394,PS001,2380,"Toll-like receptors (TLRs) polymorphism in HIV-I infected patients with and without tuberculosis (TB) co-infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gaurav KAUSHIK",India
2395,PS001,2380,"Generic HIV-1 Viral Load Ver 2.0: a dual target quantitative assay for HIV-1",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vera ALLERHEILIGEN",Germany
2396,PS001,2380,"Clinical characteristics and treatment outcomes in critically ill people living with HIV: a single-centre study from an infectious disease intensive care unit, 2002-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filip GLAVAC",Croatia
2397,PS001,2380,"Acceptability and feasibility interventions measures (AIM & FIM) of the implementation of long-acting cabotegravir plus rilpivirine (CAB LA + RPV LA) administration out of HIV units: the IMADART study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso CABELLO",Spain
2398,PS001,2380,"Gender defines factors related to linkage to HIV care and early antiretroviral therapy—The Go Holistic Go Beyond project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dominik BURSA",Poland
2399,PS001,2380,"Identification of APOBEC mutations and their impact on HIV drug resistance using next-generation sequencing (NGS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paloma MUÑOZ",Spain
2400,PS001,2380,"Longitudinal study of type I interferon neutralising antibodies in people living with HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra D'AURIA",Italy
2401,PS001,2380,"Influence of immune exhaustion receptors PD-1 and PD-1L on immune reconstitution in ART-treated patients living with HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milosz PARCZEWSKI",Poland
2402,PS001,2380,"NAFLD and hepatitis B status as predictors of liver fibrosis in PLWH who switch to LA-ART",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Ignacio MATEO GONZALEZ",Spain
2403,PS001,2380,"Development of engineered nanocarrier for controlled delivery of a protease inhibitor",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Prakash GOSAIN",India
2404,PS001,2380,"Three decades of HIV/AIDS in Iran: epidemiological trends, socioeconomic impacts, and risk factors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seyed Aria NEJADGHADERI","Islamic Republic Of"
2405,PS001,2380,"Incidence density and risk factors of hepatitis B and/or hepatitis C co-infection among newly enrolled HIV patients in a tertiary government hospital treatment hub",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Honey Jane BLANCO-LIMOS",Philippines
2406,PS001,2380,"CMV disease predictors and CMV viremia impact on immune reconstitution in advanced HIV infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula SUANZES",Spain
2407,PS001,2380,"A nationwide survey on self-perception of HIV acquisition risk among people in prisons in Iran",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seyed Aria NEJADGHADERI","Islamic Republic Of"
2408,PS001,2380,"Treatment and follow-up of HIV-infected patients diagnosed during the COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Masa JOVANOVIC",Serbia
2409,PS001,2380,"NGF levels differ by CD4+ T cell count and change after treatment in PLWH",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca MADDALONI",Italy
2410,PS001,2380,"Whole-genome sequencing: new strategies for managing HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta ILLESCAS-LÓPEZ",Spain
2411,PS001,2380,"Resistance to integrase inhibitors in HIV patients with therapeutic failure: striving for "zero resistance"",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia PEREZ RODRIGUEZ",Spain
2412,PS001,2380,"Genetic diversity in the capsid protein-coding region of HIV-1 circulating in Angola: implications for primary resistance to the novel capsid inhibitor lenacapavir",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gonçalo QUEIRÓS",Portugal
2413,PS001,2380,"Assessing the prevalence of latent tuberculosis infection among people living with HIV with viral suppression and CD4+ T cell counts = 200 cells/μl in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shodok PROMSANJAN",Thailand
2414,PS001,2380,"Phenotypic modulation of RBD-specific B cells in people living with HIV upon booster vaccinations with SARS-CoV-2 mRNA vaccines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacopo POLVERE",Italy
2415,PS001,2380,"Medication optimisation in older people living with HIV: a multidisciplinary approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fatma Nisa BALLI TURHAN",Türkiye
2416,PS001,2380,"Long-acting CAB + RPV: safety, efficacy, and discontinuation risks in ODOACRE cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea DE VITO",Italy
2417,PS001,2380,"Statins under-prescription in people with HIV in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sireethorn NIMITVILAI",Thailand
2418,PS002,NULL,"01b. Viral hepatitis (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2419,PS002,2418,"Development and characterisation of surface modified chitosan nanoparticles for selective targeting of lamivudine to hepatocyte",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saurabh BHARGAVA",India
2420,PS002,2418,"Evaluation of the new DxI 9000 ACCESS anti-HCV assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin OBERMEIER",Germany
2421,PS002,2418,"Hepatitis E virus in northern Italy: focus on wild fauna for a One Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara ARNABOLDI",Italy
2422,PS002,2418,"Performance evaluation of chemiluminescence anti-HCV assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura GRUMIRO",Italy
2423,PS002,2418,"Novel S/Co ratios for predicting HCV RNA positivity in cancer patients: a study from a tertiary care cancer centre in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shreya PANI",India
2424,PS002,2418,"Missed opportunities for diagnosing HCV infection in patients identified by an emergency department screening strategy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anny CAMELO",Spain
2425,PS002,2418,"Characterising HBV reactivation in non-liver solid organ transplant recipients: clinical insights from a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU",Türkiye
2426,PS002,2418,"Screening for Y93H resistance associated substitution in chronic HCV patients presenting to a tertiary care hospital of north India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mini P SINGH",India
2427,PS002,2418,"Refining diagnostics: a novel chemiluminescence assay for improved sensitivity and precision in HEV detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ingrid ALBRECHT-WALZ",Germany
2428,PS002,2418,"Evaluation of the new DxI 9000 ACCESS HBsAg assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin OBERMEIER",Germany
2429,PS002,2418,"Enhancing HDV detection: prevalence and diagnostic advances in northern Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helena GARCIA LOPEZ",Spain
2430,PS002,2418,"Acute HCV infection diagnosed by hepatitis C virus core antigen among people with HIV: an exploratory systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tsung-Yu TSAI",China
2431,PS002,2418,"Influence of education level on the choice of hepatitis C virus self-testing: findings from Unitaid-funded STAR project in Nasarawa state, Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwabukolami LANLOYE",Nigeria
2432,PS002,2418,"Bone metabolism and management of bone diseases in patients with chronic hepatitis B",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gamze SANLIDAG ISBILEN",Türkiye
2433,PS002,2418,"Outcomes of mitigating hepatitis B mother-to-child transmission through early detection and prophylaxis; a prospective study at a tertiary care centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sumit Kumar RAWAT",India
2434,PS002,2418,"Prevalence and risk factors of active hepatitis C infection in migrants between 2019-2023 in Madrid, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Felipe PÉREZ-GARCÍA",Spain
2435,PS002,2418,"Molecular surveillance of hepatitis A virus in Portugal, 2015 to 2024: high-impact value for outbreak case detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mafalda BRITES DE ARAÚJO LUCAS",Portugal
2436,PS002,2418,"Sex and age differences in the hepatitis C virus continuum of care among people living with HIV and key populations in Nasarawa state, Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harrison NWABUEZE",Nigeria
2437,PS002,2418,"Hepatitis C screening and treatment in the largest mariginalised Roma community with risky behavior",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristian PAVOL",Slovakia
2438,PS002,2418,"Surveillance of ratHEV in extensively raised pigs in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier CABALLERO GÓMEZ",Spain
2439,PS002,2418,"Genotypic variations of hepatitis delta virus among chronic hepatitis patients in Uzbekistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eldor URINOV",Uzbekistan
2440,PS002,2418,"Optimising molecular diagnosis of hepatitis delta",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta ILLESCAS-LÓPEZ",Spain
2441,PS002,2418,"Hepatitis delta virus prevalence in the European Union estimated with novel methodology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hugh WATSON",France
2442,PS002,2418,"Epidemiology and testing of hepatitis delta virus infection in Australia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Krispin HAJKOWICZ",Australia
2443,PS002,2418,"Diagnostic value of consecutive samples for anti-HEV IgG analyses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie Louise SLOTT JENSEN",Denmark
2444,PS002,2418,"Whole genome sequencing of hepatitis C virus from dried blood spots by hybrid capture for genotype and antiviral resistance determination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma Ann DAVIES","United Kingdom"
2445,PS002,2418,"Validation of a new molecular assay for the quantification of hepatitis D RNA in EDTA-plasma and serum samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Felipe PÉREZ-GARCÍA",Spain
2446,PS002,2418,"Treat and Follow-Up: Recontamination by Hepatitis C Virus After Effective Treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samia BENADDA",Algeria
2447,PS002,2418,"Comparative analysis of HBsAg and anti-HCV testing: dried blood spots vs whole blood",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bouchra BELEFQUIH",Morocco
2448,PS002,2418,"Relink-C study in Almería, Spain: opportunistic rescue of patients with HCV infection lost to follow-up in the healthcare system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anny CAMELO",Spain
2449,PS002,2418,"Finite NA therapy in chronic hepatits B: a retrospective study on safety and prevalence of HBsAg-HBsAb seroconversion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erika ASPERGES",Italy
2450,PS002,2418,"HDV full genome sequencing and genotype determination in a Berlin cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert EHRET",Germany
2451,PS002,2418,"Neurological injury associated with rat hepatitis E virus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia RIOS-MUÑOZ",Spain
2452,PS002,2418,"Febrile syndrome without a focus linked to rat hepatitis E infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia RIOS-MUÑOZ",Spain
2453,PS002,2418,"Y.E.L.L.O.W. score (yellow fever end-stage liver and organ worsening score)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wanessa CLEMENTE",Brazil
2454,PS002,2418,"Redetermination Anti-HCV Levels (S/Co) Based on Correlation with HCV-RNA for Diagnosing Hepatitis C Virus (HCV) Infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammet KIPLAPINAR",Türkiye
2455,PS002,2418,"Epidemiology of the hepatitis delta virus in Spain through whole genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana ALBEROLA ROMANO",Spain
2456,PS002,2418,""ProLink" HCV study: optimising the HCV elimination cascade to re-engage the unreached",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto VAZQUEZ BLANQUIÑO",Spain
2457,PS002,2418,"Characterisation of a cohort of liver transplant patients for HBV and/or HBV/HDV related complications: results of a Campania multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorenzo SALMONI",Italy
2458,PS002,2418,"Opportunistic diagnosis of hepatitis C virus infection by hypertransaminasemia: a one-year, single-centre, prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Felipe PÉREZ-GARCÍA",Spain
2459,PS003,NULL,"01c. Influenza and respiratory viruses (incl diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility/resistance)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2460,PS003,2459,"Burden of RSV hospitalisations among high-risk vs low-risk children in the second year of life: insights from a multicentre retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diana TASHER",Israel
2461,PS003,2459,"The cost-effectiveness of influenza vaccination for adults aged 50 years or older in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberto FLORES",Spain
2462,PS003,2459,"The pandemic respiratory virus epidemiological surveillance trial (PREVENT)-metagenomics study: total RNASeq enhances community-based respiratory virus surveillance in the Australian flutracking network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Krispin HAJKOWICZ",Australia
2463,PS003,2459,"Characterisation of respiratory pathogen coinfection in the bivalent RSVpreF pivotal RENOIR efficacy study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John WOODSIDE","United Kingdom"
2464,PS003,2459,"A comparative study of methods for estimating the timing of RSV epidemics: an analysis within the GERi (Global epidemiology of RSV in hospitalised and community care) study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saverio CAINI",Netherlands
2465,PS003,2459,"A deep learning model leveraging environmental information improves the forecasting accuracy of respiratory syncytial virus with seasonal patterns",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jingyi LIANG","United Kingdom"
2466,PS003,2459,"Efficacy of syndromic IVD devices in identifying influenza A strains for pandemic preparedness",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sven REISTER",Germany
2467,PS003,2459,"Wastewater-based epidemiology of respiratory viruses: integration to conventional surveillance systems in Belgium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronik HUTSE",Belgium
2468,PS003,2459,"Adaptation of commercial syndromic device for quantification of viral influenza A load in clinical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sven REISTER",Germany
2469,PS003,2459,"Monitoring the transmission and health care burden of respiratory viruses in emergency departments, Lombardy (northern Italy), 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena PARIANI",Italy
2470,PS003,2459,"Development of a predictive severity scale for respiratory syncytial virus associated acute respiratory infection in adults at the emergency department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuel GIL MOSQUERA",Spain
2471,PS003,2459,"Comparative analysis of galectin-3-mediated inflammasome activation in human and avian influenza A virus infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zih-Syuan YANG",China
2472,PS003,2459,"A low pathogenic avian influenza A/Mallard/South Korea/KNU2019-34/2019 (H1N1) virus has the potential to increase the mammalian pathogenicity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Haryoug POO","Republic Of"
2473,PS003,2459,"Severe acute respiratory infection (SARI) due to RSV in Wales: burden, symptoms and clinical risks in sentinel emergency departments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jana ZITHA","United Kingdom"
2474,PS003,2459,"Patients at risk of developing severe influenza-associated illness can be recognised at the emergency department using basic clinical assessment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanna BERGBRANT",Sweden
2475,PS003,2459,"Six-month persistence and safety of mRNA-based influenza or multicomponent influenza/COVID-19 vaccines versus licensed comparators in adults aged ≥18 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mieke SOENS","United States"
2476,PS003,2459,"Effects of high-dose vs standard-dose quadrivalent influenza vaccine among patients with chronic lung disease: a prespecified secondary analysis of the DANFLU-1 trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa Steen DUUS",Denmark
2477,PS003,2459,"Analysis of myxovirus resistance protein A for diagnosis of respiratory viral infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sunjoo KIM","Republic Of"
2478,PS003,2459,"Diagnostic efficacy of different tests for influenza and their impact on clinical decision-making",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yu LUO",China
2479,PS003,2459,"Molecular characterisation of RSV infections in elderly patients during the 2023/2024 season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amandine CAILLAULT",France
2480,PS003,2459,"Demographic, clinical and molecular epidemiology of respiratory syncytial virus infection in infants in central Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Boutheina EL KISSI",Tunisia
2481,PS003,2459,"Association between seasonal respiratory virus activity and invasive pneumococcal disease in central Ontario, Canada",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
2482,PS003,2459,"Respiratory syncytial virus (RSV) incidence estimates in primary care among adults aged 50 years and older in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joost VANHOMMERIG",Netherlands
2483,PS003,2459,"Characterization of adenovirus at the species level and association with the severity of acute respiratory infection in a Chilean paediatric population, 2022-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gustavo SAINT-PIERRE CONTRERAS",Chile
2484,PS003,2459,"Hospitalisation due to influenza infection in children: a multicentre nationwide study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kübra AYKAC",Türkiye
2485,PS003,2459,"The BEready pilot study: a population-based cohort to assess transmission of respiratory viral infections within households",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karin GRIMM",Switzerland
2486,PS003,2459,"Change in the epidemiology of influenza infection among cancer patients in the post-COVID era: insights from India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soumyadip CHATTERJI",India
2487,PS003,2459,"Respiratory viruses in patients with haematological malignancy in Boreal autumn/winter 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon SALMANTON-GARCIA",Germany
2488,PS003,2459,"Epidemiology of respiratory syncytial virus among childrens and adults in a third-level care hospital in Mexico City",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia MARTINEZ-HERNANDEZ",Mexico
2489,PS003,2459,"Evidence of oseltamivir-resistant influenza A virus transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anastasia COUZENS","United Kingdom"
2490,PS003,2459,"Respiratory syncytial virus burden of disease and molecular epidemiology in adults 50 years of age and older in Queensland, Australia: interim results from the 2024 season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Krispin HAJKOWICZ",Australia
2491,PS003,2459,"Burden and outcomes of RSV in adults aged 60 and older: a tertiary care analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oguzhan ACET",Türkiye
2492,PS003,2459,"Surveillance for respiratory viruses through DHR-ICMR VRDL network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lakshmi Jyothi TADI",India
2493,PS003,2459,"Public health impact of a single dose of the adjuvanted RSVPreF3 vaccine for the prevention of respiratory syncytial virus among patients with chronic obstructive pulmonary disease in Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea BRAMBILLA",Italy
2494,PS003,2459,"Facing the future of influenza surveillance: integrated surveillance for respiratory viruses in Serbia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dragana DIMITRIJEVIC",Serbia
2495,PS003,2459,"Impact of rapid viral screening on influenza management: less haste, more waste",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael BURROWS","United Kingdom"
2496,PS003,2459,"Genomic epidemiology of respiratory syncytial virus circulating in Lombardy in 2023-2024 and variability in binding sites of monoclonal antibodies and small-molecule inhibitors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia ALTERI",Italy
2497,PS003,2459,"Duration of recommended and reported isolation for seasonal influenza: updates from the 2023-24 influenza season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennie KWON","United States"
2498,PS003,2459,"An unconjugated composite peptide vaccine comprising epitopes from SARS-CoV-2 RNA polymerase and influenza heamagglutinin, neuraminidase, and matrix generates broadly reactive and durable antibodies to coronavirus and influenza virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nimisha RIKHI","United States"
2499,PS003,2459,"The mitochondrial carrier homolog 2 is involved in down-regulation of influenza A virus replication",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pinar ULUPINAR",Türkiye
2500,PS003,2459,"Impact of respiratory syncytial virus hospitalisation on quality of life in the Valencia region of Spain ageing population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandro ORRICO-SÁNCHEZ",Spain
2501,PS003,2459,"Phyloepidemiology of influenza A/H3N2 and A/H1N1 viruses circulating in Georgia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nino SAGIRIDZE",Georgia
2502,PS003,2459,"Comprehensive clinical validation of a novel real-time PCR assay for the detection of respiratory viruses in simulated human-like clinical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
2503,PS003,2459,"Burden of disease (BoD), healthcare resource use (HCRU) and costs of respiratory syncytial virus (RSV) among adults in the Netherlands in 2021-2023: a real-world retrospective observational study of five hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karin VELTHOVE",Belgium
2504,PS003,2459,"How has the disappearance of influenza B/Yamagata altered the proportion of Influenza A and B cases? Exploring post-COVID pandemic surveillance data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco DEL RICCIO",Italy
2505,PS003,2459,"A bench-to-data analysis workflow for the sequencing of RSV whole genomes using short- and long-read technologies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CIUFFREDA",Spain
2506,PS003,2459,"Operational framework and feasibility of the GALFLU study: a pragmatic randomised controlled trial evaluating high-dose vs standard-dose influenza vaccination in the elderly population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico MARTINÓN-TORRES",Spain
2507,PS003,2459,"Human metapneumovirus in Italian adults over 50 years: epidemiology and molecular evolution, 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandro MANCON",Italy
2508,PS003,2459,"Post-COVID-19 trends: enterovirus D68's seasonal reappearance and its public health relevance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina ANDRÉS",Spain
2509,PS003,2459,"Post-acute sequelae after non-COVID-19 community-acquired pneumonia as an underappreciated problem: findings from a prospective study in Singapore",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pei Min THONG",Singapore
2510,PS003,2459,"Between-region and serotype variations in seasonality of human parainfluenza viruses, and influence of climate factors: a global systematic analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xin WANG",China
2511,PS003,2459,"The epidemiology of severe acute respiratory tract infections in Glasgow, UK: 2023-24",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elen VINK","United Kingdom"
2512,PS003,2459,"Prevention and control of influenza: available tools in seven Latin American countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hebe Noemi VAZQUEZ","United States"
2513,PS003,2459,"Respiratory syncytial virus vs influenza virus infection: mortality and morbidity comparison over two epidemic seasons before the pandemic in adults aged =50 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin DAVIDO",
2514,PS003,2459,"Respiratory syncytial virus (RSV)-associated hospitalisations and clinical progression in adolescents and adults in Valencia, Spain, 2014/2015–2019/2020: the VALSARI study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandro ORRICO-SÁNCHEZ",Spain
2515,PS003,2459,"Shifting viral landscapes: severe disease and mortality due to respiratory infections among older adults in the VALSARI study from Valencia, Spain, 2014-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandro ORRICO-SÁNCHEZ",Spain
2516,PS003,2459,"Influenza-related mortality among hospitalised adults in a Portuguese hospital during the 2023-2024 influenza season: are the elderly more vulnerable?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fábio REIS",Portugal
2517,PS003,2459,"Outcomes of respiratory syncytial virus infections among cancer patients during the two recent respiratory viral seasons, 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amy SPALLONE","United States"
2518,PS003,2459,"Investigating Cas13d activity in RNA cleavage against influenza virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diana PEREZ-SANJOSE",Spain
2519,PS003,2459,"Sequence independent amplification and sequencing of respiratory viruses direct from clinical sample",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kate DINGLE","United Kingdom"
2520,PS003,2459,"Age-related asymptomatic rhinovirus infections contribute to the sustained prevalence of rhinovirus in adults and are not mitigated by non-pharmaceutical interventions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dong WEI",China
2521,PS003,2459,"Effectiveness of universal prophylaxis with nirsevimab for prevention of infant hospitalisations due to respiratory syncytial virus : full 2023-24 season analysis of the NIRSE-GAL study https://www.nirsegal.es/",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico MARTINÓN-TORRES",Spain
2522,PS003,2459,"Air and surface sampling to investigate bovine coronavirus shedding around calves",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susan GOULD","United Kingdom"
2523,PS003,2459,"Elucidating the novel role of cholesterol consensus motif in coronavirus infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jasper CHAN",China
2524,PS003,2459,"Clinical characteristics and outcomes in hospitalised older adults with community onset or nosocomial respiratory syncytial virus infection (RSV) in Auckland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teena MATHEW","New Zealand"
2525,PS003,2459,"Burden of chronic medical conditions that are risk factors for severe RSV among adults aged 18-59 years in the United States",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clarisse DEMONT",France
2526,PS003,2459,"Serological influenza responses over the 2023-24 winter: the SIREN study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edward CARR","United Kingdom"
2527,PS003,2459,"Respiratory syncytial virus vs parainfluenza and human metapneumovirus infections: mortality and morbidity comparison over two epidemic seasons before the pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin DAVIDO",
2528,PS003,2459,"Epidemiological shifts in paediatric respiratory infections: pre- and post-COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi-Ting CHEN",China
2529,PS003,2459,"Identifying low-frequency mutations in influenza",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fredrik DYRKELL",Sweden
2530,PS003,2459,"Bacterial co-infections and antibiotic use in adult patients hospitalised with respiratory syncytial virus compared to patients with influenza A or B, and their relation to mortality: a multicentre cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristine Lilhammer KARLSEN",Denmark
2531,PS003,2459,"Paediatric patients with respiratory syncytial virus (RSV) are at greater risk of ICU admission when co-infections are present",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SSENTONGO","United States"
2532,PS003,2459,"Overview of NA inhibitors mutations during the last 15 years in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ivan SANZ-MUÑOZ",Spain
2533,PS003,2459,"Unveiling an optimal case definition and the natural history of RSV infection in adult outpatients aged ≥50 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander DOMNICH",Italy
2534,PS003,2459,"Burden of medically-attended respiratory syncytial virus (RSV) disease in German infants: a seven-season analysis using claims data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver DAMM",Germany
2535,PS003,2459,"Prolonged fatigue post-hospitalisation: novel insights across a broad range of respiratory viral infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso MORELLI","United Kingdom"
2536,PS003,2459,"Quality of life in the toddler population (9-36 months of age) experiencing RSV infection in the 2023-2024 winter season in Italy–the EVOLUTE study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa BARBIERI",Italy
2537,PS003,2459,"Thromboembolic complications in viral respiratory tract infections: insights into the role of clinical and biochemical coagulation parameters",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merve MERT VAHABI",Türkiye
2538,PS003,2459,"Cardiac impairment during influenza flu heart: a prospective cohort study of hospitalised patients with influenza infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristoffer SKAARUP",Denmark
2539,PS003,2459,"Clinical burden of respiratory syncytial virus among adults hospitalised with acute respiratory infections in Austria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harald ROUHA",Austria
2540,PS003,2459,"Mortality among adults aged 50+ years admitted with COVID-19, influenza A or respiratory syncytial virus (RSV) in Denmark, 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frederikke LOMHOLT",Denmark
2541,PS003,2459,"How did respiratory viruses impact UK healthcare workers over winter 2023/24",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah FOULKES","United Kingdom"
2542,PS003,2459,"Hospital disease burden of respiratory syncytial virus in adults 2021-2023 compared to influenza and COVID-19 using rapid PCR testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niklas ANDREEN",Sweden
2543,PS003,2459,"SARS-CoV-2 phylogenetics in a Spanish cohort of hospital healthcare workers, 2021-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam LATORRE-MILLÁN",Spain
2544,PS003,2459,"Prospective surveillance of acute lower respiratory tract infection due to RSV and other respiratory viruses in outpatient infants under two years of age in Würzburg (Germany) since November 2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea STRENG",Germany
2545,PS003,2459,"Relative effectiveness of high-dose vsstandard-dose quadrivalent influenza vaccine in patients with hypertension: a secondary analysis of the DANFLU-1 trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Marie REIMER JENSEN",Denmark
2546,PS003,2459,"Epidemiology of respiratory pathogens in children with severe acute respiratory infection: a Tunisian three years survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarra SAYARI",Tunisia
2547,PS003,2459,"Epidemiology and seasonality of human coronaviruses in Portugal since the COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tiago P. RODRIGUES",Portugal
2548,PS003,2459,"Prevalence and determinants of respiratory virus screening and isolation among hospitalised patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elke LOOTS",Belgium
2549,PS003,2459,"Similar proportions and temporal patterns of influenza, RSV and hMPV among ESKD patients tested between 2020 and 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carla TALARICO","United States"
2550,PS003,2459,"Real-world effectiveness of live attenuated (LAIV) and inactivated (IIV) influenza vaccines in children: a systematic literature review (SLR) and network meta-analysis (NMA)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wilhelmine MEERAUS","United Kingdom"
2551,PS003,2459,"Detection of various respiratory viruses based on MALDI-TOF MS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fei CHEN",China
2552,PS003,2459,"From primary care to hospitalisation: understanding the burden of the 2024 enterovirus D68 outbreak in Catalonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna CREUS-COSTA",Spain
2553,PS003,2459,"The age factor in viral codetections: insights from a multicentric study on paediatric respiratory infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna CREUS-COSTA",Spain
2554,PS003,2459,"Changing epidemiology: impact of the COVID-19 pandemic on bacterial and viral infections in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia BRIGADOI",Italy
2555,PS003,2459,"Symptomology of influenza-like illness reported during home self-collected swab testing: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nabila SHAIKH","United Kingdom"
2556,PS003,2459,"Respiratory syncytial virus infection and heart disease: a systematic review and pooled analysis of clinical features",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo RICCÒ",Italy
2557,PS003,2459,"Trends in the circulation of influenza A/B viruses, SARS CoV2 and respiratory syncytial virus in Indian settings, 2023-2024: emerging spectre of a tridemic?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ira PRAHARAJ",India
2558,PS003,2459,"High-dose vs standard-dose influenza vaccine in patients with chronic inflammatory disease: a secondary analysis of the DANFLU-1 trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie BORCHSENIUS",Denmark
2559,PS003,2459,"Molecular characterisation of human adenovirus genotypes in paediatric patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luna COLAGROSSI",Italy
2560,PS003,2459,"Surveillance of influenza A in red foxes and seals in Ireland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maeve Louise FARRELL",Ireland
2561,PS003,2459,"Influenza vaccination rates among healthcare workers and key factors influencing vaccination in Bangladesh",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Md Golam Dostogir HARUN",Bangladesh
2562,PS003,2459,"Isolation, production and validation of the first GMP RSV-B virus for use in controlled human infection studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas NOULIN","United Kingdom"
2563,PS003,2459,"Pathogen characteristics of respiratory infections in the season after the COVID-19 pandemic: evidence from direct-to-consumer testing-based surveillance, China, 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yanxia SUN",China
2564,PS003,2459,"Association of virology swab positivity in adults aged =40 years with computerised medical record reported acute respiratory infection (ARI) subgroups: observational study of ARI (ObservatARI)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon DE LUSIGNAN","United Kingdom"
2565,PS003,2459,"Assessing immunomodulators in human challenge studies: insights from wild-type influenza infections in healthy adults and rhinovirus infections in patients with asthma",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas NOULIN","United Kingdom"
2566,PS003,2459,"Cold perception as a key endpoint in human challenge trials with respiratory viruses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas NOULIN","United Kingdom"
2567,PS003,2459,"Management of respiratory infections in primary care (RespiCare): a cluster-randomised, controlled crossover study with molecular point-of-care testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tobias TUCHSCHERER",Germany
2568,PS003,2459,"Epidemiology of five respiratory viruses circulating in Taiwan, 2015-2023: a multicentre retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tu-Hsuan CHANG",China
2569,PS003,2459,"Can unsupervised machine learning predict outbreaks of respiratory tract infections in acute Irish hospitals (2016-2021)?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Doaa AMIN",Ireland
2570,PS003,2459,"Factors influencing hospital stay length and acute respiratory failure in influenza patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor Daniel MIRON",Romania
2571,PS003,2459,"Epidemiology and burden of the human metapneumovirus among Italian inpatient and outpatient adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincenzo PAOLOZZI",Italy
2572,PS003,2459,"Comparing viral loads in nasopharyngeal swabs and bronchoalveolar lavages after normalisation of multiplex real-time PCR data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Timo FROYEN",Belgium
2573,PS003,2459,"RELAB 2023-24: compared community epidemiologies of RSV, influenza and SARS-CoV-2 in France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoit VISSEAUX",France
2574,PS003,2459,"Spectrum of respiratory viruses in in-patients with severe acute respiratory infection in north India: insights from a two-year analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruchita CHHABRA",India
2575,PS003,2459,"Broad-spectrum antiviral activity of spiro-beta-lactams: targeting SARS-CoV-2, influenza, and HIV through ferroptosis induction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paloma GONÇALVES",Portugal
2576,PS003,2459,"IFN-β administration results in mixed alterations in brain functions in elderly mice during influenza A virus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Douglas DREVETS","United States"
2577,PS003,2459,"Optimising respiratory syncytial virus (RSV) antibody pair selection for enhanced diagnostic accuracy and speed",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tarja SORSA-LESLIE",Finland
2578,PS003,2459,"Relative effectiveness of high-dose vs standard-dose influenza vaccine in immunocompromised individuals: a posthoc analysis of the DANFLU-1 trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Marie REIMER JENSEN",Denmark
2579,PS003,2459,"Epidemiological and molecular characteristic of enteroviruses identified in influenza-like illness cases in Lombardy (northern Italy), January 2022-October 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura PELLEGRINELLI",Italy
2580,PS003,2459,"Vakzimeter FLU: real-time in-season monitoring of adult influenza vaccination rates in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christine HAGEMANN",Germany
2581,PS003,2459,"Characterisation of hMPV and RSV hospitalisations in the French national hospital claims database during the 2022-2023 season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liem Binh LUONG",France
2582,PS003,2459,"Molecular epidemiology of paediatric respiratory syncytial virus infection in Hungary",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriella TERHES",Hungary
2583,PS003,2459,"Assay development and pipeline considerations for amplicon-based respiratory syncytial virus whole genome sequencing in a clinical setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kuganya NIRMALARAJAH",Canada
2584,PS003,2459,"Impact of respiratory syncytial virus (RSV) disease on health-related quality of life (HRQoL) among European older adults: combined results over three RSV seasons",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frederik VERELST",Belgium
2585,PS003,2459,"Unveiling the dynamics of respiratory infections through multiplex PCR testing after the COVID-19 pandemic in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meng-Shuan LIN",China
2586,PS003,2459,"Impact of multiplexed respiratory panel on the diagnosis and management of respiratory infections in the emergency department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel GOODFELLOW","United States"
2587,PS004,NULL,"01d. Herpesviruses (incl diagnostics & epidemiology, antiviral drugs, treatment & susceptibility/resistance, excl clinical studies in immunocompromised hosts)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2588,PS004,2587,"Estimating genital herpes prevalence and treatment patterns among US healthcare-engaged individuals: insights from claims data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jason DEER","United States"
2589,PS004,2587,"Reactivation of Ebstein-Barr virus among ARDS patients: do acute changes in the immune system play a role?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina GASSNER",Germany
2590,PS004,2587,"Characterisation of humoral and T-cell specific response to EBV, CMV and VZV in people with MS under DMT",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica DOMINELLI",Italy
2591,PS004,2587,"Trends in herpes simplex virus type 1 and type 2 seroprevalence in Croatia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filip STEVANOVSKI",Croatia
2592,PS004,2587,"Burden of herpes zoster in immunocompromised adults aged 18 years or older: a retrospective analysis of German claims data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara PEDRON",Germany
2593,PS004,2587,"Newer is not always better: evaluation of the new version of LIAISON VZV IgG CLIA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela HUZLY",Denmark
2594,PS004,2587,"Adjuvanted recombinant zoster vaccine is associated with lower risk of herpes zoster ophthalmicus, acute myocardial infarction, and stroke in adults aged ≥50 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily RAYENS","United States"
2595,PS004,2587,"Real-life drug-drug interactions between immunosuppressive treatments and letermovir in solid organ transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fanny VUOTTO",France
2596,PS004,2587,"Incidence rates of herpes zoster in immunocompromised adults aged 18 years or older in England: a large retrospective cohort study using data from the clinical practice research datalink, 2012-2019",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abda MAHMOOD",Belgium
2597,PS004,2587,"The risk of vascular events following herpes zoster: a matched cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mads Frederik EIBERG",Denmark
2598,PS004,2587,"Predictors of CMV-colitis in patients with moderate to severe ulcerative colitis needing hospitalisation: interim analysis from a prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo RINALDI",Italy
2599,PS004,2587,"Preclinical profile of ABI-5366, a novel potent HSV helicase-primase inhibitor, with potential for weekly or monthly oral dosing for the treatment of recurrent genital herpes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathryn KITRINOS","United States"
2600,PS004,2587,"Comparison of rapid multiplexed real-time PCR platform with laboratory real-time PCR platform for detection of HSV-1, HSV-2, and VZV in lesion swab specimens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Preeti PANCHOLI","United States"
2601,PS004,2587,"Genital ulcer etiology in northwest Spain: from 2019 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Noelia PARAJÓ-PAZOS",Spain
2602,PS004,2587,"Targeted screening for congenital cytomegalovirus infection in a high seroprevalence country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siwar FRIGUI EP OUESLATI",Tunisia
2603,PS004,2587,"CMV RNA: a new marker for monitoring CMV in HCT with LTV prophylaxis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice NAVA",France
2604,PS004,2587,"Enhancing EBV diagnostics: T-cell-based assay for accurate immune monitoring in patients with multiple sclerosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tatjana SCHWARZ",Germany
2605,PS004,2587,"Concordance of a multiplex PCR assay with HSV1-2 and VZV-specific PCR in diagnosing central nervous system infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaohui Chen NIELSEN",Denmark
2606,PS004,2587,"Distribution of ganciclovir in the porcine central nervous system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johan GULDBÆK",Denmark
2607,PS004,2587,"Leveraging French compassionate programme data in refractory CMV to further describe maribavir effectiveness and resistance profile",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie ALAIN",France
2608,PS004,2587,"Modelling the public health impact of herpes zoster vaccination in adults aged ≥ 50 Years via increased recombinant zoster vaccine uptake worldwide",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charles WILLIAMS",Belgium
2609,PS004,2587,"Varicella zoster virus central nervous system infections: a multi-site retrospective review of clinical features, treatments, and outcomes in an Australian setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katrina FERNANDES",Australia
2610,PS004,2587,"Comparison of two commercial real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in nasopharyngeal carcinoma (NPC) patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rym TOUATI",Algeria
2611,PS004,2587,"Role of human herpesvirus 6 in unexplained infertility: among Indian women in a tertiary care hospital of north India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vani ANGRA",India
2612,PS005,NULL,"01e. Emerging/re-emerging, vector-borne and zoonotic viral diseases (other than COVID)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2613,PS005,2612,"Correlation between building features and prevalence of Aedes aegypti mosquitoes in Singapore",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyaw Zwa THANT",Singapore
2614,PS005,2612,"Shifting pattern of circulating dengue serotypes and their associated severity in children: a report from south India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara CHANDY",India
2615,PS005,2612,"RAB3GAP2 dysregulation in adult T-cell leukemia/lymphoma (ATLL) compared to acute lymphoblastic leukemia (ALL)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arash LETAFATI","Islamic Republic Of"
2616,PS005,2612,"Molecular characterization of Tick-borne encephalitis cases in north-eastern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone MALAGÒ",Italy
2617,PS005,2612,"Secondary infection rates after mpox exposure in multiple settings: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aiman EL-SEAD","Saudi Arabia"
2618,PS005,2612,"A critical analysis of dengue epidemic in Venezuela, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso J. RODRIGUEZ-MORALES",Colombia
2619,PS005,2612,"Modes of transmission of mpox by virus clade and geographic distribution: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Majid ALSHAMRANI","Saudi Arabia"
2620,PS005,2612,"Neurologic manifestations and outcome of West Nile virus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manel BEN SELMA",Tunisia
2621,PS005,2612,"Assessing the direct and spillover protective efficacies of Wolbachia-mediated introgression to combat dengue",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jo Yi CHOW",Singapore
2622,PS005,2612,"First usutu virus infection in an asymptomatic blood donor in Greece",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna PAPA-KONIDARI",Greece
2623,PS005,2612,"Epidemiological overview of ICU-diagnosed dengue fever cases at Hargeisa group hospital, Somaliland (January-October 2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ling-Li HUANG",Somalia
2624,PS005,2612,"Seroprevalence of hantavirus exposure among healthy individuals in the Ampara district of Sri Lanka",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nipun RATHNAYAKE","Sri Lanka"
2625,PS005,2612,"Investigation of Crimean-Congo haemorrhagic fever virus in patient room air samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mert KUSKUCU",Türkiye
2626,PS005,2612,"Beyond familiar threats: numerous RNA virus families display pandemic potential",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas LEINEWEBER KRISTENSEN",Denmark
2627,PS005,2612,"Exploring transmission routes of rat hepatitis E from a One Health perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hon Kiu Estie SHUN",China
2628,PS005,2612,"Comparison of assays for assessing the humoral immune response to monkeypox virus in HIV and non-HIV individuals following two doses of the MVA vaccine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ut Man CHAN",China
2629,PS005,2612,"Antibody generation and development of a rapid test for the diagnosis of infection caused by the monkeypox virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arnaud CHALIN",France
2630,PS005,2612,"Confirmed dengue cases in returning travellers in Milan, Italy: clinical and microbiological features from 2018 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Margherita Eleonora PIERUZZI",Italy
2631,PS005,2612,"Comparative analysis of clinical features between patients with severe fever with thrombocytopenia syndrome and haemorrhagic fever with renal syndrome in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Da Young KIM","Republic Of"
2632,PS005,2612,"West Nile human infections in Europe from 2000–2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadja HEDRICH",Switzerland
2633,PS005,2612,"Dengue incidence in 26 cities affected by a tailing dam rupture at the Córrego do Feijão mine in Brumadinho/ Brazil: a ten-year ecological study.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos STARLING",Brazil
2634,PS005,2612,"whole-genome sequencing of MERS-CoV: comparison of amplicon-based approaches and short read and long read sequencing platforms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Umair HUSSAINI","United Kingdom"
2635,PS005,2612,"West Nile virus infection investigation at the clinical virology laboratory, Pasteur Institute of Tunis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hannachi HANNACHI",Tunisia
2636,PS005,2612,"Target identified: a comparison of Brazilian and Singaporean dengue control ecosystems to aid antiviral target product profile development",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice SCHARMELI","United Kingdom"
2637,PS005,2612,"Wastewater monitoring of dengue virus RNA during a local outbreak in central Italy, August-October 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina VENERI",Italy
2638,PS005,2612,"Did Marburg virus disease clinical features change overtime? A systematic review and meta-analysis,1967-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo RICCÒ",Italy
2639,PS005,2612,"Seroprevalence of dengue IgG antibodies among adult community residents in Enugu, south-east Nigeria: a cross-sectional survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chizaram ONYEAGHALA",Nigeria
2640,PS005,2612,"Integrating spatial-environmental models to evaluate Wolbachia-mediated intervention efficacy on dengue transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jue Tao LIM",Singapore
2641,PS005,2612,"Association of sonographic findings with severity of dengue fever: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana MUNIZ",Germany
2642,PS005,2612,"Exploring the anti-interferon autoantibodies in mosquito-borne viral infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica FRASCA",Italy
2643,PS005,2612,"Whole-genome sequencing based phylogenetic analysis of CCHFV strains isolated in Georgia (2013–2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gvantsa CHANTURIA",Georgia
2644,PS005,2612,"Detection of West Nile virus, Usutu virus and phleboviruses in Culex spp. mosquitoes in Central Macedonia, Greece, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna PAPA-KONIDARI",Greece
2645,PS005,2612,"Clinical characteristics of Marburg virus disease: a systematic review of the literature",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emanuele NICASTRI",Italy
2646,PS005,2612,"Promising results with anakinra in severe cases of Crimean-Congo haemorrhagic fever",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nurcan BAYKAM",Türkiye
2647,PS005,2612,"Addressing the emerging threat of oropouche virus: implications and public health responses for healthcare systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olalekan John OKESANYA",Nigeria
2648,PS005,2612,"Genetic variants of the rabies virus and prevention of diagnostic errors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeferson MANOEL TEIXEIRA",Brazil
2649,PS005,2612,"Prevalence, haematological profile, and risk factors of dengue fever in under-five children with acute febrile illness in Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ibuchukwu ORABUEZE",Nigeria
2650,PS005,2612,"Febrile illness of vector-borne and zoonotic origin in Ho Chi Minh city, Vietnam: not just dengue is in there",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olga STUKOLOVA","Russian Federation"
2651,PS005,2612,"Dengue epidemiology in the elderly population of a municipality in Bolívar, Colombia, 2018-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso J. RODRIGUEZ-MORALES",Colombia
2652,PS005,2612,"Differences in the clinical profile between ratHEV and HEV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio RIVERO-JUAREZ",Spain
2653,PS005,2612,"Epidemiology, clinical presentation, and outcome of human mpox in Rivers state Nigeria during the 2022-23 outbreak: an observational retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chizaram ONYEAGHALA",Nigeria
2654,PS005,2612,"CT-detected lymphadenopathy and prognostic markers in severe fever with thrombocytopaenia syndrome: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yoshito HOMMA",Japan
2655,PS005,2612,"Seroprevalence of toscana virus in blood donors in mainland Portugal",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael ROCHA",Portugal
2656,PS005,2612,"Return of WNV infection in Vlora",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arsilda GJATAJ",Albania
2657,PS005,2612,"Impact of dengue fever on maternal and fetal outcomes: a cross-sectional study in Guatemala",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iris CAZALI",Guatemala
2658,PS005,2612,"Role of biomarkers in predicting mortality in patients with flaviviral disease endemic to south India: a prospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rachna BHAT",India
2659,PS005,2612,"Monocyte CD169 (mCD169) expression in peripheral blood in patients with symptomatic arbovirosis: a retrospective series in the emergency department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Massimo CRAPIS",Italy
2660,PS005,2612,"Role of genetic determinants in pathogenesis and evolution of chikungunya virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Garvita MATHUR",India
2661,PS005,2612,"Tick-borne encephalitis virus (TBEV) is one the three leading causes of meningoencephalitis/encephalitis in Saint-Etienne area, France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emilie MAYER",France
2662,PS005,2612,"Clinical features of measles during the 2023-2024 outbreak in Minsk, Belarus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra BYLINA",Belarus
2663,PS005,2612,"Attitudes and knowledge of the adult population on arboviral diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabiana NUCCETELLI",Italy
2664,PS005,2612,"Expression of Galectin-3 ameliorates dengue virus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun Tzu HSU",China
2665,PS005,2612,"Retrospective molecular epidemiological survey of an unexpected dengue outbreak in Taiwan, 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sheng-Fan WANG",China
2666,PS005,2612,"A stepwise approach to developing practical guidance for healthcare professionals to safely meet the needs of patients and relatives during admission to a high-level isolation unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca ZWEERS",Netherlands
2667,PS005,2612,"???Survivors of an outbreak: exploring the patient experience of a specialised regional infectious diseases centre virtual ward during the mpox outbreak of 2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irvine MANGAWA","United Kingdom"
2668,PS005,2612,"Detection of anti-oropouche virus-specific IgM in a patient panel from a zika virus epidemic area in 2015 / 2016",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jens WARNECKE",Germany
2669,PS005,2612,"Viral haemorrhagic fever: auditing emergency care for at-risk patients at university college London hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James BEVAN","United Kingdom"
2670,PS005,2612,"Increasing incidence of neurological infections of unknown etiology in upper Corsica: a matter of arboviruses?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnieszka KOLAKOWSKA",France
2671,PS005,2612,"West Nile virus infections in Turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özlem ALHAN",Türkiye
2672,PS005,2612,"Mediating analysis of IPA in the association between steroid therapy and mortality risk in patients with SFTS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guang ZHU",China
2673,PS005,2612,"Ethical drug development for global health: an interdisciplinary analysis for the current dengue emergency",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shanghavie LOGANATHAN","United Kingdom"
2674,PS005,2612,"Unraveling global mpox cross-border transmission patterns and risks: a comprehensive analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qiangru HUANG",China
2675,PS005,2612,"Dengue seroprevalence in healthy blood donors in Romagna (Emilia-Romagna region, Italy)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra Mistral DE PASCALI",Italy
2676,PS005,2612,"Phylogenetic analysis of the autochthonous dengue cases emerged in Emilia-Romagna region, in Italy, during arbovirus surveillance in 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca RUOTOLO",Italy
2677,PS005,2612,"Clinical-laboratory features of the abortive form of tick-borne encephalitis virus infection in Italy: a 25-year retrospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole BARP",Italy
2678,PS005,2612,"The next frontier in Toscana virus (TOSV) genome analysis: development of a novel amplicon-based whole genome sequencing technology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vittorio SAMBRI",Italy
2679,PS005,2612,"Developing an evidence-based at-home specimen collection procedure for patients suspected of a high-consequence infectious disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca ZWEERS",Netherlands
2680,PS005,2612,"Clinical spectrum and diagnostic challenges of tick-borne encephalitis in Belarus: a retrospective analysis of 190 cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mikita SALAVEI",Belarus
2681,PS005,2612,"West Nile virus in European countries between 2018 and 2024: trends in case fatality rate and incidence over time",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özge EREN KORKMAZ",Türkiye
2682,PS005,2612,"Risk of cardiovascular complications during acute dengue infection: a population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jue Tao LIM",Singapore
2683,PS005,2612,"Enhancing mpox diagnostics: insights from an external quality assessment programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katherine LAU",Australia
2684,PS005,2612,"Clinical-laboratory features of tick-borne encephalitis virus infection in children and adolescents in Italy: a 25-year retrospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole BARP",Italy
2685,PS005,2612,"Mpox among Venezuelan migrants in a hospital of Pereira, Colombia, 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso J. RODRIGUEZ-MORALES",Colombia
2686,PS006,NULL,"01f. Diagnostic virology (other than respiratory viruses, herpesviruses, hepatitis & HIV; incl traditional, molecular, genomic and other methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2687,PS006,2686,"High percent of co-detections of viral versus bacterial gastrointestinal pathogens in stool samples calls for a different approach in analysis of molecular testing results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ulrich EIGNER",Germany
2688,PS006,2686,"Genomic characterisation of JC virus in progressive multifocal leukoencephalopathy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Palani GNANASOUNDARI",India
2689,PS006,2686,"Accelerating dengue detection: comparing the performance of rapid tests and ELISA for NS1, IgG, and IgM antibodies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadia WOHLWEND",Switzerland
2690,PS006,2686,"Evaluation of INSTAND EQA samples for virus genome detection: target values by dPCR results instead of consensus values?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin KAMMEL",Germany
2691,PS006,2686,"On the hotline: the imported fever service response to the mpox Clade I outbreak",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martine ALTIDOR","United Kingdom"
2692,PS006,2686,"Emergence of Enterovirus D68 infection in northern of Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Del Carmen NIETO TOBOSO",Spain
2693,PS006,2686,"Neither nor or norovirus GI/GII? Good consensus in international EQA pilot study for norovirus antigen detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heidi BERGHALL",Finland
2694,PS006,2686,"New raw materials for serology immunoassay quality controls",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Christophe PETER",France
2695,PS006,2686,"Diagnostic accuracy of MxA protein as a biomarker for acute viral infections: a multi-centre validation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Run HUANG",China
2696,PS006,2686,"Increased detection of human parvovirus B19 on a tertiary care Greek hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleni VAGDATLI",Greece
2697,PS006,2686,"Evaluating the impact of EDTA K2 vs. EDTA K3 on viral load quantification using real-time PCR assays",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
2698,PS006,2686,"Gene promoter methylation as a progression biomarker of HPV-associated precancerous lesions in young women",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia ALCOBA FLÓREZ",Spain
2699,PS006,2686,"Molecular identification of enterovirus 71 and coxsackie A16 among paediatric patients with aseptic meningitis in Khartoum state, Sudan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tarteel HASSAN",Sudan
2700,PS006,2686,"In vitro validation of a preservative media for circulating cell-free HPV-DNA stabilisation in artificial human plasma samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara SENTI",Italy
2701,PS006,2686,"Evaluation of Torque teno virus DNA as an immunological marker through correlation with clinical parameters and survival in paediatric haematopoietic stem cell transplantation patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suyeon JO","Republic Of"
2702,PS006,2686,"Determination of measles-virus-IgG titre in blood drawn by finger prick",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Volker STRENGER",Austria
2703,PS006,2686,"A lyophilised and deployable real time RT-PCR assay for the detection of viral RNA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucie MANGIN",France
2704,PS006,2686,"Ongoing MPXV infections in the Berlin MSM cohort: multiplex PCR for differentiation between MPXV Clade I; Ib and Clade II",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert EHRET",Germany
2705,PS006,2686,"Detection of immune response to rubella antigen using an anti-rubella IgM ELISA and a newly designed anti-rubella IgG ELISA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jens WARNECKE",Germany
2706,PS006,2686,"Bridging diagnostic gaps and strengthening vaccination strategies in mumps control: a tertiary care experience in western India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bhoomika RAJYAGURU",India
2707,PS006,2686,"Hybridisation-capture approaches for the diagnosis and surveillance of viruses using  real-time sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oscar Enrique TORRES MONTAGUTH","United Kingdom"
2708,PS006,2686,"Next-generation sequencing method for analysis of multi-infections and antibiotic resistance markers in self-collected swabs from HPV positive women",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karolína TOMCÍKOVÁ",Slovakia
2709,PS007,NULL,"01g. Viral epidemiology - general, prevalence studies, molecular and genomic epidemiology (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2710,PS007,2709,"An in-depth review of epidemiologic, clinical, and laboratory characteristics in women with cervical abnormalities: insights from a leading referral centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amir ABOOFAZELI","Islamic Republic Of"
2711,PS007,2709,"Serotype distribution of enterovirus associated with hand, foot, and mouth disease in China based on laboratory surveillance, 2012-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Na LIU",China
2712,PS007,2709,"Comprehensive identification of respiratory viruses in wastewater using a broad-spectrum respiratory virus manel and whole genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pamela MANCINI",Italy
2713,PS007,2709,"Vaccine hesitancy and measles resurgence: lessons from Novi Pazar",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selma HABIBOVIC",Serbia
2714,PS007,2709,"Phylogenetic analysis of human parvovirus B19, northern Italy, 2017-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia BIANCHI",Italy
2715,PS007,2709,"Coxsackieviruses type B infections: the effect of COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ioannis DANIIL",Greece
2716,PS007,2709,"Rotavirus A outbreak predominantly affecting adults in Santa Maria, southern Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priscila TRINDADE",Brazil
2717,PS007,2709,"Declining trend of HTLV-1 among organ/tissue donors in Iranian population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arash LETAFATI","Islamic Republic Of"
2718,PS007,2709,"A large outbreak of acute hemorrhagic conjunctivitis in Yunnan, China in 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaolei LI",China
2719,PS007,2709,"Hand, foot, and mouth disease amid COVID-19: an overlapping epidemic within a pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alpana MOHTA",India
2720,PS007,2709,"Compelling increase in parvovirus B19 infections: analysis of diagnostic trends, 2019–2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Flora Marzia LIOTTI",Italy
2721,PS007,2709,"Different genotypic distributions of hantaan virus causing human infections on Jeju island, South Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Keun Hwa LEE","Republic Of"
2722,PS007,2709,"An outbreak caused by imported sub-genotype B5 of EV-A71 reveals multiple recombination pattern in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tianjiao TIANJIAO",China
2723,PS007,2709,"Improved surveillance of viral gastroenteritis after implementation of wastewater surveillance in Belgium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Koenraad VAN HOORDE",Belgium
2724,PS007,2709,"Resurgence of measles: new evidence of viral circulation in Liguria, northern Italy, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giada GARZILLO",Italy
2725,PS007,2709,"Viral myocarditis manifesting as sudden death in infants and children: an ESGFOR approach from symptoms to autopsy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amparo FERNÁNDEZ-RODRÍGUEZ",Spain
2726,PS007,2709,"Parvovirus: a growing problem?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SMIELEWSKA","United Kingdom"
2727,PS007,2709,"Molecular epidemiology of human rotavirus in post-vaccination era in Chiang Mai, Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pattara KHAMRIN",Thailand
2728,PS007,2709,"Colonoscopic observations in asymptomatic norovirus infection: insights from a small-scale study at a single Japanese centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyoko YOKOTA",Japan
2729,PS007,2709,"Sequencing of MPXV positive samples in Berlin 2022 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özlem YILDIRIM",Germany
2730,PS007,2709,"Etiologic involvement of enterovirus and human boca virus in acute flaccid paralysis cases in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dharam Veer SINGH",India
2731,PS007,2709,"Clinical significance of torque teno virus (TTV) in CSF samples/TTV dynamics in paediatric population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dee DAVIS","United Kingdom"
2732,PS007,2709,"Prevalence of anti-parvovirus B19 IgG and IgM antibodies in a local population from 2019 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico FALLETTA",Italy
2733,PS007,2709,"Measles seroprevalence of medicine faculty student",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dilsah BASKOL ELIK",Türkiye
2734,PS007,2709,"Prevalence and genotype distribution of high-risk HPV genotypes by the RT-PCR method among women in Serbia in a two-year period, 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edita GREGO",Serbia
2735,PS007,2709,"Epidemiology of human sapovirus in Korea: impact of COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyun Soo KIM","Republic Of"
2736,PS007,2709,"Hospitalised dengue patients: insights from Argentina's 2023-2024 outbreak",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gustavo Adolfo MÉNDEZ",Argentina
2737,PS007,2709,"Spreading and epidemiological characteristics of measles in the area of Zenica-Doboj Canton, Bosnia-Herzegovina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhamed SKOMORAC","Bosnia And Herzegovina"
2738,PS007,2709,"Increase in parvovirus B19 cases in Barcelona: comparative analysis from 2019 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta BERNAT",Spain
2739,PS007,2709,"Incidence and severity of sporadic, medically attended norovirus infection in the United States, 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark A SCHMIDT","United States"
2740,PS007,2709,"Increased circulation of human parvovirus B19 during spring of 2024 in Madrid, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria ALBERTUZ CRESPO",Spain
2741,PS007,2709,"Clinical, laboratory profile and outcome of expanded dengue syndrome and its correlation with virus specific serotype at a tertiary care hospital in north India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harpreet SINGH",India
2742,PS007,2709,"Sexual behaviour and age related incidence of sexually transmitted infections among MSM and transgender women using daily and event-driven pre-exposure prophylaxis (PrEP): two-year follow-up",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco ROMANO",Italy
2743,PS007,2709,"Screening for human papillomavirus in women over 30 years of age at the mother and child laboratory of a west Algiers hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siham AZROU",Algeria
2744,PS007,2709,"The landscape of human papillomavirus types among women screened for cervical cancer in a rural healthcare facility in Eswatini",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clara FAPPANI",Italy
2745,PS007,2709,"Parvovirus B19 on the rise in 2024: a multifaceted pathogen with varied clinical manifestations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela JAVORSKÁ",Slovakia
2746,PS007,2709,"Adeno-associated virus (AAV2) is a common finding in adenovirus infections in children and adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xuewei ZHOU",Netherlands
2747,PS007,2709,"Prevalence and distribution of vaccine-preventable HPV genotypes in unvaccinated PrEP users",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica SALARI",Italy
2748,PS007,2709,"Molecular epidemiology of classic and novel human astroviruses in paediatric patients with acute gastroenteritis in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kattareeya KUMTHIP",Thailand
2749,PS008,NULL,"01h. Antiviral drugs, treatment, susceptibility/resistance (other than respiratory viruses, herpesviruses, hepatitis & HIV)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2750,PS008,2749,"Evaluation of the antiviral activity of new dermaseptin analogs against zika virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Houda HADDAD",Tunisia
2751,PS008,2749,"Discovery of PROTAC compounds as potent viral protease degraders and inhibitors against Corona viruses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xicheng SUN","United States"
2752,PS008,2749,"Salicylamide derivative JMX0312 protects immunosuppressed Syrian hamsters against adenovirus lethal challenge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier MARTÍN-ESCOLANO",Spain
2753,PS008,2749,"Investigation of the HPV 53 E2 protein as a potential treatment for cervical cancer",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlo FERRAZZANO","United Kingdom"
2754,PS009,NULL,"01i. Fundamental and applied virology (incl in vitro and in vivo models, novel methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2755,PS009,2754,"Exploring the pathogenesis of TBE in an infant rat model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone LEONI",Switzerland
2756,PS009,2754,"Impact of the route of EBV transmission on viral infection and reactivation in the rabbit model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gulfaraz KHAN","United Arab Emirates"
2757,PS009,2754,"Gut virome composition modifies the risk of subsequent coeliac disease in two European birth cohorts",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ondrej CINEK","Czech Republic"
2758,PS009,2754,"Preliminary analysis of viral infection in human organoids from different GI tracts: SARS-CoV-2 and beyond",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Virginia LOTTI",Italy
2759,PS009,2754,"A genetically encoded BRET-based SARS-CoV-2 main protease activity sensor",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anupriya M G",Qatar
2760,PS009,2754,"Advancing vaccine and treatment development, state-of-the-art human challenge trial facility",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas NOULIN","United Kingdom"
2761,PS009,2754,"Expression of human endogenous retroviruses in clinical samples of patients with colorectal cancer",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria DOLCI",Italy
2762,PS009,2754,"Study of the endothelial response to SARS-CoV-2 in vitro infection of human lung microvascular endothelial cells",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia SIGNORINI",Italy
2763,PS010,NULL,"01j. COVID-19 (incl virology, epidemiology, evolution, immune response, diagnosis, treatment, vaccination, prevention, response and societal impact)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","01. Viral infection & disease (incl COVID-19)",NULL,NULL,NULL,NULL
2764,PS010,2763,"Phenotyping and genotyping analysis using baseline swab samples in ensitrelvir clinical studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Keiko BABA",Japan
2765,PS010,2763,"SARS-CoV-2 reinfections in a large cohort study: results from the UnCoVER-Brazil project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia MARTELETO SCANAVEZ",Brazil
2766,PS010,2763,"Challenges on the implementation of wastewater as a prediction tool: the paradigm of SARS-CoV-2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dimosthenis CHOCHLAKIS",Greece
2767,PS010,2763,"Long-term exposure to air pollution and serum levels of inflammatory markers in acute severe COVID-19: an ICU based multicentric study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"André ALMEIDA",Portugal
2768,PS010,2763,"Long term impact on lung function of patients with moderate and severe COVID-19: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia QURESHI",Pakistan
2769,PS010,2763,"Mucocutaneous adverse events following COVID-19 vaccination- a clinico-histopathological correlation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alpana MOHTA",India
2770,PS010,2763,"The consequences of reinfections in long COVID patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lourdes MATEU PROUNONOSA",Spain
2771,PS010,2763,"The role of leptin on macrophage function in patients with COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philipp WÖHLER",Germany
2772,PS010,2763,"Risk and resilience for depression, anxiety, and stress among healthcare workers and health-related staff in Indonesia, Nepal, and Vietnam during COVID-19: a multi-site cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ha LE THANH",Vietnam
2773,PS010,2763,"Preliminary safety and effectiveness estimate of 2023-2024 COVID-19 vaccines (XBB.1.5) in preventing symptomatic infections in US adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarang YOON","United States"
2774,PS010,2763,"Viral co-infection reduces SARS-CoV-2 illness severity in community, but not in healthcare cohorts: a meta-analysis of 11 prospective studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia BRUIJNING-VERHAGEN",Netherlands
2775,PS010,2763,"Graphene biosensors: bridging basic science and applied diagnostics for viral infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anil BOZDOGAN",Austria
2776,PS010,2763,"Post-COVID condition in vulnerable populations: the ORCHESTRA Delphi consensus on prevention, diagnosis and management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa GENTILOTTI",Italy
2777,PS010,2763,"Humoral immunity after PHH-1V COVID-19 booster vaccination in adults with immunosuppressive conditions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dalia RAÏCH-REGUÉ",Spain
2778,PS010,2763,"Evolution of determinants and severity of post-COVID Condition across 24 months: the ORCHESTRA long-term sequelae extended follow up",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa GENTILOTTI",Italy
2779,PS010,2763,"Challenges in the diagnosis of SARS-CoV-2 infection in the nervous system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samya DA SILVA",Brazil
2780,PS010,2763,"Challenges in the diagnosis of SARS-CoV-2 infection in the nervous system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samya DA SILVA",Brazil
2781,PS010,2763,"Impact of SARS-CoV-2 infection and long COVID on health-related quality of life among school-aged children in Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thu-Trang VU",Vietnam
2782,PS010,2763,"Evaluation of digital PCR technique for the study of SARS-CoV-2 viremia as a predictor of poor clinical evolution",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nelly Daniela ZURITA CRUZ",Spain
2783,PS010,2763,"Assessing the synergistic effect of NMV-r and acquired immunity in reducing severe COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romina QUERCIA","United Kingdom"
2784,PS010,2763,"Assessment of the levels of some prognostic biomolecules (galectins, ACE2, SCUBE1/2/3) in COVID-19 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat KARAMESE",Türkiye
2785,PS010,2763,"Immune disturbances in individuals with post-COVID syndrome (PCS) are not characterised by enhanced SARS-CoV2-specific immunity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronica OBER",Germany
2786,PS010,2763,"Functional measurements of muscle strength and assessment of sarcopenia to evaluate post-COVID chronic fatigue",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa GENTILOTTI",Italy
2787,PS010,2763,"Evaluating the feasibility of SARS-CoV-2 and influenza genomic sequencing from lateral flow devices: a pilot study within the UK SIREN cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah FOULKES","United Kingdom"
2788,PS010,2763,"Evaluating quasi-experimental approaches for estimating vaccine effectiveness: an empirical and simulated COVID-19 study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jo Yi CHOW",Singapore
2789,PS010,2763,"Forecasting the impact of declining COVID-19 vaccination rates: scenario analysis using machine learning-enabled susceptible-infected-recovered models in England",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter MORTENSEN","United Kingdom"
2790,PS010,2763,"From evaluation to action: applying WHO IPC COVID-19 outcomes/impact evaluation findings to current public health emergency responses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hannah HAMILTON HURWITZ",Switzerland
2791,PS010,2763,"SARS-CoV-2 vaccination influence in development of long-COVID clinical phenotypes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michele ANTONACCI",Italy
2792,PS010,2763,"The association between COVID-19 vaccination with the prevalence of post-COVID conditions in Thai patients with mild COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saikhuan TOWACHIRAPORN",Thailand
2793,PS010,2763,"The impact of non-pharmaceutical interventions implemented during the COVID-19 pandemic on the number of close contacts of SARS-CoV-2 cases in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sándor MAHIEU",Netherlands
2794,PS010,2763,"Protracted COVID-19 in immunocompromised hosts: a multicentre retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria DIOVERTI","United States"
2795,PS010,2763,"Spatio-temporal modelling of inequalities in the 2020-2021 COVID-19 pandemic waves in the Netherlands using reported SARS-CoV-2 infections and hospitalisations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carsten VAN ROSSUM",Netherlands
2796,PS010,2763,"Prospective one-year post-acute sequelae of COVID-19 in youth",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kees C. VAN DEN WIJNGAARD",Netherlands
2797,PS010,2763,"Higher SARS-CoV-2 viral load and delayed viral clearance in patients with autoantibodies neutralizing type I interferons",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thibault KERDILES",France
2798,PS010,2763,"Features of long COVID-19 in the Armenian population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lyudmila NIAZYAN",Armenia
2799,PS010,2763,"Platelet-rich plasma therapy for resistant post-COVID-19 olfactory dysfunction: a systematic review and meta-analysis of placebo-controlled studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohamed Hamouda Elsayed Ahmed Ali ELKASABY",Egypt
2800,PS010,2763,"Brachial neuritis as a side effect of COVID-19 vaccine: a systematic review on reported cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanieh RADKHAH","Islamic Republic Of"
2801,PS010,2763,"Ophthalmoplegia following oculomotor, trochlear, or abducens nerves disorder after COVID-19 vaccination: a systematic review of reported cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanieh RADKHAH","Islamic Republic Of"
2802,PS010,2763,"Clinical performance evaluation of GeneFinder COVID-19/Flu antigen test and SGTi-flexM COVID-19 & flu A/B Ag for diagnosis of SARS-CoV-2, influenza A and influenza B infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeonghyun CHANG","Republic Of"
2803,PS010,2763,"Nasopharyngeal microbiome composition by SARS-CoV-2 presence and severity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juana CLAUS",Netherlands
2804,PS010,2763,"Evaluation of SARS-CoV-2 spike mutations in immunocompromised and immunocompetent patients before and after SARS-CoV-2  treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra D'ABRAMO",Italy
2805,PS010,2763,"COVID-19 outbreaks caused by different SARS-CoV-2 variants: a descriptive, comparative study from China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cao CHEN",China
2806,PS010,2763,"Antibody persistence against omicron subvariants induced by monovalent mRNA, bivalent mRNA or nuvaxovid vaccines: final results from Phase D of the PRIBIVAC study, a randomised clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xuan Ying POH",Singapore
2807,PS010,2763,"Correlation of immune response with COVID-19 outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karolina AKINOSOGLOU",Greece
2808,PS010,2763,"Comparative subgenomic RNA expression profiles in SARS-CoV-2 variants: insights from symptomatic and asymptomatic cases in Sri Lanka",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sibra R.M. SHIHAB","Sri Lanka"
2809,PS010,2763,"Uncovering mutational drivers of enhanced transmission in the B.1.411 SARS-CoV-2 lineage in Sri Lanka",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sibra R.M. SHIHAB","Sri Lanka"
2810,PS010,2763,"Work productivity losses after COVID-19 infection among high-risk US patients with or without treatment with nirmatrelvir/ritonavir",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria FERNANDEZ","United States"
2811,PS010,2763,"Trends and impacts of SARS-CoV-2 genome sharing: a comparative analysis of China and the global community, 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yenan FENG",China
2812,PS010,2763,"Fc-mediated effector functions in mild and severe COVID-19: focus on ADE and ADCP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jong Su JONG SU","Republic Of"
2813,PS010,2763,"Impact of Lactobacillus gasseri on inflammatory responses in intestinal cells exposed to SARS-CoV-2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hamidi-Fard MOJTABA","Islamic Republic Of"
2814,PS010,2763,"Early vs late vs no remdesivir initiation in patients with immunocompromising conditions hospitalised with COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark BERRY","United States"
2815,PS010,2763,"Development and internal validation of a simplified scoring model with CURB-65 plus RNAemia for predicting mortality at diagnosis of SARS-CoV-2 pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonsoles SALTO-ALEJANDRE",Spain
2816,PS010,2763,"Efficacy of HMG-CoA  reductase inhibitors in hospitalisation and mortality of COVID-19 patients: a meta-analysis of randomised control trials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammadreza SHAFIEI","Islamic Republic Of"
2817,PS010,2763,"Trends in type 1 diabetes incidence between 2007 and 2023 and its association with SARS-CoV-2 infection in a population-based matched cohort study among individuals under 30 years in Sweden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dominik DIETLER",Sweden
2818,PS010,2763,"MicroRNAs in SARS-CoV-2 infection: analysis of immunocompromised and non-immunocompromised patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara SINISCALCHI",Italy
2819,PS010,2763,"Development of the long COVID/post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruth MOKGOKONG","United Kingdom"
2820,PS010,2763,"Inflammatory biomarkers in hospitalised COVID-19 patients during different pandemic waves as predictors for outcome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Violeta BRICIU",Romania
2821,PS010,2763,"Increased MP/CP co-infection in COVID-19-positive kidney transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhonghao WANG",China
2822,PS010,2763,"Viral resistance analyses from the obeldesivir BIRCH study in high-risk nonhospitalised patients with COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte HEDSKOG","United States"
2823,PS010,2763,"Investigating the prevalence of Streptococcus pneumoniae co-infection in patients with COVID-19 in the world: a meta-analysis study and systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saeed SHAMS","Islamic Republic Of"
2824,PS010,2763,"THE EFFECT of pregnancy on the severity of the course of COVID-19: an analysis of clinical data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gulbanu SHAIMERDENOVA",Kazakhstan
2825,PS010,2763,"Remdesivir and risk of multi-systemic long-term sequelae following COVID-19 hospitalisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"An Ting TAY",Singapore
2826,PS010,2763,"Correlation between urinary neutrophil gelatinase-associated lipocalin and neutrophil-to-lymphocyte ratio in hospitalised COVID-19 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luka SVITEK",Croatia
2827,PS010,2763,"Deterioration of swallowing function among patients with COVID-19: propensity score-matched cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ishikawa KAZUHIRO",Japan
2828,PS010,2763,"Health-related quality of life, work productivity and activity levels in younger and older adults with acute COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuela DI FUSCO","United States"
2829,PS010,2763,"Cost-effectiveness of oral nirmatrelvir/ritonavir for high-risk severe COVID-19 patients in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eveline Katharina OTTE IM KAMPE",Germany
2830,PS010,2763,"Acceptance of booster dose of COVID-19 vaccine: a community based study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sanskruti SHAH",India
2831,PS010,2763,"Utility of population-wide digital contact tracing in estimating vaccine effectiveness in a real-world pandemic setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammad Ismail BIN ABDUL MALEK",Singapore
2832,PS010,2763,"Impact of adjustment for differential testing by age and sex on apparent epidemiology of SARS-CoV-2 infection in Ontario, Canada",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
2833,PS010,2763,"The evolving challenge of appropriate antibiotics use in hospitalised COVID-19 patients: a systematic literature review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guido GRANATA",Italy
2834,PS010,2763,"Risk of long-term complications following steroid treatment for COVID-19 in hospitalised Singaporean adults: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David Chien LYE",Singapore
2835,PS010,2763,"Human ACE2 and TMPRSS2 polymorphisms for predicting susceptibility to tuberculosis and COVID-19 co-infection in Cameroonian cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary Ngongang KAMENI",Cameroon
2836,PS010,2763,"Role of frailty index-laboratory (FI-LAB) to predict COVID-19 mortality: a cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elda DE VITA",Italy
2837,PS010,2763,"Breast milk secretory IgA against SARS-CoV-2 S antigen: a comparative study between pandemic and post-pandemic periods in Peru",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonella SANCHEZ ZERILLO",Peru
2838,PS010,2763,"Clinical evaluation of a SARS-CoV-2 spike receptor-binding and N-terminal domain COVID-19 vaccine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Spyros CHALKIAS","United States"
2839,PS010,2763,"The impact of convalescent immune reactions on long-term pulmonary sequelae in mild to moderate COVID-19 patients during active treatment era",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Minkyeong LEE","Republic Of"
2840,PS010,2763,"JAK inhibitors in adults hospitalised due to COVID-19: individual participant data meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alain AMSTUTZ",Switzerland
2841,PS010,2763,"Viral resistance analyses from the obeldesivir OAKTREE study in low-risk nonhospitalised patients with COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lauren RODRIGUEZ","United States"
2842,PS010,2763,"New circulating variants of SARS-CoV-2 in Asturias during the post-COVID era",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Santiago MELÓN GARCÍA",Spain
2843,PS010,2763,"Assessing the impact of public health policies affecting indoor SARS-CoV-2 transmission: a retrospective analysis in Amsterdam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sándor MAHIEU",Netherlands
2844,PS010,2763,"Bayesian estimation of counterfactual mortality reduction following COVID-19 vaccine introduction in the United States, 2020–2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillermo RODRIGUEZ-NAVA","United States"
2845,PS010,2763,"Non-invasive COVID-19 detection using FTIR spectroscopy and machine learning on nasopharyngeal and salivary samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Craig WILLIAMS","United Kingdom"
2846,PS010,2763,"Exploring the role of LAMP1 (CD107a) and PDCD1 high Tfh cells in COVID-19 immunopathogenesis and vaccine response",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhangfan FU",China
2847,PS010,2763,"SARS-Cov-2 evolution in patients with prolonged viral shedding",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julien AUCLAIRE",France
2848,PS010,2763,"Estimating population protection against emerging SARS-CoV-2 variants: a risk assessment utilising convalescent sera before the roll-out of XBB-lineage vaccines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana ATTI","United Kingdom"
2849,PS010,2763,"Understanding COVID-19 mitigation behaviours during the pandemic: comprehensive analysis from 12,626 healthcare workers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel PAN","United Kingdom"
2850,PS010,2763,"Structure of VYD2311 & in vitro neutralisation against a panel of contemporary SARS-CoV-2 variants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pamela HAWN","United States"
2851,PS010,2763,"Healthcare worker attitudes to lateral flow device testing and sick leave for influenza-like illness in the UK: a hypothetical scenario-based study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah FOULKES","United Kingdom"
2852,PS010,2763,"Molecular pathways affected by anakinra treatment in patients with severe COVID-19: analysis of the SAVE-MORE trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanouil STYLIANAKIS",Netherlands
2853,PS010,2763,"The nasal microbiome modulates risk for COVID-19 infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cindy M. LIU","United States"
2854,PS010,2763,"Clinical outcomes of immunocompromised patients using tixagevimab-cilgavimab as pre-exposure prophylaxis for COVID-19: real-world experience in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi-Tsung LIN",China
2855,PS010,2763,"Screening of COVID-19 antibodies in recovered healthcare workers after thee months and after six months",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Basant Mahmoud ABDELHAMID",Egypt
2856,PS010,2763,"The effect of immunomodulatory therapy on the incidence of secondary bacterial and fungal infections of hospitalised COVID-19 patients in England, January 2020 – August 2023: a case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chloe DAVISON","United Kingdom"
2857,PS010,2763,"Mental well-being and resilience during a pandemic: co-creating with students",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole VAN DEN BRAAK",Netherlands
2858,PS010,2763,"Risk of multi-systemic long-term sequelae following COVID-19 in older adults, stratified by frailty: a population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yong Yi TAN",Singapore
2859,PS010,2763,"Different innate immune response in SARS-CoV-2 vaccinated and unvaccinated individuals with COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca MADDALONI",Italy
2860,PS010,2763,"Evaluating blood sampling strategies in large-scale multi-site cohort studies: insights from the SIREN study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irina LUT","United Kingdom"
2861,PS010,2763,"Risk of new-incident mental health diagnoses during COVID-19 and post-SARS-CoV-2 infection amongst children and young adults in Singapore: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janice TAN",Singapore
2862,PS010,2763,"Impact of remdesivir in Portugal: enhancing healthcare capacity and outcomes in COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malwina MEJER",Belgium
2863,PS010,2763,"Relative effectiveness of COVID-19 vaccinations in immunocompromised individuals: a real-world study in South Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthew ROUSCULP","United States"
2864,PS010,2763,"Understanding winter and summer surges of COVID-19 in the post pandemic period: a multinational analysis of surveillance data for 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irini ZOGRAFAKI",Greece
2865,PS010,2763,"Longitudinal analysis of antibody dynamics post-COVID-19 vaccination in the context of healthcare worker-driven COVID-19 transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tadas ALCAUSKAS",Lithuania
2866,PS010,2763,"Variable selection for prediction models of Omicron infection: insights from two population-based cohort studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanne LACY",Switzerland
2867,PS010,2763,"Immunogenicity and safety of a SARS-CoV-2 N-terminal domain and receptor-binding domain monovalent XBB.1.5 vaccine in Japanese participants aged ≥12 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christina GRASSI","United States"
2868,PS010,2763,"Benefits and risks of systematic screening for SARS-CoV-2 in asymptomatic hospitalised patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marvin WEISS",Switzerland
2869,PS010,2763,"Post pandemic burden of COVID-19 in ix European countries: a national surveillance analysis for 2023-2024 fall-winter season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irini ZOGRAFAKI",Greece
2870,PS010,2763,"Factors associated with the development of SARS-CoV-2 RNAemia at COVID-19 diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier MARTÍN-ESCOLANO",Spain
2871,PS010,2763,"Development of a definition of post-acute sequelae of SARS-CoV-2 (PASC) in a Korean long COVID cohort by using machine learning",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Choi Young JANG","Republic Of"
2872,PS010,2763,"SARS-CoV-2 infection and hospitalisations in the omicron era: triangulation of symptom onset, positive test, and vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Essy MOZAFFARI","United States"
2873,PS010,2763,"Evaluating the efficiency of population-based infectious disease surveillance: a modelling study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David SMITH","United Kingdom"
2874,PS010,2763,"Impact of the COVID-19 pandemic on healthcare seeking and antibiotic prescribing for acute respiratory infection in primary care centres in Nam Dinh province, Vietnam: analysis of routinely collected electronic prescription data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia LEWYCKA",Vietnam
2875,PS010,2763,"Changes in management of immunosuppressed patients with SARS-CoV-2 infection: impact on cure and mortality rates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Berta PERNAS-SOUTO",Spain
2876,PS010,2763,"Persistent SARS-CoV-2 infection among immunosuppressed patients: characterisation of subpopulations of lymphocytes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Berta PERNAS-SOUTO",Spain
2877,PS010,2763,"The impact of baricitinib on systemic inflammation in COVID-19 and its association with prolactin: an exploratory analysis of interleukin levels",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Georgios SCHINAS",Greece
2878,PS010,2763,"A nationwide cohort study of delta and omicron SARS-CoV-2 outcomes in older Singaporean adults stratified by frailty",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammad Ismail BIN ABDUL MALEK",Singapore
2879,PS010,2763,"SARS-CoV-2 infection and different-term thrombotic outcomes in patients with coronary atherosclerosis disease in China: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huajie XU",China
2880,PS010,2763,"A validated threshold of protection model for monoclonal antibody pre-exposure prophylaxis against COVID-19 enabling rapid development for future SARS-CoV-2 variants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sam MATTHEWS","United Kingdom"
2881,PS010,2763,"Characterisation of serological response against SARS-CoV-2 throughout the pandemic within the UK-based SIREN study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana ATTI","United Kingdom"
2882,PS010,2763,"Long-term multi-systemic sequelae following hospitalisation for respiratory syncytial virus vs omicron SARS-CoV-2/influenza in Singaporean adults and children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janice TAN",Singapore
2883,PS010,2763,"Analysing adaptive immune responses to BBV152 (Covaxin) and ChAdOx1 nCoV-19 (Covishield)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tanu BANSAL",India
2884,PS010,2763,"Chronic stress prior to SARS-CoV-2 infection as predictor of ongoing symptomatic COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian FAZEKAS",Austria
2885,PS010,2763,"The effect of SARS-CoV-2 mRNA vaccination on contagiousness of individuals with breakthrough infection following vaccination: a systematic review and meta-analysis of over six million study participants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ji Soo CHOI","United Kingdom"
2886,PS010,2763,"Factors associated with silent hypoxia in patients with COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shinichiro MORIOKA",Japan
2887,PS010,2763,"Different transcriptional metabolic response in SARS-CoV-2 infected CFTR-defective vs wild-type bronchial cells",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna LAGNI",Italy
2888,PS010,2763,"Kinetics of neutralising antibodies against omicron BA.2 and BA.5 beyond the acute phase of infection in residential care homes for the elderly",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kwok KIN ON",China
2889,PS010,2763,"Long COVID in a cohort of patients hospitalised for COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pierantonio GRIMALDI",Italy
2890,PS010,2763,"Immunological imprinting by seasonal coronaviruses and previous herpesvirus infections in patients with long COVID",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashwin MAK",Netherlands
2891,PS010,2763,"Post-COVID in autumn 2023: pre- and post-infection comparison",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siméon DE BRUIJN",Netherlands
2892,PS010,2763,"Differential long-term serological responses to SARS-CoV-2 vaccination in patients with solid and heamatologic malignancies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Giulia CAPONCELLO",Spain
2893,PS010,2763,"Prevalence of post-COVID syndrome and its societal impact",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merlin VAN LOENEN",Netherlands
2894,PS010,2763,"Cytokine profile-based symptom clustering in patients with post-acute sequelae of COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ji-Soo KWON","Republic Of"
2895,PS010,2763,"Sequential SARS-CoV-2 antigen exposures drive durable, broad and non-waning neutralising antibodies over four years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David GREENWOOD","United Kingdom"
2896,PS010,2763,"Anti-SARS-CoV-2 antibody and cellular immune responses to third, fourth and fifth heterologous vaccine doses in Indonesian healthcare workers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raph L. HAMERS",Indonesia
2897,PS010,2763,"SARS-CoV-2 infection management in haematological malignancy patients: the ORCHESTRA Delphi consensus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna Maria AZZINI",Italy
2898,PS010,2763,"Social support in a pandemic: impact of household situation on severity of COVID outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kelvin Bryan TAN",Singapore
2899,PS010,2763,"Impact of secondary infections on the outcomes of patients with SARS-CoV-2 infection and heamatological malignancies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca BOBBIO",Italy
2900,PS010,2763,"First antigenic exposures to SARS-CoV-2 Spike inform subsequent Omicron infection risk but do not indelibly shape longitudinal neutralising immunity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joshua GAHIR","United Kingdom"
2901,PS010,2763,"Routinely captured measurements of vital signs within long-term care facilities indicate substantial and sustained physiological impacts associated with COVID-19 infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harriet DICKINSON","United Kingdom"
2902,PS010,2763,"A dynamic latent transition model for predicting post-COVID condition trajectories and guiding patient management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna GORSKA",Italy
2903,PS010,2763,"Neutralising antibody responses against omicron variants in individuals vaccinated or unvaccinated with the bivalent BA.4/5 vaccine: a six-month prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hye Hee CHA","Republic Of"
2904,PS010,2763,"Longitudinal humoral response to SARS-CoV-2 mRNA vaccines and boosters in heart and lung transplant patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arianna LIPPI",Italy
2905,PS010,2763,"Regression-based forecasting of SARS-CoV-2-related ICU admissions during the pandemic: impact of widespread vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David FISMAN",Canada
2906,PS010,2763,"Retrospective analysis of SARS-CoV-2 omicron variant prevalence over two years in southern Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priscila TRINDADE",Brazil
2907,PS010,2763,"Association of AB0 blood type with humoral immune responses to SARS-CoV-2 vaccination and infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuel KRONE",Germany
2908,PS010,2763,"Low dosage of a novel SARS-COV-2 mRNA VLP vaccine elicits equivalent cell-mediated immunity to a licensed mRNA vaccine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Phillip SWANSON","United States"
2909,PS010,2763,"Dynamics of cellular and humoral immune responses in healthcare workers following a fourth COVID-19 vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliane MEES",Germany
2910,PS010,2763,"Short-term challenges, long-term consequences: a comprehensive study of COVID-19 in solid organ transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU",Türkiye
2911,PS010,2763,"Antibody kinetics and duration of protection against SARS-CoV-2 following vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia DEICHMANN","United States"
2912,PS010,2763,"Characterisation of young vs older stroke in hospitalised patients with COVID-19 infection: a UK based, multicentred, case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Orla HILTON","United Kingdom"
2913,PS010,2763,"Correlation analysis of immune checkpoint molecules in children with post-acute sequelae of SARS-CoV-2 infection in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yu-Lung HSU",China
2914,PS010,2763,"Epidemiology of Pseudomonas aeruginosa superinfection in critical COVID-19 patients in a tertiary-care teaching hospital in Mexico City",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valente-Acosta VALENTE-ACOSTA",Mexico
2915,PS010,2763,"Validation and longitudinal analysis of the consensus immune dysregulation framework in a multi-cohort study of COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anastasiya SUSHKOVA","United States"
2916,PS010,2763,"Chronic SARS-CoV-2 infection demonstrate immune compromisation type- and intensity-dependent viral load dynamics and adaptive evolution trajectory: results from an aggregated meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tsz Kin Mark CHENG","United Kingdom"
2917,PS010,2763,"Both clinical status and practices affect microbiome dynamics of the upper respiratory tract during COVID-19 infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mi-Kyung LEE","Republic Of"
2918,PS010,2763,"Antibody responses to SARS-CoV2 among cancer patients in New York city during the 2020 wave of the COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Genovefa PAPANICOLAOU","United States"
2919,PS010,2763,"Artificial intelligence-enhanced nurse navigation: a new paradigm for long COVID diagnosis and care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana Paula BARBOZA",Brazil
2920,PS010,2763,"Nasopharyngeal microbiome evolution after SARS-CoV-2 infection: insights into long COVID progression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana Paula BARBOZA",Brazil
2921,PS010,2763,"Combination therapy with ensitrelvir and remdesivir reduces viral shedding duration in COVID-19 patients treated with anti-CD20 monoclonal antibodies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tomonori TAKANO",Japan
2922,PS010,2763,"Impact of long COVID on health-related quality-of-life among Japanese adults: findings of CARE Japan study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shinya TSUZUKI",Japan
2923,PS011,NULL,"02a. Tuberculosis and other mycobacterial infections (incl epidemiology, clinical, diagnostics, antimycobacterial drugs, susceptibility testing, treatment & prevention)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
2924,PS011,2923,"Impact of fluoroquinolone exposure on the diagnosis and prognosis of tuberculosis in immunocompromised patients: a propensity-score matched, competing risk analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sung-Woon KANG","Republic Of"
2925,PS011,2923,"Whole-genome sequencing and phenotypic DST of bedaquilin, delamanid, proteomanid and linezolid in drug-resistant Mycobacterium tuberculosis in South Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hee Joo LEE","Republic Of"
2926,PS011,2923,"Safety, tolerability and pharmacokinetics of single and multiple ascending doses and food-effect of MRX-5 tablets in healthy adult subjects",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huahui YANG",China
2927,PS011,2923,"Modulation of RISK-3 signature in patients at different tuberculosis (TB) stages enrolled in a low-TB endemic country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa PETRUCCIOLI",Italy
2928,PS011,2923,"Comparison of high-frequency ultrasound and contrast computed tomography for detection of spleen micro-abscesses in disseminated mycobacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca CATANIA",Italy
2929,PS011,2923,"Non-tuberculous and tuberculous Mycobacteria prevalence and drug resistance in Italian and foreign subjects",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara CALDRER",Italy
2930,PS011,2923,"Diagnostic utility of blood cultures and myelocultures for non-tuberculous mycobacteria infections: a retrospective study in a Portuguese tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara MAGALHÃES",Portugal
2931,PS011,2923,"Crossroads of care: TB trends among Italians and migrants in a tertiary hospital in northern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca ROSSI",Italy
2932,PS011,2923,"Clinical significance of nontuberculous mycobacteria isolates in a Chinese general hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yumeng YAO",China
2933,PS011,2923,"Secular trends in clinical features and outcomes of peritoneal tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra PÉREZ-RECIO",Spain
2934,PS011,2923,"Genetic diversity of Mycobacterium bovis BCG clinical isolates from immunocompromised patients with BCG infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suwatchareeporn ROTCHEEWAPHAN",Thailand
2935,PS011,2923,"Evaluating the performance of the BACES model in a Dutch cohort with nontuberculous mycobacterial pulmonary disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arthur LEMSON",Netherlands
2936,PS011,2923,"Can the BACES score predict clinical outcomes in a Dutch cohort with nontuberculous mycobacterial pulmonary disease?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arthur LEMSON",Netherlands
2937,PS011,2923,"Tuberculosis infection progression among pregnant women with HIV at high risk of tuberculosis: a sentinel screening study at three Ugandan health facilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ronald OLUM",Uganda
2938,PS011,2923,"Management of mycobacterial infections: experience with amikacin use in OPAT at NHS GGC",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Awilly CHOFLE","United Kingdom"
2939,PS011,2923,"Evaluation of clinical performances of the PATHFAST TB Lam Ag assay, a new diagnostic test for tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theo FOUCHET",France
2940,PS011,2923,"Early acquisition of long-term memory and decline of cytotoxic CD8+ T-cells subpopulations in blood as biomarkers of tuberculosis treatment efficacy in human",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier BAHUAUD",France
2941,PS011,2923,"Extrapulmonary tuberculosis: still a persistent issue!",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rym ABID",Tunisia
2942,PS011,2923,"Efficacy of rifapentine plus moxifloxacin vs standard of care for pulmonary tuberculosis: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taniela MARLI BES","United States"
2943,PS011,2923,"Assessment of demographic characteristics, clinical profiles, laboratory findings, and outcome of CNS tuberculosis among paediatric patients in a tertiary care hospital in Bangladesh",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah ALAM",Bangladesh
2944,PS011,2923,"Defining drug resistance beyond rifampicin: evaluation of Xpert MTB/XDR assay directly from cerebrospinal fluid (CSF) samples in patients of tuberculous meningitis (TBM)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kusum SHARMA",India
2945,PS011,2923,"Inhalable statin-encapsulated gelatin microsphere as a host targeted strategy to inhibit matrix metalloproteinases in tuberculosis pathogenesis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agrim JHILTA",India
2946,PS011,2923,"In-hospital and 90-day post-discharge outcomes in central nervous system tuberculosis: a prospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samarth BHAT K S",India
2947,PS011,2923,"Pulmonary and extrapulmonary tuberculosis at an urban setting in eastern India during 2016 to 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sidhartha GIRI",India
2948,PS011,2923,"Time to positivity correlates with treatment initiation and disease severity in patients with Mycobacterium avium-complex in sputum culture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice AXINDER",Sweden
2949,PS011,2923,"Detection of cross-border M. tuberculosis clusters using an online cloud genetics processing platform",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeremy WESTHEAD","United Kingdom"
2950,PS011,2923,"Predictors of multidrug-resistant tuberculosis in rural district of Pakistan: a case-control study, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammad Asif SYED",Pakistan
2951,PS011,2923,"The role of lipid biomarkers in inflammatory and mortality in tuberculosis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oguzhan ACET",Türkiye
2952,PS011,2923,"Evaluation of Mycobacterium tuberculosis derived cell-free DNA (CF-DNA) based multi-targeted real-time PCR (MRTPCR) from cerebrospinal fluid (CSF) samples for diagnosis of tuberculous meningitis (TBM)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ananya SHARMA",India
2953,PS011,2923,"Improved prediction of bedaquiline resistance from genetic data using automatically-built catalogues",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adlard ADLARD","United Kingdom"
2954,PS011,2923,"Analysis of clinical impact of the coronavirus disease (COVID-19) pandemic on the quality of pulmonary tuberculosis management with national reimbursement data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Young Ah KIM","Republic Of"
2955,PS011,2923,"Initiation and completion of latent tuberculosis treatment in healthcare workers across two hospital sites in Ireland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daragh MCGEE",Ireland
2956,PS011,2923,"Routine investigations for tuberculosis on bronchoalveolar fluid lavage in a low-incidence setting: is it worth it?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara SEPULCRI",Italy
2957,PS011,2923,"Performance of a novel dual marker RT-qPCR-based whole-blood test for improved detection of M. tuberculosis infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Franziska Maria KANIS",Germany
2958,PS011,2923,"Preliminary results from Europe-wide survey “EURO-SURVERY TB” on adjunctive surgical treatment of pulmonary tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raja IDRIS",Germany
2959,PS011,2923,"Unmasking hidden coinfections: a breakthrough real-time PCR approach for detecting and differentiating tuberculosis and Mycobacterial strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
2960,PS011,2923,"Evaluation of trace result from Xpert MTB/RIF ultra in a low-burden tuberculosis area",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc GORDO-BASTÉ",Spain
2961,PS011,2923,"Predicting development of tuberculosis disease by stratifying T-SPOT.TB results: a retrospective cohort study of diagnostic accuracy among 8,544 individuals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ole SKOUVIG PEDERSEN",Denmark
2962,PS011,2923,"Evaluation of Truenat drug chips directly from clinical samples for detection of  XDR, pre-XDR, and MDR in patients of extrapulmonary tuberculosis(EPTB) from north India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vijeta PATIAL",India
2963,PS011,2923,"CXCL-9 and CXCL-10 as potential biomarkers for tuberculosis severity in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina DI GIUSEPPE",Italy
2964,PS011,2923,"The effect on tuberculosis on lung function: a case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma Elisabeth POULSEN",Denmark
2965,PS011,2923,"Assessment of in vitro efficacy of three-antibiotics combinations against Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie CHARLES",France
2966,PS011,2923,"Hepatic adverse reactions in anti-tuberculosis treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanen BEN HMIDA",Tunisia
2967,PS011,2923,"Safety and efficacy of four-month short course regimen in low risk active tuberculosis-a multicentre randomised controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susan Shin-Jung LEE",China
2968,PS011,2923,"Identification of differentially expressed transcriptional profiling from active tuberculosis infection to healthy children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fang XU",China
2969,PS011,2923,"Risk of tuberculosis among patients with inflammatory bowel disease and inflammatory rheumatic disease treated with biological agents in Denmark: a nationwide population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian KRAEF",Denmark
2970,PS011,2923,"Characterising Mycobacterium tuberculosis resistance mechanisms to ganfeborole and monitoring drug resistance during Phase 2a clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana YEPES GARCIA",Spain
2971,PS011,2923,"Decoding isoniazid resistance: a comprehensive study of mutation patterns and diagnostic insights in tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Srishty Sananda HOTA",India
2972,PS011,2923,"Delayed TB diagnostics and treatment in Ukraine due to the war and preceding COVID-19 epidemics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olha KONSTANTYNOVSKA",Ukraine
2973,PS011,2923,"Targeted next-generation sequencing: a promising approach in the diagnosis of Mycobacterium tuberculosis and drug resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fang You YU",China
2974,PS011,2923,"HDAC1 mediated acetylome landscape controls mycobacteria-specific T cell memory responses during tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashima BHASKAR",India
2975,PS011,2923,"Direct identification of Mycobacterium tuberculosis and eight dominant non-tuberculous mycobacterial using a multiplex molecular point-of-care panel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qiaolian YI",China
2976,PS011,2923,"Nontuberculous mycobacterial diagnosis codes: a good proxy of NTM disease?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pernille Grand MOESTRUP",Denmark
2977,PS011,2923,"Treatment outcomes in patients with M. abscessus lung infection: national multicentre study of the IRENE project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto MATTEELLI",Italy
2978,PS011,2923,"From fish fin injury to Mycobacteroides abscessus: precision diagnosis in a complex case using shotgun metagenomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ummu Afeera ZAINULABID",Malaysia
2979,PS011,2923,"Tuberculosis infection and tuberculosis disease in household contacts of newly diagnosed multidrug-resistant tuberculosis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandeep RAO KORDCAL",India
2980,PS011,2923,"Utility of Xpert MTB/XDR in GeneXpert MTB/RIF positive extrapulmonary tuberculosis (EPTB) samples: a step towards precision in EPTB management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rohit KUMAR",India
2981,PS011,2923,"A new multiplex real-time PCR test for the diagnosis of TB and NTM patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica SORELLA",Italy
2982,PS011,2923,"Assessment of isoniazid preventive therapy and barriers of implementation among contacts of pulmonary tuberculosis patients in Raipur district",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashish SINHA",India
2983,PS011,2923,"TBSure: survey of paediatric TB management practices in the Europe region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Onya OPOTA",Switzerland
2984,PS011,2923,"Epidemiological profile and clinical presentation of cutaneous tuberculosis: systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathya SUASTE",Ecuador
2985,PS011,2923,"No evidence of nation-specific ecotypes for Mycobacterium avium in Northern Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ingrid VAN WEERDENBURG",Netherlands
2986,PS011,2923,"Asymptomatic tuberculosis: a new challenge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marina TADOLINI",Italy
2987,PS011,2923,"Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration for bladder cancer: a decade nationwide French study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanuel LAFONT",France
2988,PS011,2923,"Inpatient versus outpatient pulmonary tuberculosis management in Italy: a nationwide survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marina TADOLINI",Italy
2989,PS011,2923,"Rapid detection of isoniazid and fluoroquinolone resistance in Mycobacterium tuberculosis using the Xpert MTB/XDR assay in a low TB and low MDR-TB prevalence setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Héctor MORENO",Switzerland
2990,PS011,2923,"Increased isolation of Mycobacterium lentiflavum along the years: is it the new Mycobacterium avium?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandra ARENAS",Spain
2991,PS011,2923,"Empirical anti-tuberculous medications in adults with suspected tuberculous meningitis: a retrospective cohort study in Mashhad, Iran",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fereshteh SHEIBANI","Islamic Republic Of"
2992,PS011,2923,"Molecular diagnosis of mycobacteria: identification of tuberculous and non-tuberculous species in 733 clinical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andre DOI",Brazil
2993,PS011,2923,"Mycobacterium tuberculosis DNA detection in formalin-fixed paraffin-embedded tissue using digital PCR: a proof-of-concept study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Billie VELAPATIÑO",Canada
2994,PS011,2923,"Adjuvant use of TNF-alpha antagonists for TB meningitis: RNA signalling and clinical experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arjan VAN LAARHOVEN",Netherlands
2995,PS011,2923,"Comparative evaluation of Xpert, Xpert Ultra, and Truenat for the diagnosis of tuberculous meningitis in central India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anvita GUPTA MALHOTRA",India
2996,PS011,2923,"Evaluation of comprehensive drug resistance prediction using nanopore targeted NGS reagent with MDR-TB isolates in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akiko TAKAKI",Japan
2997,PS011,2923,"Epidemiology of non-tuberculous Mycobacteria in Denmark: seven decades of clinical occurrence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xenia Emilie Sinding IVERSEN",Denmark
2998,PS011,2923,"Clinical management of trace results in a rapid molecular TB diagnostic assay among presumptive cases in Lebanon, a low-TB burden country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marianne ANTAR",Lebanon
2999,PS011,2923,"Assessment of in vitro efficacy of three-antibiotics combinations against Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
3000,PS011,2923,"Mapping tuberculosis diversity in Lebanon: a pioneering baseline study using whole genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marianne ANTAR",Lebanon
3001,PS011,2923,"Non-tuberculous mycobacterial disease at a tertiary care centre in high tuberculosis and HIV burden setting: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saskia JANSSEN-LE ROUX",Netherlands
3002,PS011,2923,"Complicated CNS tuberculosis: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abhinav SENGUPTA",India
3003,PS011,2923,"EndTB-Q trial for pre-XDR-TB: impact of baseline tuberculosis disease extent on efficacy of a shortened, stratified-medicine treatment strategy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorenzo GUGLIELMETTI",France
3004,PS011,2923,"Definition of SNPs limit range for unknown non-tuberculous Mycobacteria genomic investigation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia GATTI",Italy
3005,PS011,2923,"Evaluation of bioline TB Ag MPT64 for detecting Mycobacterium tuberculosis complex in acid-fast bacilli-positive cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jung-Ah KIM","Republic Of"
3006,PS011,2923,"Targeted next-generation sequencing: a promising approach for Mycobacterium tuberculosis detection and drug resistance in paucibacillary clinical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wenting JIN",China
3007,PS011,2923,"Comparison of three different protocols for identification of nontuberculous mycobacteria species from liquid media by matrix-assisted laser desorption/ionisation-time-of-flight mass spectrometry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nezihat Desen BÜYÜKSOY",Türkiye
3008,PS011,2923,"Treatment of latent tuberculosis infection: obstacles to reach the goal: the TIBER study, preliminary results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlo PALLOTTO",Italy
3009,PS011,2923,"Development and validation of a novel scoring system to differentiate between tuberculous and non-tuberculous pleural effusion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Atish MOHAPATRA",India
3010,PS011,2923,"Molecular characteristics and drug susceptibility of aminoglycosides in multidrug-resistant tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yinjuan GUO",China
3011,PS011,2923,"How to manage drug-sensitive tuberculosis when rifampicin cannot be used? A survey by the study group on Mycobacteria of the Italian Society of Infectious Diseases and Tropical Medicine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amina ZAFFAGNINI",Italy
3012,PS011,2923,"Phenotypic and genotypic antimicrobial susceptibility testing of Mycobacterium avium complex and Mycobacterium kansasii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marina VICENTE CIURANS",Spain
3013,PS011,2923,"TBM PR-IRIS: a UK wide retrospective cohort study of paradoxical reaction in central nervous system tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma CARTER","United Kingdom"
3014,PS011,2923,"LeuRS-targeting prodrug, MRX-5, expresses anti-Mycobacterium abscessus activity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anqi LI",China
3015,PS011,2923,"Evaluation of the clinical performance of an enzyme-linked immunosorbent assay and an immunochromatographic lateral flow assay for the detection of Mycobacterium tuberculosis infection in human plasma samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ulrich EIGNER",Germany
3016,PS011,2923,"Study of the antimicrobial and antibiofilm activity of eugenol, gallic acid and ellagic acid in Mycobacterium avium complex clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara BATISTA ARNAU",Spain
3017,PS011,2923,"Accelerated and refined genomic analysis, coupled with epidemiological interventions, to optimise tuberculosis transmission control",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sheri M SALEEB",Egypt
3018,PS011,2923,"Treatment outcomes in Mycobacterium simiae pulmonary disease: a retrospective multicentre cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anat ARBEL",Israel
3019,PS011,2923,"Rapidly and reproducibly building a catalogue of resistance-associated variants using 46,800 M. tuberculosis samples with genomes and DST data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philip FOWLER","United Kingdom"
3020,PS011,2923,"Pro-angiogenic growth factors and matrix metalloproteinases are key drivers of dysregulated angiogenesis in tuberculosis with diabetes mellitus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi Hao WONG",Singapore
3021,PS011,2923,"The microbiological and clinical complexity of infections in patients with treatment-refractory Mycobacterium avium complex lung disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tim DOYLE","United States"
3022,PS011,2923,"Accelerating Mycobacterium abscessus drug discovery with novel double-reporter strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tânia SILVA",Portugal
3023,PS011,2923,"Longitudinal assessment of health-related quality of life in untreated Mycobacterium abscessus pulmonary disease: interim analysis from the Singapore FORMaT trial observational cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephanie SUTJIPTO",Singapore
3024,PS011,2923,"Infliximab or inflixi-mad? Disordered approaches to pre-immunosuppressive therapy latent TB infection screening",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miles EDWARDS","United Kingdom"
3025,PS011,2923,"Pangenome and CNV analysis of clinical Mycobacterium tuberculosis isolates identifies perturbations in phage immunity genes linked to drug resistance and lineage types",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nikhil BHALLA",India
3026,PS011,2923,"Mortality and causes of death in patients with Mycobacterium avium complex isolates through 28 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor NÆSTHOLT DAHL",Denmark
3027,PS011,2923,"Platelets at tuberculomas worsen CNS-TB by inducing PAD-driven NETs and PI3K/Akt-driven MMP-1 release: data from human, murine and 3D cellular models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyeyoung LEE",Singapore
3028,PS011,2923,"Development of potential and cost-effective isoniazid-phytochemical hybrid drugs using an integrated combinatorial approach against Mycobacterium tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shasank Sekhar SWAIN",India
3029,PS011,2923,"Characterisation of mycobacteriophage BluSpix and Mycobacterium smegmatis phage-resistant strain Nigel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edith MACHOWSKI","South Africa"
3030,PS011,2923,"Early bactericidal activity of contezolid in patients with drug-resistant tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peize ZHANG",China
3031,PS011,2923,"Mycobacterium chelonae infective endocarditis: data from the MYBACH registry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frieder PFÄFFLIN",Germany
3032,PS011,2923,"Evaluation of the Xpert MTB/RIF Ultra assay to detect tuberculosis in concentrated urine from inpatients with advanced HIV in Ghana",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johanna ÅHSBERG",Denmark
3033,PS011,2923,"Prevalence of tuberculosis in cancer patients: a single centre experience from India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pradnya Laxman SAMANT",India
3034,PS011,2923,"Evaluating the intracellular activity of a phage combination targeting Mycobacterium tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta POZUELO TORRES",Netherlands
3035,PS011,2923,"GenoMAB: a genomic pipeline for Mycobacterium abscessus antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Salim AGSOUS",France
3036,PS011,2923,"Advantages of fluorescence staining technique in the diagnosis of tuberculosis as an alternative to Ziehl-Neelsen: a comparative study in a tertiary Greek hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gerasimos Socrates CHRISTODOULATOS",Greece
3037,PS011,2923,"In vitro activity of imipenem/relebactam alone and in combination against cystic fibrosis isolates of Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Madeline SANDERS","United States"
3038,PS011,2923,"Clinical Mycobacterium tuberculosis isolates exhibit a molecular clock rate below 1 SNP per genome per year",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kan YU",Australia
3039,PS011,2923,"Barriers and facilitators to paediatric tuberculosis management in India: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthew WILLIS","United Kingdom"
3040,PS011,2923,"Chronic mycobacteria infection triggers macrophage senescence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edoardo SCARPA",Italy
3041,PS011,2923,"Microbiological and clinical characteristics of extrapulmonary nontuberculous mycobacterial disease in a Chinese general hospital, a ten-year retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yumeng YAO",China
3042,PS011,2923,"Increasing non-tuberculous mycobacteria recovery rate and regional difference of mycobacterial species over 11 Years in a Korean tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jae Hyeon PARK","Republic Of"
3043,PS011,2923,"Leprosy is evading eradication: epidemiology and pathogenesis in 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aidan BAKER JOHAL","United Kingdom"
3044,PS011,2923,"Extrapulmonary and disseminated tuberculosis in non-immunocompromised patients: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra  RAJME",Mexico
3045,PS011,2923,"Disseminated pneumonia associated with achalasia and a Mycobacterium fortuitum group species: phylogenetic characterisation and ESX-complex analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura Anne HUGHES",Netherlands
3046,PS011,2923,"Characteristics of tuberculosis in migrants and native population: a retrospective study in an Italian hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Drieda ZACE",Italy
3047,PS011,2923,"Non-tuberculous mycobacterial skin and soft tissue infections following cosmetic procedures: a multicentric cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brenda ACEVES SÁNCHEZ",Mexico
3048,PS011,2923,"Tuberculous meningitis: a ten-year retrospective study regarding treatment and outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joana BATISTA",Portugal
3049,PS011,2923,"Contezolid in tuberculosis therapy: a retrospective analysis of real-world practice in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peize ZHANG",China
3050,PS011,2923,"Evaluation of rifampicin resistance burden in pulmonary and extrapulmonary tuberculosis at a paediatric tertiary care facility in northern India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anushika SONI",India
3051,PS011,2923,"Pathogen and host determinants of extrapulmonary tuberculosis among 1035 patients in Frankfurt am Main, Germany, 2008-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nils WETZSTEIN",Germany
3052,PS011,2923,"Seasonality of tuberculosis at a capital city in eastern India during 2016 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sidhartha GIRI",India
3053,PS011,2923,"Impact of the new WHO critical concentration for rifampicin for diagnosis of rifampicin resistance of Mycobacterium tuberculosis in a low TB prevalence area",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bettina SCHULTHESS",Switzerland
3054,PS011,2923,"In vitro drug susceptibility of rifampicin-resistant and rifampicin-susceptible Mycobacterium tuberculosis in Shanghai, China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tao CHEN",China
3055,PS011,2923,"Species identification and antimicrobial susceptibility of Mycobacterium abscessus complex clinical isolates from a general hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rong BAO",China
3056,PS011,2923,"A study to evaluate the efficacy, safety, pharmacokinetics-pharmacodynamics of bedaquiline based regimen in multibacillary leprosy not responding to WHO-multidrug therapy (WHO-MDT)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Himanshi KHERA",India
3057,PS011,2923,"Distribution of contezolid concentrations at lesion sites in bone and joint tuberculosis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wenjuan NIE",China
3058,PS011,2923,"Screening of Mycobacterium tuberculosis in medicolegal  autopsy cases in a tertiary care centre in central India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diksha CHHABRA",India
3059,PS011,2923,"Characterisation of clinical Mycobacterium kansasii complex isolates in routine diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bettina SCHULTHESS",Switzerland
3060,PS011,2923,"Trends in isolation frequency of nontuberculous mycobacteria at the national reference laboratory of Mycobacteria, in Athens, Greece, 2015-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stavroula ANTONOPOULOU",Greece
3061,PS011,2923,"Investigation into comorbidities and mortality in clinically diagnosed tuberculosis patients in Kilifi county, Kenya",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Florah WETENDE",Kenya
3062,PS011,2923,"Evaluation of the diagnostic accuracy of the Xpert MTB/RIF ultra assay for detecting Mycobacterium tuberculosis complex in routine samples in Denmark, 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johanna ÅHSBERG",Denmark
3063,PS011,2923,"Species-specific mortality and causes of death in patients with the most common nontuberculous mycobacterial pulmonary isolates in Denmark, 1991-2018",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas ARNHOLDT PEDERSEN",Denmark
3064,PS011,2923,"The evaluation of cross-resistance to rifabutin and accompanying mutations by DNA sequence analysis in rifampicin-resistant Mycobacterium tuberculosis complex strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nalan SÜRÜCÜOGLU",Türkiye
3065,PS011,2923,"Evaluation of four matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry systems for identification of non-tuberculous Mycobacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dan ZHOU",China
3066,PS011,2923,"In silico analysis of phase-specific antigens for the diagnosis and progression prediction of tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shima MAHMOUDI",Poland
3067,PS011,2923,"Using QSAR models to refine antimicrobial peptides against Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel S. OLIVEIRA",Portugal
3068,PS011,2923,"Relative bioavailability of rifapentine and isoniazid when crushed in adults with tuberculosis infection: RPT CRUSH",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thanakorn VONGJARUDECH",Sweden
3069,PS011,2923,"Precision medicine in tuberculosis: utilising photoactivatable bedaquiline for controlled therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diego RONDELLI",Italy
3070,PS011,2923,"Chitosan-particle-based cystatin F RNA silencing as a therapeutic strategy to improve the control of intracellular Mycobacterium tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manoj MANDAL",Portugal
3071,PS011,2923,"Comparative analysis of molecular and culture-based methods for detection and drug resistance assessment of Mycobacterium tuberculosis in extrapulmonary specimens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katarzyna KANIA",Poland
3072,PS011,2923,"A comparative study of Mycobacteria species identification with immunoblot (subjective method) and liquidArray (automatic identification)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vera RIBEIRO",Portugal
3073,PS011,2923,"Mechanisms of immune evasion by Mycobacterium abscessus in human primary macrophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia MOSCHETTI",Italy
3074,PS011,2923,"Comparison between two different sequencing platform for whole-genome sequencing of Mycobacterium tuberculosis complex",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice NAVA",France
3075,PS011,2923,"Mycobacterium tuberculosis complex genotipic resistance: targeted next generation sequence vs whole-genome sequence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice NAVA",France
3076,PS011,2923,"Preliminary results from Phase 2b multicentre, randomised, open clinical trial in people with drug susceptible pulmonary tuberculosis using optimised dose rifampicin, optimised dose moxifloxacin and linezolid (RML TB trial)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adrián SÁNCHEZ-MONTALVÁ",Spain
3077,PS011,2923,"Clofazimine vs rifamycin in treating Mycobacterium avium complex pulmonary disease: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Van-Dong NGUYEN",Vietnam
3078,PS011,2923,"Drug resistance and genotypic profiling of Mycobacterium tuberculosis strains in Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dennis MUJUNI",Uganda
3079,PS011,2923,"Host blood biomarkers for the diagnosis of childhood tuberculosis: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael PRODANUK",Canada
3080,PS012,NULL,"02b. Severe sepsis, bacteraemia & endocarditis (incl epidemiology, diagnosis, host biomarkers, treatment, and outcome prediction)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3081,PS012,3080,"Impact of antimicrobial dose adjustment timing in patients with Gram-negative bacilli bacteraemia and reduced glomerular filtration rate",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gerardo Antonio MUÑETON-LÓPEZ",Colombia
3082,PS012,3080,"Staphylococcal endocarditis treatment, clinical practice vs guidelines: the experience from Agostino Gemelli university hospital, Rome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benedetta ANDRIOLO",Italy
3083,PS012,3080,"Myocardial infarction and new-onset heart failure following bacteremia: general and pathogen-specific associated risk in a nationwide Danish nested case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emilie Marie Juelstorp PEDERSEN",Denmark
3084,PS012,3080,"No gender disparities in surgical treatment of infective endocarditis: a Swiss multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jana EPPRECHT",Switzerland
3085,PS012,3080,"Staphylococcus aureus bacteraemia time to positivity for risk of infectious endocarditis and mortality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Calvin MAN",Netherlands
3086,PS012,3080,"Predictors of mortality of Enterococcus faecium bacteraemia: results from a five-year retrospective study at Padua university hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria MAZZITELLI",Italy
3087,PS012,3080,"The role of CD4+ T cells in the acute course of sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yifan ZENG",China
3088,PS012,3080,"Streptococcus dysgalactiae subsp. equisimilis bacteraemia, emm types and clinical characteristics: a four-year prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miia SAUKKOSAARI",Finland
3089,PS012,3080,"Navigating troubled waters: a systematic review of reported cases of prosthetic valve endocarditis treated with suppressive antimicrobial treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pietro VALSECCHI",Italy
3090,PS012,3080,"Ampicillin and ceftobiprole: a potent duo against Enterococcus faecalis infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca MARTINI",Italy
3091,PS012,3080,"Performance evaluation of an automated microbial detection system for diagnosing bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura DIONISI",Italy
3092,PS012,3080,"Carbapenamase gene detection and synergy testing: role in management of blood stream infections due to carbapenem resistant Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ranganathan Natarajan IYER",India
3093,PS012,3080,"Carbapenem tolerance in Enterobacter bugandensis in neonatal sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie-Liesse ETIENNE",France
3094,PS012,3080,"Splenic embolism and infective endocarditis: on radiology and histopathology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristiane LAMAS",Brazil
3095,PS012,3080,"Predictive power of LIAISON MeMed VB for bacteraemia in adult patients seen in emergency deparments due to infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura SERRANO MARTÍN",Spain
3096,PS012,3080,"Challenges in the diagnosis and management of negative blood culture infective endocarditis: insights from a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice LIGUORO",Italy
3097,PS012,3080,"Long-acting antibiotics as sequential therapy for infective endocarditis caused by Gram-positive bacteria: a propensity score-weighted cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Layla VAHEDI",Italy
3098,PS012,3080,"Clinical outcomes of penicillin-based therapy compared to alternative enterococcal treatment in patients with vancomycin-susceptible enterococcal bacteremia: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christina BAHRS",Austria
3099,PS012,3080,"Evaluation of a point-of-care sepsis risk prediction test in ICU patients: comparison with standard scores, biomarkers, and physician judgement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna WIJEN",Netherlands
3100,PS012,3080,"Antimicrobial lock therapy in the treatment of catheter-related bacteraemia in heamodialysis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanife Nur KARAKOC",Türkiye
3101,PS012,3080,"Rapid AST enables treatment optimisation over 32-h earlier than standard of care for BSI patients: interim results of the LIFETIMES study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma RENNEL-DICKENS",Sweden
3102,PS012,3080,"Long-term suppressive antimicrobial therapy in infective endocarditis: a ten-year retrospective study on 52 patients with prosthetic valve infections at Tor Vergata university hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra IMENEO",Italy
3103,PS012,3080,"Bacteraemias of unknown origin: description and prognostic analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena RUBIO-MARTÍN",Spain
3104,PS012,3080,"Infective endocarditis prediction score for non-pyogenes and non-pneumococcal streptococcal bacteremia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher LAI",China
3105,PS012,3080,"Reporting MIC results within 48 hours reduced antibiotic use and costs for patients with bloodstream infection in the intensive care unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qi ZHAO",China
3106,PS012,3080,"Improved immunodeficiency detection in patients with invasive airway pathogens: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bryan TAN",Australia
3107,PS012,3080,"Is the early versus late-onset neonatal sepsis paradigm relevant in middle-income settings? An Algerian hospital experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samar AKBI",Algeria
3108,PS012,3080,"Epidemiology and risk factors for mortality of Escherichia coli bloodstream infections in Hong Kong",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rita NG",China
3109,PS012,3080,"Epidemiology of Acinetobacter baumannii from bloodstream infections in China over the past decade",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ping LU",China
3110,PS012,3080,"A multicentre international study on Staphylococcus lugdunensis infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristiane LAMAS",Brazil
3111,PS012,3080,"Investigating the role of Streptococcus dysgalactiae bloodstream infections in Scotland, 2014-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leo HUANG","United Kingdom"
3112,PS012,3080,"Gianella risk score in the carbapenemase´s jungle: performance in mix-carbapenemase setting ??????",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricio FAVIER",Spain
3113,PS012,3080,"In quest of determining an effective antimicrobial peptide against uropathogenic Escherichia coli in silico and in vitro validation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diksha GAKHAR",India
3114,PS012,3080,"Risk of endocarditis strongly relates to Streptococcal species and should influence management: focus on the 'small five'",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gavin DEAS","United Kingdom"
3115,PS012,3080,"Type I CRISPR-Cas system in neonatal septicaemic Klebsiella pneumoniae: exploring the association with multidrug-resistant bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sulagna BASU",India
3116,PS012,3080,"Utility of various clinical scores to predict infective endocarditis in patients with Staphylococcus aureus bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepak KUMAR",India
3117,PS012,3080,"Genomic population structure and adhesion-related virulence factors of invasive nontypeable Haemophilus influenzae isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tsai-Wen WAN",China
3118,PS012,3080,"Risk of infective endocarditis in oncohaematological patients with Enterococcus faecalis bloodstream infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel Angel CONSUEGRA PEREZ",Spain
3119,PS012,3080,"Epidemiology, phenotypic and genotypic evaluation of carbapenem-resistant Enterobacterales bacteraemia in Qatar",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hamad ABDEL HADI",Qatar
3120,PS012,3080,"Effects of biological sex on mortality and complications in infective endocarditis patients: preliminary results from the multicentre DERIVE cohort study in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katharina LAST",Germany
3121,PS012,3080,"Important plasma lipid changes related to sepsis progression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alba SANCHEZ MORILLO",Spain
3122,PS012,3080,"Infective endocarditis in patients with intracardiac devices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maricela VALERIO MINERO",Spain
3123,PS012,3080,"Symptom duration and outcomes among patients with  Staphylococcus aureus bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Felicia RUFFIN","United States"
3124,PS012,3080,"Correlation of pancreatic stone protein (PSP) with septic shock, SOFA, and APACHE scores: an emerging biomarker for disease severity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ummu Afeera ZAINULABID",Malaysia
3125,PS012,3080,"Comparative genomics between Staphylococcus aureus isolates from patients with bacteraemia and infective endocarditis from public hospitals in Gauteng",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theevasha GOVENDER","South Africa"
3126,PS012,3080,"Adherence to Duke-ISCVID and ESC guidelines for infective endocarditis: insights from a three-year retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kate DRUMMOND",Australia
3127,PS012,3080,"Serotype V dominance and emerging resistance in Indian Streptococcus agalactiae: genomic insights and antibiotic profiling",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shincy METTINGAL RAMAKRISHNAN",India
3128,PS012,3080,"Long-term antibiotic therapy in non-surgical prosthetic valve endocarditis: a retrospective international multi-centre study (L-TAPE study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linda BUSSINI",Italy
3129,PS012,3080,"Clinical characteristics of endocarditis patients with negative valve culture but positive 16S RNA: a cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael THY",France
3130,PS012,3080,"Clinical utility of negative predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swabs in infective endocarditis: is there a step forward to antimicrobial stewardship goals?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura-Georgiana TÎRLESCU",Romania
3131,PS012,3080,"Role of nuclear imaging techniques in the diagnosis and management of infective endocarditis in critically ill patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael THY",France
3132,PS012,3080,"Alpha-toxin production by Staphylococcus aureus is not associated with thrombocytopenia or clinical outcome in bacteremic patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel Ángel VERDEJO GÓMEZ",Spain
3133,PS012,3080,"Association of individual-level amoxicillin prescribing in primary care on Escherichia coli bacteraemia in older adults in England, 2018-2021",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amelia ANDREWS","United Kingdom"
3134,PS012,3080,"Predictive factors of early and late mortality and evaluation of therapeutic efficacy in patients with bacteraemia associated with MDR Acinetobacter baumannii: the ITACA (ITalian Advances on Carbapenem-resistant Acinetobacter) study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara Palma GULLÌ",Italy
3135,PS012,3080,"Risk factors for mortality in Elizabethkingia spp. bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tiara Joy FOO",Singapore
3136,PS012,3080,"Levofloxacin minimum inhibitory concentration greater than 2 mg/L correlates with adverse outcomes in levofloxacin-treated patients with Stenotrophomonas maltophilia bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ka Lip CHEW",Singapore
3137,PS012,3080,"Pancreatic stone protein levels accurately predict severity in sepsis of various causes earlier than other biomarkers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dimitrios KOUROUPIS",Greece
3138,PS012,3080,"Infective endocarditis: clinical profile and prognosis of patients admitted to a university hospital in San Paulo, Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana BECKER",Brazil
3139,PS012,3080,"The clinical characteristics and prognosis of Staphylococcus argenteus bacteraemia as analysed by massively parallel sequencing in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yusuke WATANABE",Japan
3140,PS012,3080,"The impact of rapid microbiology identification report and dual AST cards on the antibiotic therapy and economics of hospitalised bloodstream infection patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lulu GONG",China
3141,PS012,3080,"Predictive utility of the lactate-to-albumin ratio in 28-day mortality among septic shock patients in Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dang Hai PHAM",Vietnam
3142,PS012,3080,"Antimicrobial resistance genes profile and 28-day mortality in Enterobacterales bacteraemia: a retrospective study from a tertiary care centre in Kerala, India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vettakkara Kandy Muhammed NIYAS",India
3143,PS012,3080,"Epidemiology and treatment of endocarditis secondary to Enterobacterales other than Serratia spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sunish SHAH","United States"
3144,PS012,3080,"Clinical impact and therapeutic management of Enterococcus faecium bloodstream infections: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica MALERBA",Italy
3145,PS012,3080,"A retrospective study: Enterobacter spp. bloodstream infection in a tertiary hospital in Balearics Islands, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandre ZIDOUH",Spain
3146,PS012,3080,"Comparative evaluation of the utility of serum amyloid A, C-reactive protein, procalcitonin, and precepsin as diagnostic markers for sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Myeong Hee KIM","Republic Of"
3147,PS012,3080,"Towards a Belgian national sepsis action plan: Be-SNAP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annelies MONDELAERS",Belgium
3148,PS012,3080,"Accurate long-term mortality prediction after BSI Using BLOOMY scores: a validation study in a challenging MDR environment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo MORRA",Italy
3149,PS012,3080,"In vitro study on the efficacy of oral antibiotic combinations for oral outpatient treatment of infective endocarditis caused by Staphylococcus aureus, Staphylococcus epidermidis, and Enterococcus faecalis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María Alexandra CAÑAS",Spain
3150,PS012,3080,"Ceftazidime/avibactam plus aztreonam vs comparators in metallo-beta-lactamase-producing Enterobacterales: a multicentre target trial emulation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emilio Felipe HUAIER ARRIAZU",Argentina
3151,PS012,3080,"Impact of hypoalbuminemia on patients receiving ertapenem combination therapy for methicillin-susceptible Staphylococcus aureus bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sunish SHAH","United States"
3152,PS012,3080,"Impact of neurological complications on infective endocarditis outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fereshteh SHEIBANI","Islamic Republic Of"
3153,PS012,3080,"Carbapenems vs non-carbapenems as definitive treatment for hypervirulent Klebsiella pneumoniae bacteraemia in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi-Tsung LIN",China
3154,PS012,3080,"Diagnostic performance and prognostic assessment of ddPCR in patients with sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xinlei XU",China
3155,PS012,3080,"Revised VIRSTA score for infective endocarditis focusing on persistent fever",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tomonori TAKANO",Japan
3156,PS012,3080,"Non-device-associated right-sided infective endocarditis: bridging gaps in epidemiology and clinical insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elif Mukime SARICAOGLU",Türkiye
3157,PS012,3080,"A nationwide genomic surveillance study of Gram-negative bacteria causing community and hospital-acquired bloodstream infections in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qiwen YANG",China
3158,PS012,3080,"Clinical features and outcomes of patients with infective endocarditis and intracardiac abscess compared to patients without intracardiac complications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel Angel CONSUEGRA PEREZ",Spain
3159,PS012,3080,"Enhanced sepsis management with a novel multiplex real-time PCR system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian FINI",Italy
3160,PS012,3080,"Herding cats with WISCAs: using weighted incidence syndromic combined antibiograms to inform community-acquired sepsis guideline development",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathryn WILKS",Australia
3161,PS012,3080,"When staph won't budge: how the world tackles persistent Staphylococcus aureus bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annette WESTGEEST",Netherlands
3162,PS012,3080,"Novel sepsis guideline adherence and useability: impact of a WISCA-derived local sepsis guideline for Queensland, Australia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathryn WILKS",Australia
3163,PS012,3080,"Prevalence and clinical presentation of prosthetic osteoarticular material infections in patients with Staphylococcus aureus bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dasa STUPICA",Slovenia
3164,PS012,3080,"Who is the true bad bug? Post COVID-19 increase in incidence of MSSA bacteraemia associated with high mortality in older adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara SEPULCRI",Italy
3165,PS012,3080,"The complexity of prescribing for sepsis:  is it in the diagnosis of source of infection?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathryn WILKS",Australia
3166,PS012,3080,"Dual beta-lactam synergy in Enterococcus faecalis infective endocarditis and its relationship with penicillin/ceftriaxone treatment outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Genevieve MCKEW",Australia
3167,PS012,3080,"Isolated spikes in temperature and leucocyte count do not predict positive blood cultures in the intensive care setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azmi RAHMAN","United Kingdom"
3168,PS012,3080,"Evaluation of septic shock patients in a tertiar-care educational university hospital: a series of 2314 cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gamze SANLIDAG ISBILEN",Türkiye
3169,PS012,3080,"Clinical features and antimicrobial susceptibility profiles of Gram-negative bloodstream infections in paediatric ICU patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia LORENZETTI",Italy
3170,PS012,3080,"High carriage of known sepsis causing ExPEC Escherichia coli are the cause of high rates of bacteraemia in Wyoming",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan Aston Tregurtha MATHIAS","United Kingdom"
3171,PS012,3080,"Molecular epidemiological study of Escherichia coli bloodstream infection-causing isolates across England using nanopore long read-only sequencing: an interim analysis of the NEKSUS study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorottya NAGY","United Kingdom"
3172,PS012,3080,"Ceftazidime/avibactam in real-world clinical practice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gustavo Adolfo MÉNDEZ",Argentina
3173,PS012,3080,"Robust, rapid and cost-effective diagnosis of bloodstream infections by FT-IR spectroscopy directly from blood culture bottles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angela NOVAIS",Portugal
3174,PS012,3080,"Burkholderia sepsis in Bangladesh: clinical impact, diagnostic challenges, and molecular epidemiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Keegan John HOOG","United Kingdom"
3175,PS012,3080,"Risk factors and prognostic influence of carbapenem-resistance in Klebsiella spp. bloodstream infections: experience from a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge CALDERON PARRA",Spain
3176,PS012,3080,"Campylobacter bacteraemia: ten years of experience in a large teaching hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James HARTLEY","United Kingdom"
3177,PS012,3080,"Sex-specific performance of SIRS, qSOFA, CURB-65, DS-CRB-65 and PSI in predicting mortality from pneumococcal bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amelieke Johanna Hendrina CREMERS",Switzerland
3178,PS012,3080,"Time efficiency in tailoring antimicrobial treatment: a propensity score-matched comparison of sepsis panel-guided and blood culture-guided therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU",Türkiye
3179,PS012,3080,"Sepsis in Germany: an estimation of incidence using two extrapolation approaches",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annika MEINEN",Germany
3180,PS012,3080,"Validating code-based algorithms to detect invasive Escherichia coli disease in US healthcare records: impact of incorporating microbiology culture data in the case definition",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark A SCHMIDT","United States"
3181,PS012,3080,"Sepsis in children with burn injuries: preliminary findings from a prospective observational study from Malawi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastian SCHÖNHERR",Germany
3182,PS012,3080,"Hypolipidemia, a novel potential predictor of mortality in infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian PATAUNER",Italy
3183,PS012,3080,"Community and hospital-acquired invasive bacterial infections in hospitalised patients with advanced-HIV disease: a prospective study in Kinshasa, DRC",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnese COMELLI",Italy
3184,PS012,3080,"High antimicrobial resistance among invasive non-typhoidal Salmonella in hospitalised patients with advanced-HIV disease: a prospective study in Kinshasa, DRC",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnese COMELLI",Italy
3185,PS012,3080,"Rising rates of sepsis in England: an ecological study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victoria ALLEN","United Kingdom"
3186,PS012,3080,"Validation of Pro-SOFA and Pro-SAPS models incorporating biomarkers PCT, NLR, and CRP in a new patient cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anandakrishnan NANDAKUMAR",India
3187,PS012,3080,"Predictive factors for sepsis by or associated with Stenotrophomonas maltophilia complex (SMC) in adult critically ill patients in Rio de Janeiro: prospective, nested case-case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marisa ZENAIDE RIBEIRO GOMES",Brazil
3188,PS012,3080,"Cardiac CT scan in infective endocarditis: correlation with transoesophageal findings and feasibility of coronary artery evaluation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pietro VALSECCHI",Italy
3189,PS012,3080,"How does infective endocarditis due to non-HACEK Gram-negative bacilli progress?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nuran SARI",Türkiye
3190,PS012,3080,"Clinical outcomes of cefepime dosing in patients with Pseudomonas infections undergoing renal replacement therapies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Islam GHAZI","United States"
3191,PS012,3080,"Neonatal sepsis in quaternary unit in south of Mozambique: preliminary result/study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lena Vania MANHIQUE-COUTINHO",Mozambique
3192,PS012,3080,"Hypervirulent Klebsiella pneumoniae (HvKp) causing bacteraemia in a tertiary referral hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Domingo FERNANDEZ VECILLA",Spain
3193,PS012,3080,"Exploring the virulence potential of Escherichia coli of ST131 fimH27 subclone causing infantile bacteraemia in Mozambican children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inacio MANDOMANDO",Mozambique
3194,PS012,3080,"Implementation of bedside consultation for Staphylococcus aureus bacteraemia: a pre-post intervention study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos TARRAZO TARRAZO",Spain
3195,PS012,3080,"Restrictive versus liberal fluid management in adult patients with septic shock: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian Jay DOMINGO",Philippines
3196,PS012,3080,"Modified PRIEST score for predicting adverse outcome in emergency room patients with suspected infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oren TURGMAN",Netherlands
3197,PS012,3080,"Evaluation of the role of geriatrician in the endocarditis team",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brice ANDRIAMIRADO",France
3198,PS012,3080,"Body temperature and serum levels of C-reactive protein and procalcitonin in hospitalised geriatric patients with bacteriaemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra SCHÜTZE",Germany
3199,PS012,3080,"Double-valve infective endocarditis: real-life experience in a tertiary hospital in Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gloria SANGALETTI",Italy
3200,PS012,3080,"Sepsis code programme: outcomes after two years of implementation in a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel SUAREZ ROBLES",Spain
3201,PS012,3080,"Infective endocarditis in immunocompromised patients: pathogens, complications, and outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nuran SARI",Türkiye
3202,PS012,3080,"A metric to measure mortality due to antibiotic-resistant bacteraemia in the UK using public health data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James STIMSON","United Kingdom"
3203,PS012,3080,"Clinical spectrum of Enterococcal endocarditis: key findings from a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mustafa DENIZ",Türkiye
3204,PS012,3080,"Definition of early prosthetic valve endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge CALDERON PARRA",Spain
3205,PS012,3080,"Short antibiotic treatment for uncomplicated Gram-negative bacilli bacteraemia: real-world experience in a single centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karen Viviana CABEZAS MARQUEZ",Argentina
3206,PS012,3080,"Endocarditis due to Gram-negative bacilli and its comparison with endocarditis due to other microorganisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maricela VALERIO MINERO",Spain
3207,PS012,3080,"Pantoea spp bacteraemia in national hospital Abuja",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philip NWAJIOBI-PRINCEWILL",Nigeria
3208,PS012,3080,"Genetic characterisation of Enterobacter cloacae strains causing paediatric sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maia DE LUCA",Italy
3209,PS012,3080,"Sequencing for pathogen detection in valve tissue in clinical diagnostics of infective endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annamária MACHÁCKOVÁ","Czech Republic"
3210,PS012,3080,"Microbiological profile of infective endocarditis episodes in two high-complexity hospitals in Chile, 2012-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"José Miguel ORTEGA FUENZALIDA",Chile
3211,PS012,3080,"Artificial intelligence assisted management impact on clinical outcomes of sepsis in a tertiary care setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suhail Hassan JALAL",India
3212,PS012,3080,"Emergence, adaptation and genomic insights into human variant of methicillin-resistant Staphylococcus aureus clonal complex 398 in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tsung-Hua WU",China
3213,PS012,3080,"Point-of-care testing of procalcitonin serum level: a rapid approach to diagnose sepsis post mortem",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arneet ARORA",India
3214,PS012,3080,"The resistance phenotype and molecular epidemiology of Klebsiella pneumoniae causing bloodstream infections in Indian population: a multicentric retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harshitha GK",India
3215,PS012,3080,"Utilising rapid next generation metagenomic sequencing for pathogen identification and antimicrobial resistance characterisation in bloodstream infections: a preliminary study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rhoda Cheuk-Ying LEUNG",China
3216,PS012,3080,"Linezolid vs high dose daptomycin for the treatment of vancomycin-susceptible Enterococcus faecium blood stream infections: a retrospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario KAROLYI",Austria
3217,PS012,3080,"A descriptive study of patients treated with monotherapy for Stenotrophomonas maltophilia bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberta MONARDO",Italy
3218,PS012,3080,"Combination therapy vsmonotherapy for persistent MRSA bacteraemia: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ali ALTHUBYANI","United States"
3219,PS012,3080,"Aging and infective endocarditis: outcomes and challenges in the elderly population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martha KESTLER HERNANDEZ",
3220,PS012,3080,"Should antimicrobial treatment be initiated immediately after blood culture collection among all patients with suspicion of infective endocarditis?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisavet STAVROPOULOU",Switzerland
3221,PS012,3080,"Genomic diversity of bloodstream infections caused by typhoidal and non-typhoidal Salmonella enterica serovars in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sowmya PR",India
3222,PS012,3080,"Cefazolin vs antistaphylococcal penicillins for the treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Connor PROSTY",Canada
3223,PS012,3080,"Evaluation of the NOVA and DENOVA scores and the different versions of Duke criteria for the diagnosis of infective endocarditis among patients with enterococcal bacteremia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Virgile ZIMMERMANN",Switzerland
3224,PS012,3080,"Repeat PET/CT in the follow up of unoperated patients with prosthetic valve endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristiane LAMAS",Brazil
3225,PS012,3080,"Role of CBC positional parameters in defining sepsis and bacteremia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cinzia TAVANO",Italy
3226,PS012,3080,"Severe invasive Streptococcus pyogenes infections in children and adults: are they the same?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marek STEFAN","Czech Republic"
3227,PS012,3080,"Injecting drug use related septic thrombophlebitis: a retrospective review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie FOX","United Kingdom"
3228,PS012,3080,"The antimicrobial resistance patterns and epidemiology of community onset bloodstream infections among children in Liverpool city region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marwa ALLAM","United Kingdom"
3229,PS012,3080,"Bloodstream infections burden and trend in hospitalised patients over ten years: a national bottom-up initiative for disease burden on public healthcare data, 2013-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos KIFFER",Brazil
3230,PS012,3080,"Overuse of blood cultures and its associated factors: a single-centre retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shun KOSAKA",Japan
3231,PS012,3080,"Genomic epidemiology and phylodynamics of Acinetobacter baumannii bloodstream isolates in China: population superseding and toxification",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qixia LUO",China
3232,PS012,3080,"In-hospital mortality associated with bacteraemia caused by Escherichia coli and Klebsiella spp. with priority resistances",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omar Fernando MENDOZA-VÁZQUEZ",Mexico
3233,PS012,3080,"In vitro antibiotic combination testing-guided therapy vs standard care for the treatment of difficult-to-treat resistant pseudomonal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jing Heng TOH",Singapore
3234,PS012,3080,"Bacteraemia due to Lactobacillus species: a Mayo Clinic experience from 2012 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sofia MOLINA GARCIA","United States"
3235,PS012,3080,"The impact of antibiotic resistance on 30-day fatality in BSI: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lal Sude GÜCER",Türkiye
3236,PS012,3080,"Outpatient parenteral antimicrobial therapy (OPAT): a four years review in a tertiary care hospital in Belgium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara KAMEL REY",Belgium
3237,PS012,3080,"A prospective cohort study on the performance of chatbot artificial intelligence in infective endocarditis management compared to infectious diseases consultation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta VECCHI",Italy
3238,PS012,3080,"Diagnosis and severity prediction of bacterial infections and sepsis using a 29-gene host-response test from whole blood",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel HORNUSS",Germany
3239,PS012,3080,"Impact of nuclear imaging in the management of infections in critically ill patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camilla GENOVESE",Italy
3240,PS012,3080,"Synergistic killing of methicillin-resistant Staphylococcus aureus with ceftaroline or vancomycin combined with carbapenems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erlinda R ULLOA","United States"
3241,PS012,3080,"An AI-driven learning health system to improve sepsis quality of care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvain MEYLAN",Switzerland
3242,PS012,3080,"Evaluating the impact of delayed concordant empirical antibiotics treatment on 30-day mortality in patients with Enterobacterales bloodstream infection in low- and middle-income country settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Myo Maung Maung SWE","United Kingdom"
3243,PS012,3080,"The genotypic and phenotypic continuum of hypervirulence in Klebsiella pneumoniae invasive infection in an endemic region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfred Lok Hang LEE",China
3244,PS012,3080,"Positron emission tomography/computed tomography utilisation in infective endocarditis: a retrospective audit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huseyin BILGIN","United Kingdom"
3245,PS012,3080,"Trends in bloodstream infections in critical care: incidence, antimicrobial resistance and mortality (English national surveillance, 2017-2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea MAZZELLA","United Kingdom"
3246,PS012,3080,"Bloodstream infection with Aerococcus vs Escherichia and Enterococcus: does species matter?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Torgny SUNNERHAGEN",Sweden
3247,PS012,3080,"Gram-negative sepsis, antimicrobial drug susceptibility, and treatment outcomes at two NICU in Addis Ababa, Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Biniyam Tedla MAMO",Ethiopia
3248,PS012,3080,"The clinical and economic effects of rapid antimicrobial susceptibility testing report and the dual susceptibility cards on adult ICU patients with bloodstream infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jingxing XIE",China
3249,PS012,3080,"BALANCE+ platform trial for Gram-negative bloodstream infections: vanguard phase",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean Wei Xiang ONG",Australia
3250,PS012,3080,"Delphi consensus document on treatment and follow-up of vascular graft/endograft infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta HERNÁNDEZ-MENESES",Spain
3251,PS012,3080,"Incidence, outcomes and risk factors for mortality of patients with sepsis in Korea: a nationwide cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yongseop LEE","Republic Of"
3252,PS012,3080,"Impact of duration of antibiotic treatment for ESBL-producing Enterobacteriaceae bacteraemia in critically patients on in-ICU mortality: a French multicentric retrospective observational cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnes MEYBECK",France
3253,PS013,NULL,"02c. Community-acquired respiratory infections (incl epidemiology, clinical features, imaging,  treatment & prevention)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3254,PS013,3253,"Doxycycline in the treatment of outpatient community-acquired pneumonia: propensity matched control cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Genady DROZDINSKY",Israel
3255,PS013,3253,"Interactions between SARS-CoV-2 and S. pneumoniae in adults: from colonisation to disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara CALVO-SILVERIA",Spain
3256,PS013,3253,"Burden and risk factors of 30-day readmissions and mortality after CAP hospitalisation: a population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian REICHEL",Germany
3257,PS013,3253,"Persistence of Haemophilus influenzae and Pseudomonas aeruginosa strains in bronchiectasis patients: a longitudinal study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irene CADENAS JIMÉNEZ",Spain
3258,PS013,3253,"Post COVID-19 disruption of the respiratory microbiome modulates Mycoplasma pneumoniae infections: a multi-centre retrospective investigation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shiyu HUANG",China
3259,PS013,3253,"Immunogenicity insights: comparing pneumococcal antibody levels in healthy and diabetic Indian adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akhila M M",India
3260,PS013,3253,"Whooping cough outbreak during 2024 in the fourth healthcare area in Asturias (north of Spain): epidemiological analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María Soledad ZAPICO GONZÁLEZ",Spain
3261,PS013,3253,"Incidence of respiratory tract infections and complications in Sweden 2014-2023; developing a surveillance framework to evaluate antibiotic stewardship interventions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katarina HEDIN",Sweden
3262,PS013,3253,"Comparison of Streptococcus pneumoniae serotypes between children with paediatric parapneumonic pleural effusions/empyema and other invasive pneumococcal diseases: results from two nationwide surveillance systems, Germany, 2010/11-2023/24",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea STRENG",Germany
3263,PS013,3253,"A critical analysis of the trends in low immunisation coverage of under-one-year-old against diphtheria, tetanus, and pertussis in Venezuela, 1995-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso J. RODRIGUEZ-MORALES",Colombia
3264,PS013,3253,"Re-emergence of diphtheria in Algeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sadjia MAHRANE",Algeria
3265,PS013,3253,"Epidemiology of Mycoplasma pneumoniae infections in paediatric patients: trends and positivity rates from 2017 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Del Carmen PEREYRA BOZA",France
3266,PS013,3253,"Mortality in community-acquired pneumonia patients with and without microbial detection: a hospitalised cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Preudtipong NOOPETCH",Thailand
3267,PS013,3253,"Whooping cough: the summer B. pertussis epidemic increase in France driven by young vaccine-targeted populations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoit VISSEAUX",France
3268,PS013,3253,"Pneumococcal carriage and capsular serotype prevalence among healthy children attending childcare centres in Klang valley, Malaysia: a pre-vaccination retrospective analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Revathy ARUSHOTHY",Malaysia
3269,PS013,3253,"Hospitalisation rates, disease burden, and aetiology for community-acquired pneumonia before, during and after the COVID-19 pandemic: a register-based cohort study among adults in Stockholm county, Sweden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ridwanul AMIN",Sweden
3270,PS013,3253,"Penicillin V as first-line treatment for pneumonia in outpatient care: a register-based study of treatment failures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katarina HEDIN",Sweden
3271,PS013,3253,"Non-invasive pneumococcal disease in Portugal: serotype distribution, comparison with invasive pneumococcal disease and potential vaccine coverage, 2023-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario RAMIREZ",Portugal
3272,PS013,3253,"Neurological manifestations associated with Mycoplasma pneumoniae infection in adult patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia NADAL-BARON",Spain
3273,PS013,3253,"The atypical return of Mycoplasma pneumoniae in a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucía TEJEDOR CANTERO",Spain
3274,PS013,3253,"Detection of respiratory pathogens in the nasopharynx of children hospitalised with severe pneumonia in sub-Saharan Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan Pablo RODRIGUEZ-RUIZ",Belgium
3275,PS013,3253,"Clinical and antibiotic resistance patterns in paediatric pneumococcal infections: a retrospective analysis from a tertiary care centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gülsüm Iclal BAYHAN",Türkiye
3276,PS013,3253,"Mycoplasma pneumoniae infection in the paediatric population at a tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther DE LA HOZ SERENO",Spain
3277,PS013,3253,"Active nationwide surveillance of invasive pneumococcal disease (IPD) to enable choice of extended-spectrum PCV for elderlies in Israel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romy RIEGER",Israel
3278,PS013,3253,"Epidemiology of whooping cough in a Spanish tertiary hospital beyond COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel Cristina LÓPEZ MESTANZA",Spain
3279,PS013,3253,"Resurgence of pertussis in southern Brazil: a two-year analysis of increasing Bordetella pertussis cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dariane PEREIRA",Brazil
3280,PS013,3253,"The gastrointestinal resistome and microbiota of children hospitalised with severe pneumonia in sub-Saharan Africa in the PediCAP trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan Pablo RODRIGUEZ-RUIZ",Belgium
3281,PS013,3253,"Risk factors influencing the carriage of Streptococcus pneumoniae among children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tian-Chi ZHOU",China
3282,PS013,3253,"Re-emergence of diphtheria in Pakistan: a call for reinforced immunisation efforts to prevent future outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zurva ASHRAF",Pakistan
3283,PS013,3253,"Study of S. pneumoniae serotypes and their associations with clinical factors/mortality and antimicrobial resistance in the Comunidad Valenciana",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura DIAB CASARES",Spain
3284,PS013,3253,"Immunoglobulin M of respiratory viral and atypical pathogens among adults with respiratory tract infections in Shanghai, China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yinjuan GUO",China
3285,PS013,3253,"Insight into the microbiological diagnosis of Streptococcus pneumoniae in pleural fluid in paediatric population with complicated pneumonia: a decade-long study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"José Luis CARRIÓN FRÍAS",Spain
3286,PS013,3253,"Identification of clinical phenotypes in community-acquired pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonsoles SALTO-ALEJANDRE",Spain
3287,PS013,3253,"Post-pandemic shifts in Streptococcus pneumoniae serotypes causing invasive pneumococcal disease (IPD) among US and Canadian children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pullagura GOKUL RAJ",Canada
3288,PS013,3253,"The role of viridans Streptococci and anaerobic bacteria of the oral cavity in children with parapneumonic pleural effusions/empyema: nationwide hospital surveillance (Germany, 2010/11-2022/23)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johannes FORSTER",Germany
3289,PS013,3253,"Characteristics, epidemiology and treatment of adults hospitalised for Mycoplasma pneumoniae pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karl HAGMAN",Sweden
3290,PS013,3253,"Comparison of microbial diversity in upper and lower respiratory tracts of children using 16S metagenomics sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Richa RAO",India
3291,PS013,3253,"Pathogen distribution and Pneumococcus disease burden of clinical diagnosed pneumonia among children, a multi-centre case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jingwen AI",China
3292,PS013,3253,"Pneumonia burden and temporal trend in hospitalised patients over ten years: a national bottom-up initiative for disease burden based on public healthcare system secondary data 2013-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos KIFFER",Brazil
3293,PS013,3253,"Pneumonia related antimicrobial resistance burden in hospitalised patients over ten years: a national bottom-up initiative for disease and AMR burden on public healthcare data 2013-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos KIFFER",Brazil
3294,PS013,3253,"Whole-genome analysis unveils genetic factors driving the Mycoplasma pneumoniae outbreak among children post-COVID-19 in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Weiwei JIAO",China
3295,PS013,3253,"Sputum yields higher viral detection than oropharyngeal swabs in non-COVID-19 community-acquired pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pei Min THONG",Singapore
3296,PS013,3253,"Automated lateral flow immunoassay based on upconverting nanoparticles for serological point-of-care diagnosis of pertussis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teppo SALMINEN",Finland
3297,PS013,3253,"Integrated study of respiratory microbiota and host response in children with macrolide-unresponsive Mycoplasma pneumoniae pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lin SUN",China
3298,PS013,3253,"Monitoring genomic evolution of Bordetella pertussis patient isolates in Austria before and after the COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zsófia SZOJKA",Austria
3299,PS013,3253,"Impact of shortages of amoxicillin and amoxicillin/clavulanate on the outcome of bacterial sinusitis in adults: a French retrospective, single-centre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra DEVATINE",France
3300,PS013,3253,"Reemergence of Bordetella parapertussis and Bordetella pertussis after COVID-19 pandemic in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sang Bong HAN","Republic Of"
3301,PS013,3253,"Epidemiological features of pertussis in the Zenica-Doboj canton, Bosnia-Herzegovina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhamed SKOMORAC","Bosnia And Herzegovina"
3302,PS013,3253,"Impact of a multimodal algorithm on antibiotic use for acute community-acquired pneumonia in the emergency department: a quasi-experimental time series study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Donia BOUZID",France
3303,PS013,3253,"Outbreak of pneumococcal pneumonia among vaccinated patients in a mental health facility",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Núria BORRELL-SOLÉ",Spain
3304,PS013,3253,"Predatory bacteria to combat respiratory infections: friend or foe?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeinab MOHSENIPOUR","Islamic Republic Of"
3305,PS013,3253,"Revolutionising respiratory pathogen detection: evaluation of a multiplex real-time PCR assay for Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
3306,PS013,3253,"Mycoplasma pneumoniae significantly contributes to the burden of hospitalisations due to respiratory infections in Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanne-Dorthe EMBORG",Denmark
3307,PS013,3253,"An estimation of costs associated with lower-tract respiratory infections in older adults in Sweden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleana TSOUMANI",Greece
3308,PS013,3253,"The largest epidemic of Mycoplasma pneumoniae in more than ten years in Wales: an epidemiological summary, symptoms and risks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Panoraia KALAPOTHARAKOU","United Kingdom"
3309,PS013,3253,"Clinical impact of combined treatment of beta-lactam with azithromycin in hospitalised community-acquired pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilona ZHYGALOVA ZHYGALOVA",Spain
3310,PS013,3253,"Increasing numbers of Legionnaires' disease cases caused by Legionella longbeachae during 2024 in Sweden, Scotland, Denmark and Finland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa WASSERSTROM",Sweden
3311,PS013,3253,"Amoxicillin is non-inferior to other antibiotics as treatment of CAP in adults and children: results of a systematic review and meta-analysis of 44 trials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lilia POTTER-SCHWARTZ","United States"
3312,PS013,3253,"Risk of infection in pregnant women with and without chronic respiratory diseases, and association with adverse pregnancy outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katarina MONDRUP FUNCH",Denmark
3313,PS013,3253,"Post-pandemic trends and clinical features of severe community-acquired pneumonia (CAP) due to Streptococcus pyogenes: a retrospective study in a tertiary care centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary Paz ROCHE MATHEUS",Spain
3314,PS013,3253,"Pneumococcal colonisation in adult patients with acute respiratory infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Catalina MEDINA GOMEZ",Spain
3315,PS013,3253,"Diagnostic performance of short-trained emergency department physicians for pneumonia using lung ultrasound",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julien OPPLIGER",Switzerland
3316,PS013,3253,"Current epidemiological profile of pertussis diagnosed in children in Tunis, Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yasmine CHELBI",Tunisia
3317,PS013,3253,"Characterisation and analysis of a whooping cough outbreak in Albacete, Castilla-La Mancha, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara SIERRA ALCAÑIZ",Spain
3318,PS013,3253,"Changes in the prevalence of bacteria detected in respiratory infections and antibiotic resistance before and after the COVID-19 pandemic in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chorong HAHM","Republic Of"
3319,PS013,3253,"Comparative outcomes of severe pneumonia: home vs conventional hospitalisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andres BLANCO-DI MATTEO",Spain
3320,PS014,NULL,"02d. Community-acquired abdominal/gastrointestinal infections (incl epidemiology, clinical, imaging, treatment & prevention)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3321,PS014,3320,"Enteroaggregative Escherichia coli: from a diarrhoeal pathogen to a superbug uropathogen?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harpreet KAUR",India
3322,PS014,3320,"Campylobacter bacteraemia outcomes: a systematic review with meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Verena ZERBATO",Italy
3323,PS014,3320,"Helicobacter pullorum isolated from stool culture in a tertiary hospital in Madrid",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alejandra ARENAS",Spain
3324,PS014,3320,"Prevalence and drug-resistance patterns of enterotoxigenic Escherichia coli among children with diarrhea in Ouagadougou, Burkina Faso",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alimatou HEMA","Burkina Faso"
3325,PS014,3320,"Enteric pathogens in flood-affected populations: insights from the Valencia flood event",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura ANDRÉS ESLAVA",Spain
3326,PS014,3320,"Application of whole-genome sequencing and bioinformatics in the epidemiological surveillance of non-typhoidal Salmonella enterica at the clinical level",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ramón VELA FERNANDEZ",Spain
3327,PS014,3320,"Management of diarrhea among patients attending public health centre and private clinics in Addis Ababa, Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tadesse EGUALE",Ethiopia
3328,PS014,3320,"The role of H. pylori virulence factors triggering pyroptosis in gastritis and ulcer pathology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yaren BUYUKCOLAK CEBECI",Türkiye
3329,PS014,3320,"The application value of mNGS and etiologic features in liver abscess with underlying intra-abdominal risk factors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beidi ZHU",China
3330,PS014,3320,"A two-year longitudinal study of the epidemiology of Escherichia coli enteritis in a Spanish secondary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcos HERNANDO GOZALO",Spain
3331,PS014,3320,"A retrospective study of Salmonella enterica in Lombardy (northern Italy) drew attention back to invasive serotypes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priscilla PASUTTO",Italy
3332,PS014,3320,"A species-specific PCR approach to enhance probiotic studies exploring Christensenella minuta",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nayna BABAR",Hungary
3333,PS014,3320,"Genomic and epidemiological insights into Campylobacter fetus subsp. testudinum B1200: analysis of two clinical isolates with divergent outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammad Ridhuan MOHD ALI",Malaysia
3334,PS014,3320,"Evaluating the awareness of campylobacteriosis among adults in Sri Lanka",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aadhil AHAMED","Sri Lanka"
3335,PS014,3320,"I am here if you want to detect me, i am important too: campylobacteriosis in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neelam TANEJA",India
3336,PS014,3320,"Clinical characteristics of campylobacteriosis in immunocompromised patients in comparison with immunocompetent patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Koh SHINOHARA",Japan
3337,PS014,3320,"Symptom profiles and stool shedding dynamics from a first-in-human Salmonella paratyphi murium-controlled human infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher SMITH","United Kingdom"
3338,PS014,3320,"Prevalence of campylobacteriosis and antimicrobial resistance in Vallès Occidental: a three-year descriptive study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sofia NARVÁEZ MORALES",Spain
3339,PS014,3320,"Salmonella typing: from serum agglutination to WGS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irene MILETO",Italy
3340,PS014,3320,"Salmonella enterica serotypes causing infection in Kuwait during 2018-2021, determined by multi-locus sequence typing and whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amani ALFADHLI",Kuwait
3341,PS014,3320,"Description of the first two human cases of infection with Helicobacter zhangjianzhongii, a new Helicobacter closely related to Helicobacter canis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philippe LEHOURS",France
3342,PS014,3320,"Audit of enteric fever management in Manchester, UK: opportunities for antimicrobial stewardship due to high rates of ceftriaxone susceptibility",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph THOMPSON","United Kingdom"
3343,PS014,3320,"Clinical and microbiological differences in Klebsiella pneumoniae liver abscess by metastatic spread",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyun Ah KIM","Republic Of"
3344,PS014,3320,"Global warming can exacerbate the infectious diseases occurrence: an analysis of Brazilian typhoid fever cases over 17 years, 2007-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wania FREITAS",Brazil
3345,PS014,3320,"Short-course vs long-course antibiotic therapy for pyogenic liver abscess: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Geoffrey ROSSI",France
3346,PS014,3320,"Identification of potentially new anti-infectives against Helicobacter pylori by repurposing FDA-approved drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dietmar PFEIFFER",Germany
3347,PS014,3320,"Comparison of the high-dose dual treatment with standard quadruple treatment methods containing bismuth subcitrate as the first line of treatment in eradicating Helicobacter pylori infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohsen ROKNI","Islamic Republic Of"
3348,PS014,3320,"Diagnostic stewardship for paediatric diarrhea: a qualitative study of parent and provider perspectives",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna JONES","United States"
3349,PS015,NULL,"02e. Community-acquired urinary tract & genital tract infections (incl epidemiology, clinical, imaging, treatment & prevention)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3350,PS015,3349,"Microbiome analysis of cervical cancer identified Stenotrophomonas as a potential pathogen involved in tumor progression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shruptha KUMARI",India
3351,PS015,3349,"Empirical ESBL vs NON-ESBL therapy in a cohort of patients admitted to the emergency department for urinary tract infections: the UTILY study, a multicentre prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria DE LUCA",Italy
3352,PS015,3349,"Scoping review of reported outcomes in clinical trials on complicated urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastiaan MOGGRE",Netherlands
3353,PS015,3349,"A brief look at the genome of Treponema pallidum in clinical samples from Slovenian patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tina TRIGLAV",Slovenia
3354,PS015,3349,"Varied community burden of Chlamydia trachomatis and Neisseria gonorrhoeae infections by anatomic site in men who have sex with men: a longitudinal study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rui ZHANG",China
3355,PS015,3349,"Effect of E.coli on plasma NTproBNP levels in patients cardiosclerosis after myocardial infarction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sevinc ALIYEVA",Azerbaijan
3356,PS015,3349,"TechTrials' Brazilian public health documentation of urinary tract infection during COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bruna DA SILVA MIRANDA",Brazil
3357,PS015,3349,"Adjunctive treatment with doxycycline for the treatment of Mycoplasma genitalium infection: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tadhg SULLIVAN","United Kingdom"
3358,PS015,3349,"In vitro activity of thiamphenicol against drug-susceptible and -resistant strains of Mycoplasma genitalium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sofie Skovmand RASMUSSEN",Denmark
3359,PS015,3349,"Chronic bacterial prostatitis a neglected disease: reevaluation of  pathogen spectrum and new treatment options",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus HELL",Austria
3360,PS015,3349,"Investigation of individuals diagnosed with ocular syphilis, with and without HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat Hakan KIR",Türkiye
3361,PS015,3349,""Ex vivo-response" to antibiotic therapy in urinary tract infection: early treatment response detected by monitoring bacterial counts in consecutive urines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bastian DIRK",Germany
3362,PS015,3349,"Surveillance of STIs in symptomatic male patients attending the STI clinic of the university hospital in Buenos Aires, Argentina: high prevalence of extragenital infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Lucia GALLO VAULET",Argentina
3363,PS015,3349,"Ocular syphilis frequently presents without known sexual risk factors: the importance of ophthalmology screening",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wayne LEUNG",Canada
3364,PS015,3349,"Urinary tract infection related antimicrobial resistance burden in hospitalised patients over 10 years: a national bottom-up initiative for disease and AMR burden on public healthcare data 2013-2022.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos KIFFER",Brazil
3365,PS015,3349,"Urinary tract infection burden and trend in hospitalised patients over ten years: a national bottom-up initiative for disease burden on public healthcare data, 2013-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos KIFFER",Brazil
3366,PS015,3349,"Pelvic inflammatory disease in hospitalised patients: a retrospective single-centre analysis in developing country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oguzhan ACET",Türkiye
3367,PS015,3349,"Impact of bacteraemia on clinical outcomes and costs in urinary tract infections: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleni POLYZOU",Greece
3368,PS015,3349,"Designing and validating real-time PCR assays for Prevotella bivia, Peptostreptococcus anaerobius, and Dialister micraerophilus, three genital anaerobic bacteria associated with HIV acquisition",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sydney NELSON","United States"
3369,PS015,3349,"Is Haemophilus sp. a pathogenic species to consider in the clinical entity of urethritis?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia BORONAT MUÑOZ",Spain
3370,PS015,3349,"Utilisation of a simplified and practical algorithm to assess potentially unnecessary antibiotic use for suspected urinary tract infections in nursing homes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carl LLOR",Spain
3371,PS015,3349,"Chlamydia trachomatis prevalence in patients suspected with keratitis: unravelling insights among diverse eye specimen type",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arash LETAFATI","Islamic Republic Of"
3372,PS015,3349,"Screening for sexually transmitted infections in a cohort of people living with HIV: a retrospective analysis of a single centre in 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neva BRACCIALARGHE",Italy
3373,PS015,3349,"Sexually transmitted infections and their impact on bacterial vaginosis: findings from a one-year review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia GARCIA",Spain
3374,PS015,3349,"Individualised autovaccine therapy significantly reduces recurrence and improves quality of life in women with recurrent urinary tract infections (rUTI), regardless of non-modifiable risk factors (nmRF).",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vicens DIAZ BRITO FERNANDEZ",Spain
3375,PS015,3349,"Cumulative antibiograms can support adequate management of urinary tract infections if done properly",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan ZÁVORA","Czech Republic"
3376,PS015,3349,"Trends and clinical characteristics of anorectal Chlamydia trachomatis infections: a comparative analysis of lymphogranuloma venereum (LGV) and non-LGV serovars",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Loreto SANGORRIN-LAPIEZA",Spain
3377,PS015,3349,"Distribution of human papillomavirus genotypes in endocervical exudates from women, Malaga, Spain, 2021-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta LERATE ALBA",Spain
3378,PS015,3349,"Heterogeneity in assessing the burden of urinary tract infections: a literature review and recommendations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena ADDIS",Italy
3379,PS015,3349,"Feasibility of pooling urogenital and extragenital specimens for sexual transmitted infections (STI) screening in asymptomatic individuals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aida RAMIREZ MARINERO",Spain
3380,PS015,3349,"Validity of leukocyte esterase and/or nitrite results for the diagnosis of bacteriuria in older individuals: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana MORAGAS MORENO",Spain
3381,PS015,3349,"The prevalence of sexually transmitted infection pathogens in a Korean single-commercial laboratory over the last three years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dongheui AN","Republic Of"
3382,PS015,3349,"Impact of age on antibiotic resistance and efficacy of antibiotics for women with uncomplicated urinary tract infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steven ARONIN","United States"
3383,PS015,3349,"Immunosuppressive macrolides inhibit transcription factors and epithelial-mesenchymal transition (EMT) related parameters induced by Chlamydia trachomatis infection in conjunctival epithelial cells",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javeria PERVAIZ",Austria
3384,PS015,3349,"High prevalence and incidence of bacterial sexually transmitted infections among HIV pre-exposure prophylaxis users in Croatia, 2018-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Loris MOCIBOB",Croatia
3385,PS015,3349,"Diagnosis and management with urinary behavioral therapy of recurrent acute bacterial cystitis in women: preliminary results of the URICA study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maxime VALLÉE",France
3386,PS015,3349,"Population structure of CTX-M-producing uropathogenic Escherichia coli recovered from patients with complicated urinary tract infection (cUTI) in a high complexity hospital in Bogota (Colombia)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan Carlos GARCÍA-BETANCUR",Colombia
3387,PS015,3349,"Epidemiological profile of Neisseria gonorrhoeae in the west of Ireland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fiona MURPHY",Ireland
3388,PS015,3349,"Multi-anatomic site prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection among male in HIV care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ngai Sze WONG",China
3389,PS015,3349,"Prevalence of sexually transmitted infections in women infected with human papilloma virus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam LATORRE-MILLÁN",Spain
3390,PS015,3349,"Performance evaluation of a boric acid-free device designed for pre-analytics in urine culture testing for UTIs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina IMPERADORI",Italy
3391,PS015,3349,"Aerococcus spp., emerging pathogens isolated from a Spanish tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María DE LA MATA FERNÁNDEZ",Spain
3392,PS015,3349,"Prospective evaluation of ESBL risk factors and empirical treatment based on culture result suitability of community-acquired pyelonephritis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gülsah GELISIGÜZEL",Türkiye
3393,PS015,3349,"Streptococcus dysgalactiae as the cause of peripartum infections: a population-based cohort study with a phylogenetic analysis of hospital clusters",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erik SENNEBY",Sweden
3394,PS015,3349,"Vulnerability of people living whith autism: the urgency of inclusive sexual education",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeferson MANOEL TEIXEIRA",Brazil
3395,PS015,3349,"Actively looking for cases of lymphogranuloma venereum in the southern Tenerife population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia ALCOBA FLÓREZ",Spain
3396,PS015,3349,"Evaluating a boric acid-free device designed for UTIs pre-analytics in urine molecular and antigenic testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina IMPERADORI",Italy
3397,PS015,3349,"Investigation of Streptococcus agalactiae colonisation in pregnancy by culture and molecular methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bilge MAZLUMOGLU",Türkiye
3398,PS015,3349,"Antibiotic class comparisons for acute pyelonephritis: a systematic review of randomised, controlled trials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Digbijay KUNWAR",Nepal
3399,PS015,3349,"Breaking the cycle: barriers to UTI prevention in primary care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merel E.P. WILMSEN",Netherlands
3400,PS015,3349,"A multi-centre retrospective study on urinary tract infections from patients in Turkey reveals alarming antibiotic resistance levels",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansel VATANSEVER",Türkiye
3401,PS015,3349,"Microbiology and risk factors for bacteremic urinary tract infection: insights from the largest urological centre in Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Asma NASEEM",Pakistan
3402,PS015,3349,"Antimicrobial prophilaxis in endourological procedures: early results and challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carla MIMOSO SANTOS",Portugal
3403,PS015,3349,"Could second and third trimester urine culture increase the detection of Group B Streptococcus (GBS) colonisation in pregnancy?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia GALAR",Spain
3404,PS015,3349,"The controversial significance of Stenotrophomonas maltophilia isolation in urine samples: insights from a 15-year single-centre experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara MACI",Italy
3405,PS015,3349,"Patient characteristics and clinical outcomes among patients with complicated urinary tract infection caused by extended-spectrum beta-lactamase-producing Enterobacterales: a US cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alanna FARRELL-FOSTER","United States"
3406,PS015,3349,"Exudative sexually transmitted infections among PrEP-users, people living with HIV and general population: a retrospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayla YARCI CARRION",Spain
3407,PS015,3349,"Temporal trends of sexually transmitted infections from 2018 to 2023 in two community hospitals in Liguria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rachele PINCINO",Italy
3408,PS015,3349,"A multicentre, observational study on efficacy and safety of six-month long-term therapy with Uro-Vaxom in patients with recurrent urinary tract infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeong Woo LEE","Republic Of"
3409,PS015,3349,"Infections caused by Mycoplasma genitalium: an emerging pathogen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose BAEZA ROS",Spain
3410,PS015,3349,"Does age influence the effectiveness of OPAT programmes?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azucena RODRIGUEZ-GUARDADO",Spain
3411,PS015,3349,"Improving urine culture appropriateness and reducing unnecessary testing through education and feedback in a hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debby BEN-DAVID",Israel
3412,PS015,3349,"Treatment failure in patients with uncomplicated urinary tract infection in the United States: a latent class cluster analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meghan LUCK","United States"
3413,PS015,3349,"Understanding polymicrobial UTIs : results from a retrospective study and prospective sample collection indicate significant differences in urinary microbial composition and AMR patterns by sample type",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashim Kumar DUBEY",Switzerland
3414,PS015,3349,"Establishment and validation of a lower genital tract Neisseria gonorrhoeae infection in ovariectomised mice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David VALTIERRA","United States"
3415,PS015,3349,"Exposure to continuous suppressive antibiotic therapy in women with recurrent urinary tract infections and the severity of infectious complications: a population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carl LLOR",Spain
3416,PS015,3349,"What is the most effective culture-based detection approach for Streptococcus agalactiae colonisation in pregnant women?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Franziska Dorothee SCHULER",Germany
3417,PS015,3349,"The O25b-ST131 pandemic uropathogenic E. coli in India: examining antibiotic resistance, virulence, and phylogenetic distribution in community-acquired UTIs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepak KOCHER",India
3418,PS015,3349,"Five-Year Review of Diagnostic Practices and Antibiotic Prescribing Patterns for Acute Cystitis: Insights from a University Hospital in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Naruemit SAYABOVORN",Thailand
3419,PS015,3349,"Streptococcus agalactiae carriage among women living in Tunis, Tunisia over a period of ten years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Skander CHAABOUNI",Tunisia
3420,PS015,3349,"A single-centre outpatient parenteral antimicrobial therapy (OPAT) management experience for severe pelvic inflammatory disease in Ireland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaitlyn O'BRIEN",Ireland
3421,PS015,3349,"Risk factors for ciprofloxacin-resistant and ESBL-producing E. coli or Klebsiella spp. in patients with urinary tract infections: implications for empirical treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
3422,PS015,3349,"Prevalence of Streptococcus agalactiae colonisation in the general female population and description of its phenotypic resistance profile",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta ROLO",Spain
3423,PS015,3349,"Molecular surveillance of Neisseria gonorrhoeae in north Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María Del Rosario ALMELA FERRER",Spain
3424,PS015,3349,"Optimising diagnostic and antibiotic stewardship with BLADDER score",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaya PRASANTHI",India
3425,PS015,3349,"LGV are we trying too hard?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mikel URRUTIKOETXEA-GUTIERREZ",Spain
3426,PS015,3349,"Causative  microorganisms  of sexually  transmitted infections in a STI clinic during the year 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge-Alfredo PEREZ-GARCÍA",Spain
3427,PS016,NULL,"02f. Community-acquired skin, soft tissue, bone & joint infections (incl epidemiology, clinical, imaging, treatment & prevention, excl prostheses)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3428,PS016,3427,"Blood ozonisation as a complementary treatment in infective chronic wound healing: a single centre experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto PAGOTTO",Italy
3429,PS016,3427,"Comparative analysis of community-acquired and hospital-acquired necrotising soft-tissue infections in critically ill patients: a ten-year retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael THY",France
3430,PS016,3427,"Clinical epidemiology, risk factors, and outcomes of carbapenem-resistant Klebsiella pneumoniae wound infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yan FENG",China
3431,PS016,3427,"Clonal persistence of methicillin-susceptible Staphylococcus aureus ST672 in paediatric patients with invasive infections: genomic insights into virulence and resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David Eduardo JUÁREZ HINOJOS",Mexico
3432,PS016,3427,"Anti-virulence activity of dalbavancin against clinical isolates of Staphylococcus aures: a comparison with "gold standard" antibiotics in paediatric infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra GIARDINA",Italy
3433,PS016,3427,"Prevalence and characterisation of PVL-positive MRSA isolates in Moravian region, Czech Republic, 2021-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Renáta KARPÍSKOVÁ","Czech Republic"
3434,PS016,3427,"Comparative efficacies of amoxicillin/clavulanate acid, oxacillin alone or in combination with rifampin against experimental methicillin-susceptible Staphylococcus aureus (MSSA) joint prosthesis infection in rabbit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azzam SALEH-MGHIR",France
3435,PS016,3427,"Epidemiology and microbiological patterns of fracture related infections among different regions in Brazil: observational and multicentre cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael BRULL TUMA",Brazil
3436,PS016,3427,"Outpatient management of complex bone and joint infections in a virtual hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simran THADANI","United Kingdom"
3437,PS016,3427,"Clinical characteristics and follow-up of children with primary haematogenous osteomyelitis and septic arthritis: a single-centre experience from Hungary",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Szofia HAJÓSI-KALCAKOSZ",Hungary
3438,PS016,3427,"Ceftazidime±ciprofloxacin twice-daily has better outcomes to piperacillin-tazobactam infusion for necrotising otitis externa: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sathyavani SUBBARAO","United Kingdom"
3439,PS016,3427,"Vessels, nerves, and vision: the overlooked trio in diabetic foot infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansu TOL",Türkiye
3440,PS016,3427,"The role of dalbavancin in managing acute bacterial skin and skin structure infection with treatment noncompliance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Layan AKKIELAH",Canada
3441,PS016,3427,"Use of dalbavancin as an alternative therapy for osteomyelitis, spondylodiscitis and prosthetic joint infections: a retrospective single-centre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filippo BARRECA",Italy
3442,PS016,3427,"Skull base osteomyelitis (SBO): an observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nisarg SHAH",India
3443,PS016,3427,"Outpatient management of complex bone and joint infections in a virtual hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simran THADANI","United Kingdom"
3444,PS016,3427,"Assessment of topical phage therapy for Pseudomonas aeruginosa burn wound infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sidrah ASGHAR",Pakistan
3445,PS016,3427,"Omadacycline for skin and soft tissue infections: a multicentre retrospective analysis of efficacy and safety in real-world clinical practice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammed AL MUSAWA","United States"
3446,PS016,3427,"Prevalence of PVL toxin in S. aureus isolated from patients with invasive infections in a tertiary hospital in Navarra",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ander URIBARRI",Spain
3447,PS016,3427,"Streptococcus agalactiae, a frequent but not so well-known cause of bone and joint infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon JAMARD",France
3448,PS016,3427,"Improved peroxidase-like activity and photothermal/photodynamic effect of MAX phase with copper single-atom sites for facilitating diabetic wound repair",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mei YANG",China
3449,PS016,3427,"Emerging insights into Corynebacterium kroppenstedtii associated breast abscesses: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sreethish SASI",Qatar
3450,PS016,3427,"Risk factors for erysipelas and cellulitis: a national cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filip JANSÅKER",Sweden
3451,PS016,3427,"Diagnostic value of CT-guided percutaneous needle biopsy and/or aspiration in suspected spondylodiscitis cases: five-year audit at Ramón y Cajal University Hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta GONZÁLEZ-SANZ",Spain
3452,PS016,3427,"In vitro evaluation of the antibacterial activity of hypochlorite products",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karolina DYDAK",Poland
3453,PS016,3427,"A retrospective review of granulomatous mastitis over four years in a large district general hospital serving a diverse patient population: largest UK dataset",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas MASSIE","United Kingdom"
3454,PS016,3427,"Dramatic upsurge of invasive Group A streptococcal infections during 2023-2024 among younger patients without comorbidities in western Sweden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ulrika SNYGG-MARTIN",Sweden
3455,PS016,3427,"Effectiveness of phage therapy for treatment of acute vs chronic wounds",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna NANAVA",Georgia
3456,PS016,3427,"Improved peroxidase-like activity and photothermal/photodynamic effect of MAX phase with copper single-atom sites for facilitating diabetic wound repair",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mei YANG",China
3457,PS016,3427,"Clinical efficacy and safety of omadacycline in the treatment of enterococcal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean VAN HELDEN","United States"
3458,PS016,3427,"Evaluation of the antibiotic treatment against a polymicrobial biofilm made of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Estíbaliz TORRECILLA-SÁDABA",Spain
3459,PS016,3427,"Patients' characteristics, treatment and prognosis of Enterobacter cloacae osteomyelitis: about 146 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Léna SANDJAKIAN",France
3460,PS016,3427,"Low-grade infections as a potential cause of arthrofibrosis following total knee arthroplasty",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ander URIBARRI",Spain
3461,PS016,3427,"Optimising regimen of co-amoxiclav (ORCA): the safety and efficacy of intravenous co-amoxiclav at higher dosing frequency in patients with diabetic foot infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jun Jie TAN",Singapore
3462,PS016,3427,"Culture-negative native vertebral osteomyelitis: ten-year retrospective analysis at the Mayo clinic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rita IGWILO-ALANEME","United States"
3463,PS016,3427,"High prevalence of pathogenic methicillin-susceptible Staphylococcus aureus ST398-MSSA among atopic dermatitis patients in Portugal",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diana CAIEIRO",Portugal
3464,PS016,3427,"The role of antimicrobial prophylaxis in the treatment of snakebite: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel MOODY","United Kingdom"
3465,PS016,3427,"External validation of the baseline recurrence risk in cellulitis (BRRISC) score and the additional impact of incorporating acute clinical response",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin LLEWELYN","United Kingdom"
3466,PS017,NULL,"02g. Community-acquired nervous system and other multi-system or invasive bacterial infections?(incl epidemiology, clinical, imaging, treatment & prevention)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3467,PS017,3466,"A retrospective study of intracranial abscess and implications of early oral antibiotic switch",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vishal VARGHESE","United Kingdom"
3468,PS017,3466,"Changing aetiology and outcomes of brain abscesses in a UK tertiary neurological centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Orla HILTON","United Kingdom"
3469,PS017,3466,"Origins of S. epidermidis strains causing endophthalmitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leandro Andrés ESCOBAR-HERRERA",Denmark
3470,PS017,3466,"In-hospital clinical outcomes of adult tetanus patients admitted at a tertiary government hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amille Joy TY-LUISTRO",Philippines
3471,PS017,3466,"The spectrum of CNS infections at a teaching hospital in Kenya",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adeel SHAH",Kenya
3472,PS017,3466,"Characterisation of paediatric pneumococcal meningitis before and after introduction of 10-valent pneumococcal conjugate vaccine in Tunisia, 2016-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Khaoula MEFTAH",Tunisia
3473,PS017,3466,"Neurobrucellosis: a retrospective cohort study in Mashhad, Iran",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fereshteh SHEIBANI","Islamic Republic Of"
3474,PS017,3466,"Clinical and microbiological characteristics of invasive pneumococcal diseases in a Hungarian tertiary care institute: 20 years and counting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Béla KÁDÁR",Hungary
3475,PS017,3466,"Visual impairment in community acquired bacterial meningitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eva Nadine SCHEPERS",Netherlands
3476,PS017,3466,"Exploring the relationship between environmental change and meningitis risk in Angola",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James BEVAN","United Kingdom"
3477,PS017,3466,"Community-acquired bacterial meningitis in adults in the Netherlands: outcome and neurological sequelae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evelien Hendrika Gerarda Maria DROST",Netherlands
3478,PS017,3466,"Hospital-based surveillance of paediatric pneumococcal meningitis in southern Vietnam: clinical features and antibiotic resistance patterns (2012-2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cong Hieu TRUONG",Vietnam
3479,PS017,3466,"Streptococcus pneumoniae meningitis: clinical review and antimicrobial susceptibility trends over 13 years (2012-2024), a tertiary centre experience in the United States",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayesha SAMREEN","United States"
3480,PS017,3466,"Screening for neuronal auto-antibodies in adults after community-acquired bacterial meningitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steven Lukas STAAL",Netherlands
3481,PS017,3466,"Pneumococcal meningitis in adults: a 33-year analysis of serotype distribution and antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara CALVO-SILVERIA",Spain
3482,PS017,3466,"Trends in primary meningitis: a 14-year retrospective study at hospital universitario Nuestra Senora de la Candelaria, Tenerife",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria De Las Huertas GARCIA ATIENZA",Spain
3483,PS017,3466,"Comparing the radiological features of infective ring-enhancing brain lesions: a four-year retrospective study in a tertiary referral centre in Singapore",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edwin SNG",Singapore
3484,PS018,NULL,"02h. Zoonotic bacterial infections (incl vector-borne pathogens, excl AMR)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3485,PS018,3484,"Q fever in Majorca, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mercedes GARCIA",Spain
3486,PS018,3484,"Prevalence of Borrelia burgdorferi sensu lato infection in the Czech Republic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roman CHLIBEK","Czech Republic"
3487,PS018,3484,"Comparative evaluation of the infectious potential of zoonotic and human atypical enteropathogenic Escherichia coli (aEPEC) strains using in vivo infection models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helvécio CARDOSO CORRÊA PÓVOA",Brazil
3488,PS018,3484,"Seroprevalence of Bartonella henselae IgG among the healthy population in Korea and associated risk factors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna LEE","Republic Of"
3489,PS018,3484,"Epidemiological and clinical characteristics of psittacosis using cgMLST by capture sequencing: a multicentre, genome-based study in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jintao HE",China
3490,PS018,3484,"Sitafloxacin monotherapy vs standard rifampicin-doxycycline dual therapy for uncomplicated brucellosis: a multicentre, open-label, randomised, non-inferiority trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gang WANG",Belgium
3491,PS018,3484,"Functional characterisation of CD57+ OMP-specific CD8+ T cells in acute and chronic brucellosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guanmin YUAN",China
3492,PS018,3484,"Tick-borne pathogens in Switzerland: surveillance of Rickettsia, Anaplasma, Coxiella, and Chlamydiae in Ixodes ricinus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ehsan GHASEMIAN",Switzerland
3493,PS018,3484,"Clinical evaluation of a novel real-time PCR assay for Leptospira DNA detection: advancing leptospirosis diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
3494,PS018,3484,"Changing incidence of human granulocytic anaplasmosis in Slovakia, Central Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Klaudia Mária SVIRLOCHOVÁ",Slovakia
3495,PS018,3484,"Quality assessment of the diagnostic testing for Q fever: lessons from five years of external quality control in medical laboratories",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathalie WEISS",Germany
3496,PS018,3484,"Bacterial genera identified by metagenomics in ticks collected from a Brazilian university",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debora Stefany FERNANDES GUEDES",Brazil
3497,PS018,3484,"TIck-borne lymphadenopathy in northeastern France: human and vector clinical-epidemiological study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pierre BOYER",France
3498,PS018,3484,"Clinical and epidemiological characteristics of leptospirosis in the Kharkiv region, Ukraine in 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yaroslava BURMA",Ukraine
3499,PS018,3484,"112 year global analysis of human botulinum toxin serotyping",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tristan LEAROYD","United Kingdom"
3500,PS018,3484,"Evaluation of human brucellosis patients with and without decreasing serum agglutination test titers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayse Nur CEYLAN",Türkiye
3501,PS018,3484,"A case series of rickettsial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meriem ABDELJELIL",Tunisia
3502,PS018,3484,"Comparison of different treatments and durations for brucellosis: a randomised study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Petek KONYA",Türkiye
3503,PS018,3484,"Identification of Coxiella species by metagenomics in in ticks collected from a Brazilian university",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debora Stefany FERNANDES GUEDES",Brazil
3504,PS018,3484,"Rickettsiosis by Rickettsia aeschlimannii from  Hyalomma marginatum tick bite in a cattle breeder (southern Italy)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Grazia CARIGLIA",Italy
3505,PS018,3484,"Dengue mortality in southeast Asia region: exploring regional trends and disparities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Supta Rani SARKER",Bangladesh
3506,PS018,3484,"Claims-based algorithm to classify Lyme disease manifestations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Holly YU","United States"
3507,PS018,3484,"The burden of Lyme disease (BOLD) study in Europe: PTLD in six European countries and an examination of its criteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Holly YU","United States"
3508,PS018,3484,"Metabolomic profiling of cerebrospinal fluid in Lyme neuroborreliosis: a diagnostic insight",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilari KUUKKANEN",Finland
3509,PS018,3484,"Background incidence rates of health outcomes for Lyme disease vaccine safety monitoring in hospitalised and outpatient German populations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karla Therese L. SY","United States"
3510,PS018,3484,"Epidemiology of leptospirosis in the United Kingdom",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ameeka THOMPSON","United Kingdom"
3511,PS018,3484,"Epidemiology and clinical outcomes of scrub typhus in rural and urban settings: a hospital-based study from south India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arvind Krishna DEVARAJ",India
3512,PS018,3484,"Foodborne botulism in Brazil: analysis of cases over the last 17 years (2007-2024) and occurrence of an outbreak related to the consumption of chicken mortadella at popular fairs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wania FREITAS",Brazil
3513,PS018,3484,"Spinal brucellosis: the great mimicker",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helmi ERNANDES",Tunisia
3514,PS018,3484,"Epidemiological and clinical outcomes of human monocytic ehrlichiosis (HME) presenting to a single centre university hospital in the state of Florida, USA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liliana FRANCO MOREIRA","United States"
3515,PS018,3484,"Scrub typhus trend in northeastern Thailand, 2011-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yupin SUPUTAMONGKOL",Thailand
3516,PS018,3484,"Influence of different Leptospira serovars on lung damage in leptospirosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olena ZUBACH",Ukraine
3517,PS018,3484,"Development and validation of the microarray for the detection of IgG against Bacillus anthracis, Yersinia pestis and Francisella tularensis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olga STUKOLOVA","Russian Federation"
3518,PS018,3484,"Diagnosis and visualisation of biofilms in Bartonella quintana endocarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kurosh SARBANDI",Germany
3519,PS018,3484,"Comparison of gene detection rates in whole blood, eschar, and erythematous skin samples by polymerase chain reaction in Japanese spotted fever cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shigetoshi SAKABE",Japan
3520,PS018,3484,"Challenges in case management of brucellosis: prospective study from an endemic region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özlem ALHAN",Türkiye
3521,PS018,3484,"Evaluating the value of serological follow-up in managing Q fever infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pablo PILLADO ALONSO",Spain
3522,PS018,3484,"Epidemiological evolution of leptospirosis in French Guiana: a descriptive and comparative analysis of 2016-2022 cases with 2007-2014",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathilde ZENOU",France
3523,PS018,3484,"Development of monoclonal antibodies and immunoassays targeting VlsE to improve Lyme disease diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victoria DOLANGE",France
3524,PS018,3484,"Detection of Leptospira licerasiae, a P2 sub-clade species, in febrile patients, rodents, and livestock in Sri Lanka",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nipun RATHNAYAKE","Sri Lanka"
3525,PS018,3484,"Clinical data on symptomatic cutaneous reinfections due to Borrelia burgdorferi sensu lato in Europe: erythema migrans from reinfection differs from primary erythema migrans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Franc STRLE",Slovenia
3526,PS018,3484,"High seroprevalence of Coxiella burnetii among blood donors in Mallorca: implications for diagnostics and surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrés SUÁREZ IBARRA",Spain
3527,PS018,3484,"A novel approach for utilising IgG avidity in Lyme serology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"András ZÓKA",Hungary
3528,PS018,3484,"The role of serology in the diagnosis of Brucella endocarditis: a literature search",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reyhan BALKAYA DEMI?RTAS",Türkiye
3529,PS018,3484,"Neoehrlichia mikurensis and Borrelia miyamotoi: emerging and neglected pathogens in northern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emanuela OLIVIERI",Italy
3530,PS018,3484,"Molecular detection of Borrelia burgdorferi in off-season questing ticks: impact of environmental and climatic variables",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra Mistral DE PASCALI",Italy
3531,PS018,3484,"The epidemiology of brucellosis in Oman: a seven-year retrospective analysis, 2017-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ahad AL BALUSHI",Oman
3532,PS019,NULL,"02i. Other intracellular or rare bacteria","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","02. Bacterial infection & disease",NULL,NULL,NULL,NULL
3533,PS019,3532,"Low counts predict mortality in melioidosis: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Prithvishree RAVINDRA",India
3534,PS019,3532,"Characterisation of an emerging pathogen Pantoea dispersa causing neonatal sepsis in a tertiary healthcare facility in Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia RZASKA","United Kingdom"
3535,PS019,3532,"Melioidosis in India: emerging or neglected?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayush GUPTA",India
3536,PS019,3532,"Retrospective review of patients with clinically significant Fusobacterium gonidiaformans infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ellen SUGRUE",Ireland
3537,PS019,3532,"Enteropathogenic Providencia alcalifaciens: a subgroup of P. alcalifaciens that causes diarrhea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"M. John ALBERT",Kuwait
3538,PS019,3532,"Emergence of cases of neurolisteriosis in a single centre: insights into genomic analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadim CASSIR",France
3539,PS019,3532,"Survival mechanism of pancreatic tumor bacteria and their ability to metabolise chemotherapy drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zara Ahmad KHAN",Sweden
3540,PS020,NULL,"03a. Resistance surveillance & epidemiology: Community-acquired bacteria","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
3541,PS020,3540,"Genomic surveillance identifies C. jejuni lineages carrying a multi resistance gene cassette of Gram-positive origin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sangeeta BANERJI",Germany
3542,PS020,3540,"Ten-year study of Shigella sonnei: antimicrobial susceptibility trends and risk factors in a Croatian tertiary care clinic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvija SOPREK STRUGAR",Croatia
3543,PS020,3540,"Gepotidacin activity against Escherichia coli and Klebsiella pneumoniae, including molecularly characterised fluoroquinolone not susceptible subsets causing urinary tract infections in Europe and adjacent regions (2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo E. MENDES","United States"
3544,PS020,3540,"Ten-year trends in methicillin resistance rates of Staphylococcus lugdunensis: a multi-centre surveillance study in Kagawa prefecture, Japan (2013-2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taichi ITO",Japan
3545,PS020,3540,"Emergence of fluoroquinolone resistance in Salmonella paratyphi A isolates from sub-Saharan Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra SERRIS",France
3546,PS020,3540,"Genotype and phenotype of clinical isolates of Aeromonas species and epidemiology of carbapenem-resistant strains in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daisuke KITAGAWA",Japan
3547,PS020,3540,"Increasing eight-year trend in fusidic acid resistance among MRSA isolates in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Feline VELTHUIS",Netherlands
3548,PS020,3540,"Global phylogeography and genomic surveillance of a recent epidemic Bordetella pertussis ST2 high-risk international clone: a multicentre study in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xi LI",China
3549,PS020,3540,"Trends of azithromycin resistance in Neisseria gonorrhoeae from across the Indian subcontinent: time to reflect",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Devanshi SHARMA",India
3550,PS020,3540,"Activity of gepotidacin against molecularly characterised beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from patients with urinary tract infections in Europe and adjacent regions (2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo E. MENDES","United States"
3551,PS020,3540,"Mycoplasma genitalium: what is going on in Argentina? First report",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Belén MANCINO",Argentina
3552,PS020,3540,"In vitro activity of ceftaroline against bacterial pathogens from paediatric patients collected during the ATLAS global surveillance programme in 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meredith HACKEL","United States"
3553,PS020,3540,"In vitro activity of ceftaroline and comparator agents against bacterial pathogens from adult patients collected during the ATLAS global surveillance programme in 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meredith HACKEL","United States"
3554,PS020,3540,"Antibiotic susceptibility profiles of Gram-negative bacteria isolated from paediatric and adult UTI patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan-Vasile CRISTEA",Romania
3555,PS020,3540,"Improving geospatial coverage and granularity of global AMR prevalence estimates: comprehensive systematic literature reviews to complement WHO's global AMR surveillance system (2018-2022)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gilbert LAZARUS",Indonesia
3556,PS020,3540,"Comparison of antimicrobial susceptibility of Streptococcus pneumoniae and Haemophilus influenzae from blood and non-blood cultures: analysis from the survey of antibiotic resistance (SOAR) study, 2018-2021",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anand MANOHARAN",India
3557,PS020,3540,"Gepotidacin activity against and analysis of susceptibility to oral standard-of-care antibiotics for urinary tract infections caused by Escherichia coli and Klebsiella pneumoniae collected in Europe in 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"S. J. Ryan ARENDS","United States"
3558,PS020,3540,"Trends in clindamycin and metronidazole susceptibility of anaerobic clinical isolates: a ten year surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ander URIBARRI",Spain
3559,PS020,3540,"Virulence and fitness of  CTX-M producing Escherichia coli O25 ST131 in community acquired urinary tract infections in Croatia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tajana BALABAN",Croatia
3560,PS020,3540,"Six-year trend in decreasing (benzyl)penicillin diameter distribution in Streptococcus pyogenes in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rony Elisabeth ZOETIGHEID",Netherlands
3561,PS020,3540,"Phenotypic and genotypic distribution of ESBL uropathogens in the community setting of India: a multicentric cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Swati PUNDIR",India
3562,PS020,3540,"Multidrug-resistant invasive non-typhoidal Salmonella in children: asymptomatic shedding as an important source of community infection spread in Kenya",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel KARIUKI",
3563,PS020,3540,"Multidrug-resistant and distribution of ß-lactamase genes among diarrheagenic Escherichia coli isolated from under-five children in central Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tizazu ZELELIE",Ethiopia
3564,PS020,3540,"Antimicrobial resistance and genomic diversity of Neisseria gonorrhoeae in Maseru, Lesotho",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liteboho MADUNA",Lesotho
3565,PS020,3540,"Assessment of the European antibiotic resistance epidemiology in community care across drug-bacterium pairs: a spatial-temporal analysis using national surveillance data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pauline SORLIN",France
3566,PS020,3540,"Molecular epidemiology of mupirocin-resistant Staphylococcus aureus isolated from skin and soft-tissue infections in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mormeneo Bayo SARAY",Spain
3567,PS020,3540,"Prevalence and risk factors for ESBL-producing Enterobacterales rectal carriage in a public hospital from Argentina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maximiliano Gabriel CASTRO",Argentina
3568,PS020,3540,"Mycoplasma genitalium: two years prevalence of azithromycin and moxifloxacin resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice NAVA",France
3569,PS020,3540,"Molecular genetic analysis of extended-spectrum beta-lactamase-producing Escherichia coli isolated from outpatients at a tertiary care emergency centre: emergence of CTX-M-132-producing Escherichia coli in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yasumitsu NOMURA",Japan
3570,PS020,3540,"Risk factors associated with community-acquired multidrug-resistant infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diamantina LYMPERATOU",Greece
3571,PS020,3540,"Genomic epidemiology and distribution of carbapenemases and extended-spectrum beta-lactamases in Escherichia coliand Klebsiella pneumoniae at a Spanish hospital during 2019-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra A. MARTÍNEZ-ÁLVAREZ",Spain
3572,PS020,3540,"Improving understanding of Staphylococcus aureus carriage and resistance patterns in high-risk UK armed forces populations: prevalence of MRSA,  PVL-SA carriage and emergence of a MSSA ST398 clone",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"William NEVIN","United Kingdom"
3573,PS020,3540,"Distribution of macrolide resistance among Streptococcus pneumoniae clinical isolates collected from global populations, 2018-2019 and 2022-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meredith HACKEL","United States"
3574,PS020,3540,"Analysis of studies about antibiotic resistance of Enterobacter spp. between 2015 and 2022 through One Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angie Katherine CASTILLO PEÑA",Peru
3575,PS020,3540,"Antimicrobial resistance trends of Campylobacter species from a tertiary hospital, 2010-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shaikha AL-SHOKRI","United States"
3576,PS020,3540,"Impact of national guidelines for the treatment of community acquitted urinary tract infection on antibiotic resistance in Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier LEMENAND",France
3577,PS020,3540,"Evidence for antimicrobial stewardship and reduced antimicrobial resistance in the mid-west of Ireland, 2012 - 2023: findings from a One Health study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James POWELL",Ireland
3578,PS020,3540,"High prevalence of extended-spectrum beta-lactamase-producing Enterobacterales in patients admitted to a rural hospital in Tanzania",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iren Høyland LÖHR",Norway
3579,PS020,3540,"Molecular characterisation of Staphylococcus aureus from persistent respiratory infections: high detection of CC398 isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula EGUIZÁBAL",Spain
3580,PS020,3540,"Comparing the activity of oral cefditoren with other cephalosporins in Streptococcus pneumoniae clinical isolates non-susceptible to penicillin, 2019-2020",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julio SEMPERE",Spain
3581,PS020,3540,"A five-year antimicrobial resistance trends in Gram-negative bacteraemia isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lynette PHEE","United Kingdom"
3582,PS020,3540,"Epidemiology and prevalence of antimicrobial-resistant bacteria in wildlife in Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jemimmah MWANGI",Kenya
3583,PS020,3540,"Higher prevalence of blaOXA-244 in ESBL producing Escherichia coli isolates in the Netherlands: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julinha THELEN",Netherlands
3584,PS020,3540,"Distribution of Mycoplasma pneumoniae macrolide-resistant strains in two regional hospitals in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michinori SHIRANO",Japan
3585,PS020,3540,"/em>Neisseria gonorrhoeae resistance rates in Cardiff Wales compared to those at a national level according to gonococcal resistance to antimicrobial susceptibility programme (GRASP)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leanne DAVIES","United Kingdom"
3586,PS020,3540,"Increase in azithromycin resistance rate of Neisseria gonorrhoeae during the period 2020-2023 in Greece",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eirini SIATRAVANI",Greece
3587,PS020,3540,"Associations of CRISPR-Cas systems with antibiotic resistance and virulence genes of clinical Enterococcus faecalis isolates in Gauteng, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zander NIEHAUS","South Africa"
3588,PS020,3540,"Antimicrobial agents in dentifrices and mouthwashes: induction of antiseptic and antibiotic tolerance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sílvia OLIVEIRA",Brazil
3589,PS020,3540,"High prevalence of macrolide resistance in Streptococcus pneumoniae isolated from nasopharyngeal samples among naïve six-week-old children in Sierra Leone: a resistome approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mercedes MONTERO-VALE",Spain
3590,PS020,3540,"Circulation of blaOXA-244, an emerging resistance gene, in polyclonal E. coli strains in Jerusalem, Israel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janko SATTLER",Germany
3591,PS020,3540,"Investigation of Escherichia coli ST131 characteristics, an emerging pathogen in Rio de Janeiro",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isadora BARCELLOS",Brazil
3592,PS020,3540,"Antimicrobial susceptibility of Legionella pneumophila to azithromycin and levofloxacin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio CASABELLA PERNAS",Spain
3593,PS020,3540,"The aetiologic agents and resistance rates in community-acquired complicated intra-abdominal infections: where are we locally?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eren OZTURK",Türkiye
3594,PS020,3540,"A systematic review of resistance patterns of Corynebacterium diphtheriae.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amy PRICE","United Kingdom"
3595,PS020,3540,"Colistin resistance as an emergent threat among Uropathogenic Escherichia coli and Klebsiella pneumoniae from a rural community health centre, India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shipra TOMAR",India
3596,PS020,3540,"The impact of ceragenins on Streptococcus mitis clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cemre ÖZKANCA",Türkiye
3597,PS020,3540,"Prevalence and characteristics of methicillin-resistant Staphylococci colonisation in the nasal vestibule of healthy individuals in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sayaka ANDO",Japan
3598,PS020,3540,"Multidrug-resistant Streptococcus pneumoniae in Vietnamese children: results from a household prevalence survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thu-Trang VU",Vietnam
3599,PS020,3540,"Conflict-associated wounds and burns infected with GLASS pathogens in the eastern Mediterranean region: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aula ABBARA","United Kingdom"
3600,PS020,3540,"E. coli antimicrobial susceptibility patterns and social determinants of health: an ecological study in Ontario, Canada from 2017-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rada RUSU",Canada
3601,PS020,3540,"High household co-carriage of extended-spectrum beta-lactamases in Hong Kong",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kwok KIN ON",China
3602,PS020,3540,"Prevalence and antimicrobial susceptibility of community-acquired urinary isolates of ESBL-producing Enterobacterales: a three-year retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hugo CRUZ",Portugal
3603,PS020,3540,"Molecular characterisation of livestock-associated methicillin-resistant Staphylococcus aureus causing bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mormeneo Bayo SARAY",Spain
3604,PS020,3540,"Carbapenemase-producing Enterobacterales on the rise in community-onset infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yoleidys MARTINEZ-YSASIS",Spain
3605,PS020,3540,"A multicentre study: emm typing, PFGE analysis, antimicrobial resistance and biofilm production in Streptococcus pyogenes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özgen KÖSEOGLU ESER",Türkiye
3606,PS020,3540,"Knowledge of medical residents towards antibiotic resistance and appropriate prescribing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Asma AMMAR",Tunisia
3607,PS020,3540,"Prevalence of multidrug-resistant CS31A-producing E. coli in neonatal calf diarrhea outbreaks in central France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eduarda SILVEIRA",Portugal
3608,PS020,3540,"Antimicrobial susceptibility testing of Gardnerella spp. vaginal isolates from a tertiary care centre in Slovenia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kitty ZNIDAR",Slovenia
3609,PS020,3540,"Piperacillin/tazobactam susceptibility in AmpC beta-lactamase producing Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kitty ZNIDAR",Slovenia
3610,PS020,3540,"Antimicrobial resistance surveillance in Belgian ambulatory care: SARPRIC-UTI study focussing on uncomplicated urinary tract infections in 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matijs HOUBEN",Belgium
3611,PS020,3540,"Whole-genome sequencing analysis of an ESBL producer Shigella sonnei causing an outbreak in Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lamia KANZARI",Tunisia
3612,PS020,3540,"Genomic characterisation of community-level transmission dynamics of extended-spectrum E. coli in rural Burkina Faso",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iana AMKE","United Kingdom"
3613,PS020,3540,"Study of antimicrobial susceptibility in Brucella spp. strains isolated at CHU Rabta, Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Salma ABBES",Tunisia
3614,PS020,3540,"Genomic insights of carbapenemase-producing Enterobacter spp. in Argentina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando PASTERAN",Argentina
3615,PS021,NULL,"03b. Resistance surveillance & epidemiology: Healthcare-associated bacteria","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
3616,PS021,3615,"Prevalence of carbapenem-resistant Enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii ????colonisation among hospitalised immunocompromised and critically ill paediatric patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophida BOONSATHORN",Thailand
3617,PS021,3615,"Admission incidence rate and diffusion dynamics of ESBL-producing Klebsiella pneumoniae in adult intensive care units: a five-year genomic monocentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Coraline BERNACHOT",France
3618,PS021,3615,"In vitro susceptibility of cefiderocol against carbapenem-resistant Gram-negative bacilli (CRGNB) from Singapore",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jocelyn TEO",Singapore
3619,PS021,3615,"Synergistic and additive effects of fosfomycin in MBL-producing Klebsiella pneumoniae and Pseudomonas aeruginosa isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther WOHLFARTH",Germany
3620,PS021,3615,"The integrated genomic surveillance reveals extensive clustering among increasing rates of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jörg B. HANS",Germany
3621,PS021,3615,"Molecular characterisation of OXA-48-like-producing Enterobacterales in Germany: insights from the DIOGENES study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janko SATTLER",Germany
3622,PS021,3615,"Antimicrobial resistance and genetic insights into clinical pathogens from a Kyiv polyclinic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tim ERLER",Germany
3623,PS021,3615,"Global epidemiology, trends, and clinical severity of hypervirulent Klebsiella pneumoniae infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nagendra Babu DANAVATH",India
3624,PS021,3615,"Assessment of in vitro synergy of colistin combined with meropenem, minocycline and Tigecycline in clinical isolates of carbapenem-resistant Klebsiella pneumoniae, Pseudomonas aeruginosa, Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nida FATIMA",India
3625,PS021,3615,"Diversity of the vanB cassette within ST117 vancomycin-resistant Enterococcus faecium isolates from Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyriaki XANTHOPOULOU",Germany
3626,PS021,3615,"Emergence and outbreak of ST80 vancomycin-resistant Enterococcus faecium in Guangdong province, China from 2021 to 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cong SHEN",China
3627,PS021,3615,"Medical tourism in western Germany: review of Arab and Russian patients and their MRSA- and MRGN-status at a tertiary care facility in north Rhine-Westphalia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annette EYKING-SINGER",Germany
3628,PS021,3615,"Prevalence of healthcare-associated infections and antimicrobial use in ICU wards in Georgia: results of the first ECDC point prevalence survey in 25 hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Otar CHOKOSHVILI",Georgia
3629,PS021,3615,"Intra- and inter-patient evolution of cgMLST in ST-512 KPC-producing Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María Alejandra MATEO VARGAS",Spain
3630,PS021,3615,"Unveiling hidden reservoirs of carbapenemases in Pseudomonas spp. beyond P. aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillem PUIGSECH BOIXEDA",Spain
3631,PS021,3615,"Greater multidrug resistance in Enterococcus faecium but greater pathogenicity in Enterococcus faecalis isolated from Welsh ICU patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caitlin FARLEY","United Kingdom"
3632,PS021,3615,"Silent dissemination of identical VanA-carrying linear plasmids in vancomycin-variable Enterococcus faecium: a growing diagnostic concern",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana ALMEIDA SANTOS",Portugal
3633,PS021,3615,"Enterobacterales involved in plasmid-mediated carbapenem resistance outbreaks in Portuguese hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rani Rashmani DE LA RIVIÈRE",Portugal
3634,PS021,3615,"Retrospective evaluation of culture-proven carbapenem-resistant Gram-negative infections a tertiary care educational university hospital: analysis of 888 cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merve MERT VAHABI",Türkiye
3635,PS021,3615,"Emergence and spread of OXA-48-like carbapenemase-producing Escherichia coliin Baranya County, Hungary",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnes Maria SONNEVEND",Hungary
3636,PS021,3615,"Genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae in Taiwan, 2014-2020",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tzu-Wen HUANG",China
3637,PS021,3615,"Characterisation of carbapenem-resistant Klebsiella pneumoniae lineages in bloodstream infections in Barcelona (2021-2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aida CASTANY CARRASCO",Spain
3638,PS021,3615,"First identification of Enterobacterales co-producing mcr-10 and broad-spectrum β-lactamase genes in Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael SILVA ROSA",Brazil
3639,PS021,3615,"Risk factors for development of hospital-acquired pneumonia in colonised patients by carbapenem-resistant Acinetobacter baumannii and the role of multisite colonisation: a multicentre clinical experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rocco MORENA",Italy
3640,PS021,3615,"Retrospective analysis of 22 years of surveillance of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary hospital in northern Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maitane ARANZAMENDI ZALDUMBIDE",Spain
3641,PS021,3615,"Comparative effectiveness of cefiderocol and ceftazidime/avibactam plus aztreonam against metallo-beta-lactamase-producing Gram-negative isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando DEL NOGAL",Spain
3642,PS021,3615,"Prevalence and genetic context of the blaOXA-1 gene in bloodstream isolates of Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos SAÚCO CARBALLO",Spain
3643,PS021,3615,"Is the glass half empty? High resistance rates amongst carbapenem-resistant bacteria in a cefiderocol-naive setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christina LOUKA",Greece
3644,PS021,3615,"High genetic relatedness between historical and contemporary multidrug resistant bacteria associated with Ukraine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhayne HACKETT","United States"
3645,PS021,3615,"Emergence and spread of transferable linezolid resistance among Enterococcus faecium in a tertiary hospital in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria SÁNCHEZ CUETO",Spain
3646,PS021,3615,"Molecular epidemiology and clinical characteristics of carbapenem-resistant Klebsiella pneumoniae bloodstream and pneumonia isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Phillip COX","United States"
3647,PS021,3615,"Prevalence and mechanism of colistin heteroresistance in Klebsiella pneumoniae in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ying ZHU",China
3648,PS021,3615,"VanA Enterococcus faecalis isolated from blood in Poland between 2022-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malgorzata GRZEGORCZYK",Poland
3649,PS021,3615,"Evolution of incidence, risk factors and management of carbapenemase-producing Enterobacterales in a tertiary hospital over the last ten years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia GALAR",Spain
3650,PS021,3615,"Geographic variations in distributions of carbapenemase-encoding genes, susceptibilities, and minimum inhibitory concentrations of inpatient meropenem-resistant Enterobacterales to ceftazidime/avibactam, meropenem/vaborbactam, and aztreonam/avibactam across four global regions: 2020-2022 data from the antimicrobial testing leadership and surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Po-Ren HSUEH",China
3651,PS021,3615,"Prevalence and risk factors of fluoroquinolone resistance in Gram-negative bacterial infections: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"I Made Bayu ANGGRIAWAN","United Kingdom"
3652,PS021,3615,"Transmission dynamics of multidrug-resistant Klebsiella pneumoniae ST792 and novel ST7120 strains in the paediatric intensive care unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tu-Hsuan CHANG",China
3653,PS021,3615,"Phylogenomic analysis of IMP-producing Acinetobacter colistiniresistens revealed a predominant lineage in the regional spread",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Satoshi NISHIDA",Japan
3654,PS021,3615,"Emergence of a novel sequence type carbapenem-resistant Klebsiella pneumoniae ST7462 in a healthcare-associated outbreak in Estonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Regina RUSSANOVA",Estonia
3655,PS021,3615,"Genomic insights into Enterococcus faecium: resistance, virulence, and phylogenetic analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kuenyoul PARK","Republic Of"
3656,PS021,3615,"Cephalosporin use and the rise of multidrug-resistant infections: evidence from Guatemala",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diego ERDMENGER",Guatemala
3657,PS021,3615,"Cefiderocol-resistant Acinetobacter baumannii:  before cefiderocol introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alina GONCHAROVA","Russian Federation"
3658,PS021,3615,"Antimicrobial resistance patterns among patients admitted with sepsis at a tertiary hospital in Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elias NDIBAREMA",Uganda
3659,PS021,3615,"Retrospective detection of mcr-9-carrying Enterobacter cloacae cpx. clinical isolates in a tertiary hospital in Tenerife",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eduardo PÉREZ ROTH",Spain
3660,PS021,3615,"The activity of cefiderocol against Achromobacter xylosoxidans clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annarita MAZZARIOL",Italy
3661,PS021,3615,"Characterisation of coagulase-negative Staphylococci neonatal sepsis isolates from low-to-middle-income countries for resistance, virulence and phylogeny",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jawaria AZIZ","United Kingdom"
3662,PS021,3615,"Fifteen-year trends in resistance patterns of urinary pathogens at a Lebanese tertiary care centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Serge TOMASSIAN",Lebanon
3663,PS021,3615,"Prevalence of rectal carriage and genomic characterisation of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae: results of annual point prevalence studies in a Dutch hospital, 2013-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronica WETERINGS",Netherlands
3664,PS021,3615,"CTX-M-15-producing high-risk Escherichia coli CC131 and first report of ST1193 causing urinary tract infections in Algeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azucena MORA GUTIÉRREZ",Spain
3665,PS021,3615,"Carbapenamese resistance in European hospitals: two consecutive point prevalence surveys of Acinetobacter baumannii and Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eline VERHAGEN",Netherlands
3666,PS021,3615,"Arising from the shadows: clonal analysis of multi-drug resistant Enterococcus faecium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iván BLOISE",Spain
3667,PS021,3615,"Insight into the evolution of a carbapenemase-producing Klebsiella pneumoniae ST395 strain in Hungary",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akos TOTH",Hungary
3668,PS021,3615,"Understanding antimicrobial resistance mortality in intensive care units in Paraguay (2022-2023): pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ada Evangelina BRIZUELA",Paraguay
3669,PS021,3615,"Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa strains in Portugal",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria MENESES",Portugal
3670,PS021,3615,"Trends in fatal burden of antibiotic-resistant infections across EU countries from 1990 to 2021",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gisela ROBLES AGUILAR","United Kingdom"
3671,PS021,3615,"Multicentre spread of vancomycin- and linezolid-resistant Enterococcus faecium ST2023 in Polish hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ewa Nina WARDAL",Poland
3672,PS021,3615,"Concerning rise in antibiotic resistance: insights from clinical bacterial isolates at an Albanian university hospital (TWIW 2020 Study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silva TAFAJ",Albania
3673,PS021,3615,"MDR bacteraemia in critically ill patients during the COVID-19 pandemic: the MARTINI study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Georgios SCHINAS",Greece
3674,PS021,3615,"A five year trend analysis of prevalence and antimicrobial susceptibility pattern of coagulase-negative Staphylococci (CoNS) in a tertiary care centre, south India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaya PRASANTHI",India
3675,PS021,3615,"Surveillance of temporal trends and antimicrobial resistance in nosocomial respiratory pathogens, Switzerland, 2007 to 2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rami SOMMERSTEIN",Switzerland
3676,PS021,3615,"Genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates recovered in intensive care units in Paraguay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra SANCHEZ-URTAZA",Spain
3677,PS021,3615,"Evaluation of the efficacy of novel beta-lactam/beta-lactamase inhibitors against carbapenem-resistant Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sae Am SONG","Republic Of"
3678,PS021,3615,"Synergistic effect of ceftazidime/avibactam with aztreonam on carbapenemase-producing Enterobacteriaceae: the ray of hope against NDM",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dip MUKHERJEE",India
3679,PS021,3615,"The changing epidemiology of carbapenemase producing Enterobacterales in a Spanish tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Estíbaliz UGALDE",Spain
3680,PS021,3615,"In vitro activity of delafloxacin against quinolone-resistant Staphylococcus aureus should always be tested",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Celia SÁNCHEZ-MARTÍNEZ",Spain
3681,PS021,3615,"Prevalence and Antimicrobial Susceptibility of blaOXA-51 negative Acinetobacter spp. as a Cause of Human Infection in Perú.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rosario OPORTO LLERENA",Peru
3682,PS021,3615,"Description of susceptibility profile of metallo-beta-lactamases-producing and non-carbapenemase-producing P. aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana Belén BORREGO ALCAIDE",Spain
3683,PS021,3615,"A Klebsiella pneumoniae ST147 NDM-1/OXA-48 unique clone circulating in diverse hospitals in southern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emanuele NICITRA",Italy
3684,PS021,3615,"Activity of novel broad-spectrum antimicrobials against multi-carbapenemase producers Enterobacterales from southern Spain, 2018-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mercedes DELGADO VALVERDE",Spain
3685,PS021,3615,"Antibiotic resistance patterns in Pseudomonas spp.: an eight year surveillance study in an Algerian hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Asma BENMOHAMMED",Algeria
3686,PS021,3615,"Coproduction of carbapenemases in Enterobacterales: emergence of a new phenomenon in a Spanish tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Estíbaliz UGALDE",Spain
3687,PS021,3615,"Recent emergence of carbapenem-resistant Salmonella paratyphi in India: resistance profile and phylogenetic analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tharani Priya THIRUMOORTHY",India
3688,PS021,3615,"Genotype and phenotype of carbapenemase-producing Escherichia coli in England, 2023-24",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina PENNETTA","United Kingdom"
3689,PS021,3615,"Impact of the cessation and reopening of international travel during the COVID-19 pandemic on the incidence of MRSA and CPO in Norway, 2016-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anders SKYRUD DANIELSEN",Norway
3690,PS021,3615,"Molecular epidemiology of carbapenemase-producing Enterobacterales, extended-spectrum beta-lactamase-producing Enterobacterales, and carbapenem-producing Pseudomonas aeruginosa in hospitalised patients in Suriname",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlotte ROZEMOND",Netherlands
3691,PS021,3615,"Molecular epidemiology of carbapenemase-producing Enterobacter spp. in Hungary",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adrienn HANCZVIKKEL",Hungary
3692,PS021,3615,"Comprehensive study on healthcare-associated urinary tract infections in Serbia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ina GAJIC",Serbia
3693,PS021,3615,"WHO's global antimicrobial resistance and use surveillance system (GLASS): is national surveillance coverage improving?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther VAN KLEEF",Netherlands
3694,PS021,3615,"One-year epidemiological surveillance of Klebsiella pneumoniae producing both NDM and OXA-48 Carbapenemases in an acute-care healthcare setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sofia ZERVA",Greece
3695,PS021,3615,"In vitro susceptibility to sulbactam/durlobactam of carbapenem-resistant Acinetobacter baumannii isolated from bloodstream infections: a multicentre study in Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CZEKSTER ANTOCHEVIS",Brazil
3696,PS021,3615,"Antimicrobial susceptibility and clonal structure of Acinetobacter spp. isolated from hospitalised patients in Poland in 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorota ZABICKA",Poland
3697,PS021,3615,"Trends in antimicrobial resistance: a three-year cumulative AST analysis of blood culture isolates in a tertiary hospital in Istanbul",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yunus Emre TOK",Türkiye
3698,PS021,3615,"Enhanced surveillance and outbreak investigation through the use of whole-genome sequencing (WGS) in Greece",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michalis POLEMIS",Greece
3699,PS021,3615,"Emergence of carbapenemase-producing Enterobacter hormaechei in Marseille hospitals, France: a success-story analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linda HADJADJ",France
3700,PS021,3615,"Tracking resistance in anaerobic bacteria (2016-2024) from an Irish hospital's perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Damien KELLY",Ireland
3701,PS021,3615,"Colistin and carbapenem-resistant Klebsiella pneumoniae isolates from Tunisia: a decade of rising resistance, 2012-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wejdene MANSOUR",Tunisia
3702,PS021,3615,"Increase in blaNDM-1 among carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex clinical isolates collected in 2023 from US and European medical centres",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana CASTANHEIRA","United States"
3703,PS021,3615,"Molecular epidemiology of methicillin-resistant Staphylococcus aureus in central, eastern, and south-eastern Europe: systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan TKADLEC","Czech Republic"
3704,PS021,3615,"Emergence and persistent spread of NDM-carrying Klebsiella pneumoniae high-risk clones in a tertiary hospital in Tenerife",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria De Las Huertas GARCIA ATIENZA",Spain
3705,PS021,3615,"Resistance to antimicrobial agents in Escherichia coli and Klebsiella pneumoniae from hospitalised patients: results of the PEG surveillance study, 1984-2022/23",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther WOHLFARTH",Germany
3706,PS021,3615,"Multidrug-resistant Pseudomonas aeruginosa: Mayo Clinic ten-year experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kemar BARRETT",Jamaica
3707,PS021,3615,"Fosfomycin resistance in Enterobacterales: a one-year surveillance in northern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katerina CHUDEJOVA","Czech Republic"
3708,PS021,3615,"Prevalence and mechanisms of drug-resistant Acinetobacter baumannii isolated from hospitals in Japan: emergence of colistin resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sayaka YAMAGUCHI",Japan
3709,PS021,3615,"Colistin resistance among multidrug-resistant Enterobacterales in an Algerian hospital: preliminary findings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samar AKBI",Algeria
3710,PS021,3615,"Real world in vitro synergy to doxycycline, ceftriaxone/sulbactam/edetate, and chloramphenicol in ceftazidime/avibactam-resistant, aztreonam synergy-negative isolates from a tertiary referral centre in southern India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nimitha K MOHAN",India
3711,PS021,3615,"Molecular epidemiology of methicillin susceptible Staphylococcus aureus in the Czech Republic: prospective multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan TKADLEC","Czech Republic"
3712,PS021,3615,"Cefepime/taniborbactam exhibits limited cross-resistance with ceftazidime/avibactam and ceftolozane/tazobactam against carbapenem-nonsusceptible Enterobacterales and multidrug-resistant Pseudomonas aeruginosa from Europe 2018-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meredith HACKEL","United States"
3713,PS021,3615,"In vitro activity of aztreonam/avibactam and comparator agents against metallo-beta-lactamase (MBL)-positive carbapenem-resistant E. coli and Klebsiella  spp.collected from patients with bloodstream infections (BSI) as part of the ATLAS surveillance programme (2020-2022), India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akshata Sushant MANE",India
3714,PS021,3615,"Antimicrobial resistance in bacterial isolates from nine Ukrainian war casualties: a retrospective bicentric observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diana Isabela STRACHINARU",Belgium
3715,PS021,3615,"Multidrug-resistant organisms amidst ongoing conflict in Ukraine: surveillance and resistance patterns",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Magda METREVELI",Georgia
3716,PS021,3615,"Cefiderocol activity against resistant bacteria from patients with ventilator associated pneumonia from European and US hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean NGUYEN","United States"
3717,PS021,3615,"Analysis of multidrug-resistant organisms from Poland and Estonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nino TRAPAIDZE",Georgia
3718,PS021,3615,"Activity of cefiderocol against clinical isolates of Acinetobacter baumannii complex collected from five European countries as part of SENTRY antimicrobial surveillance programme, 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher LONGSHAW","United Kingdom"
3719,PS021,3615,"Activity of cefiderocol against clinical isolates of Stenotrophomonas maltophilia collected from five European countries as part of the SENTRY antimicrobial surveillance programme 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher LONGSHAW","United Kingdom"
3720,PS021,3615,"Activity of omadacycline against multidrug-resistant and molecularly characterised Acinetobacter baumannii-calcoaceticus complex clinical isolates from United States hospitals, 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo E. MENDES","United States"
3721,PS021,3615,"In vitro activity of cefepime/taniborbactam and comparators against Enterobacterales and P. aeruginosa collected in Europe (2018-2023) stratified by beta-lactamase carriage",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3722,PS021,3615,"The landscape of carbapenemases in Canada 2019-2023, data from the Canadian nosocomial infection surveillance programme (CNISP)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura MATASEJE",Canada
3723,PS021,3615,"In vitro activity of mecillinam against multi-drug resistant Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariano Paulo ECHEGORRY",Argentina
3724,PS021,3615,"Carbapenem resistance enterobacteriaceae (CRE) at university college hospital, Ibadan, Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul TURNER",Cambodia
3725,PS021,3615,"In vitro activity of ceftazidime/avibactam, imipenem/relebactam and meropenem/vaborbactam against clinical isolates of KPC-producing Klebsiella pneumoniae from a Greek hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anastasios VOGIATZAKIS",Greece
3726,PS021,3615,"Evaluating chlorhexidine antimicrobial susceptibility of S. aureus and methicillin-resistant S. aureus blood culture isolates following implementation of CHG-bathing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peiyi Vicki CHOW",Singapore
3727,PS021,3615,"Molecular characterisation and epidemiology of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa (CRE/CRPA) among hospitalised patients in five public hospitals from South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Renata DA COSTA",Switzerland
3728,PS021,3615,"Microbiological and epidemiological characteristics of carbapenemase-producing Enterobacteriaceae in urine cultures during the year 2024 at a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura LOPEZ GONZALEZ",Spain
3729,PS021,3615,"Outbreak investigation of extensively drug-resistant Acinetobacter baumannii of ST2 in the intensive care unit of a Lebanese hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tsolaire SOURENIAN","Czech Republic"
3730,PS021,3615,"Molecular characterisation and epidemiology of carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa (CRE/CRPA) among hospitalised patients in five public/private hospitals from India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balaji VEERARAGHAVAN",India
3731,PS021,3615,"RpoB mutations and their association with rifampicin resistance in clinical Staphylococcus epidermidis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mia AARRIS",Denmark
3732,PS021,3615,"Linking carbapenem-resistant E. coli in hospital-admitted patients and the environment in Bangladesh: An emerging public health threat.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amrita PONDIT","United Kingdom"
3733,PS021,3615,"In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa isolates from geriatric patients with respiratory tract infections in the Asia/Pacific region: SMART, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3734,PS021,3615,"Activity of the novel beta-lactam/beta-lactamase inhibitor combination cefepime/enmetazobactam against Acinetobacter spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriela Alejandra BAEZ BARROSO",Spain
3735,PS021,3615,"Activity of ceftolozane/tazobactam, imipenem/relebactam and comparators against clinical isolates of Pseudomonas aeruginosa from hospitalised patients in Kuwait, Oman, Qatar, and United Arab Emirates: SMART 2018-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3736,PS021,3615,"Activity of ceftolozane/tazobactam and comparators against phenotypic ESBL-producing, carbapenemase-negative clinical Enterobacterales isolates from South Africa: SMART 2018-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3737,PS021,3615,"Activity of ceftolozane/tazobactam, imipenem/relebactam and comparators against clinical isolates of Pseudomonas aeruginosa from hospitalised patients in Southeastern Europe: SMART 2018-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3738,PS021,3615,"A systematic review of prevalence and epidemiological characteristics of carbapanemease-producing Enterobacterales (CPE) in the United Kingdom",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Uzair Akbar ALI","United Kingdom"
3739,PS021,3615,"Activity of imipenem/relebactam and comparators against clinical Gram-negative isolates collected in the Latin American region: SMART 2021-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3740,PS021,3615,"Precision analysis of the carbapenemase- and/or ESBL-producing Acinetobacter baumannii clinical isolates by national microbiology reference laboratory in Latvia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inara KAMPENUSA",Latvia
3741,PS021,3615,"Emergence of Klebsiella pneumoniae ST-11 expressing KPC-2 and NDM-5 carbapenemases in an Algerian university hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadjat AGGOUNE KHINACHE",Algeria
3742,PS021,3615,"The clonal diversity of extensively resistant Acinetobacter baumannii isolated in Egyptian clinical settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Salma SALEM",Egypt
3743,PS021,3615,"Epidemiology of multi-drug resistant bacteria among foreign combatants wounded in Ukraine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aubrey POWELL","United States"
3744,PS021,3615,"In vitro activity of aztreonam/avibactam against ceftazidime/avibactam-resistant Enterobacterales isolates collected as a part of the ATLAS global surveillance Sstudy, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3745,PS021,3615,"The highly resistant NDM-14-producing K. pneumoniae ST147 clone reaching the Canary Islands, Spain, 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tania BLANCO MARTÍN",Spain
3746,PS021,3615,"Temporal changes in carbapenem resistance genes in Klebsiella pneumoniae: a 12-year study from a university hospital in Turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat TELLI",Türkiye
3747,PS021,3615,"In vitro antimicrobial susceptibility testing of cefiderocol against Gram-negative bacteria isolated from cystic fibrosis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marjan MOTAMEDI",Austria
3748,PS021,3615,"Surveillance of Acinetobacter baumannii by clustering analysis with sequence type characterisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina DIMARTINO",Italy
3749,PS021,3615,"Trends in incidence rates of microorganisms among patients with bloodstream infections at intensive care units in South Korea from 2011 to 2022: data from the Korean national healthcare-associated infections surveillance system (KONIS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yu-Mi LEE","Republic Of"
3750,PS021,3615,"Evaluating cefiderocol susceptibility in carbapenem-resistant Klebsiella pneumoniae: a comparative analysis of CLSI and EUCAST guidelines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yüsra AGAOGLU",Türkiye
3751,PS021,3615,"Characterisation of colistin resistant Enterobacterales isolated from clinical specimens from public hospitals in Gauteng, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohamed SAID","South Africa"
3752,PS021,3615,"Antimicrobial susceptibility and virulence profiles of invasive and non-invasive vancomycin-resistant Enterococci at the university hospital centre Zagreb: preliminary results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ivana MAREKOVIC",Croatia
3753,PS021,3615,"The prevalence and prognostic value of antimicrobial resistance within nosocomial settings: a global systematic review and meta-analysis of over 20,000 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel PAN","United Kingdom"
3754,PS021,3615,"Activity of cefiderocol against metallo-beta-lactamase-carrying Enterobacterales, stratified by allele, collected as part of the SENTRY antimicrobial surveillance programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Boudewijn DEJONGE","United States"
3755,PS021,3615,"ACORN2: prospective clinically oriented antimicrobial resistance surveillance data from 19 hospitals across Africa and Asia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jill HOPKINS",Thailand
3756,PS021,3615,"In vitro activities of the essential antimicrobial agents including aztreonam/avibactam, eravacycline, colistin, and other comparators against carbapenem-resistant organisms with different carbapenemase genes: a multicentre study in China, 2021",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun WU",China
3757,PS021,3615,"Activity of cefiderocol against carbapenem-resistant Pseudomonas aeruginosa, including molecularly characterised clinical isolates, causing infections in hospitals in European and adjacent regions, 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo E. MENDES","United States"
3758,PS021,3615,"The activity of cefiderocol against Enterobacterale carrying multiple carbapenemases, collected as part of the SENTRY antimicrobial surveillance programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jason J. BRYOWSKY","United States"
3759,PS021,3615,"Activity of cefiderocol against carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex, including molecularly characterised clinical isolates, causing infections in hospitals in European and adjacent regions, 2020-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rodrigo E. MENDES","United States"
3760,PS021,3615,"Tracking of trimethoprim resistance determinants in MRSA: a genetic analysis of hospital isolates in Kuwait",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samar BOSWIHI",Kuwait
3761,PS021,3615,"Association of integron diversity with reduced biocide susceptibility of multidrug-resistant Pseudomonas aeruginosa isolates from public hospitals in Gauteng, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Egan MULONDO","South Africa"
3762,PS021,3615,"Frequency and antimicrobial resistance pattern of microorganisms isolated from cerebrospinal fluid samples in Brazilian public hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jussimara MONTEIRO NURMBERGER",Brazil
3763,PS021,3615,"Automated surveillance of bloodstream infections in Germany: a proof-of-concept study and first results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imke WIETERS",Germany
3764,PS021,3615,"Exploring the role of KPC variants in cross-resistance to last-line antibiotics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando PASTERAN",Argentina
3765,PS021,3615,"Genomic insights into methicillin resistant Staphylococcus aureus population structure, dissemination and diversity in the United Arab Emirates using whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Syrine Nouara BOUCHERABINE","United Arab Emirates"
3766,PS021,3615,"Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global urveillance study in Latin America, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3767,PS021,3615,"Trends in the in vitro activity of ceftazidime/4avibactam and beta-lactamase carriage among Pseudomonas aeruginosa isolates collected as a part of the ATLAS global surveillance study in 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3768,PS021,3615,"Prevalence and risk factors for multi-drug resistant Enterobacterales in long-term care facilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erika ASPERGES",Italy
3769,PS021,3615,"Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Middle East/Africa, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3770,PS021,3615,"Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Asia/Pacific, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3771,PS021,3615,"Trends in the in vitro activity of aztreonam/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Europe, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3772,PS021,3615,"In vitro activity of aztreonam/avibactam against Enterobacterales isolates collected from patients in intensive care units and other wards, by global region ATLAS surveillance study, 2019-20",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3773,PS021,3615,"Susceptibility of Enterobacterales collected globally to aztreonam/avibactam and comparator agents stratified by infection source: ATLAS surveillance programme 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark WISE","United States"
3774,PS021,3615,"High prevalence of NDM-production and its adverse impact on in-vitro susceptibility of newer antibiotics against Indian Pseudomonas aeruginosa isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Umang AGRAWAL",India
3775,PS021,3615,"In vitro activity of aztreon/amavibactam against carbapenem-resistant Enterobacterales isolates by region collected as a part of the ATLAS global surveillance study, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3776,PS021,3615,"In vitro activity of ceftazidime/avibactam (CAZ-AVI) and comparators against Pseudomonas aeruginosa collected worldwide stratified by ICU vs non-ICU, ATLAS global surveillance programme, 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meredith HACKEL","United States"
3777,PS021,3615,"Antimicrobial activity of aztreonam-avibactam against carbapenemase-producing Pseudomonas aeruginosa from German hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie Louise MÖLLER",Germany
3778,PS021,3615,"Emergence of resistance and consumption of cefazolin vs anti-Staphylococcal penicillins: an exploratory cross-sectional study in French healthcare facilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laure-Line JOUBERT",France
3779,PS021,3615,"Trends in the in vitro activity of ceftazidime/avibactam and beta-lactamase carriage among Enterobacterales isolates collected as a part of the ATLAS global surveillance study in Europe, by subregion 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3780,PS021,3615,"In vitro activity of ceftazidime/avibactam against Enterobacterales stratified by global region and year of collection, ATLAS global surveillance programme, 2018-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meredith HACKEL","United States"
3781,PS021,3615,"Phylogenetic and population structure analyses reveal intra-clonal diversification and emergence of successful clades of carbapenemase-producing Klebsiella pneumoniae ST258 from Argentina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabrizzio Nicolás MORANDINI",Argentina
3782,PS021,3615,"Proportion of Staphylococcus aureus with a vancomycin MIC of 1 mg/L increases from 12% in 2013 to 70% in 2020, during COVID-19 restrictions in Singapore",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Timothy BARKHAM",Singapore
3783,PS021,3615,"In vitro activity of sulbactam/durlobactam against clinical Acinetobacter baumannii isolates in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qingye XU",China
3784,PS021,3615,"In vitro evaluation of the efficacy of aztreonam/avibactam and aztreonam plus ceftazidime/avibactam against carbapenem-resistant Pseudomonas aeruginosa: revisiting the role of ceftazidime",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana CAIERÃO",Brazil
3785,PS021,3615,"Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated in intensive care unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiao TINGTING",China
3786,PS021,3615,"Contact precautions vs horizontal strategies to limit the spread of third-generation cephalosporin resistant Gram-negative bacteria on intensive care units: results of a country-wide, multicentred, non-randomised, before-after studies on intensive care units",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beate SCHLOSSER",Germany
3787,PS022,NULL,"03c. Susceptibility testing methods (incl assay validation, phenotypic assays and comparative studies, excl TB)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
3788,PS022,3787,"Evaluation of FDA-cleared rapid antimicrobial susceptibility testing (AST) methods for bloodstream infections: impact on clinical decision-making in a tertiary care setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manohar MUTNAL","United States"
3789,PS022,3787,"Rifabutin MIC test strip development for susceptibility testing against Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit SCHELLHORN",Switzerland
3790,PS022,3787,"Evaluation of a two-hour antimicrobial susceptibility assay for bacteraemia using flow cytometry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Adelina GIMENO",Spain
3791,PS022,3787,"Evaluation of a wide panel of antibiotic discs and Mueller-Hinton agar plates with laboratory automation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo LUCCHINI",Italy
3792,PS022,3787,"In vitro synergistic activity of amoxicillin and cephalosporin on non-faecalis and non-faecium Enterococcaceae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romain MILLOT",France
3793,PS022,3787,"Performance evaluation of a novel rapid AST system on Gram-negative blood culture isolates at a tertiary university hospital in northern Greece",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paraskevi MANTZANA",Greece
3794,PS022,3787,"A novel ultra-rapid phenotypic susceptibility method for ceftazidime/avibactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cidália PINA-VAZ",Portugal
3795,PS022,3787,"Direct antimicrobial susceptibility testing on clinical urine samples by laboratory automation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jamie WORSWICK","United Kingdom"
3796,PS022,3787,"Evaluation of VITEK REVEAL fast antimicrobial susceptibility testing compared to disk diffusion for Gram-negative bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebekah DUMM","United States"
3797,PS022,3787,"Rapid direct antibiotic susceptibility testing of positive blood cultures using cell pellet",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paraskevi MANTZANA",Greece
3798,PS022,3787,"Cefiderocol is a promising treatment alternative agent against highly virulent and antimicrobial-resistant Stenotrophomonas maltophilia, an emerging pathogen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özgen KÖSEOGLU ESER",Türkiye
3799,PS022,3787,"Antimicrobial susceptibility and resistance mechanisms in clinical Bacteroides fragilis group isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleni KALOGEROPOULOU",Greece
3800,PS022,3787,"Performance for detecting carbapenemase classes with an automated antimicrobial susceptibility testing system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurence PAGES MONTEIRO",France
3801,PS022,3787,"Antimicrobial susceptibility testing assay using scanning electron microscopy for aminoglycosides: a pilot investigation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omar ZMERLI",France
3802,PS022,3787,"Penicillin-resistant, ampicillin-susceptible Enterococcus faecalis (PRASEF) strains and their extended beta-lactam resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernardo Alfonso MARTINEZ-GUERRA",Mexico
3803,PS022,3787,"Antimicrobial susceptibility testing and clinical outcomes of non-cystic fibrosis Burkholderia cepacia complex infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ka Lip CHEW",Singapore
3804,PS022,3787,"Towards antibiotic susceptibility testing (AST) direct from urine: interim results from the analytical validation of microcapillary AST",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie HART","United Kingdom"
3805,PS022,3787,"In vitro synergistic effect of mecillinam with avibactam against Klebsiella pneumoniae clinical isolates producing various carbapenemases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleni VOUDANTA",Greece
3806,PS022,3787,"Detection and differentiation of carbapenemases among Enterobacterales isolates using advanced system expert and new expertise rules of the VITEK 2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent DORTET",France
3807,PS022,3787,"Synergistic potential of colistin combinations against carbapenem- and colistin-resistant enterobacteriaceae: in-vitro and in-vivo insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Archana ANGRUP",India
3808,PS022,3787,"Two years with RAST in Enterobacteria: clinical impact and concordance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena ALVARADO",Spain
3809,PS022,3787,"Evaluation of the card VITEK AST-N442 among a collection of clinical Enterobacteriaceae isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"François GRAVEY",France
3810,PS022,3787,"Comparison of various methods for identifying Nocardia isolates and determining antibiotic susceptibilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ekin KIRBAS",Türkiye
3811,PS022,3787,"A prospective, observational, cross-sectional, single-arm study using nanomotion-based technology (Resistell AST) for rapid Gram-negative antibiotic susceptibility testing (NANO-RAST)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia CARUANA",Switzerland
3812,PS022,3787,"Rapid antimicrobial resistance diagnosis in sepsis: a comparative study of a microfluidic rapid AST system and broth microdilution on Gram-negative pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah DI SOPRA",Italy
3813,PS022,3787,"Performance of antibiotic susceptibility testing methods for novel beta-lactam/beta-lactamase inhibitors and temocillin in carbapenemase-producing Enterobacterales: a comparative study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansu CIMEN",Germany
3814,PS022,3787,"Extraction of viable Gram-positive bacteria from blood for rapid antimicrobial susceptibility testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel SPENCER","United Kingdom"
3815,PS022,3787,"Development of a novel antibiotic susceptibility test using Raman spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giang NGUYEN","United Kingdom"
3816,PS022,3787,"Synergy between orally bioavailable antibiotics and dalbavancin against MRSA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brian WERTH","United States"
3817,PS022,3787,"In vitro activity of delafloxacin against Escherichia coli isolates producing bacteraemia with different susceptibility profiles to ciprofloxacin and levofloxacin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina ELÍAS LÓPEZ",Spain
3818,PS022,3787,"Rapid susceptibility testing of cefiderocol directly from positive blood cultures using a microfluidic agar-diffusion assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amanda ÅMAN",Sweden
3819,PS022,3787,"Synergistic effect of ceftazidime/avibactam with meropenem and aztreonam against carbapenem-resistant Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun WU",China
3820,PS022,3787,"Optimisation and improvement of in vitro drug susceptibility method for mucoid Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun WU",China
3821,PS022,3787,"In-vitro activity of cefiderocol and eravacycline in multidrug-resistant strains of Achromobacter xylosoxidans and Achromobacter denitrificans: implementation of a rapid testing protocol",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angela CHARLES","United States"
3822,PS022,3787,"Colistin, meropenem/vaborbactam, imipenem/relebactam, and eravacycline testing in carbapenem-resistant Gram-negative rods: a comparative evaluation of broth microdilution, gradient test, and VITEK 2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patrick FORSTNER",Austria
3823,PS022,3787,"Evaluation of the VITEK REVEAL  AST system vs Accelerate Pheno for antimicrobial susceptibility testing of Gram-negative bacteria directly from positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suzane SILBERT","United States"
3824,PS022,3787,"Evaluating in vitro antibiotic synergy for paediatric multidrug-resistant Gram-negative bloodstream isolates at a tertiary public hospital in South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Prenika JAGLAL","South Africa"
3825,PS022,3787,"In vitro activity of cefiderocol against Burkholderia cepacia complex from patients with cystic fibrosis assessed by two methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hedda Luise VERHASSELT",Germany
3826,PS022,3787,"Cefiderocol susceptibility against carbapenem-resistant Gram-negative bacilli: a study on Indian clinical strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarita MOHAPATRA",India
3827,PS022,3787,"Comparison of three methods for detecting metronidazole resistance determinants (nim) in Bacteroides fragilis group organisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanshu FANG",China
3828,PS022,3787,"Evaluation of an automated antimicrobial susceptibility testing system performance for colistin susceptibility in Klebsiella pneumoniae and Escherichia coli isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arzu ILKI",Türkiye
3829,PS022,3787,"Resistance levels to beta-lactams based on oxacillin disk difusion test in Sreptococcus pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleni KALOGEROPOULOU",Greece
3830,PS022,3787,"Comparative evaluation of an automated antimicrobial testing system for carbapenemase detection in K. pneumoniae and E. coli isolates using CIM and genotypic methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özlem Gizem NIGDELIOGLU SEZER",Türkiye
3831,PS022,3787,"Are disk diffusion and agar gradient diffusion reliable for mecillinam susceptibility?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vasiliki KOUMAKI",Greece
3832,PS022,3787,"The effect of beta-lactamase genes and chromosomal gene mutations on the cefiderocol susceptibility of New Delhi metallo-beta-lactamase (NDM) producing Enterobacterales isolates from Merseyside hospitals, comparing cefiderocol antibiotic susceptibility testing methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caitlin DUGGAN","United Kingdom"
3833,PS022,3787,"The PIM test: rapid phenotypic detection of penicillinase-producing Staphylococcus aureus without zone edge reading",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dhouha KARRAY",Tunisia
3834,PS022,3787,"Identification of Corynebacterium clinical isolates at the species level using phenotypic, molecular methods and assessment of the rapid emergence of high-level resistance to daptomycin and vancomycin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özgen KÖSEOGLU ESER",Türkiye
3835,PS022,3787,"In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacqueline FINDLAY",Switzerland
3836,PS022,3787,"Evaluation of rapid phenotypic antimicrobial susceptibility testing from positive blood cultures at a quaternary care academic medical centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew E. CLARK","United States"
3837,PS022,3787,"Metallo-beta-lactamase producing Pseudomonas aeruginosa: the fractional inhibitory concentration index as a tool to evaluate antibiotic synergy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guido GRANATA",Italy
3838,PS022,3787,"Evaluation of a ready-to-use metronidazole agar dilution panel for antimicrobial susceptibility testing of anaerobic bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ulrik Stenz JUSTESEN",Denmark
3839,PS022,3787,"Comparative analysis using linear regression models to identify predictors of AMR in Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwasegun DARAMOLA",Nigeria
3840,PS022,3787,"Influence of pH on antibiotic efficacy against uropathogenic Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne-Christine AUST",Germany
3841,PS022,3787,"Evaluation of aztreonam/avibactam alone and in combination with colistin against ESBL- and carbapenemase-producing Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elin FERMÉR",Sweden
3842,PS022,3787,"Evaluation of direct blood culture antimicrobial susceptibility testing in routine diagnostic settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Al Hawaj HASSAN","Saudi Arabia"
3843,PS022,3787,"Resistance detection to fluoroquinolones by an automated AST system in Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gilles ZAMBARDI",France
3844,PS022,3787,"Evaluation of cefepime/enmetazobactam efficacy against BLEE + OXA 48 resistant strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis GAGO MANTILLA",Spain
3845,PS022,3787,"Rapid AST for patients with suspected urosepsis: optimised sample management to reduce time to guide antibiotic therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria ROLF",Sweden
3846,PS022,3787,"Evaluation of CLSI, EUCAST and a lab developed rapid antimicrobial susceptibility test directly from positive blood culture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yan CHEN",Canada
3847,PS022,3787,"Laboratory performance in antimicrobial susceptibility testing of anaerobic bacteria (EUCAST disc diffusion methodology): results of an external quality assessment study, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael BUHL",Germany
3848,PS022,3787,"Evolution of rapid colistin resistance detection methods in Klebsiella pneumoniae and  Acinetobacter baumannii strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fatma ERDEM",Türkiye
3849,PS022,3787,"In vitro activity of cefepime/zidebactam (FPZ) against extended-spectrum beta-lactamase (ESBL) producers and carbapenem-resistant Enterobacterales (CRE) isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia MACCARI",Argentina
3850,PS022,3787,"Area of technical uncertainty: a paradigm for clinical microbiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Carlos DE GRACIA DÍAZ",Spain
3851,PS022,3787,"Evaluation of direct-from-blood-culture disc diffusion testing for Gram-negative bacteraemia at a regional microbiology laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Austin YAN",Canada
3852,PS022,3787,"Comparison of broth microdilution and antimicrobial gradient strip test in determining in vitro activity of aztreonam/avibactam in metallo-beta-lactamase-producing Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna DUDAKOVA",Germany
3853,PS022,3787,"Performance assessment of a cefepime-taniborbactam gradient diffusion strip for antimicrobial susceptibility testing of Enterobacterales and Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Greg MOECK","United States"
3854,PS022,3787,"Evaluation of a novel rapid phenotypic antimicrobial susceptibility testing system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ping REN","United States"
3855,PS022,3787,"Cefepime/taniborbactam (FTB) epidemiological cutoff values (ECOFFs) against key Enterobacterales species and Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Greg MOECK","United States"
3856,PS022,3787,"Biofilms and beta-lactamases affect cefiderocol activity in multidrug-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria CAVALLO",Italy
3857,PS022,3787,"Do we still have treatment options for infections caused by carbapenemase-producing Enterobacterales?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anezka GRYNDLEROVA","Czech Republic"
3858,PS022,3787,"Evaluation of meropenem, ertapenem and temocillin screening breakpoints in the EUCAST rapid antimicrobial susceptibility testing (RAST) for rapid detection of OXA-48-producing Klebsiella pneumoniae directly from positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yeliz TANRIVERDI CAYCI",Türkiye
3859,PS022,3787,"Meropenem/vaborbactam against planktonic and biofilm forms of carbapenem-resistant Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca SIVORI",Italy
3860,PS022,3787,"Colistin resistance in Klebsiella pneumoniae: phenotypic assays shed light on genomic mechanisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kavitha KUMAR",India
3861,PS022,3787,"Novel antibiotic susceptibility testing (AST) of Coxiella burnetii towards doxycycline using tabletop scanning electron microscopy (SEM)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rita ABOU ABDALLAH",Lebanon
3862,PS022,3787,"A sepsis solution in a large clinical laboratory: evaluation of three fast phenotypic antimicrobial susceptibility testing approaches from positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eric RANSOM","United States"
3863,PS022,3787,"In vitro activity of aztreonam and aztreonam/avibactam against carbapenemase-producing Enterobacterales in Peru",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liliana CAYTUIRO",Peru
3864,PS022,3787,"Standardising aztreonam/relebactam disk diffusion susceptibility testing in Enterobacterales: a step towards reliable clinical application",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariano Paulo ECHEGORRY",Argentina
3865,PS022,3787,"Combining oxacillin and benzylpenicillin disk diffusion to categorise benzylpenicillin susceptibility in Streptococcus pneumoniae without MIC testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erika MATUSCHEK",Sweden
3866,PS022,3787,"Evaluation of imipenem/relebactam for MicroScan dried Gram-negative MIC panels from a multicentre assessment of Enterobacterales and Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christine HASTEY","United States"
3867,PS022,3787,"ETEST imipenem/relebactam (IRPA) for antimicrobial susceptibility testing of Pseudomonas aeruginosa: performance results from a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aurélie COLLANGE",France
3868,PS022,3787,"Personalised antimicrobial susceptibility clinical breakpoint interpretation using clinical prediction modelling: a microsimulation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alex HOWARD","United Kingdom"
3869,PS022,3787,"Performance of the LifeScale rapid AST vsclinical standards of care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Masaw AKBARI","United States"
3870,PS022,3787,"Colistin susceptibility in Klebsiella pneumoniae isolates: comparison of broth microdilution and automated systems with qPCR-based investigation of mcr gene presence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irmak OZKUBAT KORKMAZ",Türkiye
3871,PS022,3787,"Emerging evidence of antimicrobial resistance in Capnocytophaga canimorsus may have significant implications for empiric treatment choices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zoja GERMUSKOVA",Switzerland
3872,PS022,3787,"In vitro activities of aztreonam/nacubactam and cefepime/nacubactam against carbapenemase-producing Enterobacterales collected as part of a global surveillance study in 2021-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
3873,PS022,3787,"Increased antibiotic susceptibility of Gram-positive bacteria in cerebrospinal fluid compared to broth",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer Stella WIRTH",Germany
3874,PS022,3787,"Delafloxacin as the only anionic flouroquinolone with excellent activity against multi-drug resistant bacteria especially in acidic environments: an in vitro study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus HELL",Austria
3875,PS022,3787,"Controlled inoculum functionality of an automated rapid AST system leads to consistent MIC determination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jenny GÖRANSSON",Sweden
3876,PS022,3787,"Study on the susceptibility of the fifth-generation cephalosporin ceftaroline to Gram-positive bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Li ZHIDONG",China
3877,PS022,3787,"Comparative evaluation of cefepime/taniborbactam MIC testing with gradient strip and CLSI broth microdilution methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion POMPILO",France
3878,PS022,3787,"Early evaluation of rapid antimicrobial susceptibility testing by volatile organic compounds detection: a comparative study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Min Kyung SO","Republic Of"
3879,PS022,3787,"A systematic review and individual bacterial species-level meta-analysis of in vitro studies on the efficacy of ceftazidime/avibactam combined with other antimicrobials against carbapenem-resistant Gram-negative bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Getnet ASSEFA",Australia
3880,PS022,3787,"A 2-plate method for the detection of ESBL and carbapenemase-producing Enterobacterales.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie CREIGHTON","New Zealand"
3881,PS022,3787,"Antibiotic susceptibility of Gram-negative bacteria in cerebrospinal fluid compared to Mueller-Hinton broth and artificial cerebrospinal fluid",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roland NAU",Germany
3882,PS022,3787,"Evaluation of the Sysmex PA-100 system for rapid antibiotic susceptibility testing in urinary samples from borate tubes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chloé BELOT",France
3883,PS022,3787,"Evaluation of the broth disk elution method for determining the synergistic activity of the aztreonam and ceftazidime-avibactam combination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Banu BAYRAKTAR",Türkiye
3884,PS022,3787,"A prospective comparison of five methods for rapid antimicrobial susceptibility testing (RAST) for Gram-negative bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christine UITZ",Austria
3885,PS022,3787,"Phenotypic detection of transferable linezolid resistance in Enterococcus faecalis: implications for monitoring gene dissemination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clara MORETÓ-CASTELLSAGUÉ",Spain
3886,PS022,3787,"Inducible clindamycin resistance in Streptococcus harboring erm genes: evaluation of a new screening test",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer GIESEN","United States"
3887,PS022,3787,"Comparative study of nalidixic acid and pefloxacin for quinolone resistance screening in Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorena LÓPEZ CERERO",Spain
3888,PS022,3787,"Challenges of cefiderocol susceptibility testing: agreement between a commercial method and disk-diffusion in metallobetalactamase-producing Klebsiella spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines Maria PORTILLO CALDERON",Spain
3889,PS022,3787,"Cefiderocol's dark side: the challenge of accurate in vitro testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara CARLONI",Italy
3890,PS022,3787,"Antimicrobial susceptibility of anaerobic bacteria from bloodstream infections in Germany: a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Denise STARK",Germany
3891,PS022,3787,"Gepotidacin MIC determination: comparative evaluation of a new gradient strip to the CLSI 2024 reference method on 290 clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronique SAUVONNET",France
3892,PS022,3787,"In vitro antibacterial activity of a fosfomycin/trimethoprim/sulfamethoxazole combination plus anti-mycobacterial agents against reference strains of non-tubercular Mycobacterium spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dalon ARRINGTON","United States"
3893,PS022,3787,"Performance evaluation of three routine methods for testing the susceptibility of 450 outpatient Escherichia coli isolates to mecillinam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther WOHLFARTH",Germany
3894,PS022,3787,"Exploring microtubule targeting agents as novel antimicrobial therapeutics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amira Zhor Rim ZINAI",France
3895,PS022,3787,"In vitro activity of cefiderocol against carbapenem-resistant Escherichia coli (CREC): a multicentre study in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ye LU",China
3896,PS022,3787,"Comparative study on the effectiveness of two gradient strips with imipenem/relebactam on Enterobacterales and P. aeruginosa strain collections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion POMPILO",France
3897,PS022,3787,"Performance of ceftazidime/avibactam and ceftolozane/tazobactam automated susceptibility testing results for carbapenem-resistant Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily JACOBS","United States"
3898,PS022,3787,"Evaluation of MIC determination with dalbavancin gradient test in Enterococcus faecalis, Enterococcus faecium and Staphylococcus epidermidis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frida MALM",Sweden
3899,PS022,3787,"Evaluation of a semi-automated system for antibiotic susceptibility testing: a comparison with manual method",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merav STRAUSS",Israel
3900,PS022,3787,"Performance of a new system for rapid antimicrobial susceptibility testing of Gram-negative bacteraemia: results from a prospective mono centric study in South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yohann BALA",France
3901,PS022,3787,"Rapid phenotypic susceptibility testing from patient blood cultures with growth of Streptococci or other Gram-positive bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jenny GÖRANSSON",Sweden
3902,PS022,3787,"Ultra-rapid antibiotic susceptibility testing workflow for neonatal sepsis: from blood sample to AST result in nine hours",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander STURM",Switzerland
3903,PS022,3787,"Phenotypic and molecular analysis of the in vitro activity of fluoroquinolones against clinical isolates of Corynebacterium spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Montserrat MUÑOZ ROSA",Spain
3904,PS022,3787,"Unlocking rapid phenotypic AST direct-from-blood with automated microbial detection and quantitative growth monitoring",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elinor MCSORLEY","United Kingdom"
3905,PS023,NULL,"03d. Resistance mechanisms (incl in vitro and in vivo studies, mobile elements, excl TB)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
3906,PS023,3905,"Emergence of Klebsiella pneumoniae ST15 isolates harbouring blaSFO-1 on a conjugative plasmid: a silent and persistent threat in community-acquired infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanni LORENZIN",Italy
3907,PS023,3905,"Aztreonam/avibactam resistance rates and resistance mechanisms of NDM-carbapenemase-producing-Enterobacterales (CPE) and NDM/OXA48-like-dual-CPE in Singapore",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ka Lip CHEW",Singapore
3908,PS023,3905,"Persistence, dissemination and evolution of IMP-15 carbapenemase-producing isolates of Pseudomonas aeruginosa in Gran Canaria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel TALTAVULL PONS",Spain
3909,PS023,3905,"DNA methyltransferases in Escherichia coli affects fitness and genome stability",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jee Hong KIM","Republic Of"
3910,PS023,3905,"Presence of the hypervirulent Clone ST23 of Klebsiella pneumoniae producing VIM-1 in the Canary Islands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Piña Delgado CARMEN",Spain
3911,PS023,3905,"Molecular and microbiological characteristics of E. coli harboring mutant CTX-M-15 (A80V)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bongyoung KIM","Republic Of"
3912,PS023,3905,"Energy metabolism deficiencies enhance the susceptibility of Staphylococcus aureus and its small colony variants (SCVs) to lugdunin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mei-Hui LIN",China
3913,PS023,3905,"Characterisation of a novel KPC-2 variant, KPC-228, conferring resistance to ceftazidime-avibactam in an ST11-KL64 hypervirulent Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bingjie WANG",China
3914,PS023,3905,"Description of the first cases of GES-type Class A carbapenemase-producing Pseudomonas aeruginosa in the Canary Islands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Piña Delgado CARMEN",Spain
3915,PS023,3905,"Optimising ceftolozane/tazobactam therapy against OXA-type beta-lactamase producing XDR Pseudomonas aeruginosa: insights from clinical case and hollow-fiber model correlations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra DOMENE",Spain
3916,PS023,3905,"Preventing OXA-type beta-lactamase producing XDR Pseudomonas aeruginosa infections: correlating clinical outcomes with hollow-fiber model results for ceftazidime/avibactam therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Milagro MONTERO",Spain
3917,PS023,3905,"Investigating the prevalence and mechanisms of antibiotic resistance in Enterobacteriaceae: insights into carbapenemase and colistin resistance genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zahra SADEGHI","Islamic Republic Of"
3918,PS023,3905,"High level of clindamycin resistance in clinically relevant anaerobes and emergence of cfiA gene mediated carbapenem-resistance in Bacteroides spp., a phenotypic and molecular perspective from Croatia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anita NOVAK",Croatia
3919,PS023,3905,"Complex evolution of KPC variants conferring ceftazidime-avibactam resistance from a single patient during ceftazidime-avibactam therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shen SIQUAN",China
3920,PS023,3905,"Colistin and octenidineiInduced in-vitro selective pressure on Pseudomonas aeruginosa clinical isolates: antimicrobial activity and mechanisms of cross-resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent POIREL",Switzerland
3921,PS023,3905,"Description and characterisation of blaIMP-106: a new blaIMP variant from Pseudomonas aeruginosa isolated in a bacteriemia from a paediatric haematological patient in Canary Islands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel TALTAVULL PONS",Spain
3922,PS023,3905,"Tigecycline resistance in Staphylococcus aureus resulting from the combined action of tetracycline resistance determinants tetM and tetL",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mollie M. HURST","United Kingdom"
3923,PS023,3905,"Plasmid-mediated antimicrobial resistance in Enterobacter cloacae blood isolates: a bioinformatic approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano Adrián ENDARA REGALADO",Ecuador
3924,PS023,3905,"Prevalence of vancomycin variable enterococci in the Netherlands and the mechanism of resistance induction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian VON WINTERSDORFF",Netherlands
3925,PS023,3905,"In vivo emergence of cefiderocol resistance in both Klebsiella pneumoniae and Acinetobacter baumannii during prolonged treatment in a single patient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valerio CAPITANI",Italy
3926,PS023,3905,"Integrated genomic and transcriptomic analysis of multi-drug resistant colistin tolerant Pseudomonas aeruginosa to identify tolerance related genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansel VATANSEVER",Türkiye
3927,PS023,3905,"Role of S155, D159 and R214 amino-acid residues in the active site of OXA-48 variants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thierry NAAS",France
3928,PS023,3905,"Engineered conjugative vectors as vehicles to study resistance and virulence in Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Riccardo POLANI",Italy
3929,PS023,3905,"Staphylococcus aureus bacteraemia: detection and characterisation of blaZ",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dhouha KARRAY",Tunisia
3930,PS023,3905,"Pseudomonas aeruginosa mechanisms involved in decreased susceptibility to a quaternary ammonium compound",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille COTET",France
3931,PS023,3905,"Mechanisms of antimicrobial peptide and antibiotic interactions on membrane permeabilisation and deactivation of Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Terri CAMESANO","United States"
3932,PS023,3905,"Antimicrobial resistance and virulence in Pseudomonas aeruginosa strains from hospitalised COVID-19 patients in an international hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yolanda SAENZ",Spain
3933,PS023,3905,"Understanding bacterial resistance mechanisms: insights from porin mutations in Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo CECCARELLI",Italy
3934,PS023,3905,"Emergence of polymyxin B-resistant Klebsiella pneumoniae in experiment tigecycline resistance evolution without exposure to polymyxin B",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaojuan WANG",China
3935,PS023,3905,"Temocillin efficacy and emergence of resistance in Enterobacter cloacae complex in a murine peritonitis model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nelly ALANBARI",France
3936,PS023,3905,"Whole-genome sequencing characterisation of a new KPC variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia VAIANA",Italy
3937,PS023,3905,"Prevalence and genetic characterisation of carbapenem-resistance mechanisms and integrons in Pseudomonas aeruginosa isolates from poultry in Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sirine MEJRI",Tunisia
3938,PS023,3905,"Heteroresistance to cefiderocol in clinical isolates of Stenotrophomonas maltophilia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina ELÍAS LÓPEZ",Spain
3939,PS023,3905,"Genetic correlates of synergy mechanisms of daptomycin plus fosfomycin in daptomycin-susceptible and -resistant methicillin-resistant Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Warren ROSE","United States"
3940,PS023,3905,"Emergence and spread of ST5 methicillin-resistant Staphylococcus aureus with accessory gene regulator dysfunction: genomic insights and therapeutic challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shengnan JIANG",China
3941,PS023,3905,"NagX, a periplasmic b-N-acetylglucosaminidase, contributes to NagZ-independent beta-lactamase expression in Stenotrophomonas maltophilia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tsuey-Ching YANG",China
3942,PS023,3905,"Phage-plasmid borne methionine tRNA ligase mediates epidemiologically relevant antimicrobial persistence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kate BAKER","United Kingdom"
3943,PS023,3905,"Impact of pBMB9393 plasmid in biofilm formation and autolysis in MRSA ST239",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raquel NUNES",Brazil
3944,PS023,3905,"Resistance mechanisms in multidrug-resistant Klebsiella pneumoniae ST792 and ST7120 strains causing invasive disease in the paediatric intensive care unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tu-Hsuan CHANG",China
3945,PS023,3905,"Phenotypic and genomic characterisation of ST11-K1 CR-hvKP with highly homologous blaKPC-2-bearing plasmids in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Han YU-LING",China
3946,PS023,3905,"Dated evolutionary analysis of ST-78 A. baumannii pinpoints acquisition of antimicrobial resistance genes prior to clonal expansion and global spread",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ting LUO","United States"
3947,PS023,3905,"Characterisation of DHFR mutation conferring resistance to trimethoprim in Burkholderia thailandensis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie GUILLIER",France
3948,PS023,3905,"First report of OXA-204-producing Pseudomonas guariconensis: expanding the horizon of carbapenemase dissemination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadia JAIDANE",Tunisia
3949,PS023,3905,"Emergence of resistance to beta-lactam/beta-lactamase inhibitor combinations through horizontally acquired carbapenem-hydrolysing class D beta-lactamase OXA-1054 in Pseudomonas aeruginosa sequence type 303",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucía GONZÁLEZ PINTO",Spain
3950,PS023,3905,"Ribosomal mutations mediated reduced omadacycline susceptibility in Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yue YAO",China
3951,PS023,3905,"KHM-2, a novel metallo-carbapenemase identified in Pseudomonas mosselii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katie HOPKINS","United Kingdom"
3952,PS023,3905,"Resistance, transfer and evolution mechanism research of ceftazidime/avibactam-resistant Klebsiella pneumoniae causing nosocomial cloning spread",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Weiwei YANG",China
3953,PS023,3905,"Dual AmpC and AmpD mutations in Pseudomonas aeruginosa: unraveling the mechanisms of resistance to ceftazidime and avibactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albane ROZEHOLC",France
3954,PS023,3905,"Molecular mechanism of eravacycline resistance in tigecycline-nonsusceptible Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zitong PAN",China
3955,PS023,3905,"In vivo acquired-resistance to ceftazidime/avibactam, cefiderocol and meropenem/vaborbactam in KPC-producing Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lydia GALVEZ BENITEZ",Spain
3956,PS023,3905,"Ceftazidime/avibactam resistance characteristics emerged diversely in carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa from an intensive care unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junxin ZHOU",China
3957,PS023,3905,"Characterising cas gene variability and its impact on antibiotic resistance in carbapenem-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mullika CHOMNAWANG",Thailand
3958,PS023,3905,"Investigation of carbapenem-resistant Klebsiella pneumoniae harboring double resistance mechanisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olga KOUTSOPETRA",Greece
3959,PS023,3905,"Experimental evolution of mutational pathways to aminoglycoside resistance in Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peechanika PINWEHA","United Kingdom"
3960,PS023,3905,"Decreased porin transcription promotes resistance to taniborbactam when combined with meropenem",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhuoren ZHUOREN","United Kingdom"
3961,PS023,3905,"LiaF is required for LiaX-mediated protection against cell membrane acting antibiotics like daptomycin and bacitracin but not vancomycin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diana PANESSO","United States"
3962,PS023,3905,"The GelE metalloprotease is a key modulator of the LiaFSR response against daptomycin and antimicrobial peptides through LiaX cleavage in Enterococcus faecalis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kavindra SINGH","United States"
3963,PS023,3905,"Molecular mechanisms and distribution of cefiderocol-non-susceptible NDM-producing Escherichia coli in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chengkang TANG",China
3964,PS023,3905,"Genetic and phenotypic characterization of a novel ST45-K43 Carbapenem-resistant Klebsiella pneumoniae strain causing bloodstream infection: a potential clinical threat",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaobing CHU",China
3965,PS023,3905,"A strain of Serratia marcescens exhibiting high-level tolerance to meropenem",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaobing CHU",China
3966,PS023,3905,"Scarless excision of an insertion sequence in the OmpK36 promoter restores meropenem susceptibility in a non-carbapenemase-producing Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yingying DU",China
3967,PS023,3905,"The role of Pseudomonas aeruginosa extracellular vesicles in antimicrobial resistance and virulence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura LEAL-VÉLEZ",Spain
3968,PS023,3905,"Tigecycline drives the adaptive evolution of TetX-positive Klebsiella pneumoniae into hyper-resistant mutants of different mucoid types",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadira RAKHI","United Kingdom"
3969,PS023,3905,"Macrolide resistance determinants and their associations in streptococci from selected livestock and wildlife species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillem LÓPEZ DE EGEA VEGAS",Spain
3970,PS023,3905,"Phenotypic and kinetic characterisation of in vivo selected KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina ELÍAS LÓPEZ",Spain
3971,PS023,3905,"Sub-inhibitory concentration of imipenem exposure influences the transcriptional response of auto-inducer II quorum-sensing system in Escherichia coli harbouring blaNDM",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chandrayee DESHAMUKHYA",India
3972,PS023,3905,"First national survey of antibiotic susceptibility in E. coli isolated from urine cultures in Uruguay and the emergence of blaCTX-M-27 in human clinical isolates in South America",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael VIGNOLI",Uruguay
3973,PS023,3905,"A dominant antimicrobial resistance plasmid in multidrug-resistant Escherichia coli isolates of a tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vera SCHWIERZECK",Germany
3974,PS023,3905,"Emergence of blaCTX-M-65 producing non-typhoidal Salmonella isolates in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeong Hwan SHIN","Republic Of"
3975,PS023,3905,"Comparative molecular study of virulence factors and antibiotic resistance between exoU and exoS Pseudomonas aeruginosa from microbial keratitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tanzina AKTER",Australia
3976,PS023,3905,"First detection of plasmid-mediated PAC-2 beta-lactamase conferring resistance to ceftazidime/avibactam in Klebsiella quasipneumoniae ST526",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra Y. SAAVEDRA",Colombia
3977,PS023,3905,"Multiple dissemination mechanisms of blaNDM-1 in a single institution revealed by whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romina PAPA-EZDRA",Uruguay
3978,PS023,3905,"Linezolid-resistance in the Finegoldia genus: a yet undescribed resistance emergent in bone infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincent JEAN-PIERRE",France
3979,PS023,3905,"Jumping to conclusions: the role of tetM in Group B Streptococcus (GBS) evolution",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rachael DELLAR","United Kingdom"
3980,PS023,3905,"Do CRISPR-Cas control the levels of plasmid-associated antimicrobial resistance genes in coagulase-negative staphylococci?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Idris Nasir ABDULLAHI",Nigeria
3981,PS023,3905,"Genomic characterisation of acquired colistin resistance determinants in Pseudomonas aeruginosa isolated from people with cystic fibrosis in Gauteng, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thabo HAMIWE","South Africa"
3982,PS023,3905,"Molecular basis of amoxicillin-clavulanate resistance in clinical isolates of Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sofia ASENSIO GALLEGO",Spain
3983,PS023,3905,"Hypervirulance profiling of Klebsiella pneumoniae in abscess samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selin BELGE",Türkiye
3984,PS023,3905,"Description of lysogenic phages present in carbapenem-resistant Pseudomonas aeruginosa isolates from Peru",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luciano Augusto PALOMINO KOBAYASHI",Peru
3985,PS023,3905,"Comparative in silico characterisation of plasmids carrying the high-level mupirocin resistance ileS2 gene",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eduardo PÉREZ ROTH",Spain
3986,PS023,3905,"Influence of iron acquisition systems on the in vitro activity of cefiderocol on Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurence ARMAND-LEFEVRE",France
3987,PS023,3905,"Mercury exposure stimulates colistin resistance and virulence in Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ghazal SHAHROKHI",Türkiye
3988,PS023,3905,"Natural rare alleles in NucS increased mutation rates to clarithromycin and amikacin in Mycobacterium abscessus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bing LI",China
3989,PS023,3905,"In238 mediated dissemination of blaVIM-4 gene into various species of Enterobacterales at a university hospital in Hungary",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Réka MESZÉNA",Hungary
3990,PS023,3905,"Longitudinal antimicrobial resistance development in uropathogenic Escherichia coli in kidney transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaan KOCER",Germany
3991,PS023,3905,"In vivo efficacy of cefiderocol in a murine sepsis model against Pseudomonas aeruginosa: impact of resistance development to ceftolozane/tazobactam and ceftazidime/avibactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arianna RODRÍGUEZ COELLO",Spain
3992,PS023,3905,"Molecular mechanism of Sed-1 beta-lactamase expression and high-level resistance in Citrobacter sedlakii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ryuichi NAKANO",Japan
3993,PS023,3905,"Chromosomal integration of vanA operon conferring vancomycin resistance in Enterococcus faecium: a genomic investigation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tram VO",France
3994,PS023,3905,"Emergence of novel genetic combination in blaIMP-6 encoding plasmids harboured by Enterobacterales: diverse genetic backgrounds",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Koichi YAMAGUCHI",Japan
3995,PS023,3905,"Characterisation of major OXA-48-carrying plasmids within a tertiary healthcare institution",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jocelyn TEO",Singapore
3996,PS023,3905,"Investigation of OXA-48 variants in Enterobacterales isolates in an OXA-48 endemic area",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sevval ARDUC",Türkiye
3997,PS023,3905,"The emerging concern of IMP variants being resistant to the only IMP-type metallo-beta-lactamase inhibitor, xeruborbactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christophe LE TERRIER",Switzerland
3998,PS023,3905,"Drugging the epigenome: G4s as a new therapeutical target in bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ángela ALCARAZ MARTÍNEZ",Spain
3999,PS023,3905,"Evolving characteristics of multidrug-resistant Gram-negative conflict-associated wound infections in Ukraine, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Scott PALLETT","United Kingdom"
4000,PS023,3905,"Production of multiple carbapenemases linked to heteroresistance in Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberto SIERRA",Switzerland
4001,PS023,3905,"IncHI2 plasmids drive dissemination of carbapenemase gene blaIMP among healthcare-associated Enterobacterales in the UK, 2014-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frank WILLIAMS","United Kingdom"
4002,PS023,3905,"Distribution of carbapenemase genes in A. baumannii isolates in a region with high carbapenem resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanife TUTAN",Türkiye
4003,PS023,3905,"Molecular detection of gyr A and par C mutations in clinical isolates of Pseudomonas aeruginosa obtained from Farwaniya hospital in Kuwait",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wadha ALFOUZAN",Kuwait
4004,PS023,3905,"Are we overdosing with vancomcyin? Eagle effect of vancomycin against Clostridioides difficile observed in vitro",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jane FREEMAN","United Kingdom"
4005,PS023,3905,"Correlating phenotypic and genotypic determinants of biocide tolerance and adaptation in Proteus mirabilis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vicky BENNETT","United Kingdom"
4006,PS023,3905,"A high-resolution genomic and phenotypic analysis of resistance evolution of an Escherichia coli strain from a critically unwell patient treated with piperacillin/tazobactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice FRASER","United Kingdom"
4007,PS023,3905,"Detection of OXA-48-like in carbapenem-resistant Klebsiella pneumonia: a challenge for diagnostic microbiological laboratories",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arwa AL RUJAIBI",Oman
4008,PS023,3905,"Clonal analysis of multidrug-resistant Pseudomonas aeruginosa: differences between carbapenemase-producing and non-carbapenemase-producing isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iván BLOISE",Spain
4009,PS023,3905,"Carbapenem resistance mechanisms in Bacteroides spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria AZNAR FERNANDEZ",Spain
4010,PS023,3905,"Characterisation of plasmids harboured by drug-resistant Acinetobacter baumannii isolates and their role in antibiotic resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thabo HAMIWE","South Africa"
4011,PS023,3905,"In vivo development of high-level cefiderocol and ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae associated with mutations in KPC and the sensor histidine kinase, EnvZ",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacqueline FINDLAY",Switzerland
4012,PS023,3905,"Activity of zidovudine against carbapenemase-producing Enterobacterales, including cefiderocol and aztreonam/avibactam resistant isolates, and characterisation of in vitro selected resistant isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberta Maria ANTONELLO",Italy
4013,PS023,3905,"Influence of ligand gated ion channel on cefiderocol susceptibility in clincal E. hormaechei isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pia TUROWSKI",Germany
4014,PS023,3905,"Characterisation of the novel carbapenemase OXA-1207",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julian SOMMER",Germany
4015,PS023,3905,"Plasmid network analysis reveals key drivers of third generation cephalosporin resistance in urinary Escherichia coli isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bálint TIMMER",Hungary
4016,PS023,3905,"First characterisation of newly discovered extended spectrum betalactamase SED-2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa-Marie HÖFKEN",Germany
4017,PS023,3905,"First report of CTX-M-15-producing Salmonella enterica ser. Typhimurium (S. Typhimurium) in South America",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inés BADO",Uruguay
4018,PS023,3905,"Improvement of hydrolytic activity against meropenem in NDM-1Q123Y variant: first identification in a P. aeruginosa clinical strain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra PICCIRILLI",Italy
4019,PS023,3905,"An elevated expression of mrcB is an indicative potential biomarker for AMR detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nikita KARMAKAR",India
4020,PS023,3905,"Exploring the whole-genome of XDR A. baumannii strains isolated from patients treated with cefiderocol",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra PICCIRILLI",Italy
4021,PS023,3905,"Genomic islands as drivers of carbapenem resistance and virulence in Pseudomonas aeruginosa ST235",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yolanda SAENZ",Spain
4022,PS023,3905,"Comparative genomic analysis identifies specific genes associated with a high-risk diffusion Klebsiella pneumoniae ST405 intensive care unit clone",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Coraline BERNACHOT",France
4023,PS023,3905,"Diversity and characterisation of intrinsic Ambler class B metallo-beta-lactamases in Sphingobacterium spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent DORTET",France
4024,PS023,3905,"Development of Colistin Resistance is associated with loss Of Hypermucoviscocity phenotype In CR-HVKP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reham SOBHY",Egypt
4025,PS023,3905,"Phenotypic and kinetic characterisation of PER-14: a novel beta-lactamase variant resistant to avibactam and relebactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melina RUGGIERO",Argentina
4026,PS023,3905,"The role of the AcrAB-TolC efflux pump in glyphosate tolerance and its antagonistic effect with ciprofloxacin in Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie Alexandra BARON",France
4027,PS023,3905,"Identification of the RamR regulon of Enterobacter cloacae complex by omic approaches",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Blandine HAREL",France
4028,PS023,3905,"Heteroresistance to polymyxin B in Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aimee DAUM","United Kingdom"
4029,PS024,NULL,"03e. Resistance detection/prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
4030,PS024,4029,"Optimising an accurate amplification-free CRISPR/Cas12a-based assay for GES beta-lactamases detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel PABLO MARCOS",Spain
4031,PS024,4029,"Molecular characterisation of carbapenemase-producing Serratia marcescens in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lukas Markus SCHAFFARCZYK",Germany
4032,PS024,4029,"Reinvigorating AMR resilience leveraging CRISPR-Cas technology potentials to combat the 2024 WHO bacterial priority pathogens for enhanced global health security : a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olalekan John OKESANYA",Nigeria
4033,PS024,4029,"AMRrules: expert-curated interpretive standards for AMR genotypes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathryn HOLT","United Kingdom"
4034,PS024,4029,"Detection of major high-risk clones of Pseudomonas aeruginosa using MALDI-TOF mass spectrometry and machine learning algorithms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xavier MULET",Spain
4035,PS024,4029,"Whole-genome sequencing of carbapenemase-producing Klebsiella pneumoniae isolated from a medical laboratory in Yaounde: first report of a blaNDM-1 positive- high-risk clone  ST 147 in Cameroon",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roméo TSAYEM FOUÉMÉNÉ",Cameroon
4036,PS024,4029,"New accurate point-of-care device for detection of Klebsiella pneumoniae carbapenemase",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Leonor SANTOS",Portugal
4037,PS024,4029,"Genomic traits associated with phenotypic antimicrobial resistance to trimethoprim-sulfamethoxazole in Staphylococcus epidermidis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ella SVEGRUP",Sweden
4038,PS024,4029,"Evaluation of the NG-TEST blood culture PREP kit for ESBL detection directly from positive blood cultures using the NG-TEST CTX-M MULTI lateral flow immunoassay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arnaud CHALIN",France
4039,PS024,4029,"Lethal pan-drug-resistant hypervirulent strains of Klebsiella pneumoniae with diverse genotypes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leila VALI","United Kingdom"
4040,PS024,4029,"Detection of carbapenemases in extensively-drug resistant Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amal BERRIRI",Tunisia
4041,PS024,4029,"Rapid detection of carbapenemase-producing Enterobacterales from positive blood cultures using the NG-TEST blood culture PREP and the NG-TEST CARBA 5 assays",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arnaud CHALIN",France
4042,PS024,4029,"Expediting carbapenemase-producing Enterobacterales detection in positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Callebaut CALLEBAUT",Belgium
4043,PS024,4029,"Evaluation of a rapid automatised system for MDR bacteria carriers detection on ICU patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillermo Carlos MARTÍNEZ CARRIÓN",Spain
4044,PS024,4029,"Molecular mechanisms of CAZ-AVI resistance in K. pneumoniae from a tertiary care hospital in Turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ozlem KOYUNCU OZYURT",Türkiye
4045,PS024,4029,"CefiderocolFinder: a pipeline to detect genetic adaptations implicated in cefiderocol resistance in multidrug-resistant microorganisms of Ukrainian patients in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bryan VAN DEN BRAND",Netherlands
4046,PS024,4029,"Molecular characterisation of Klebsiella pneumoniae clinical isolates through whole-genome sequencing: a comprehensive analysis of serotypes, sequence types, and antimicrobial and virulence genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tarun Kumar SUVVARI",India
4047,PS024,4029,"Extended susceptibility testing for refractory Helicobacter pylori infection: an argument for regional testing to guide antimicrobial decision making",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harin NAVALAN","United Kingdom"
4048,PS024,4029,"Iridium oxide-based biosensors towards the quantification of ESBL production",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer LAWRENCE","United Kingdom"
4049,PS024,4029,"Using random mutagenesis to predict mutations within the KPC-2 gene that confer resistance to beta-lactam/beta-lactamase inhibitor combinations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hawa AHMED","United Kingdom"
4050,PS024,4029,"Genomic characterisation of zoonotic multidrug-resistant Salmonella isolated from slaughtered chickens in northwest Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdurrahman Hassan JIBRIL",Nigeria
4051,PS024,4029,"Predicting carbapenem-resistant Klebsiella pneumoniae from flagged blood cultures with MALDI-TOF mass spectrometry and machine learning",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jiaxin YU",China
4052,PS024,4029,"Rapid and cost-effective detection of blaOXA-23-like carbapenemase genes in Acinetobacter baumannii using the LAMP technique",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nanphanita CHOMNAWANG",Thailand
4053,PS024,4029,"A DNA nanopore sensor for the rapid detection of antibiotic resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ivan BARISIC",Austria
4054,PS024,4029,"Transcriptomic analysis of ceftriaxone tolerant- phenotypes of Neisseria gonorrhoeae reveals downregulation of ribosomal gene expression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sheeba Santhini BASIL",Belgium
4055,PS024,4029,"Antibiotic resistance and genetic determinants in Helicobacter pylori: insights from Omani clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zaaima AL-JABRI",Oman
4056,PS024,4029,"Comparative analysis of rapid phenotypic tests for carbapenem-resistance in Aeromonas",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bin SUN",China
4057,PS024,4029,"Genomic characterisation of extended-spectrum beta-lactamase-producing and third-generation cephalosporin-resistant Escherichia coli isolates from Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deneke WOLDE",Ethiopia
4058,PS024,4029,"Comparative performance of two PCR-based platforms for the detection of Staphylococcus aureus small colony variants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille HAMULA",Canada
4059,PS024,4029,"Advancing monitoring and prediction of antimicrobial resistance trajectories using flexible spatiotemporal modelling: a roadmap for early warning systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kasim ALLEL","United Kingdom"
4060,PS024,4029,"Integrative metagenomics and an ensemble learning model reveals novel microbial biomarkers and pathogenic elements in colorectal cancer patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdulaziz ASCANDARI",Morocco
4061,PS024,4029,"Increasing prevalenc and molecular epidemiology of carbapenemase-producing carbapenem resistant Enterobacterales in Taiwan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hsi-Hsun LIN",China
4062,PS024,4029,"Detection of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Enterobacterales in wildlife",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Babatunde BEYIOKU",Israel
4063,PS024,4029,"Rapid detection of cfia-positive Bacteorides fragilis from blood culture using matrix-assisted laser desorption ionisation time of flight mass spectrometry in a tertiary hospital in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel Cristina LÓPEZ MESTANZA",Spain
4064,PS024,4029,"Widespread diversity of fosfomycin resistance gene in Staphylococci: a silent threat",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yiyi CHEN",China
4065,PS024,4029,"whole-genome sequencing of linezolid-resistant Enterococcus faecium: unravelling resistance mechanisms and outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ema HOLUBOVÁ","Czech Republic"
4066,PS024,4029,"Pilot study on development of a fast clinical diagnostic test to detect synergy between two antibiotics using growth curve kinetics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sanne VAN DEN BERG",Netherlands
4067,PS024,4029,"Genomic analysis of invasive Streptococcus pneumoniae isolates in the Canary Islands: role of penicillin-binding protein transpeptidase domains in predicting beta-lactam susceptibility",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Noelia HERNANDO PARREÑO",Spain
4068,PS024,4029,"Genomic analysis of vancomycin-resistant Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Geehan SULEYMAN","United States"
4069,PS024,4029,"Rapid detection of temocillin resistance in third-generation cephalosporin resistant Enterobacteriaceae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorena LÓPEZ CERERO",Spain
4070,PS024,4029,"Antibiotic resistance in metagenomes on global and population scales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mahkameh SALEHI",Finland
4071,PS024,4029,"Rapid NP detection of cefepime/taniborbactam susceptibility/resistance in Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christophe LE TERRIER",Switzerland
4072,PS024,4029,"Diagnostic algorithm for the detection of carbapenemases and extended spectrum beta-lactamases in carbapenem-resistant Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano MANCINI",Switzerland
4073,PS024,4029,"Importance of rapid species identification vs rapid AST in processing positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaisu Hellevi RANTAKOKKO-JALAVA",Finland
4074,PS024,4029,"Whole-genome analysis of extensively drug-resistant Enterobacter hormaechei isolated from two US hospitalised patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christen ARENA","United States"
4075,PS024,4029,"Genomic insights into CRISPR-Cas systems vsvirulence platforms and drug resistance among Escherichia coli isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra A. MARTÍNEZ-ÁLVAREZ",Spain
4076,PS024,4029,"Evaluation of Bacteroides fragilis cfiA subtyping by matrix-assisted laser desorption ionisation time-of-flight mass spectrometry and comparison of EUCAST and CLSI based susceptibility testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tin Long LUI",China
4077,PS024,4029,"Optimising long-read sequencing for AMR gene detection: a comparative study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tim T. SEVERS",Netherlands
4078,PS024,4029,"Use of melting curve assays for the characterisation of macrolides and fluoroquinolones resistance in Mycoplasma genitalium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria De Las Huertas GARCIA ATIENZA",Spain
4079,PS024,4029,"Tracking the emergence of cephalosporinase cepA and carbapenemase cfiA Bacteroides hominis (former Bacteroides fragilis division II) strain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando COBO",Spain
4080,PS024,4029,"Clinical performance evaluation of a vancomycin resistance real time PCR assay in the context of a vanB-carrying Enterococci outbreak in a tertiary hospital in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
4081,PS024,4029,"Rethinking AMR sampling: can non-sterile samples predict resistance in blood/sterile samples at a country level?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Quentin J LECLERC",France
4082,PS024,4029,"Klebsiella pneumoniae ST22: a novel menace?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vittoria MATTIONI MARCHETTI",Italy
4083,PS024,4029,"Analysis of available Phytobacter spp. genomes indicates the emergence of a potential new multidrug-resistant opportunistic pathogen within the Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcelo PILLONETTO",Brazil
4084,PS024,4029,"A long-awaited tool for reliable detection of staphylococcal penicillinase using an innovative fluorogenic probe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frederic LAURENT",France
4085,PS024,4029,"Suboptimal performance of three screening methods in rectal swab for the detection of carbapenemase-producing Gram-negative bacilli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diego JOSA",Colombia
4086,PS024,4029,"Simple models can be used to assess impact of antibiotic consumption on resistance in critical priority bacteria and the role of interventions in its reduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefanus Petrus RAUTENBACH","United Kingdom"
4087,PS024,4029,"Evaluation of a diagnostic algorithm for rapid detection of extended-spectrum β-lactamase and carbapenemase directly from blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandros GRECO",Greece
4088,PS024,4029,"Methyltransferases in candidate phyla radiation: a weapon or a simple shield?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Riyad RAZZOUK",France
4089,PS024,4029,"Investigation of a modified carbapenem inactivation method for rapid detection and characterisation of carbapenemase production in Klebsiella pneumoniae isolates from blood culture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yunus Emre TOK",Türkiye
4090,PS024,4029,"Novel chromosomal target of cefiderocol resistance in Acinetobacter baumannii: a genomic and functional analysis to identify and validate in vivo acquired chemoresistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara CARLONI",Italy
4091,PS024,4029,"Are cycle threshold (Ct) values useful for predicting culture results of molecular positive carbapenemase producing Enterobacterales (CPE) screening samples?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mairead SKALLY",Ireland
4092,PS024,4029,"Cefiderocol resistance in clinical isolates of KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: molecular insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina RIAZZO",Spain
4093,PS024,4029,"Development and comparative evaluation of antimicrobial resistance quality control materials through absolute quantification using ddPCR and dPCR systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liang-Chun LIU","United States"
4094,PS024,4029,"Mutational analysis of hypermutable Pseudomonas aeruginosa from people with cystic fibrosis in South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shristi MAHABIR","South Africa"
4095,PS024,4029,"Comparative genomic analysis of extended spectrum beta-lactamase (ESBL) producing Salmonella enteritidis showed ESBL dissemination pattern mediated by transposon Tn21",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junbum LEE","Republic Of"
4096,PS024,4029,"Rectal resistome analysis of patients colonised and non-colonised by carbapenemases by PCR and hybridisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diego JOSA",Colombia
4097,PS024,4029,"Development of a clinical scoring system to predict carbapenem-resistant Enterobacterales in patients with pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernardo Alfonso MARTINEZ-GUERRA",Mexico
4098,PS024,4029,"Development of loop-mediated isothermal amplification (LAMP)-based assay for rapid detection of fosfomycin resistance gene",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Scaccia NAZARENO",Brazil
4099,PS024,4029,"Shared resistome and mobilome in global human and poultry gut metagenomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shivang BHANUSHALI",Finland
4100,PS024,4029,"Clinical performance of the RIDA GENE MRSA real-time PCR assay in human nasal/throat swabs, wound swabs, and culture under IVDR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eva NAUMANN",Germany
4101,PS025,NULL,"03f. Clinical outcome of resistant infections (retrospective and prospective studies, excl clinical trials of new drugs, excl case series)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
4102,PS025,4101,"Early vs late combination daptomycin and ceftaroline therapy in patients with persistent MRSA (methicillin-resistant Staphylococcus aureus) bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bibek KOIRALA","United States"
4103,PS025,4101,"Comparison of clinical characteristics and outcomes in non multidrug-resistant and multidrug-resistant Pseudomonas aeruginosa bacteraemia: preliminary results of a Spanish multicentre prospective cohort study (IRVIPA study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena SENDRA ÁLVAREZ DE CIENFUEGOS",Spain
4104,PS025,4101,"Ceftolozane/tazobactam vs carbapenems for treatment of ESBL bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dimitrios BASOULIS",Greece
4105,PS025,4101,"Clinical, microbiological and costs dynamics of Streptococcus pneumoniae infections related to COVID-19 pandemic: could macrolide resistance tell a story?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raluca-Mihaela MATORU",Romania
4106,PS025,4101,"Comparison of novel β-lactam/β-lactamase inhibitors in a prospective single-institution study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amalia ANASTASOPOULOU",Greece
4107,PS025,4101,"Preliminary analysis of a retrospective cohort of patients with invasive infections caused by difficult-to-treat-resistance Pseudomonas aeruginosa (DTR-PA)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonella GALLICCHIO",Italy
4108,PS025,4101,"Universal need for appropriate treatment: risk factors for mortality in patients with infections due to carbapenem-resistant Gram-negative bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernardo Alfonso MARTINEZ-GUERRA",Mexico
4109,PS025,4101,"Effectiveness and safety of ceftazidime/avibactam in the paediatric population: an interim analysis of prospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorenzo CHIUSAROLI",Italy
4110,PS025,4101,"Determinants of the change of empiric antibiotic therapy upon reception of laboratory data: results from a nationwide antibiotic surveillance system in Madagascar, the TSARA project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christelle ELIAS",France
4111,PS025,4101,"Comparative efficacy and renal safety of ceftazidime/avibactam vscolistin-based regimens in XDR Gram-negative infections: a propensity score matched cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU",Türkiye
4112,PS025,4101,"Evaluating the efficacy of tobramycin and gentamicin spacers in managing prosthetic joint infections caused by Pseudomonas aeruginosa, implications of changing minimal inhibitory concentration breakpoints",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pansachee DAMRONGLERD",Thailand
4113,PS025,4101,"Real-life use of cefiderocol in the treatment of carbapenem-resistant Acinetobacter baumannii (CRAB) infections: comparison between cefiderocol regimens and monotherapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara COVINO",Italy
4114,PS025,4101,"Mortality risk associated with healthcare-associated infections caused by multidrug-resistant Pseudomonas aeruginosa in southern China: a competing risk model analysis using a propensity-score-matching longitudinal cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jiancong WANG",Germany
4115,PS025,4101,"Management and outcomes of haematological patients colonised by MBL-producing Enterobacterales: a single-centre retrospective analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Flavia BADALUCCO CIOTTA",Italy
4116,PS025,4101,"Analysis of 30-day mortality in patients with carbapenem-resistant Enterobacterales (CRE) bacteraemia: non-carbapenemase CRE and antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yoon Soo PARK","Republic Of"
4117,PS025,4101,"The impact of carbapenem-resistant infections in intensive care units: focus on non-fermenting Gram-negative bacilli and survival analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliette DESSEMON",France
4118,PS025,4101,"High prevalence of multi-drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae isolates amongst mechanically ventilated acute respiratory distress syndrome patients as an independent predictor of mortality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thejesh SRINIVAS",India
4119,PS025,4101,"Ceftaroline as a therapeutic option: an in vitro study on methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates from Alexandria, Egypt",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammed A. EL-KHOLY",Egypt
4120,PS025,4101,"Trends, management and outcome of infections caused by MBL-producing organisms in paediatric ICUs: a five-year experience at an Italian tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah BARNI",Italy
4121,PS025,4101,"Ceftolozane/tazobactam for the treatment of pulmonary exacerbations in adult cystic fibrosis patients: clinical experience from a tertiary care centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso MANCIULLI",Italy
4122,PS025,4101,"Clinical characteristics of patients with hospital-acquired P. aeruginosa ST773 NDM-1 clonal spread",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura MORATA",Spain
4123,PS025,4101,"Impact of antimicrobial resistance on mortality in Spanish hospitals (2022–2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lina Marcela PARRA",Spain
4124,PS025,4101,"Comparison of the clinical outcomes of patients with carbapenem-resistant and susceptible Enterobacterales in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sho SAITO",Japan
4125,PS025,4101,"Impact of macrolide resistance on clinical outcomes in Mycoplasma pneumoniae infections: a retrospective observational review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yen Tsen SAW","United Kingdom"
4126,PS025,4101,"Extensively drug-resistant Acinetobacter baumannii complex (XDR-AB) colonisation and clinical outcomes in neonates: a retrospective case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gugulethu PHAMBANE","South Africa"
4127,PS025,4101,"Adherence to EUCAST-2024 guidelines in the management of urinary tract infections caused by inducible AmpC beta-lactamase-producing Enterobacterales in a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis FUERTES",Spain
4128,PS025,4101,"Has survival from difficult-to-treat antibiotic resistant (DTR) Gram-negative infections improved in the era of next-generation antibiotics? Retrospective cohort study, 262 US hospitals, 2016-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Morgan WALKER","United States"
4129,PS025,4101,"Exploring antibiotic options for different carbapenemase-producing CRE strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bin SUN",China
4130,PS025,4101,"Comparison of ceftazidime/avibactam with best available therapy for the treatment of OXA-48- or KPC-producing Enterobacterales infections: a multi-centre retrospective matched-cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdullah Tarik ASLAN",Australia
4131,PS025,4101,"Socio-economic status is linked to disparities in 30-day mortality among patients with antibiotic non-susceptible Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heather HENDERSON","United States"
4132,PS025,4101,"Evolution of carbapenemase-producing Enterobacteriaceae during 2023 and 2024 in urine cultures at a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis GAGO MANTILLA",Spain
4133,PS025,4101,"Monomicrobial infections by carbapenemase-resistant A. baumannii, difficult-to-treat resistant Pseudomonas aeruginosa and metallo-beta-lactamase-producing Enterobacterales: preliminary data from an emulation trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Flavio SANGIORGI",Italy
4134,PS025,4101,"Increasing antimicrobial resistance in chronic endometritis: a 2020-2024 cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luisa FRALLONARDO",Italy
4135,PS025,4101,"The burden of antimicrobial resistant bacteraemia in Ontario: a population-wide cohort study of attributable mortality from 110 pathogen-antibiotic combinations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kevin BROWN",Canada
4136,PS025,4101,"Reassess the breakpoint of polymyxin B: comparing polymyxin B and ceftazidime/avibactam in CRE infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dayu CHEN",China
4137,PS025,4101,"Molecular and clinical characteristics of community-acquired, community-onset healthcare-associated, and hospital-acquired extended-spectrum beta-lactamases-producing Escherichia coli bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wei Ting LIN",China
4138,PS025,4101,"Risk factors for mortality in patients treated with ceftazidime/avibactam for carbapenem-resistant Klebsiella pneumoniae bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi-Tsung LIN",China
4139,PS025,4101,"Treatment failure rates do not differ according to temocillin MIC in the treatment of Enterobacterales blood stream infection: an observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohamed TOORANI","United Kingdom"
4140,PS025,4101,"Clinical outcomes of Stenotrophomonas maltophilia bloodstream infection: role of comorbidities and antimicrobial susceptibility profile",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sergio ALVAREZ MULETT","United States"
4141,PS025,4101,"Cefepime vs carbapenems for AmpC-producing Enterobacterales in bacteraemia from deep-seated sources: phenotypic and genotypic focus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole SLAIN","United States"
4142,PS025,4101,"Effectiveness of ceftazidime/avibatam in carbapenem-resistant Enterobacterales bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yongseop LEE","Republic Of"
4143,PS025,4101,"A two-year prospective study on hospital-acquired bacteraemias caused by multidrug-resistant organisms in a high-prevalence country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sotiria GRIGOROPOULOU",Greece
4144,PS025,4101,"Impact of extended-spectrum beta-lactamase (ESBL) production on mortality in patients with bloodstream infection due to Escherichia coli: analysis of the PROBAC cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula OLIVARES NAVARRO",Spain
4145,PS025,4101,"Clinical profile and outcomes of patients infected with carbapenemase-producing carbapenem-resistant Enterobacterales: a cross sectional study from two hospitals in Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kibrewossen AKILILU",Ethiopia
4146,PS025,4101,"Piperacillin/tazobactam vs cefepime or carbapenems for the treatment of bloodstream infections due to bacteria producing chromosomal AmpC beta-lactamase: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria DE LUCA",Italy
4147,PS025,4101,"Comparative evaluation of definitive therapy for deep-seated Stenotrophomonas maltophilia infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hunter CURRY","United States"
4148,PS025,4101,"Epidemiology and clinical outcomes of carbapenem-resistant Klebsiella pneumoniae infections in cancer patients: a prospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akshay Arjun SHELKE",India
4149,PS025,4101,"Effect of Escherichia coli and Staphylococcus aureus antimicrobial resistance on bloodstream infection outcomes in low- and middle-income countries: results from the ACORN2 study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jill HOPKINS",Thailand
4150,PS025,4101,"Comparative analysis of 30-day and one-year mortality in carbapenem-resistant vs non-carbapenem resistant Enterobacterales bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mabel Zhi Qi FOO",Singapore
4151,PS026,NULL,"03g. Spread of resistance (incl carriage, reservoirs, ecology, One Health models, excl nosocomial transmission)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
4152,PS026,4151,"Diversity of SCCmec elements in bovine methicillin-resistant Staphylococcus haemolyticus: uncovering shared and novel multidrug-resistance cassettes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chahrazed BELHOUT",Switzerland
4153,PS026,4151,"MDRO Colonisation in HIV patients: effects of probiotic and synbiotic treatments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria PIQUET FERRET",Spain
4154,PS026,4151,"Faecal colonisation with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in rural Burkina Faso",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel VALIA","Burkina Faso"
4155,PS026,4151,"Wildlife or human health in danger? Wild boar (Sus scrofa) as environmental sentinels of antimicrobial resistance (AMR) and food safety risks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanesa GARCÍA MENÉNDEZ",Spain
4156,PS026,4151,"High prevalence of mecC-carrying S. aureus isolates in nasal microbiota of European-wild-rabbits in the Iberian-Peninsula",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carmen GONZÁLEZ-AZCONA",Spain
4157,PS026,4151,"Wastewater based epidemiology (WBE) as a tool for tracking pathogens and antimicrobial resistance within care homes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deirdre GILPIN","United Kingdom"
4158,PS026,4151,"Prevalence of extended spectrum beta-lactamase (ESBL)-producing Enterobacterales among wildlife in Israel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Babatunde BEYIOKU",Israel
4159,PS026,4151,"The global emergence of tmexCD-toprJ and blakpc/ndm co-carrying superbugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaiwen SONG",China
4160,PS026,4151,"Monitoring pathogens and AMR in wastewater using nanopore sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter DELPUTTE",Belgium
4161,PS026,4151,"Carbapenem resistance in ESPAKEE pathogens isolated from filth-flies collected from hospital wards",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teresa IANNETELLI","United Kingdom"
4162,PS026,4151,"Emergence and spread of ceftriaxone resistant Salmonella Kentucky in India: One Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Praveen THILAGAN",India
4163,PS026,4151,"Diffusion of OXA-48-producing Enterobacterales strains in Normandy: a five years prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille COTET",France
4164,PS026,4151,"Critical antibiotic resistance detected in pig and rabbit farms threatens public health: high-risk clones on the rise",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adriana SILVA",Portugal
4165,PS026,4151,"Novel strains of Escherichia coli among paediatric population of rural communities in India: genomic insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Geetha NAGARAJ",India
4166,PS026,4151,"Quantifying the bystander effect of antimicrobials on microbiome composition and resistome to optimise antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph LEWIS","United Kingdom"
4167,PS026,4151,"Critically important antimicrobials consumption and resistance in the One Health context in Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mashkoor MOHIN",Pakistan
4168,PS026,4151,"Intra and interhost evolution analysis revealed the circulation of two closely related plasmids carrying blaNDM-1 gene",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentine BERTI",France
4169,PS026,4151,"Negative correlation between bloodstream iron acquisition virulence factors and non-classical terminal class 1 integrons in ESBL-producing Escherichia coli suggests potential fitness trade-offs between virulence and resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang ZHONG",Singapore
4170,PS026,4151,"Investigating ESBL-producing E. coli circulating among domestic dogs and wild hooded crows in Hungary's largest cities using whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isma BENMAZOUZ",Hungary
4171,PS026,4151,"One Health approach to antimicrobial resistance: insights from a Portuguese open air laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pedro TEIXEIRA",Portugal
4172,PS026,4151,"Carbapenemase-producing Kluyvera: epidemiology of an evolving species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabrielle LEVI",Israel
4173,PS026,4151,"Core genome analysis of 1302 IncI1 plasmids from a multi-species international collection reveals geographic- and/or species-specific plasmid evolution",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier Eduardo FERNANDEZ",Switzerland
4174,PS026,4151,"Carriage of antibiotic-resistant Escherichia coli in Swedish children: a nationwide study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ellinor BERGGREN",Sweden
4175,PS026,4151,"Focus on the neglected class A carbapenemases (IMI, NmcA and FRI) using a One Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chloé DUPONT",France
4176,PS026,4151,"Wastewater environment as reservoir of carbapenem-resistant and extended-spectrum beta-lactamase-producing Enterobacteriaceae: a molecular characterisation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario Sergio PINO HURTADO",Spain
4177,PS026,4151,"Development and deployment of robotic antimicrobial susceptibility platform (RASP) for high resolution One Health AMR surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sam ABRAHAM",Australia
4178,PS026,4151,"Drivers of community-level transmission dynamics of antimicrobial resistance in rural Burkina Faso",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raneem AIZOUK","United Kingdom"
4179,PS026,4151,"Characterisation of antibiotic-resistant Klebsiella spp. isolated from wastewater and drinking water treatment plants in the metropolitan area of Barcelona, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victoria Del Pilar BALLÉN TORRES",Spain
4180,PS026,4151,"The emerging resistance index: ranking resistance to newly-approved antibiotics in the 2024 WHO critical- and high-priority bacterial pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacopo GARLASCO",Italy
4181,PS026,4151,"Resistome and phylogenomic of Escherichia coli strains obtained from diverse sources in Jimma, Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mulatu GASHAW",Ethiopia
4182,PS026,4151,"LuxS/AI-2 system facilitate the dissemination of antibiotic-resistant plasmids in Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fang You YU",China
4183,PS026,4151,"Identification of antibiotic resistance genes in bacterial pathogens from street food sold at urban parks in Quito, Ecuador",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaime David ACOSTA ESPAÑA",Ecuador
4184,PS026,4151,"Prevalence and antimicrobial resistance of Salmonella strains isolated from chicken samples in southern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fiorenza PETRUZZI",Italy
4185,PS026,4151,"Multi-layered ecological interactions determine growth of clinical antibiotic-resistant strains within human microbiomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ricardo LEON-SAMPEDRO",Switzerland
4186,PS026,4151,"Phenotypic and genomic characterization of cephalosporinase-producing Proteus mirabilis isolates from gulls in southern France",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas MARTEL",France
4187,PS026,4151,"Global landscape of community carriage of antimicrobial resistant bacterial pathogens: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaokun HONG","United Kingdom"
4188,PS026,4151,"Antimicrobial resistance through a One Health perspective: insights from a survey on the commensal microbiota of heavy breeder hens from Bolivian farms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria MICIELI",Italy
4189,PS026,4151,"Where global warming stands on plasmids-encoded resistance transfer?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Otavio RARO",Switzerland
4190,PS026,4151,"Microbial biodiversity as a barrier to the spread of antimicrobial resistance in soil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia GALAZKA",Austria
4191,PS026,4151,"Molecular epidemiology of NDM-producing Escherichia coli isolates in Croatia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Josip UJEVIC",Croatia
4192,PS026,4151,"Prevalence, antibiotic resistance, and molecular characterisation of methicillin-resistant Staphylococcus aureus: a study from peri-urban dairy farms in Pakistan????",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aitezaz AHSAN",Pakistan
4193,PS026,4151,"Antibiotic resistance of Escherichia coli isolated from European hedgehogs (Erinaceus europaeus) in a wildlife rehabilitation centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria PRANDI",Italy
4194,PS026,4151,"Phylogroups, resistance, and risk: a study of STEC in Brazilian dairy sheep",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natália CARRILLO GAETA",Brazil
4195,PS026,4151,"Staphylococcus aureus carriage in hedgehogs (Erinaceus europaeus) admitted to a wildlife rescue centre in north-western Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandro BELLATO",Italy
4196,PS026,4151,"Nation-wide spread of an outbreak-associated IncFIB-multidrug-resistance plasmid, the Netherlands, 2016-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gijs TEUNIS",Netherlands
4197,PS026,4151,"Large-scale genomic survey of non-typhoidal Salmonella enterica Serovar Minnesota strains in chicken products reveals the emergence of multidrug-resistant clones",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Khaloud ALZAHRANI","Saudi Arabia"
4198,PS026,4151,"Identification of IncF plasmids conferring both glyphosate and paraquat tolerance in Klebsiella spp. clinical strains isolated from farmers in Thailand: a new One Health threat?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie Alexandra BARON",France
4199,PS026,4151,"Prevalence of resistance to critically important antibiotics for human health in different intensive livestock production systems in Uruguay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael VIGNOLI",Uruguay
4200,PS026,4151,"Pre-treatment microbiome predicts ESBL-producing Enterobacteriaceae colonisation in ceftriaxone-exposed patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Quentin LE BASTARD",France
4201,PS026,4151,"Detection of cefotaxime resistance Escherichia coli isolates collected from livestock waste",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amir IBRAHIMAGIC","Bosnia And Herzegovina"
4202,PS026,4151,"Prevalence and role of contact-dependent growth inhibition (CDI) system, cdiTYTH-1, in carbapenem-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chen CHYI-LIANG",China
4203,PS026,4151,"Epidemiology and genomic features of blaNDM-carrying carbapenem-resistant Salmonella enterica",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hui LIU",China
4204,PS026,4151,"Identification of cefiderocol resistance genes in environmental samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rémi GSCHWIND",France
4205,PS026,4151,"Surveillance of wastewater in San Paulo, Brazil, identifies geographic and socio-economic factors linked to antimicrobial resistance and virulence in Escherichia coli strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yanfang ZHANG","United Kingdom"
4206,PS026,4151,"Molecular and genetic characteristics of drug resistant Enterobacterales isolated from hospital sewage in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yuki SUZUKI",Japan
4207,PS026,4151,"Carbapenemase producing Enterobacterales monitoring in dogs and cats in the Netherlands",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Els BROENS",Netherlands
4208,PS026,4151,"Spread of multiple E. coli clones from pigs carrying blaCTX-M-32 on the chromosome in Cuba",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rosa Elena HERNÁNDEZ",Cuba
4209,PS026,4151,"EARS-Vet: a network for surveillance of antimicrobial resistance in clinical isolates from animals in the EU/EEA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucie COLLINEAU",France
4210,PS026,4151,"Travelling increases the diversity of extended-spectrum beta-lactamases carrying Enterobacterales and plasmids in the Czech Republic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suhanya Veronica PRASAD","Czech Republic"
4211,PS026,4151,"Sources of methicillin-resistant Staphylococcus aureus isolates in Swedish dogs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ulrika WINDAHL",Sweden
4212,PS026,4151,"Detection of blaKPC-2-carrying IncP-6 plasmids in Aeromonas isolates from different wastewaters settings in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura MONGE-OLIVARES",Spain
4213,PS026,4151,"Relationship between the molecular diversity of plasmids and antibiotic resistance of Staphylococcus aureus isolates from private hospitals in Gauteng, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thabo HAMIWE","South Africa"
4214,PS026,4151,"Identifying antibiotic resistance genes against novel beta-lactamase inhibitor-antibiotic combinations in environmental and clinical resistomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erika NAGRAND",Hungary
4215,PS026,4151,"Nasal carriage and multiple antibiotic resistance indices of Staphylococcus aureus among healthcare students at the Ahmadu Bello university, Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Idris Nasir ABDULLAHI",Nigeria
4216,PS026,4151,"Guts of healthy humans and animals habor critical priority and pandemic Escherichia coli clones",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Idris Nasir ABDULLAHI",Nigeria
4217,PS026,4151,"One Health circulation of carbapenemase-producing Enterobacterales in Lome, Togo",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Signara GUEYE",France
4218,PS026,4151,"Unveiling the sex-specific impact on antimicrobial resistance (AMR): a Bayesian hierarchical model approach using vivli data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon PROCTER","United Kingdom"
4219,PS026,4151,"Mechanistic exploration of the factors contributing to differing patterns of antibiotic resistance in Staphylococcus aureus bloodstream infection by demography in the UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gwen KNIGHT","United Kingdom"
4220,PS026,4151,"Predicting the future burden of antimicrobial resistance depends on population demographics, and the age and sex-specific rates of incidence and resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gwen KNIGHT","United Kingdom"
4221,PS026,4151,"Carbapenemase-positive Enterobacterales from residual waters: prevalence of high-risk clones producing KPC-2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"João Pedro RUEDA FURLAN",Brazil
4222,PS026,4151,"Imported herbs represent a source of clinically-relevant lineages of Klebsiella spp. in the food chain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isidro GARCÍA-MENIÑO",Germany
4223,PS026,4151,"Critical emergence and spread of multidrug-resistant CTX-M-15-producing Enterobacteriaceae in a veterinary teaching hospital settings: implications for infection control and One Health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natália CARRILLO GAETA",Brazil
4224,PS026,4151,"Isolation of hospital-associated vancomycin resistant Enterococcus faecium clones from German rivers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul G. HIGGINS",Germany
4225,PS026,4151,"WGS analysis of ESBL-producing Enterobacterales and aeromonas from Singapore surface water reveals aquatic drug-resistant isolates as hidden reservoirs of mobile resistance elements",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang ZHONG",Singapore
4226,PS026,4151,"High-risk clones and plasmids associated with extended spectrum beta-lactamase producing Klebsiella pneumoniae isolates from environmental water, broiler poultry and humans in South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theevasha GOVENDER","South Africa"
4227,PS026,4151,"First identification of carbapenemase genes in Delftia tsuruhatensis isolated from hospital sewage in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiroyuki FUJIKURA",Japan
4228,PS026,4151,"Evaluation of humans, dogs, and household dust as reservoirs of methicillin-resistant Staphylococcus spp. in the community and analysis of an intervention to reduce air-bound dissemination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilana CAMARGO",Brazil
4229,PS026,4151,"Emergence of IMP-producing Pseudomonas aeruginosa ST1047 with pandemic potential from Ukraine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brendan JONES","United States"
4230,PS026,4151,"Evaluating the effect of feeding calves waste milk on the distribution of bacterial taxa and resistance genes distribution in faecal samples in dairy farms in New Zealand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia GONZALEZ","New Zealand"
4231,PS026,4151,"Acceptable' concentrations of enrofloxacin in food lead to reduced enrofloxacin susceptibility in a mouse model of gastrointestinal Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chris KENYON",Belgium
4232,PS026,4151,"Prevalence and genetic characteristics of drug-resistant Escherichia coli isolated from wild deer inhabiting tourist spots in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akiyo NAKANO",Japan
4233,PS026,4151,"Comparing aminoglycoside and β-lactam resistance gene prevalence in neonatal gut microbiome according to mode of delivery",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rida TOUFIQ","United Kingdom"
4234,PS026,4151,"Circulation of emerging MCR-1-producing Salmonella infantis from retail food in Egypt",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hazem RAMADAN",Egypt
4235,PS026,4151,"Third-generation cephalosporins-resistant Enterobacterales in community-dwelling individuals, their pet dogs, and household dust",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilana CAMARGO",Brazil
4236,PS026,4151,"High-frequency detection of vancomycin- and linezolid-resistant Enterococci in poultry caecum samples from slaughterhouses in Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Islem TRABELSI",Tunisia
4237,PS026,4151,"Clinical threat of blaNDM-positive Providencia spp. harboured by flies collected in hospitals across Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shonnette PREMCHAND-BRANKER","United Kingdom"
4238,PS026,4151,"Occurrence of carbapenemase resistance genes and proteins in Klebsiella pneumoniae extracellular membrane vesicles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marina MURILLO TORRES",Spain
4239,PS026,4151,"Population dynamics of multidrug-resistant Klebsiella pneumoniae infections in Portuguese companion animals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa SILVA",Portugal
4240,PS026,4151,"Prevalence and characterisation of extended-spectrum beta-lactamase-producing Escherichia coli from hospital patients and poultry farmers in Ibadan, Oyo state",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ini ADEBIYI",Nigeria
4241,PS026,4151,"Multidrug-resistant Salmonella in slaughtered food animals: a growing public health concern in Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aitezaz AHSAN",Pakistan
4242,PS026,4151,"Clonal spread of topical treatment-resistant Staphylococcus aureus causing childhood impetigo in Navarra",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iñaki BEGUIRISTAIN CALVO",Spain
4243,PS026,4151,"Escherichia coli carrying extended spectrum of beta-lactamase in pets and pregnant women in San Paulo, Brazil: an One Health view, preliminary data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillermo Moisés PORRAS COTRINA",Brazil
4244,PS026,4151,"A first step towards One Health: genomic comparison of Klebsiella pneumonia from different ecological niches in Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Trang NGUYEN",Vietnam
4245,PS026,4151,"Antibiotic resistance profiles and genetic characterisation of Gram-negative bacteria isolated from lake Nokoué and surrounding environments in Benin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victorien DOUGNON",Benin
4246,PS026,4151,"ESBL-/AmpC- and carbapenemase-producing Escherichia coli detection in urine samples of companion animals in Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriele RATTI",Italy
4247,PS026,4151,"The ARISE project: evaluating wastewater-based antimicrobial resistance surveillance strategies in alignment with EU regulatory changes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theresa HOHL",Austria
4248,PS026,4151,"Wildlife and aquatic reservoirs of mecC-MRSA: a study on prevalence, genetic diversity, and resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa SILVA",Portugal
4249,PS026,4151,"Presence of carbapenem-resistant Enterobacteriaceae and antibiotics residues in urban surface water",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia Figueiredo COSTA",Brazil
4250,PS026,4151,"Genomic analysis of tetX(4) carrying colistin-resistant E. coli from pigs in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nwai Oo KHINE",China
4251,PS027,NULL,"03h. Policy aspects of AMR (incl societal impact, economics, mitigation)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","03. Bacterial susceptibility & resistance",NULL,NULL,NULL,NULL
4252,PS027,4251,"A cross-sectional study on the prevalence and patterns of over-the-counter purchase of antibiotics in Liberia; an urgent call for rational use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bode Ireti SHOBAYO",Sweden
4253,PS027,4251,"Antibiotic dispensing in community pharmacies: a critical area for multifaceted antimicrobial stewardship on the supply and demand sides",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdullah Al MASUD",Australia
4254,PS027,4251,"Vaccines and AMR: an analysis of the funding landscape for human bacterial vaccines in low-and middle-income countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Catherine FLECK-VIDAL",Sweden
4255,PS027,4251,"Economic burden of antibiotic resistance on the human health sector: a cost of illness study in tertiary hospitals in Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elly NUWAMANYA",Uganda
4256,PS027,4251,"Current framing of antimicrobial resistance to the public, subject experts, and policy makers: a scoping review of national action plans and key policy documents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samkele MKUMBUZI","South Africa"
4257,PS027,4251,"It is not the lack of access but the lack of money that affects patients' ability to treat uncomplicated UTIs in the community in Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam NANTAMU","United Kingdom"
4258,PS027,4251,"Understanding the contextual factors in the management of antimicrobial resistance in Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deborah EKUSAI SEBATTA",Uganda
4259,PS027,4251,"Operationalising One Health to combat antimicrobial resistance in Brazil: challenges, governance, and pathways to integration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana CORRÊA",Brazil
4260,PS027,4251,"Understanding power dynamics and financial interest among stakeholders: antibiotic transaction in commercial poultry farming in Bangladesh",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"S M Murshid HASAN",Bangladesh
4261,PS027,4251,"Strengthening antimicrobial stewardship: the role of national surveillance and reporting in reducing antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diego ORTIZ",Germany
4262,PS027,4251,"Women with higher household bargaining power have greater knowledge of antibiotics and antimicrobial resistance: evidence from rural Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepshikha BATHEJA",India
4263,PS027,4251,"Length of hospital stay and associated treatment costs for patients with susceptible and antibiotic-resistant Salmonella infections: systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chaelin KIM","United Kingdom"
4264,PS027,4251,"Fair share of AWaRe using benchmarking to derive "expected" levels of access/watch/reserve antibiotic use for 177 countries based on population health needs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aislinn COOK","United Kingdom"
4265,PS027,4251,"Prevalence of antibiotic self-medication and knowledge of antimicrobial resistance among community members in Neno district rural Malawi: a cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"George Dalitso LIMWADO",Malawi
4266,PS027,4251,"Insights from STAR 2 on understanding changing attitudes and perceptions towards antibiotic use for respiratory tract infections in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adrian SHEPHARD","United Kingdom"
4267,PS027,4251,"AMROrbit Scorecard: a dynamic phase space model for strategic monitoring and actionable insights on global AMR trajectories",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jasmine KAUR",India
4268,PS027,4251,"Health economic impact of antimicrobial resistance in bloodstream infections in low- and middle-income countries: results from the ACORN2 study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jill HOPKINS",Thailand
4269,PS027,4251,"Bacterial culture practices and views on antimicrobial resistance among hospital physicians in Africa and Asia: ACORN2 KAP survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jill HOPKINS",Thailand
4270,PS027,4251,"Social determinants of antibiotic use in Vietnam: a mediation analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ha LE THANH",Vietnam
4271,PS027,4251,"Strengthening antimicrobial resistance surveillance through external quality assessment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Menuk JAYAWARDENA",Australia
4272,PS027,4251,"Expansion of antimicrobial stewardship and infection control programme of ICMR in secondary care hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arya KUMAR",India
4273,PS027,4251,"Impact of disparities in access to antibiotics on inferring burdens of difficult-to-treat antibiotic resistance: a real-world data analysis and simulation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah WARNER","United States"
4274,PS027,4251,"Global pricing of key AWaRe (access, watch, reserve) antibiotics: ensuring affordability and equity in optimising antimicrobial use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kasim ALLEL","United Kingdom"
4275,PS027,4251,"From people to leaders: bridging communities and policy for global AMR mitigation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna Karin SJOBLOM",Sweden
4276,PS027,4251,"Wider health system strengthening would be required to optimise the impact of new AWaRe antibiotics in low- and middle-income countries across sub-Saharan Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily GAURUHN",Netherlands
4277,PS028,NULL,"04a. Diagnostic bacteriology (incl culture based, traditional and general microbiology, serology, excl AST methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4278,PS028,4277,"Evaluation of shorter incubation time for automated blood culture systems in critically ill patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayan MANDAL",India
4279,PS028,4277,"Reaffirming the role of the reverse algorithm diagnostic strategy in syphilis screening through the performance of a treponemal point-of-care test",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maitrayee NARAYAN",India
4280,PS028,4277,"Synergy of electric field-mediated sample preparation and light-scattering based pathogen growth detection for accelerated time to positivity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra REISCHL",Austria
4281,PS028,4277,"Contamination of CSF culture: serious risk to patient safety",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rahul GARG",India
4282,PS028,4277,"Evaluating semi-automatic homogenisation of tissue samples for improved diagnostics of tissue infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Callebaut CALLEBAUT",Belgium
4283,PS028,4277,"Evaluation of an immunofluorescence point-of-care device for to detect cell wall polysaccharides of Streptococcus pneumoniae in urine samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manuel Antonio RODRIGUEZ IGLESIAS",Spain
4284,PS028,4277,""Beat it!": tissue homogenisation by vibratory mill provides high bacteriological culture yield in routine tissue samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Farah FIECHTER",Switzerland
4285,PS028,4277,"Where do we stand with the Gram stain? Evaluation of the reproducibility of Gram stain preparation and reading of bronchoalveolar lavage and endotracheal aspirate specimens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melanie YARBROUGH","United States"
4286,PS028,4277,"Comparative performance evaluation of routine swab systems in microbiology and molecular diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter Michael KELLER",Switzerland
4287,PS028,4277,"Validation of a new microbiological control protocol for corneal grafts stored in tissue-C",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin FAYOLLE",France
4288,PS028,4277,"Evaluation of the impact of a rapid test for Group A streptococcal antigen in a community pharmacy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana CARVALHO",Portugal
4289,PS028,4277,"Towards improved diagnostics: a tunable sputum model for streamline sample preparation and diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zahra AZIZI",Austria
4290,PS028,4277,"Sputum collection in children 6 -14 years: sequence randomised crossover trial of a low-cost positive expiratory pressure device for tuberculosis testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ellen MITCHELL",Belgium
4291,PS028,4277,"I-dOne: a diagnostic tool in the field of identification of clinically relevant microbial strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulio CAMARLINGHI",Italy
4292,PS028,4277,"Early diagnosis of urinary tract infection requires direct testing of bacterial counts in urine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bastian DIRK",Germany
4293,PS028,4277,"Investigating chlamydia specific antibody titres and avidity in trachoma infection and disease progression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hannah JEAL","United Kingdom"
4294,PS028,4277,"Performance of a rapid test for Group A Streptococcus in paediatric pleural empyema",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helene FAURY",France
4295,PS028,4277,"Evaluation of the suitability of MDR enterobacteria chromogenic media for Fourier-transform infrared spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4296,PS028,4277,"A single centre prospective comparative study: roll-plate vs sonication technique of microbiological diagnosis of tunneled long-term catheters",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian Johann LERCHE",Denmark
4297,PS028,4277,"Impact of delayed incubation on blood culture diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas JACOBS ØSTERHEGN JENSEN",Denmark
4298,PS028,4277,"Evaluation of a sponge-based transport device for urine culture in a nephrology outpatient clinic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lamiss MEJDOUBI",Austria
4299,PS028,4277,"Diagnostic pitfalls of auramine O smear microscopy: a retrospective study of adult nontuberculous mycobacteria infections misdiagnosed with and treated for tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leong Tung ONG",Malaysia
4300,PS028,4277,"Reducing the blood culture contamination rate in the emergency department: a good start",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ellen BROWNE",Ireland
4301,PS028,4277,"Early detection of Aerococcus species from automated incubation of chromogenic media",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Delphine JACOB",France
4302,PS028,4277,"Capability of automated individual blood volume measurement system for monitoring paediatric blood culture volumes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joshua HERR","United States"
4303,PS028,4277,"Not all positive blood cultures are significant, so why process them as such?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Colin HUDSON","United Kingdom"
4304,PS028,4277,"Improved time-to-detection with the new formulation of commercially available aerobic blood culture vials: a real-world evidence study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kayla VAN BENTEN","United States"
4305,PS028,4277,"The ongoing relevance of conventional culture method in the recovery of Salmonella spp. from faecal samples tested with real-time PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"A.M.B. Nilmini WIJESOORIYA","United Kingdom"
4306,PS028,4277,"Comparison of multiple blood cultures and unique blood cultures in testing performance for suspected bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hui YANG",China
4307,PS028,4277,"Evaluation of performance of antimicrobial-neutralising effect of novel resin blood culture vials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eun Jeong WON","Republic Of"
4308,PS028,4277,"Comparison of commercially available liquid amies collection and transport systems for the viability preservation of aerobes, anaerobes and fastidious bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco BONOMETTI",Italy
4309,PS028,4277,"A service evaluation of peritoneal dialysis fluid culture methods: universal and blood culture bottles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica LEWIS","United Kingdom"
4310,PS028,4277,"Retrospective study of an urinary antigen detection test performance for the diagnosis of Legionella pneumophila pneumonia in a Spanish tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"García García SAMUEL",Spain
4311,PS028,4277,"Discrimination of foodborne bacteria using an electronic nose based on MOS sensors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia Figueiredo COSTA",Brazil
4312,PS028,4277,"A new formulation of CHROM-ID OXA48 chromogenic media: a before/after impact study for carbapenemase-producing Enterobacterales detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier DAUWALDER",France
4313,PS028,4277,"Comparison of the performance of a new chemiluminescent immunoassay for Helicobacter pylori faecal antigen detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco Antonio SEMPERE ALCOCER",Spain
4314,PS028,4277,"No culture left behind and no sepsis left unchecked: use the latest technologies at their full potentials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xuan QIN","United States"
4315,PS028,4277,"A novel ultrasensitive single-molecule counting C. difficile toxin A/B assay for reduced testing complexity and more accurate diagnosis of disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johanna SANDLUND","United States"
4316,PS029,NULL,"04b. Laboratory management (incl automation, data management, QC/QA, regulatory aspects)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4317,PS029,4316,"Does lab automation reduce incubation time in diagnosis of orthopaedic infections? Laboratory automation combined with NGS for the diagnosis of infections: first results from a reference centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara Giordana RIMOLDI",Italy
4318,PS029,4316,"Barriers to quality management system implementation and accreditation in Teso sub-region, Uganda: a study on laboratory non-conformances",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charline KATUROLE",Uganda
4319,PS029,4316,"Pre-analytical features of the first routine blood culture from 55,558 patients at a tertiary hospital in San Paulo, Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evangelina ARAUJO",Brazil
4320,PS029,4316,"Optimising blood culture turnaround times: analysis of a regional microbiology hub and spoke laboratory network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Conor MULROONEY",Ireland
4321,PS029,4316,"Automated culture systems in a microbiology laboratory specialising in gastroenteric samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stanca-Luci PANDREA",Romania
4322,PS029,4316,"Consequences of method change on plastic waste consumption in clinical microbiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Volkan ÖZENCI",Sweden
4323,PS029,4316,"Automatising the identification of invasive Group A Streptococcus through laboratory data available in the Norwegian surveillance system for communicable diseases laboratory database",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"João PIRES",Norway
4324,PS029,4316,"Encoding culture media tests using LOINC terminology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Béatrice CELLIÈRE",France
4325,PS029,4316,"Automated inoculation of respiratory samples for enhanced bacteriological analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Demi ELSHOUT",Netherlands
4326,PS029,4316,"Early MDRO screening on chromogenic media with automated culture systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Delphine JACOB",France
4327,PS029,4316,"Automation of blood cultures using microbiology laboratory automation: enhancing efficiency in microbiological diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Colin MANS",Netherlands
4328,PS029,4316,"How to implement a 24/7 lab with full automation to improve patient management and antimicrobial stewardship: a preliminary single-centre experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Riccardo CAPUANO",Italy
4329,PS029,4316,"Setting automatic review rules to improve the accuracy of rapid antimicrobial susceptibility testing results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yuling XIAO",China
4330,PS029,4316,"Round-the-clock microbiology: a game changer for early bacteraemia detection and treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto VAZQUEZ BLANQUIÑO",Spain
4331,PS029,4316,"5Ws analysis of blood culture contamination rates in an Australian medical laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zahraa AL-SULTANI",Australia
4332,PS029,4316,"Improving diagnostic stewardship: an example from Coxiella serology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ameeka THOMPSON","United Kingdom"
4333,PS029,4316,"Pre-analytical resource development supporting clinical integration of microbiology services in LMICs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maxencia NABIRYO",Uganda
4334,PS029,4316,"Laboratory automation in microbiology: a positive impact on turnaround time (TAT) of paediatric microbiological samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paola BERNASCHI",Italy
4335,PS030,NULL,"04c. MALDI-TOF and other proteomic methods","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4336,PS030,4335,"DOT-MGA for rapid determination of susceptibility to ceftazidime/avibactam and aztreonam combination among Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana CAIERÃO",Brazil
4337,PS030,4335,"Toward sustainable and reproducible MALDI-TOF MS: impact of target selection and hardware maintenance on mass spectral quality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yukino GÜTLIN",Switzerland
4338,PS030,4335,"Evaluation of FT-IR spectroscopy for E. coli ST-131 differentiation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4339,PS030,4335,"Evaluation of the performance of a bacterial identification system by mass spectrometry by matrix-assisted laser desorption/ionisation and time of flight (MALDI-TOF MS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kamelia Zahra YALA",Algeria
4340,PS030,4335,"Streamlining pathogen identification: advanced rapid blood culture enrichment technology for MALDI-TOF MS diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Run HUANG",China
4341,PS030,4335,"Performance of a rapid MALDI-TOF MS assay for antimicrobial susceptibility testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evgeny A. IDELEVICH",Germany
4342,PS030,4335,"Comparison of mass spectrometry (MALDI-TOF MS) and genomic analysis (rMLST, hsp60 and chromosomal AmpC) for the identification of Enterobacter cloacae complex species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther RECACHA",Spain
4343,PS030,4335,"A novel approach for Klebsiella pneumoniae typing by Fourier-transform infrared spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Donatella LOMBARDO",Italy
4344,PS030,4335,"Evaluation of a new device using MALDI-TOF systems for fast identification of Gram-negative pathogens from positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaley REEDY","United States"
4345,PS030,4335,"Infra-red spectroscopy (FTIR) for the rapid identification of Gram-negative bacteria involved in urosepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Craig WILLIAMS","United Kingdom"
4346,PS030,4335,"Application evaluation of MALDI-TOF MS in rapid identification of filamentous fungi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guangyu FU",China
4347,PS030,4335,"Application of MALDI-TOF MS in the detection of drug-resistant phenotype of Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dehao ZHOU",China
4348,PS030,4335,"Fast and user-friendly discrimination of highly virulent Streptococcus agalactiae clonal complexes by MALDI-TOF MS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4349,PS030,4335,"Comparison of the filamentous fungi library database of the matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) with the MSI-2 database for identification of medically important molds",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter LASCARIDES","United States"
4350,PS030,4335,"Mycobacterium avium complex (MAC): a group of emerging pathogenic species, in patients with diseases associated to the respiratory tract",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia BORONAT MUÑOZ",Spain
4351,PS030,4335,"Discrimination of cronobacter sakazakii from other Cronobacter strains using lipid analysis with MALDI-ToF MS in negative ion mode",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam STERNEL",Germany
4352,PS030,4335,"Prediction of linezolid-resistant Enterococcus faecium using MALDI-TOF MS and machine learning",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andre INGEBRETSEN",Norway
4353,PS031,NULL,"04d. Molecular diagnostics (incl POCT and syndromic testing)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4354,PS031,4353,"Distribution of microorganisms in patients followed up with a diagnosis of central nervous system infection and evaluation of clinical usefulness of cerebrospinal fluid multiplex PCR panel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elif Ozge DAMAR MIDIK",Türkiye
4355,PS031,4353,"Performance of two multiplex-real-time PCR kits detecting sexually transmitted pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Florence DOUCET POPULAIRE",France
4356,PS031,4353,"Evidence of phage as the source of unconfirmed positive Neisseria gonorrhoeae results in throat swabs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Owen SPILLER","United Kingdom"
4357,PS031,4353,"Optimisation of microbiological diagnosis of suspected meningitis using an off-label syndromic molecular panel in paediatric cerebrospinal fluid samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Venere CORTAZZO",Italy
4358,PS031,4353,"Sepsis on critical patients: performance and evaluation of a new molecular test from direct whole blood",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonina Tindara FERRARA",Italy
4359,PS031,4353,"Impact of molecular biology on the diagnosis of sexually transmitted infections at a public hospital in Montevideo, Uruguay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matilde OUTEDA",Uruguay
4360,PS031,4353,"False positive pathogen detection in central nervous system infections by syndromic testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Friederike VON LOEWENICH",Germany
4361,PS031,4353,"Rapid molecular detection of antibiotic resistance markers using PathCRISP test",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bhargava C N",India
4362,PS031,4353,"Comparison of molecular testing methods for diagnosing non-tuberculous mycobacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leilei WANG",China
4363,PS031,4353,"Long-term preservation of bacterial DNA using a transport medium: evaluation across different storing temperatures and molecular assays",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria TRIVA",Italy
4364,PS031,4353,"Development and evaluation of a rapid and sensitive RPA-assisted CRISPR/Cas12a assay for detecting Salmonella paratyphi and Salmonella paratyphi A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jobin JACOB JOHN",India
4365,PS031,4353,"Analytical performance evaluation of automated multiplex real-time PCR for detection of pathogens related with acute undifferentiated febrile illnesses: severe fever with thrombocytopenia syndrome virus, Orientia tsutsugamushi, Leptospira, and hantavirus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyun-Seung LEE","Republic Of"
4366,PS031,4353,"Evaluation of the BD COR automated random access system for the high-throughput testing of genital and non-genital samples for Chlamydia trachomatis and Neisseria gonorrhoeae with the BD CTGCTV2 assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shoshanna MAY","United Kingdom"
4367,PS031,4353,"Seasonal patterns of gastrointestinal pathogens in a tertiary-care hospital in northern Greece: a multi-pathogen surveillance study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zafeirios TSINARIS",Greece
4368,PS031,4353,"Evaluation of the co-morbidity of HPV, STIs and bacterial vaginosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melanie POLKE",Germany
4369,PS031,4353,"Determination of bacteria and fungi by sequencing in clinical practise",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lenka KRAMNA","Czech Republic"
4370,PS031,4353,"Performance evaluation of the QIAstat-Dx meningitis/encephalitis panel: results from five studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Flora Marzia LIOTTI",Italy
4371,PS031,4353,"Accelerating molecular diagnostics: development of a novel rapid, integrated PCR system for acute respiratory infections detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Run HUANG",China
4372,PS031,4353,"Colorimetric-loop mediated isothermal amplification assay for Helicobacter pylori detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yosita LEEPROMMA",Thailand
4373,PS031,4353,"Enhancing STI and UTI detection with a novel, versatile, fast and reliable tool for nucleic acid extraction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura PASTOR-BERNAD",Spain
4374,PS031,4353,"Transforming Salmonella detection via One-Pot CRISPR-Cas12-based assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mandar NAIK",India
4375,PS031,4353,"Etiologies and ophthalmological characteristics of infectious uveitis: insights from multiplex real-time PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selin Gamze KILIC SINCI",Türkiye
4376,PS031,4353,"BioFire joint infection panel for samples other than synovial fluid",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicola BENVENUTO",Italy
4377,PS031,4353,"Synergising PlexPlus chemistry, instrumentation and software: advancing multiplex PCR solutions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sabrina ALBET",France
4378,PS031,4353,"Performance of a direct-from-sample next generation sequencing based pan-bacterial, pan-fungal assay on tissue samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone JETHA",India
4379,PS031,4353,"Fabrication of a sensitive surface plasmon resonance-based nanorods-shaped gold nanobiosensor for the specific detection of Vibrio cholerae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saeed SHAMS","Islamic Republic Of"
4380,PS031,4353,"Evaluation of a laboratory-developed RT-PCR assay for the detection of Pneumocystis jirovecii using a high throughput system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jae Hyeon PARK","Republic Of"
4381,PS031,4353,"Oropharyngeal swabs as a non-invasive alternative for diagnosis of lower respiratory tract infections in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wen-Tyng KANG",China
4382,PS031,4353,"Performance of interspace profiling (ISpro) for diagnosis of bacterial pericarditis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martine BOS",Netherlands
4383,PS031,4353,"Development of a multiplex real-time PCR assay for the simultaneous detection of three fungal pathogens in respiratory samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeqi ZHOU",China
4384,PS031,4353,"Interventional study to evaluate the impact of a rapid screening strategy in improving control of carbapenemase-producing organisms (CPOs) and vancomycin-resistant Enterococci (VREs)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandrine BOISSET",France
4385,PS031,4353,"Replacing stool culture with multiplex PCR in a primary care setting: a six months experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie BLÜMEL",Austria
4386,PS031,4353,"Identification of Staphylococcus aureus by polymerase chain reaction using novel primers from heat shock protein",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tomiwa ADESOJI",Nigeria
4387,PS031,4353,"Introduction and initial validation of a novel real time-PCR system for rapid identification of bacteria and resistance genes from positive blood cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadine THEISSEN",Germany
4388,PS031,4353,"Bringing the heat: a new generation of thermophilic Bst polymerases mitigate non-specific LAMP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rita SIMÕES",Portugal
4389,PS031,4353,"Fast, thermostable and inhibitor-resistant: the future of reverse transcription in molecular diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inês FONSECA COSTA",Portugal
4390,PS031,4353,"Evaluation of the EasySeq full-length 16S sequencing kit for bacterial identification in clinical samples: a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tim T. SEVERS",Netherlands
4391,PS031,4353,"Culture-independent identification of microbial pathogens and antimicrobial resistance genes in intensive care units",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zihan XIA",China
4392,PS031,4353,"Utility of stool Xpert assay in the diagnosis of paediatric pulmonary and intestinal tuberculosis: a study from western India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dhruv GANDHI",India
4393,PS031,4353,"New microfluidic device with magnetic attraction for resistance genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Leonor SANTOS",Portugal
4394,PS031,4353,"Diagnostic yield of bacterial PCRs for identifying the infectious etiology for paediatric pleural effusion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amy LEBER","United States"
4395,PS031,4353,"Evaluation of the BioFire FilmArray RP2.1 panel for detection and quantification of viral and bacterial respiratory pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Onya OPOTA",Switzerland
4396,PS031,4353,"Evaluating the efficacy of a multiplex PCR sepsis panel for pathogen detection in non-blood neurosurgical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis BRUSCA",Spain
4397,PS031,4353,"Application and performance of 16S/18S amplicon sequencing in diagnostic management of culture-negative infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincenzo DI PILATO",Italy
4398,PS031,4353,"Influence of rapid molecular testing in optimising clinical and therapeutic management of pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia GALAR",Spain
4399,PS031,4353,"Optimisation of diagnostic specificity in bacterial infections by duplex 16S rDNA PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Coralie BOUCHIAT",France
4400,PS031,4353,"Very rapid and accurate detection of acute bacterial meningitis in clinical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan ZIMMERMANN",Germany
4401,PS031,4353,"Impact of multiplex PCR for rapid microbiological diagnosis of patients with severe pneumonia in emergency department: a pragmatic controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chien-Chang LEE",China
4402,PS031,4353,"New NAAT kits for rapid and accurate detection and differentiation of pathogenic E. coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heike ABICHT",Germany
4403,PS031,4353,"Comparison of GP and central laboratory BioFire FilmArray point-of-care test performance as part of the RAPID-TEST RCT",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily BROWN","United Kingdom"
4404,PS031,4353,"Rapid molecular diagnostics for respiratory infections: cycle thresholds and co-infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Antonella ZINGAROPOLI",Italy
4405,PS031,4353,"Automated high-throughput molecular diagnostic system for the simultaneous detection of four sexually transmitted infection pathogens in human urine and vaginal swab specimen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeonghee KIM","Republic Of"
4406,PS031,4353,"Molecular diagnostics for paediatric bone and joint infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zain CHAUDHRY","United Kingdom"
4407,PS031,4353,"Evaluation of multiplex PCR panel dynamics during antibiotic treatment to predict clinical success in ICU patients with severe hospital-acquired pneumonia: a multicentre prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julien DESSAJAN",France
4408,PS031,4353,"No time, no problem: transitioning to extraction-free workflow for stool testing using PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne WOLFENSTETTER",Germany
4409,PS031,4353,"Analytical feasibility of the cobas eplex gastrointestinal panel: a multiplex PCR syndromic test currently in development",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pedro L. RODRIGUEZ","United States"
4410,PS031,4353,"Performance of a novel molecular test in culture-negative periprosthetic hip and knee periprosthetic joint infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susana GARDETE-HARTMANN",Austria
4411,PS031,4353,"Clinical performance of a fully automated real-time PCR assay for the detection of Clostridium difficile in human stool samples under IVDR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jasmin KÖFFER",Germany
4412,PS031,4353,"Clinical performance of a fully automated real-time PCR assay for the detection of Chlamydophila pneumonia, Legionella pneumophila and Mycoplasma pneumoniae in human bronchoalveolar lavage under IVDR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jasmin KÖFFER",Germany
4413,PS031,4353,"Ct values in fast syndromic testing: putative applications in CNS infection diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camenforte NESTOR",Spain
4414,PS031,4353,"Selective application of FilmArray for effective antibiotic management in meningitis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathan NICOLAU-GUILLAUMET",France
4415,PS031,4353,"Enhanced pathogen detection and antimicrobial optimisation in ARDS: multiplex PCR vs standard diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina GASSNER",Germany
4416,PS031,4353,"Improved accuracy in Group B Streptococcus detection: a validation study across two medical centres",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pninit SHAKED MISHAN",Israel
4417,PS031,4353,"A comparative evaluation of multiplex PCR panels for gastrointestinal pathogen detection in clinical stool samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura SEIJAS PEREDA",Spain
4418,PS031,4353,"Comparative evaluation of the standard M10 and Xpert C. difficile assays for the detection of toxigenic Clostridioides difficile in stools",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frédéric BARBUT",France
4419,PS031,4353,"Evaluation of the hologic aptima vaginitis assays for microbiological diagnosis of vaginitis in women with abnormal vaginal discharge attending primary care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter MUIR","United Kingdom"
4420,PS031,4353,"Evaluation of the effect of gastrointestinal system multiplex PCR panel positivity on the relapse of ulcerative colitis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merve BUYUKKORUK",Türkiye
4421,PS031,4353,"Validation of a real time PCR assay using cerebrospinal fluid samples with clinical suspicion of bacterial meningitis from a tertiary hospital in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
4422,PS031,4353,"Updated coverage of circulating and emerging toxigenic Clostridioides difficile strains by a commercial PCR test",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabella ELLENA TICKLER",Italy
4423,PS031,4353,"Rapid detection of ESKAPE pathogens from whole blood in patients with spondylodiscitis and infective endocarditis combining PCR and MRI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucie CÍCHOVÁ","Czech Republic"
4424,PS031,4353,"Transforming reagents for revolutionary point-of-care molecular diagnostics: lyophilised PCR master mix beads for cold-chain-free and rapid testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Golara GOLBAGHI",Canada
4425,PS031,4353,"Lyophilisation as a successful technique to produce easy-to-use, robust, and room-temperature-stable magnetic particles for molecular diagnostic applications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Golara GOLBAGHI",Canada
4426,PS031,4353,"Can syndromic molecular tests be used for the diagnosis of urinary tract infections?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tugçe ÖZYOL ATKAYA",Türkiye
4427,PS031,4353,"Performance of an automated, multiplex RT-PCR panel with external quality assessment programmes for respiratory pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elizabeth PAZ GOMERO",Sweden
4428,PS031,4353,"Mucorales PCR testing in bronchoalveolar lavage samples of immunocompromised patients with and without fungal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah SEDIK",Austria
4429,PS031,4353,"Utilisation of the BioFire FilmArray blood culture identification 2 panel for rapid and accurate identification of bacteraemia pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeonghyun CHANG","Republic Of"
4430,PS031,4353,"Rapid random-access molecular diagnostic assay for STI pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dana SAGAS",Israel
4431,PS031,4353,"Outcomes of a meningitis/encephalitis syndromic PCR algorithm at a regional UK hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James Roderick GRIFFITHS","United Kingdom"
4432,PS031,4353,"Failure to detect Streptococcus pneumoniae due to false negative PCR results caused by a large insertion in the Spn9802 fragment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Myrthe Margriet Anne TOOROP",Netherlands
4433,PS031,4353,"Highly multiplexed broad pathogen detection assay for diagnosis of intraocular infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paulo Jose MARTINS BISPO","United States"
4434,PS031,4353,"Validation of targeted next-generation nanopore sequencing for routine diagnosis of gastroenteritis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas VERGAUWE",Belgium
4435,PS031,4353,"Comparison of three commercial nucleic amplification tests for CT and GC testing in urine and vaginal swabs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Salma KODSI","United States"
4436,PS031,4353,"Diagnosis of sexually transmitted infections with multiplex RT-PCR and analysis of symptoms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Füsun KIRCA",Türkiye
4437,PS031,4353,"Evaluation of an innovative RT-PCR assay allowing detection of all respiratory viruses in a single classic PCR well",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoit VISSEAUX",France
4438,PS031,4353,"Comparison of RHAM isothermal nucleic acid amplification technology and culture method: advancing screening for Streptococcus agalactiae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Colosimo CLAUDIA",Italy
4439,PS031,4353,"Clinical diagnostic performance of droplet digital PCR for pathogen detection in patients with Staphylococcus aureus bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiroki KITAGAWA",Japan
4440,PS031,4353,"Diagnostic value of PCR whipple: a retrospective multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eloïse LE BANNER",France
4441,PS031,4353,"Comparative analysis of workflow efficiency and safety in enteric bacterial pathogen detection methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lauren COOPER","United States"
4442,PS031,4353,"Urgent care (UC) clinician perceptions and identification of target populations for a novel point-of-care test (POCT) for pharyngitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander LEPAK","United States"
4443,PS031,4353,"Evaluation of PCR in saliva and stool for Whipple's disease diagnosis: a retrospective study from 2019 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillermo Carlos MARTÍNEZ CARRIÓN",Spain
4444,PS031,4353,"Molecular assay of atypical community-acquired pneumonia from different matrices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Colosimo CLAUDIA",Italy
4445,PS031,4353,"Laboratory evaluation of the Biofire FilmArray pneumonia panel compared to standard-of-care testing in patients admitted to an ICU in Swansea, UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rhys EVANS","United Kingdom"
4446,PS031,4353,"Development of a simple tool for the detection of pneumonia-causing bacteria in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arturo MARTÍNEZ TREJO",Spain
4447,PS031,4353,"Rapid and accurate pathogen detection in joint infections: assessing the performance of the BioFire joint infection panel in Korean tertiary hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hae-Seong JEONG","Republic Of"
4448,PS031,4353,"Evaluation of a real-time polimerase chain reaction assay for the direct diagnosis and genital colonisation of Streptococcus agalactiae in pregnant women",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aida RAMIREZ MARINERO",Spain
4449,PS031,4353,"Impact of multiplex polymerase chain reaction testing in patients with bacteraemia in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daisuke KITAGAWA",Japan
4450,PS031,4353,"In silico evaluation of pilV-I PCR for identifying the hyperepidemic Klebsiella pneumoniae ST258 clone in contemporary isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando PASTERAN",Argentina
4451,PS031,4353,"Evaluation of clinical usefulness of a commercial multiplex PCR for diagnosing mycobacterial infections: a multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Llanos SALAR-VIDAL",Spain
4452,PS031,4353,"Promising novel molecular approaches compared to culture for detecting periprosthetic joint infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elizabeth MORREEL",Belgium
4453,PS031,4353,"Assessment of a qPCR syndromic device's C. difficile tcdA/tcdB assay with clinical relevance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca SMITH AGUASCA",Spain
4454,PS031,4353,"The impact of targeted molecular ciprofloxacin resistance testing on positive gonorrhoea samples in NHS Grampian",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ijeoma OKOLIEGBE","United Kingdom"
4455,PS031,4353,"Filmarray GI system for the diagnosis of gastrointestinal tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Konstantina KONTOPOULOU",Greece
4456,PS031,4353,"Epidemiology and antibiotic resistance genotypes of respiratory pathogens in critical care units and non-critical care units in private chain hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anis Farhanah ROSLEE",Malaysia
4457,PS031,4353,"Neuro-meningeal infections caused by enterovirus: epidemiological and microbiological profiles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Doria BENSERSA-NEDJAR",Algeria
4458,PS031,4353,"Microbial cell-free DNA NextGen sequencing diagnostics in solid organ transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edison CANO CEVALLOS","United States"
4459,PS031,4353,"Application of a film array meningitis/encephalitis panel for the diagnostic investigation of adult patients with syndromic symptomatology: a five-year retrospective epidemiological study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria TERZAKI",Greece
4460,PS032,NULL,"04e. Strain typing and surveillance (incl molecular, genomic and other advanced methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4461,PS032,4460,"Optimising IR-FTIR spectroscopy for epidemiological tracking Klebsiella pneumoniae ST512 strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria RIESGO",Spain
4462,PS032,4460,"Invasive Streptococcus pyogenes population in the Russian Federation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irina TSVETKOVA","Russian Federation"
4463,PS032,4460,"Whole-genome analysis to establish genetic thresholds for excluding recent transmission of livestock-associated MRSA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thera HABBEN JANSEN",Netherlands
4464,PS032,4460,"Comparative genomic analysis of sequence type 72 (ST72), a successful community clone of Staphylococcus aureus strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jae-Seok KIM","Republic Of"
4465,PS032,4460,"Sequencing for Listeria monocytogenes outbreak detection and source attribution: latest advances",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael BIGGEL",Switzerland
4466,PS032,4460,"Unveiling the molecular epidemiology of invasive Group A Streptococcus in Bologna and Imola (2022–2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eva MANNINO",Italy
4467,PS032,4460,"Impact of different whole-genome sequences production procedures and sequence analysis pipelines on genotyping and clustering of Campylobacter strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philippe LEHOURS",France
4468,PS032,4460,"A 12-year molecular surveillance and virulence determination of Listeria monocytogenes in Slovenia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tom KORITNIK",Slovenia
4469,PS032,4460,"Long-read sequencing: a standalone tool for Listeria monocytogenes outbreak investigations?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Asta LILI LAUGESEN",Denmark
4470,PS032,4460,"Molecular epidemiology of invasive Streptococcus pyogenes in Hungary, January 2023-May 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tóth KINGA",Hungary
4471,PS032,4460,"Multi locus sequence typing of Pseudomonas aeruginosa strains isolated from people with cystic fibrosis in elexacaftor/tezacaftor/ivacaftor treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Francesca LIPORACE",Italy
4472,PS032,4460,"Is Group A Streptococcus emm1/ST28 a new threat in Brazil?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"André RIO TINTO",Brazil
4473,PS032,4460,"Xpert Carba-R screening of digestive carriers of carbapenemase-producing GNB vs conventional techniques",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohamed Azzedine BACHTARZI",Algeria
4474,PS032,4460,"Long term Staphylococcus aureus carriage dynamics in people who inject drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jimmy JÖRGENSEN",Sweden
4475,PS032,4460,"Developing a robust approach to determining plasmid transmission in the hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jane HAWKEY",Australia
4476,PS032,4460,"Genotypic methods directly from epidemiological samples to detect resistance markers of Gram-negative bacilli: a reality?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leticia FONTÁN GARCÍA-RODRIGO",Spain
4477,PS032,4460,"Comprehensive comparative and pan-genome analysis of Staphylococcus lugdunensis isolates from the UK and globally",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucy LAMB","United Kingdom"
4478,PS032,4460,"Discrimination of Salmonella serogroups and differentiation between typhoidal and non-typhoidal strains using ATR-FTIR spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maira NAPOLEONI",Italy
4479,PS032,4460,"Fourier-transform infrared spectroscopy as a new tool to investigate Clostridioides difficile outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kerstin LOCHER",Canada
4480,PS032,4460,"Typing of food- and water-borne pathogens by Fourier transform infrared-spectroscopy (FT-IR)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan ZIMMERMANN",Germany
4481,PS032,4460,"A longitudinal surveillance on molecular evolution of methicillin-resistant Staphylococcus aureus from children in Shanghai, China, 2013-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bingjie WANG",China
4482,PS032,4460,"Discrimination of genus Legionella and serogroup of Legionella pneumophila strains using ATR-FTIR spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ignazio ARRIGO",Italy
4483,PS032,4460,"Local genomic surveillance of laboratory-confirmed human Salmonella isolates in Vigo-Galicia, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos DAVIÑA NUÑEZ",Spain
4484,PS032,4460,"The clinical spectrum of cutaneous nocardiosis using gene sequencing at tertiary care centre, India: an observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sudeshna DAS",India
4485,PS032,4460,"Implementation of Fourier-transform infrared (FTIR) spectroscopy into clinical microbiology lab",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ola SALACH",Israel
4486,PS032,4460,"Bioinformatic updates addressing methylation-related basecalling issues of long-read sequencing data resolve typing issues in a multicentre performance study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johanna DABERNIG-HEINZ",Austria
4487,PS032,4460,"Validation by whole-genome sequencing of the use of Fourier-transform infrared spectroscopy (FTIR) to rapidly assess Pseudomonas aeruginosa clonality in the microbiological management of patients with cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Serena RAIMONDI","Holy See (vatican City State)"
4488,PS032,4460,"Molecular typing to discriminate between typhoid and nontyphoid Salmonella species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvia BRUISTEN",Netherlands
4489,PS032,4460,"Evaluation of FT-IR for the differentiation of Campylobacter jejuni strains regarding their potential to induce Guillain-Barré syndrome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4490,PS032,4460,"Evaluation of Fourier-transform infrared spectroscopy as a method for rapid Streptococcus pneumoniae serotyping",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pere-Joan CARDONA",Spain
4491,PS032,4460,"Application of Fourier-transform infrared spectroscopy to differentiate the Bacillus cereus group",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4492,PS032,4460,"Differentiation of Shigella spp. serotypes by FT-IR spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4493,PS032,4460,"Characterisation of an outbreak caused by vancomycin-resistant Enterococcus faecium and linezolid-resistant E. faecium using Fourier-transform infrared (FTIR) spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria SÁNCHEZ CUETO",Spain
4494,PS032,4460,"Tackling invasive listeriosis outbreaks in northern Italy: the role of genomic surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria GORI",Italy
4495,PS032,4460,"Optimisation of long-read whole-genome sequencing for surveillance of antibiotic resistance detection and typing in low-and-middle-income countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natasia THORNVAL",Denmark
4496,PS032,4460,"Evaluation of Fourier-transform infrared spectroscopy for typing of Klebsiella pneumoniae strains involved in hospital outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federica MARINO",Italy
4497,PS032,4460,"Rapid outbreak detection of Raoultella bacteraemia in haemodialysis patients: evaluating the use of FTIR spectroscopy and whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco Antonio ROLDÁN RUIZ",Spain
4498,PS032,4460,"Evaluation of Fourier-transform infrared spectroscopy as an alternative technique for typing Salmonella enterica",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathaly LADINES REYES",Spain
4499,PS032,4460,"Study of the epidemiology of emm types of Group A Streptococcus strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Konstantina KONTOPOULOU",Greece
4500,PS032,4460,"Evaluation of IR BIOTYPER performance for identification of Streptococcus pneumoniae serotypes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana CAIERÃO",Brazil
4501,PS032,4460,"Application of  IR technology for rapid typing and resistance prediction in carbapenem-resistant Klebsiella oxytoca complex",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wei Yu HSU",China
4502,PS032,4460,"Emergence of emm3.93 Streptococcus pyogenes clone in iGAS infections: epidemiological insights from Belgium, May 2023-September 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefanie VAN KLEEF VAN KOEVERINGE",Belgium
4503,PS032,4460,"Phage-inspired rapid Klebsiella K-typing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zuzanna DRULIS-KAWA",Poland
4504,PS032,4460,"Clonality of Acinetobacter baumannii blaOXA-24/40-like isolated from hospitals in southern Brazil using Fourier-transform infrared spectroscopy (FT-IR) methodology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcelo PILLONETTO",Brazil
4505,PS032,4460,"Evaluation of FT-IR spectroscopy for vancomycin-resistant Enterococcus faecium outbreak delimitation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antoni ESCALAS BORDOY",Spain
4506,PS032,4460,"Enhancing infectious disease diagnostics: hierarchical strain typing from high to low resolution and genomic context-based language model for antibiotic resistance prediction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sein PARK","Republic Of"
4507,PS032,4460,"Fourier transform infrared (FT-IR) spectroscopy for discrimination between global Escherichia coli ST131 subclades",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Astrid RASMUSSEN",Denmark
4508,PS032,4460,"Evaluation of FT-IR spectroscopy and machine learning for the serotyping of Streptococcus pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam CORDOVANA",Germany
4509,PS032,4460,"Enhanced genomic relatedness determination of Group A Streptococcus isolates using whole-genome sequencing compared to emm typing in England",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathrin LOOSLI","United Kingdom"
4510,PS032,4460,"Rapid differentiation of global multidrug-resistant and hypervirulent Klebsiella pneumoniae sublineages using FT-IR spectroscopy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rita MARTINS",Portugal
4511,PS032,4460,"An emm typing study performed in Turkey utilising the quadriplex real-time PCR assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bedia DINC",Türkiye
4512,PS032,4460,"Fourier-transform infrared spectroscopy as a tool for clonal clustering in hospital-associated Serratia marcescens outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sam VAN GOETHEM",Belgium
4513,PS032,4460,"Two Group B Streptococci ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario RAMIREZ",Portugal
4514,PS033,NULL,"04f. Whole genome sequencing (incl pathogen characterisation, diagnostics, excl typing)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4515,PS033,4514,"Species clustering of the viridans group streptococci with whole-genome sequencing (WGS)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wa Ode Dwi DANINGRAT","United Kingdom"
4516,PS033,4514,"Plasmidome analysis of the Klebsiella pneumoniae diversity panel collection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"William STRIBLING","United States"
4517,PS033,4514,"Emergence of Vibrio paracholerae with co-occurrence of Vibrio cholerae and its diagnostic-public health implications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammad Ridhuan MOHD ALI",Malaysia
4518,PS033,4514,"Developing pipeline partnerships: the use of GenomeKey's genomic analysis pipeline to understand the epidemiology of Staphylococcus aureus (SA) isolates from a UK Teaching hospital with a high incidence of both blood stream infection (SABSI) and people who inject drugs (PWID)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Phillipa BURNS","United Kingdom"
4519,PS033,4514,"Tiny patient, big challenge: decoding MDR Salmonella enterica Typhimurium ST29 with whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Salamah Faisal UMMU",Malaysia
4520,PS033,4514,"The explorative analysis of multiple copies of tigecycline resistance genes on bacterial genome assemblies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aditya Kumar LANKAPALLI","United Kingdom"
4521,PS033,4514,"Can be antimicrobial resistance predicted from metagenomic data of culture-negative 16S rDNA-positive synovial fluid samples?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jakub KANTOR","Czech Republic"
4522,PS033,4514,"Identification of Listeria monocytogenes persister types in the Austrian food chain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia STEGER",Austria
4523,PS033,4514,"In vivo detection, isolation and genomic characterisation of predatory bacteria in human faecal samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario ROMERO RIVERA",Spain
4524,PS033,4514,"From environmental to epidemic: how genomic surveillance allowed identification and characterisation of a new epidemic clone of Pseudomonas aeruginosa in our cystic fibrosis centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina ROSSITTO",Italy
4525,PS033,4514,"Evaluation of three commercial kits for Pseudomonas aeruginosa genomic DNA extraction: optimising yield and quality for long read sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anurag Kumar BARI",Netherlands
4526,PS033,4514,"Phenotypic and genotypic characterisation of Klebsiella pneumoniae isolates from ten Colombian hospitals using the EPISEQ CS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nelly Carolina MENA",Colombia
4527,PS033,4514,"Genomic insights into Streptococcus pneumoniae in Indian paediatric carriage: serotype, virulence, and antimicrobial resistance profiles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vaishnavi Vishram NAIK",India
4528,PS033,4514,"Optimised methods for bacterial whole-genome sequencing from positive blood culture broths",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia SIMNER","United States"
4529,PS033,4514,"Double-zone-haemolysis in coagulase-positive staphylococci and in silico analysis of haemolysin (hlb) gene polymorphisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier LATORRE",Spain
4530,PS033,4514,"Haemophilus influenzae genomes harbour novel prophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saskia PROUD","United Kingdom"
4531,PS033,4514,"Molecular insights into Group B Streptococci from antenatal women attending a tertiary care centre in South India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sheela Devi CHANDRAKESAN",India
4532,PS033,4514,"Application of whole-genome sequencing to investigate a collection of Elizabethkingia spp. isolates in a surgical and transplantation ICU",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Georgia CHASIOTI",Greece
4533,PS033,4514,"Is there a difference between invasive and non-invasive Streptococcus pyogenes isolates?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marek STEFAN","Czech Republic"
4534,PS033,4514,"Whole-genome characterisation of Escherichia coli isolates from older women with urinary tract infection or asymptomatic bacteriuria: a pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caroline SCHNEEBERGER-VAN DER LINDEN",Netherlands
4535,PS033,4514,"Culture vs next-generation sequencing for infective endocarditis: performance of the 16S/ITS NGS in cardiac valve samples as a rapid and direct diagnostic tool",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose ALEXANDER","United States"
4536,PS033,4514,"Genome-based identification of Desulfovibrio strains from bacteraemia in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francisco FRANCO ÁLVAREZ DE LUNA",Spain
4537,PS033,4514,"Analysing uropathogenic Escherichia coli isolates with mutations conferring low-level resistance to quinolones and low-level resistance to fosfomycin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soraya HERRERA-ESPEJO",Spain
4538,PS033,4514,"Antimicrobial resistance and molecular typing of Streptococcus suis causing systemic clinical cases in pig production in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna VILARÓ VIVES",Spain
4539,PS034,NULL,"04g. Microbiome studies (incl clinical and diagnostic studies, One Health aspects, excl fundamental science)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4540,PS034,4539,"Skin microbiome in intensive care unit patients: temporal shifts in bacterial and fungal communities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teresa NASCIMENTO",Portugal
4541,PS034,4539,"Dietary habits and vaginal environment: can a beneficial impact be expected?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marielle Ezekielle DJUSSE",Italy
4542,PS034,4539,"Microbial signatures of sexual contact: forensic and clinical implications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jasmin BAUMGARTNER",Switzerland
4543,PS034,4539,"Comparison of two 16S metagenomic protocols for high-throughput microbiome sequencing: library preparation and bioinformatics performance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna FAGERSTRÖM",Sweden
4544,PS034,4539,"Evaluation of a shotgun metagenomic NGS workflow for microbial pathogen detection from complex clinical samples using a host DNA depletion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jakub KANTOR","Czech Republic"
4545,PS034,4539,"Assessing potential bias introduced by sequential vaginal swab collection on microbiome profiling",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna FRANZONI",Italy
4546,PS034,4539,"Gut microbiota and hypothalamic inflammation as determinants of binge eating behavior prior to obesity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sedreh NASSIRNIA",Switzerland
4547,PS034,4539,"Exploration of urinary microbiome in patients at various stages of bladder cancer, India: association of Campylobacterales with muscle-invasive carcinoma",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inderjit SINGH",India
4548,PS034,4539,"Effect of antibiotic use on the gut microbiome of neonates: a northern Nigeria cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chinenye AKPULU","United Kingdom"
4549,PS034,4539,"The bile microbiota composition in pathological conditions: a pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia GATTI",Italy
4550,PS034,4539,"Culturomics insights into phenotypic antimicrobial resistance evolution in the gut microbiota of allogenic stem cell transplant patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa SOSA",Switzerland
4551,PS034,4539,"Tips and tricks for microbiota investigation using SEM: sample preparation, imaging and landscape analysis correlated to multi-omics approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara BELLALI",France
4552,PS034,4539,"Comparative analysis of two comercial sequencing platforms for 16S rRNA profiling of respiratory microbial communities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillem MACIP SANCHO",Spain
4553,PS034,4539,"Gut microbiota differences linked to weight gain and antiretroviral therapy in people living with HIV are enterotype specific but minor compared to those linked to sexual orientation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan KEHRMANN",Germany
4554,PS034,4539,"Towards optimal endometrial microbiota sampling: a comparison of flush and biopsy using nanopore sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastien BONTEMS",Belgium
4555,PS034,4539,"Rapid determination of the vaginal microbiome using nanopore sequencing at lowlands science",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eefje SCHRAUWEN",Netherlands
4556,PS034,4539,"Microbiota and resistome nanopore-based metagenomic analysis of Swiss expatriates living in Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edgar Igor CAMPOS-MADUENO",Switzerland
4557,PS034,4539,"Characterisation of the skin and oral microbiome in younger and older adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Duncan NEWMAN","United Kingdom"
4558,PS034,4539,"Analyses of hospital microbiomes revealed critical pathogens associated with HAIs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julio Cesar ORTEGA CAMBARA","United Kingdom"
4559,PS035,NULL,"04h. Clinical metagenomics","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4560,PS035,4559,"Benchmarking bacterial DNA extraction protocols to recover high molecular weight DNA from faecal reference material for long-read metagenomic sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Molly HALES","United Kingdom"
4561,PS035,4559,"Implementation of a rapid next-generation sequencing (NGS) based agnostic diagnostic for enhanced intensive care unit (ICU) care at a tertiary hospital in Dhaka, Bangladesh",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jannat Ara KHANOM",Bangladesh
4562,PS035,4559,"Correlation between nanopore respiratory metagenomics and quantitative respiratory culture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Virve Irene ENNE","United Kingdom"
4563,PS035,4559,"Detection of pathogenic microorganisms usingmetagenomic next-generation sequencing in the emergency department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Torsten SCHROEDER",Germany
4564,PS035,4559,"Using metagenomics for pathogen screening in pregnancy complications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leysa FORREST","United Kingdom"
4565,PS035,4559,"The use of metagenomics to evaluate different ESBL stool screening methods",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura DI MURRO","United Kingdom"
4566,PS035,4559,"Accurate and cost-effective metagenomic next-generation sequencing for meningitis and encephalitis on a novel sequencing platform",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ryan SHEAN","United States"
4567,PS035,4559,"Proof-of-concept of a clinical metagenomics method for bacterial bloodstream infection detection using selective cell lysis and adaptive sampling",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia NGUYEN",Switzerland
4568,PS035,4559,"Impact of saponin treatment on human mycoplasmas and implications for clinical metagenomics sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte DIXON","United Kingdom"
4569,PS035,4559,"Diagnostic utility of nanopore full-length 16S rRNA gene sequencing for direct bacterial identification in chronic endometritis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Geetha NAGARAJ",India
4570,PS035,4559,"Enhancing pathogen detection: shotgun metagenomics for tropical parasitic and fungal diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cécile ANGEBAULT",France
4571,PS035,4559,"Optimisation of routine workflow for 16SrRNA and ITS-2 targeted-NGS in a clinical laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Richard CHALVIGNAC",France
4572,PS035,4559,"When should targeted 16S-metagenomics be performed? A 15-months feedback",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aubin SOUCHE",France
4573,PS035,4559,"Improvement of pathogen detection using metagenomic shotgun sequencing in cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eline CAUWENBERGHS",Belgium
4574,PS035,4559,"25 vs 35 cycles of amplification of 16S rRNA gene for targeted NGS in PJI diagnosis: which does it better?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ander URIBARRI",Spain
4575,PS035,4559,"Refining 16S rRNA targeted NGS diagnostic criteria and thresholds for PJI diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ander URIBARRI",Spain
4576,PS035,4559,"Exploring DNA and RNA plant viruses as internal controls for clinical metagenomic sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kira WAAGNER BIRKELAND",Norway
4577,PS035,4559,"Pathogen detection and anti-microbial resistance prediction performance of mNGS and tNGS in HIV+ pulmonary infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wei FEILI",China
4578,PS035,4559,"Impact of next generation sequencing (NGS) in culture negative infections coupled with infectious diseases consultation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edwin VARGAS","United States"
4579,PS035,4559,"Defining criteria for the distinction between infective versus non-infective in metagenomic analysis of CSF samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amos ADLER",Israel
4580,PS035,4559,"Semi-quantitative targeted next-generation sequencing in pathogen diagnosis and drug resistance prediction in severe lower respiratory tract infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sun WENKUI",China
4581,PS035,4559,"Partial V6-V8 or full 16SrRNA PCR + targeted-NGS for clinical diagnosis?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aubin SOUCHE",France
4582,PS035,4559,"A 16s turnkey pipeline at last! Routine evaluation of a commercial software",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tiphaine ROUSSEL-GAILLARD",France
4583,PS035,4559,"Metagenomics in the diagnosis of pneumonia: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel QUARTON","United Kingdom"
4584,PS035,4559,"Diagnostic utility of metagenomics next generation sequencing (mNGS) based on 16S rRNA sequencing in sterile samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pugazhvanan CHIDAMBARAM RAJENDRAN",India
4585,PS036,NULL,"04i. Bioinformatics tools & pipelines","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4586,PS036,4585,"A validation and evaluation study of successive phylogenetic analysis by timely antimicrobial resistant organisms tracking (TAROT) for STEC",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kotaro AOKI",Japan
4587,PS036,4585,"MethylomeMiner: a simple tool for processing and analysing DNA methylation data from sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katerina SABATOVA","Czech Republic"
4588,PS036,4585,"Comparative analysis of a commercial platform and an in-house pipeline for processing whole genome sequencing data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"García García SAMUEL",Spain
4589,PS036,4585,"Phylogenetic, serologic and sequence type analysis of 28,000 human and animal Escherichia coli genomes: on the lookout for the colibactin pks-island",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charbel AL BAYSSARI",Lebanon
4590,PS036,4585,"Automated detection of antimicrobial resistance markers in next-generation sequencing data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sam DIERICKX",Belgium
4591,PS036,4585,"Visualising reference laboratory test results using dashboards: an aid to public health reporting and action",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Janie OLVER","United Kingdom"
4592,PS036,4585,"AMRProfiler: a comprehensive tool for identifying antimicrobial resistance genes and mutations across species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anargyros SKOULAKIS",Greece
4593,PS036,4585,"The PHAPRO toolbox: from phage characterisation to product quality assessment for phage therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessia CARRARA",Switzerland
4594,PS036,4585,"zAMPExplorer: a versatile shiny app for microbiota profiling in clinical microbiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sedreh NASSIRNIA",Switzerland
4595,PS036,4585,"Computational methylome analysis pipeline for uncovering DNA methylation sites in Klebsiella pneumoniae core genome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marketa JAKUBICKOVA","Czech Republic"
4596,PS036,4585,"Kraken visualisation tool for clinical mNGS infectious disease diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer LU","United States"
4597,PS036,4585,"Automated offline container with graphic user interface for genome assembly of both short-read and long-read",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"H. Rogier VAN DOORN",Vietnam
4598,PS036,4585,"A comprehensive tool for analysing Klebsiella pneumoniae genomes: the BGA pipeline",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan Carlos GARCÍA-BETANCUR",Colombia
4599,PS036,4585,"A rapidly adaptable platform for processing and analysing sequences of tiled amplicon-sequenced viruses to inform responses to future epidemics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junko TAKATA","United Kingdom"
4600,PS036,4585,"Comparative analysis of new bioinformatic pipelines for enhanced surveillance and outbreak investigation of Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hege Vangstein AAMOT",Norway
4601,PS036,4585,"Comparing bacterial plasmid recovery in Hybracter vs Trycycler for long-read assemblies data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Messiah ODEYALE","United States"
4602,PS036,4585,"Bioinformatics analysis for low-frequency drug resistance mutations in HIV-1",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fredrik DYRKELL",Sweden
4603,PS036,4585,"Enhancing AMR research and surveillance: introducing the AMRgen R package for gene and phenotypic resistance interpretation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natacha COUTO","United Kingdom"
4604,PS037,NULL,"04j. Artificial intelligence based tools and digital health","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4605,PS037,4604,"When ESCMID meets OpenAI over cups of coffee: brewing collaborative insights to streamline utility and interpretation of clinical guidelines with ChatGPT-4",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raksha KOCHI",India
4606,PS037,4604,"How can large language models be used for clinical microbiology and infectious diseases: a tale of two applications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin MCFADDEN",Australia
4607,PS037,4604,"AIM-GNB: an artificial intelligence-assisted monitor for early prediction of Gram-negative bacteraemia using machine learning and heamatological data in the emergency department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Po-Ren HSUEH",China
4608,PS037,4604,"Prediction of methicillin-resistant Staphylococcus aureus and carbapenem-resistant Klebsiella pneumoniae from raman spectra by artificial intelligent raman detection and identification system (AIRDIS) with machine learning",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Po-Ren HSUEH",China
4609,PS037,4604,"Artificial intelligence (AI)-driven lab automation releases urine culture results without human intervention",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
4610,PS037,4604,"Developing a mobile application for the delivery of personalised test-guided antibiotic combinations for difficult-to-treat bacterial infections: a user-centered design study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tze-Peng LIM",Singapore
4611,PS037,4604,"Identification of unmet needs for design and procuring digital services to address antimicrobial resistance (AMR) in hospital settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maddalena ILLARIO",Italy
4612,PS037,4604,"Integrating AI into microbiology laboratory automation (MLA) for screening of urine cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lee TAI FEN",China
4613,PS037,4604,"Applying human-centred design (HCD) to develop an assisted microbiological order set: an innovative prototype from Aragon, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Galadriel PELLEJERO-SAGASTIZÁBAL",Spain
4614,PS037,4604,"Using artificial intelligence to integrate dynamic antibiograms and research into electronic medical record systems for enhanced antibiotic decision support",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fredrick MUTISYA",Kenya
4615,PS037,4604,"AI-powered innovations: enhancing accuracy in antibiotic susceptibility testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariska OKKEMA-VAN DER LEI",Netherlands
4616,PS037,4604,"BakRep: a searchable large-scale web repository for bacterial genomes, characterisations and metadata",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver SCHWENGERS",
4617,PS037,4604,"Machine learning for genomic AST prediction in metagenomic data from respiratory clinical samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jason D WITTENBACH","United States"
4618,PS037,4604,"Revolutionising sepsis diagnosis: AI-powered pathogen identification from blood smears",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monika BRZYCHCZY-WLOCH",Poland
4619,PS037,4604,"Evaluation of six large language models answering pre-analytical questions in medical microbiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michelle BRESSAN",Switzerland
4620,PS037,4604,"Performance of Orienter-FA280 automated faeces analyser: preliminary evaluation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Orcun ZORBOZAN",Türkiye
4621,PS037,4604,"Machine learning as a diagnostic tool for intestinal methanogen overgrowth and small intestinal bacterial overgrowth: a new frontier diagnosing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Haseeb TARIQ","United Kingdom"
4622,PS037,4604,"Streamlining MRSA screens and urine cultures with AI-driven automatic release",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gemma STAITE","United Kingdom"
4623,PS037,4604,"Machine learning models incorporating virulence genes and serotype for identifying hypervirulent Klebsiella pneumoniae: a proof of concept study with 569 strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Han YU-LING",China
4624,PS037,4604,"Evaluation of the comercial urine culture application for automated urine culture analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Petrus VAN DER WALT",Canada
4625,PS037,4604,"MicroBIS A novel AI/ML based platform for bacterial and antimicrobial resistance identification and prediction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harry AKLIGOH","United States"
4626,PS037,4604,"Predicted pathogens from blood culture with advanced pre-trained vision transformer models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mei-Hui LEE",China
4627,PS037,4604,"Application of machine learning models for prediction of AMR in Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tochukwu AGBOEZE",Nigeria
4628,PS037,4604,"Assessing the quality and appropriateness of artificial intelligence-generated outputs for sepsis management: a comparative study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sriram RADHAKRISHNAN",India
4629,PS037,4604,"Can artificial intelligence (AI) models be trusted? Determining the variables for building accurate prediction models for antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Neha NITYADARSHINI",India
4630,PS037,4604,"Enhancing antimicrobial prescription accuracy: an integrated evaluation of a clinical decision support system in a private hospital setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucas OLIVEIRA DE MORAIS",Brazil
4631,PS037,4604,"Using machine learning to identify factors associated with blood culture contamination in an Australian medical laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zahraa AL-SULTANI",Australia
4632,PS037,4604,"Artificial intelligence modelling prediction for rapid serotype prediction of Shiga-toxin Escherichia coli by lipid profiling mass spectrometry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tania BLANCO MARTÍN",Spain
4633,PS037,4604,"Machine learning-guided clustering: a new approach for KPC detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valêncio Siqueira ANDRÉ","United States"
4634,PS037,4604,"Fourier-transform infrared spectroscopy (FTIR) as a tool for predicting Group A Streptococcus (GAS) emm-type using a machine learning model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valeria FOX",Italy
4635,PS037,4604,"Digital holographic microscopy: use of AI to enable rapid slide digitisation and interpretation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kenneth SMITH","United States"
4636,PS037,4604,"Artificial intelligence vs clinical scores: evaluating mortality prediction in sepsis patients in a tertiary care hospital South India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roshni MURALI",India
4637,PS037,4604,"Automated species identification of clinically common Aspergillus using artificial intelligence based on colony morphology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jinhan YU",China
4638,PS037,4604,"ShigaMS: an artificial intelligence prediction tool for Shigella spp identification and serotyping from MALDI-TOF MS lipid profiles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert MORENO-MINGORANCE",Spain
4639,PS037,4604,"Integrating artificial intelligence to optimise STI PCR testing decisions: a data-driven approach to enhancing diagnostic microbiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thunyapon PIPATTAWEEPON",Thailand
4640,PS038,NULL,"04k. Other novel diagnostic technologies","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","04. Diagnostic microbiology",NULL,NULL,NULL,NULL
4641,PS038,4640,"Sequencing of bacterial rpoB and 16S rRNA gene amplicons for infectious disease diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanna Malgorzata BIVAND",Norway
4642,PS038,4640,"Ultrafast antibiotic susceptibility testing of 8 multidrug resistant Gramnegative rods with Raman single beam trapping using the Biospex platform",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jürgen HELD",Germany
4643,PS038,4640,"Agnostic sample preparation for bacteria, yeasts and viruses from blood, sputum and saliva",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia DOLEZEL",Austria
4644,PS038,4640,"Catalase-based sputum liquefaction for diagnosing respiratory infections caused by Pseudomonas aeruginosa at the point-of-care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberto DE LA RICA",Spain
4645,PS038,4640,"Rapid, repeatable cell counting of bacteria using cytometric methods and FiSH",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robbie HAINES",Australia
4646,PS038,4640,"Sampling washing machine water to detect scabies (Sarcoptes scabiei)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gregorius Johannes SIPS",Netherlands
4647,PS038,4640,"Ultra-fast pathogen identification in sepsis diagnosis using an optomechanical sensor assisted by artificial intelligence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Blanca CABALLERO",Spain
4648,PS038,4640,"Quartz crystal microbalance as a diagnostic tool for Lyme borreliosis: a proof-of-concept study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sofia SOMAJO",Sweden
4649,PS038,4640,"Neural network prediction of bacterial pneumonia by host transcriptomic analysis of metagenomic data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kelvin TO",China
4650,PS038,4640,"Viability assessment of Neisseria gonorrhoeae in male urine samples by a novel nucleic acid amplification test (NAAT)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sabrina ALBET",France
4651,PS038,4640,"Multicentre evaluation of the pattern single-cell microbiology platform for microorganism identification and antimicrobial susceptibility testing directly from lower respiratory tract specimens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carey-Ann BURNHAM","United States"
4652,PS038,4640,"Improving blood culture interpretation: the role of IR biotyper for S. hominis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco Antonio ROLDÁN RUIZ",Spain
4653,PS038,4640,"Rapid detection of carbapenem-resistant Klebsiella pneumoniae using CRISPR/Cas13a technology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jing HUANG",China
4654,PS038,4640,"PEDOT:PSS OECTs as versatile devices for real-time monitoring of monkeypox virus antiviral assays",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra SCAGLIARINI",Italy
4655,PS038,4640,"Harnessing synthetic nanobodies for characterisation and diagnosis of Staphylococcus aureus infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arpita SAHOO",Switzerland
4656,PS038,4640,"Rapid detection of antimicrobial susceptibility based on holographic imaging system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Li ZHIDONG",China
4657,PS038,4640,"Loop mediated isothermal amplification assay: a reliable tool to detect SNPs in chloroquine resistance genes of Plasmodium falciparum in field settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Davinder KAUR",India
4658,PS038,4640,"Feasibility of microbiology interventions for surveillance of antimicrobial resistance in district level hospitals in Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Huong VU THI LAN",Vietnam
4659,PS038,4640,"Metabolic profiling of Pseudomonas aeruginosa infection in cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rutuja H. PATIL","Czech Republic"
4660,PS038,4640,"A newly developed method for rapidly and accurately detecting the hypervirulent genotype of Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia ROTONDO",Italy
4661,PS038,4640,"Rapid nanopore sequencing as a key diagnostic tool in adrenal histoplasmosis after a year of uncertainty",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ummu Afeera ZAINULABID",Malaysia
4662,PS038,4640,"[13C]CO2 breath testing for detecting and monitoring bacterial infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marina LOPEZ-ALVAREZ","United States"
4663,PS038,4640,"A novel phage-derived receptor binding protein for rapid and specific detection of Escherichia coli O157:H7 and related Shiga toxin-producing strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sílvio SANTOS",Portugal
4664,PS039,NULL,"05a. Drug discovery and new compounds mechanisms of action & spectrum, preclinical data & basic pharmacology (incl drug design, investigational and non-traditional therapeutics)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
4665,PS039,4664,"Metformin attenuates quorum sensing-regulated virulence factors in Pseudomonas aeruginosa: novel aspects of a multifaceted drug",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lavanya KHULLAR",India
4666,PS039,4664,"Metallo-beta-lactamase inhibitor APC148: impact of choice of Mueller-Hinton broth brand on results from antimicrobial susceptibility testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronika SMITH",Norway
4667,PS039,4664,"Activity of bacteriophages targeting Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Regis TOURNEBIZE",France
4668,PS039,4664,"PZ-2645 as a potential agent against biofilm-forming vancomycin-resistant Enterococci (VRE)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karolina KLESIEWICZ",Poland
4669,PS039,4664,"Eco-friendly resveratrol nano-capsules to combat virulence of methicillin-resistant Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael SHEHAT",Egypt
4670,PS039,4664,"A novel class of antibiotics against multidrug-resistant Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raquel Lobato ALMEIDA",Portugal
4671,PS039,4664,"Assessing the therapeutic potential of an apramycin-gallium combination for treating Acinetobacter baumannii lung infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anissa BENKHALED",France
4672,PS039,4664,"Effect of zosurabalpin, a pathogen-focused antibiotic, on the gut microbiome of healthy participants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrej TRAUNER",Switzerland
4673,PS039,4664,"Phage-antibiotic synergy induces genomic restructuring in multidrug-resistant Pseudomonas aeruginosa to mitigate resistance and virulence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang ZHONG",Singapore
4674,PS039,4664,"Enhancing the efficacy of phytic acid as an antimicrobial agent",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maryam AL SHARQI","United Arab Emirates"
4675,PS039,4664,"Kill two strains with one phage: broadening the host range of an Italian Acinetobacter baumannii bacteriophage",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano STRACQUADANIO",Italy
4676,PS039,4664,"Genomic surveillance as a scalable framework for phage therapy against critically resistant bacterial pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balint KINTSES",Hungary
4677,PS039,4664,"Effect of GCurNPs on biofilm formation and quorum sensing genes of Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jyothi EMBEKKAT KAVIYIL",India
4678,PS039,4664,"Potential of phage training to extend the host spectrum of anti-Staphylococcus aureus phages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthieu DEGREZE",France
4679,PS039,4664,"Antibacterial susceptibility testing of bacteriophages against Gram-negative pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paschalis PARANOS",Greece
4680,PS039,4664,"Bacteriophage isolation and characterisation against multidrug-resistant Stenotrophomonas maltophilia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
4681,PS039,4664,"Comparative assessment of interactions between phages and antibacterial agents inhibiting DNA and protein synthesis against Gram-negative clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paschalis PARANOS",Greece
4682,PS039,4664,"Phage heteroresistance in multidrug-resistant Klebsiella pneumoniae clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paschalis PARANOS",Greece
4683,PS039,4664,"Unraveling novel approaches to manage biofilm-associated infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nouha BENTEBBAL","United Arab Emirates"
4684,PS039,4664,"FNDR-20364: a novel topical antibiotic for skin infections caused by Gram-positive bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Naveenkumar C N",India
4685,PS039,4664,"Novel bacteriophage therapy for multi-drug resistant methicillin-resistant Staphylococcus aureus (MRSA) infectious keratitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thet Tun AUNG",Singapore
4686,PS039,4664,"In vitro effectiveness of endodontic triple antibiotic associated with daptomycin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia IORIO",Brazil
4687,PS039,4664,"Wound healing potentials of crude bacteriocins from Lactobacillus rhamnosus and Lactobacillus fermentum  isolated from decaying fruit using albino mice model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Favour Okwukweka NWAJIOBI",Nigeria
4688,PS039,4664,"Evaluation of inhibition of biofilm production after treatment with the combination of phage PSE1720 and meropenem,  in Pseudomonas aeruginosa strains isolated from people with cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia TOCCACIELI",Italy
4689,PS039,4664,"Go big or go home? Efficacy of two- vs three-phage cocktail targeting DNS-MRSA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Callan BLEICK","United States"
4690,PS039,4664,"Beyond the surface: how the transdermal delivery of cannabidiol can unlock new antimicrobial sustained effects",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bianca-Maria TIHAUAN",Romania
4691,PS039,4664,"In vitro activity of cefepime/enmetazobactam and comparators against ESBL and plasmid-AmpC-producing Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne SANTERRE HENRIKSEN",Denmark
4692,PS039,4664,"In vitro efficacy of cefepime/enmetazobactam against AmpC beta-lactamase-producing Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clement MARLAT",France
4693,PS039,4664,"Interplay between sulbactam/durlobactam and imipenem against penicillin-binding proteins (PBPs) of Acinetobacter spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balaji VEERARAGHAVAN",India
4694,PS039,4664,"?????In vitro activity of once-daily, investigational combination, ertapenem/zidebactam (WCK 6777) against cefiderocol non-susceptible E. coli  harbouring NDM and PBP3 insertions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balaji VEERARAGHAVAN",India
4695,PS039,4664,"Impact of Pseudomonas aeruginosa biofilm composition on bacteriophage activity: overcoming barriers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean VAN HELDEN","United States"
4696,PS039,4664,"Monitoring of PHAXIAM's phage spectrum of activity on clinical strains (PST CE-IVD)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rafael GOMES VON BOROWSKI",France
4697,PS039,4664,"Novel 1,3,4-oxadiazole derivatives as promising antibacterial agents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theresa HERMANN",Austria
4698,PS039,4664,"Italian compassionate phage therapy pipeline: in vitro evaluation of bacteriophages to treat an Acinetobacter baumannii prosthetic joint infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caterina FERRETTI",Italy
4699,PS039,4664,"Sustained antimicrobial activities of antibiotic and metal nanoparticles loaded biopolymers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sibel DOSLER",Türkiye
4700,PS039,4664,"Phage therapy and antibiotics combination as the best standard treatment for Klebsiella??????: urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rizka JARIAH","United Kingdom"
4701,PS039,4664,"The anti-virulence and immunomodulatory potential of the peptide oreoch-1 against enteroinvasive E. coli infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna DE FILIPPIS",Italy
4702,PS039,4664,"Inhibition of gene expression by multiple mechanisms using locked-nucleic acid gapmers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angel MAGAÑA","United States"
4703,PS039,4664,"Phage display-derived neutralising monoclonal antibody as possible vaccine against Staphylococcus aureus collagen adhesin CNA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa RESTIVO",Italy
4704,PS039,4664,"New approach for high eradication of multidrug-resistant bacteria by biosynthesised copper oxide nanoparticle ST@CuONPs using Streptomyces thinghirensis sp. nov",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Souad LOQMAN",Morocco
4705,PS039,4664,"Isolation and characterisation of bacteriophages against carbapenemase-resistant strains of Acinetobacter baumannii (CR-Ab)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa D'ALIESIO",Italy
4706,PS039,4664,"Decoding the MIC-permeability relationship in Escherichia coli using advanced statistical machine learning approaches",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefan MILENKOVIC",Italy
4707,PS039,4664,"Bacteriophages against pulmonary infection and colonisation of the gut by multidrug-resistant Klebsiella pneumoniae in murine models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anni-Maria ÖRMÄLÄ-TIZNADO",Sweden
4708,PS039,4664,"Does order of administration matter? Bacteriophage antibiotic combinations against DNS-MRSA isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Callan BLEICK","United States"
4709,PS039,4664,"Bacteriophage EC10P1 re-sensitises multidrug-resistant Escherichia coli 456 to aztreonam/avibactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea GARCÍA NAVARRO",Sweden
4710,PS039,4664,"Influence of outer membrane permeability and KPC amino acid variation on the activity of cefepime/enmetazobactam against KPC-producing Enterobacterales showing ceftazidime/avibactam resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberto RILO-ANTELO",Spain
4711,PS039,4664,"In vitro activity of aztreonam/durlobactam against MbetaL-producing Enterobacterales strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana Carolina RAMOS DA SILVA","United Kingdom"
4712,PS039,4664,"New potential antibacterial agents using natural product extracts against important foodborne pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adriana SILVA",Portugal
4713,PS039,4664,"Novel C5-alpha-substituted carbapenems targeting Mycobacterium abscessus: enhanced peptidoglycan protein binding and reduced BlaMab hydrolysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eunjeong SHIN","United States"
4714,PS039,4664,"Efficacy of solid drug nanoparticles against MRSA: a promising approach to combat AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samantha DONNELLAN","United Kingdom"
4715,PS039,4664,"Activity of cefepime/enmetazobactam in highly resistant Gram-negative bacteria in a tertiary care setting in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia BARTSCH",Germany
4716,PS039,4664,"Multiplicity of infection ratios for determining phage activity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paschalis PARANOS",Greece
4717,PS039,4664,"In vitro activity of a BV500 lead compound against M. abscessus and other NTMs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marija MILJKOVIC",Switzerland
4718,PS039,4664,"Cefepime/zidebactam: a novel beta-lactam-enhancer mechanism based triple action BCH-DBO antibiotic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dilip DUBEY",India
4719,PS039,4664,"Probiotics-loaded electrospun matrices: an innovative approach for enhanced wound healing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oksana GERULIS",Estonia
4720,PS039,4664,"Susceptibility patterns of Pseudomonas aeruginosa isolates exhibiting difficult-to-treat resistance against available and upcoming beta-lactam agents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charalampos MYSTAKELIS","United States"
4721,PS039,4664,"Selection of Pseudomonas aeruginosa phages and improvement of their lytic activity for a therapeutic approach in lung infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara BOLOGNINI",Italy
4722,PS039,4664,"Study of antibacterial activity of aromatic plants extracts on multiresistant bacteria of avian origin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Naouel KLIBI",Tunisia
4723,PS039,4664,"Broad coverage of antibiotic-resistant Klebsiella pneumoniae by multi-specific antibodies against the lipopolysaccharide O-antigen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio DIGIANDOMENICO","United States"
4724,PS039,4664,"In vitro activity of a novel synthetic macrocyclic peptide, BRII-693, against carbapenem-resistant A. baumannii and P. aeruginosa isolates from China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun WU",China
4725,PS039,4664,"Treating infected wounds with plasma-activated water in vivo in mice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katharina RICHTER",Australia
4726,PS039,4664,"Bacteriophage-derived endolysin as a therapeutic protein candidate: in vitro activity, stability, and in vivo efficacy in an MRSA-induced skin wound model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Semra TASDURMAZLI",Türkiye
4727,PS039,4664,"In vitro activity of gepotidacin against baseline uropathogens including drug-resistant phenotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole E. SCANGARELLA-OMAN","United States"
4728,PS039,4664,"Assessment of zosurabalpin activity in combination with other antibiotics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabelle ERBETTI",Italy
4729,PS039,4664,"Antibacterial-bacteriophage interactions: evaluation of E. coli kill kinetics using a combination of meropenem plus an E. coli phage cocktail",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie ATTWOOD","United Kingdom"
4730,PS039,4664,"Synergistic antibacterial activity of SC5005 and DHA against multidrug-resistant Mycobacterium abscessus without detectable resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hao-Chieh CHIU",China
4731,PS039,4664,"Using marine sponge-derived pyrrole-imidazole alkaloids to combat antibiotic resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victoria KLEIN","United States"
4732,PS039,4664,"Identification of antibiotic-producing Pseudomonas guguanensis from seawater in Kuwait",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Khadijah DASHTI",Kuwait
4733,PS039,4664,"Ready-to-eat food samples as sources of promising bacteriophages for the treatment of multidrug-resistant Klebsiellae including ST147-KL64 and the hypervirulent clone ST23-KL57",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isidro GARCÍA-MENIÑO",Germany
4734,PS039,4664,"Effect of cefepime/enmetazobactam (FEP-META) versus ceftazidime/avibactam (CAZ-AVI) in combination with aztreonam (ATM) against clinical isolates resistant to different β-lactamase classes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alina Karoline NUSSBAUMER-PRÖLL",Austria
4735,PS039,4664,"The in vitro activity of aztreonam-avibactam against Enterobacterales isolates positive for metallo-beta-lactamases or serine-carbapenemases by commonly used in vitro diagnostic kits",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark ESTABROOK","United States"
4736,PS039,4664,"Phage tail like bacteriocins or tailocins as antimicrobial agents against Pseudomonas aeruginosa clinical strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clara IBARGUREN  QUILES",Spain
4737,PS039,4664,"Enhanced antimicrobial activity of the novel polymyxin analogue SPR206 compared to colistin against colistin-susceptible and colistin-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michelle OUTEDA GARCÍA",Spain
4738,PS039,4664,"Conjugated oligoelectrolytes: a novel antibiotic platform with activity against nontuberculous mycobacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaixi ZHANG",Singapore
4739,PS039,4664,"Activity of the novel combination therapies cefepime/nacubactam against 12,613 clinical isolates of Enterobacterales collected worldwide during 2021-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephen HAWSER",Switzerland
4740,PS039,4664,"Singlet-oxygen producing BODIPYs for topical treatment of wound infections: an in vitro light activated antibacterial study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kaja TURZANSKA",Ireland
4741,PS039,4664,"Susceptibility of a worldwide collection of 12,613 Enterobacterales isolated during 2021-2023 to the novel combination therapy aztreonam/nacubactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephen HAWSER",Switzerland
4742,PS039,4664,"Cefepime/enmetazobactam as a carbapenem-sparing alternative: activity against extended-spectrum beta-lactamase-producing Enterobacteriaceae, with or without carbapenemases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose GUTIERREZ-FERNANDEZ",Spain
4743,PS039,4664,"In vivo and in vitro activity of durlobactam vs Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samir MOUSSA","United States"
4744,PS039,4664,"In vitro susceptibility studies of several novel antimicrobial drugs against carbapenem-resistant and hypervirulent Klebsiella pneumoniae isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jie ZHANG",China
4745,PS039,4664,"Chemistry centre for combating antibiotic resistant bacteria (CC4CARB)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bruce BLOUGH","United States"
4746,PS039,4664,"Evaluating phage therapy for multidrug-resistant Klebsiella pneumoniae UTI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruxandra CALIN",France
4747,PS039,4664,"Overcoming bacterial defense mechanisms: strategic considerations for effective bacteriophage therapy against Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Soledad RAMIREZ","United States"
4748,PS039,4664,"Enhancing colistin efficacy against multidrug-resistant Klebsiella pneumoniae using farnesol-loaded lipid nanoparticles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Farras Daffa IMTIYAZ",France
4749,PS039,4664,"Efficacy, safety and caecal microbiome analysis of nitroxoline for preventing Salmonella infection in chickens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yuqing ZHOU","United Kingdom"
4750,PS039,4664,"Bacteriophage genome annotation: comparing automatic and manual approaches",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antoine CULOT",France
4751,PS039,4664,"GLP 13-week repeat-dose toxicology studies of MRX-5 in sprague dawley rats and beagle dogs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wen WANG","United States"
4752,PS039,4664,"Benzoxaborole leucyl-tRNA synthetase inhibitor MRX-5: preclinical pharmacokinetics and in vitro drug-drug interaction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wen WANG","United States"
4753,PS039,4664,"N-(4-chlorophenyl)-5-nitro-3-thiophenecarboxamide: a novel, narrow-spectrum antimicrobial agent targeting Helicobacter pylori",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier CASADO",Spain
4754,PS039,4664,"DDD02049209, a lysyl-tRNA synthetase inhibitor, is active against M. avium in vitro",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Haiqing CHU",China
4755,PS039,4664,"The activity of a new bicyclic peptide against colistin-resistant Pseudomonas aeruginosa biofilms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Núria MARTÍN-VILARDELL",Spain
4756,PS039,4664,"Bacteriophages-derived endolysins for next tuberculosis stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Loris RIZZELLO",Italy
4757,PS039,4664,"Dynamics of phage sensitivity in multidrug-resistant and non-resistant Pseudomonas aeruginosa: implications for phage therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Viviane Cássia OLIVEIRA",Spain
4758,PS039,4664,"Structural determinants of inhibitor selectivity towards Enoyl ACP Reductase, FabK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristiana AVAD","United States"
4759,PS039,4664,"Presence of antiphage defense mechanisms in carbapenemase-producing strains isolated from blood cultures in Uruguay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inés BADO",Uruguay
4760,PS039,4664,"A bispecific monoclonal antibody targeting Psl and PcrV enhances bronchiectasis atient neutrophil-mediated killing of Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio DIGIANDOMENICO","United States"
4761,PS039,4664,"Evaluating the efficacy of lytic bacteriophages against multidrug-resistant Enterobacter cloacae strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carl Jay BREGENTE",Philippines
4762,PS039,4664,"Investigating probiotic lactobacilli and their bacteriocin-like inhibitory substances (BLISs) as potential therapeutic agents for vaginal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thuy TRAN THI DIEU",China
4763,PS039,4664,"Antibacterial in vitro activity of the novel epimutilins AR-7731, AR-7732, AR-10058, and AR-9842 against MDR and pre-XDR Mycobacterium tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne PAUKNER",Austria
4764,PS039,4664,"Jumbo bacteriophages demonstrate indirect anti-bacterial effects against carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shuhua THONG",Singapore
4765,PS039,4664,"In vitro anti-bacterial activity of bacteriophages (phages) to guide treatment against refractory Pseudomonas aeruginosa (PAE) infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shuhua THONG",Singapore
4766,PS039,4664,"Olive leaf extract as an antimicrobial agent against Staphylococcus aureus and its resistant strains: in vitro results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam LATORRE-MILLÁN",Spain
4767,PS039,4664,"Universal beta-lactamase coverage and potent antimicrobial activity of xeruborbactam plus meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new beta-lactam/beta-lactamase inhibitor combinations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucía SÁNCHEZ-PEÑA",Spain
4768,PS039,4664,"Impact of bacterial inoculum on the activity of cefepime and cefepime/enmetazobactam against AmpC-hyperproducing Enterobacter spp",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa CIORATA MIHALCEA",Spain
4769,PS039,4664,"Optimising combination antibiotic-phage therapies against MRSA: an interdisciplinary approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alastair CLEMENTS","United Kingdom"
4770,PS039,4664,"Anti-bacterial and anti-inflammatory activity of chitosan nanoparticles as carrier for supernatant of mesenchymal stem cells in a cholera mouse model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saeed SHAMS","Islamic Republic Of"
4771,PS039,4664,"Comprehensive bacteriophage sequencing analysis pipeline empowers insights into host specificity for treating multidrug-resistant Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang ZHONG",Singapore
4772,PS039,4664,"Exploring nanomotion technology for phage therapy: a novel diagnostic tool to combat antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anthony VOCAT",Switzerland
4773,PS039,4664,"Disarming carbapenemase-producing Acinetobacter baumannii: high potency of the novel therapeutic combination of meropenem with the diazabyciclooctane beta-lactamase inhibitor ANT3310",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge ARCA-SUÁREZ",Spain
4774,PS039,4664,"Impact of engineered Mycoplasma pneumoniae on P. aeruginosa biofilms and respiratory microbiota during experimental ventilator-associated pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laia FERNANDEZ-BARAT",Spain
4775,PS039,4664,"Bacteriophage (phage) cocktail resuscitates antibiotics for management of multidrug-resistant Pseudomonas aeruginosa (PAE) infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shuhua THONG",Singapore
4776,PS039,4664,"Immune monitoring by flow cytometry (FCM) in patient undergoing phage therapy (PT).",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jia Hao YEO",Singapore
4777,PS039,4664,"Assessment of antibacterial and wound healing potential of bacteriogenic silver nanoparticles (BSNP) synthesised by Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kunal MADHAV",India
4778,PS039,4664,"Enhancement of mupirocin anti-staphylococcal decolonisation therapy by combination with phages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alena SIVÁKOVÁ","Czech Republic"
4779,PS039,4664,"Antimicrobial activity of zosurabalpin against a diverse collection of aerobic and anaerobic bacterial and yeast isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana CASTANHEIRA","United States"
4780,PS039,4664,"Potent in vitro activity of novel beta-lactam/ beta-lactam enhancer cefepime/zidebactam against K. pneumoniae and P. aeruginosa, enriched with carbapenem resistance collected from four tertiary-care hospitals in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amol SHINDIKAR",India
4781,PS039,4664,"Phage therapy induces colonisation resistance for an OXA-48 Salmonella Kentucky ST198 during in vivo Zoophobas morio larvae gut colonisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia ALDEIA",Switzerland
4782,PS039,4664,"Phage-embedded hydrogel: an emerging personalised therapy for antimicrobial-resistant Staphylococcus aureus skin infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabrice PIROT",France
4783,PS039,4664,"The antimicrobial potential with detailed chemical characterisation of linden honeydew honey from Bosnia and Herzegovina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana BARBARIC","Bosnia And Herzegovina"
4784,PS039,4664,"Biological role of prolyl hydroxylation in Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jabir ALI","United Kingdom"
4785,PS040,NULL,"05b. Pharmacokinetics/pharmacodynamics of antibacterial drugs & therapeutic drug monitoring (incl lab methods, models, in vitro and in vivo studies)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
4786,PS040,4785,"A comparative pharmacodynamic evaluation of epithelial lining fluid exposures of piperacillin/tazobactam achieved by intermittent, extended, and continuous infusion regimens against Pseudomonas aeruginosa clinical isolates in an in vitro hollow-fibre infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yixuan LI",Australia
4787,PS040,4785,"Real-world evidence: cefiderocol therapeutic drug monitoring in critically ill, obese patients in NDM infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia MENEGATTI",Italy
4788,PS040,4785,"A beta-lactam antibiotic dose adaptation feasibility randomised controlled trial utilising therapeutic drug monitoring  (ADAPT-TDM study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rekha PAI MANGALORE",Australia
4789,PS040,4785,"Population target pharmacokinetic/pharmacodynamic attainment rates among cefepime-treated patients admitted to the ICU with hospital-acquired pneumonia with and without ECMO",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adrian VALADEZ","United States"
4790,PS040,4785,"Fosfomycin and ceftazidime/avibactam combination as a possible treatment for blaIMP-4 harbouring Escherichia coli: a hollow fibre infection model evaluation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mikaela WALKER",Australia
4791,PS040,4785,"Piperacillin population pharmacokinetic/pharmacodynamic target attainment with continuous infusion dosing in patients admitted to the ICU with hospital-acquired pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta ZURAWSKA","United States"
4792,PS040,4785,"Do current piperacillin-tazobactam dosing regimens achieve optimal epithelial lining fluid (ELF) concentrations in intensive care unit (ICU) patients with pneumonia?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helmi SULAIMAN",Malaysia
4793,PS040,4785,"Development of a novel complicated urinary tract infection (cUTI) mouse model utilising heamatogenous pyelonephritis in neutropenic thigh-infected mice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander LEPAK","United States"
4794,PS040,4785,"Efficacy of ceftazidime/avibactam against ten clinical isolates of Pseudomonas aeruginosa in peritoneal dialysis fluid",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephanie SUPPARITSCH",Austria
4795,PS040,4785,"A Phase 1, randomised, double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacokinetics (PK) of intravenous ertapenem (ERT) with zidebactam (ZID) in combination (WCK 6777) in healthy adult subjects",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas LODISE","United States"
4796,PS040,4785,"Phage K exposure generates phage K neutralising activity in a rabbit septic arthritis model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastian HERREN","United States"
4797,PS040,4785,"Pharmacokinetics of intrapartum benzylpenicillin: insights into candidate regimens to prevent early onset neonatal Group B Streptococcus disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bonniface OBURA","United Kingdom"
4798,PS040,4785,"Prediction of vancomycin area-under-the-curve using trough concentrations only: performance evaluation of paediatric population pharmacokinetic models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit KOCH",Netherlands
4799,PS040,4785,"Cefepime/enmetazobactam for Gram-negative PJIs? A porcine study evaluating target tissue concentrations following intermittent short-term infusion and continuous infusion of a novel antibiotic combination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Bech Damsgaard NIELSEN",Denmark
4800,PS040,4785,"Phase 1, randomised, double-blind, placebo-controlled, single-dose study to evaluate the pharmacokinetics of cefepime/zidebactam (WCK 5222) in healthy adult Chinese subjects",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk Edwina MULLER",Netherlands
4801,PS040,4785,"Identifying predictors of cefepime pharmacokinetics in bone marrow transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ronaldo MORALES JUNIOR","United States"
4802,PS040,4785,"Sub-MIC exposure linked in vivo pharmacokinetic/pharmacodynamic targets (PDTs) of beta-lactam enhancer zidebactam in presence of cefepime against carbapenem-resistant Acinetobacter baumannii (CRAB)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk Edwina MULLER",Netherlands
4803,PS040,4785,"Pharmacokinetics of vancomycin in patients with methicillin-resistant Staphylococcus aureus (MRSA) infections: a comparison between AUC and trough level monitoring for optimising vancomycin dose",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harivenkatesh NATARAJAN",India
4804,PS040,4785,"Determination of the pharmacodynamic targets of BV100 in the neutropaenic murine thigh infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michel PIEREN",Switzerland
4805,PS040,4785,"Determination of the pharmacodynamic targets of BV100 in the neutropaenic murine lung infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michel PIEREN",Switzerland
4806,PS040,4785,"Induction of Meningeal Inflammation via Intraventricular Lipopolysaccharide Inoculation in a Porcine Model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theis MARIAGER",Denmark
4807,PS040,4785,"Aztreonam/avibactam is more sparing to the gut microbiome than ceftazidime/avibactam with aztreonam in a human in vitro gut model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jane FREEMAN","United Kingdom"
4808,PS040,4785,"Leveraging clinical data to enhance the performance evaluation of ceftriaxone population pharmacokinetic models in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit KOCH",Netherlands
4809,PS040,4785,"Pharmacokinetics and target attainment of teicoplanin: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arnaud DE CLERCQ",Belgium
4810,PS040,4785,"Unraveling phage pharmacodynamics against KPC-5 Pseudomonas in the hollow fiber infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas NGUYEN","United States"
4811,PS040,4785,"Pharmacokinetics and intra-individual variability of multidose oritavancin in real-life use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia MENEGATTI",Italy
4812,PS040,4785,"Dealing with the myth of 40% T>MIC for amoxicillin clavulanate: a hollow-fiber study using clinically relevant concentrations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oscar DELLA PASQUA","United Kingdom"
4813,PS040,4785,"Predicting ciprofloxacin target non-attainment in critically ill patients at treatment initiation: development and external validation of two novel (machine learning) models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andre WIERINGA",Netherlands
4814,PS040,4785,"PK/PD of colistin in combination with bacteriophages against carbapenemase-producing Klebsiella pneumoniae clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paschalis PARANOS",Greece
4815,PS040,4785,"Understanding meropenem disposition in critically ill children: a population PK analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thi Van Anh NGUYEN",Belgium
4816,PS040,4785,"A murine disease model of Pseudomonas aeruginosa lung infection for drug candidate characterisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lynn MIESEL",China
4817,PS040,4785,"Unraveling the bone pharmacokinetics of cefuroxime in periprosthetic joint infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit KOCH",Netherlands
4818,PS040,4785,"Clavulanate pharmacokinetics in severe paediatric community-acquired pneumonia: findings from PediCAP-A and -B",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennie VAN DYK","South Africa"
4819,PS040,4785,"Efficacy of different piperacillin/tazobactam (TZP) - amikacin (AMK) regimens against ESBL Escherichia coli in a hollow fiber infection model (HFIM) simulating sepsis augmented renal clearance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion GIRY",France
4820,PS040,4785,"Effect of augmented renal clearance on in vitro bactericidal activity of cefepime/nemetazobactam against ESBL-producing Escherichia coli evaluated via a mechanism-based modelling",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion GIRY",France
4821,PS040,4785,"Cefiderocol: stability study in elastomeric device at 32°C",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Clara BERARDI",France
4822,PS040,4785,"Population pharmacokinetics and optimised initial dosing of piperacillin in in haematologic patients with febrile neutropenia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia LAPORTE-AMARGOS",Spain
4823,PS040,4785,"Focus on enmetazobactam chemical stability in association with cefepime for prolonged infusions, in syringe and elastomeric diffusers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akim CHAYEM",France
4824,PS040,4785,"Population pharmacokinetic/pharmacodynamic analysis of intravenous temocillin for the treatment of 3rd generation cephalosporin-resistant Escherichia coli bacteraemia (ASTARTE study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando DOCOBO PÉREZ",Spain
4825,PS040,4785,"Evaluation of candidate drugs for repurposing in a Galleria mellonella staphylococcal infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana ANDRADE",Portugal
4826,PS040,4785,"Urinary pharmacodynamic profiling of oral amoxicillin-clavulanate in a bladder infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iain ABBOTT",Australia
4827,PS040,4785,"Intense care medicine-optimised dosing nomograms for beta-lactams administered by continuous infusion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa LEYENBERGER",France
4828,PS040,4785,"Pharmacokinetics and safety of BV100 in epithelial lining fluid and plasma",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentin AL JALALI",Austria
4829,PS040,4785,"External validation of vancomycin population pharmacokinetics models in hospitalised patients with bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo MORRA",Italy
4830,PS040,4785,"Pharmacokinetic/pharmacodynamic target attainment of continuous infusion of ceftazidime and avibactam in plasma and epithelial lining fluid in critically ill patients with nosocomial pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adela BENITEZ-CANO MARTINEZ",Spain
4831,PS040,4785,"Distribution of ampicillin and sulbactam into the cerebrospinal fluid of children and adolescents with brain tumors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentin AL JALALI",Austria
4832,PS040,4785,"A pooled population pharmacokinetic study of intravenous cefuroxime in neonates and infants: renal function dependent underexposure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit KOCH",Netherlands
4833,PS040,4785,"Clinical trial ProVanc evaluating individualised model selection and dosing tool for vancomycin: safety review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanna Kadri LAAS",Estonia
4834,PS040,4785,"Pharmacodynamic target attainment of commercially available fixed-dose daptomycin preparations in hospitalised patients with blood stream infections caused by Staphylococcus aureus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily JAIME","United States"
4835,PS040,4785,"Sex-dependent variability of isoniazid and rifampicin serum levels in patients with tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raja IDRIS",Germany
4836,PS040,4785,"Characterisation of pharmacokinetics/pharmacodynamics for efficacy of CZ-02-833 against Escherichia coli in a one-compartment in vitro infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brian VANSCOY","United States"
4837,PS040,4785,"Antibacterial effect of BV100 plus polymyxin B, at simulated human drug exposures, against Acinetobacter baumannii in an in vitro infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie ATTWOOD","United Kingdom"
4838,PS040,4785,"PKPD modelling of ceftazidime/avibactam and colistin against five KPC-producing Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Romain AUBRY",Sweden
4839,PS040,4785,"Early beta-lactam target attainment in critically ill patients: a three-year retrospective cohort study using therapeutic drug monitoring",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Layios NATHALIE",Belgium
4840,PS040,4785,"Pharmacokinetics of contezolid in plasma and pulmonary epithelial lining fluid of patients with community-acquired pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hailan WU",China
4841,PS040,4785,"Piperacillin in adults 75-year-old and over should be monitored as exposure is two times above the expected levels",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel J.G. THIRION",Canada
4842,PS040,4785,"Clinical, microbiological, and pharmacokinetic/pharmacodynamic (PK/PD) target attainment analyses to support EUCAST aztreonam/avibactam minimum inhibitory concentration (MIC) breakpoints against Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena SOTO","United Kingdom"
4843,PS040,4785,"Development of a murine pneumonia model with methicillin-resistant Staphylococcus aureus (MRSA) to evaluate antibiotic treatments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carina MATIAS",Denmark
4844,PS040,4785,"Penetration of contezolid into bone tissues and body fluids in patients undergoing artificial hip or knee replacement surgery",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hailan WU",China
4845,PS040,4785,"Lessons from a large multi-national database of children: standard paediatric dosing for vancomycin results in unacceptable exposure variability",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc SCHEETZ","United States"
4846,PS040,4785,"Pharmacokinetics/pharmacodynamics of ANT3310, in combination with meropenem, against carbapenem-resistant Enterobacterales using a neutropaenic murine acute pyelonephritis model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brian VANSCOY","United States"
4847,PS040,4785,"Comparing the impact of renal replacement therapy on clarithromycin pharmacokinetic exposure in critically unwell adults using population pharmacokinetic analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reya SHAH","United Kingdom"
4848,PS040,4785,"Amoxicillin blood concentration in high-dose intravenous amoxicillin: look beyond the numbers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Magali VIDAL",France
4849,PS040,4785,"Pharmacokinetic/pharmacodynamic target attainment of cefuroxime in adult patients on general wards with different degrees of renal function: a prospective observational cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saskia Eliena ZIECK",Netherlands
4850,PS040,4785,"Effect of pH on the bacteriostatic and bactericidal activities of delafloxacin against Escherichia coli isogenic strains harboring diverse chromosomal and plasmid-mediated fluoroquinolone resistance mechanisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kévin ALEXANDRE",France
4851,PS040,4785,"Optimisation of cefepime dosing regimen for Pseudomonas aeruginosa infection in Japanese patients using Monte Carlo simulation with pharmacokinetic/pharmacodynamic analysis for efficacy and safety",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yukihiro HAMADA",Japan
4852,PS040,4785,"Pharmacodynamic evaluation of short vs long durations of amikacin combined with meropenem against meropenem-resistant Pseudomonas aeruginosa in hollow fibre infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yalew WALE",Australia
4853,PS040,4785,"Quantification of vancomycin and clindamycin in synovial tissue and bone using ultra-performance liquid chromatography-tandem mass spectrometry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soma HERBERS-BAHMANY",Netherlands
4854,PS040,4785,"Urinary KIM-1 and vancomycin exposure in children with sepsis-induced MODS",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justin SHIAU","United States"
4855,PS040,4785,"Quantification of ceftazidime in vitreous humor using ultra-performance convergence chromatography-tandem mass spectrometry",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soma HERBERS-BAHMANY",Netherlands
4856,PS040,4785,"Ten years of susceptibility testing of linezolid in a tertiary care hospital: model-informed precision dosing as a strategy for rising resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johannes STARP",Germany
4857,PS040,4785,"Effectiveness of meropenem/avibactam combination in suppressing emergence of meropenem-resistant carbapenemase-producing Klebsiella pneumoniae: predictive potential of a pharmacokinetically-based approach to MIC determination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristina SHAPOSHNIKOVA","Russian Federation"
4858,PS040,4785,"Aztreonam combined with avibactam against Klebsiella pneumoniae: a pharmacokinetically-based approach to MIC determination to improve the prediction of efficacy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristina SHAPOSHNIKOVA","Russian Federation"
4859,PS040,4785,"Meropenem levels in critically ill patients on continuous veno-venous hemodiafiltration (CVVHDF): exploration of variables and their influence on dose requirements",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jun Jie TAN",Singapore
4860,PS040,4785,"Clinical evaluation of PK/PD target attainment for meropenem therapy: a retrospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone ZONNENBERG",Netherlands
4861,PS040,4785,"The use of vancomycin with drug trough monitoring in methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis: a retrospective cohort study in Gaza",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathilde BERGHMANS",Belgium
4862,PS040,4785,"Stability of ceftobiprole medocaril in portable elastomeric infusion devices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatriz ESTEBAN-CARTELLE",Spain
4863,PS040,4785,"Population pharmacokinetics and Monte Carlo simulations of ceftriaxone to optimise dosage regimen in patients with sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nattapat SANGKAKUL",Thailand
4864,PS040,4785,"Complementary killing activities of  pbunavirus LS1 and bruynoghevirus LUZ24 phages on planktonic and biofilm of Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cindy FEVRE",France
4865,PS040,4785,"Inadequate linezolid plasma concentrations in critical ill patients with extracorporeal membrane oxygenation (ECMO): results from 53 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joerg STEINMANN",Germany
4866,PS040,4785,"Population pharmacokinetics (PK) of posaconazole in critically ill patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christina KÖNIG",Germany
4867,PS040,4785,"Adjunctive antimicrobial effect of ticagrelor at conventional antiplatelet dosages against methicillin-resistant Staphylococcus aureus in vitro and in vivo models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taeeun KIM","Republic Of"
4868,PS040,4785,"Optimised target recommendations against systemic infections in ICU settings caused by Gram-positive cocci: lessons from a hollow-fibre infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaap MOUTON",Netherlands
4869,PS040,4785,"External evaluation of popPK models for model-informed precision dosing of oral linezolid therapy administered to hospitalised patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonia LEONHARDT",Germany
4870,PS040,4785,"Lateral flow assay innovation for vancomycin: advancing point-of-care therapeutic drug monitoring",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vasin VASIKASIN",Thailand
4871,PS040,4785,"Pharmacodynamic optimisation of temocillin treatment against CTX-M-15-producing K. pneumoniae isolates in a hollow-fiber infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos SAÚCO CARBALLO",Spain
4872,PS040,4785,"Safety and pharmacokinetics of single ascending doses of APC148, a zinc-chelating MBL-inhibitor, in healthy volunteers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bjørg BOLSTAD",Norway
4873,PS040,4785,"Checkerboard coupling PopPK/PD: a rapid optimising solution for drug combination efficacy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yan CHEN",Canada
4874,PS040,4785,"A draft EUCAST rationale for antimicrobial susceptibility testing and treatment of ESBL infections with cefepime/sulbactam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agata SOLTYSINSKA","United Kingdom"
4875,PS040,4785,"Antibacterial effect of zosurabalpin using simulated human doses against carbapenem resistant Acinetobacter baumannii studied in an in vitro model of infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pippa GRIFFIN","United Kingdom"
4876,PS040,4785,"Development of a quantitative lateral flow assay for meropenem: a proof-of-concept study for point-of-care therapeutic drug monitoring",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vasin VASIKASIN",Thailand
4877,PS040,4785,"Determining the appropriateness of standard cefepime dosing in septic paediatric cancer patients: a pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio ARRIETA","United States"
4878,PS040,4785,"Evaluating the clinical impact of targeting lower versus higher serum vancomycin trough: a retrospective study using a desirability of outcome ranking (DOOR) analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zong Heng SHI",Canada
4879,PS040,4785,"Population pharmacokinetic model averaging for a priori dose optimisation of meropenem and piperacillin in intensive care patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiie SOEORG",Estonia
4880,PS040,4785,"Population pharmacokinetics of vancomycin in critically ill adult patients undergoing continuous renal replacement therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Keely MORRIS","United States"
4881,PS040,4785,"Predictive score for selecting patients candidate to linezolid therapeutic drug monitoring and need for dosage individualisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia LUQUE",Spain
4882,PS040,4785,"Pharmacokinetic analysis of ceftazidime/avibactam dosing in patients utilising renal replacement therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Islam GHAZI","United States"
4883,PS041,NULL,"05c. New or repurposed antibacterial agents: Clinical studies and randomised trials","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
4884,PS041,4883,"Clinical, microbiological and laboratory predictors of on- and off-label dalbavancin treatment failure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria MAZZITELLI",Italy
4885,PS041,4883,"Outcomes by MIC values for patients infected with Enterobacterales treated with cefepime/enmetazobactam or piperacillin/tazobactam for complicated urinary tract infections in the phase 3 ALLIUM trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne SANTERRE HENRIKSEN",Denmark
4886,PS041,4883,"Antibacterial compounds against non-growing and intracellular bacteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tanel TENSON",Estonia
4887,PS041,4883,"Microbiological outcome of eradication of cefepime/enmetazobactam vs piperacillin/tazobactam against most common Enterobacterales at test of cure; a posthoc analysis from the ALLIUM Phase 3 trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan Luis QUEVEDO MARIN","United Kingdom"
4888,PS041,4883,"Systematic review of the efficacy and safety of ceftolozane/tazobactam (C/T) for the treatment of complicated intra-abdominal infections (cIAI) and complicated urinary tract infections (cUTI): ZEBRA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre YUCEL","United States"
4889,PS041,4883,"Systematic literature review of efficacy and safety of ceftolozane/tazobactam (C/T) for the treatment of hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP): INSIGHT",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre YUCEL","United States"
4890,PS041,4883,"Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections: A Systematic Literature Review of Clinical Trials: RESOLVE",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre YUCEL","United States"
4891,PS041,4883,"Single-centre real-life experience with imipenem/cilastatin/relebactam use at a tertiary care hospital in Italy, June 2022-November 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michele SPINICCI",Italy
4892,PS041,4883,"Ceftazidime/avibactam plus aztreonam vs cefiderocol in the treatment of infections caused by metallo-beta-lactamase-producing microorganisms: real-world data from the Italian cohort SUSANA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luca MEZZADRI",Italy
4893,PS041,4883,"Bacteriological profile, antimicrobial susceptibility, and treatment outcomes of multidrug-resistant Gram-negative infections using a novel antibiotic combination ceftriaxone/sulbactam+EDTA",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Haritha MADIGUBBA",India
4894,PS041,4883,"Ceftaroline for the treatment of Staphylococcus aureus infections: a systematic review with Bayesian meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eugenia MAGRINI",Italy
4895,PS041,4883,"Bacteriophage therapy: an effective approach against multidrug-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pooja SACHDEVA",India
4896,PS041,4883,"Comparison of meropenem/vaborbactam vs ceftazidime/avibactam in the treatment of KPC-producing Klebsiella pneumoniae infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo FALTONI",Italy
4897,PS041,4883,"Rifabutin exerts potent intracellular and biofilm eradication activity against Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marija MILJKOVIC",Switzerland
4898,PS041,4883,"Real-world vs trial populations. a comparison between the clinical characteristics and outcome of the REACT-MDR and five pathogen-focused randomised clinical trials populations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriele Maria LEANZA",Italy
4899,PS041,4883,"Colistin prescribing and outcomes in Kuwait public hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah ALGHANEM",Kuwait
4900,PS041,4883,"Evidence of reinfection and no emergence of resistance following a single oral 3g dose of zoliflodacin demonstrated by whole-genome sequencing (WGS) in a global Phase 3 randomised controlled trial (RCT) for treatment of uncomplicated gonorrhoea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Magnus UNEMO",Sweden
4901,PS041,4883,"Polycationic PEI-based nanoparticles enhance antimicrobial delivery against multidrug-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Krit THIRAPANMETHEE",Thailand
4902,PS041,4883,"A Phase 1, randomised, double-blind, first-in-human, dose-escalation study investigating the safety, recovery, and pharmacodynamics of a novel CRISPR-Cas therapeutic (SNIPR001)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jonas HINK",Denmark
4903,PS041,4883,"Gepotidacin and nitrofurantoin efficacy by baseline uropathogen drug-resistant phenotypes recovered from EAGLE-2/EAGLE-3 clinical trials for uncomplicated urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicole E. SCANGARELLA-OMAN","United States"
4904,PS041,4883,"Impact of hypoalbuminemia on outcomes of ertapenem",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lauren FORTIER","United States"
4905,PS041,4883,"Efficacy and safety of monoclonal antibodies for prevention and treatment of multidrug-resistant organisms' infections: a scoping review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emanuele PALOMBA",Italy
4906,PS041,4883,"Studies in vitro and in vivo of phage therapy medical products (PTMPs) targeting clinical strains of Klebsiella pneumoniae belonging to the clone ST512",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines Maria BLERIOT RIAL",Spain
4907,PS041,4883,"Reviving old drugs: targeting FliN of uropathogenic Escherichia coli to treat urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harpreet KAUR",India
4908,PS041,4883,"Cefiderocol treatment in patients with Gram-negative bacterial infections: European results of the global retrospective observational PROVE study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano VERARDI","United Kingdom"
4909,PS041,4883,"Design of a Phase 3b, open-label, single-arm study evaluating clinical symptom improvement with gepotidacin in participants with uncomplicated urinary tract infection (uUTI)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jazmin DIAZ-REGAÑON",Spain
4910,PS041,4883,"Preliminary zosurabalpin (5µg) disk diffusion quality control ranges using clinical and laboratory standards institute M23 criteria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael HUBAND","United States"
4911,PS041,4883,"Preliminary findings from a systematic literature review: bactericidal research on multi-drug resistant Pseudomonas aeruginosa (MDR-PsA) infections of Gram-negative using high-level therapeutics (BRIGHT)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emre YUCEL","United States"
4912,PS041,4883,"Off-label use of oritavancin: a case series on clinical efficacy, bed day savings, and cost benefits",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amani PATEL","United Kingdom"
4913,PS041,4883,"Clinical application of customised and non-customised bacteriophage therapy in patients with persistent and difficult-to-treat bacterial infections: systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang LIU",Singapore
4914,PS041,4883,"Real-life experience with cefiderocol treatment of multidrug-resistant Gram-negative infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriela ABELENDA-ALONSO",Spain
4915,PS041,4883,"Efficacy of aztreonam/avibactam, ceftazidime-avibactam, and cefiderocol against multidrug-resistant and putative-hypervirulent Klebsiella pneumoniae isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernd NEUMANN",Germany
4916,PS041,4883,"Efficacy and safety of oral nafithromycin as a three- and five-day treatment regimen compared with moxifloxacin in adult patients with community-acquired bacterial pneumonia (CABP): a global Phase 2 randomised trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anouk Edwina MULLER",Netherlands
4917,PS041,4883,"Ganfeborole in combination with novel antitubercular agent BTZ-043 administered for 14-days to participants with rifampicin-susceptible pulmonary tuberculosis: interim analysis results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon TIBERI","United Kingdom"
4918,PS041,4883,"Real-world, multicentre experience with ceftazidime/avibactam in the paediatric population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taylor MORRISETTE","United States"
4919,PS041,4883,"Three-year retrospective analysis of the use of cefiderocol in a Spanish tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nuria TORMO",Spain
4920,PS042,NULL,"05d. Antimicrobial stewardship and prescribing?(incl interventions, monitoring, impact, decision-support/prediction tools, behavioural aspects)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
4921,PS042,4920,"In vitro susceptibility of NDM-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae to cefepime/zidebactam from a tertiary-care cancer hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gaurav SALUNKE",India
4922,PS042,4920,"Impact of pharmacist-led interventions on antibiotic management in critical care: a prospective observational study of culture-guided therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ammar MOHAMED MOHIDEEN",India
4923,PS042,4920,"Antimicrobial stewardship implementation in a Philippine tertiary hospital: a seven-year surveillance of surgical prophylaxis prescribing practices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gina DE GUZMAN BETITO",Philippines
4924,PS042,4920,"Where do physicians look for information on antibiotics and antimicrobial resistance? Challenges in keeping up to date, Germany 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne Barbara SCHINK",Germany
4925,PS042,4920,"Evaluation of a broad-spectrum antibiotic monitoring tool across a large academic hospital system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalie TUCKER","United States"
4926,PS042,4920,"Building a foundation of a functioning microbiology diagnostic service in Kilifi county referral hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica GENTRY","United Kingdom"
4927,PS042,4920,"Reduction of carbapenem prescribing inappropriateness: an antimicrobial stewardship intervention through post-prescription review with feedback",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessia FRATER",Italy
4928,PS042,4920,"Successful implementation and evaluation of challenges for an antimicrobial stewardship programme at a university hospital emergency department",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ieva VOITA",Latvia
4929,PS042,4920,"The role of early appropriate antibiotic treatment in febrile neutropaenia: identifying targets for antimicrobial stewardship interventions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca SCARDELLATO",Italy
4930,PS042,4920,"Point prevalence survey of antibiotic use in hospitals in northern Lesotho",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nikita SASS",Switzerland
4931,PS042,4920,"Joint expertise, smarter antibiotics: a collaborative approach to improving orthopaedic surgical antibiotic prophylaxis in a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia KILFOYLE",Australia
4932,PS042,4920,"2024 assessment of Belgium's national antimicrobial stewardship core elements: progress and areas for improvement",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucy CATTEAU",Belgium
4933,PS042,4920,"Hospital antimicrobial prescribing in Belgium: linking reimbursement data with clinical context",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie DOMEN",Belgium
4934,PS042,4920,"Towards tailored perioperative antibiotic prophylaxis: a multicentre pre-intervention analysis in the H2020 REVERSE project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena CARRARA",Italy
4935,PS042,4920,"Need for speed: earlier targeted treatment with BCID2 panel, report from an Indian ICU",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Umang AGRAWAL",India
4936,PS042,4920,"From overuse to optimised use: reducing fluoroquinolone prescribing through targeted antimicrobial stewardship interventions in tertiary care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgit UNTERKOEFLER",Austria
4937,PS042,4920,"Attitudes towards anticipated antibiotic resistance development varies by medical specialty, physician's gender, number of prescriptions, and years in practice, Germany 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Susanne Barbara SCHINK",Germany
4938,PS042,4920,"The challenge of preserving reserve antimicrobials in acute surgical wards",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melwin Kyle SOLIS",Ireland
4939,PS042,4920,"Clinical outcomes in gentamicin prescribing and monitoring in United Kingdom hospitals (CO-GENT): national audit, service evaluation and rates of AKI with pre-dose vs nomogram monitoring",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raqib HUQ","United Kingdom"
4940,PS042,4920,"Feasibility and cost-saving potential of outpatient antimicrobial therapy using elastomeric pumps in bone marrow transplant patients: a single-centre study in a tertiary care setting in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ritika Kondel BHANDARI",India
4941,PS042,4920,"Inappropriate antibiotic prescriptions for cystitis in primary care in the Republic of Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hey Jin KO","Republic Of"
4942,PS042,4920,"Changes in antibiotic use in South Korea from 2016 to 2023: using health insurance claim data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yujeong KIM","Republic Of"
4943,PS042,4920,"Implementation of a multi-modal One Health training programme for antimicrobial stewardship in the Asia Pacific region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rod JAMES",Australia
4944,PS042,4920,"Post-prescription review of carbapenem-based therapies and occurrence of Clostridioides difficile infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco PERACCHI",Italy
4945,PS042,4920,"Nationwide analysis of antimicrobial prescription in Korean hospitals between 2018 and 2022: the 2024 KONAS report",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kim YONG CHAN","Republic Of"
4946,PS042,4920,"Cost savings from outpatient parenteral antimicrobial therapy programme: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Solomon Ahmed MOHAMMED",Australia
4947,PS042,4920,"Antibiotic use in outpatient departments of general hospitals in Vietnam and the opportunities for outreach interventions to improve patient and community knowledge and practices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hai Yen NGUYEN",Vietnam
4948,PS042,4920,"Antimicrobial photodynamic therapy against a mixed biofilm composed of a cariogenic microbial consortium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia IORIO",Brazil
4949,PS042,4920,"An international multi-centre survey of antimicrobial use in outpatient parenteral antimicrobial therapy (OPAT) or hospital-in-the-home (HITH) programmes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zenaw WOLIE",Australia
4950,PS042,4920,"The global point prevalence survey (Global-PPS): quality indicators for antimicrobial use for adult patients in the Philippines, 2017-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jemelyn GARCIA",Philippines
4951,PS042,4920,"Antimicrobial stewardship ward rounds: a strategy to reduce ICU antibiotic use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pietro VITALE",Italy
4952,PS042,4920,"Comparability of outcomes in antimicrobial stewardship research",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria NUNEZ-NUNEZ",Spain
4953,PS042,4920,"Reinventing the antimicrobial stewardship wheel: specialist-led prospective meropenem prescription review and targeted prescriber's feedback",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer BRITTON",Ireland
4954,PS042,4920,"Investigating the prevalence of statin co-prescription with known interacting antimicrobials and compliance with necessary intra-therapy biochemical monitoring in Beaumont hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melwin Kyle SOLIS",Ireland
4955,PS042,4920,"Impact of a regional antimicrobial stewardship intervention on enhancing antimicrobial appropriateness in E. coli bacteraemia treatment management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esther CALBO",Spain
4956,PS042,4920,"Comprehensive assessment of antimicrobial use through yearly point prevalence surveys, 2012-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lina Marcela PARRA",Spain
4957,PS042,4920,"Implementation of antimicrobial consumption dashboard: a data-driven approach at university hospitals of Birmingham, United Kingdom",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nirlep AGRAVEDI","United Kingdom"
4958,PS042,4920,"Evaluating the impact of a multifaceted antimicrobial stewardship intervention on age and gender inequity in antibiotic utilisation at a tertiary care centre in Karachi, Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nosheen NASIR",Pakistan
4959,PS042,4920,"Impact of an antimicrobial stewardship intervention in residential aged care: a multicentre, stepped-wedge cluster randomised trial (START trial)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natali JOKANOVIC",Australia
4960,PS042,4920,"Appropriateness of antibiotic access and use practices at the community level in eastern Ethiopia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dumessa EDESSA",Ethiopia
4961,PS042,4920,"Aragon regional bacteraemia surveillance & stewardship (ARBASS) system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Ramon PANO-PARDO",Spain
4962,PS042,4920,"Utilising technology to strengthen and inform antimicrobial stewardship strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Uforma OGRIGRI","United Kingdom"
4963,PS042,4920,"Enhancing outpatient antimicrobial stewardship: the integral role of infection control nurses",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio CÁRDENAS",Spain
4964,PS042,4920,"The role of dedicated infectious disease consultant within an antimicrobial stewardship programme: towards a better patients' CARE (deIDcare)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristiana LEANZA",Italy
4965,PS042,4920,"Short- versus long-course antibiotic durations for uncomplicated infections in solid tumor patients receiving care in ambulatory oncology clinics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christen ARENA","United States"
4966,PS042,4920,"What are the factors associated with inappropriate antibiotic prescription in UTIs with a high prevalence of MDR pathogens?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco MUSSA",Italy
4967,PS042,4920,"Antibiotic consumption patterns of selected narrow- and broadspectrum antibiotics in German acute care hospitals from 2017 to 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Birgitta SCHWEICKERT",Germany
4968,PS042,4920,"Three-year experience of antimicrobial stewardship in a tertiary care hospital in Pakistan: successes and challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Quratulain SHAIKH",Pakistan
4969,PS042,4920,"Analysis of antibiotic prescription trends in Tunisian tertiary hospitals based on the WHO AWaRe framework",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ahmed TRIGUI",Tunisia
4970,PS042,4920,"What indicators are used to estimate or measure appropriateness of antibiotic prescribing in high-income countries: a rapid systematic review protocol and initial findings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rachel BERRY","United Kingdom"
4971,PS042,4920,"Antimicrobial stewardship in practice: designing interventions to improve surgical prophylaxis practices in a Rwandan university hospital, a mixed methods study using the behaviour change wheel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caroline THEUNISSEN",Belgium
4972,PS042,4920,"Impact of penicillin allergy label (PAL) on fluoroquinolone prescriptions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bee Yean NG","United Kingdom"
4973,PS042,4920,"Prolonged carbapenem use in the context of a dedicated antimicrobial stewardship programme: a sub-analysis of the CASAS (CArbapenem Sparing Antimicrobial Stewardship) project",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paola BELLINI",Switzerland
4974,PS042,4920,"Dalbavancin in OPAT: a retrospective review of NHS greater Glasgow and Clyde experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Awilly CHOFLE","United Kingdom"
4975,PS042,4920,"Successful implementation of surgical antibiotic prophylaxis (SAP) in ten hospitals of Georgia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marika TSERETELI",Georgia
4976,PS042,4920,"The impact of β-lactam allergy labels on antibiotics guideline adherence",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco BONGIOVANNI",Switzerland
4977,PS042,4920,"Remote stewardship, local impact: a case study assessing effectiveness of tele-stewardship on establishing antimicrobial stewardship programmes in Kenya",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evelyn Nelima WESANGULA","United Republic Of"
4978,PS042,4920,"Point-of-care detection of carbapenemase-producing Enterobacterales and antimicrobial stewardship interventions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Leonor SANTOS",Portugal
4979,PS042,4920,"The impact of prospective pharmacist-led fluroquinolone review on fluoroquinolone consumption",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bee Yean NG","United Kingdom"
4980,PS042,4920,"Impact of the implementation of an antimicrobial stewardship programme (ASP) in a haematologic ward of a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina BELTRAMI",Italy
4981,PS042,4920,"Battling the sepsis clock using BIOFIRE BCID2 Panel: a pre-post intervention audit of time to active antibiotic therapy in an Indian ICU",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sayli GORE",India
4982,PS042,4920,"Comparative clinical care with use of two rapid susceptibility testing techniques: BLT (2021) and MIC-RAST (2023) in Gram-negative bacilli bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mélanie KERANFLEC'H",France
4983,PS042,4920,"Enhancing nursing roles in antimicrobial stewardship: a clinical simulation-based training programme for ICU",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wanda CORNISTEIN",Argentina
4984,PS042,4920,"The impact of antimicrobial stewardship ward rounds on antimicrobial use and predictors of advice, uptake, and outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bee Yean NG","United Kingdom"
4985,PS042,4920,"Strategies adopted for the implementation of clinical decision support systems for antimicrobial stewardship in hospital settings: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathan PEIFFER-SMADJA",France
4986,PS042,4920,"Pharmacist's perspective of antimicrobial stewardship programmes at primary care setting in San Paulo",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maura OLIVEIRA",Brazil
4987,PS042,4920,"Third-day AMS interventions in a medical ward: implementation and results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joana BATISTA",Portugal
4988,PS042,4920,"Availability and quality of selected essential antibiotics circulating in Bangladesh: a cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matin MD ABDUL",Bangladesh
4989,PS042,4920,"Model-based evaluation of an optimised meropenem dosing strategy for critically ill patients with preserved or augmented renal clearance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nada DIA",Belgium
4990,PS042,4920,"Global antibiotic usage in humans, 2018-2021: an updated spatial modelling study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frederick FELL","United Kingdom"
4991,PS042,4920,"Impact of an Antimicrobial Stewardship Bundle on the outcome of high-risk neutropenic patients with fever; a pre-post study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suzanne KUIJPERS",Netherlands
4992,PS042,4920,"Training future antimicrobial stewards in the ESCMID AMS certificate training programme: from knowledge to action",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suzanne KUIJPERS",Netherlands
4993,PS042,4920,"Impact of an intervention aimed at nursing staff on antibiotic use for nursing home residents with common infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carl LLOR",Spain
4994,PS042,4920,""Squeezing the balloon": impact of preauthorisation of broad-spectrum antimicrobials on DASC and antimicrobial usage patterns",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Toshibumi TANIGUCHI",Japan
4995,PS042,4920,"Impact of hospital relocation and antibiotic consumption on the incidence of multidrug-resistant microorganisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca Rowena PEÑA-ZALBIDEA",Spain
4996,PS042,4920,"Analysis of antibiotic prescriptions preceding carbapenem-resistant Enterobacterales infections: opportunities for antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sock Hoon TAN",Singapore
4997,PS042,4920,"Using PEN-FAST score to guide prescription of alternative beta-lactam in penicillin-allergic patients by non-allergists",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sock Hoon TAN",Singapore
4998,PS042,4920,"Pharmacist led cephalosporin drug challenge programme in inpatients with low risk penicillin allergy: an assessment of physician acceptance and outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junhao, Ray LIN",Singapore
4999,PS042,4920,"Antibiotic prescribing for common acute infections in Indonesia: an analysis using IQVIA prescriber healthcare surveys",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nam NGUYEN","United Kingdom"
5000,PS042,4920,"Benchmarking hospital antibiotic use in ten countries: comparing observed versus expected empiric use based on the WHO AWaRe antibiotic book",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Myo Maung Maung SWE","United Kingdom"
5001,PS042,4920,"Hospital multidisciplinary antimicrobial stewardship on clinical and economic impact of critical blood culture-positive patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Minhua CHEN",China
5002,PS042,4920,"Antibiotic prescribing patterns by age and sex in English primary care: how it varies and why is it important for AMR?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gwen KNIGHT","United Kingdom"
5003,PS042,4920,"Impact of mobile health applications in the implementation of antimicrobial stewardship programme among healthcare professionals: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ng RONG XIANG",Malaysia
5004,PS042,4920,"Leveraging outpatient antibiotic use data to shape targeted stewardship interventions in Switzerland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tamara HABEGGER",Switzerland
5005,PS042,4920,"A comparative study of AI-generated vs pharmacist-generated prescription recommendations in south Indian pharmacies: a multicentre cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suhail Hassan JALAL",India
5006,PS042,4920,"Assessment of physicians' knowledge and attitudes towards antibiotic prescription practices and antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helmi ERNANDES",Tunisia
5007,PS042,4920,"Retrospective analysis of antibiotic consumption patterns in defined daily dose among primary MSF settings in north-west Syria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carine NAIM",Lebanon
5008,PS042,4920,"Antimicrobial point prevalence survey (PPS) made easy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raghu MAMULLAPALLY","United Kingdom"
5009,PS042,4920,""They've got other fish to fry": illuminating why surgeons don't prioritise antimicrobial stewardship, and strategies for change",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hazel PARKER","United Kingdom"
5010,PS042,4920,"Leveraging a simple tool for sustaining antimicrobial stewardship: a prospective audit and feedback initiative at a tertiary care centre in western India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sayli GORE",India
5011,PS042,4920,"Watch the piperacillin! Raising awareness and reducing the use of piperacillin/tazobactam in a U.K. district general hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean O'DRISCOLL","United Kingdom"
5012,PS042,4920,"Cost-consequence analysis of diagnostic strategies for community-acquired pneumonia in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lopamudra DAS","United States"
5013,PS042,4920,"The carbapenem sparing antimicrobial stewardship (CASAS) project: an innovative approach to reduce carbapenem consumption in low-users hospital settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco BONGIOVANNI",Switzerland
5014,PS042,4920,"Effectiveness of oral step-down therapy and early oral switch for bloodstream infections caused by Enterobacterales: a post hoc emulation trial of the SIMPLIFY randomised trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emanuele RANDO",Italy
5015,PS042,4920,"Fluoroquinolones, UK advisories, local guidelines: compliance and consideration of prescribing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivia BARTON-EVANS","United Kingdom"
5016,PS042,4920,"The impact of a multidisciplinary team featuring a clinical pharmacist on adherence to recommended antimicrobial therapy in neurosurgical units in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kittiya JANTARATHANEEWAT",Thailand
5017,PS042,4920,"Unveiling the DOOR for optimising antimicrobial stewardship in Escherichia coli and Klebsiella pneumoniae bloodstream infections in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sriram RADHAKRISHNAN",India
5018,PS042,4920,"We removed all urine dipstick tests from our regional hospital in north Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shakil A. SHAKAR",Denmark
5019,PS042,4920,"Effect of including infectious disease experts in the primary care antibiotic stewardship team on prescribing for upper respiratory tract infections: the IDASP study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evelyn SHAW PERUJO",Spain
5020,PS042,4920,"The French society for infectious diseases top-five list of recommendations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathan PEIFFER-SMADJA",France
5021,PS042,4920,"Large language model-based chatbot to promote prudent antibiotic use among patients: a mixed-methods usability study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ermira TARTARI",Malta
5022,PS042,4920,"Analysis of antibiotic prescriptions preceding Clostridioides difficile infection: opportunities for antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sock Hoon TAN",Singapore
5023,PS042,4920,"All you need is... a team! A successful antimicrobial stewardship programme in an ICU in a low middle income country (LMIC)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea Paola CASSATA",Argentina
5024,PS042,4920,"Outpatient point prevalence survey on antimicrobial use at a district hospital in Ghana using the global PPS outpatient protocol",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Obed Kwabena Offe AMPONSAH",Ghana
5025,PS042,4920,"Effectiveness of clinical decision support system use for antibiotic stewardship in primary care: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Racha IBRAHIM",France
5026,PS042,4920,"Reducing fluoroquinolone prescribing in high-risk patients to minimise toxicities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephen HUGHES","United Kingdom"
5027,PS042,4920,"Impact of early patient engagement on the outcome of their antimicrobial 48-72 hour review: an interrupted time-series intervention study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephen HUGHES","United Kingdom"
5028,PS042,4920,"Comparison of surveillance methodologies of respiratory tract infections and antibiotic prescribing in primary care practices in Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aislinn COOK","United Kingdom"
5029,PS042,4920,"AWaRe antibiotic prescribing in outpatient clinics at JU hospital: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amal AL-BAKRI",Jordan
5030,PS042,4920,"Impact of an outpatient parenteral antimicrobial therapy stewardship programme in a hospital at home unit",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ainhoa VIVERO",Spain
5031,PS042,4920,"Software to support antimicrobial stewardship programme: scoping review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria NUNEZ-NUNEZ",Spain
5032,PS042,4920,"Quality and reporting of antimicrobial treatment guidelines in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria NUNEZ-NUNEZ",Spain
5033,PS042,4920,"Limited evidence of regulatory approval of oral AWaRe antibiotics not included in the WHO Essential Medicines List: the Grey Group",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shrey MATHUR","United Kingdom"
5034,PS042,4920,"Monocyte distribution width (MDW): a biomarker to discriminate infectious from central fever in brain injury",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonella FRATTARI",Italy
5035,PS042,4920,"Antimicrobial use in a tertiary care hospital in a lower middle-income country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kushlani JAYATILLEKE","Sri Lanka"
5036,PS042,4920,"Reducing inappropriate fluoroquinolone prescribing in England in 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Philip HOWARD","United Kingdom"
5037,PS042,4920,"Impact of a multistep antimicrobial stewardship intervention in cephalosporins prescription for community acquired pneumonia: an interrupted time series analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raquel DURO",Portugal
5038,PS042,4920,"Changes in human antimicrobial consumption in 21 European countries between 2018 and 2021",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tilleye RUNGHIEN","United Kingdom"
5039,PS042,4920,"Antibiotic spectrum scores to evaluate antimicrobial stewardship programmes: where are we?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatrice BARDA",Switzerland
5040,PS042,4920,"A standardised approach for measuring outpatient antimicrobial use data: development and evaluation of the outpatient global point prevalence survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annelies BOVEN",Netherlands
5041,PS042,4920,"Penicillin allergy delabeling in a German university hospital: implementation in inpatient settings (PENGUIN-study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hannah NÜRNBERG",Germany
5042,PS042,4920,"Out-patient penicillin allergy de-labelling is safe, acceptable, and effective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucy TUNN","United Kingdom"
5043,PS042,4920,"Outcomes of implementation of a multidimensional antimicrobial stewardship programme in a medical ward of a third-level university hospital in northern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria MAZZITELLI",Italy
5044,PS042,4920,"A step towards rational antibiotic use: impact of a multicentre interventional study in ten German non-university hospitals on antimicrobial use, costs and patient outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gesche FÖRST",Germany
5045,PS042,4920,"Antibiotic prescribing practices among Belgian dentists: 2017-2021",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Moira KELLY",Belgium
5046,PS042,4920,"Priorities for updating the World Health Organisation AWaRe antibiotic book",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deborah TONG",Switzerland
5047,PS042,4920,"Quality of care, in-hospital mortality and length of hospital stay for community acquired pneumonia in German non-university hospitals before and after an antimicrobial stewardship and infectious diseases specialist intervention",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roland GIESEN",Germany
5048,PS042,4920,"Model-informed precision dosing of vancomycin in critically ill patients infected with Gram-positive organisms: a multi-centre cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xi LIN",China
5049,PS042,4920,"Antibiotic and diagnostic stewardship programms in low and lower-middle-income countries: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emelyne GRES",Italy
5050,PS042,4920,"Identifying predictors for antibiotic use: a global point prevalence survey study among 130 hospitals in Belgium, the Philippines and South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annelies BOVEN",Netherlands
5051,PS042,4920,"Socio-demographic patterns in outpatient antibiotic use in Belgium (2019-2023)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena DAMIAN",Belgium
5052,PS042,4920,"Multicentre outpatient monitoring of long-term co-trimoxazole treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niamh SPENCE","United Kingdom"
5053,PS042,4920,"Number of emails sent correlated with implementation metrics in a national antimicrobial stewardship programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Barbara TRAUTNER","United States"
5054,PS042,4920,"First-line antibiotic usage used in clinically diagnosed cases of neonatal sepsis in secondary and tertiary healthcare centres in Pakistan, Bangladesh and Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathryn THOMSON","United Kingdom"
5055,PS043,NULL,"05e. Safety, hypersensitivity and adverse effects of treatment","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
5056,PS043,5055,"Penicillin allergy de labelling: a whole system approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heather KENNEDY","United Kingdom"
5057,PS043,5055,"Reduction of vancomycin-associated nephrotoxicity with zileuton",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cole HUDSON","United States"
5058,PS043,5055,"Assessing the skin sensitisation potential of common antiseptics using a novel in vitro bioassay developed for medical devices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karin RIEDL",Austria
5059,PS043,5055,"Adverse effects of long-term use of the oxazolidinones tedizolid and linezolid: a retrospective matched-cohort analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan HAHN","United States"
5060,PS043,5055,"Detection of early acute kidney injury with urinary metabolomics in a high-dose vancomycin rat model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justin SHIAU","United States"
5061,PS043,5055,"An evaluation of the myelosuppressive effects of co-trimoxazole: a single centre observational review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aneeka CHAVDA","United Kingdom"
5062,PS043,5055,"Ceftibuten/ledaborbactam etzadroxil in participants with varying degrees of renal function",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul MCGOVERN","United States"
5063,PS043,5055,"Promising efficacy of oral nano-silymarin formulation on prevention of vancomycin induced nephrotoxicity: a randomised, triple-blinded, placebo-controlled clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sepideh ELYASI","Islamic Republic Of"
5064,PS043,5055,"Safety reporting in neonatal antibiotic trials: lessons from NeoSep1",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Louise F HILL","United Kingdom"
5065,PS044,NULL,"05f. Pharmacoepidemiology/pharmacoeconomics (incl cost-effectiveness, modelling, data tools)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","05. New antibacterial agents, PK/PD & Stewardship",NULL,NULL,NULL,NULL
5066,PS044,5065,"Counting the pennies: calculating the cost of ancillaries in IV antibiotic administration",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Syed Anas Daud GILANI","United Kingdom"
5067,PS044,5065,"Cost to families for severe community-acquired childhood pneumonia treatment with oral amoxicillin or co-amoxiclav vs IV-only antibiotic treatment in five sub-Saharan African countries: an economic analysis of the PediCAP randomised controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gillian LEVINE",Switzerland
5068,PS044,5065,"Cost-effectiveness analysis of dalbavancin in an acute district hospital in UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice LIU","United Kingdom"
5069,PS044,5065,"Using the STEDI AMR value framework to estimate the clinical and economic value of aztreonam/avibactam in treating metallo-beta-lactamase-producing Enterobacterales infections in Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alfonso DE LOSSADA JUSTE",Spain
5070,PS044,5065,"Sweden's partially de-linked reimbursement model for new antibiotics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anders TERNHAG",Sweden
5071,PS044,5065,"Cefotaxime vs ceftriaxone: current practices in Paris hospitals and new considerations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Etienne RAPHAËL",France
5072,PS044,5065,"What is the cost of antibiotic prescriptions if the costs of antibiotic resistant infections are considered?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephanie EVANS","United Kingdom"
5073,PS045,NULL,"06a. Fundamental mycology (incl in vitro and in vivo studies, pathogenesis, virulence, mycobiome)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","06. Fungal infection & disease",NULL,NULL,NULL,NULL
5074,PS045,5073,"Unveiling the skin mycobiome: fungal diversity in intensive care patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teresa NASCIMENTO",Portugal
5075,PS045,5073,"Integrative transcriptome profiling and flow cytometric analysis of Th1/Th17 cell dynamics in chronic dermatophytosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gargi RAI",India
5076,PS045,5073,"Impact of loss of heterozygosity in diploid fungi on outbreak detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bram SPRUIJTENBURG",Netherlands
5077,PS045,5073,"Planktonic and sessile Candida albicans cells release extracellular vesicles carrying the virulence factor Eno1p",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia ANCONA",Italy
5078,PS045,5073,"In vitro evaluation of thermal stress on the biofilm formation by a neurotropic fungus, Cladophialophora bantiana",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Haseen AHMAD",India
5079,PS045,5073,"The influence of biofilm forming abilities and fluconazole trailing effect of clinical candida albicans isolates on the outcomes of children with Candida bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ming Horng TSAI",China
5080,PS045,5073,"Longitudinal analysis of the mycobiome in acute leukaemia using metagenomic long-read sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas TAYNTON","United Kingdom"
5081,PS045,5073,"Impact of extracellular vesicles from various species of Candida fungi on the cross-species adhesion to human epithelial cells",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Justyna KARKOWSKA-KULETA",Poland
5082,PS045,5073,"Rapid onset cardiac pathology caused by a virulent and antifungal-resistant Candida auris outbreak lineage isolate",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa MEZA-PEREZ","United States"
5083,PS045,5073,"Serum cytokine profiles in patients with candidaemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jack MCHUGH","United States"
5084,PS045,5073,"Candidemia's silent weapon: biofilm's role and the race against time in candidemia outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alberto PAGOTTO",Italy
5085,PS045,5073,"Nakaseomyces glabratus yapsins are involved in antimicrobial peptides degradation and fungal biofilm detachment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorota SATALA",Poland
5086,PS046,NULL,"06b. Fungal disease epidemiology","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","06. Fungal infection & disease",NULL,NULL,NULL,NULL
5087,PS046,5086,"Cavitary pneumonia unveiled: tracing causes in the arid landscapes of southern Arizona, United States",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandhya NAGARAKANTI","United States"
5088,PS046,5086,"Surveillance of fungi in Germany: first results 2019-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines NOLL",Germany
5089,PS046,5086,"Impact of candidemia and septic metastases on survival in critically ill patients colonised with Candida auris: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kemel HAMMU",Spain
5090,PS046,5086,"Predictors of bloodstream infection caused by Candida auris in comparison to other Candida species in adults in Colombia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge Alberto CORTES LUNA",Colombia
5091,PS046,5086,"Short tandem repeat genotyping of extensive Sporothrix brasiliensis collection reveals spread is largely driven by clonal clades",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eelco F.J. MEIJER",Netherlands
5092,PS046,5086,"Urgent consultation: evaluation of 47 invasive fungal sinusitis cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sukru DIRIK",Türkiye
5093,PS046,5086,"Keratomycosis in a tertiary hospital: an eight-year experience from southwest Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anthony ANUFORO",Nigeria
5094,PS046,5086,"Corneal keratitis: a clinical and microbiological analysis of fungal and bacterial species in a tertiary hospital over 14 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula MUÑOZ-BRELL",Spain
5095,PS046,5086,"Invasive aspergillosis (IA) and survival of acute myeloid leukemia (AML) patients at 12 weeks and 12 months after AML diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra MICOZZI",Italy
5096,PS046,5086,"The epidemiology of chronic pulmonary aspergillosis in Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie Louise JOERGENSEN",Denmark
5097,PS046,5086,"Pneumocystis jirovecii pneumonia in South Africa: trends and insights from 2018 to 2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nkosi MBALI","South Africa"
5098,PS046,5086,"Characteristics, treatment outcomes and Aspergillus susceptibility in chronic pulmonary aspergillosis patients treated with echinocandins",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura MICHON",Netherlands
5099,PS046,5086,"Pneumocystis jirovecii colonisation in mothers of preterm newborns and risk of vertical transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena CHARPENTIER",Spain
5100,PS046,5086,"Identifying the impact of fungal exposure on TB patient outcomes in Ivory Coast",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David KOFFI","Côte D'ivoire"
5101,PS046,5086,"An analysis of risk factors associated with high mortality of candidaemia by Candida albicans compared with Candida parapsilosis (CANDIPAR study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana SORIANO-MARTÍN",Spain
5102,PS046,5086,"Determining the significance of Candida growth in nephrostomy urine samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yusuf KAMESHKI","United Kingdom"
5103,PS046,5086,"Trichophyton indotineae or not-indotineae, that is the question: evaluation of Piacenza epidemiology of dermatophytes and presence of emerging species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina LEPERA",Italy
5104,PS046,5086,"Trends in invasive Candida infections in Swiss hospitals: a 15-year surveillance study (2009-2023) on species distribution, resistance, and antifungal use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier FRIEDLI",Switzerland
5105,PS046,5086,"T. indotineae as an agent of dermatophytosis in Barcelona, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"M.Teresa MARTIN-GOMEZ",Spain
5106,PS046,5086,"Detection of causative agents of infectious keratitis in patients from western Rajasthan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Twishi SHRIMALI",India
5107,PS046,5086,"Paediatric eumycetoma patients: a threefold neglected patient group",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanna BRODERSEN",Austria
5108,PS046,5086,"Risk factors for mortality among adult patients with bloodstream infection caused by Candida auris in Colombia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jorge Alberto CORTES LUNA",Colombia
5109,PS046,5086,"Characterisation and risk factors of occupational aspergillosis: a national multicentre retrospective study using RNV3P data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anastasia SAADE-ANTYPAS",France
5110,PS046,5086,"High prevalence of behaviours known to increase the risk of recurrent vulvovaginal candidiasis in Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel Adetona FAYEMIWO",Nigeria
5111,PS046,5086,"Epidemiology of Meyerozyma guilliermondii species complex isolated from invasive fungal diseases: a multicentre study in China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yuyan HUANG",China
5112,PS046,5086,"Rhinosporidiosis in South Africa (2012 to 2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte SRIRUTTAN-NEL","South Africa"
5113,PS046,5086,"Impact of the Candida auris management protocol on epidemiological trends: a study at IRCCS San Martino hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia INGLESE",Italy
5114,PS046,5086,"Fungal endocarditis: experience in a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maricela VALERIO MINERO",Spain
5115,PS046,5086,"Otomycosis: a retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yousra ZEKRI",Morocco
5116,PS046,5086,"Candidemia and the Candida equal score: a clinical evaluation in a tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kruthi MALUR KUMARASWAMY",India
5117,PS046,5086,"Global transmission of Candida auris to Austria: epidemiological, phenotypical, and phylogenetic insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathrin SPETTEL",Austria
5118,PS046,5086,"High prevalence of histoplasmosis among persons with advanced HIV disease in Ivory Coast, 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Serge DOU","Côte D'ivoire"
5119,PS046,5086,"International survey on the diagnosis and treatment of disseminated histoplasmosis in people living with HIV (PLHIV): the PROPULS2A study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frédégonde ABOUT","French Guiana"
5120,PS046,5086,"Incidence of Aspergillus species isolates in samples from the lower respiratory tract in the years 2017 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María Paula VARGAS DURÁN",Spain
5121,PS046,5086,"Factors associated with mortality in critically ill patients: a comparison between HIV-infected and non-immunodeficient individuals with histoplasmosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula FIGUEROA",Guatemala
5122,PS046,5086,"Management of Candida spp. prosthetic joint infections (PJI) according to country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christel MAMONA",France
5123,PS046,5086,"Parinaud syndrome as a clinical manifestation of Sporothrix brasiliensis more often than it should!",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filipe PROHASKA BATISTA",Brazil
5124,PS046,5086,"Culture-positive-CAPA of three German tertiary care hospitals: incidence, management and risk factors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexander Maximilian ALDEJOHANN",Germany
5125,PS046,5086,"Candidemia epidemiology and antifungal resistance during and after COVID-19 pandemic: comparison between two tertiary care hospitals in Greece and Turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esma ERYILMAZ EREN",Türkiye
5126,PS046,5086,"Strengthening fungal infection diagnosis and treatment: an in-depth analysis of capabilities in Honduras",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon SALMANTON-GARCIA",Germany
5127,PS046,5086,"Disseminated histoplasmosis in non-endemic area: comparative analysis of clinical features, risk factors, and outcome of histoplasmosis in HIV-positive and HIV-negative cohorts in western India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akshatha RAVINDRA",India
5128,PS046,5086,"The role of a fungal multidisciplinary team in diagnosing and managing respiratory fungal disease: a retrospective study at a tertiary referral centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lydia FINNEY","United Kingdom"
5129,PS046,5086,"Retrospective analysis of risk factors and outcomes in Candida auris and non-Candida auris candidemia in critically ill patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ezgi GÜLTEN",Türkiye
5130,PS046,5086,"Epidemiology of HIV and non-HIV cryptococcosis at a tertiary care hospital of a developing country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harsimran KAUR",India
5131,PS046,5086,"Pneumocystis primary infection in infants is a community-acquired infection: results of a single-centre prospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Solène LE GAL",France
5132,PS046,5086,"Evaluation of EQUAL Candida score and other risk factors predicting mortality in patients with candidemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melike INAN HEKIMOGLU",Türkiye
5133,PS046,5086,"Nationwide surveillance of Candida bloodstream infections in Korea: species distribution, antifungal resistance, and molecular characteristics (2022-2024)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yong Jun KWON","Republic Of"
5134,PS046,5086,"Candida infective endocarditis: clinical insights and outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muammer ÇELIK",Türkiye
5135,PS046,5086,"Trichophyton indotineae, an emerging and recalcitrant dermatophytosis agent in Iran and Middle East: a two-centre study from Iran and literature review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammad Taghi HEDAYATI","Islamic Republic Of"
5136,PS046,5086,"Epidemiological analysis of candidaemias in a Spanish tertiary hospital during a five-year period",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maddalen GURRUTXAGA OLANO",Spain
5137,PS046,5086,"Clinical, diagnostic and therapeutic characterstics of CNS fungal infections: insights from a single-centre reptrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilias MASOURIS",Germany
5138,PS046,5086,"Changing epidemiology of Candida spp. isolated from patients with candidemia in a tertiary hospital in northern Greece: appearance of Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dimitrios KOUROUPIS",Greece
5139,PS046,5086,"Characterisation of cryptococcal isolates and clinical outcomes in HIV-negative Korean patients with cryptococcosis: a four-year multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eun Jeong WON","Republic Of"
5140,PS046,5086,"Invasive fungal diseases among COVID-19 patients at a tertiary university hospital in Thailand",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aliyavong THAMMAVONG","Lao People's Democratic Republic"
5141,PS046,5086,"Prediction of in-hospital mortality and persistence by biofilm phenotype in patients with Candida glabarata bloodstream infections and screening of related biofilm genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jing LIN",China
5142,PS046,5086,"Distribution of Candida species colonising skin of inpatients in Southern Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tshiama Miriam MWAMBA","South Africa"
5143,PS046,5086,"Comparative clinical profile of non-neutropaenic patients with Candida auris vs non-C.auris candidemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jui ATHAVALE",India
5144,PS046,5086,"Burden of fungal keratitis(FK) in Sagarmatha Choudhary eye hospital (SCEH), Nepal: epidemiological and microbiological profile",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pankaj CHAUDHARY",Nepal
5145,PS046,5086,"Risk stratification in candidemia: a case-control study from 2016-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shashikala SHIVAPRAKASHA",India
5146,PS046,5086,"A retrospective study of ocular fungal infections over a two-year period in a tertiary Hellenic hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kalliopi AVGOULEA",Greece
5147,PS046,5086,"Isolation of a novel genus in the family Myriangiales from a patients with onychomycoses using whole-genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mi-Kyung LEE","Republic Of"
5148,PS046,5086,"Molecular characterisation of the genotype of Candida albicans in patients with candidemia in Ecuador",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeannete ZURITA",Ecuador
5149,PS046,5086,"Factors associated with the development of esophageal candidiasis in oncological patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julian Andres HOYOS PULGARIN",Colombia
5150,PS046,5086,"Candidemia in paediatric population: a nine-year review at a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula MUÑOZ-BRELL",Spain
5151,PS046,5086,"Long-term survival of patients undergoing myelosuppressive therapy for acute leukemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Denise D'ELIA",Switzerland
5152,PS046,5086,"Inter-hospital spread of fluconazole-resistant C. parapsilosis in northern Italy: study of clonality aspects, resistance mechanisms and their correlation with biofilm production",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia PALLADINI",Italy
5153,PS046,5086,"Candida and non- yeasts prevalence in vulvovaginal infection during pregnancy: Serbian national survey viewed through the MALDI-TOF MS analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentina ARSIC ARSENIJEVIC",Serbia
5154,PS046,5086,"An analysis of Candida albicans and Candida parapsilosis candidaemia in the last 14-years (CANDIPAR Study)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana SORIANO-MARTÍN",Spain
5155,PS046,5086,"Candida auris colonisation in multiple facilities in Kenya",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Loice OMBAJO",Kenya
5156,PS046,5086,"Breakthrough invasive mold infections under posaconazole prophylaxis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille MARCHETTI",Switzerland
5157,PS046,5086,"Whole-genome sequencing of recently introduced Clade I Candida auris clinical isolates from hospitals in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yong Jun KWON","Republic Of"
5158,PS046,5086,"Candidemia caused by different Candida species: a five-years retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna MAVROMMATI",Greece
5159,PS046,5086,"Candida auris in polymicrobial bloodstream infections: probably a deadlier foe compared to other Candida species?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Konstantina GKARTZONIKA",Greece
5160,PS046,5086,"A six-year evaluation of invasive candidiasis epidemiology including emergence of Candida auris from a large, southern US metro area",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ricky HUYNH-PHAN","United States"
5161,PS046,5086,"Chromoblastomycosis in Peru: an underreported infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina Mercedes SANCHEZ DIAZ",Peru
5162,PS046,5086,"Establishing the optimal length of testing to detect Candida auris colonisation after discharge from an endemic area",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura MEZZOGORI",Italy
5163,PS046,5086,"Changes in the epidemiology of candidemia after the COVID-19 pandemic at a Brazilian",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simone NOUÉR",Brazil
5164,PS047,NULL,"06c. Diagnostic mycology (incl traditional, molecular and other methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","06. Fungal infection & disease",NULL,NULL,NULL,NULL
5165,PS047,5164,"Value of CRISPR-Cas12-based polymerase chain reaction for diagnosing invasive fungal infection and chronic fungal pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qingqing WANG",China
5166,PS047,5164,"Epsilometer test-based limitations in detecting anidulafungin resistance in Candida parapsilosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cornelia LASS-FLÖRL",Austria
5167,PS047,5164,"Performance of Aspergillus PCR on mini broncho-alveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis using BM-aspICU criteria: a cross-sectional diagnostic test validation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sayan MAHARATNA",India
5168,PS047,5164,"Service evaluation of fungal antigen testing in renal transplant patients at a UK regional transplant centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jonathan BYROM","United Kingdom"
5169,PS047,5164,"Fungal DNA-barcoding on a chip: ITS-DNA biosensors for yeast infection diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria ZOLOTAREVA",Portugal
5170,PS047,5164,"Enhancing the diagnosis of invasive candidiasis using Candida real-time PCR: uncovering hidden challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elizabeth ISKANDAR",Italy
5171,PS047,5164,"Prognostic value of serum and bronchoalveolar lavage fluid galactomannan in invasive aspergillosis: an eight-year experience at a tertiary cancer centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saliba WEHBE","United States"
5172,PS047,5164,"Results of a universal fungal PCR performed in clinical samples of patients: experience of a Chilean university centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claudia CASTILLO",Chile
5173,PS047,5164,"The diagnostic value of metagenomic next-generation sequencing for mucormycosis and the risk factors of poor prognosis in mucormycosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Weili ZHANG",China
5174,PS047,5164,"Comparison of clinical performances between a commercial real-time PCR kit and in-house real-time PCR assay in plasma and paraffin-embedded tissue samples for diagnosis of Aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ji Yeun KIM","Republic Of"
5175,PS047,5164,"A promising combination for fast molecular diagnosis of dermatophytosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Truong Giang NGUYEN",France
5176,PS047,5164,"Evaluation of a new multiplex-tandem PCR assay for the diagnosis of superficial fungal infections of the skin, hair and nails",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean MENOTTI",France
5177,PS047,5164,"The Candida auris surveillance: why do we need to implement it? A validation study on new enrichment broth to increase the sensibility of Candida auris detection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia GATTI",Italy
5178,PS047,5164,"Evaluation of real-time PCR assay for detection of Candida auris in surveillance specimens on a fully automated system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tin Long LUI",China
5179,PS047,5164,"1,3-beta-D-glucan on ascitic fluid: possible early marker of fungal infection in patients with cirrhosis and/or acute liver failure?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa MATARAZZO",Italy
5180,PS047,5164,"Performance evaluation of a novel Candida auris differentiation medium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hannah PAY","United Kingdom"
5181,PS047,5164,"Prospective evaluation of a new multiplex PCR for dermatophyte detection in clinical samples from a tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvia BOLAÑO GARCÍA",Spain
5182,PS047,5164,"Application of the Fourier transform-infrared (FT-IR) biotyper for Candida auris clade level differentiation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lara Rubbia FERREIRA","United Kingdom"
5183,PS047,5164,"Assessing the utility of a pan-fungal (ITS2 gene) PCR assay on whole blood in the paediatric setting: five years' experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Surjo DE","United Kingdom"
5184,PS047,5164,"Evaluation of endotracheal aspirate galactomannan antigen detection for diagnosis of invasive pulmonary aspergillosis: a diagnostic test validation study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandeep RAO KORDCAL",India
5185,PS047,5164,"External validation and refinement of a clinical predictive model of candidemia by Candida auris in critically ill patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor GARCIA-BUSTOS",Spain
5186,PS047,5164,"Using MALDI-TOF MS for identification of dermatophyte and non-dermatophyte molds: single centre experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marko ARSENIJEVIC",Serbia
5187,PS047,5164,"Microsatellite typing: validating a new tool for molecular epidemiology of Trichosporon asahii infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elaine Cristina FRANCISCO",Brazil
5188,PS047,5164,"Pneumocystis jirovecii pneumonia and the possible prognostic role of quantitative polymerase chain reaction: preliminary results from a retrospective multicentre study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Riccardo PAGGI",Italy
5189,PS047,5164,"QCMD Candida auris: a new EQA scheme designed in response to a serious global health threat from an emerging pathogen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorothy MONTGOMERY","United Kingdom"
5190,PS047,5164,"Beta-d-glucan where are you? Impact of false negative BDG on antifungal treatment initiation in patients with candidemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Enrica BONO",Italy
5191,PS047,5164,"Candida albicans nucleic acid sample preparation in 15-seconds with Autolab HBH",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alem ABEBE","United States"
5192,PS047,5164,"Integration of MALDI-TOF and ITS sanger sequencing into a streamlined pipeline for identification of fungi from clinical specimens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Corrie BELANGER",Canada
5193,PS047,5164,"Mycological testing in Australasian clinical mycology laboratories: survey of the current state and access to testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam STEWART","United States"
5194,PS047,5164,"Effect of galactomannan in food on serum levels in suspected IPA patients: insights from a hospital-based and mouse study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Animesh RAY",India
5195,PS047,5164,"Mycological evaluation of sinus lavage fluid in patients with heamatological malignancies and suspected invasive fungal sinusitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammadreza SALEHI","Islamic Republic Of"
5196,PS047,5164,"Detection of clinically relevant Candida species from positive blood culture using an automated point-of-care assay: MoiM Dx Candida 9-plex assay",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eun Jeong WON","Republic Of"
5197,PS047,5164,"Assessment of prioritised fungal pathogen detection in aerobic blood culture system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christopher CANTRELL","United States"
5198,PS047,5164,"Fungi under fire: addressing a Peruvian health challenge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jon SALMANTON-GARCIA",Germany
5199,PS047,5164,"Evaluation of a novel Aspergillus galactomannan chemiluminescence immunoassay for the diagnosis of invasive pulmonary aspergillosis: a multicentre controlled study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeqi ZHOU",China
5200,PS047,5164,"Evaluation of SYBR green real-time PCR for rapid and specific detection of Trichophyton indotineae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Faezeh ROUHI","Islamic Republic Of"
5201,PS047,5164,"Time- and temperature-dependent pentraxin 3 stability in serum and bronchoalveolar lavage fluid samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea LANGER SERMEÑO","Czech Republic"
5202,PS047,5164,"Implementation of in-house Histoplasma antigen tesing from serum and urine samples using",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ruben MERTENS ALBUSAC","United Kingdom"
5203,PS047,5164,"MP65/ENO1 ratio as a diagnostic marker for pathogenic Candida albicans in vulvovaginal candidiasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert MARKS",Israel
5204,PS047,5164,"Evaluation of a new commercial real-time PCR assay to detect dermatophytes in nails",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rosalie SACHELI",Belgium
5205,PS047,5164,"High volume culture technique: a good alternative to conventional culture on the bronchioalveolar lavage samples in invasive pulmonary aspergillosis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Renu KUMARI",India
5206,PS047,5164,"Development and evaluation of simple molecular methods for the distinction of the newly emerging dermatophyte Trichophyton indotineae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shima ABOUTALEBIAN","Islamic Republic Of"
5207,PS047,5164,"Pentraxin-3 as a novel prognostic biomarker in nonneutropaenic invasive pulmonary aspergillosis patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xin SU",China
5208,PS047,5164,"Comparative analysis of chemiluminescence immunoassay (CLIA)-based tests in the diagnosis of invasive aspergillosis in patients with heamatologic malignancies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayse KALKANCI",Türkiye
5209,PS047,5164,"Optimisation of C.auris culture: the influence of temperature, enrichment broth and chromogenic agar",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monique WETZELS-VRANCKEN",Netherlands
5210,PS047,5164,"Real-time application of ITS and D1-D3 nanopore amplicon metagenomic sequencing in fungal infections: enhancing fungal infection diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kon CHU","Republic Of"
5211,PS047,5164,"Comparison of two Aspergillus galactomannan detection tests: platelia galactomannan and virclia galactomannan mono test",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ioanna MARINOU",Greece
5212,PS047,5164,"Development and validation of a TaqMan-based real-time PCR assay for direct detection of Trichosporon asahii in spiked blood culture bottles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elaine Cristina FRANCISCO",Brazil
5213,PS047,5164,"Clinical evaluation of a novel qPCR assay for the detection of dermatophyte fungi and Candida albicans in skin and nail material",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel FERNÁNDEZ-HUERTA",Spain
5214,PS047,5164,"Usefulness of sequence-based identification methods for differentiating clade II and non-clade II Candida auris isolates from Korean hospitals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jong Hee SHIN","Republic Of"
5215,PS047,5164,"Sequential serum galactomannan as predictive response marker for invasive aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jannik STEMLER",Germany
5216,PS047,5164,"Verification of a new enrichment broth and two chromogenic agars for the identification of Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dina OULKADI",Belgium
5217,PS047,5164,"Aspergillus IgG antibodies in diagnosing pulmonary aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tingting WANG",China
5218,PS047,5164,"Diagnostic value of combined detection of BDG assay and GM assay in invasive aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeqi ZHOU",China
5219,PS047,5164,"A novel multiplex Aspergillus PCR assay for detection of of invasive aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeqi ZHOU",China
5220,PS047,5164,"Accuracy and actionability of mold PCR panel on bronchoalveolar lavage for the diagnosis of invasive mold disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Koray DEMIR","United States"
5221,PS047,5164,"A novel multiplex real-time quantitative PCR detecting system approach for detection of Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeqi ZHOU",China
5222,PS047,5164,"Prospective national multicentre study to determine the usefulness of 18-FDG-PET-TC for the management of invasive fungal infection (PETIFI project)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana FERNÁNDEZ-CRUZ",Spain
5223,PS047,5164,"Efficient lateral flow assay for rapid sporothricosis diagnostic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hervé BOUTAL",France
5224,PS047,5164,"Use of MT-PCR (multiplex tandem) in dermatomycosis diagnostic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Enrico FURCHI",Italy
5225,PS047,5164,"Enhancing molecular detection of Candida auris through broth media enrichment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara SENTI",Italy
5226,PS047,5164,"Is a good KOH Calcoflour white microscopic examination sufficient for diagnosis of mucormycosis in a resource limited setting instead of an expensive real time PCR assay?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priyadarshini PADAKI",India
5227,PS048,NULL,"06d. Antifungal susceptibility testing & resistance (incl surveillance, mechanisms)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","06. Fungal infection & disease",NULL,NULL,NULL,NULL
5228,PS048,5227,"Declining azole susceptibility in candida parapsilosis: a ten-year analysis of US blood culture isolates, 2015-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jack MCHUGH","United States"
5229,PS048,5227,"P-bromodomiphen bromide potentiates conventional antifungal activity against Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca TRIVA",Italy
5230,PS048,5227,"In vitro activitiy of rezafungin in comparison with anidulafungin and caspofungin against invasive fungal isolates in China, 2017-2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wenjuan WU",China
5231,PS048,5227,"Activity of the new antifungal oteseconazole against Pichia kudriavzevii clinical isolates from invasive fungal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isaac ALONSO GARCIA",Spain
5232,PS048,5227,"First report of fluconazole-resistant Candida parapsilosis harbouring the G438S ERG11p substitution in a Brazilian hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pilar ESCRIBANO",Spain
5233,PS048,5227,"Fungal colonisation, resistance, and invasive infections in spanish ICUs: findings from 22 centres",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura ALGUACIL CUÉLLAR",Spain
5234,PS048,5227,"Study of Tac1a and Tac1b in azole resistance in Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille MARCHETTI",Switzerland
5235,PS048,5227,"Spread of Y132F fluconazole-resistant C. parapsilosis genotypes causing candidemia in patients admitted to a tertiary hospital in Genoa, Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teresa CARRASCO GIL",Spain
5236,PS048,5227,"Antifungal resistance surveillance: insights from a multicentre survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandre ALANIO",France
5237,PS048,5227,"Understanding multiazole resistance in Aspergillus fumigatus: the impact of non-cyp51A mutation and efflux pump overexpression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pooja SEN",India
5238,PS048,5227,"Photodynamic inactivation and the paucity of the antifungal arsenal against oral fluconazole-resistant non-Candida albicans Candida species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia CERNÁKOVÁ",Slovakia
5239,PS048,5227,"The new triterpenoid antifungal SCY-247 retained activity against most echinocandin- and fluconazole-resistant Candida spp isolates: reduced susceptibility in C. glabrata isolates showing substitutions at the first amino acid in hotspot 1 FKS2 gene",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesus GUINEA",Spain
5240,PS048,5227,"In vitro activity of rezafungin against antifungal-resistant Candida spp isolates: loss of activity against C. glabrata isolates harbouring S663 and delF659 substitutions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Celia SÁNCHEZ-MARTÍNEZ",Spain
5241,PS048,5227,"Unlocking the fungicidal activity of triazoles against Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura DOORLEY","United States"
5242,PS048,5227,"Fluconazole heteroresistance in Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erganis SIDRE",Türkiye
5243,PS048,5227,"Investigation of expression levels of 14-alpha lanosterol demethylase gene (ERG11) and efflux pump-encoding genes (CDR1, CDR2, and MDR1) in C. albicans isolates with decreased susceptibility to azoles from vaginal cultures",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayse BARIS",Türkiye
5244,PS048,5227,"Evaluation of rezafungin on the thermo scientific sensititre YeastOne panel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dylan STAATS","United States"
5245,PS048,5227,"In vitro antagonism between voriconazole and olorofim against 30 clinical strains of Aspergillus fumigatus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Illan LALOUM",France
5246,PS048,5227,"Optimising the screening method for fluconazole-resistant Candida parapsilosis with chromogenic media",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nazaret BETANZOS GUTIERREZ",Spain
5247,PS048,5227,"Antifungal susceptibility profile of Aspergillus species isolated from 2019 to 2024 in a tertiary care hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maddalena ALBERTINI",Italy
5248,PS048,5227,"Cladophialophora bantiana: first insights into susceptibility patterns and whole-genome sequencing analysis of a clinical case",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kathrin SPETTEL",Austria
5249,PS048,5227,"DBRMC: database for resistance mutations in Candida",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Richard KRIZ",Austria
5250,PS048,5227,"Effect of rezafungin against biofilm of Candida parapsilosis fluconazole-resistant isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elizabeth ISKANDAR",Italy
5251,PS048,5227,"Prospective single centre surveillance of clinically isolated azole-resistant Aspergillus fumigatus in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yasuhiro TSUCHIDO",Japan
5252,PS048,5227,"Identification of antifungal resistance mechanisms in the Tardiomyces genus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bram SPRUIJTENBURG",Netherlands
5253,PS048,5227,"Resistance profiles of Candida auris strains in Cluj-Napoca, Romania: a minireview",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Teodora SHERBAN",Romania
5254,PS048,5227,"ECMM-Candida IV: a worldwide study on antifungal tolerance, resistance, and clinical outcomes in candidemia caused by non-albicans Candida species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stella WOLFGRUBER",Austria
5255,PS048,5227,"Characteristics of Candida auris colonized in different sites of the same patient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zitong PAN",China
5256,PS048,5227,"Novel rapid antifungal susceptibility testing system for yeasts based on fast cell growth",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zeqi ZHOU",China
5257,PS048,5227,"Echinocandin susceptibility patterns and genetic changes in nonsusceptible Candida glabrata with non-hotspot FKS alterations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marisa WINKLER","United States"
5258,PS048,5227,"Antifungal susceptibility patterns and genomic mutations in Candida glabrata isolates from patients with candidemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eloy ORDAYA","United States"
5259,PS048,5227,"Activity of manogepix against a worldwide collection of yeast isolates from 2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marisa WINKLER","United States"
5260,PS048,5227,"Rapid antifungal susceptibility testing direct from positive blood culture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ken BABCOCK","United States"
5261,PS048,5227,"Copy number variants (CNVs) at chromosome 3 as azole resistance mechanisms additional to ERG11p substitutions in azole-resistant Candida parapsilosis isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pilar ESCRIBANO",Spain
5262,PS048,5227,"Biocide, antifungal susceptibilities and virulence characteristics of Clade 1 Candida auris strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ayse KALKANCI",Türkiye
5263,PS048,5227,"Trends of azole-resistant Aspergillus fumigatus susceptibility over more than one decade from a German ECMM excellence centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hedda Luise VERHASSELT",Germany
5264,PS048,5227,"whole-genome sequencing of Candida glabrata and Candida albicans for detection of resistance mutations against echinocandins",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fanny WEGNER",Switzerland
5265,PS048,5227,"Revolutionising the fight against fungi with clinically relevant in silico tools for fungal drug resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aakriti JAIN",India
5266,PS048,5227,"Antifungal susceptibility testing of SCY-247 against contemporary clinical yeast isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis OSTROSKY-ZEICHNER","United States"
5267,PS048,5227,"Antifungal susceptibility profiles of Cryptococcus neoformans isolates from Czech Republic: a 20-year surveillance study, 2002-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Radim DOBIAS","Czech Republic"
5268,PS048,5227,"Phylogenomics reveals patterns of azole activity against Aspergillus section Nigri clinical isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana CASTANHEIRA","United States"
5269,PS048,5227,"Azole-resistant Aspergillus fumigatus in people with cystic fibrosis with lung transplantation: susceptibility patterns and molecular epidemiology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ulrike SCHARMANN",Germany
5270,PS048,5227,"Fluconazole-nonsusceptible Candida tropicalis bloodstream isolates in South Korea, 2003–2024: resistance mechanisms and genetic relatedness",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soo Bin LEE","Republic Of"
5271,PS048,5227,"Isavuconazole MIC determination: comparative evaluation of a new gradient strip to the EUCAST E.DEF 9.4 BMD on 110 Aspergillus isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Veronique SAUVONNET",France
5272,PS048,5227,"Rapid vs standard susceptibility testing to echinocandins: is RAST for antifungal agents possible?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucía GÓMEZ BARRAL",Spain
5273,PS048,5227,"In vitro susceptibility testing of rare moulds "RaMo Study": an ECMM-EC/EFISG/ECMM/ISHAM initiative",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa HAHN",Austria
5274,PS048,5227,"The susceptibility of Meyerozyma guilliermondii and Kluyveromyces marxianus to manogepix and other antifungal drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aleksandra GÓRZYNSKA",Poland
5275,PS048,5227,"National survey on azole-resistant clinical Aspergillus fumigatus collected in 2023: environmentally generated azole-resistant isolates (TR34-L98H and TR46-Y121F-T289A substitutions) are expanding across Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesus GUINEA",Spain
5276,PS048,5227,"New insights into antifungal susceptibility testing on Sporothrix brasiliensis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina DO PRADO",Brazil
5277,PS048,5227,"A guanidine-functionalised anthranilamide peptidomimetic RK758 targets Candidozyma auris: integrative mechanistic insights from morphology to transcriptomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shyam Kumar MISHRA BAISHNAB",Australia
5278,PS049,NULL,"06e. Antifungal drugs & treatment (incl pre-clinical studies and clinical trials)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","06. Fungal infection & disease",NULL,NULL,NULL,NULL
5279,PS049,5278,"Effectiveness and safety of echinocandins combination therapy with the standard of care compared to the standard of care monotherapy for the treatment of invasive aspergillosis infection: a meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yazed ALSOWAIDA","Saudi Arabia"
5280,PS049,5278,"Potent and broad-spectrum antifungal activity of 6-alpha-(3'-methoxy-4'-hydroxybenzoyl)-lup-20(29)-ene-3-one, a triterpenoid from Paullinia pinnata",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benjamin Kingsley HARLEY",Ghana
5281,PS049,5278,"Manogepix and amphotericin B combination is synergistic against Candida glabrata as evidenced by a new pharmacodynamic-modelling approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincent ARANZANA-CLIMENT",France
5282,PS049,5278,"Fluconazole-resistant Candida urinary tract infections: rare but difficult to manage",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma OLIOSI",France
5283,PS049,5278,"Isavuconazole comparison with other azoles regarding CYP3A-based drug-drug interactions in combination with ibrutinib, venetoclax, or midostaurin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theunis GOOSEN","United States"
5284,PS049,5278,"Antifungal alternatives to itraconazole for the treatment of histoplasmosis: a multicentre retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frédégonde ABOUT","French Guiana"
5285,PS049,5278,"In-vitro investigation of the gold nanoparticles efficiency in the treatment of multidrug-resistant Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pelinsu ARMUTCUOGLU",Türkiye
5286,PS049,5278,"Cytotoxicity and antifungal activity of Felimare lajensis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia IORIO",Brazil
5287,PS049,5278,"Posaconazole tablets in preventing invasive fungal diseases in patients with end-stage liver disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tianyan CHEN",China
5288,PS049,5278,"Collateral sensitivity counteracts the evolution of antifungal drug resistance in Candida auris",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patrick VAN DIJCK",Belgium
5289,PS049,5278,"SCY-247, a novel second-generation IV/oral triterpenoid antifungal, demonstrates in vitro activity against C. auris including the majority of strains exhibiting high MICs for echinocandins",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eelco F.J. MEIJER",Netherlands
5290,PS049,5278,"Assessment of in vitro activity of the new triterpenoid antifungal, SCY-247, against a collection of yeasts causing fungaemia in patients admitted to a tertiary hospital in Madrid from 2014 to 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesus GUINEA",Spain
5291,PS049,5278,"Evaluation of posaconazole therapeutic drug monitoring for anti-fungal prophylaxis in patients with a heamatological malignancy: a tertiary referral centre's experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashok AADITH",Australia
5292,PS049,5278,"Mold-active therapy in critically ill patients from 2008 to 2023 in a tertiary care hospital in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dominic WICHMANN",Germany
5293,PS049,5278,"Clinical outcome of different treatments in patients with vulvovaginal candidiasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vasiliki KROUSTALI",Greece
5294,PS049,5278,"Tolerability and pharmacological monitoring of voriconazole and isavuconazole in chronic pulmonary aspergillosis: a real-world comparison",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico FAMA",Italy
5295,PS049,5278,"Fluconazole pharmacodynamics against Candidozyma auris isolates in an in vitro pharmacokinetic/pharmacodynamic model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria-Ioanna BEREDAKI",Greece
5296,PS049,5278,"Inhibition of tumor necrosis factor-alpha production by azole antifungal agents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ippei SAKAMAKI",Japan
5297,PS049,5278,"Isavuconazole pharmacokinetics in critically ill patients with acute-on-chronic liver failure and continuous haemodialysis: an observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emily BEHRENS",Germany
5298,PS049,5278,"A survey on candidemia management in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilana REINHOLD",Germany
5299,PS049,5278,"ASLdC3 elevates mitochondrial dysfunction by impeding the central carbon metabolism to inhibit yeast-to-hyphae transition in Candida albicans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yachna KUMARI",India
5300,PS049,5278,"Deciphering connections between isavuconazole (ISAV) drug exposures and responses among different infections: Mucorales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura KOVANDA","United States"
5301,PS049,5278,"Real-world dataset demonstrates favorable safety profile of liposomal amphotericin B for the treatment of invasive aspergillosis in high-risk haemato-oncology patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Johan MAERTENS",
5302,PS049,5278,"Antifungal treatment regimens as primary therapy for invasive aspergillosis: a systematic review and network meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dayu CHEN",China
5303,PS049,5278,"Healthcare resource utilisation, all-cause treatment costs, and mortality in patients with malignancies that develop invasive aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Craig COLEMAN","United States"
5304,PS049,5278,"Retrospective, multicentre study of the renal safety of liposomal amphotericin B in critically ill with invasive pulmonary aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Borja SUBERVIOLA",Spain
5305,PS049,5278,"Azole-loaded mucosomes: a hopeful approach to fight Candida albicans in mucosal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giuliana BANCHE",Italy
5306,PS049,5278,"Real-world experience with rezafungin: a novel long-acting echinocandin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucinda VAN ANGLEN","United States"
5307,PS049,5278,"Safety and pharmacokinetics of SF001, a next-generation polyene antifungal, following single and multiple doses in healthy adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kieren MARR","United States"
5308,PS049,5278,"Deciphering connections between Isavuconazole (ISAV) drug exposures and responses among different infections: dimorphic fungi/mould/other filamentous fungi and mixed infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amit DESAI","United States"
5309,PS049,5278,"Availability of antifungals in low- and middle-income countries: updating the maps",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stella WOLFGRUBER",Austria
5310,PS049,5278,"Deciphering connections between isavuconazole (ISAV) drug exposures and responses among different infections: invasive candidiasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura KOVANDA","United States"
5311,PS049,5278,"Evaluation of the compliance of the antifungal treatment approach with the recommendations in current international guidelines in patients with invasive candida infection or candida colonisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zarifa ORTA",Türkiye
5312,PS049,5278,"A study on intensive care unit invasive fungal stewardship (IFS) cognition and clinical practice among ICU physicians in Sichuan province",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lingai PAN",China
5313,PS049,5278,"Old friends, new foes: explorative assessment of the potential drug-drug interaction between metamizole and mold-active azoles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dorian VANNESTE",Belgium
5314,PS049,5278,"Study design: Phase 2, multicentre, open-label, randomised, active-controlled trial to evaluate the efficacy and safety of rezafungin adjunctive therapy in HIV-associated Pneumocystis jirovecii pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sean WASSERMAN","United Kingdom"
5315,PS049,5278,"Clinical outcomes with rezafungin or caspofungin in adults with invasive infections due to  non-albicans Candida: pooled analysis from STRIVE and ReSTORE trials (including extension phase data)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oliver A. CORNELY",Germany
5316,PS049,5278,"Implementation of antifungal stewardship rounds at a large teaching hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Navjeet NAGI","United Kingdom"
5317,PS049,5278,"Isavuconazole therapeutic drug monitoring and dosage adjustments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara COBO SACRISTÁN",Spain
5318,PS050,NULL,"07a. Fundamental parasitology","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
5319,PS050,5318,"Hookworm modulated immune responses to bystander antigens among adults in endemic rural communities in southern India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ramya MADHAVAN",India
5320,PS050,5318,"Advancing blastocystis research through a One Health approach: insights from a COST action",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anja GODFREY","United Kingdom"
5321,PS050,5318,"Bulk and single-cell transcriptome profiling revealed dynamic pathological changes of granulomatous amebic encephalitis caused by Balamuthia mandrillaris: a cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jingjia ZHANG",China
5322,PS050,5318,"Evaluation of natural killer cell exhaustion markers in the peripheral blood of hydatid cyst patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soodeh GHADIMI","Islamic Republic Of"
5323,PS050,5318,"Emsb microsatellites analysis of Echinococcus multilocularis specimens isolated from Belgian patients with alveolar echinococcosis and host animals",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sabrina EGREK",Belgium
5324,PS050,5318,"Spatiotemporal transcriptomic profiling reveals the dynamic immunological landscape of alveolar echinococcosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhihua OU",China
5325,PS050,5318,"Single-cell analysis of gene expression in a pathogenic strain of Entamoeba species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hiroshi TACHIBANA",Japan
5326,PS050,5318,"Evaluation of natural killer cell frequency and exhaustion markers in the peripheral blood of patients with cutaneous leishmaniasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammadreza SHAFIEI","Islamic Republic Of"
5327,PS050,5318,"Stage-specific immune response to AgB T-peptides in patients with cystic echinococcosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Settimia SBARRA",Italy
5328,PS050,5318,"Prevalence of parasites in three-spot gourami (Trichopodus trichopterus) from natural water sources in Khlong 7, Thanyaburi district, Pathum Thani province",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Surachai TECHAOEI",Thailand
5329,PS051,NULL,"07b. Parasitic disease epidemiology","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
5330,PS051,5329,"Presence of Wolbachia bacteria in Mansonella perstans isolates from migrants of different geographical origin: a pilot study from the ESCMID study group on clinical parasitology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca TAMAROZZI",Italy
5331,PS051,5329,"D-dimer as a marker of severe disease in imported P. falciparum malaria: a retrospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea POLONI",Italy
5332,PS051,5329,"Optimisation of PCR-based detection of Wolbachia bacterial strains in Anopheles malaria vectors in the field",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel HUGHES","United Kingdom"
5333,PS051,5329,"Visceral leishmaniasis and lymphatic filariasis co-endemicity in Bihar, India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sundaram PANDEY",India
5334,PS051,5329,"Unveiling Ehrlichia canis: genetic diversity, population structure, and haplotype variations of an emerging zoonotic pathogen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anil Kumar NEHRA",India
5335,PS051,5329,"Visceral leishmaniasis among children and adults in a Tunisian hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meriem ABDELJELIL",Tunisia
5336,PS051,5329,"Epidemiological investigation of a malaria outbreak in overseas deployment units in 2022",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suryeong GO","Republic Of"
5337,PS051,5329,"Prevalence and molecular typing of the parasite Dientamoeba fragilis in patients from two hospitals in the Czech Republic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jolana HAVLOVÁ","Czech Republic"
5338,PS051,5329,"Unveiling the molecular diversity of Leishmania infantum in human tegumentary leishmaniasis: evidence from Italy and Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso GRITTI",Italy
5339,PS051,5329,"Intestinal parasitic infections in upper Corsica: current epidemiology and diagnostic approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arthur MAKA",France
5340,PS051,5329,"Risk factors for Trichuris trichuira infection in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rose Chimezie IHEZIE",Nigeria
5341,PS051,5329,"Comprehensive mapping of Blastocystis epidemiology and subtypes: insights from COST action CA21105 'One Health Blastocystis`",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eylem AKDUR ÖZTÜRK",Türkiye
5342,PS051,5329,"Recent spread and outcomes of human alveolar echinococcosis in Croatia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia OSLAJ",Croatia
5343,PS051,5329,"Congenital toxoplasmosis screening of pregnant women in Cameroon: proposing a novel algorithm with a cost savings analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malika MADHAVA","United States"
5344,PS051,5329,"Investigating hybrid Schistosoma spp. imported infections to Europe: a cohort from the ESCMID study group on clinical parasitology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca TAMAROZZI",Italy
5345,PS051,5329,"Clinical outcomes in chagas disease among military personnel: a retrospective observational study in Bogota, Colombia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Santiago RODRÍGUEZ",Colombia
5346,PS051,5329,"Knowledge on female genital schistosomiasis among women attending public healthcare facilities in Namayingo and Mayuge Districts, Uganda",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eddy KYAGULANYI",Uganda
5347,PS051,5329,"Neglected blood parasitic diseases and malaria in the Peruvian Amazon: molecular screening employing a new multiplex qPCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria Delmans FLORES-CHAVEZ",Spain
5348,PS051,5329,"Mitochondrial nad5 gene-based molecular insights into zoonotic Echinococcus granulosus sensu lato genotypes endemic in north India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pallavi MOUDGIL",India
5349,PS051,5329,"Breakthrough infection with Plasmodium species in deployed military personnel who completed prophylactic antimalarial medication during their deployment period and returned home: a case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junwon SEO","Republic Of"
5350,PS051,5329,"Ultrasonographic prevalence of cystic echinococcosis in school-aged children in Chile: results of a pilot survey in the context of a developing control programme",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesca TAMAROZZI",Italy
5351,PS051,5329,"Risk factors for trichomoniasis in women: a nationwide study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Filip JANSÅKER",Sweden
5352,PS051,5329,"Awareness and knowledge of human leishmaniasis in a mediterranean endemic area: a cross-sectional study from Sardinia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara FANELLI",Italy
5353,PS052,NULL,"07c. Diagnostic parasitology (incl traditional, molecular and genomic methods)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
5354,PS052,5353,"Detecting Plasmodium falciparum histidine-rich proteins 2 and Plasmodium lactate dehydrogenase in saliva: a non-invasive means of diagnosing malaria in children",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Enoch ANINAGYEI",Ghana
5355,PS052,5353,"Evaluation of the BioFire global fever panel compared to laboratory-developed PCR for malaria diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Allison HAAS","United States"
5356,PS052,5353,"Concordance between computed tomography and transfontanellar ultrasound for diagnosing central nervous system lesions in congenital toxoplasmosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos Mauricio CULMA RAMIREZ",Colombia
5357,PS052,5353,"Molecular assays on cutaneous swabs as an effective and less invasive diagnostic technique for cutaneous leishmaniasis: results from a retrospective study conducted in Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna BARBIERO",Italy
5358,PS052,5353,"Benefit of pan-nematode PCR in unusual clinical presentations of nematodosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie Gladys ROBERT",France
5359,PS052,5353,"Investigation the transmission dynamics of Cryptosporidium sp. and Giardia duodenalis in humans, animals, and the environment in rural Turkey: a One Health approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eylem AKDUR ÖZTÜRK",Türkiye
5360,PS052,5353,"Diagnostic practices and therapeutic modalities for the management of visceral leishmaniasis: a joint ESCMID-ESGCP and LeishMan study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Pierre GANGNEUX",France
5361,PS052,5353,"Comparing molecular methods for the identification of Leishmania infantum in blood samples: a retrospective study of diagnostic accuracy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tommaso GRITTI",Italy
5362,PS052,5353,"Performance of VIRapid HYDATIDOSIS  test for diagnosis of cystic echinococcosis: can it be used for field screening?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gian Luca D'ALESSANDRO",Italy
5363,PS052,5353,"Screening and diagnosis access for neglected and tropical parasitic diseases in Italy: a national survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnese COMELLI",Italy
5364,PS052,5353,"Comparative analysis of chronic schistosomiasis cases diagnosed by microscopy or by serology only: a retrospective study in the Belgian national reference centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pierre Martin ENGLERT",Belgium
5365,PS052,5353,"LAMP for malaria diagnosis in a non-endemic country Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Didi BANG",Denmark
5366,PS052,5353,"Comparison of the sensitivity and specificity of diagnostic tests to detect Schistosoma spp. infection in the adult population of Chókwè district in Mozambique",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joao SERRA",Portugal
5367,PS052,5353,"Establishing a diagnostic algorithm with high performance for Schistosoma serology: an approach using composite reference standard and latent class analysis ??????",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caroline RÖNNBERG",Sweden
5368,PS052,5353,"Diagnostic performance of a novel real-time PCR assay for Toxoplasma gondii DNA using amniotic fluid and plasma clinical-like samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
5369,PS052,5353,"Advancing Chagas disease diagnosis: a real-time PCR validation for congenital and chronic infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
5370,PS052,5353,"Usefulness of molecular diagnostic techniques in imported strongyloidiasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azucena RODRIGUEZ-GUARDADO",Spain
5371,PS052,5353,"Polymerase chain reaction for malaria diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SMIELEWSKA","United Kingdom"
5372,PS052,5353,"The 18S rDNA sequencing of Plasmodium species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silje HOEGH",Denmark
5373,PS052,5353,"Evaluation of the humoral immune response to Plasmodium vivax antigens in patients with Plasmodium vivax malaria recurrences",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariana RIBEIRO GONÇALVES",Brazil
5374,PS052,5353,"Verification of an ultra-sensitive mitochondrial cytochrome c oxidase III (cox3) gene primer for the detection of Plasmodium spp. using conventional PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lena BAUKART",Denmark
5375,PS052,5353,"Emerging tools in parasitological diagnostics: a comparative study of AI, microscopy, and rapid antigen testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Varol TUNALI",Türkiye
5376,PS052,5353,"A simple, extraction-free molecular assay for the diagnosis of malaria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jamie LEMON","United States"
5377,PS052,5353,"Detecting and differentiating plasmodium species using real-time PCR in clinical samples collected over five years in a Spanish tertiary hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Henar ALONSO-EZCURRA",Spain
5378,PS052,5353,"Evaluation of bead beating preparation of stool samples for detection of helminths by multiplex PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia VIVAS",France
5379,PS052,5353,"Demodex sp.: parasitological diagnosis, molecular identification and clinical expressions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lilia KRICHENE",Tunisia
5380,PS053,NULL,"07d. Antiparasitic drugs & treatment (incl pre-clinical studies and clinical trials)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
5381,PS053,5380,"The anti-Leishmanial potential of Toona ciliata leaf extract: harnessing nature's arsenal against leishmaniasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vishal Kumar SINGH",India
5382,PS053,5380,"Carrier-mediated delivery of amphotericin-B through mannosylated liposomes for effective management of leishmaniasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Varun BHARGAVA",India
5383,PS053,5380,"Ligand conjugated carbon nanotubes for effective antileishmanial therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Toshi NEMA",India
5384,PS053,5380,"Optimising deworming interventions: a study on Taenia multiceps control in rural northern Tanzanian livestock and dog populations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tito KIBONA","United Republic Of"
5385,PS053,5380,"Design, characterisation, and in vitro assessment of amine-functionalised graphene quantum dots conjugated with amphotericin B for visceral leishmaniasis therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Prasoon MADHUKAR",India
5386,PS053,5380,"Long-term follow up of Chagas disease individuals treated with posaconazole and benznidazole: the CHAGASAZOL cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joan ROIG SANCHIS",Spain
5387,PS053,5380,"Concentrations of artemether/lumefantrine in hair: a potential tool to retrospectively determine drug exposure following malaria treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanna DE JONG",Netherlands
5388,PS053,5380,"Screening of a chalcone-based library for anti-Leishmania activity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara MORSELLI",Italy
5389,PS053,5380,"Nucleo-cytoplasmic shuttling inhibitors as novel anti-Leishmania agents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara MORSELLI",Italy
5390,PS053,5380,"Investigation of anti-leishmanial activities of Aspergillus metabolites and their effects on the pathogenesis of Leishmania virus at molecular level: in vitro studies from Turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kurt ÖZGÜR",Türkiye
5391,PS053,5380,"Unveiling the veil: risk factors for Chagas disease treatment discontinuation in a non-endemic country: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina BELTRAMI",Italy
5392,PS054,NULL,"07e. Antiparasitic susceptibility & drug resistance (incl surveillance, mechanism)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
5393,PS055,NULL,"07f. Travel medicine, migrant and refugee health","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","07. Parasitic diseases, travel medicine & migrant health",NULL,NULL,NULL,NULL
5394,PS055,5393,"The difference in seasonal variation in the number of arrival aircrafts investigated for invasive mosquitoes between airports in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soichi TAKEISHI",Japan
5395,PS055,5393,"Impact of Chagas disease on quality of life in women diagnosed through neonatal screening",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paloma MERINO AMADOR",Spain
5396,PS055,5393,"Dynamics and persistence of antimicrobial resistance genes and gut microbiome of healthy individuals after travel",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cong SHEN",China
5397,PS055,5393,"Challenges for malaria control among Myanmar migrants in western Thailand: a qualitative study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pyae Linn AUNG",Thailand
5398,PS055,5393,"Traveller profiles and pre-travel counselling: a retrospective cross-sectional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milan TROJANEK","Czech Republic"
5399,PS055,5393,"Describing immigrants' experiences of accessing healthcare in an Irish infectious diseases clinic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fergal HOWLEY",Ireland
5400,PS055,5393,"What probabilistic antibiotic therapy for skin abscess in the Amazon?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier LESENS","French Guiana"
5401,PS055,5393,"National genomic surveillance of travellers with co-infections involving typhoidal Salmonella over a 20-year period in England",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa WONG","United Kingdom"
5402,PS055,5393,"Carriage of multidrug-resistant bacteria among Ukrainian refugees",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tuomas ARO",Finland
5403,PS055,5393,"Breaking barriers to health: the urgent need for targeted screening in migrant populations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnese COLPANI",Italy
5404,PS055,5393,"Prevalence of neglected tropical diseases among migrants living in Europe: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giacomo GUIDO",Italy
5405,PS055,5393,"Assessing health disparities and access: a data-driven analysis of Afghan refugee health in Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Saeed AHMAD",Finland
5406,PS055,5393,"Differential characteristics of imported schistosomiasis in female immigrant population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azucena RODRIGUEZ-GUARDADO",Spain
5407,PS055,5393,"Strongyloidiasis diagnosed by ELISA in Brussels: a bicentric retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliette BECU",Belgium
5408,PS055,5393,"Incidence of Hymenolepis nana infection within people seeking asylum and refugees attending health screening at an integrated refugee health service (respond)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kieran KILLINGTON","United Kingdom"
5409,PS055,5393,"Burden of dengue fever in travellers from non-endemic areas: a systematic literature review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin P. GROBUSCH",Netherlands
5410,PS055,5393,"A successful checklist order set for infectious disease screening in immigrant patients in the US",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eirini ILIAKI","United States"
5411,PS055,5393,"A cross-sectional study on diphtheria and other wound infections among asylum seekers arriving in Baden-Wuerttemberg, Germany, August-October 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bernadette WALTER",Germany
5412,PS055,5393,"Preliminary evaluation of a multiplex PCR assay for detecting protozoan and helminth infections in travelers returning to Berlin, Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul Clemens PITZINGER",Germany
5413,PS055,5393,"Empowering migrants health: results from a monocentric prospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanni MORI",Italy
5414,PS055,5393,"Appropriateness of malaria treatment according to WHO criteria for severe malaria in a non-endemic country",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anatolio ALONSO CRESPO",Spain
5415,PS055,5393,"Malaria and travel medicine: how to prevent it",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jeferson MANOEL TEIXEIRA",Brazil
5416,PS065,NULL,"09a. Microbial pathogenesis & virulence","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
5417,PS065,5416,"Sub-minimum inhibitory concentrations of rifampicin attenuate methicillin-resistant Staphylococcus aureus virulence by suppressing SaeRS two-component system and arginine biosynthesis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yinjuan GUO",China
5418,PS065,5416,"Turicella otitidis: from an external auditory canal coloniser to a cause of severe ear infections in children, a three-year retrospective study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helen KIRIKOU",Greece
5419,PS065,5416,"Knockout of the wza gene significantly affects capsule formation in Acinetobacter baumannii, weakening its virulence and environmental adaptability",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ping LU",China
5420,PS065,5416,"Predicting high-risk clone pathogenesis in Pseudomonas aeruginosa through a random forest model of the pangenome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansel VATANSEVER",Türkiye
5421,PS065,5416,"Bacterial fluid dynamics unmasked: how Klebsiella pneumoniae capsules rewrite virulence mechanics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luisa Maria Vieira PEIXE",Portugal
5422,PS065,5416,"SalComSNP: an interactive platform for shortlisting key genes putatively associated with bloodstream infections of invasive non-typhoidal Salmonella",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lijuan LUO","United Kingdom"
5423,PS065,5416,"Staphylococcus aureus biofilm metabolite interactome act as key modulators for host immune evasion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepak KUMAR",India
5424,PS065,5416,"Prophage and central metabolic genome adaptations drive virulent Staphylococcal infections in the community",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Grace LEE","United States"
5425,PS065,5416,"Molecular conservation of itaconate metabolism and type 6 secretion in the high-risk clone of Pseudomonas aeruginosa ST235",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansel VATANSEVER",Türkiye
5426,PS065,5416,"Compensatory mechanisms in capsule production following RmpA deletion in hypervirulent Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyun Ah KIM","Republic Of"
5427,PS065,5416,"Plt-1 acted as a novel virulence factor by enhancing inflammation level and macrophage death in ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peiyao JIA",China
5428,PS065,5416,"Functional genomics of hypervirulent Klebsiella pneumoniae, a step forward for accurate diagnosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francois LEBRETON","United States"
5429,PS065,5416,"Biofilm formation of lactose-pre-adapted Streptococcus mutans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natalia IORIO",Brazil
5430,PS065,5416,"Serotype O16:H5 ST131 Escherichia coli are significantly more virulent in the galleria mellonella insect model than O25:H4 ST131",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan Aston Tregurtha MATHIAS","United Kingdom"
5431,PS065,5416,""Superbugs vs bugs": Galleria mellonella (greater wax moth) larvae as a model for the pathogenicity of Staphylococcus aureus neonatal bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan Aston Tregurtha MATHIAS","United Kingdom"
5432,PS065,5416,"Neuraminidase structural diversity across bacteria, metazoa, fungi and viruses: observations for target-based development of new selective drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giulia Chiara Maria PERRONE",Italy
5433,PS065,5416,"Differential cultivability of isogenic Staphylococcus aureus sub-populations in diferent growth environments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nadia AFTAB",Norway
5434,PS065,5416,"Genetic diversity and regulatory context of vaginolysin in Gardnerella species: implications for virulence and host-pathogen interactions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Márcia SOUSA",Portugal
5435,PS065,5416,"Capsular cluster expression in hypermucoviscous KPC-producing Klebsiella pneumoniae sequence type 101",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice DE FRANCESCO",Italy
5436,PS065,5416,"Molecular epidemiology of Pseudomonas aeruginosa in cystic fibrosis patients: insights from the Brazilian Amazon region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yan Corrêa RODRIGUES",Brazil
5437,PS065,5416,"The role of ompW on infectivity and adherence of Acinetobacter baumannii in relation to colistin resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jale BORAL",Sweden
5438,PS065,5416,"The multidrug efflux pump AcrAB contributes to the aggregative-adherence phenotype of enteroaggregative Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martina LAUDAZZI",Italy
5439,PS065,5416,"Potential Role of malR-malABC Operon in Enhanced Virulence of Staphylococcus pseudintermedius During Canine Otitis Externa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soojin YANG","Republic Of"
5440,PS065,5416,"Virulence potential and characteristics of multidrug-resistant Corynebacterium amycolatum strains in mountainous region of Rio de Janeiro state",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helvécio CARDOSO CORRÊA PÓVOA",Brazil
5441,PS065,5416,"In vivo transcriptome analysis of Aeromonas dhakensis isolated from fatal cases of multidrug-resistant bacteraemia reveals novel virulence genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Blake NEIL","United States"
5442,PS065,5416,"Strain-dependent internalisation of S. aureus in podocytes and renal epithelial cells",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Franziska Dorothee SCHULER",Germany
5443,PS065,5416,"Klebsiella oxytoca subgroup KO5: highly resistant and superior immune evasion capability",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yun WU",China
5444,PS065,5416,"Impact of insertion mutation in the accessory gene regulator agrC gene in the Staphylococcus aureus: reduced virulence and enhanced persistence capacity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jiawei JIAWEI",China
5445,PS065,5416,"Epidemiological analysis and functional characterisation of HlyA hemolysin in Morganella morganii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jiawei JIAWEI",China
5446,PS065,5416,"Characterisation of Pseudomonas aeruginosa virulence factors and immune response during exacerbations and stable phase in bronchiectasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberto CABRERA ORTEGA",Spain
5447,PS065,5416,"Preliminary investigation of how Acinetobacter baumannii enhances intracellular survival via the specific TonB-dependent transporter BauA in outer membrane vesicles",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jiayuan QIN",China
5448,PS065,5416,"Virulence signature of the dominating vancomycin-resistant Enterococcus faecium clones in Denmark, 2015-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ingrid Maria Cecilia RUBIN",Denmark
5449,PS065,5416,"Monoclonal lung dissemination by Pseudomonas aeruginosa precipitating bilateral lung transplantation in primary ciliary dyskinesia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Steven TAYLOR",Australia
5450,PS065,5416,"The impact of type IV pili-mediated twitching motility in biofilm formation by Streptococcus sanguinis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yi-Ywan Margaret CHEN",China
5451,PS065,5416,"Molecular epidemiology and comparative virulence patterns of Acinetobacter baumannii isolates from war-related injuries in Ukraine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jale BORAL",Sweden
5452,PS065,5416,"You are not my type: large-scale bioinformatics analysis uncovers the distribution and diversity of Type VI secretion systems in Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristina NESPOROVA",Belgium
5453,PS065,5416,"Investigating Staphylococcus aureus infections in human-derived musculoskeletal tissue slices: a new ex vivo approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kerstin STRENGER",Switzerland
5454,PS065,5416,"Unveiling the role of the glc locus in Campylobacter: a key to glucose metabolism, survival, and niche adaptation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammed ALOSAIMI","Saudi Arabia"
5455,PS065,5416,"Uncovering the mechanisms behind carbapenem-resistant Escherichia coli causing recurrent and multi-site infections: adaptive genotypic and phenotypic evolution within the host",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cheng-Yen KAO",China
5456,PS065,5416,"High lethality of methicillin-susceptible Staphylococcus aureus ST398 in animal models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miquel SÁNCHEZ-OSUNA",Spain
5457,PS065,5416,"Dynamic evolutionary strategies of clinically isolated hypervirulent carbapenem-resistant Klebsiella pneumoniae in response to drug and survival pressures within the host",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rui WENG",China
5458,PS065,5416,"Resistance and persistence: a reciprocal driving force of survivability in uropathogenic E. coli?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jad ATRISSI",Belgium
5459,PS065,5416,"Carbapenem-resistant Acinetobacter baumannii causing the dual-strain persistent infection with significant loss-of-function mutations in virulence factors and the ability to form persisters under PMB-MEM combination therapy: an eight-month genetic-based ICU patient monitoring study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yang ZHONG",Singapore
5460,PS065,5416,"A-to-I RNA editing in Klebsiella pneumoniae influences the oxidative stress tolerance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xingyu WU",China
5461,PS065,5416,"Novel inhibitors targeting lipid A phosphoethanolamine transferase (EptA) to break beta-lactam resistance in extensively drug-resistant Neisseria gonorrhoeae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Van Chi THAI",Australia
5462,PS065,5416,"Genomic characterisation of a novel capsular operon in extensively drug-resistant Haemophilus parainfluenzae urogenital strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucía SAIZ-ESCOBEDO",Spain
5463,PS065,5416,"Characterisation of the susceptibility and adaptive mechanisms of Legionella to serum bactericidal activity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophie JARRAUD",France
5464,PS066,NULL,"09b. Host-pathogen interaction (incl basic microbiome studies, animal models)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
5465,PS066,5464,"Naringin is a possible protective agent in a rat model of polymicrobial sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat KARAMESE",Türkiye
5466,PS066,5464,"The influence of time of day of vaccination and infection on immunity in rodent animal models, and translational aspects: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Astrid Christine ERBER",Austria
5467,PS066,5464,"Galleria mellonela as an experimental model for the study of bacterial co-infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helvécio CARDOSO CORRÊA PÓVOA",Brazil
5468,PS066,5464,"Peste des petits ruminats virus (PPRV) non-structural C and V proteins modulate the NF-kB signalling pathway",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juhi JAIN",India
5469,PS066,5464,"Study on the interaction mechanism of Paeniclostridium sordellii haemorrhagic toxin and its host",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xingxing LI",China
5470,PS066,5464,"Prospective case-control study on bacterial gut microbiota and invasive enterococcal disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diaz BENITEZ",Spain
5471,PS066,5464,"Staphylococcus capitis NRCS-A target tight junctions to disrupt intestinal epithelial barrier and induce bacteraemia in vivo",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aurélien PEYRON",France
5472,PS066,5464,"Commensal vs clinical staphylococci, the yin and yang of bacterial interaction with the host",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alaa ABOUELFETOUH",Egypt
5473,PS066,5464,"Female urinary microbiota characterisation by culturomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille VILLENAVE",France
5474,PS066,5464,"Gastrointestinal symptomatology in Sanfilippo syndrome is related to gut microbiota metabolism",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario ROMERO RIVERA",Spain
5475,PS066,5464,"Gut microbiota in patients with metastasic prostate cancer: analysis of potential effects of androgen receptor pathway inhibitors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia PÉREZ CASTRO",Spain
5476,PS066,5464,"Gut microbiota alterations in relapsing-remitting multiple sclerosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo Domenico MARSIGLIA",Italy
5477,PS066,5464,"Limiting the spread of nosocomial bacterial pathogens through endotracheal illumination in a long-term ventilation pig model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Barbara SPELLERBERG",Germany
5478,PS066,5464,"Microbiome bacterial DNA quantity is unchanged during antimicrobial therapy in patients with Clostridioides difficile infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Khurshida BEGUM","United States"
5479,PS066,5464,"The secondary messenger ppGpp controls virulence and pathogenicity of adherent-invasive Escherichia coli strains through changes in gene expression",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Llorenç FERNÁNDEZ-COLL",Spain
5480,PS066,5464,"Peripheral CD34+ cells as a niche for Mycobacterium tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tonino ALONZI",Italy
5481,PS066,5464,"Exploring residual antigen distribution and neuroinflammation in calcified neurocysticercosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luz M. TORIBIO","United Kingdom"
5482,PS066,5464,"Dynamics of gut microbiome enterotypes in a healthy Hungarian cohort using whole-length 16S metabarcoding",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Csongor FREYTAG",Hungary
5483,PS066,5464,"Airway epithelial air-liquid-interface culture systems for high-resolution investigations of bacterial infection dynamics during treatment with elexacaftor/tezacaftor/ivacaftor",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria PALS BENDIXEN",Denmark
5484,PS066,5464,"Phage-antibiotics synergy and antagonism in Pseudomonas aeruginosa clinical isolate ZS-PA-35",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bijie HU",China
5485,PS066,5464,"Lung pathogens persist in the gut microbiome during critical illness",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brendan KELLY","United States"
5486,PS066,5464,"Exploring microbial diversity in calcific aortic valve disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angela KUKA",Italy
5487,PS066,5464,"Development of a chronic wound infection model in rats for testing novel wound therapies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariliis HINNU",Estonia
5488,PS066,5464,"The role of periodontal disease in modulating salivary microbiome in atherosclerotic cardiovascular patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Monika BRZYCHCZY-WLOCH",Poland
5489,PS066,5464,"Evaluation of mobilome impact in isolates of Staphylococcus aureus sequence type 8 during in vitro cellular internalisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dafne BONGIORNO",Italy
5490,PS066,5464,"Fecal microbiota features and pathways potentially associated with spontaneous clearance of carbapenem-resistant Enterobacterales colonization",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lima Rodriguez OLALLA",Spain
5491,PS066,5464,"Membrane vesicles as potential surrogate for impaired intestine barrier",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vera RAUSCHENBERGER",Germany
5492,PS066,5464,"The protective effects of a single dose myricetin application on CLP-induced rat sepsis model by analysing some immune mechanisms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ali GÜRASLAN",Türkiye
5493,PS066,5464,"Pulmonary microbiota analysis and host gene expression: a diagnostic model for distinguishing respiratory colonisation and pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhangfan FU",China
5494,PS066,5464,"Two flavonoids, baicalein and naringin, are effective as anti-inflammatory and anti-oxidant agents in a rat model of polymicrobial sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selina AKSAK KARAMESE",Türkiye
5495,PS066,5464,"Investigation of the anti-inflammatory, anti-oxidant and anti-apoptotic activity of 18-beta-glycyrrhetinic-acid on the model of LPS-induced lung injury in rats",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gulfem Nur YILDIZ",Türkiye
5496,PS066,5464,"Giardia infection is associated with alterations in the community structure of the murine gut microbiome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sucheta GULERIA",India
5497,PS066,5464,"The effect of selective estrogen receptor modulators on the clearance of Staphylococcus aureus and Pseudomonas aeruginosa by monocyte-derived macrophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica MCLOUGHLIN","United Kingdom"
5498,PS066,5464,"Relative abundance of bacterial phyla and diversity of pathogenic bacteria in patients with irritable bowel syndrome compared with healthy controls relative abundance of bacterial phyla and diversity of pathogenic bacteria in patients with irritable bowel syndrome compared with healthy controls",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ganji LEILA","Islamic Republic Of"
5499,PS066,5464,"The beneficial effects of dose-dependent umbelliferone application on CLP-induced experimental sepsis model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ali GÜRASLAN",Türkiye
5500,PS066,5464,"An assessment of breastmilk microbiome focusing on probiotics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nazila KASSAIAN","Islamic Republic Of"
5501,PS066,5464,"Escherichia coli division and nonresponse factors to antibiotic therapy in a murine model of acute prostatitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guillaume COSSON",France
5502,PS066,5464,"Evolution of phage resistance through CRISPR-Cas adaptation in the  mucosal environment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sophia GOLADZE",Finland
5503,PS066,5464,"Autologous host-pathogen pairing enhances early immune responses and bacterial control in tuberculosis in vitro granuloma model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oana DUMITRESCU",France
5504,PS066,5464,"Identification of anti-CRISPR (Acr genes) proteins harbored in Pseudomonas aeruginosa clinical strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lucia ARMAN FERNANDEZ",Spain
5505,PS066,5464,"Breaking new ground: human intestinal organoids reveal Shigella's invasive strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nidhi KAMBOJ",India
5506,PS066,5464,"Klebsiella pneumoniae diversity and lifestyle factors in the healthy gut: a role for the food chain?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia ANTUNES",Portugal
5507,PS066,5464,"Post-coital dynamics of the male and female genital microbiome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel PARK","United States"
5508,PS066,5464,"Blastocystis sp. relationship with gut microbiota composition in healthy donors from a microbiota transplant centre",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa RUBIO GARCÍA",Spain
5509,PS066,5464,"Interactions between respiratory viruses, airway microbiome and immune response during pulmonary exacerbations in children with cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joke BASTIAENSSEN",Belgium
5510,PS066,5464,"Androgen receptor blockade induces the phagocytosis of wound associated bacteria by monocyte-derived macrophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica MCLOUGHLIN","United Kingdom"
5511,PS066,5464,"Clinical infection patterns and pulmonary tropism of Yarrowia lipolytica in murine models",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jinhan YU",China
5512,PS066,5464,"Interactions between Dolosigranulum pigrum and Corynebacterium species, health-associated bacterial commensals of the human nasopharynx",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kan YU",Australia
5513,PS066,5464,"DPP4 activity and translocation of membrane vesicles of Enterococcus faecium",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabell RAMMING",Germany
5514,PS066,5464,"Phage-host interaction in Pseudomonas aeruginosa clinical isolates with functional and altered quorum sensing systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dandan LI",China
5515,PS066,5464,"Oral microbiome landscape under household quarantine measures during the first wave of COVID-19 pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel BLANCO FUERTES",Spain
5516,PS066,5464,"Interpretation of respiratory virus detection in adults hospitalised with acute respiratory infection: insights from a host response profiling study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alex TANNER","United Kingdom"
5517,PS066,5464,"Mouse model for eradication of Streptococcus pyogenes from the upper respiratory tract",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabio FIORINO",Italy
5518,PS066,5464,"Live-cell confocal microscopy reveals that intracellular Staphylococcus aureus producing phenol-soluble modulins triggers an autophagic response prior to cytosol access in HeLa cells",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alicia EYMARON",France
5519,PS067,NULL,"09c. Pre-clinical biofilm studies","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
5520,PS067,5519,"Assessment of the cefiderocol anti-biofilm effect against 28 clinical strains of multidrug-resistant Gram-negative bacilli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta DÍAZ-NAVARRO",Spain
5521,PS067,5519,"VG111 and its impact on Stenotrophomonas sepilia biofilms: unveiling a promising antibiofilm strategy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vikas GAUTAM",India
5522,PS067,5519,"Efficacy testing of antimicrobial fibrous wound dressings against in vitro polybacterial biofilm",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kelli RANDMÄE",Estonia
5523,PS067,5519,"Activity of individual drugs against biofilm in hypervirulent Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qingqing XU",China
5524,PS067,5519,"Beyond resistance ? Exploring biofilm dynamics in carbapenem-resistant Acinetobacter baumannii from urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kavitha KUMAR",India
5525,PS067,5519,"Biofilm characterisation and antimicrobial susceptibility of Gram-positive bacteria associated with osteoarticular infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paola BOCANEGRA IBARIAS",Mexico
5526,PS067,5519,"The role of Cutibacterium acnes in adolescent acne: a study of microbiome diversity and biofilm production",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alpana MOHTA",India
5527,PS067,5519,"Biofilm induction by glucose and/or sodium chloride in S. aureus isolates from the airways of Spanish people with cystic fibrosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paula EGUIZÁBAL",Spain
5528,PS067,5519,"Analysis and photodynamic inactivation of biofilm of carbapenemase-resistant isolates of Klebsiella pneumoniae in a regional hospital in Slovakia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaroslava DEKKEROVÁ",Slovakia
5529,PS067,5519,"Reduction of bacterial adhesion on wrinkled surfaces under fluid shear",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rossella MAURO",Italy
5530,PS067,5519,"Effects of small molecules and antimicrobial peptides targeting small RNA00203: pioneering antimicrobial solutions for biofilm-producing, multidrug-resistant Acinetobacter baumannii",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abebe Mekuria SHENKUTIE",China
5531,PS067,5519,"Are biomass and metabolic activity staining biofilm techniques reliable enough to be used in microbiology laboratories?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta DÍAZ-NAVARRO",Spain
5532,PS067,5519,"Exploring the interaction between antimicrobials and bioactive glass in the Cutibacterium acnes in vitro biofilm formation and in the Galleria mellonella in vivo model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mauro Jose COSTA SALLES",Brazil
5533,PS067,5519,"Evaluation of biofilm formation and the effectiveness of antimicrobial photodynamic therapy on polydioxanone yarns",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helvécio CARDOSO CORRÊA PÓVOA",Brazil
5534,PS067,5519,"Trace/sublethal antimicrobials in hospital wastewaters act as stressors which promote enhanced biofilm-expression in Pseudomonas aeruginosa in clinical and environmental colonisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Özge YETIS","United Kingdom"
5535,PS067,5519,"Differences in pathogenic mechanisms of Gram-positive and Gram-negative strains in medical device-associated infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alba SANCHEZ MORILLO",Spain
5536,PS067,5519,"Evaluation of rifampicin's potential for preventing the development and treating Pseudomonas aeruginosa biofilm in respiratory infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Estíbaliz TORRECILLA-SÁDABA",Spain
5537,PS067,5519,"Synergistic potential of rifampicin and aztreonam against Pseudomonas aeruginosa biofilm in respiratory infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Estíbaliz TORRECILLA-SÁDABA",Spain
5538,PS067,5519,"Genomic characterisation and antibiotic susceptibility of biofilm-forming Borrelia afzelii and Borrelia garinii from patients with erythema migrans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giorgia FABRIZIO",Italy
5539,PS067,5519,"Impact of penicillin susceptibility and endocarditis source on Enterococcus faecalis biofilm production",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julian AZZOUZI","United States"
5540,PS067,5519,"Determination of the MBIC and MBEC of ciprofloxacin and colistin in biofilms produced by Pseudomonas aeruginosa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ohiana RODRIGUEZ MEDINA",Spain
5541,PS067,5519,"Exploring the biofilm-mediated resistance in polymicrobial infections involving clinically relevant pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joana ARAÚJO ALVES DE CAMPOS",Portugal
5542,PS068,NULL,"09d.?Experimental and cellular microbiology","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
5543,PS068,5542,"Siderophore-PNA conjugates for antisense targeted control of bacterial pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mateusz WDOWIAK",Poland
5544,PS068,5542,"Extracellular vesicles of minimalistic bacteria as mediators of immune modulation and horizontal gene transfer",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theresa WAGNER",Switzerland
5545,PS068,5542,"3D model of monoculture of lung epithelial cells with/without bacterial infection to evaluate mucosomes interaction and their antibacterial activity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emanuela PELUSO",Italy
5546,PS068,5542,"Characterisation of a novel H. pylori bacteriophage with therapeutic potential",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luís MELO",Portugal
5547,PS068,5542,"Deciphering the redox environment in bacteriophage-infected bacteria by flow cytometry (FCM)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jia Hao YEO",Singapore
5548,PS068,5542,"Green tea antioxidant epicatechin to inhibit the SOS response and tackle antibiotic resistance dissemination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marina MURILLO TORRES",Spain
5549,PS068,5542,"Nisin A and cefoxitin combination against staphylococcal biofilms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathieu GREGOIRE",Belgium
5550,PS068,5542,"New discovery on the mode of action of letermovir and the resistance mechanism of human cytomegalovirus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claire GOURIN",France
5551,PS068,5542,"ADAR-mediated RNA editing of influenza A virus RNA is age-dependent and inversely correlates with viral load",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julia WIDSTRÖM",Sweden
5552,PS068,5542,"Pangenomic analysis of Haemophilus parainfluenzae reveals distinct metabolic patterns according to colonisation niche",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia PÉREZ CASTRO",Spain
5553,PS068,5542,"Typing and whole-genome analysis of lysogenic bacteriophages isolated from carbapenem-resistant Acinetobacter baumannii strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gulsen ULUCAM ATAY",Türkiye
5554,PS068,5542,"Monoclonal antibodies for functional studies and therapeutic applications in pneumococcal infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sven HAMMERSCHMIDT",Germany
5555,PS068,5542,"Model of activated macrophages infected with Streptococcus pneumoniae for immunomodulatory assays",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alba SOLER COMAS",Spain
5556,PS069,NULL,"09e. Fundamental science studies using Omics (in vitro and in vivo)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
5557,PS069,5556,"The establishment of a lytic phage library targeting carbapenem-resistant Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qingqing FANG",China
5558,PS069,5556,"Characteristics of outer membrane vesicles from Klebsiella pneumoniae: a proteomic insights",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qiwen YANG",China
5559,PS069,5556,"Pan-genomic analyses of digestive persistent Klebsiella pneumoniae in ICU patient",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benedicte LANGLOIS",France
5560,PS069,5556,"Evolution of human metapneumovirus A2 in vitro and post human challenge: tracking viral polymorphism using next-generation sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas NOULIN","United Kingdom"
5561,PS069,5556,"Multi-OMICS techniques decipher distinct immunotypes and novel diagnostic signatures for EPTB",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan RYBNIKER",Germany
5562,PS069,5556,"Multi-omics profiling immunosuppressive status in severe pneumonia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hongyu WANG",China
5563,PS069,5556,"The potential of using photodynamic inactivation to treat microbial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helena BUJDÁKOVÁ",Slovakia
5564,PS069,5556,"Metagenomic analysis reveals enterotype-based prognostic stratification in severe COVID-19 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Etienne RUPPE",France
5565,PS069,5556,"Genomic landscape of Achromobacter xylosoxidans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luis Angel NUÑEZ GARCIA",Mexico
5566,PS069,5556,"Penetrating the pilus biogenesis in ESKAPE pathogens through in-silico and in vitro approaches",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sanket KAUSHIK",India
5567,PS069,5556,"in vitro metabolic profiling of Acinetobacter baumannii in artificial urine medium and CAMHB: investigating the synergistic effects of colistin and sulbactam combination therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xiaolan HUANG",China
5568,PS069,5556,"Could archaea belong to Halobacteriales and Methanosarcinales order be biomarkers of schizophrenia? Studies on a rat model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dominika SALAMON",Poland
5569,PS069,5556,"A PCR-based test for classifying Staphylococcus aureus ST30 strains in phylogenetic groups",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Agnes Marie FIGUEIREDO",Brazil
5570,PS069,5556,"Proteomic characterisation of extracellular vesicles from Enterococcus faecalis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Christophe GIARD",France
5571,PS069,5556,"Response regulator OmpR-regulated metabolite succinate suppresses mucoviscosity of hypervirulence Klebsiella pneumoniae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Wang LIJUN",China
5572,PS069,5556,"Unraveling the regulatory circuits underlying human memory T cell precursor differentiation for developing improved vaccine co-adjuvants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuele NOTARBARTOLO",Italy
5573,PS069,5556,"Genomic characteristics of Listeria monocytogenes in clinical listeriosis: implications for pathogenicity and antibiotic resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammad SHAFIQ",China
5574,PS070,NULL,"09f. Immune response to infection (incl in vitro, animal and human studies, laboratory assessment of immunity and response, excl sepsis biomarkers)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","09. Fundamental microbiology, pathogenesis & immunity to infection",NULL,NULL,NULL,NULL
5575,PS070,5574,"Age-stratified analysis of the association between cytokine profiles and clinical outcomes in severe fever with thrombocytopenia syndrome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chenxi ZHAO",China
5576,PS070,5574,"Therapy modulates the response to T cell epitopes over the spectrum of tuberculosis infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linda PETRONE",Italy
5577,PS070,5574,"The PI3K-mTOR-HIF-alpha pathway regulates fibroblast-driven tissue destruction in tuberculosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ramla CUSMAN","United Kingdom"
5578,PS070,5574,"Engineering Klebsiella pneumoniae's outer membrane proteins as novel antigen for therapeutic purposes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Virginia BATIGNANI",Italy
5579,PS070,5574,"V-delta-2 T-cells response in people with mpox infection: a three-month longitudinal assessment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eleonora CIMINI",Italy
5580,PS070,5574,"Can the Torque teno virus viral load predict Clostridioides difficile infection and evolution?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Assaf MIZRAHI",France
5581,PS070,5574,"Antigen-specific modulation of inflammation and tissue remodelling in neurocysticercosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luz M. TORIBIO","United Kingdom"
5582,PS070,5574,"Pre-transplant anti-cytomegalovirus immunoglobulin G titers as predictor of cytomegalovirus infection in seropositive Filipino kidney transplant recipients: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vienne PINLAC",Philippines
5583,PS070,5574,"Lipopolysaccharide-induced inflammation and cardiomyocyte dysfunction in a cardiac spheroid model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon ATHLIN",Sweden
5584,PS070,5574,"Patients with TB disease differ from subjects with TB infection in the ability to in vitro control mycobacterial replication",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra AIELLO",Italy
5585,PS070,5574,"Cytokine modulation of mycobacterial restriction by macrophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Auliana Ratri Prabandari HIDAYAT",Indonesia
5586,PS070,5574,"Differential miRNA signatures in circulating CD4+ T cells of Indian patients with visceral leishmaniasis and post-kala-azar dermal leishmaniasis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ritirupa ROY",
5587,PS070,5574,"Single-cell profiling of T-dependent immune response of Borrelia burgdorferi infection in a murine model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Varpu RINNE",Finland
5588,PS070,5574,"Exploring the antimicrobial response of MAIT cells to Staphylococcus aureus and the impact of bacterial immune evasion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa Justine Melina RAINERI",Sweden
5589,PS070,5574,"Alteration of transcriptional immune profile in patients with severe Legionnaires' disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Camille ALLAM",France
5590,PS070,5574,"Molecular pathways affected by clarithromycin treatment in community-acquired pneumonia: analysis of the ACCESS trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanouil STYLIANAKIS",Netherlands
5591,PS070,5574,"Reduction in respiratory pathogen exposure and immunity in European children following COVID-19 non-pharmaceutical interventions: a link to the post-pandemic Group A Streptococcus outbreak",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kitt DOKAL","United Kingdom"
5592,PS070,5574,"Micro- and nanoplastics  reduce the phagocytosis of E. coli by THP-1 macrophages",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Florian EDBAUER",Germany
5593,PS070,5574,"Systemic and mucosal antibody responses to Streptococcus pneumoniae serotype 3 carriage",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwasefunmi AKEJU","United Kingdom"
5594,PS070,5574,"Differential local immune responses in Group A streptococcal necrotising soft tissue infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura Marcela PALMA MEDINA",Sweden
5595,PS070,5574,"Sepsis-induced immune dysfunction weakens tumour defense and undermines immunotherapy efficacy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Santiago LETONA",Spain
5596,PS070,5574,"Impaired neutrophil respiratory burst response in elderly and infectious states",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yuhan SUN",China
5597,PS070,5574,"Genome-wide DNA methylation profiling in acute Lyme neuroborreliosis and over a one-year follow-up period",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna J HENNINGSSON",Sweden
5598,PS070,5574,"FTY720-induced cryptococcosis reactivation in persistently infected mice: mechanisms uncovered",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michiko YOSHIDA",Japan
5599,PS070,5574,"Virus and bacteria co-infection breaks the host adaptive immunity against IAV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hui QI",China
5600,PS070,5574,"Mitigating infectious disease by early neutrophil activation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan CUPPEN",Netherlands
5601,PS070,5574,"Arginase-1-mediated T cell suppression by MDSCs in dermatophytic infection: a combined transcriptomic and functional study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Praveen Kumar SINGH",India
5602,PS070,5574,"Co-infection with persistent HPV and Merkel cell polyomavirus enhances IFN-lambdas production in the anal mucosa of MLWH",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matteo FRACELLA",Italy
5603,PS071,NULL,"10a. Host genetics: Susceptibility to infection & primary immunodeficiency","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
5604,PS071,5603,"Metagenomic sequencing reveals differences in lung microenvironment among patients with nontuberculous Mycobacterium pulmonary disease under different immune states",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Le QIN",China
5605,PS072,NULL,"10b. Infections related to solid organ transplantation","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
5606,PS072,5605,"Hepatitis B crossover boosters using a different product vs the boosters using the same product for renal transplant patients: a retrospective study with Bayesian inference",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kentaro IWATA",Japan
5607,PS072,5605,"Epidemiological burden of and risk factors for ganciclovir resistant /refractory cytomegalovirus in solid organ transplant patients and haematopoietic stem cell transplant patients: a multicentre cohort study, the ReCySOHT study: preliminary results",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Renato PASCALE",Italy
5608,PS072,5605,"Post-surgical infections in liver transplantation performed using robotic surgery: preliminary results of a case-control study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena GHIDONI",Italy
5609,PS072,5605,"Infectious complications in heart transplant recipients: a focus on fungal and mycobacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sukru DIRIK",Türkiye
5610,PS072,5605,"Impact of extended criteria donor transplants on infections in kidney and liver transplant recipients and marginal donor definition criteria: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cecilia BONAZZETTI",Italy
5611,PS072,5605,"Is nebulised liposomal amphotericin B universal prophylaxis in lung transplant recipients still useful? A single-centre cohort",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arnau MONFORTE PALLARÈS",Spain
5612,PS072,5605,"Clinical impact of preservation fluid culture in solid organ transplantation: a prospective observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea CONA",Italy
5613,PS072,5605,"HHV8-related diseases in solid organ transplantation: a case series",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cecilia BONAZZETTI",Italy
5614,PS072,5605,"Vancomycin-resistant Enterococcus infections after liver transplantation: clinical presentation and factors associated with mortality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maristela P. FREIRE",Brazil
5615,PS072,5605,"Kidney transplantation in people living with HIV: ten-year experience in Modena",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adriana CERVO",Italy
5616,PS072,5605,"Comparison of risk factors and outcome between high and low cytomegalovirus viremia in living donor R+D+ renal transplant recipients from Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sunil Kumar DODANI",Pakistan
5617,PS072,5605,"Single-centre experience with the use of letermovir for prophylaxis of cytomegalovirus in liver transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Regino RODRIGUEZ-ALVAREZ",Spain
5618,PS072,5605,"Diagnostic stewardship in early postoperative kidney transplantation: the role of CRP and procalcitonin in infection prediction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Imran HASANOGLU",Türkiye
5619,PS072,5605,"Experience with isavuconazole in lung transplant recipients with Aspergillus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose Tiago SILVA",Spain
5620,PS072,5605,"Impact of pre-transplant infection and multi-drug resistant (MDR) bacteria colonisation on in-hospital post-transplant survival in subjects with pre-transplant liver failure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alice MULÈ",Italy
5621,PS072,5605,"Inpatient antimicrobial usage among solid organ transplant recipients in Japan: a ten-year nationwide database study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Koh OKAMOTO",Japan
5622,PS072,5605,"Comprehensive insights into post-liver transplant infections: a study from a Quaternary care hospital in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vaishnavi VELMANI",India
5623,PS072,5605,"Invasive aspergillosis after lung transplantation: effectiveness of nebulised amphotericin-B prophylaxis and statins as preventive strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Douwe Frans POSTMA",Netherlands
5624,PS072,5605,"Evaluating maribavir use in solid organ transplant recipients: a real-world perspective",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark HERRINGTON","United States"
5625,PS072,5605,"Vancomycin systemic absorption in lung trasplant recipients treated with inhaled vancomycin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gonzalo ESCUDERO ARNÉS",Spain
5626,PS072,5605,"Lifestyle habits to minimise infection risk in kidney transplant recipients: a single-centre survey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tamara RUIZ MERLO",Spain
5627,PS072,5605,"Safety of adjuvant respiratory syncytial virus vaccine in lung and allogeneic haematopoietic cell transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adrian Anthony ALEXANDER",Canada
5628,PS072,5605,"Impact of prior mycobacterial and Aspergillus infections on post-lung transplant infections: risk factors, clinical features and prognosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miki NAGAO",Japan
5629,PS072,5605,"Impact of recipient age on the incidence of infection following kidney transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario FERNANDEZ RUIZ",Spain
5630,PS072,5605,"Go the extra mile: a solid organ transplant-specific antibiogram in a tertiary care centre in Japan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Satoshi KITAURA",Japan
5631,PS072,5605,"Evaluating the efficacy of HBIG and antiviral therapy in preventing hepatitis B recurrence in liver transplant patients: a study from data registry of Montaseriyeh hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rozita KHODASHAHI","Islamic Republic Of"
5632,PS072,5605,"Epithelial lining fluid (ELF) concentrations of beta-lactam agents in the lung allograft",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura N. WALTI",Switzerland
5633,PS072,5605,"Pre-transplant lymphocyte count and HCMV-specific T-cell response as predictive markers of severe HCMV reactivations in kidney transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irene CASSANITI",Italy
5634,PS072,5605,"Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients : an interim analysis of a three-year prospective, observational study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Milo GATTI",Italy
5635,PS072,5605,"Burden of first severe infections in kidney transplant recipients: a nationwide French cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanna MELICA",France
5636,PS073,NULL,"10c. Infections related to haematopoietic stem cell transplantation","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
5637,PS073,5636,"Prospective evaluation of short- and long-term immune responses to DTaP-IPV and DTaP vaccination in adult allogeneic HSCT recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Taiichiro KOBAYASHI",Japan
5638,PS073,5636,"Ethnic disparities in response to CMV immunotherapy using intravenous CMV hyperimmune globulin in paediatric allo-HSCT recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara RODARO",Italy
5639,PS073,5636,"Toxoplasmosis after allogeneic haematopoietic cell transplantation: 17 years of experience with Toxoplasma gondii  PCR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan GEA-BANACLOCHE","United States"
5640,PS073,5636,"Changing epidemiology of febrile neutropenia in patients undergoing allogeneic haematopoietic stem cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Siwar FRIGUI EP OUESLATI",Tunisia
5641,PS073,5636,"Implementing de-escalation of antimicrobial therapy to targeted agents in haematopoietic stem cell transplantation patients with bloodstream infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicoletta DI LAURIA",Italy
5642,PS073,5636,"Oral contezolid treatment for skin and soft tissue infections in paediatric patients with heamatologic disorders: a retrospective analysis of 13 cases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yu ZHANG",China
5643,PS073,5636,"Letermovir primary cytomegalovirus prophylaxis in allogeneic haematopoietic cell transplant recipients: data from the first multicentre Latin American study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian Armando HERRERA",Argentina
5644,PS073,5636,"Toxoplasma and allogeneic stem cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cristina Teresa FUENTES MORALES",Spain
5645,PS073,5636,"Hospital-acquired and ventilator-associated bacterial pneumonia in neutropaenic cancer patients or haematopoietic stem cell transplant recipients: the CARINA study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlota GUDIOL",Spain
5646,PS073,5636,"Tuberculosis among allogeneic bone marrow transplant recipients in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Satish SWAIN",India
5647,PS073,5636,"Cellular immune response to RSV vaccine and quadrivalent inactivated influenza vaccine in allogeneic stem cell transplant recipients in the early post-transplant period",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ellen WALSH",Ireland
5648,PS073,5636,"SARS-CoV-2 infection prior to hematopoietic stem cell transplantation does not increase mortality or the risk of graft-versus-host disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bruno RANDI",Brazil
5649,PS073,5636,"Assessment of T-cell-mediated, SARS-CoV-2-specific immune responses in patients after allogeneic haematopoietic stem cell transplantation: a prospective diagnostic study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michaela STEINHILPER",Germany
5650,PS073,5636,"Evaluation of invasive pneumococcal diseases and vaccination adherence in patients undergoing hematopoietic stem cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adriana BAQUEIRO ABAD RIBEIRO",Brazil
5651,PS073,5636,"Epidemiology and outcomes of carbapenem resistant Enterobacterales in immunosuppressed population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Basem ALRADDADI","Saudi Arabia"
5652,PS073,5636,"Isavuconazole for invasive fungal infections in patients with haematologic malignancies and haematopoietic stem cell transplantation: data from the first multicentre Latin American study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian Armando HERRERA",Argentina
5653,PS073,5636,"Antifungal prophylaxis strategies in patients with allogeneic haematopoietic stem cell transplantation: impact on empirical antifungal treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian Armando HERRERA",Argentina
5654,PS073,5636,"Infection in VEXAS patients undergoing haematopoietic stem cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Megan BIGGS","United States"
5655,PS073,5636,"Incidence of acute kidney injury in patients treated with beta-lactam monotherapy or beta-lactam/amikacin combination therapy after autologous haematopoietic stem cell transplantation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah DRÄGER",Switzerland
5656,PS073,5636,"Risk factors and a machine learning model to predict adenovirus infection in allogeneic haematopoietic stem cell transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabel Cristina RAMÍREZ-SÁNCHEZ",Colombia
5657,PS073,5636,"Safety and efficacy of contezolid in haematological patients with Gram-positive infections: a retrospective analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luyang CHANG",China
5658,PS074,NULL,"10d. Infections related to cell-based therapies","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
5659,PS074,5658,"Cytomegalovirus infections in patients with relapsed/refractory multiple myeloma on novel therapies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer MAKHOUL","United States"
5660,PS074,5658,"Longitudinal cytokine expression in CAR-T-treated aggressive-lymphoma patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gemma REYNOLDS",Australia
5661,PS074,5658,"Predicting risk of infection in CAR-T-treated lymphoma patients: utility of immune-profiling",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gemma REYNOLDS",Australia
5662,PS075,NULL,"10e. Infections related to cancer treatment (incl neutropaenia)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
5663,PS075,5662,"Infectious risks with blinatumomab exposure in B-cell acute lymphoblastic leukemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Seohyeon IM","United States"
5664,PS075,5662,"Epidemiology, risk factors and outcome of neutropaenic enterocolitis in onco-heamatological patients according to chemotherapy regimen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pierre-Yves BOCHUD",Switzerland
5665,PS075,5662,"Microbiological background of medical-related osteonecrosis of the jaw bones",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Edit ZSOLDINÉ URBÁN",Hungary
5666,PS075,5662,"Cytomegalovirus (CMV) reactivation after chimeric antigen receptor (CAR) T-cell therapy or bispecific antibodies treatment for hematologic malignancies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juhui HAN","Republic Of"
5667,PS075,5662,"Phenotypic and genotypic characterisation of atypical non-lactose-fermenting Escherichia coli in cancer patients: an emerging diagnostic challenge",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vijeta BAJPAI BATRA",India
5668,PS075,5662,"Molecular epidemiology and antimicrobial resistance profiles of Pseudomonas aeruginosa causing bloodstream infections in neutropenic cancer patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Irene CADENAS JIMÉNEZ",Spain
5669,PS075,5662,"Characterisation of bacteraemia caused by Staphylococcus aureus in oncologic patients and mortality-related factors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juan Fernando CONTRERAS VALERO",Colombia
5670,PS075,5662,"Risk of infection by carbapenemase-producing Enterobacterales, associated factors, and a predictive model for its development in oncological patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julian Andres HOYOS PULGARIN",Colombia
5671,PS075,5662,"Comparison of virus-specific T-cell therapy and CD45RA+ T-cell-depleted donor lymphocyte infusion against COVID-19 among adult patients with hematologic malignancies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balint Gergely SZABO",Hungary
5672,PS075,5662,"NGS-based pathogen detection in bronchoalveolar lavage fluid obtained from immunocompromised patients with pulmonary infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna Marie RUCKDESCHEL",Germany
5673,PS075,5662,"Risk of infection in multiple myeloma patients receiving bispecific antibodies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eduardo APARICIO-MINGUIJÓN",Spain
5674,PS075,5662,"Clinical utility of serum procalcitonin in cancer patients with suspected sepsis episode",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nitin BANSAL",India
5675,PS075,5662,"Enterococcal bacteraemia in children undergoing anticancer therapy or haematopoietic stem cell transplantation: a multicentre nationwide survey in Poland (2014-2021)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aleksandra KRÓLAK",Poland
5676,PS075,5662,"Infectious complications in patients with relapsed and refractory multiple myeloma undergoing novel bispecific antibody therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silpa JETTY","United States"
5677,PS075,5662,"Antibiotic de-escalation in neutropenic patients with Enterobacterales bacteraemia: an important antimicrobial stewardship programme strategy in the multi-drug resistant era",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian Armando HERRERA",Argentina
5678,PS075,5662,"Characterisation of infections in immunosuppressed patients with lung cancer in Northwest Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Berta PERNAS-SOUTO",Spain
5679,PS075,5662,"Guideline adherence for vancomycin prescribing in febrile neutropaenia cases in Jordan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aseel ABUSARA",Jordan
5680,PS075,5662,"Bacteraemia in neutropaenic patients admitted to the intensive care unit with septic shock: aetiology, clinical characteristics, outcome and impact of multidrug resistance on mortality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fabian Armando HERRERA",Argentina
5681,PS075,5662,"Clinical impact of OXA-48-producing Enterobacterales rectal colonisation on heamatologic patients with febrile neutropaenia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miguel RODRÍGUEZ-FERNÁNDEZ",Spain
5682,PS075,5662,"Bacterial agents and antibiotic resistance in febrile neutropenia in Africa: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Temitope OBADARE",Nigeria
5683,PS075,5662,"Tuberculosis (TB) screening and TB disease in patients on immune checkpoint inhibitors (ICIs)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yii Ean TEH",Singapore
5684,PS075,5662,"Bloodstream infection in heamatological malignancy patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ebru ORUC",Türkiye
5685,PS076,NULL,"10f. Infections related to other forms of immunosuppression (e.g. gastrointestinal, rheumatological, dermatological disease, biologicals)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","10. Immune compromise & transplant ID",NULL,NULL,NULL,NULL
5686,PS076,5685,"A proposal of the refined diagnostic criteria for invasive pulmonary aspergillosis in autoimmune inflammatory rheumatic diseases treated with immunosuppressive agents",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Takashi KURITA",Japan
5687,PS076,5685,"Bloodstream infection and risk for plasma cell neoplasms: a large population-based cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adam STEWART","United States"
5688,PS076,5685,"Temporal timing patterns of herpes zoster events in relation to diagnosis of immunocompromising conditions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omid REZAHOSSEINI",Denmark
5689,PS076,5685,"Timing of pneumococcal infections in adults with diseases associated with immunocompromised states: temporal patterns and implications for vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omid REZAHOSSEINI",Denmark
5690,PS076,5685,"IL-5 inhibitors and screening for helminth infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah JAWAD","United Kingdom"
5691,PS077,NULL,"11a. General vaccinology (incl in vitro and in vivo studies, safety, regulatory, policy, social aspects)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5692,PS077,5691,"Correlation of sociodemographic vulnerability versus RSV vaccination rates: preliminary results from a U.S. metropolitan area.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernanda VALDEZ-BLANCO","United States"
5693,PS077,5691,"The emergence of a hypervirulent Streptococcus pneumoniae serotype 3 after PCV13: a whole-genome sequencing study in Zhejiang, China",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lin LIU",China
5694,PS077,5691,"High hydrostatic pressure technology for low-cost vaccine production: preclinical in vivo testing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vittorio SAMBRI",Italy
5695,PS077,5691,"A nationwide randomised trial to confirm effectiveness of electronically delivered nudges in increasing influenza vaccination uptake among young and middle-aged adults with chronic disease: NUDGE-FLU-CHRONIC-2",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niklas Dyrby JOHANSEN",Denmark
5696,PS077,5691,"Profiling vaccination patterns in immunosuppressed patients against respiratory infections in community pharmacies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel J.G. THIRION",Canada
5697,PS077,5691,"Immunisation against Chlamydia trachomatis polymorphic membrane protein D tetrapeptide motifs limits early female reproductive tract infection in a mouse model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andzoa JAMUS","United States"
5698,PS077,5691,"The effect of time since first dose of measles-containing vaccine on measles IgG concentration and seronegativity: a retrospective cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Archchun ARIYARAJAH",Canada
5699,PS077,5691,"Investigation of influenza, COVID-19 and pneumococcal vaccination status in adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gamze SANLIDAG ISBILEN",Türkiye
5700,PS077,5691,"Hybrid protection against laboratory-confirmed SARS-CoV-2 infection in a European multi-centre prospective cohort of healthcare workers, 2021–2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Madelyn ROJAS CASTRO",France
5701,PS077,5691,"Pneumococcal disease and vaccination: descriptive results from a systematic literature review of knowledge, attitudes, and practices surveys and preference elicitation studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heather VANSEGGELEN",Canada
5702,PS077,5691,"Pneumococcal vaccination with PCV13 during hospitalisation for acute infection disease: a real-life opportunity for vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Julie MERINDOL",France
5703,PS077,5691,"Investigating the state of vaccine confidence among the general public and parents with young children in Flanders (Belgium)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jade PATTYN",Belgium
5704,PS077,5691,"Short-term survival following an event of HZ: a register-based matched cohort study in Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mads Frederik EIBERG",Denmark
5705,PS077,5691,"People living with HIV and vaccination: insights into awareness, recommendations, and attitudes at a tertiary care centre in Turkey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Derya KAYA",Türkiye
5706,PS077,5691,"Roadmap to improve vaccine effectiveness research and evidence synthesis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matt LOIACONO","United States"
5707,PS077,5691,"Public health impact of herpes zoster vaccination for immunocompromised individuals aged 18-49 years in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Franziska JAKOBS",Germany
5708,PS077,5691,"Strategies for introducing and implementing vaccines for adults into National Immunisation Programmes in Europe: exemplary approaches and key insights of the adult immunisation board meeting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco DEL RICCIO",Italy
5709,PS077,5691,"Safety and immunogenicity of co-administration of herpes zoster vaccines with other vaccines in adults: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omid REZAHOSSEINI",Denmark
5710,PS077,5691,"Development of bipolymer based novel nanoparticles in microsphere system as vaccine adjuvant",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mani BHARGAVA",India
5711,PS077,5691,"Assessing vaccine hesitancy and vaccine literacy in adults in Saudi Arabia, United Arab Emirates, Turkey and South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dzhumber UGREKHELIDZE",Switzerland
5712,PS077,5691,"Oral combination vaccine against hepatitis B and influenza: development and characterisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Himanshu SARAF",India
5713,PS077,5691,"Antibody coated liposomes for transmucosal vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priyanka GOSAIN",India
5714,PS077,5691,"Evaluation of functional antibody responses to sequential PCV13 and PPSV23 vaccination in type 2 diabetes mellitus adults: insights from a first study in the Indian population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sravani DHARMAVARAM",India
5715,PS077,5691,"The impact of COVID-19 pandemic on poliomyelitis surveillance and immunisation in Armenia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Goulia OHAN",Armenia
5716,PS077,5691,"Current status of seasonal influenza vaccination policy in poultry industry workers in LATAM",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jose MONTES",Argentina
5717,PS077,5691,"Safety and immunogenicity of a novel RH5.1/matrix-M malaria vaccine in UK healthy adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kyra HOLLIDAY","United Kingdom"
5718,PS077,5691,"Truncated VZV gE induces high-titer neutralising antibodies in micetruncated VZV gE induces high-titer neutralising antibodies in mice",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Song XU",China
5719,PS077,5691,"Exploration of the risk-benefit profile of administering dengue vaccines with mixed efficacy estimates in different epidemiological contexts",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yehuda DAVIS","United Kingdom"
5720,PS077,5691,"Co-administration of pneumococcal vaccines with common travel vaccines: a systematic review of immunogenicity and safety",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omid REZAHOSSEINI",Denmark
5721,PS077,5691,"Perception of vaccination during mild fever, insights from patients with a recent febrile illness and healthcare professionals: a qualitative study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soumaya ESSALIM",France
5722,PS077,5691,"Assessing the willingness of future healthcare providers to participate in vaccine trials: a cross-sectional VACCELERATE European study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zoi Dorothea PANA",Cyprus
5723,PS077,5691,"Current status of HPV gender neutral vaccination (GNV) in Latin America: a call for health equity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hebe Noemi VAZQUEZ","United States"
5724,PS077,5691,"Impact of BCG vaccination on innate immune responses in HIV-exposed uninfected infants in Uganda: a randomised controlled trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rhoda NAMAKULA",Norway
5725,PS077,5691,"Immunogenicity and adverse effects of pneumococcal vaccines coadministered with influenza or SARS-CoV-2 vaccines in adults: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Omid REZAHOSSEINI",Denmark
5726,PS077,5691,"Effect of  intravenous immunoglobulins on vaccine response of routine childhood vaccines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benno KOHLMAIER",Austria
5727,PS078,NULL,"11b. Antiviral vaccines (excl respiratory and bloodborne viruses)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5728,PS078,5727,"Paced immune activation by AS04 drives superior cross-protective antibody response in Cervarix",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Valentino D'ONOFRIO",Belgium
5729,PS078,5727,"Consolidating evidence on the number needed to vaccinate against herpes zoster in older adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marie NISHIMWE",France
5730,PS078,5727,"Kinetics of B and T cell responses to vaccination with chikungunya virus virus-like particle vaccine",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lauren TINDALE",Canada
5731,PS078,5727,"Impact of rotavirus vaccination on the aetiological profile of viral diarrhoea in under-five children in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debasis BISWAS",India
5732,PS078,5727,"Identification of immunity gaps and risk groups for future outbreaks of measles, mumps, and rubella: cross-sectional study of seroprevalence in young healthcare professionals in Serbia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana BANKO",Serbia
5733,PS078,5727,"Prevalence of HPV and associated risk factors for cervical lesions among women in northern Cameroon: a community-based study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fouelifack Nzeko ERIC",Cameroon
5734,PS078,5727,"Recombinant zoster vaccine (RZV) does not increase the recurrence of herpes zoster (HZ) in adults ≥50 years of age with HZ history: a randomised clinical trial",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bisi JEGEDE","United States"
5735,PS078,5727,"Vaccination uptake among patients on PrEP: patterns and associated factors, 2021-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albiana CEKREZI",Italy
5736,PS078,5727,"Safety of LC16m8 vaccine in HIV-positive and high-risk populations in Bogotá, Colombia: a cohort study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos Arturo ALVAREZ MORENO",Colombia
5737,PS079,NULL,"11c. Antibacterial vaccines","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5738,PS079,5737,"Immunogenicity and safety of the higher valent pneumococcal conjugated vaccine compared to the 13-Valent pneumococcal conjugated vaccine in older adults: a systematic review and meta-analysis of randomised controlled trials",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thundon NGAMPRASERTCHAI",Thailand
5739,PS079,5737,"Recombinant subunit combined vaccine, a preventable zoonotic One Health approach for enhanced safety and immunogenicity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Qaiser AKRAM",Pakistan
5740,PS079,5737,"Fifteen years of Streptococcus pneumoniae laboratory surveillance: alarming serotype shift and the impact of PCV in Serbia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Natasa OPAVSKI",Serbia
5741,PS079,5737,"Post-pandemic Streptococcus pneumoniae serotype epidemiology and antimicrobial susceptibility among adults =18 years old with invasive and noninvasive pneumococcal disease in the United States, 2022-2023",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mekki BENSACI","United States"
5742,PS079,5737,"Silver and gold bimetallic nanoparticles as an innovative bacterial vaccine platform against infections caused by ESKAPE group species",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathália ANDRADE",Argentina
5743,PS079,5737,"Streptococcus pneumoniae carriage in children less than 25 months in North of Algeria (Blida) after introduction of PCV13",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Selma BOUHERAOUA",Algeria
5744,PS079,5737,"Serotype distribution of invasive disease-causing Streptococcus pneumoniae after 14 years of systematic vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"María ALONSO GIRÓN",Spain
5745,PS079,5737,"Safety, tolerability, and immunogenicity of 31-valent pneumococcal conjugate vaccine (VAX-31) in healthy adults =50 years: a Phase 1/2, randomised, active-controlled, dose-finding study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"James WASSIL","United States"
5746,PS079,5737,"Early changes in incidence of paediatric invasive pneumococcal disease after introduction of 15-valent pneumococcal conjugate vaccine in Catalonia, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria CISNEROS",Spain
5747,PS079,5737,"Factors influencing uptake of pneumococcal vaccination after invasive pneumococcal disease in two centres in northern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giacomo PONTA",Italy
5748,PS079,5737,"Pneumococcal vaccination rates among patients hospitalised for Pneumococcal infection at a community teaching hospital",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shikha MISHRA","United States"
5749,PS079,5737,"Development of a double-auxotrophic Klebsiella pneumoniae strain as a safe and effective oral vaccine candidate to prevent gastrointestinal colonisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebeca SANTAMARINA",Spain
5750,PS079,5737,"Invasive pneumococcal disease and impact of 7- and 13-valent pneumococcal conjugate vaccines in Singapore children over 24 years",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jiahui LI",Singapore
5751,PS079,5737,"Systematic literature review of the efficacy/effectiveness, immunogenicity and safety of booster vaccinations against pertussis in adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian RAUSCHERT",Germany
5752,PS079,5737,"Torque teno virus load as a predictor of serotype-specific antibody response to the 13-valent conjugated pneumococcal vaccine in adult kidney transplant recipients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lykke LARSEN",Denmark
5753,PS079,5737,"Estimating the public health impacts of introducing an age-based national Immunisation programme for adult pneumococcal vaccination in Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwaseun SHAROMI","United States"
5754,PS079,5737,"Predicting the public health impacts of using different adult pneumococcal vaccines in ≥65-years-old adults in Sweden",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oluwaseun SHAROMI","United States"
5755,PS079,5737,"Invasive Streptococcus pneumoniae infections in southern Switzerland: a preventable condition that is not actually prevented",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niccolò RAMPONI",Switzerland
5756,PS079,5737,"Development of live attenuated candidate vaccine by gene knockout method",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deepak KUMAR",India
5757,PS079,5737,"Estimating the health and economic burden of pneumococcal diseases attributable to V116 vs PCV20 serotypes among adults in Austria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Peter MUELLER","United States"
5758,PS079,5737,"Estimating the pneumococcal vaccine preventable incidence of childhood pneumonia towards the mitigation of AMR: a vaccine probe study of cross-sectional data from a household survey in rural Vietnam",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Prince Kelechi CHIMA","United Kingdom"
5759,PS079,5737,"Use of new 21-valent pneumococcal conjugate adult vaccine in the presence of uncertainties around increases in invasive pneumococcal disease clusters caused by serotype 4 in the United States: a model-based threshold analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zinan YI","United States"
5760,PS079,5737,"Implications of recently revised pneumococcal vaccination recommendation for adults in Germany",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark VAN DER LINDEN",Germany
5761,PS079,5737,"Encapsulation of L7/L12 and OMP19 proteins from Brucella melitensis in liposomal adjuvant system as a strategy to develop an effective vaccine against brucellosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mohammadreza ASADIKARAM","Islamic Republic Of"
5762,PS080,NULL,"11d. Other preventive modalities (incl new vaccine technologies, antibody-based treatments)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5763,PS080,5762,"Evaluation of immunoglobulin use as post-exposure prophylaxis during a national measles outbreak in England",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luke MCGEOCH","United Kingdom"
5764,PS080,5762,"Design of a smartphone app for recall-based contact tracing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Caspar GEENEN",Belgium
5765,PS080,5762,"Potential public health impacts of gonorrhoea vaccination programmes under declining incidences: a modelling analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lin GENG",Singapore
5766,PS081,NULL,"11e. Food & water safety, environmental health, vector epidemiology","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5767,PS081,5766,"Insecticide susceptibility of the sand fly leishmaniasis vector Phlebotomus argentipes in Bihar, India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ashish SHUKLA",India
5768,PS081,5766,"Compatibility study of transport medium with PCR kits for detecting listeria spp. and Staphylococcus aureus from environmental samples",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilaria TRIVA",Italy
5769,PS081,5766,"Rabbit production system and zoonotic Salmonella serovars: an Italian outbreak associated with Salmonella enteritidis ST11",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Letizia CIRASELLA",Italy
5770,PS081,5766,"Antiadherent effect of a polysilazane-based sol-gel coating against Listeria monocytogenes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"John Jairo AGUILERA CORREA",Spain
5771,PS081,5766,"Cross-contamination pathways and risk behaviours: insights from food and domestic surfaces in urban slums of bangladesh Enabl",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Syeda NURUNNAHAR",Bangladesh
5772,PS081,5766,"Seasonal distribution and diversity of Vibrio spp. in the Baltic Sea of northeastern Germany and associated water systems",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evgeny A. IDELEVICH",Germany
5773,PS081,5766,"Prevalence and genetic characterisation of Listeria monocytogenes isolated from pork production chain in South Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kun Taek PARK","Republic Of"
5774,PS081,5766,"Prevalence of multiresistant: Enterobacteriaceae in aquatic ecosystems in Osona, Spain",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Javier DÍEZ DE LOS RÍOS",Spain
5775,PS081,5766,"From sea to clinic: a 13-year study of Vibrio and Shewanella infections in the Atlantic coastal waters in southern Spain and their environmental links",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra TAPIA POZA",Spain
5776,PS081,5766,"Prevalence of extended-spectrum beta-lactamase producing-and carbapenemase-resistant Enterobacterales and methicillin-resistant S. aureus isolated from surface water in southern Italy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gaia NOBILI",Italy
5777,PS081,5766,"Emergence and spreading of blaCTX-M-65 carrying Salmonella infantis in retail poultry meats in Korea",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yeona KIM","Republic Of"
5778,PS081,5766,"Monitoring rabbit colibacillosis and antimicrobial resistance: insights for effective interventions and public health impact",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Azucena MORA GUTIÉRREZ",Spain
5779,PS081,5766,"Detection of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacterales in hospital effluent: a pilot study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Martin ANDRE",Belgium
5780,PS081,5766,"Highest levels of antibiotic resistance seen in exclusively ExPEC Escherichia coli in Wyoming and Wales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan Aston Tregurtha MATHIAS","United Kingdom"
5781,PS081,5766,"Re-measuring community ExPEC Escherichia coli carriage in wastewater five years on, 2019-2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan Aston Tregurtha MATHIAS","United Kingdom"
5782,PS081,5766,"Using wastewater to survey community carriage of Staphylococcus aureus at a genomic level in rural Wyoming",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jordan Aston Tregurtha MATHIAS","United Kingdom"
5783,PS081,5766,"The role of antibiotics in the management of persistent shedding of shiga toxin-producing Escherichia coli (STEC)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gauri GODBOLE","United Kingdom"
5784,PS081,5766,"Phenotypic heterogeneity and biofilm formation in foodborne neomycin-resistant P. aeruginosa isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shaista UROOJ",Pakistan
5785,PS081,5766,"The role of microbiological criteria for foodstuffs notably GSO 1016/2015 in controlling Escherichia coli O157 in meat in Saudi Arabia and other countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meshari ALHADLAQ","Saudi Arabia"
5786,PS081,5766,"Emergence and clonal spread of livestock-associated methicillin-resistant Staphylococcus aureus harboring a novel variant staphylococcal chromosome cassette mec in Korean pig farms",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hyeon Woo CHO","Republic Of"
5787,PS081,5766,"Co-occurrence of Legionella pneumophila and free-living Amoebae in water conduits in southern Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sameh BELGACEM",Tunisia
5788,PS081,5766,"Wastewater-based genomic surveillance key to population-level monitoring of AmpC/ESBL-producing Escherichia coli",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ahmad Ibrahim AL-MUSTAPHA",Finland
5789,PS081,5766,"Detection and molecular characterisation of aflatoxin and ochratoxin produce Aspergillus species in Capsicum spices in Saudi Arabia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manal ALMUSA","Saudi Arabia"
5790,PS081,5766,"Contamination of leafy vegetables and strawberries with Echinococcus granulosus sensu lato and Taenia spp. in Tunisia: implication for food safety",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines KAMOUN",Tunisia
5791,PS081,5766,"Genomic characterisation of zoonotic bacteria carried by wild birds during the migratory season in Gauteng, South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Theevasha GOVENDER","South Africa"
5792,PS081,5766,"Evaluation of water quality through pipe microbiome characterisation using 16S gene metagenomics approach",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura CALIGARIS",Italy
5793,PS081,5766,"Prevalence and associated risk factors of vancomycin-resistant Enterococcus faecium in well water used for domestic purposes in Ile-Ife, southwestern Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Babatunde ODETOYIN",Nigeria
5794,PS081,5766,"Large scholar food-borne outbreak caused by Clostridium perfringens type F with plasmid enterotoxin CPE",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernando COBO",Spain
5795,PS081,5766,"Advancing wastewater-based surveillance of antimicrobial resistance: a novel hybrid approach combining cultivation-based and molecular techniques for the detection of antibiotic resistant bacteria and resistance genes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra FOBE",Austria
5796,PS081,5766,"Surface hygiene in food environments: challenges with biocide efficacy and bioindicators",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia ANTUNES",Portugal
5797,PS081,5766,"Negligible impact of quaternary ammonium compounds on the spread of toxigenic and antibiotic-resistant Clostridium perfringens in rivers used for drinking water production",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carla NOVAIS",Portugal
5798,PS081,5766,"Dominant species and serogroups of Legionella spp. in swimming pool water in the Federation of Bosnia and Herzegovina",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emilija HRAPOVIC","Bosnia And Herzegovina"
5799,PS081,5766,"Summer surge of sequence type 283 in Hong Kong: a five-year review of Group B Streptococcus molecular distribution in non-pregnant adults",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tiffany DIDIK",China
5800,PS081,5766,"Environmental surface sampling of respiratory and gastrointestinal pathogens during the 2022-2023 Grand Magal of Touba",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ihssane OUADDANE",France
5801,PS081,5766,"Mapping antimicrobial resistance landscape at a city scale sewage network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miquel SÁNCHEZ-OSUNA",Spain
5802,PS081,5766,"Detection and prevalence of moulds and mycotoxins in food for young children and infants, nuts and grains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Amir IBRAHIMAGIC","Bosnia And Herzegovina"
5803,PS081,5766,"Performance comparison of two different sampling strategies in deli food production plant: FLOQSwab and sponges, for the detection of Listeria monocytogenes and Bacillus cereus",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erica TIRLONI",Italy
5804,PS081,5766,"Foodborne Listeria monocytogenes in chicken viscera products: implications for food safety and public health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vanessa SILVA",Portugal
5805,PS081,5766,"Methicillin resistant Staphylococcus aureus prevalance in abbatoirs and meat shops in the northern border regions between Pakistan and Afghanistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sohail KHAN",Pakistan
5806,PS081,5766,"A surveillance study of Cryptosporidium parvum present in organic waste used as fertiliser in Ireland",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma HEFFERNAN",Ireland
5807,PS082,NULL,"11f. Veterinary microbiology and One Health (excl AMR)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5808,PS082,5807,"Genomic analysis of Campylobacter coli strains tolerant to stress conditions associated to food safety suggests possible contamination amongst diverse sources in Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina Nogueira GOMES",Brazil
5809,PS082,5807,"Detection of Leptospira spp. in Marmosets (Callithrix spp.) from the Atlantic Forest (Rio de Janeiro-RJ) of Brazil",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Juliana ARAUJO NOBRE",Brazil
5810,PS082,5807,"Multidrug-resistant and ESBL-producing Salmonella Kentucky ST198: a veterinary outbreak with public health implications",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandro BELLATO",Italy
5811,PS082,5807,"Potentially azole-resistant and thermal tolerant human and coral pathogen Aspergillus sydowii in wild Spanish Cetaceans: implications for One Health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor GARCIA-BUSTOS",Spain
5812,PS082,5807,"Cure of a difficult-to-treat Pseudomonas aeruginosa chronic otitis externa (OE) in a dog with the PYO bacteriophage cocktail followed by antibiotics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raphaël BAUDIN",Switzerland
5813,PS082,5807,"Exploring nitroxoline as a solution to antibiotic resistance in poultry production",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mariia TRUSH","United Kingdom"
5814,PS082,5807,"Impact of different temperatures on Chlamydia abortus survival and infectivity over time",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Efe ALTUNTAS",Switzerland
5815,PS082,5807,"An unconjugated single composite peptide vaccine targeting highly conserved influenza epitopes induced broadly reactive and durable antibodies to multiple influenza viruses in pigs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kellie Ann KROSCHER","United States"
5816,PS082,5807,"Exploring the distribution of virulence factors associated with Escherichia coli through the One Health paradigm",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandra A. MARTÍNEZ-ÁLVAREZ",Spain
5817,PS082,5807,"Active surveillance in an equine intensive care unit identifies clusters of ESKAPEE pathogens in the veterinary hospital environment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Els BROENS",Netherlands
5818,PS082,5807,"Global insights into the accessory genome of Streptococcus equi subspecies equi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lingyu HE",China
5819,PS082,5807,"Elucidating the endemicity of amphixenotic Ascaris lumbricoides in pigs: the most prospective cross-transmission threat to humans in Haryana, India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aman Dev MOUDGIL",India
5820,PS082,5807,"Cold atmospheric plasma as an alternative antimicrobial therapy to treat livestock wound infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica GHODKE","United Kingdom"
5821,PS082,5807,"Unveiling tick diversity in cattle in Cameroon: emergence of Rhipicephalus microplus, replacing the original Rhipicephalus spp.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Muhammad Umair AZIZ",China
5822,PS082,5807,"Prevalence of Gram-positive cocci isolated from livestock and livestock farmers in Japan: high prevalence of Mammaliicoccus sciuri",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ryusei TANIGUCHI",Japan
5823,PS082,5807,"Global prevalence and molecular features of high-priority Enterococcus faecium and E. faecalis from guts of food-producing and wild birds",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Idris Nasir ABDULLAHI",Nigeria
5824,PS082,5807,"One Health lens on rabies: genomic insights and human-animal interactions in rural Lilongwe, Malawi",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nathan SINGANO",Zambia
5825,PS082,5807,"Toxigenic Corynebacterium ulcerans in raw milk of a cow with acute mastitis and the risk of milk-associated diphtheria in humans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anja BERGER",Germany
5826,PS082,5807,"Zoonotic gastrointestinal parasites in dogs: an epidemiologic study of agricultural zones in Tunisia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lamia ZEMZEMI",Tunisia
5827,PS082,5807,"Azole-resistant Aspergillus and Candida isolates in bottlenose dolphins: implications for One Health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Victor GARCIA-BUSTOS",Spain
5828,PS083,NULL,"11g. Global health & health security (incl policy-making, climate change, biosafety/biosecurity)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5829,PS083,5828,"The relationship between COVID-19 and final consumption expenditure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soichi TAKEISHI",Japan
5830,PS083,5828,"Advancing antimicrobial stewardship with the SMART-AMS model: a strategic framework to combat antimicrobial resistance for a healthier future",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rasha ABDELSALAM ELSHENAWY","United Kingdom"
5831,PS083,5828,"Korean pandemic response repository through microbial and immunological surveillance and epidemiology (K-PREMISE)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shinhee HONG","Republic Of"
5832,PS083,5828,"Climate-driven antifungal resistance: new challenges in public health",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniela DEBONE",Brazil
5833,PS083,5828,"Clinical-epidemiologic versus laboratorial exam in the diagnosis on dengue fever in the environmental catastrophe scenario in Rio Grande do Sul, Brazil in 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Manoela LENZI PINTO",Brazil
5834,PS083,5828,"Modeling the potential public health and economic impact of timely COVID-19 vaccination with an adapted vaccine in the United Kingdom",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cale HARRISON","United Kingdom"
5835,PS083,5828,"A comprehensive analysis of disability-adjusted life years (DALYs) across 85 pathogens: the first-ever pathogen impact atlas on a global, regional and national scale",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tomislav MESTROVIC",Croatia
5836,PS083,5828,"Learning from post-COVID-19 condition for pandemic preparedness: a catalogue of variables for future post-acute infection syndromes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lorenzo Maria CANZIANI",Italy
5837,PS083,5828,"Heavy rainfall and flooding events and infectious diseases in Denmark",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nina RISE",Denmark
5838,PS083,5828,"Excess mortality during the COVID-19 pandemic compared to previous influenza seasons: estimates from 26 countries in the EuroMOMO network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah Kristine NØRGAARD",Denmark
5839,PS083,5828,"One Health criteria: considerations for One Health interventions and AMR national action plan designs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristina ALUZAITE","United Kingdom"
5840,PS083,5828,"Time for a multi-generational household respiratory infection vaccination strategy: scoping review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ahreej ELTAYEB","United Kingdom"
5841,PS083,5828,"Effects of climate change on Aedes aegypti abundance and dengue transmission",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lin GENG",Singapore
5842,PS083,5828,"Newest insights into the burden of antimicrobial resistance in Southeast Asia in 2021: a comparative evaluation of predominant resistant pathogens and pathogen-drug combination across countries of the region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tomislav MESTROVIC",Croatia
5843,PS083,5828,"Trends in prescriber applications to access unregistered antimicrobials in Australia: demonstrating the unmet need in a smaller population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew BOWSKILL",Australia
5844,PS083,5828,"Political, ethical, administrative, regulatory and legal (PEARL) barriers to site activation experienced in a pan-European warm-base clinical trial network",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Priya SHREEDHAR",Germany
5845,PS083,5828,"Learning from strengthening national laboratory systems towards global health security: experience of the UK Health Security Agency (UKHSA) international health regulations strengthening project (IHR-SP) laboratory team working across countries in Asia and Africa.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olajumoke SULE","United Kingdom"
5846,PS083,5828,"Sustainability challenges and opportunities of SARS-CoV-2 antigen rapid detection tests in the COVID-19 pandemic: a life cycle assessment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Isabell WAGENHÄUSER",Germany
5847,PS083,5828,"An investigation of national age–specific fertility rates in the Middle East using cluster analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Soichi TAKEISHI",Japan
5848,PS083,5828,"Under-estimated pertussis burden among older adults in Taiwan: a longitudinal seroepidemiological study from 2014 to 2020",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ming-Han TSAI",China
5849,PS083,5828,"Comparative analysis of NS1/IgM rapid diagnostic tests (RDT) with NS-1 and IgM ELISA for dengue cases and its possible correlation with under-reporting of dengue cases in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vishwa Deepak TIWARI",India
5850,PS083,5828,"Strategic positioning of the ESGVH-ESCMID for global hepatitis E virus vaccination",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonio RIVERO-JUAREZ",Spain
5851,PS083,5828,"The impact of armed conflict on the development and global spread of antibiotic resistance: a systematic review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guido GRANATA",Italy
5852,PS083,5828,"GENTRAIN: genome-based infection chain analysis to increase digitalisation level in the public health sector",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Airin FRANKE",Germany
5853,PS083,5828,"A digital tool for the selection of portable screening technologies for detecting substandard and falsified anti-infectives",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Céline CAILLET","United Kingdom"
5854,PS083,5828,"Omadacycline demonstrated efficacy as both therapeutic treatment and post-exposure prophylaxis against inhalation anthrax and pneumonic plague in cynomolgus macaques",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jessica PIERCE","United States"
5855,PS083,5828,"A cross-country comparison of antimalarial drug prices, availability, and affordability: insights from India and Nigeria",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sriram RADHAKRISHNAN",India
5856,PS083,5828,"Developing AWaRe-based antibiotic use quality indicators using sequential consensus methodology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jan GOELEN","United Kingdom"
5857,PS083,5828,"Evaluating the international performance of diagnostics systems for addressing antimicrobial resistance in 174 countries and territories: a systematic global analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jay PATEL","United Kingdom"
5858,PS083,5828,"Impact of French public health alerts in a specialty laboratory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Benoit VISSEAUX",France
5859,PS083,5828,"Factors influencing work absenteeism due to acute respiratory infections (ARIs) among healthcare workers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helen MUELLER",Germany
5860,PS083,5828,"Automating systematic reviews and meta-analyses: a framework for living evidence synthesis in infectious diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna GORSKA",Italy
5861,PS083,5828,"Differences in causes of death between males and females during periods with and without elevated mortality",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christel Baagø SCHJØRRING",Denmark
5862,PS083,5828,"When the rain pours, soars the pill: a pharmaco-audit of doxycycline sales in Chennai following Tamil Nadu's flood advisory",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarika SARIKA",India
5863,PS083,5828,"Epidemiological study of Streptococcus pyogenes in China and data mining based on global isolates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shiyu CHEN",China
5864,PS084,NULL,"11h. Infections in low-resource settings (incl disease burden, health infrastructure, health disparities and vulnerable populations)","Poster area |","12:00 - 13:30CETPoster Session",,CET,"Poster Session","11. Public health & vaccines",NULL,NULL,NULL,NULL
5865,PS084,5864,"Outbreak investigation of visceral leishmaniasis in Bihar, India: insights from an endemic region",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Urvashi Geeta RAI",India
5866,PS084,5864,"Assessment of HIV-related stigma among healthcare providers",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Merve MERT VAHABI",Türkiye
5867,PS084,5864,"Challenges in preventing pneumococcal disease in Costa Rica: serotypes, vaccination, and risk factors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raquel GARCIA-BATAN","Costa Rica"
5868,PS084,5864,"Acceptance of self-sampling and knowledge about human papilloma virus among women in north India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alpana MOHTA",India
5869,PS084,5864,"Atypical distribution of cervical HR-HPV in the Congo basin: implication for cervical cancer prevention",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent BÉLEC",France
5870,PS084,5864,"Socioeconomic factors and treatment limitations of intensive care in hospitalised COVID-19 patients",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Adonis SOTOODEH",Sweden
5871,PS084,5864,"Implementation of urine-based HR-HPV testing for cervical cancer prevention in a rural clinic in Eswatini, January 2023-February 2024",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sante Leandro BALDI",Italy
5872,PS084,5864,"Latent tuberculosis infection (LTBI) in an urban homeless population",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David MOYNAN",Ireland
5873,PS084,5864,"The mini-lab: the next step towards integrated antimicrobial resistance surveillance in South-Kivu Province, Democratic Republic of Congo",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chasinga BAHARANYI","The Democratic Republic Of The"
5874,PS084,5864,"Patient satisfaction with antiretroviral therapy services in selected hospitals of addis ababa, ethiopia using the donabedian model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Eskedar AZEREFEGNE",Ethiopia
5875,PS084,5864,"Antimicrobial resistance of bacterial infections in Mozambique: a systematic review and meta-analysis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nafital Joao FRANCISCO",Mozambique
5876,PS084,5864,"Awareness, misconceptions and uptake of HPV vaccination among university students in Georgia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nita VERULAVA",Georgia
5877,PS084,5864,"Development of a WHO list of essential diagnostic tests for bacterial and fungal infections and antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raghu SRIRAM",Switzerland
5878,PS084,5864,"Understanding acute encephalitis syndrome in adults: an etiological perspective from Eastern Uttar Pradesh",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jaya TAPADAR NÉE CHAKRAVARTY",India
5879,PS084,5864,"Correlates of acceptability of COVID-19 vaccine among health care workers(HCWs) at Ndola teaching hospital (NTH), Ndola, Zambia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hope KALASA",Zambia
5880,PS084,5864,"Evaluating the burden of Streptococcus pneumoniae and the pneumococcal vaccine implementation in Mexico",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcelo DIAZ-CONDE",Mexico
5881,PS084,5864,"Clinical care for adults with chronic Chagas disease in Bolivia: a scoping review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miriam MÜLLER",Germany
5882,PS084,5864,"Antibiotic misuse via OTC medications in south India: results from the BEWARE study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Harshitha SURESHKUMAR",India
5883,PS084,5864,"Development, implementation, and evaluation of a cross-generational strategy to support introduction of the human papillomavirus vaccine and utilisation of cervical cancer screening in Nepal",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Linda KALJEE","United States"
5884,PS084,5864,"The malaria care cascade and factors associated with receiving a malaria test in children under five and pregnant women with fever : a cross-sectional household survey from Guinea and Sierra Leone",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gerrit BURGER",Germany
5885,PS084,5864,"Improving global access to microbiology diagnostics by means of a comprehensive online open repository",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Liselotte HARDY",Belgium
5886,PS084,5864,"Bottom-up approach for an infection burden estimate approach: a Brazilian experience on ICD-10 standardisation process for the use on local secondary database studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos KIFFER",Brazil
5887,PS084,5864,"A distributional regression approach to socioeconomic inequalities in infectious diseases in the UK",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murong YANG","United Kingdom"
5888,PS084,5864,"Results of a randomised feasibility study of an intestinal adsorbent in acute diarrhoea in children in the Gambia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul RAHDEN",Gambia
5889,PS084,5864,"Multicentre insights into outpatient parenteral antimicrobial therapy (OPAT): a comprehensive analysis of Türkiye's unstructured system",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elif AGULOGLU-BALI",Türkiye
5890,PS084,5864,"Infectious disease control: vaccine access and healthcare disparities in Pakistan",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fahmeeda IDREES",Finland
5891,PS084,5864,"Burden of sexually transmitted diseases (STDs) and impact of the comprehensive health promotion package on screening and prevention among commercial sex workers in northeast India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shanthosh Priyan SUNDARAM",India
5892,S2,NULL,"Poster Sessions Categories 1, 6, 7, 9 & 10","Poster area |","11:59 - 13:30CETPoster Session",,CET,"Poster Session",,NULL,NULL,NULL,NULL
5893,S3,NULL,"Poster Sessions Categories 2, 5 & 11","Poster area |","11:59 - 13:30CETPoster Session",,CET,"Poster Session",,NULL,NULL,NULL,NULL
5894,S4,NULL,"Poster Sessions Categories 3 & 4","Poster area |","11:59 - 13:30CETPoster Session",,CET,"Poster Session",,NULL,NULL,NULL,NULL
5895,S6,NULL,"Improving infectious disease prevention: vaccination strategies focusing on AI technology, public health, and communications","Hall 7 |","08:30 - 16:00CETIntegrated Workshop",,CET,"Integrated Workshop","32. Industry session","Giovanni CHECCUCCI LISI",Italy,NULL,NULL
5896,S6,5895,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanni CHECCUCCI LISI",ItalyChair
5897,S6,5895,"Welcome and Introduction",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanni CHECCUCCI LISI",Italy
5898,S6,5895,"Integration of AI into preventative vaccine strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5899,S6,5895,"Integration of AI a public health perspective: vaccination impact on infectious respiratory diseases preventative vaccine strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5900,S6,5895,Break,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5901,S6,5895,"Behavioural science: supporting vaccination conversations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5902,S6,5895,"Panel Discussion and Q&A",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5903,S6,5895,"Lunch Break",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5904,S6,5895,"Workshop 1: Using behavioural science to support vaccine conversations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5905,S6,5895,Break,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5906,S6,5895,"Wokrshop 2: Navigating the complexity of vaccine schedules and the potential role of generative AI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5907,S6,5895,Break,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5908,S6,5895,"Workshop 3: Real-world application of AI and behavioural science for a vaccine implementation strategy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
5909,S6,5895,"Closing Remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giovanni CHECCUCCI LISI",Italy
5910,SCI1,NULL,"UNGA political declaration on AMR: moving from commitments to action - Science to inform policy: Implementing UNGA targets on AMR","Hall 4 |","15:00 - 16:45CETScience-Policy Forum",,CET,"Science-Policy Forum",,"Onyebuchi CHUKWU",Nigeria,NULL,NULL
5911,SCI1,5910,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Onyebuchi CHUKWU",NigeriaChair
5912,SCI1,5910,"Welcome and opening remarks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5913,SCI1,5910,"The overall impact of currently known AMR interventions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph LEWNARD","United States"
5914,SCI1,5910,"Reducing AMR-related mortality: monitoring and achieving the 10% reduction by 2030",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yvan HUTIN",Switzerland
5915,SCI1,5910,"Monitoring and achieving meaningful reductions in antimicrobial use in the animal health sector",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chantal MOREL",Switzerland
5916,SCI1,5910,"Global antibiotic policy: achieving the global 70 per cent access target",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mike SHARLAND","United Kingdom"
5917,SCI1,5910,"Accelerating One Health action in agrifood systems to meet UNGA commitments on AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Junxia SONG",Italy
5918,SCI1,5910,"Setting and implementation targets at the country level",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tochi OKWOR",Nigeria
5919,SCI1,5910,"Q&A/Panel discussion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5920,SCI2,NULL,"UNGA political declaration on AMR: moving from commitments to action - Policy to drive action: establishing the independent panel on evidence for action on AMR and updating the Global Action Plan","Hall 4 |","17:00 - 18:30CETScience-Policy Forum",,CET,"Science-Policy Forum",,"Lothar WIELER",Germany,NULL,NULL
5921,SCI2,5920,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lothar WIELER",GermanyChair
5922,SCI2,5920,"Progress update by the Quadripartite Joint Secretariat on setting up the panel and updating the GAP",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Pierre NYEMAZI",Switzerland
5923,SCI2,5920,"Lessons from the Intergovernmental Panel on Climate Change",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Abdalah MOKSSIT",Switzerland
5924,SCI2,5920,"Q&A/Panel discussion",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sabiha ESSACK","South Africa"
5925,SCI2,5920,"Closing remarks and next steps",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL
5926,SEL,NULL,"Selective Pressure","Hall 1 |","13:30 - 15:30CETSpecial Session",,CET,"Special Session","12. Professional and educational affairs","Jacob MORAN-GILAD",Israel,NULL,NULL
5927,SEL,5926,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob MORAN-GILAD",IsraelChair
5928,SP1,NULL,"Antimicrobial Stewardship in Different Scenarios","Hall 0 |","08:30 - 10:30CETSpecial Session",,CET,"Special Session","05. New antibacterial agents, PK/PD & Stewardship","Murat AKOVA",Türkiye,NULL,NULL
5929,SP1,5928,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat AKOVA",TürkiyeChair
5930,SP2,NULL,"Principles of systematic reviews (with and without meta-analysis)","Hall 0 |","11:00 - 12:00CETSpecial Session",,CET,"Special Session","12. Professional and educational affairs","Chiara IARIA",Italy,NULL,NULL
5931,SP2,5930,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Chiara IARIA",ItalyChair
5932,SP3,NULL,"Top five mistakes in Infection prevention and control","Hall 0 |","13:30 - 14:30CETSpecial Session",,CET,"Special Session","08. Healthcare-associated infections, infection prevention & control","Maeve DOYLE",Ireland,NULL,NULL
5933,SP3,5932,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maeve DOYLE",IrelandChair
5934,SP4,NULL,"Science Slam - How to Communicate Science with Clarity","Hall 0 |","14:45 - 15:45CETSpecial Session",,CET,"Special Session","12. Professional and educational affairs","Mary HORGAN",Ireland,NULL,NULL
5935,SP4,5934,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary HORGAN",IrelandChair
5936,SP5,NULL,"Multidisciplinary approach to early sepsis management","Hall 0 |","16:15 - 18:15CETSpecial Session",,CET,"Special Session","02. Bacterial infection & disease","Markus BALD",Germany,NULL,NULL
5937,SP5,5936,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus BALD",GermanyChair
5938,SY031,NULL,"To screen or not to screen prior to transplant?","Hall 6 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","10. Immune compromise & transplant ID","Laura Alicia BARCAN",Argentina,NULL,NULL
5939,SY031,5938,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laura Alicia BARCAN",ArgentinaChair
5940,SY031,5938,"HHV-8 Screening",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra MULARONI",Italy
5941,SY031,5938,"TB screening and prevention in endemic regions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rubina NAQVI",Pakistan
5942,SY031,5938,"Screening for and prevention of chagas in immunocompromised hosts",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcelo Victor RADISIC",Argentina
5943,SY031,5938,"Screening of lung donors for Molicutes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael G ISON","United States"
5944,SY032,NULL,"New insights into Candida pathogenesis","Hall 7 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","06. Fungal infection & disease","Aleksandra BARAC",Serbia,NULL,NULL
5945,SY032,5944,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aleksandra BARAC",SerbiaChair
5946,SY032,5944,"Insights into the evolution of Candida under antifungal pressure",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Attila GACSER",Hungary
5947,SY032,5944,"How do Candida extracellular vesicles modify virulence during disease?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leonardo NIMRICHTER",Brazil
5948,SY032,5944,"The commensal to pathogen transition: kind to killer",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ilse D. JACOBSEN",Germany
5949,SY032,5944,"Fungal-bacterial interactions: who wins?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rebecca HALL","United Kingdom"
5950,SY033,NULL,"Single-cell approaches to dissect cellular phenotypic heterogeneity of bacterial pathogen populations.","Hall 8 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","09. Fundamental microbiology, pathogenesis & immunity to infection","Christian Stephan LENTZ",Norway,NULL,NULL
5951,SY033,5950,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian Stephan LENTZ",NorwayChair
5952,SY033,5950,"Adaptive evolution and phenotypic heterogeneity of bacterial pathogens during infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christoph ERNST",Germany
5953,SY033,5950,"Single-cell imaging and heterogeneity in antimicrobial resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano PAGLIARA","United Kingdom"
5954,SY033,5950,"Single-cell RNAseq and heterogeneity in bacterial transcription",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna KUCHINA","United States"
5955,SY033,5950,"Dissecting the function of individual bacteria in their spatial context",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Knut DRESCHER",Switzerland
5956,SY034,NULL,"Endoscopy: infection risks and mitigation","Hall 10 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Elisabeth PRESTERL",Austria,NULL,NULL
5957,SY034,5956,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisabeth PRESTERL",AustriaChair
5958,SY034,5956,"Should we be concerned about infection from contaminated endoscopes?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Claire AUMERAN",France
5959,SY034,5956,"Prevention of multidrug-resistant infections from contaminated duodenoscopes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Margreet C. VOS",Netherlands
5960,SY034,5956,"Understanding the causes of medical device contamination: it is all biofilm!",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roberto RUSCONI",Italy
5961,SY034,5956,"Does the European medical Device Regulation bring us safer duodenoscopes?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Markus HELL",Austria
5962,SY035,NULL,"Barriers to TB/HIV elimination in low- and high-incidence settings","Hall 12 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","02. Bacterial infection & disease","Daria PODLEKAREVA",Denmark,NULL,NULL
5963,SY035,5962,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daria PODLEKAREVA",DenmarkChair
5964,SY035,5962,"HIV and TB epidemic: the storm hasn't subsided yet",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tetiana KOVAL",Ukraine
5965,SY035,5962,"Approaches for latent and active TB screening in people living with HIV",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Raimonda MATULIONYTE",Lithuania
5966,SY035,5962,"Integration of HIV and TB care to improve patient outcome in resource-limited settings",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Akaki ABUTIDZE",Georgia
5967,SY035,5962,"How researchers can influence policy and practice in HIV/TB care",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jens D. LUNDGREN",Denmark
5968,SY036,NULL,"The quality of antibiotics used in the communities of LMICs","Hall 15 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","11. Public health & vaccines","Thi Thuy Nga DO",Vietnam,NULL,NULL
5969,SY036,5968,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thi Thuy Nga DO",VietnamChair
5970,SY036,5968,"The quality of antibiotics and their potential impact on patient outcome and AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul NEWTON","United Kingdom"
5971,SY036,5968,"Community antibiotic access and use in Sub-Sahara Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Samuel AFARI-ASIEDU",Ghana
5972,SY036,5968,"Encountered challenges and reflections on conducting multi-country medicine quality studies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Noudy SENGXEU","Lao People's Democratic Republic"
5973,SY036,5968,"Confusion in appearance of common used antibiotics in LMICs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Heiman WERTHEIM",Netherlands
5974,SY037,NULL,"Unveiling the challenges: nosocomial infections in ECMO-supported patients","Hall 16 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Antonios KATSOUNAS",Germany,NULL,NULL
5975,SY037,5974,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonios KATSOUNAS",GermanyChair
5976,SY037,5974,"Source of infection and pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian ECKMANN",Germany
5977,SY037,5974,"Prophylaxis and empiric treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Giacomo GRASSELLI",Italy
5978,SY037,5974,"Diagnostic criteria and definitions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Graeme MACLAREN",Singapore
5979,SY037,5974,"Microbial films",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marta HERNÁNDEZ-MENESES",Spain
5980,SY043,NULL,"Year in infection control","Hall 1 |","09:30 - 10:30CETCME1-hour Symposium",,CET,"1-hour Symposium","12. Professional and educational affairs","Nico Tom MUTTERS",Germany,NULL,NULL
5981,SY043,5980,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nico Tom MUTTERS",GermanyChair
5982,SY043,5980,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew James STEWARDSON",Australia
5983,SY043,5980,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kalisvar MARIMUTHU",Singapore
5984,SY045,NULL,"What happens following TB infection?","Hall 2 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","02. Bacterial infection & disease","Catherine ONG",Singapore,NULL,NULL
5985,SY045,5984,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Catherine ONG",SingaporeChair
5986,SY045,5984,"Post-TB disease: burden and treatment strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Deborah CHONG","United Kingdom"
5987,SY045,5984,"TB sequelae and fungal infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helmut SALZER",Austria
5988,SY046,NULL,"New frontiers in bacterial pathogenesis","Hall 5 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","09. Fundamental microbiology, pathogenesis & immunity to infection","Silvio Daniel BRUGGER",Switzerland,NULL,NULL
5989,SY046,5988,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvio Daniel BRUGGER",SwitzerlandChair
5990,SY046,5988,"Bacterial infections and cellular immunity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte ODENDALL","United Kingdom"
5991,SY046,5988,"Immuno-metabolism in bacterial diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tania WONG","United States"
5992,SY047,NULL,"How long should contact isolation precautions be continued?","Hall 11 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Cansu CIMEN",Germany,NULL,NULL
5993,SY047,5992,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cansu CIMEN",GermanyChair
5994,SY047,5992,"Contact isolation in patients with MDR organisms: Why, when, where?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gabriel BIRGAND",France
5995,SY047,5992,"Is discontinuation of contact precautions associated with an increase in infections?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel DIEKEMA","United States"
5996,SY051,NULL,"Year in infectious diseases","Hall 1 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","12. Professional and educational affairs","Nur BENZONANA",Türkiye,NULL,NULL
5997,SY051,5996,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nur BENZONANA",TürkiyeChair
5998,SY051,5996,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yoav KEYNAN",Canada
5999,SY051,5996,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa CORDERO MATIA",Spain
6000,SY052,NULL,"Exploring children's role in infection spread","Hall 2 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","11. Public health & vaccines","Angelika BERGER",,NULL,NULL
6001,SY052,6000,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Angelika BERGER",
6002,SY052,6000,"Are children really super-spreaders of respiratory viruses?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emmanuel ANDRÉ",Belgium
6003,SY052,6000,"Should schools be closed at the start of the next pandemic?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vittoria COLIZZA",France
6004,SY053,NULL,"Developing guidelines with AI tools: are they ready for prime time?","Hall 16 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","12. Professional and educational affairs","Miranda LANGENDAM",Netherlands,NULL,NULL
6005,SY053,6004,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Miranda LANGENDAM",NetherlandsChair
6006,SY053,6004,"The PROs and CONs of using AI tools for developing guidelines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Holger SCHUENEMANN",Italy
6007,SY053,6004,"AI in action: validated tools for speeding up your systematic reviews and how to use them",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara FERNANDEZ",Norway
6008,SY057,NULL,"Macrolides in community-acquired pneumonia: therapeutic necessity or path to overuse?","Hall 2 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","05. New antibacterial agents, PK/PD & Stewardship","Marc J.M. BONTEN",Netherlands,NULL,NULL
6009,SY057,6008,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marc J.M. BONTEN",NetherlandsChair
6010,SY057,6008,"Pro: maximising outcomes with evidence-based use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Evangelos GIAMARELLOS-BOURBOULIS",Greece
6011,SY057,6008,"Con: the risks of routine (over)use",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Aurélien DINH",France
6012,SY058,NULL,"Top papers in transplant ID","Hall 4 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","10. Immune compromise & transplant ID","Nicolas MUELLER",Switzerland,NULL,NULL
6013,SY058,6012,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas MUELLER",SwitzerlandChair
6014,SY058,6012,"Top 10 papers in infections in SOT",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia MUNOZ",Spain
6015,SY058,6012,"Top 10 paper in infections in HCT and cellular therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joshua HILL","United States"
6016,SY059,NULL,"Value-based syndromic diagnostics in medical microbiology: Pro / Con debate","Hall 13 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","04. Diagnostic microbiology","Hege Vangstein AAMOT",Norway,NULL,NULL
6017,SY059,6016,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hege Vangstein AAMOT",NorwayChair
6018,SY059,6016,"Pro: clinical benefit and potential for improved patient outcomes",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kirstine K. SØGAARD",Denmark
6019,SY059,6016,"Con: limitations, costs, and possible overuse of syndromic panels",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gilbert GREUB",Switzerland
6020,SY060,NULL,"We need to talk about toilets.","Hall 14 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Stephanie J. DANCER","United Kingdom",NULL,NULL
6021,SY060,6020,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephanie J. DANCER","United KingdomChair"
6022,SY060,6020,"Infection risks from sanitation engineering",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Davey JONES","United Kingdom"
6023,SY060,6020,"Ventilation in toilets: how can we improve it?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michael GORMLEY","United Kingdom"
6024,SY064,NULL,"PK/PD to avoid emergence of resistance?","Hall 2 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","05. New antibacterial agents, PK/PD & Stewardship","Joseph MELETIADIS",Greece,NULL,NULL
6025,SY064,6024,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph MELETIADIS",GreeceChair
6026,SY064,6024,"PK/PD and antibacterial therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dolors SOY-MUNER",Spain
6027,SY064,6024,"PK/PD and antifungal therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Roger BRÜGGEMANN",Netherlands
6028,SY064,6024,"PK/PD and antiviral therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joe STANDING","United Kingdom"
6029,SY064,6024,"PK/PD considerations in anthelminthic treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jennifer KEISER",Switzerland
6030,SY065,NULL,"Gram-positives, are they still going?","Hall 4 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","03. Bacterial susceptibility & resistance","Diederik BATHOORN",Netherlands,NULL,NULL
6031,SY065,6030,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diederik BATHOORN",NetherlandsChair
6032,SY065,6030,"The vanco chronicles: enterococci's global journey",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Guido WERNER",Germany
6033,SY065,6030,"Pitfall in susceptibility testing of Gram-positives",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helena ZEMLICKOVA","Czech Republic"
6034,SY065,6030,"Drivers for daptomycin and linezolid resistance in Gram-positives",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Glen CARTER",Australia
6035,SY065,6030,"What is new in treatment against MDR Gram-positives?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alex SORIANO",Spain
6036,SY066,NULL,"Biomarker testing to manage respiratory infections in primary care in low resource settings","Hall 5 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","04. Diagnostic microbiology","Sonia LEWYCKA",Vietnam,NULL,NULL
6037,SY066,6036,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sonia LEWYCKA",VietnamChair
6038,SY066,6036,"The Vietnamese experience with CRP testing in the community setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thi Thuy Nga DO",Vietnam
6039,SY066,6036,"The Nigerian experience with CRP testing in the community setting",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Augustine ONWUNDUBA",Nigeria
6040,SY066,6036,"CRP testing in diagnosing tuberculosis in Zambia and South Africa",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helen AYLES",Zambia
6041,SY066,6036,"The health economics of CRP testing in LMICs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yoel LUBELL",Thailand
6042,SY067,NULL,"STIs: an ongoing crisis","Hall 11 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","02. Bacterial infection & disease","Dagmar HEUER",Germany,NULL,NULL
6043,SY067,6042,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Dagmar HEUER",GermanyChair
6044,SY067,6042,"STI treatment options are running out due to AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Magnus UNEMO",Sweden
6045,SY067,6042,"Genomic surveillance of Neisseria gonorrhoeae strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Petra WOLFFS",Netherlands
6046,SY067,6042,"Evolutionary insights into syphilis and Treponema pallidum",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mathew BEALE","United Kingdom"
6047,SY067,6042,"Challenges in chlamydial STI infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cecile BEBEAR",France
6048,SY068,NULL,"Tick-borne encephalitis: contemporary diagnosis and management","Hall 12 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","01. Viral infection & disease (incl COVID-19)","Joanna Maria ZAJKOWSKA",Poland,NULL,NULL
6049,SY068,6048,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanna Maria ZAJKOWSKA",PolandChair
6050,SY068,6048,"Tick-borne encephalitis: immune response and clinical experience",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sara GREDMARK RUSS",Sweden
6051,SY068,6048,"TBE immune responses and vaccine effectiveness",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Karin STIASNY",Austria
6052,SY068,6048,"NS1 antibodies: diagnostics and screening of seroprevalence of TBE virus infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gerhard DOBLER",Germany
6053,SY068,6048,"Treatment for TBE: where do we stand?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel RUZEK","Czech Republic"
6054,SY069,NULL,"Controlled human infection models","Hall 16 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","11. Public health & vaccines","Frederick HAYDEN","United States",NULL,NULL
6055,SY069,6054,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frederick HAYDEN","United StatesChair"
6056,SY069,6054,"Updates on the dengue human infection model",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kirsten LYKE","United States"
6057,SY069,6054,"CHIM in endemic countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Melissa KAPULU",Kenya
6058,SY069,6054,"Controlled human infection models of parasitic infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Meta ROESTENBERG",Netherlands
6059,SY069,6054,"Controlled human infection models of non-typhoidal Salmonella",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Malick GIBANI","United Kingdom"
6060,SY072,NULL,"Tackling the emergence of dengue and other Aedes-borne diseases in Europe","Hall 3 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","01. Viral infection & disease (incl COVID-19)","Fernanda BOULOS",Brazil,NULL,NULL
6061,SY072,6060,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fernanda BOULOS",BrazilChair
6062,SY072,6060,"How dengue, chikungunya and zika virus disease became emerging threats to Europe",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Celine GOSSNER",Sweden
6063,SY072,6060,"Surveillance of dengue in urbanised tropical regions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vincent Junxiong PANG",Singapore
6064,SY072,6060,"Mosquito surveillance and control: opportunities and challenges",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"David ROIZ",France
6065,SY072,6060,"Tracking autochthonous arboviral infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luisa BARZON",Italy
6066,SY073,NULL,"Proxy indicators: bridging the gap between surveillance and antimicrobial stewardship","Hall 12 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","05. New antibacterial agents, PK/PD & Stewardship","Bhanu SINHA",Netherlands,NULL,NULL
6067,SY073,6066,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bhanu SINHA",NetherlandsChair
6068,SY073,6066,"A broad spectrum of possibilities: spectrum scores as a unifying metric",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Céline PULCINI",France
6069,SY073,6066,"Proxy indicators to estimate appropriateness of antibiotic prescriptions",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diane ASHIRU-OREDOPE","United Kingdom"
6070,SY073,6066,"How to bridge the gap between surveillance and antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mark G. J. DE BOER",Netherlands
6071,SY073,6066,"Health economics, surveillance and antimicrobial stewardship",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Zhu NINA JIAYUE","United Kingdom"
6072,SY074,NULL,"Difficile to treat: advanced management strategies in difficult to treat CDI","Hall 13 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Frédéric BARBUT",France,NULL,NULL
6073,SY074,6072,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Frédéric BARBUT",FranceChair
6074,SY074,6072,"Severe CDI: when standard protocols fail",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hynek BARTOS","Czech Republic"
6075,SY074,6072,"Therapies for complicated CDI",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Emma BISHOP",Australia
6076,SY074,6072,"Recurrent CDI: Breaking the cycle",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea MARINO",Italy
6077,SY074,6072,"Live biotherapeutic products for Clostridioides difficile infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon GOLDENBERG","United Kingdom"
6078,SY075,NULL,"Diphtheria: from re-emergence to vaccine strategies","Hall 15 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","11. Public health & vaccines","Helena SETH-SMITH",Switzerland,NULL,NULL
6079,SY075,6078,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Helena SETH-SMITH",SwitzerlandChair
6080,SY075,6078,"Diphtheria: from clinical picture to medical management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Regina OLADOKUN",Nigeria
6081,SY075,6078,"The epidemiology of diphtheria worldwide over the last half-century: more than one comeback",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andreas HOEFER",Sweden
6082,SY075,6078,"There's more than one toxigenic Corynebacterium: the current genomics landscape of diphtheria-associated strains",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvain BRISSE",France
6083,SY075,6078,"Diphtheria vaccination: a reappraisal",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gayatri AMIRTHALINGAM","United Kingdom"
6084,SY076,NULL,"AMR Surveillance in low resource countries: insights into clinical and policy translation","Hall 16 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","03. Bacterial susceptibility & resistance","Kwame Ohene BUABENG",Ghana,NULL,NULL
6085,SY076,6084,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kwame Ohene BUABENG",GhanaChair
6086,SY076,6084,"New indicators in national monitoring and evaluation of AMR supported by improved data utilisation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Direk LIMMATHUROTSAKUL",Thailand
6087,SY076,6084,"Interdisciplinary investigation of the drivers and burden of AMR in urinary tract infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stephen MSHANA","United Republic Of"
6088,SY076,6084,"A clinically-oriented AMR surveillance network: case-based surveillance and implementation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paul TURNER",Cambodia
6089,SY076,6084,"National prescribing guidelines based on AMR surveillance data",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Vilada CHANSAMOUTH","Lao People's Democratic Republic"
6090,SY082,NULL,"How to address anti-science in our community?","Hall 6 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","11. Public health & vaccines","Tuba DAL",Türkiye,NULL,NULL
6091,SY082,6090,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tuba DAL",TürkiyeChair
6092,SY082,6090,"The rise of anti-science: lessons for the future scientist",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marion KOOPMANS",Netherlands
6093,SY082,6090,"Open science for public trust",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lisa HANSEN",Canada
6094,SY083,NULL,"Lyme neuroborreliosis: challenges in diagnosis and treatment","Hall 7 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","02. Bacterial infection & disease","Alexandra MAILLES",France,NULL,NULL
6095,SY083,6094,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alexandra MAILLES",FranceChair
6096,SY083,6094,"Challenges in diagnosis of Lyme neuroborreliosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rick DERSCH",Germany
6097,SY083,6094,"Challenges in treatment of Lyme neuroborreliosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne Marit SOLHEIM",Norway
6098,SY084,NULL,"Sleeping sickness and Chagas: a tale of the two trypanosomes","Hall 10 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","07. Parasitic diseases, travel medicine & migrant health","Hanne BREKKE",Norway,NULL,NULL
6099,SY084,6098,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanne BREKKE",NorwayChair
6100,SY084,6098,"Human African Trypanosomiasis: recent diagnostic and medical practices",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jean-Mathieu BART",Guinea
6101,SY084,6098,"American Trypanosomiasis: Diagnosis, screening and management",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
6102,SY085,NULL,"Diagnosing the undiagnosed fraction: the final step towards viral hepatitis elimination","Hall 13 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","01. Viral infection & disease (incl COVID-19)","Mojca MATICIC",Slovenia,NULL,NULL
6103,SY085,6102,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mojca MATICIC",SloveniaChair
6104,SY085,6102,"Role of reflex testing strategies in identifying patients with chronic viral hepatitis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Oana SANDULESCU",Romania
6105,SY085,6102,"Management and elimination of hepatitis in hard-to-reach persons",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suda TEKIN",Türkiye
6106,SY086,NULL,"Impact on including a measure of viability in molecular diagnostic tests","Hall 14 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","04. Diagnostic microbiology","Fusun CAN",Türkiye,NULL,NULL
6107,SY086,6106,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fusun CAN",TürkiyeChair
6108,SY086,6106,"Viability markers in support of development of Chlamydia screening recommendations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Petra WOLFFS",Netherlands
6109,SY086,6106,"Measuring viability to improve the correlation of AMR markers and clinical outcomes in Neisseria gonorrhoeae",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tatum MORTIMER","United States"
6110,SY087,NULL,"Innovating antimicrobial drug discovery and host-pathogen interaction studies using chemical biology","Hall 16 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","09. Fundamental microbiology, pathogenesis & immunity to infection","Laurent POIREL",Switzerland,NULL,NULL
6111,SY087,6110,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Laurent POIREL",SwitzerlandChair
6112,SY087,6110,"Bacterial PROTACs: Do proteolysis-targeting degraders represent a viable strategy for new antimicrobials?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Morreale FRANCESCA ESTER","United Kingdom"
6113,SY087,6110,"Activity-based protein profiling of bacterial pathogens: new enzymes and their functions at the host-microbe interface",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Christian Stephan LENTZ",Norway
6114,SY091,NULL,"Emerging infectious diseases: staying informed and prepared in a globalised world","Hall 4 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","01. Viral infection & disease (incl COVID-19)","Nitin GUPTA",India,NULL,NULL
6115,SY091,6114,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nitin GUPTA",IndiaChair
6116,SY091,6114,"Lessons learnt from previous outbreaks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL," TBA",
6117,SY091,6114,"Disease X: preparedness for the next pandemic",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yee Sin LEO",Singapore
6118,SY092,NULL,"Sex differences in management and outcome of patients with serious bacterial infections","Hall 5 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","02. Bacterial infection & disease","Michele BARTOLETTI",Italy,NULL,NULL
6119,SY092,6118,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michele BARTOLETTI",ItalyChair
6120,SY092,6118,"Sex impacts incidence, management, and outcome in bacteraemia",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Annette WESTGEEST",Netherlands
6121,SY092,6118,"The complex interplay between gender and sepsis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ines LAKBAR",France
6122,SY093,NULL,"Immunosenescence and immune response to vaccination","Hall 11 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","11. Public health & vaccines","Petar VELIKOV",Bulgaria,NULL,NULL
6123,SY093,6122,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Petar VELIKOV",BulgariaChair
6124,SY093,6122,"How immunosenescence impacts vaccine response",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrea COSSARIZZA",Italy
6125,SY093,6122,"Strategies to tackle immunosenescence and improve immune response to vaccination in the elderly",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Inna OVSYANNIKOVA","United States"
6126,SY094,NULL,"Farm to fork: food-borne antimicrobial resistance","Hall 14 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","03. Bacterial susceptibility & resistance","Beatriz GUERRA ROMÁN",Spain,NULL,NULL
6127,SY094,6126,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beatriz GUERRA ROMÁN",SpainChair
6128,SY094,6126,"Foodborne risk in meat and fishery products and impact on AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anders DALSGAARD",Denmark
6129,SY094,6126,"Control challenges associated with food-borne multidrug resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Luisa Maria Vieira PEIXE",Portugal
6130,SY099,NULL,"How innovations of AMR and HAI surveillance systems help the clinical practice","Hall 4 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Pascal ASTAGNEAU",France,NULL,NULL
6131,SY099,6130,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pascal ASTAGNEAU",FranceChair
6132,SY099,6130,"The EUCAST system in surveillance of AMR",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sören G. GATERMANN",Germany
6133,SY099,6130,"Insights into developments in the surveillance of HAIs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Diamantis PLACHOURAS",Sweden
6134,SY100,NULL,"The challenge of a healthy microbiota in neonates","Hall 12 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","04. Diagnostic microbiology","Maria VEHRESCHILD",Germany,NULL,NULL
6135,SY100,6134,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maria VEHRESCHILD",GermanyChair
6136,SY100,6134,"Infant gut microbiome development",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Debby BOGAERT","United Kingdom"
6137,SY100,6134,"Metagenomic signatures and antibiotic disruption of the gut microbiome in neonates",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gautam DANTAS","United States"
6138,SY104,NULL,"Targeted vs. standard perioperative prophylaxis in Solid Organ Transplant with MDR Gram-negative colonisation","Hall 3 |","16:15 - 17:15CETCME1-hour Symposium",,CET,"1-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Elda RIGHI","United Kingdom",NULL,NULL
6139,SY104,6138,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elda RIGHI","United KingdomChair"
6140,SY104,6138,"Standard prophylaxis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maddalena GIANNELLA",Italy
6141,SY104,6138,"Targeted approaches",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maristela P. FREIRE",Brazil
6142,SY105,NULL,"Novel beta-lactams and beta-lactamase inhibitors: a diagnostic and therapeutic approach","Hall 4 |","16:15 - 17:15CETCME1-hour Symposium",,CET,"1-hour Symposium","03. Bacterial susceptibility & resistance","Robert A. BONOMO","United States",NULL,NULL
6143,SY105,6142,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Robert A. BONOMO","United StatesChair"
6144,SY105,6142,"Novel beta-lactams and beta-lactamase inhibitors: challenges for laboratory diagnostics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna SRAMKOVA","Czech Republic"
6145,SY105,6142,"Clinical perspectives of novel beta-lactams and beta-lactamase inhibitors",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Parikshit PRAYAG",India
6146,SY106,NULL,"Strain dynamics in determining gut microbial colonisation resistance","Hall 14 |","16:15 - 17:15CETCME1-hour Symposium",,CET,"1-hour Symposium","09. Fundamental microbiology, pathogenesis & immunity to infection","Silvio Daniel BRUGGER",Switzerland,NULL,NULL
6147,SY106,6146,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Silvio Daniel BRUGGER",SwitzerlandChair
6148,SY106,6146,"Strain dynamics in serious bacterial infections in infants",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Drew SCHWARTZ","United States"
6149,SY106,6146,"Long-term colonisation dynamics of carbapenemase-producing Enterobacterales",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Niranjan NAGARAJAN",Singapore
6150,SY107,NULL,"Communicating (your) ID science for policy and societal impact","Hall 15 |","16:15 - 17:15CETCME1-hour Symposium",,CET,"1-hour Symposium","12. Professional and educational affairs","Leonard LEIBOVICI",Israel,NULL,NULL
6151,SY107,6150,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Leonard LEIBOVICI",IsraelChair
6152,SY107,6150,"Communicating to policy makers and for societal impact",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Balázs BABARCZY",Hungary
6153,SY107,6150,"Influencing behaviour through the media and a multichannel communications strategy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Charlotte HUTCHINSON","United Kingdom"
6154,SY110,NULL,"Immune reconstitution syndrome in infectious diseases: Who. Are. You?","Hall 3 |","17:30 - 18:30CETCME1-hour Symposium",,CET,"1-hour Symposium","01. Viral infection & disease (incl COVID-19)","Elisa BORGHI",Italy,NULL,NULL
6155,SY110,6154,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa BORGHI",ItalyChair
6156,SY110,6154,"IRIS in HIV immunocompromised hosts: a failure of success",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Paola Maria CINQUE",Italy
6157,SY110,6154,"Dysregulated host responses to infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Michal HOLUB","Czech Republic"
6158,SY111,NULL,"PK/PD in drug development: what's in it for me?","Hall 11 |","17:30 - 18:30CETCME1-hour Symposium",,CET,"1-hour Symposium","05. New antibacterial agents, PK/PD & Stewardship","Sandrine MARCHAND",France,NULL,NULL
6159,SY111,6158,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sandrine MARCHAND",FranceChair
6160,SY111,6158,"PK/PD from the EUCAST/regulatory perspective: what tools do we need?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph MELETIADIS",Greece
6161,SY111,6158,"PK/PD for new anti-TB drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elin SVENSSON",Sweden
6162,SY112,NULL,"Year in public health","Hall 1 |","17:30 - 18:30CETCME1-hour Symposium",,CET,"1-hour Symposium","12. Professional and educational affairs","Ziad A. MEMISH","Saudi Arabia",NULL,NULL
6163,SY112,6162,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ziad A. MEMISH","Saudi ArabiaChair"
6164,SY112,6162,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Li Yang HSU",Singapore
6165,SY112,6162,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rita OLADELE",Nigeria
6166,SY113,NULL,"Haemorrhagic viral infections","Hall 3 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","01. Viral infection & disease (incl COVID-19)","Önder ERGÖNÜL",Türkiye,NULL,NULL
6167,SY113,6166,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Önder ERGÖNÜL",TürkiyeChair
6168,SY113,6166,"Filovirus disease: evolving therapeutic strategies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ian CROZIER","United States"
6169,SY113,6166,"Jack in the box: Re-emergence of Kyasanur Forest Disease in India",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kavitha SARAVU",India
6170,SY113,6166,"Crimean Congo Haemorrhagic Fever: Newer insights into pathogenesis leading to new vaccines and therapeutics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ali MIRAZIMI",Sweden
6171,SY113,6166,"Venezuelan Equine Encephalitis: Impact of newer strategies for vector control",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carlos SEAS",Peru
6172,SY114,NULL,"Sepsis Global 2025","Hall 13 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","02. Bacterial infection & disease","Brigitte LAMY",France,NULL,NULL
6173,SY114,6172,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Brigitte LAMY",FranceChair
6174,SY114,6172,"The ESCMID-ISF Sepsis Award Lecture",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Andrew MOORE","United States"
6175,SY114,6172,"The WHO Global Maternal Sepsis Study",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Carolina CARVALHO RIBEIRO DO VALLE",Brazil
6176,SY114,6172,"Sepsis: year in review",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sylvain MEYLAN",Switzerland
6177,SY114,6172,"How to design and implement a Sepsis National Action Plan (SNAP)",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Erika VLIEGHE",Belgium
6178,SY115,NULL,"Challenges in infection management, prevention and antimicrobial stewardship in long-term care facilities","Hall 14 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Gaetan GAVAZZI",France,NULL,NULL
6179,SY115,6178,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gaetan GAVAZZI",FranceChair
6180,SY115,6178,"The burden of nosocomial infections in long-term facilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Virginie PRENDKI",Switzerland
6181,SY115,6178,"Pneumonia in the elderly: management and prevention",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcos RESTREPO","United States"
6182,SY115,6178,"Challenges in the clinical diagnosis of infection in the elderly",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Maheen ABIDI","United States"
6183,SY115,6178,"Challenges in implementing antimicrobial stewardship in long-term care facilities",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elena CARRARA",Italy
6184,SY116,NULL,"Climate Change: changing risks and adaptation strategies for a world on the move","Hall 15 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","11. Public health & vaccines","Rachel LOWE",Spain,NULL,NULL
6185,SY116,6184,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Rachel LOWE",SpainChair
6186,SY116,6184,"Vector-borne diseases in Europe and clinical consequences",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Tuba DAL",Türkiye
6187,SY116,6184,"Rising temperatures and risks of fungal disease",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anuradha CHOWDHARY",India
6188,SY116,6184,"Strategies for climate prevention and adaptation in a moving world",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kristie EBI","United States"
6189,SY116,6184,"AMR in climate change-affected countries",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Esmita CHARANI","South Africa"
6190,SY117,NULL,"Survival of the parasites: is treatment failure due to antimicrobial resistance?","Hall 16 |","08:30 - 10:30CETCME2-hour Symposium",,CET,"2-hour Symposium","07. Parasitic diseases, travel medicine & migrant health","Hanne BREKKE",Norway,NULL,NULL
6191,SY117,6190,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Hanne BREKKE",NorwayChair
6192,SY117,6190,"Nitroimidazole refractory Giardia intestinalis infection",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pavla TUMOVÁ","Czech Republic"
6193,SY117,6190,"Treatment failure in scabies",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francisco BRAVO",Peru
6194,SY117,6190,"Recurrent Enterobius infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sarah EISEN","United Kingdom"
6195,SY117,6190,"Recent advances in the treatment of Visceral Leishmaniasis and PKDL",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Shyam SUNDAR",India
6196,SY120,NULL,"Year in clinical microbiology","Hall 1 |","09:30 - 10:30CETCME1-hour Symposium",,CET,"1-hour Symposium","12. Professional and educational affairs","Fidelma FITZPATRICK",Ireland,NULL,NULL
6197,SY120,6196,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fidelma FITZPATRICK",IrelandChair
6198,SY120,6196,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mario RAMIREZ",Portugal
6199,SY120,6196,,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anna PAPA-KONIDARI",Greece
6200,SY122,NULL,"Chronic infections in the era of CFTR modulators: what is going on in cystic fibrosis lungs these days?","Hall 3 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","04. Diagnostic microbiology","Pavel DREVINEK","Czech Republic",NULL,NULL
6201,SY122,6200,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pavel DREVINEK","Czech RepublicChair"
6202,SY122,6200,"The lung microbiome of people with cystic fibrosis receiving modulator therapy",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Sebastien BOUTIN",Germany
6203,SY122,6200,"Tackling chronic infections in people with cystic fibrosis receiving modulator therapy: is it still necessary?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Alessandra BRAGONZI",Italy
6204,SY123,NULL,"Infection prevention and control and intensive care: challenges and solutions","Hall 4 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","08. Healthcare-associated infections, infection prevention & control","Antonios KATSOUNAS",Germany,NULL,NULL
6205,SY123,6204,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Antonios KATSOUNAS",GermanyChair
6206,SY123,6204,"Intensive care unit (ICU) and infection: two sides of a coin",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Reto SCHUEPBACH",Switzerland
6207,SY123,6204,"Ventilator- associated pneumonia (VAP) and ICU enviroment: how can we improve practices?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Despoina KOULENTI","United Kingdom"
6208,SY124,NULL,"Antimicrobial prescribing: myths or pearls?","Hall 6 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","05. New antibacterial agents, PK/PD & Stewardship","Massimo FANTONI",Italy,NULL,NULL
6209,SY124,6208,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Massimo FANTONI",ItalyChair
6210,SY124,6208,"Why treat IV when PO is possible?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Bradley SPELLBERG","United States"
6211,SY124,6208,"De-escalation of antibiotic therapy to narrow-spectrum IV drugs",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Flaminia OLEARO",Germany
6212,SY125,NULL,"Cutting edge methods in mycology","Hall 7 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","06. Fungal infection & disease","Katrien LAGROU",Belgium,NULL,NULL
6213,SY125,6212,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katrien LAGROU",BelgiumChair
6214,SY125,6212,"Imaging for diagnosing mycoses: focus on 18F-FDG PET/CT",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ana FERNÁNDEZ-CRUZ",Spain
6215,SY125,6212,"Exploring the intersection of fungal metagenomics and medical mycology",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marcus DE MELO TEIXEIRA",Brazil
6216,SY126,NULL,"Why is the concept of complicated UTI so complicated?","Hall 13 |","11:00 - 12:00CETCME1-hour Symposium",,CET,"1-hour Symposium","02. Bacterial infection & disease","Gernot BONKAT",Switzerland,NULL,NULL
6217,SY126,6216,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Gernot BONKAT",SwitzerlandChair
6218,SY126,6216,"The concept of complicated UTI: underlying conditions matter",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Suzanne GEERLINGS",Netherlands
6219,SY126,6216,"The concept of complicated UTI: the site of infection matters most",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jesús RODRÍGUEZ-BAÑO",Spain
6220,SY131,NULL,"Vaccines and antimicrobial resistance","Hall 2 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","11. Public health & vaccines","Iva BUTIC",Croatia,NULL,NULL
6221,SY131,6220,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Iva BUTIC",CroatiaChair
6222,SY131,6220,"The impact of current and future vaccines on AMR: from pneumococcal to COVID-19",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mateusz HASSO-AGOPSOWICZ",Switzerland
6223,SY131,6220,"Can vaccines against AMR be translated into policy?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"William HAUSDORFF","United States"
6224,SY132,NULL,"Predicting antibiotic susceptibility profiles from whole genome sequences: state-of-the-art","Hall 13 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","03. Bacterial susceptibility & resistance","Werner RUPPITSCH",Austria,NULL,NULL
6225,SY132,6224,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Werner RUPPITSCH",AustriaChair
6226,SY132,6224,"Impact of the WHO's developed catalogue of mutations on rapid TB diagnosis and treatment",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thomas SCHÖN",Sweden
6227,SY132,6224,"Antimicrobial resistance prediction using whole genome sequencing",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia SIMNER","United States"
6228,SY133,NULL,"Probiotics in infectious diseases: current state-of-play","Hall 15 |","13:30 - 14:30CETCME1-hour Symposium",,CET,"1-hour Symposium","05. New antibacterial agents, PK/PD & Stewardship","Nicolas BENECH",France,NULL,NULL
6229,SY133,6228,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Nicolas BENECH",FranceChair
6230,SY133,6228,"Probiotics in infectious diseases: the perfect complement to antimicrobial therapies?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Lena BIEHL",Germany
6231,SY133,6228,"The horizon of next generation probiotics for infectious diseases",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Cormac GAHAN",Ireland
6232,SY138,NULL,"Global clones and evolving resistance mechanisms towards newer beta-lactams: Where are we heading?","Hall 4 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","03. Bacterial susceptibility & resistance","Yesim BESLI",Türkiye,NULL,NULL
6233,SY138,6232,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Yesim BESLI",TürkiyeChair
6234,SY138,6232,"Carbapenemase-producing Enterobacterales: the not so good, the bad and the ugly.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Arjana TAMBIC ANDRASEVIC",Croatia
6235,SY138,6232,"The P. aeruginosa frightening cocktail: high-risk clones, horizontally-acquired resistance and evolving mutational resistome",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Katy JEANNOT",France
6236,SY139,NULL,"How to manage bacterial meningitis in low resource settings","Hall 16 |","14:45 - 15:45CETCME1-hour Symposium",,CET,"1-hour Symposium","02. Bacterial infection & disease","Joseph DONOVAN",Vietnam,NULL,NULL
6237,SY139,6236,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joseph DONOVAN",VietnamChair
6238,SY139,6236,"Bacterial meningitis diagnosis and surveillance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Divya DEODHAR",Oman
6239,SY139,6236,"Clinical presentation and management of CNS infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Kartika MAHARANI",Indonesia
6240,SY142,NULL,"Precision genomics to improve infectious diseases management","Hall 4 |","16:15 - 18:15CETCME2-hour Symposium",,CET,"2-hour Symposium","04. Diagnostic microbiology","Jacob MORAN-GILAD",Israel,NULL,NULL
6241,SY142,6240,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Jacob MORAN-GILAD",IsraelChair
6242,SY142,6240,"Human genomics approaches to infection immunity",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Fergus HAMILTON","United Kingdom"
6243,SY142,6240,"Applying bacterial GWAS to uncover new mechanisms of antibiotic resistance",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Marco GALARDINI",Germany
6244,SY142,6240,"Evolution in action: large-scale within-host evolution analyses of persistent bacterial infections",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Stefano GIULIERI",Australia
6245,SY142,6240,"Machine learning in bacterial genomics and metagenomics",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Francesco ASNICAR",Italy
6246,SY143,NULL,"ESCMID guidelines for the vaccination of immunocompromised individuals: solid organ transplant recipients","Hall 11 |","16:15 - 17:15CETCME1-hour Symposium",,CET,"1-hour Symposium","10. Immune compromise & transplant ID","Elisa CORDERO MATIA",Spain,NULL,NULL
6247,SY143,6246,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Elisa CORDERO MATIA",SpainChair
6248,SY143,6246,"Vaccination against respiratory pathogens",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Albert VOLLAARD",Netherlands
6249,SY143,6246,"Other vaccines",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Olivier EPAULARD",France
6250,SY144,NULL,"What's the role of infant and maternal immunisation for paediatric RSV prevention?","Hall 14 |","16:15 - 17:15CETCME1-hour Symposium",,CET,"1-hour Symposium","11. Public health & vaccines","Joanne M. LANGLEY",Canada,NULL,NULL
6251,SY144,6250,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Joanne M. LANGLEY",CanadaChair
6252,SY144,6250,"Pros and cons of passive infant immunisation with mAb before their first RSV season",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Federico MARTINÓN-TORRES",Spain
6253,SY144,6250,"Pros and cons of maternal vaccination in preventing severe RSV infections in infants.",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anne VERGISON",Luxembourg
6254,SY147,NULL,"Avian influenza in mammals: jumps under the radar","Hall 11 |","17:30 - 18:30CETCME1-hour Symposium",,CET,"1-hour Symposium","01. Viral infection & disease (incl COVID-19)","Patricia ANTUNES",Portugal,NULL,NULL
6255,SY147,6254,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Patricia ANTUNES",PortugalChair
6256,SY147,6254,"Threat of highly pathogenic avian influenza to non-traditional hosts, including humans",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Thijs KUIKEN",Netherlands
6257,SY147,6254,"Recent changes in the epidemiology of avian influenza in relation to human health risks",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ron FOUCHIER",Netherlands
6258,SY148,NULL,"Echinococcosis: neglected but expanding","Hall 15 |","17:30 - 18:30CETCME1-hour Symposium",,CET,"1-hour Symposium","07. Parasitic diseases, travel medicine & migrant health","Daniel GRUPEL",Israel,NULL,NULL
6259,SY148,6258,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Daniel GRUPEL",IsraelChair
6260,SY148,6258,"Expansion and diversity of cystic echinococcosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Pedro LEGUA",Peru
6261,SY148,6258,"Management of echinococcosis: evidence, eminence and new developments",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Beate GRÜNER",Germany
6262,TAE1,NULL,"TAE Day: morning round","Krieau 1+2  (Courtyard Hotel) |","08:30 - 12:00CETCongress Event",,CET,"Congress Event","12. Professional and educational affairs","Murat AKOVA",Türkiye,NULL,NULL
6263,TAE1,6262,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Murat AKOVA",TürkiyeChair
6264,TAE2,NULL,"TAE Day: afternoon round","Krieau 1+2  (Courtyard Hotel) |","13:30 - 17:00CETCongress Event",,CET,"Congress Event","12. Professional and educational affairs","Mary HORGAN",Ireland,NULL,NULL
6265,TAE2,6264,"Untitled Presentation",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Mary HORGAN",IrelandChair
6266,YIA,NULL,"Young Investigator Award Session","Hall 3 |","11:00 - 12:00CETAwards",,CET,Awards,"12. Professional and educational affairs",NULL,NULL,NULL,NULL
6267,YIA,6266,"Deciphering the pathogenic traits and epidemiological identities of Staphylococcus pseudintermedius: an emerging and underestimated zoonotic pathogen",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Ikechukwu Benjamin MOSES",Nigeria
6268,YIA,6266,"Drugs for Vector-borne Infections: Facts and Fibrillations",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Xin Hui CHAN","United Kingdom"
6269,YIA,6266,"Duke criteria for the diagnosis of infective endocarditis in clinical practice: are we there yet?",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Matthaios PAPADIMITRIOU OLIVGERIS",Switzerland
6270,YIA,6266,"Finding a place for observational studies in infectious diseases research",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Anthony BAI",Canada
6271,YIA,6266,"Clearing fungal fog in viral storms: deciphering influenza- and COVID-19-associated pulmonary aspergillosis",NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,"Simon FEYS",Belgium
